Citrus Sinensis ID: 024091

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270--
Protein Sequence
MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGEANLVERSASSLEQHMASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM
Secondary Structure (PSIPRED)
cHHHHHHHHHHcccccccccccccccccccccHHHHcccccccccccccccHHHHHcccccccccccccccccccccccccccccHHHHHcccccccccccccccccccccccccccccEEEEEEcccccccccEEEEEEEEEEEEcccEEEEEEEEEcccccEEEEEEEccccHHHHHHHHHHHHcccccEEEEEEEEEcccccccEEEEEEEEcccccHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHcccccEEccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccccccccccEEccccccccEEEEEEEccccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEE
Coil and Loop (DISEMBL)
MNVMRRLKSIasgrtsissdpggdsgikrakvdkelevngeaNLVERSASSLEQHmastslepvastseaatvartersgfdqlpkeMNEMrirdeknvnhddkdlepsivngngteAGQVIATtvggrngqpkqTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLlnhpnvvslkhcffstteKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGvchrdikpqnllm
Flexible Loop (DISEMBL)
MNVMRRLKSiasgrtsissdpggdsgikrAKVDKELEVNGEANLVERSASSLEQHMAStslepvastseaatvartersgfdqlpkemnemrirdeknvnhddkdlepsivngngteAGQVIATtvggrngqpKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRllnhpnvvSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRdikpqnllm
Low Complexity Region (SEG)
MNVMRRLKSIASGRTsissdpggdsgiKRAKVDKELEVNGEANLVERSASSLEQHMASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM
Disordered region (IsUnstruct)
************************************************************************************************************************VIATTVG*******QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDI*******
Disordered Region (DISOPRED)
****************************************************************************************************************************TVG*****P**TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM
Disordered Region (DISEMBL)
***********************DSGIKRAKVDKELEVNGEANLVER***************************RTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM
Disordered Region (DISPRO)
************************************************************************************************************SIV***GTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGEANLVERSASSLEQHMASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	272	2.2.26 [Sep-21-2011]
Q96287	472	Shaggy-related protein ki	yes	no	0.992	0.572	0.721	1e-112
O04160	468	Shaggy-related protein ki	N/A	no	0.955	0.555	0.688	1e-104
Q40518	409	Shaggy-related protein ki	N/A	no	0.757	0.503	0.691	4e-87
P43288	405	Shaggy-related protein ki	no	no	0.742	0.498	0.708	6e-87
Q8VZD5	410	Shaggy-related protein ki	no	no	0.761	0.504	0.700	7e-87
P43289	409	Shaggy-related protein ki	no	no	0.757	0.503	0.686	4e-85
P51137	411	Glycogen synthase kinase-	N/A	no	0.764	0.506	0.686	7e-85
P51139	411	Glycogen synthase kinase-	N/A	no	0.683	0.452	0.747	1e-84
P51138	411	Glycogen synthase kinase-	N/A	no	0.742	0.491	0.684	2e-82
O23145	431	Shaggy-related protein ki	no	no	0.863	0.545	0.566	1e-80

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  403 bits (1035), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 197/273 (72%), Positives = 229/273 (83%), Gaps = 3/273 (1%)

Query: 1   MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE-VNGEANLVERSASSLEQHMAST 59
           MNVMRRLKSIASGRTSISSDPGGD  +KRAK+D+E + +  +   V++++S  E      
Sbjct: 1   MNVMRRLKSIASGRTSISSDPGGDYALKRAKLDQENDNLCVDPMQVDQNSSCFEMKADVL 60

Query: 60  SLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAG 119
           S E VA TS    V  +E+   DQLP  M EM+IRDE+N N +DKD+E ++VNG+GTE G
Sbjct: 61  SQESVAGTSNVPAV--SEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118

Query: 120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR 179
           QVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178

Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           ELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLEY+ ETVYR SKHYT+MNQH+PI++
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238

Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           VQLYTYQICRALNYLH VVGVCHRDIKPQNLL+
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLV 271

May mediate extracellular signals to regulate transcription in differentiating cells.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O04160|KSGT_BRANA Shaggy-related protein kinase theta OS=Brassica napus PE=2 SV=2

 Score =  377 bits (969), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 192/279 (68%), Positives = 219/279 (78%), Gaps = 19/279 (6%)

Query: 1   MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGEANLVERSASSLE----QHM 56
           MNVMRRLKSIASGRTSISSDPG DS +KR K+D++ +     NL  R    ++      M
Sbjct: 1   MNVMRRLKSIASGRTSISSDPGVDSSLKRPKLDQDND-----NLSSRGDDPMQVDQSTDM 55

Query: 57  ASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIR-DEKNVN--HDDKDLEPSIVNG 113
              S + VA TS             DQLP+ MN+MR+R DE + N   +DKD+EP IVNG
Sbjct: 56  VVVSQDTVAGTSNVPPPP-------DQLPEVMNDMRLREDEPHANRGEEDKDMEPPIVNG 108

Query: 114 NGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD 173
            GTE GQVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQD
Sbjct: 109 CGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQD 168

Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ 233
           KRYKNRELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLE++ ETVYR  KHYT+MNQ
Sbjct: 169 KRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEFVPETVYRALKHYTKMNQ 228

Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           H+PI+ VQLYTYQICRALNYLH VVGVCHRDIKPQNLL+
Sbjct: 229 HMPIILVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLV 267

May mediate extracellular signals to regulate transcription in differentiating cells.

Brassica napus (taxid: 3708)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  321 bits (822), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 150/217 (69%), Positives = 181/217 (83%), Gaps = 11/217 (5%)

Query: 56  MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
           M S  L PV+   E+++       G D+LP+EMN+MRIRD       DK++E +IV+GNG
Sbjct: 1   MTSVGLAPVSGLRESSS----HSVGVDRLPEEMNDMRIRD-------DKEIEAAIVDGNG 49

Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
           TE G +I TT+GGR+GQPKQTISYMAER+VG GSFGVVFQAKCLETG++VAIKKVLQDKR
Sbjct: 50  TETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR 109

Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
           YKNRELQ MRLL+HPNVV LKHCFFSTTEKDE+YLNLVLEY+ ETV+RV KHY ++NQ +
Sbjct: 110 YKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRM 169

Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           P++ V+LYTYQI RAL+Y+HH +GVCHRDIKPQNLL+
Sbjct: 170 PLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLV 206

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  320 bits (821), Expect = 6e-87,   Method: Compositional matrix adjust.
 Identities = 148/209 (70%), Positives = 178/209 (85%), Gaps = 7/209 (3%)

Query: 64  VASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIA 123
           +AS   A      + +G D+LP+EMN+M+IRD       DK++E ++V+GNGTE G +I 
Sbjct: 1   MASVGIAPNPGARDSTGVDKLPEEMNDMKIRD-------DKEMEATVVDGNGTETGHIIV 53

Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQI 183
           TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+RYKNRELQ 
Sbjct: 54  TTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQT 113

Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
           MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +P++YV+LY
Sbjct: 114 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLY 173

Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           TYQI RAL+Y+H  +GVCHRDIKPQNLL+
Sbjct: 174 TYQIFRALSYIHRCIGVCHRDIKPQNLLV 202

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  320 bits (820), Expect = 7e-87,   Method: Compositional matrix adjust.
 Identities = 152/217 (70%), Positives = 179/217 (82%), Gaps = 10/217 (4%)

Query: 56  MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
           MAS    P +S    AT         ++LP+ +NEM+I+D       DK++E ++V+GNG
Sbjct: 1   MASVGTLPASSM---ATKQSNASICAEKLPEGINEMKIKD-------DKEMEAAVVDGNG 50

Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
           TE G +I TT+GG+NGQPKQTISYMAER+VG GSFG+VFQAKCLETG++VAIKKVLQDKR
Sbjct: 51  TETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKR 110

Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
           YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETVYRVSKHY+R NQ +
Sbjct: 111 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRM 170

Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           PI+YV+LYTYQICRAL Y+H  VGVCHRDIKPQNLL+
Sbjct: 171 PIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLV 207

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  314 bits (804), Expect = 4e-85,   Method: Compositional matrix adjust.
 Identities = 149/217 (68%), Positives = 180/217 (82%), Gaps = 11/217 (5%)

Query: 56  MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
           MAS  +EP A+  E+        +  D+LP+EM +M+I+D       DK++E +IVNGN 
Sbjct: 1   MASVGIEPSAAVRESTG----NVTDADRLPEEMKDMKIQD-------DKEMEATIVNGNV 49

Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
           TE G +I TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+R
Sbjct: 50  TETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRR 109

Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
           YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +
Sbjct: 110 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRM 169

Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           P++YV+LYTYQI R+L+Y+H  +GVCHRDIKPQNLL+
Sbjct: 170 PLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLV 206

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  313 bits (802), Expect = 7e-85,   Method: Compositional matrix adjust.
 Identities = 149/217 (68%), Positives = 180/217 (82%), Gaps = 9/217 (4%)

Query: 56  MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
           MAS  + P +   E   +   E    D LP+EM++M+IRD       D+++E ++V+GNG
Sbjct: 1   MASVGVAPTSGFREV--LGDGEIGVDDILPEEMSDMKIRD-------DREMEATVVDGNG 51

Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
           TE G +I TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQDKR
Sbjct: 52  TETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKR 111

Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
           YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY+++NQ +
Sbjct: 112 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRM 171

Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           P++YV+LYTYQI RAL+Y+H  +GVCHRDIKPQNLL+
Sbjct: 172 PMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLV 208

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  313 bits (801), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 145/194 (74%), Positives = 172/194 (88%), Gaps = 8/194 (4%)

Query: 80  GFDQLPKEMNEMRIRDEKNVNHDDKDLEP-SIVNGNGTEAGQVIATTVGGRNGQPKQTIS 138
           G ++LP+EMN+M+IRD       DK++E  +IV+GNGTE G +I TT+GG+NGQPKQTIS
Sbjct: 21  GVEKLPEEMNDMKIRD-------DKEMEAATIVDGNGTETGHIIVTTIGGKNGQPKQTIS 73

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHC 198
           YMAERVVG GSFGVVFQAKCLETG++VAIKKVLQDKRYKNRELQ MRLL+HPNVVSLKHC
Sbjct: 74  YMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 133

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
           FFSTTEKDELYLNLVLEY+ ETV RV +HY +MNQ +P++YV+LY+YQICRAL Y+H+ +
Sbjct: 134 FFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSYQICRALAYIHNSI 193

Query: 259 GVCHRDIKPQNLLM 272
           GVCHRDIKPQNLL+
Sbjct: 194 GVCHRDIKPQNLLV 207

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  305 bits (782), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 143/209 (68%), Positives = 172/209 (82%), Gaps = 7/209 (3%)

Query: 64  VASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIA 123
           VA  S    V  +     D+LP E+  MRI+D       DK++E  +V+GN TEAG VI 
Sbjct: 6   VAPASGIVDVNASSAIAVDKLPDEILGMRIKD-------DKEMEAHVVDGNSTEAGHVIV 58

Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQI 183
           TT+GG+NGQPKQTISYMAER VG GSFGVVFQAKCLETG++VAIKKVLQDKRYKNRELQ 
Sbjct: 59  TTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT 118

Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
           MRLL+HPNVV+LKHCFFSTTEKDELYLNLVLE++ ETV+RV +HY++MNQ +P++YV+LY
Sbjct: 119 MRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIYVKLY 178

Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +YQICR+L Y+H+ VGV HRDIKPQNLL+
Sbjct: 179 SYQICRSLAYIHNCVGVSHRDIKPQNLLV 207

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O23145|KSG2_ARATH Shaggy-related protein kinase beta OS=Arabidopsis thaliana GN=ASK2 PE=2 SV=1

 Score =  300 bits (767), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 154/272 (56%), Positives = 189/272 (69%), Gaps = 37/272 (13%)

Query: 1   MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGEANLVERSASSLEQHMASTS 60
           MNV+RRL SIASGR  +SSD  G++   R+K ++                         +
Sbjct: 1   MNVVRRLTSIASGRNFVSSDNVGETETPRSKPNQN---------------------REET 39

Query: 61  LEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQ 120
                ++ E  +V+ +E S  D LPKE+ E              D++  I+ GNGTE+G+
Sbjct: 40  ESTETTSYEKDSVSSSENS--DHLPKEIRE--------------DMDCGIIKGNGTESGR 83

Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
           +I T   G N Q  +TISY AE V+GTGSFGVVFQAKCLET + VAIKKVLQDKRYKNRE
Sbjct: 84  IITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEKVAIKKVLQDKRYKNRE 143

Query: 181 LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV 240
           LQIMR+L+HPNVV LKH FFSTTEKDELYLNLVLEY+ ET+YR S+ YT+MNQH+P++Y+
Sbjct: 144 LQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYI 203

Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           QLYTYQICRA+NYLH VVGVCHRDIKPQNLL+
Sbjct: 204 QLYTYQICRAMNYLHQVVGVCHRDIKPQNLLV 235

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	272
255541478	474	Glycogen synthase kinase-3 beta, putativ	1.0	0.573	0.781	1e-124
225453724	468	PREDICTED: shaggy-related protein kinase	0.992	0.576	0.777	1e-123
449454478	469	PREDICTED: shaggy-related protein kinase	0.996	0.577	0.791	1e-121
449522286	469	PREDICTED: shaggy-related protein kinase	0.996	0.577	0.791	1e-121
356520459	470	PREDICTED: shaggy-related protein kinase	1.0	0.578	0.722	1e-116
62857012	467	Ser/Thr protein kinase [Lotus japonicus]	0.988	0.576	0.722	1e-114
356504991	470	PREDICTED: shaggy-related protein kinase	1.0	0.578	0.711	1e-113
357507067	470	Shaggy-related protein kinase [Medicago	1.0	0.578	0.697	1e-112
224130108	438	predicted protein [Populus trichocarpa]	0.875	0.543	0.803	1e-112
15236918	472	Shaggy-related protein kinase theta [Ara	0.992	0.572	0.721	1e-110

>gi|255541478|ref|XP_002511803.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223548983|gb|EEF50472.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis]

 Score =  450 bits (1158), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 215/275 (78%), Positives = 246/275 (89%), Gaps = 3/275 (1%)

Query: 1   MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
           MN+MRRLKSIASGRTSISSDPGGDS  KR KVD+E E  ++GE    ER+A+ LEQHMAS
Sbjct: 1   MNMMRRLKSIASGRTSISSDPGGDSLTKRVKVDQETEQKIDGEVYSDERNATGLEQHMAS 60

Query: 59  TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
           TSLE  ASTS +A+V +TE+SGFDQLPKEM+EMRI+D+K  +HD+KD+E +IV+G GTE 
Sbjct: 61  TSLENPASTSNSASVVKTEKSGFDQLPKEMHEMRIKDDKTTSHDEKDMEAAIVSGTGTET 120

Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
           G +IATT+GGRNGQPKQTIS+MAERVVGTGSFGVV+QAKCLETG++VAIKKVLQD+RYKN
Sbjct: 121 GHIIATTLGGRNGQPKQTISFMAERVVGTGSFGVVYQAKCLETGEAVAIKKVLQDRRYKN 180

Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN-QHVPI 237
           RELQIMRLL HPNVV LKHCF STTEKDELYLNLVLEYI ETVYRVS+HY +MN QH+PI
Sbjct: 181 RELQIMRLLGHPNVVELKHCFISTTEKDELYLNLVLEYIPETVYRVSRHYNKMNHQHMPI 240

Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +YVQLY YQICR L+YLHHVVGVCHRDIKPQNLL+
Sbjct: 241 IYVQLYAYQICRGLSYLHHVVGVCHRDIKPQNLLV 275

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225453724|ref|XP_002272112.1| PREDICTED: shaggy-related protein kinase theta isoform 1 [Vitis vinifera] gi|296089061|emb|CBI38764.3| unnamed protein product [Vitis vinifera]

 Score =  448 bits (1153), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 213/274 (77%), Positives = 249/274 (90%), Gaps = 4/274 (1%)

Query: 1   MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
           MNVMRRLKSIASGR+S+S DPGGDS  KRAKVD+E E  V  E + VE+S +SLEQHMAS
Sbjct: 1   MNVMRRLKSIASGRSSVS-DPGGDSSTKRAKVDQEAEQKVADETHSVEKS-TSLEQHMAS 58

Query: 59  TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
           TS E  ASTS  +++ARTE+SG+DQLPKEM++M+IRDEK   HDDKD EP++V+G+GTE 
Sbjct: 59  TSQETAASTSNVSSIARTEQSGYDQLPKEMHDMKIRDEKVDPHDDKDAEPTVVSGSGTET 118

Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
           GQ+IATT+GGRNGQPKQT+SYMAERVVGTGSFGVVFQAKCLETG++VAIKKVLQDKRYKN
Sbjct: 119 GQIIATTIGGRNGQPKQTVSYMAERVVGTGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN 178

Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
           RELQIMR+L+HPNVV LKHCFFST+EKD +YLNLVLEY+SETVYRVS+H++RMNQH+PI+
Sbjct: 179 RELQIMRVLDHPNVVQLKHCFFSTSEKDVVYLNLVLEYVSETVYRVSRHHSRMNQHMPII 238

Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           YVQLY YQICRALNY+H V+GVCHRDIKPQNLL+
Sbjct: 239 YVQLYAYQICRALNYMHSVIGVCHRDIKPQNLLV 272

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449454478|ref|XP_004144981.1| PREDICTED: shaggy-related protein kinase theta-like [Cucumis sativus] gi|449473157|ref|XP_004153803.1| PREDICTED: shaggy-related protein kinase theta-like [Cucumis sativus]

 Score =  440 bits (1131), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 217/274 (79%), Positives = 248/274 (90%), Gaps = 3/274 (1%)

Query: 1   MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
           MN+MRRLKSIASGRTSISSDPGGD GIKRAKVD+E E  V G ++ V R+AS L    +S
Sbjct: 1   MNMMRRLKSIASGRTSISSDPGGDFGIKRAKVDQETEQKVGGVSDDVGRAASGLGLDSSS 60

Query: 59  TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
           +SL+ VASTS  +++A  E+SGFD LP+EM EMRI+DEK+ NHD+KDLEP++VNGNGTEA
Sbjct: 61  SSLDNVASTSNISSIAGAEKSGFDHLPREMREMRIKDEKS-NHDEKDLEPAVVNGNGTEA 119

Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
           GQ+IATTVGGRNG+PKQTISYMAERVVGTGSFGVVFQAKCLET ++VAIKKVLQDKRYKN
Sbjct: 120 GQIIATTVGGRNGKPKQTISYMAERVVGTGSFGVVFQAKCLETNEAVAIKKVLQDKRYKN 179

Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
           RELQIMR+L+H N+V LKHCFFSTT+KDELYLNLVLEYISETVY+VSKHY RMN+ +PI+
Sbjct: 180 RELQIMRMLDHSNIVQLKHCFFSTTDKDELYLNLVLEYISETVYKVSKHYIRMNRSMPII 239

Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL+
Sbjct: 240 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 273

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449522286|ref|XP_004168158.1| PREDICTED: shaggy-related protein kinase theta-like [Cucumis sativus]

 Score =  439 bits (1129), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 217/274 (79%), Positives = 247/274 (90%), Gaps = 3/274 (1%)

Query: 1   MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
           MN+MRRLKSIASGRTSISSDPGGD GIKRAKVD+E E  V G ++ V R+AS L    +S
Sbjct: 1   MNMMRRLKSIASGRTSISSDPGGDFGIKRAKVDQETEQKVGGVSDDVGRAASGLGLDSSS 60

Query: 59  TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
           +SL+ VASTS  +++A  E+SGFD LP+EM EMRI+DEK+ NHD+KDLEP++VNGNGTEA
Sbjct: 61  SSLDNVASTSNISSIAGAEKSGFDHLPREMREMRIKDEKS-NHDEKDLEPAVVNGNGTEA 119

Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
           GQ+IATTVGGRNG+PKQTISYMAERVVGTGSFGVVFQAKCLET ++VAIKKVLQDKRYKN
Sbjct: 120 GQIIATTVGGRNGKPKQTISYMAERVVGTGSFGVVFQAKCLETNEAVAIKKVLQDKRYKN 179

Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
           RELQIMR+L H N+V LKHCFFSTT+KDELYLNLVLEYISETVY+VSKHY RMN+ +PI+
Sbjct: 180 RELQIMRMLEHSNIVQLKHCFFSTTDKDELYLNLVLEYISETVYKVSKHYIRMNRSMPII 239

Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL+
Sbjct: 240 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 273

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356520459|ref|XP_003528879.1| PREDICTED: shaggy-related protein kinase theta-like [Glycine max]

 Score =  422 bits (1085), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 198/274 (72%), Positives = 237/274 (86%), Gaps = 2/274 (0%)

Query: 1   MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
           MN+MRRLKSIASGRTSISSDPGGDS  KRAK + E E   + + N +E   +  EQ + +
Sbjct: 1   MNMMRRLKSIASGRTSISSDPGGDSNSKRAKFEPETEGKADEKTNTIETICTDQEQPIDT 60

Query: 59  TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
           +       TS+ +TVARTE+SGFD+LPKE+NEM+IRDEK+ N+++KD+E ++V+GNGTE 
Sbjct: 61  SKETSNVGTSDVSTVARTEKSGFDELPKELNEMKIRDEKSKNNNEKDIEATVVSGNGTET 120

Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
           GQ+I T +GGR+GQPKQTISYMAERVVGTGSFGVVFQAKCLETG+SVAIKKVLQD+RYKN
Sbjct: 121 GQIITTAIGGRDGQPKQTISYMAERVVGTGSFGVVFQAKCLETGESVAIKKVLQDRRYKN 180

Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
           RELQ+MR ++HPNVV LKH FFSTT+KDELYLNLVLEY+ ETVY+VSKHY RM+QH+PI+
Sbjct: 181 RELQVMRTVDHPNVVKLKHYFFSTTDKDELYLNLVLEYVPETVYKVSKHYVRMHQHMPII 240

Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           YVQLYTYQICRALNYLH V+GVCHRDIKPQNLL+
Sbjct: 241 YVQLYTYQICRALNYLHQVIGVCHRDIKPQNLLV 274

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|62857012|dbj|BAD95891.1| Ser/Thr protein kinase [Lotus japonicus]

 Score =  417 bits (1072), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 198/274 (72%), Positives = 237/274 (86%), Gaps = 5/274 (1%)

Query: 1   MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
           MN+MRRLKSIASGRTSISSDPGGDS  KRAK+D+E E  VN E   +       EQH+  
Sbjct: 1   MNMMRRLKSIASGRTSISSDPGGDSNSKRAKLDQETEKKVNEETKTL--GGKDQEQHV-D 57

Query: 59  TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
            S E    TS+ +TVA+TE+SGFD+LPKE++EM+I+DEK+ N+++KD+E SIV+GNGTE 
Sbjct: 58  ASKESTVGTSDVSTVAKTEKSGFDELPKELHEMKIKDEKSKNNNEKDIEASIVSGNGTET 117

Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
           GQ+I T +GGR+GQPKQTISYMAERVVGTGSFGVVFQAKCLETG++VAIKKVLQDKRYKN
Sbjct: 118 GQIITTAIGGRDGQPKQTISYMAERVVGTGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN 177

Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
           RELQ+MR ++HPN+V LKHCFFSTT+KDELYLNLVLE++ ETVY+VSK Y R++QH+PI+
Sbjct: 178 RELQVMRTVDHPNIVKLKHCFFSTTDKDELYLNLVLEFVPETVYKVSKQYIRVHQHMPII 237

Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           YVQLY YQICRALNYLH V+GVCHRDIKPQNLL+
Sbjct: 238 YVQLYIYQICRALNYLHQVIGVCHRDIKPQNLLV 271

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356504991|ref|XP_003521276.1| PREDICTED: shaggy-related protein kinase theta [Glycine max]

 Score =  414 bits (1063), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 195/274 (71%), Positives = 234/274 (85%), Gaps = 2/274 (0%)

Query: 1   MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGE--ANLVERSASSLEQHMAS 58
           MN+MRRLKSIASGRTSISSDPGGDS  KRAK + E EV  +   N  E   +  EQ + +
Sbjct: 1   MNMMRRLKSIASGRTSISSDPGGDSNSKRAKFEPETEVKADEKTNTTETICTDQEQLIDT 60

Query: 59  TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
           +       TS+ +TVARTE+SGF++LPKE+NEM+IRDEK+ N+ +KD+E ++V+GNGTE 
Sbjct: 61  SKETSNVGTSDVSTVARTEKSGFEELPKELNEMKIRDEKSKNNSEKDIEATVVSGNGTET 120

Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
           GQ+I T +GGR+GQPKQTISYMAERVVGTGSFG+VFQAKCLETG+SVAIKKVLQD+RYKN
Sbjct: 121 GQIITTAIGGRDGQPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKN 180

Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
           RELQ+MR +++ NVV LKH FFSTT+KDELYLNLVLEY+ ETVY+VSKHY RM+QH+PI+
Sbjct: 181 RELQVMRTVDNSNVVKLKHYFFSTTDKDELYLNLVLEYVPETVYKVSKHYVRMHQHMPII 240

Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           YVQLYTYQICRALNYLH V+GVCHRDIKPQNLL+
Sbjct: 241 YVQLYTYQICRALNYLHQVIGVCHRDIKPQNLLV 274

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357507067|ref|XP_003623822.1| Shaggy-related protein kinase [Medicago truncatula] gi|355498837|gb|AES80040.1| Shaggy-related protein kinase [Medicago truncatula]

 Score =  411 bits (1056), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 191/274 (69%), Positives = 235/274 (85%), Gaps = 2/274 (0%)

Query: 1   MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
           MN+MRRLKSIASGRTS+SSDPGGDS  KRAK D E E   N E N  ER  ++ ++++ +
Sbjct: 1   MNMMRRLKSIASGRTSVSSDPGGDSTTKRAKFDLETEGKENEETNRGERGGNNQDKYVDA 60

Query: 59  TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
                 +  S  + VA+TE+SGFDQLPKE++EM+I+D+K+ N+++KD+E ++VNGNGTE 
Sbjct: 61  VEETSSSCNSNVSAVAKTEKSGFDQLPKELHEMKIKDDKSKNNNEKDMEATVVNGNGTET 120

Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
           GQ+I T++GGR+GQPK+ ISYMAERVVGTGSFGVV+QAKC+ETG+SVAIKKVLQDKRYKN
Sbjct: 121 GQIITTSIGGRDGQPKRIISYMAERVVGTGSFGVVYQAKCVETGESVAIKKVLQDKRYKN 180

Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
           RELQ+MR+L H NV+ LKHCF+ST EKDE+YLNLVLE++ ETVYRVSKHY RM+QH+PI+
Sbjct: 181 RELQVMRMLEHTNVLKLKHCFYSTAEKDEVYLNLVLEFVPETVYRVSKHYVRMHQHMPII 240

Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           YVQLYTYQICR LNYLHHVVGVCHRDIKPQNLL+
Sbjct: 241 YVQLYTYQICRGLNYLHHVVGVCHRDIKPQNLLV 274

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224130108|ref|XP_002320754.1| predicted protein [Populus trichocarpa] gi|222861527|gb|EEE99069.1| predicted protein [Populus trichocarpa]

 Score =  409 bits (1051), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 192/239 (80%), Positives = 217/239 (90%), Gaps = 1/239 (0%)

Query: 35  ELEVNGEANLVERSASSLEQHMASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIR 94
           E +++GE+ LVERS +  EQHMASTS E  AS S   +V RTE+ G+DQLPKEM+EM+IR
Sbjct: 2   EQKIDGESYLVERSVTEQEQHMASTSQENAASASNVTSVTRTEKPGYDQLPKEMHEMKIR 61

Query: 95  DEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVF 154
           D+KN NHD+KD+E +IV+GNGTE GQ+IATTVGGRNGQPKQ ISYMAERVVGTGSFGVV+
Sbjct: 62  DDKNTNHDEKDMEAAIVSGNGTETGQIIATTVGGRNGQPKQIISYMAERVVGTGSFGVVY 121

Query: 155 QAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214
           QAKCLETG++VAIKKVLQDKRYKNRELQIMRLL+HPNVV LKHCF+STTEKDELYLNLVL
Sbjct: 122 QAKCLETGEAVAIKKVLQDKRYKNRELQIMRLLDHPNVVQLKHCFYSTTEKDELYLNLVL 181

Query: 215 EYISETVYRVSKHYTRMN-QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           EYISETV+RVS+H+ RMN QH PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL+
Sbjct: 182 EYISETVHRVSRHFNRMNQQHTPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 240

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15236918|ref|NP_191981.1| Shaggy-related protein kinase theta [Arabidopsis thaliana] gi|12643793|sp|Q96287.3|KSG8_ARATH RecName: Full=Shaggy-related protein kinase theta; AltName: Full=ASK-theta gi|1944518|emb|CAA69156.1| Shaggy-like kinase tetha [Arabidopsis thaliana] gi|3047105|gb|AAC13616.1| protein kinase [Arabidopsis thaliana] gi|7267411|emb|CAB80881.1| Shaggy related protein kinase tetha [Arabidopsis thaliana] gi|17063158|gb|AAL32976.1| AT4g00720/F6N23_11 [Arabidopsis thaliana] gi|21700933|gb|AAM70590.1| AT4g00720/F6N23_11 [Arabidopsis thaliana] gi|110740517|dbj|BAE98364.1| Shaggy related protein kinase theta [Arabidopsis thaliana] gi|332656525|gb|AEE81925.1| Shaggy-related protein kinase theta [Arabidopsis thaliana]

 Score =  403 bits (1035), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 197/273 (72%), Positives = 229/273 (83%), Gaps = 3/273 (1%)

Query: 1   MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE-VNGEANLVERSASSLEQHMAST 59
           MNVMRRLKSIASGRTSISSDPGGD  +KRAK+D+E + +  +   V++++S  E      
Sbjct: 1   MNVMRRLKSIASGRTSISSDPGGDYALKRAKLDQENDNLCVDPMQVDQNSSCFEMKADVL 60

Query: 60  SLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAG 119
           S E VA TS    V  +E+   DQLP  M EM+IRDE+N N +DKD+E ++VNG+GTE G
Sbjct: 61  SQESVAGTSNVPAV--SEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118

Query: 120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR 179
           QVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178

Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           ELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLEY+ ETVYR SKHYT+MNQH+PI++
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238

Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           VQLYTYQICRALNYLH VVGVCHRDIKPQNLL+
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLV 271

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	272
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.992	0.572	0.688	3.3e-95
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.742	0.498	0.708	1.1e-78
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.761	0.504	0.700	4.8e-78
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.757	0.503	0.695	2.7e-77
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.794	0.493	0.640	3.2e-72
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.628	0.415	0.719	2.7e-68
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.794	0.513	0.603	4.4e-68
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.625	0.417	0.711	1.5e-67
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.628	0.45	0.695	8.2e-67
WB|WBGene00001746	362	gsk-3 [Caenorhabditis elegans	0.573	0.430	0.583	1.1e-46

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 947 (338.4 bits), Expect = 3.3e-95, P = 3.3e-95
 Identities = 188/273 (68%), Positives = 219/273 (80%)

Query:     1 MNVMRRLKSIASGRTXXXXXXXXXXXXKRAKVDKELE-VNGEANLVERSASSLEQHMAST 59
             MNVMRRLKSIASGRT            KRAK+D+E + +  +   V++++S  E      
Sbjct:     1 MNVMRRLKSIASGRTSISSDPGGDYALKRAKLDQENDNLCVDPMQVDQNSSCFEMKADVL 60

Query:    60 SLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAG 119
             S E VA TS    V+  E+   DQLP  M EM+IRDE+N N +DKD+E ++VNG+GTE G
Sbjct:    61 SQESVAGTSNVPAVS--EKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118

Query:   120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR 179
             QVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQDKRYKNR
Sbjct:   119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178

Query:   180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
             ELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLEY+ ETVYR SKHYT+MNQH+PI++
Sbjct:   179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238

Query:   240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             VQLYTYQICRALNYLH VVGVCHRDIKPQNLL+
Sbjct:   239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLV 271

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 791 (283.5 bits), Expect = 1.1e-78, P = 1.1e-78
 Identities = 148/209 (70%), Positives = 178/209 (85%)

Query:    64 VASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIA 123
             +AS   A      + +G D+LP+EMN+M+IRD       DK++E ++V+GNGTE G +I 
Sbjct:     1 MASVGIAPNPGARDSTGVDKLPEEMNDMKIRD-------DKEMEATVVDGNGTETGHIIV 53

Query:   124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQI 183
             TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+RYKNRELQ 
Sbjct:    54 TTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQT 113

Query:   184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
             MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +P++YV+LY
Sbjct:   114 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLY 173

Query:   244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             TYQI RAL+Y+H  +GVCHRDIKPQNLL+
Sbjct:   174 TYQIFRALSYIHRCIGVCHRDIKPQNLLV 202

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 785 (281.4 bits), Expect = 4.8e-78, P = 4.8e-78
 Identities = 152/217 (70%), Positives = 179/217 (82%)

Query:    56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
             MAS    P +S    AT         ++LP+ +NEM+I+D       DK++E ++V+GNG
Sbjct:     1 MASVGTLPASSM---ATKQSNASICAEKLPEGINEMKIKD-------DKEMEAAVVDGNG 50

Query:   116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
             TE G +I TT+GG+NGQPKQTISYMAER+VG GSFG+VFQAKCLETG++VAIKKVLQDKR
Sbjct:    51 TETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKR 110

Query:   176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
             YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETVYRVSKHY+R NQ +
Sbjct:   111 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRM 170

Query:   236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             PI+YV+LYTYQICRAL Y+H  VGVCHRDIKPQNLL+
Sbjct:   171 PIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLV 207

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 778 (278.9 bits), Expect = 2.7e-77, P = 2.7e-77
 Identities = 151/217 (69%), Positives = 182/217 (83%)

Query:    56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
             MAS  +EP A+  E+ T   T+    D+LP+EM +M+I+D       DK++E +IVNGN 
Sbjct:     1 MASVGIEPSAAVRES-TGNVTDA---DRLPEEMKDMKIQD-------DKEMEATIVNGNV 49

Query:   116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
             TE G +I TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+R
Sbjct:    50 TETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRR 109

Query:   176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
             YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +
Sbjct:   110 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRM 169

Query:   236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             P++YV+LYTYQI R+L+Y+H  +GVCHRDIKPQNLL+
Sbjct:   170 PLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLV 206

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 730 (262.0 bits), Expect = 3.2e-72, P = 3.2e-72
 Identities = 146/228 (64%), Positives = 175/228 (76%)

Query:    46 ERSASSLEQHMASTSLEPVASTS-EAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDK 104
             E   S   Q+   T  E   +TS E  +V+ +E S  D LPKE+ E+ + D       DK
Sbjct:    26 ETPRSKPNQNREET--ESTETTSYEKDSVSSSENS--DHLPKEIREVGLGD-------DK 74

Query:   105 DLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDS 164
             D++  I+ GNGTE+G++I T   G N Q  +TISY AE V+GTGSFGVVFQAKCLET + 
Sbjct:    75 DMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEK 134

Query:   165 VAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRV 224
             VAIKKVLQDKRYKNRELQIMR+L+HPNVV LKH FFSTTEKDELYLNLVLEY+ ET+YR 
Sbjct:   135 VAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRA 194

Query:   225 SKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             S+ YT+MNQH+P++Y+QLYTYQICRA+NYLH VVGVCHRDIKPQNLL+
Sbjct:   195 SRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLV 242

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 693 (249.0 bits), Expect = 2.7e-68, P = 2.7e-68
 Identities = 123/171 (71%), Positives = 150/171 (87%)

Query:   102 DDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLET 161
             +DK++  +++ GN    G +I+TT+GG+NG+PKQTISYMAERVVGTGSFG+VFQAKCLET
Sbjct:    35 NDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 94

Query:   162 GDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221
             G+SVAIKKVLQD+RYKNRELQ+MRL++HPNVVSLKHCFFSTT +DEL+LNLV+EY+ ET+
Sbjct:    95 GESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETL 154

Query:   222 YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             YRV KHYT  NQ +PI YV+LYTYQI R L Y+H   GVCHRD+KPQNLL+
Sbjct:   155 YRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLV 205

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 691 (248.3 bits), Expect = 4.4e-68, P = 4.4e-68
 Identities = 131/217 (60%), Positives = 171/217 (78%)

Query:    56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
             MAS+ L     TS +A   ++  S  D L +++ E RIRD+   + D++D EP I++G G
Sbjct:     1 MASSGLGNGVGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETD-DERDSEPDIIDGAG 59

Query:   116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
              E G VI TT+ GRNGQ +QT+SY++E VVGTGSFG+VFQAKC ETG+ VAIKKVLQDKR
Sbjct:    60 AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119

Query:   176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
             YKNRELQIM++L+HPN V+LKH FFS T+ +E+YLNLVLE++ ETV RV++ Y+R NQ +
Sbjct:   120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179

Query:   236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             P++YV+LYTYQICRAL Y+H+  G+CHRDIKPQNLL+
Sbjct:   180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLV 216

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 686 (246.5 bits), Expect = 1.5e-67, P = 1.5e-67
 Identities = 121/170 (71%), Positives = 149/170 (87%)

Query:   103 DKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETG 162
             DK++  +++ GN    G +I+TT+GG+NG+PKQTISYMAERVVGTGSFG+VFQAKCLETG
Sbjct:    34 DKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 93

Query:   163 DSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVY 222
             +SVAIKKVLQD+RYKNRELQ+MR ++HPNV+SLKHCFFSTT +DEL+LNLV+EY+ ET+Y
Sbjct:    94 ESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLY 153

Query:   223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             RV +HYT  NQ +PI YV+LYTYQI R L Y+H V GVCHRD+KPQNLL+
Sbjct:   154 RVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 203

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 679 (244.1 bits), Expect = 8.2e-67, P = 8.2e-67
 Identities = 119/171 (69%), Positives = 152/171 (88%)

Query:   102 DDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLET 161
             DDK++  ++V+G+    G +I+TT+GG+NG+PKQTISYMAERVVGTGSFG+VFQAKCLET
Sbjct:     3 DDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62

Query:   162 GDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221
             G++VAIKKVLQD+RYKNRELQ+MR+++HPNVV LKHCFFSTT KDEL+LNLV+EY+ E++
Sbjct:    63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESL 122

Query:   222 YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             YRV KHY+  NQ +P++YV+LY YQI R L Y+H+V GVCHRD+KPQNLL+
Sbjct:   123 YRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLV 173

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

WB|WBGene00001746 gsk-3 [Caenorhabditis elegans (taxid:6239)]

 Score = 489 (177.2 bits), Expect = 1.1e-46, P = 1.1e-46
 Identities = 94/161 (58%), Positives = 125/161 (77%)

Query:   114 NGTEAGQVIATTVGGRNGQPKQT-ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ 172
             +G +   V+A+     +G  +Q  ISY  ++V+G GSFGVVF AK   T + VAIKKVLQ
Sbjct:    12 SGKQVTMVVASVA--TDGVDQQVEISYYDQKVIGNGSFGVVFLAKLSTTNEMVAIKKVLQ 69

Query:   173 DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELYLNLVLEYISETVYRVSKHYTRM 231
             DKR+KNRELQIMR LNHPN+V LK+ F+S+ EK DELYLNL+LEY+ ETVYRV++HY++ 
Sbjct:    70 DKRFKNRELQIMRKLNHPNIVKLKYFFYSSGEKKDELYLNLILEYVPETVYRVARHYSKQ 129

Query:   232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
              Q +P++YV+LY YQ+ R+L Y+H + G+CHRDIKPQNLL+
Sbjct:   130 RQQIPMIYVKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLI 169

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0009792 "embryo development ending in birth or egg hatching" evidence=IMP

GO:0040010 "positive regulation of growth rate" evidence=IMP

GO:0002119 "nematode larval development" evidence=IMP

GO:0007052 "mitotic spindle organization" evidence=IMP

GO:0006898 "receptor-mediated endocytosis" evidence=IMP

GO:0035188 "hatching" evidence=IMP

GO:0010467 "gene expression" evidence=IMP

GO:0040011 "locomotion" evidence=IMP

GO:0043652 "engulfment of apoptotic cell" evidence=IMP

GO:0007281 "germ cell development" evidence=IGI

GO:0060069 "Wnt receptor signaling pathway, regulating spindle positioning" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q96287	KSG8_ARATH	2, ., 7, ., 1, 1, ., 1	0.7216	0.9926	0.5720	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	272
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-34
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-33
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-29
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-29
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-29
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-29
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-28
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-24
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-21
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-21
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-20
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-20
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-20
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-20
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-19
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-19
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-18
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-18
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-17
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-17
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-16
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-16
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-14
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-14
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-10
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-09
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-07
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-07
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-07
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-07
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-06
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-06
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-06
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-06
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-06
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-05
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-05
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-05
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-05
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-05
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-05
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-04
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-04
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-04
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-04
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	0.001
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.001
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	0.002
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	0.002
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	0.002
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	0.003
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	0.003
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.003
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.003
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.003
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.003
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.004
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	0.004

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  161 bits (409), Expect = 7e-47
 Identities = 76/164 (46%), Positives = 110/164 (67%), Gaps = 6/164 (3%)

Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
           N N  E            N  P +  SY    ++G GSFGVV++A C++T + VAIKKVL
Sbjct: 43  NNNAGEDEDEEKMIDNDINRSPNK--SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL 100

Query: 172 QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTT-EKDE--LYLNLVLEYISETVYRVSKHY 228
           QD +YKNREL IM+ LNH N++ LK  +++   +K+E  ++LN+V+E+I +TV++  KHY
Sbjct: 101 QDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY 160

Query: 229 TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            R N  +P+  V+LY+YQ+CRAL Y+H    +CHRD+KPQNLL+
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIHSKF-ICHRDLKPQNLLI 203

Length = 440

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  124 bits (315), Expect = 1e-34
 Identities = 50/140 (35%), Positives = 78/140 (55%), Gaps = 16/140 (11%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPNVV 193
           Y     +G GSFG V+ A+  +TG  VAIK +      +D+    RE++I++ L HPN+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
            L   F    ++D+LY  LV+EY     ++ + K   R+++       + Y  QI  AL 
Sbjct: 61  RLYDVF---EDEDKLY--LVMEYCEGGDLFDLLKKRGRLSEDE----ARFYLRQILSALE 111

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH   G+ HRD+KP+N+L+
Sbjct: 112 YLHS-KGIVHRDLKPENILL 130

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  121 bits (306), Expect = 3e-33
 Identities = 49/137 (35%), Positives = 70/137 (51%), Gaps = 15/137 (10%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
            R +G+GSFG V++AK   TG  VA+K + +            RE++I+R L+HPN+V L
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
              F    +KD LY  LV+EY           Y      +     +    QI R L YLH
Sbjct: 64  IDAF---EDKDHLY--LVMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 256 HVVGVCHRDIKPQNLLM 272
              G+ HRD+KP+N+L+
Sbjct: 116 S-NGIIHRDLKPENILL 131

Length = 260

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  112 bits (283), Expect = 3e-29
 Identities = 46/141 (32%), Positives = 75/141 (53%), Gaps = 15/141 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
           Y   + +G+G++GVV  A    TG  VAIKK+      L D +   RE++++R L H N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 193 VSLKHCF--FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           + L       S  + +++Y  +V E +   +++V     +  Q +   ++Q + YQI R 
Sbjct: 62  IGLLDILRPPSPEDFNDVY--IVTELMETDLHKV----IKSPQPLTDDHIQYFLYQILRG 115

Query: 251 LNYLHHVVGVCHRDIKPQNLL 271
           L YLH    V HRD+KP N+L
Sbjct: 116 LKYLHS-ANVIHRDLKPSNIL 135

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 4e-29
 Identities = 48/140 (34%), Positives = 78/140 (55%), Gaps = 17/140 (12%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKN---RELQIMRLLNHPNV 192
           Y     +G G++GVV++A+   TG+ VAIKK+              RE+++++ LNHPN+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           + L   F     K +LY  LV E++   +Y++ K   R    +P   ++ Y YQ+ + L 
Sbjct: 61  IKLLDVFR---HKGDLY--LVFEFMDTDLYKLIKDRQR---GLPESLIKSYLYQLLQGLA 112

Query: 253 YLH-HVVGVCHRDIKPQNLL 271
           + H H  G+ HRD+KP+NLL
Sbjct: 113 FCHSH--GILHRDLKPENLL 130

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  110 bits (277), Expect = 5e-29
 Identities = 46/138 (33%), Positives = 78/138 (56%), Gaps = 17/138 (12%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----RELQIMRLLNHPNVVSLK 196
            ++G GSFG V+ A   +TG+ +A+K V L     +      RE++I+  L HPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 197 HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
             + S  ++++  LN+ LEY+S  ++  + K + ++ + V    ++ YT QI   L YLH
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118

Query: 256 -HVVGVCHRDIKPQNLLM 272
            +  G+ HRDIK  N+L+
Sbjct: 119 SN--GIVHRDIKGANILV 134

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  108 bits (273), Expect = 6e-29
 Identities = 44/134 (32%), Positives = 68/134 (50%), Gaps = 15/134 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
           +G G FG V+ A+  +TG  VAIK + ++          RE++I++ LNHPN+V L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
                +DE +L LV+EY    ++             +    +     QI   L YLH   
Sbjct: 61  -----EDENHLYLVMEYCEGGSLK---DLLKENEGKLSEDEILRILLQILEGLEYLHS-N 111

Query: 259 GVCHRDIKPQNLLM 272
           G+ HRD+KP+N+L+
Sbjct: 112 GIIHRDLKPENILL 125

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 2e-28
 Identities = 49/134 (36%), Positives = 75/134 (55%), Gaps = 15/134 (11%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKN---RELQIMRLLNHPNVVSLKH 197
           VVG G++GVV + +   TG+ VAIKK  +   D+  K    RE++++R L H N+V+LK 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
            F     K  LY  LV EY+  T+  + +        +P   V+ Y +Q+ +A+ Y H  
Sbjct: 68  AFRR---KGRLY--LVFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHS- 118

Query: 258 VGVCHRDIKPQNLL 271
             + HRDIKP+N+L
Sbjct: 119 HNIIHRDIKPENIL 132

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 3e-26
 Identities = 42/136 (30%), Positives = 72/136 (52%), Gaps = 19/136 (13%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHPNVVSLK 196
           +G G++GVV++A+  +TG+ VA+KK+  D   +         RE+ +++ L HPN+V L 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
               +   + +LY  LV EY       + K+  +    +    ++   YQ+ R L Y H 
Sbjct: 65  DVIHT---ERKLY--LVFEYCD---MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KPQN+L+
Sbjct: 117 -HRILHRDLKPQNILI 131

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  100 bits (252), Expect = 2e-25
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 23/146 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
           Y   + +G GSFG V+  +    G    +K++       +++     E++I++ LNHPN+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVP---ILYVQLYTYQIC 248
           +     F    EK    L +V+EY     + +  K   +  +  P   IL    +  Q+C
Sbjct: 62  IKYYESFE---EKG--KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD---WFVQLC 113

Query: 249 RALNYLH--HVVGVCHRDIKPQNLLM 272
            AL YLH   ++   HRDIKPQN+ +
Sbjct: 114 LALKYLHSRKIL---HRDIKPQNIFL 136

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 96.9 bits (242), Expect = 6e-24
 Identities = 44/136 (32%), Positives = 74/136 (54%), Gaps = 17/136 (12%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----RELQIMRLLNHPNVVSLKH 197
           ++G G+FGVV++   LETGD VAIK++ L+  + +      +E+ +++ L HPN+V    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
                  +    L ++LEY    ++ ++ K +    + +  +YV    YQ+ + L YLH 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV----YQVLQGLAYLHE 117

Query: 257 VVGVCHRDIKPQNLLM 272
             GV HRDIK  N+L 
Sbjct: 118 -QGVIHRDIKAANILT 132

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 96.8 bits (242), Expect = 8e-24
 Identities = 49/137 (35%), Positives = 77/137 (56%), Gaps = 18/137 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQ-IMRLLNHPNVVS 194
           + +G G+FG V+ A+  ETG+ VAIKK+ +  ++ +       RE++ + +L  HPN+V 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           LK  F    E DELY   V EY+   +Y++ K   R  +      ++   YQI + L ++
Sbjct: 63  LKEVF---RENDELY--FVFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 255 HHVVGVCHRDIKPQNLL 271
           H   G  HRD+KP+NLL
Sbjct: 116 HK-HGFFHRDLKPENLL 131

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 94.6 bits (236), Expect = 3e-23
 Identities = 44/137 (32%), Positives = 71/137 (51%), Gaps = 18/137 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
             +G G FG V++A+   TG  VAIK + L+ K  K     E+QI++   HPN+V     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-- 255
           +    +KDEL+  +V+E+ S  ++  + K   +      I YV     ++ + L YLH  
Sbjct: 66  YL---KKDELW--IVMEFCSGGSLKDLLKSTNQTLTESQIAYV---CKELLKGLEYLHSN 117

Query: 256 HVVGVCHRDIKPQNLLM 272
            ++   HRDIK  N+L+
Sbjct: 118 GII---HRDIKAANILL 131

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 93.9 bits (234), Expect = 1e-22
 Identities = 43/135 (31%), Positives = 67/135 (49%), Gaps = 15/135 (11%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
             +G G+ G+VF+AK  ETG++VA+KKV   +          RE++ ++   HP VV L 
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
             F            LV+EY+   +  V +   R    +P   V+ Y   + + + Y+H 
Sbjct: 66  DVF-----PHGSGFVLVMEYMPSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA 117

Query: 257 VVGVCHRDIKPQNLL 271
             G+ HRD+KP NLL
Sbjct: 118 -NGIMHRDLKPANLL 131

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 92.6 bits (231), Expect = 4e-22
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 24/146 (16%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNH 189
           Y   + +G G++ VV++A+  ETG  VAIKK+   +R +          RE+++++ L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS---ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
           PN++ L   F     K    +NLV E++    E V +  K             ++ Y   
Sbjct: 62  PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK-DKSIVLTPAD-----IKSYMLM 110

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
             R L YLH    + HRD+KP NLL+
Sbjct: 111 TLRGLEYLHS-NWILHRDLKPNNLLI 135

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 90.1 bits (224), Expect = 2e-21
 Identities = 44/135 (32%), Positives = 79/135 (58%), Gaps = 17/135 (12%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----RELQIMRLLNHPNVVSLKHC 198
           +G G+FG V+ A  L+TG+ +A+K++ +QD   K       E++++ LL HPN+V     
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64

Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
           +     ++++Y  + +EY S  T+  + +H   +++HV    +++YT Q+   L YLH  
Sbjct: 65  YGVEVHREKVY--IFMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLHS- 117

Query: 258 VGVCHRDIKPQNLLM 272
            G+ HRDIKP N+ +
Sbjct: 118 HGIVHRDIKPANIFL 132

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 90.2 bits (224), Expect = 5e-21
 Identities = 48/139 (34%), Positives = 78/139 (56%), Gaps = 11/139 (7%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
           Y  + V+G GS+GVV  A    TG+ VAIKK+      + D     RE++++RLL HP++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           V +KH     + ++   + +V E +   +++V K     N  +   + Q + YQ+ RAL 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117

Query: 253 YLHHVVGVCHRDIKPQNLL 271
           Y+ H   V HRD+KP+N+L
Sbjct: 118 YI-HTANVFHRDLKPKNIL 135

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 89.3 bits (222), Expect = 6e-21
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 17/134 (12%)

Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLN-HPNVVSLKH 197
           G G+F  V +A+  +TG   AIK +   K +K+       RE+Q +R L+ HPN++ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
             F         L LV E +   +Y + K   R    +P   V+ Y YQ+ ++L+++H  
Sbjct: 66  VLFDRKTGR---LALVFELMDMNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMHR- 118

Query: 258 VGVCHRDIKPQNLL 271
            G+ HRDIKP+N+L
Sbjct: 119 NGIFHRDIKPENIL 132

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 88.8 bits (221), Expect = 1e-20
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK--NRELQIMRLLNHPNVVSL 195
           + +GTGSFG V   +   +G   A+K     K+++ K+ +    E +I++ + HP +V+L
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
              F     +D+  L LV+EY+   E        + R +   P    + Y  Q+  AL Y
Sbjct: 67  YGSF-----QDDSNLYLVMEYVPGGELF-----SHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 254 LHHVVGVCHRDIKPQNLL 271
           LH  + + +RD+KP+NLL
Sbjct: 117 LHS-LDIVYRDLKPENLL 133

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 86.8 bits (216), Expect = 3e-20
 Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 20/141 (14%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
            + +G G+FG V++      GD     VA+K + +D   +      RE +IMR L+HPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
           V L       TE++ L   +V+EY+          Y R N+   +    L  +  QI R 
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 251 LNYLHHVVGVCHRDIKPQNLL 271
           + YL       HRD+  +N L
Sbjct: 116 MEYLES-KNFIHRDLAARNCL 135

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 87.3 bits (217), Expect = 5e-20
 Identities = 44/141 (31%), Positives = 70/141 (49%), Gaps = 17/141 (12%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
           Y     VG+G++G V  A   +TG  VAIKK+ +        KR Y  REL++++ ++H 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 191 NVVSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           NV+ L   F   +  ++   + LV   +   +  + K     + H+  L      YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL-----VYQILR 129

Query: 250 ALNYLHHVVGVCHRDIKPQNL 270
            L Y+H   G+ HRD+KP N+
Sbjct: 130 GLKYIHS-AGIIHRDLKPSNI 149

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.5 bits (215), Expect = 5e-20
 Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 23/145 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE----------LQIMRLLN 188
           +   +++G GSF  V  AK  ET    AI K+L DKR   +E            + RL  
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KIL-DKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           HP ++ L + F     +DE  L  VLEY     + +  + Y  +++       + Y  +I
Sbjct: 61  HPGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEI 111

Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
             AL YLH   G+ HRD+KP+N+L+
Sbjct: 112 LLALEYLHS-KGIIHRDLKPENILL 135

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 87.5 bits (215), Expect = 8e-20
 Identities = 49/142 (34%), Positives = 67/142 (47%), Gaps = 17/142 (11%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHP 190
           SY   R +G GSFG V+ A+  +    VA+K + +    K+       RE+QI+  LNHP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 191 -NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
            N+V L   F     +DE  L LV+EY+                 +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 250 ALNYLHHVVGVCHRDIKPQNLL 271
           AL YLH   G+ HRDIKP+N+L
Sbjct: 113 ALEYLHS-KGIIHRDIKPENIL 133

Length = 384

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 85.3 bits (212), Expect = 9e-20
 Identities = 45/137 (32%), Positives = 70/137 (51%), Gaps = 20/137 (14%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKR--YKNRELQIMRLLNHPNVVSLKH 197
           +G GSFG V   +  +TG   A+K     K+++ K   +   E  I+  +NHP +V L +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 198 CFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
            F     + E  L LVLEY    E    +SK   R ++       + Y  +I  AL YLH
Sbjct: 61  AF-----QTEEKLYLVLEYAPGGELFSHLSKE-GRFSEER----ARFYAAEIVLALEYLH 110

Query: 256 HVVGVCHRDIKPQNLLM 272
            + G+ +RD+KP+N+L+
Sbjct: 111 SL-GIIYRDLKPENILL 126

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 86.2 bits (214), Expect = 1e-19
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 12/140 (8%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKK------VLQDKRYKNRELQIMRLLNHPN 191
            Y     +G+G++GVV  A    +G  VAIKK      V    +   REL+I+R   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           +++++         D   + +V++ +   ++    H    +Q +   +++ + YQ+ R L
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLH----HIIHSDQPLTEEHIRYFLYQLLRGL 120

Query: 252 NYLHHVVGVCHRDIKPQNLL 271
            Y+H    V HRD+KP NLL
Sbjct: 121 KYIHS-ANVIHRDLKPSNLL 139

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 1e-19
 Identities = 47/139 (33%), Positives = 75/139 (53%), Gaps = 26/139 (18%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  +   +       RE+ +++ LNHPN+V L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY-----VQLYTYQICRALNY 253
             S     +LY  LV E++   +    K Y  M+   P+       ++ Y YQ+ + + Y
Sbjct: 67  VHSEN---KLY--LVFEFLDLDL----KKY--MD-SSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 254 LH-HVVGVCHRDIKPQNLL 271
            H H   V HRD+KPQNLL
Sbjct: 115 CHSH--RVLHRDLKPQNLL 131

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 85.3 bits (212), Expect = 1e-19
 Identities = 40/135 (29%), Positives = 69/135 (51%), Gaps = 15/135 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKH 197
           +G G++G V++A+  +TG+ VA+KK+  +   K        RE+++++ L HPN+V LK 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
                T K +  + +V EY+   +  +               ++ Y  Q+   L YLH  
Sbjct: 66  I---VTSKGKGSIYMVFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS- 118

Query: 258 VGVCHRDIKPQNLLM 272
            G+ HRDIK  N+L+
Sbjct: 119 NGILHRDIKGSNILI 133

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 84.9 bits (210), Expect = 4e-19
 Identities = 49/143 (34%), Positives = 78/143 (54%), Gaps = 16/143 (11%)

Query: 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNH 189
           T  Y+  + VG G+FG+V  A+   TG +VAIKK+++        +   REL++++ L H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
            N++SL   F S  E  ++Y   V E +   ++R+        Q     ++Q + YQI R
Sbjct: 69  ENIISLSDIFISPLE--DIY--FVTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQILR 119

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
            L Y+H   GV HRD+KP N+L+
Sbjct: 120 GLKYVHS-AGVVHRDLKPSNILI 141

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 83.2 bits (206), Expect = 1e-18
 Identities = 46/134 (34%), Positives = 74/134 (55%), Gaps = 15/134 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHC 198
           +G GS+GVVF+ +  ETG  VAIKK ++       K+   RE+++++ L HPN+V+L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
           F     + +  L+LV EY   TV    +   R    VP   ++   +Q  +A+N+ H   
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHK-H 119

Query: 259 GVCHRDIKPQNLLM 272
              HRD+KP+N+L+
Sbjct: 120 NCIHRDVKPENILI 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 81.0 bits (201), Expect = 4e-18
 Identities = 44/141 (31%), Positives = 66/141 (46%), Gaps = 21/141 (14%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
            + +G G+FG V++ K    G      VA+K + +D   +      RE +IMR L+HPNV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
           V L       TE++ LY  +V+EY+          Y R N+   +    L  +  QI R 
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPK-LSLSDLLSFALQIARG 114

Query: 251 LNYLHHVVGVCHRDIKPQNLL 271
           + YL       HRD+  +N L
Sbjct: 115 MEYLES-KNFIHRDLAARNCL 134

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 8e-18
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 17/142 (11%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
           Y     +G G++G+V  A    TG  VAIKK+         +R   RE++I+R   H N+
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-TLREIKILRRFKHENI 65

Query: 193 VSLKHCFFSTT--EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           + +       +    +++Y  +V E +   +Y++ K     N H     +Q + YQI R 
Sbjct: 66  IGILDIIRPPSFESFNDVY--IVQELMETDLYKLIKTQHLSNDH-----IQYFLYQILRG 118

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L Y+H    V HRD+KP NLL+
Sbjct: 119 LKYIHS-ANVLHRDLKPSNLLL 139

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.2 bits (198), Expect = 9e-18
 Identities = 46/142 (32%), Positives = 75/142 (52%), Gaps = 14/142 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNR---ELQIMRLLNHPN 191
           +  E+ +G G F VV++A CL  G  VA+KKV    + D + +     E+ +++ L+HPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           V+     F    E     LN+VLE      + R+ KH+ +  + +P   +  Y  Q+C A
Sbjct: 64  VIKYLASFIENNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L ++H    + HRDIKP N+ +
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 80.3 bits (199), Expect = 1e-17
 Identities = 42/136 (30%), Positives = 70/136 (51%), Gaps = 19/136 (13%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN--RELQIMRLLNHPNVVSLKHCFF 200
            +G G+ G V++A    TG  VAIKK+ L+ +  +    E+ IM+   HPN+V     + 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY- 84

Query: 201 STTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--H 256
                    L +V+EY+        +++++ RMN+   I YV     ++ + L YLH  +
Sbjct: 85  ----LVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-QIAYVCR---EVLQGLEYLHSQN 136

Query: 257 VVGVCHRDIKPQNLLM 272
           V+   HRDIK  N+L+
Sbjct: 137 VI---HRDIKSDNILL 149

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 79.6 bits (197), Expect = 2e-17
 Identities = 44/139 (31%), Positives = 70/139 (50%), Gaps = 23/139 (16%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYK-NRELQIMRLLNHPNVVSLKHC 198
           V+G GS GVV++ +   TG   A+KK+     ++ R +  REL+ +R    P VV     
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 199 FFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           F+      E  +++VLEY     +++ + +V K        +P   +     QI + L+Y
Sbjct: 68  FYK-----EGEISIVLEYMDGGSLADLLKKVGK--------IPEPVLAYIARQILKGLDY 114

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH    + HRDIKP NLL+
Sbjct: 115 LHTKRHIIHRDIKPSNLLI 133

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 79.1 bits (196), Expect = 2e-17
 Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 20/137 (14%)

Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVS 194
           + +G G+FG V++ K          VA+K + +D   + R     E ++M+ L HPNVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 195 LKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQL--YTYQIC 248
           L       TE++ LY  LVLEY+         R S+      +   +    L  +  QI 
Sbjct: 61  LLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 249 RALNYLHHVVGVCHRDI 265
           + + YL       HRD+
Sbjct: 116 KGMEYLAS-KKFVHRDL 131

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 79.1 bits (195), Expect = 3e-17
 Identities = 44/137 (32%), Positives = 79/137 (57%), Gaps = 20/137 (14%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQICRALNYLH- 255
             +   +++LY  LV E++ + +    K +   +    +P+  ++ Y +Q+ + L + H 
Sbjct: 68  IHT---ENKLY--LVFEFLHQDL----KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 256 HVVGVCHRDIKPQNLLM 272
           H   V HRD+KPQNLL+
Sbjct: 119 H--RVLHRDLKPQNLLI 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 78.6 bits (194), Expect = 5e-17
 Identities = 44/141 (31%), Positives = 75/141 (53%), Gaps = 27/141 (19%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLLNHPNVVS 194
           +G G++GVV++ +  +TG  VA+KK+    R ++          RE+ +++ L HPN+V 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY---TRMNQHVPILYVQLYTYQICRAL 251
           L+       ++  LY  L+ E++S  +    K Y       Q++    V+ Y YQI + +
Sbjct: 64  LQDVLM---QESRLY--LIFEFLSMDL----KKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            + H    V HRD+KPQNLL+
Sbjct: 115 LFCHS-RRVLHRDLKPQNLLI 134

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 78.1 bits (193), Expect = 5e-17
 Identities = 45/132 (34%), Positives = 67/132 (50%), Gaps = 18/132 (13%)

Query: 148 GSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR------ELQIMRLLNHPNVVSLKHCFF 200
           G++G VF AK   TGD  AIK +   D   KN+      E  I+     P VV L   ++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60

Query: 201 STTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
           S   K  LYL  V+EY+    +  + ++   +++ V     ++Y  +I  AL YLH   G
Sbjct: 61  SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113

Query: 260 VCHRDIKPQNLL 271
           + HRD+KP N+L
Sbjct: 114 IIHRDLKPDNIL 125

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 44/139 (31%), Positives = 71/139 (51%), Gaps = 18/139 (12%)

Query: 145 VGTGSFGVVFQAKCLE--TGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
           +G G++G V++AK      G   AIKK   DK           RE+ ++R L H NVVSL
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYL 254
              F    +K  +Y  L+ +Y    ++++ K + +  +  +P   V+   +QI   ++YL
Sbjct: 68  VEVFLEHADK-SVY--LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 255 H--HVVGVCHRDIKPQNLL 271
           H   V+   HRD+KP N+L
Sbjct: 125 HSNWVL---HRDLKPANIL 140

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 23/149 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKK-VLQDKR---YKNRELQIMRLLNHPNVVS 194
           YM  R +G GS G+VF A   +    VA+KK VL D +   +  RE++I+R L+H N+V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 195 LKHCFFST-----------TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
           +      +           TE + +Y  +V EY+   +  V +      +H      +L+
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVY--IVQEYMETDLANVLEQGPLSEEH-----ARLF 119

Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            YQ+ R L Y+H    V HRD+KP N+ +
Sbjct: 120 MYQLLRGLKYIHS-ANVLHRDLKPANVFI 147

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 76.4 bits (189), Expect = 2e-16
 Identities = 36/143 (25%), Positives = 61/143 (42%), Gaps = 27/143 (18%)

Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           + +G G+FG V++      G+     VA+K + +    +       E  IM+ L+HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRA 250
            L       T+ + LY  +V EY    +       + R +    +    L     QI + 
Sbjct: 65  RLLGVC---TQGEPLY--IVTEY----MPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKG 114

Query: 251 LNYLH--HVVGVCHRDIKPQNLL 271
           + YL   + V   HRD+  +N L
Sbjct: 115 MEYLESKNFV---HRDLAARNCL 134

Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 75.9 bits (187), Expect = 3e-16
 Identities = 47/136 (34%), Positives = 70/136 (51%), Gaps = 15/136 (11%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHC 198
           V+G G+  VV+ A CL   + VAIK++  +K   +     +E+Q M   NHPNVV   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKH-YTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F     DEL+  LV+ Y+S  ++  + K  Y R      I+   L   ++ + L YLH 
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 257 VVGVCHRDIKPQNLLM 272
             G  HRDIK  N+L+
Sbjct: 121 -NGQIHRDIKAGNILL 135

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 76.3 bits (188), Expect = 3e-16
 Identities = 50/134 (37%), Positives = 73/134 (54%), Gaps = 15/134 (11%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKN---RELQIMRLLNHPNVVSLKH 197
           +VG GS+G+V + K  ETG  VAIKK L+   DK  K    RE+++++ L H N+V+L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
            F     K  LY  LV E++  TV    + Y      +    V+ Y +QI R + + H  
Sbjct: 68  VF---RRKKRLY--LVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHS- 118

Query: 258 VGVCHRDIKPQNLL 271
             + HRDIKP+N+L
Sbjct: 119 HNIIHRDIKPENIL 132

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 75.7 bits (187), Expect = 8e-16
 Identities = 45/142 (31%), Positives = 73/142 (51%), Gaps = 20/142 (14%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIM---RLLNH 189
           Y   + +G G++G+V++A    T + VA+KK+        D +   RE  IM    L +H
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE--IMFLQELGDH 66

Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           PN+V L +   +  +KD +Y  LV EY+   ++ V +     + H      +   YQ+ +
Sbjct: 67  PNIVKLLNVIKAENDKD-IY--LVFEYMETDLHAVIRANILEDVH-----KRYIMYQLLK 118

Query: 250 ALNYLHHVVGVCHRDIKPQNLL 271
           AL Y+H    V HRD+KP N+L
Sbjct: 119 ALKYIHS-GNVIHRDLKPSNIL 139

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 75.5 bits (186), Expect = 8e-16
 Identities = 44/142 (30%), Positives = 79/142 (55%), Gaps = 15/142 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
           Y+  + +G G++G+V  AK  ET + VAIKK+        D +   RE++++R L+H NV
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 193 VSLKHCFFSTTEK--DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           +++K        +  +++Y  +V E +   ++++     R +Q +   + Q + YQ+ R 
Sbjct: 67  IAIKDIMPPPHREAFNDVY--IVYELMDTDLHQI----IRSSQTLSDDHCQYFLYQLLRG 120

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L Y+H    V HRD+KP NLL+
Sbjct: 121 LKYIHS-ANVLHRDLKPSNLLL 141

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 74.3 bits (182), Expect = 1e-15
 Identities = 49/143 (34%), Positives = 77/143 (53%), Gaps = 14/143 (9%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHP 190
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+ +++ LNHP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           NV+     F    E     LN+VLE   +  + R+ KH+ +  + +P   V  Y  Q+C 
Sbjct: 63  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           AL ++H    V HRDIKP N+ +
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 41/134 (30%), Positives = 67/134 (50%), Gaps = 13/134 (9%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++G+V++A+   +G+ VA+KKV  D           RE+ ++  L HPN+V LK  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
                  D ++  LV+EY  + +  +  +   M        V+    Q+ R L YLH   
Sbjct: 75  VVG-KHLDSIF--LVMEYCEQDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 259 GVCHRDIKPQNLLM 272
            + HRD+K  NLL+
Sbjct: 129 -IIHRDLKVSNLLL 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 44/135 (32%), Positives = 71/135 (52%), Gaps = 17/135 (12%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++G VF+AK  ET + VA+K+V  D   +       RE+ +++ L H N+V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             S  +     L LV EY  +    + K++   N  +    V+ + +Q+ + L + H H 
Sbjct: 68  LHSDKK-----LTLVFEYCDQD---LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 119 -NVLHRDLKPQNLLI 132

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 72.3 bits (178), Expect = 6e-15
 Identities = 32/140 (22%), Positives = 63/140 (45%), Gaps = 14/140 (10%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
            +G GSFG V + +    G  +  K++       ++K+    E+ I+R L HPN+V    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
                + +    L +V+EY     + ++ +   +  +++   ++     Q+  AL   H+
Sbjct: 67  RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 257 VVG----VCHRDIKPQNLLM 272
                  V HRD+KP N+ +
Sbjct: 124 RSDPGNTVLHRDLKPANIFL 143

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 72.6 bits (179), Expect = 7e-15
 Identities = 39/131 (29%), Positives = 71/131 (54%), Gaps = 13/131 (9%)

Query: 148 GSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHCFFS 201
           G++GVV++A+  +TG+ VA+KK+  +K  +       RE+ I+  L HPN+V++K     
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75

Query: 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
           +   D++Y  +V+EY+   +  + +    M Q      V+    Q+   + +LH    + 
Sbjct: 76  SNL-DKIY--MVMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD-NWIL 128

Query: 262 HRDIKPQNLLM 272
           HRD+K  NLL+
Sbjct: 129 HRDLKTSNLLL 139

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.4 bits (177), Expect = 7e-15
 Identities = 44/143 (30%), Positives = 75/143 (52%), Gaps = 14/143 (9%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHP 190
           ++  E+ +G G F  V++A CL     VA+KKV    + D + +    +E+ +++ LNHP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           NV+     F    E     LN+VLE      + ++ K++ +  + +P   V  Y  Q+C 
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           A+ ++H    V HRDIKP N+ +
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 71.2 bits (175), Expect = 1e-14
 Identities = 43/139 (30%), Positives = 74/139 (53%), Gaps = 20/139 (14%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPNVVSL 195
           RV+G G+FG V   +  +T    A+K     K ++    +N   E +I++ LNHP +V+L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 196 KHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
            + F     +DE  + LV++ +   +  Y +S+   + ++      V+ +  +I  AL Y
Sbjct: 66  WYSF-----QDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQ----VKFWICEIVLALEY 115

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH   G+ HRDIKP N+L+
Sbjct: 116 LHSK-GIIHRDIKPDNILL 133

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 71.3 bits (175), Expect = 1e-14
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 20/139 (14%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVL---QDKRYK------NRELQIMRLLNHPNVV 193
            ++G+GSFG V++   L+ GD  A+K+V      +  +       +E+ ++  L HPN+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
                 +  TE++E  L + LE +   ++ ++ K Y    + V    ++LYT QI   L 
Sbjct: 66  Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV----IRLYTRQILLGLE 116

Query: 253 YLHHVVGVCHRDIKPQNLL 271
           YLH      HRDIK  N+L
Sbjct: 117 YLHD-RNTVHRDIKGANIL 134

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 71.1 bits (175), Expect = 1e-14
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 20/136 (14%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFFS 201
            +G GS+G V++A   ETG  VAIK V  ++  +   +E+ I++  + P +V     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 202 TTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            T+     L +V+EY     +S+ +   +K  T          +    YQ  + L YLH 
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEE-------IAAILYQTLKGLEYLHS 117

Query: 257 VVGVCHRDIKPQNLLM 272
                HRDIK  N+L+
Sbjct: 118 -NKKIHRDIKAGNILL 132

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 70.8 bits (173), Expect = 2e-14
 Identities = 49/135 (36%), Positives = 74/135 (54%), Gaps = 15/135 (11%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKH 197
           VVG G++GVV + +  ET + VAIKK          K    REL+++R L   N+V LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
            F     + +LY  LV EY+ + +  + +    M   VP   V+ Y YQ+ +A+++ H  
Sbjct: 68  AF---RRRGKLY--LVFEYVEKNMLELLE---EMPNGVPPEKVRSYIYQLIKAIHWCHK- 118

Query: 258 VGVCHRDIKPQNLLM 272
             + HRDIKP+NLL+
Sbjct: 119 NDIVHRDIKPENLLI 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 2e-14
 Identities = 41/137 (29%), Positives = 74/137 (54%), Gaps = 22/137 (16%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDK---RYKNRELQIMRLLNHPNVVSLKHCFF 200
           +G+G++G V++A+ + TG+ VAIK + L+         +E+ +++   HPN+V+    + 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 201 STTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
               +D+L+  +V+EY     + + +Y+V++      Q   I YV   T +    L YLH
Sbjct: 71  R---RDKLW--IVMEYCGGGSLQD-IYQVTRGPLSELQ---IAYVCRETLK---GLAYLH 118

Query: 256 HVVGVCHRDIKPQNLLM 272
              G  HRDIK  N+L+
Sbjct: 119 E-TGKIHRDIKGANILL 134

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 70.7 bits (174), Expect = 3e-14
 Identities = 46/146 (31%), Positives = 74/146 (50%), Gaps = 32/146 (21%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLL---NHPN 191
           +G G++G V++A+ L TG  VA+KKV    R             RE+ +++ L    HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 192 VVSLKH-CFFSTTEKDELYLNLVLEYISE--TVY--RVSKHYTRMNQHVPILYVQLYTYQ 246
           +V L   C    T++ EL L LV E++ +    Y  +  K        +P   ++    Q
Sbjct: 63  IVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPK------PGLPPETIKDLMRQ 115

Query: 247 ICRALNYLH-HVVGVCHRDIKPQNLL 271
           + R +++LH H   + HRD+KPQN+L
Sbjct: 116 LLRGVDFLHSHR--IVHRDLKPQNIL 139

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 70.7 bits (173), Expect = 5e-14
 Identities = 45/139 (32%), Positives = 69/139 (49%), Gaps = 14/139 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN---RELQIMRLLNHPNV 192
           Y + + VG+G++G V  A    TG+ VAIKK+    Q + +     REL +++ + H NV
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           + L   F S    DE     LV+ Y+   + ++      M   +    VQ   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI------MGHPLSEDKVQYLVYQMLCGL 130

Query: 252 NYLHHVVGVCHRDIKPQNL 270
            Y+H   G+ HRD+KP NL
Sbjct: 131 KYIHS-AGIIHRDLKPGNL 148

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 9e-14
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 27/145 (18%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLL-NHPNVVSLKH 197
           V+G G++G V++A+  +TG  VAIK  + D           E  I+R   NHPN+ +   
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 198 CFF---STTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
            F         D+L+  LV+E      +++ V  + K   R+ +   I Y+     +  R
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAYI---LRETLR 124

Query: 250 ALNYLH--HVVGVCHRDIKPQNLLM 272
            L YLH   V+   HRDIK QN+L+
Sbjct: 125 GLAYLHENKVI---HRDIKGQNILL 146

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 20/143 (13%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKR----YKNRELQIMRLLNHPNV 192
           +Y     +G GS+  V++ +   TG  VA+K++ L+ +        RE  +++ L H N+
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY---VQLYTYQICR 249
           V+L H    T +     L LV EY    +    K Y  M+     L    V+L+ +Q+ R
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEY----LDTDLKQY--MDDCGGGLSMHNVRLFLFQLLR 114

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
            L Y H    V HRD+KPQNLL+
Sbjct: 115 GLAYCHQR-RVLHRDLKPQNLLI 136

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 68.3 bits (167), Expect = 3e-13
 Identities = 51/141 (36%), Positives = 71/141 (50%), Gaps = 23/141 (16%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMR----LLN---HPNVV 193
           +V+G GSFG V  AK    G   A+ KVLQ K    K  +  IM     LL    HP +V
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            L H  F T +K  LY   VL+Y++  E  +    H  R  +  P    + Y  +I  AL
Sbjct: 60  GL-HYSFQTADK--LY--FVLDYVNGGELFF----HLQR-ERSFPEPRARFYAAEIASAL 109

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            YLH  + + +RD+KP+N+L+
Sbjct: 110 GYLHS-LNIIYRDLKPENILL 129

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 67.7 bits (166), Expect = 3e-13
 Identities = 32/135 (23%), Positives = 61/135 (45%), Gaps = 12/135 (8%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVL--QDKRYKN---RELQIMRLLNHPNVVSLKH 197
             +G G+ GVV +     TG  +A+K +    ++  +    REL I+   N P +V    
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
            F++  +     +++ +EY+      + K    +   +P   +      + + L YLH  
Sbjct: 67  AFYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 258 VGVCHRDIKPQNLLM 272
             + HRD+KP N+L+
Sbjct: 120 HKIIHRDVKPSNILV 134

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 67.5 bits (165), Expect = 3e-13
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 25/149 (16%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--------LQDKRYK------NRELQIM 184
           ++   ++G G++G V+ A  + TG+ +A+K+V          D R K        E++ +
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLY 243
           + L+H N+V          E  E YL++ LEY+   ++    + Y R  + +    V+ +
Sbjct: 63  KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113

Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           T Q+   L YLH   G+ HRD+K  NLL+
Sbjct: 114 TEQVLEGLAYLHS-KGILHRDLKADNLLV 141

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 67.5 bits (165), Expect = 4e-13
 Identities = 37/136 (27%), Positives = 68/136 (50%), Gaps = 9/136 (6%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++G V++A+   TG  VA+KK   +   +       RE+ ++++L+    +     
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 199 FFSTTEKD-ELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYLHH 256
                EK+ +  L LV EY+   + +      R     +P   ++ + YQ+ + + + H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 257 VVGVCHRDIKPQNLLM 272
             GV HRD+KPQNLL+
Sbjct: 129 H-GVMHRDLKPQNLLV 143

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 67.5 bits (165), Expect = 6e-13
 Identities = 48/145 (33%), Positives = 72/145 (49%), Gaps = 29/145 (20%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKK---VLQD----KRYKNRELQIMRLLNHPNVVS 194
           +R +G G+FGVV+       G  VA+KK   V Q+    KR   REL+++    H NV+S
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63

Query: 195 --------LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
                       F      +E+Y+  V E +   ++++        Q +   +V+++ YQ
Sbjct: 64  ALDILQPPHIDPF------EEIYV--VTELMQSDLHKI----IVSPQPLSSDHVKVFLYQ 111

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLL 271
           I R L YLH   G+ HRDIKP NLL
Sbjct: 112 ILRGLKYLHS-AGILHRDIKPGNLL 135

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 8e-13
 Identities = 32/140 (22%), Positives = 56/140 (40%), Gaps = 17/140 (12%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPNVV 193
           +     +G GSFG V++A    T   VAIK +       +     +E+Q +     P + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
                F   ++     L +++EY    +   + K       ++  +       ++   L 
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGKLDETYIAFI-----LREVLLGLE 112

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH   G  HRDIK  N+L+
Sbjct: 113 YLHE-EGKIHRDIKAANILL 131

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 66.6 bits (163), Expect = 8e-13
 Identities = 42/141 (29%), Positives = 68/141 (48%), Gaps = 21/141 (14%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKH- 197
           +G G+FG VF+A+  +T   VA+KKVL +   +       RE++I++LL H NVV+L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 198 CFFSTTE----KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRAL 251
           C    T     K   Y  LV E+    +  +       N++V     ++      +   L
Sbjct: 80  CRTKATPYNRYKGSFY--LVFEFCEHDLAGLLS-----NKNVKFTLSEIKKVMKMLLNGL 132

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            Y+H    + HRD+K  N+L+
Sbjct: 133 YYIHR-NKILHRDMKAANILI 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 41/149 (27%)

Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKHC 198
           G G+FG V++A+ ++TG  VA+KK+L     K+       RE++I++ L HPNVV L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPL--- 72

Query: 199 FFSTTEKDELYLNLVLEYISET------VYRVSK----------HYTRMNQHVPILYVQL 242
                      +++ +E   ++      VY V+               +        ++ 
Sbjct: 73  -----------IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES--QIKC 119

Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLL 271
           Y  Q+   +NYLH    + HRDIK  N+L
Sbjct: 120 YMLQLLEGINYLHE-NHILHRDIKAANIL 147

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 66.0 bits (161), Expect = 1e-12
 Identities = 45/142 (31%), Positives = 68/142 (47%), Gaps = 19/142 (13%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKH 197
            +G G++G V++A+  +TG+ VA+KKV  D   +       RE++I+R LNH N+V+LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 198 CFFSTTE-----KDELYLNLVLEYISETVYRV--SKHYTRMNQHVPILYVQLYTYQICRA 250
                 +     KD+    LV EY+   +  +  S        H+     QL        
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL-----EG 128

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           LNY H      HRDIK  N+L+
Sbjct: 129 LNYCHK-KNFLHRDIKCSNILL 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 43/134 (32%), Positives = 70/134 (52%), Gaps = 15/134 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
           VG+G++G V  A    TG  VAIKK+       L  KR   REL++++ + H NV+ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMKHENVIGLLD 81

Query: 198 CFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F      D  +   LV+ ++   + ++ KH  ++++      +Q   YQ+ + L Y+ H
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSED----RIQFLVYQMLKGLKYI-H 135

Query: 257 VVGVCHRDIKPQNL 270
             G+ HRD+KP NL
Sbjct: 136 AAGIIHRDLKPGNL 149

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 64.5 bits (157), Expect = 4e-12
 Identities = 44/144 (30%), Positives = 76/144 (52%), Gaps = 22/144 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
           Y     +G G++GVV++A+   T +++A+KK+  ++  +       RE+ +++ + H N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYR---VSKHYTRMNQHVPILYVQLYTYQICR 249
           V L+    S     E  L LV EY+   + +    S  + + N  +    ++ Y YQI R
Sbjct: 64  VRLQDVVHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILR 113

Query: 250 ALNYLH-HVVGVCHRDIKPQNLLM 272
            + Y H H   V HRD+KPQNLL+
Sbjct: 114 GIAYCHSH--RVLHRDLKPQNLLI 135

Length = 294

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 64.1 bits (156), Expect = 5e-12
 Identities = 42/141 (29%), Positives = 76/141 (53%), Gaps = 21/141 (14%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV--------LQDKRYKN--RELQIMRLLNHPNV 192
           + +GTG+F   +QA+ ++TG  +A+K+V         Q++  +   +E+++M  LNHP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           +       +T E    + NL +E+++  +V  +   Y    + V I     YT Q+ R L
Sbjct: 66  I---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEAVII----NYTEQLLRGL 116

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           +YLH    + HRD+K  NLL+
Sbjct: 117 SYLHE-NQIIHRDVKGANLLI 136

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.4 bits (157), Expect = 5e-12
 Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 18/136 (13%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
           +G G++  V++ +   TG+ VA+K++  D          RE+ +M+ L H N+V L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH---VPILYVQLYTYQICRALNYLHH 256
             T  K    L LV EY+ + +    K Y   +     +    V+ +TYQ+ + + + H 
Sbjct: 67  IHTENK----LMLVFEYMDKDL----KKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 257 VVGVCHRDIKPQNLLM 272
              V HRD+KPQNLL+
Sbjct: 119 N-RVLHRDLKPQNLLI 133

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 16/137 (11%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
           R +G GSFG V+ A+ + T + VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           K C+       E    LV+EY   +   + + + +  Q V I  +    +   + L YLH
Sbjct: 81  KGCYLR-----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI---CHGALQGLAYLH 132

Query: 256 HVVGVCHRDIKPQNLLM 272
                 HRDIK  N+L+
Sbjct: 133 S-HERIHRDIKAGNILL 148

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 47/141 (33%), Positives = 73/141 (51%), Gaps = 23/141 (16%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ---------IMRLLNHPNVV 193
           +V+G GSFG V  AK    G   A+ KVLQ K   NR+ Q         +++ + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAV-KVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            L H  F TTEK    L  VL++++  E  + + +  +      P    + Y  +I  AL
Sbjct: 60  GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASAL 109

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            YLH  + + +RD+KP+N+L+
Sbjct: 110 GYLHS-INIVYRDLKPENILL 129

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 62.1 bits (151), Expect = 2e-11
 Identities = 43/141 (30%), Positives = 67/141 (47%), Gaps = 15/141 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR-----ELQIMRLLNHPNV 192
           Y+  RV+G G+FG     +  E    V  K+V L     K R     E+ I+ LL HPN+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           ++  + F      D+  L + +EY +  T+Y       +  Q      V  Y +QI  A+
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           +Y+H   G+ HRDIK  N+ +
Sbjct: 115 SYIHK-AGILHRDIKTLNIFL 134

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 61.4 bits (149), Expect = 5e-11
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 24/148 (16%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-------QDKRYKN------RELQIMR 185
           ++   ++G+GSFG V+      +G+ +A+K+V           R ++      RE+ +++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYT 244
            L H N+V            D  +LN+ LEY+   +V  +  +Y    + +    V+ + 
Sbjct: 62  ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
            QI + LNYLH+  G+ HRDIK  N+L+
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILV 139

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 61.6 bits (149), Expect = 6e-11
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 17/141 (12%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
           Y     VG+G++G V  A        VA+KK+      L   R   REL++++ + H NV
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 193 VSLKHCFFSTT---EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           + L   F   T     +E+YL  V   +   +  + K     ++HV     Q   YQ+ R
Sbjct: 77  IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVKCQKLSDEHV-----QFLIYQLLR 129

Query: 250 ALNYLHHVVGVCHRDIKPQNL 270
            L Y+H   G+ HRD+KP N+
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNV 149

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 61.3 bits (149), Expect = 8e-11
 Identities = 48/144 (33%), Positives = 76/144 (52%), Gaps = 24/144 (16%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKR-YKNRELQIMRLLNHP 190
           Y   + +G+G+ G+V  A    TG +VAIKK       V   KR Y  REL +M+L+NH 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 191 NVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMN-QHVPILYVQLYTYQ 246
           N++ L + F    S  E  ++Y  LV+E +   + +V     +M+  H  + Y+    YQ
Sbjct: 76  NIIGLLNVFTPQKSLEEFQDVY--LVMELMDANLCQV----IQMDLDHERMSYL---LYQ 126

Query: 247 ICRALNYLHHVVGVCHRDIKPQNL 270
           +   + +LH   G+ HRD+KP N+
Sbjct: 127 MLCGIKHLHS-AGIIHRDLKPSNI 149

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 48/134 (35%), Positives = 71/134 (52%), Gaps = 18/134 (13%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVSLKHC 198
           +G GS G+V  A    TG  VA+KK+  D R + R      E+ IMR   HPN+V +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
           + S    DEL+  +V+E++          +TRMN+   I  V L    + +AL++L H  
Sbjct: 82  YSSYLVGDELW--VVMEFLEGGALTDIVTHTRMNEE-QIATVCL---AVLKALSFL-HAQ 134

Query: 259 GVCHRDIKPQNLLM 272
           GV HRDIK  ++L+
Sbjct: 135 GVIHRDIKSDSILL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 41/145 (28%), Positives = 64/145 (44%), Gaps = 30/145 (20%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------------------RELQIMR 185
           +G G++G V +A    TG  VAIKKV +     N                   REL+IM 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
            + H N++ L   +    E D  ++NLV++ ++  + +V     R+        V+    
Sbjct: 76  EIKHENIMGLVDVY---VEGD--FINLVMDIMASDLKKVVDRKIRLT----ESQVKCILL 126

Query: 246 QICRALNYLHHVVGVCHRDIKPQNL 270
           QI   LN LH    + HRD+ P N+
Sbjct: 127 QILNGLNVLHKWYFM-HRDLSPANI 150

Length = 335

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.5 bits (146), Expect = 1e-10
 Identities = 47/143 (32%), Positives = 74/143 (51%), Gaps = 20/143 (13%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKR----YKNRELQIMRLLNHPNV 192
           SY     +G GS+  V++ K    G  VA+K + LQ++        RE  +++ L H N+
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY---VQLYTYQICR 249
           V L H    T E     L LV EY+   + +       M++H   L+   V+L+ +Q+ R
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDLCQY------MDKHPGGLHPENVKLFLFQLLR 114

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
            L+Y+H    + HRD+KPQNLL+
Sbjct: 115 GLSYIHQRY-ILHRDLKPQNLLI 136

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 24/141 (17%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR------ELQIMRLLNHPNVV 193
           +++G G+FG V+    ++TG  +A+K+V         K        E+Q+++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
               C      +D+  L++ +EY+   +V    K Y  + + V     + YT QI   + 
Sbjct: 68  QYYGC-----LRDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118

Query: 253 YLH--HVVGVCHRDIKPQNLL 271
           YLH   +V   HRDIK  N+L
Sbjct: 119 YLHSNMIV---HRDIKGANIL 136

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 48/139 (34%), Positives = 68/139 (48%), Gaps = 19/139 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGD--SVAIKKVLQDKRYKNR-------ELQIMRLLNHPNVV 193
           R +GTGSFG V  A   +  D   VAIK+  + K  K +       E +I+  +NHP  V
Sbjct: 36  RTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           +L   F     KDE YL LVLE++    +     + R N+  P      Y  QI     Y
Sbjct: 95  NLYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEY 146

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           L  +  + +RD+KP+NLL+
Sbjct: 147 LQSL-NIVYRDLKPENLLL 164

Length = 340

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 43/134 (32%), Positives = 65/134 (48%), Gaps = 15/134 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQIMRLLNHPNVVSLKH 197
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H NV+ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 198 CFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F      +E   + LV   +   +  + K     + HV     Q   YQI R L Y+H 
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-----QFLIYQILRGLKYIHS 138

Query: 257 VVGVCHRDIKPQNL 270
              + HRD+KP NL
Sbjct: 139 A-DIIHRDLKPSNL 151

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 19/150 (12%)

Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKK-----VLQDKRYKNRELQ 182
            K+ + ++  + +G G FG V      +     TG+ VA+K        Q +    RE++
Sbjct: 2   EKRHLKFI--KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIE 58

Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
           I+R L+H N+V  K        +    L L++EY+     R      R   ++  L   L
Sbjct: 59  ILRTLDHENIVKYKGVCEKPGGRS---LRLIMEYLPSGSLRDYLQRHRDQINLKRLL--L 113

Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           ++ QIC+ ++YL       HRD+  +N+L+
Sbjct: 114 FSSQICKGMDYLGS-QRYIHRDLAARNILV 142

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 43/145 (29%), Positives = 73/145 (50%), Gaps = 24/145 (16%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
           +Y+    +G G++  VF+ +   T + VA+K++  +          RE+ +++ L H N+
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY-----TRMNQHVPILYVQLYTYQI 247
           V+L H    T    E  L LV EY+   +    K Y       M+ H     V+++ +Q+
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSDL----KQYLDNCGNLMSMH----NVKIFMFQL 112

Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
            R L+Y H    + HRD+KPQNLL+
Sbjct: 113 LRGLSYCHKR-KILHRDLKPQNLLI 136

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 22/144 (15%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPN 191
           SY+    +G GS+  V++      G  VA+K V+  K  +       RE  +++ L H N
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY---VQLYTYQIC 248
           +V L H    T E     L  V EY+   + +       M QH   L+   V+L+ +Q+ 
Sbjct: 65  IVLL-HDIIHTKET----LTFVFEYMHTDLAQY------MIQHPGGLHPYNVRLFMFQLL 113

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
           R L Y+H    + HRD+KPQNLL+
Sbjct: 114 RGLAYIHGQ-HILHRDLKPQNLLI 136

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 58.6 bits (142), Expect = 4e-10
 Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 15/135 (11%)

Query: 146 GTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR-----ELQIMRLLNHPNVVSLKHCF 199
           G GS+G V++ K L      A+K+V L     K R     E++I+  +NHPN++S K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 200 FSTTEKDELYLNLVLEY--ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
                 D   L +V+EY    +    +SK   +    +P   +     Q+ R L  LH  
Sbjct: 69  L-----DGNKLCIVMEYAPFGDLSKAISKRKKKRKL-IPEQEIWRIFIQLLRGLQALHE- 121

Query: 258 VGVCHRDIKPQNLLM 272
             + HRD+K  N+L+
Sbjct: 122 QKILHRDLKSANILL 136

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 59.0 bits (143), Expect = 4e-10
 Identities = 46/139 (33%), Positives = 65/139 (46%), Gaps = 21/139 (15%)

Query: 145 VGTGSFGVVFQAKCLETGDS--VAIKKV-------LQDKRYKNRELQIMRLL-NHPNVVS 194
           +G G++G+V  A+  ET +   VAIKK+       +  KR   REL+++R    H N+  
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-ALRELKLLRHFRGHKNITC 66

Query: 195 LKHCFFSTTEK-DELYLNLVL-EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L           +ELYL   L E     + R  +  T  + H      Q + YQI   L 
Sbjct: 67  LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT--DAHF-----QSFIYQILCGLK 119

Query: 253 YLHHVVGVCHRDIKPQNLL 271
           Y+H    V HRD+KP NLL
Sbjct: 120 YIHSA-NVLHRDLKPGNLL 137

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 24/145 (16%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
           +Y+    +G G++  V++ +   T + VA+K++  +          RE+ +++ L H N+
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY-----TRMNQHVPILYVQLYTYQI 247
           V+L       TEK    L LV EY+ + +    K Y       +N H     V+L+ +Q+
Sbjct: 67  VTLHDIIH--TEKS---LTLVFEYLDKDL----KQYLDDCGNSINMH----NVKLFLFQL 113

Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
            R LNY H    V HRD+KPQNLL+
Sbjct: 114 LRGLNYCHRR-KVLHRDLKPQNLLI 137

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.1 bits (140), Expect = 6e-10
 Identities = 46/140 (32%), Positives = 77/140 (55%), Gaps = 17/140 (12%)

Query: 145 VGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN------RELQIMRLLN---HPNVVS 194
           +G G++G VF+A+ L+ G   VA+K+V      +       RE+ ++R L    HPNVV 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 195 L-KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM-NQHVPILYVQLYTYQICRALN 252
           L   C  S T++ E  L LV E++ + +   + +  ++    VP   ++   +Q+ R L+
Sbjct: 69  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +LH    V HRD+KPQN+L+
Sbjct: 125 FLHSH-RVVHRDLKPQNILV 143

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 42/137 (30%), Positives = 74/137 (54%), Gaps = 13/137 (9%)

Query: 145 VGTGSFGVVFQAKCLETGDS--VAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFF 200
           VG G++G V++AK  +  D    A+K++          RE+ ++R L HPNV+SL+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 201 STTEKDELYLNLVLEYISETVYRVSKHY--TRMNQ---HVPILYVQLYTYQICRALNYLH 255
           S  ++    + L+ +Y    ++ + K +  ++ N+    +P   V+   YQI   ++YL 
Sbjct: 69  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL- 124

Query: 256 HVVGVCHRDIKPQNLLM 272
           H   V HRD+KP N+L+
Sbjct: 125 HANWVLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 58.7 bits (142), Expect = 6e-10
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 25/167 (14%)

Query: 116 TEAGQVIATTVGGRNGQPKQTISYMA-ERV--VGTGSFGVVFQAKCLETGDSVAIKKVLQ 172
             +    +++       P    S    ERV  +G+G+ G V++     TG   A+K +  
Sbjct: 50  PSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109

Query: 173 D-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKH 227
           +     +R   RE++I+R +NHPNVV     F    E     + ++LE++       S  
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE-----IQVLLEFMD----GGSLE 160

Query: 228 YTRMNQHVPILYVQLYTYQICRALNYLH--HVVGVCHRDIKPQNLLM 272
            T +       ++     QI   + YLH  H+V   HRDIKP NLL+
Sbjct: 161 GTHIADE---QFLADVARQILSGIAYLHRRHIV---HRDIKPSNLLI 201

Length = 353

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 57.9 bits (140), Expect = 7e-10
 Identities = 39/136 (28%), Positives = 61/136 (44%), Gaps = 16/136 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSLK 196
           +G G FG V   +   TG   A KK L  KR K R        E +I+  ++   +VSL 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
           + F +   KD+L L + L    +  Y +             ++   Y  QI   L +LH 
Sbjct: 60  YAFET---KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF---YAAQIICGLEHLHQ 113

Query: 257 VVGVCHRDIKPQNLLM 272
              + +RD+KP+N+L+
Sbjct: 114 R-RIVYRDLKPENVLL 128

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 37/137 (27%), Positives = 66/137 (48%), Gaps = 20/137 (14%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSLK 196
           V+G G+FG V+  +  +TG   A+K + +    K  ++        I+   + P +V L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           +  F    +DE +L LV+EY+   + +  + +         P    + Y  ++  AL+ +
Sbjct: 67  YYSF----QDEEHLYLVMEYMPGGDLMNLLIRKDV-----FPEETARFYIAELVLALDSV 117

Query: 255 HHVVGVCHRDIKPQNLL 271
           H  +G  HRDIKP N+L
Sbjct: 118 HK-LGFIHRDIKPDNIL 133

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 39/139 (28%), Positives = 64/139 (46%), Gaps = 22/139 (15%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNH---PNVVSL 195
           ++G G++G V++ K + TG  VA+K +  D    +     RE+ ++  L     PN+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPI--LYVQLYTYQICRALNY 253
              +          L +++EY      R     T M    PI   Y+ +   ++  AL Y
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVR-----TLMKAG-PIAEKYISVIIREVLVALKY 116

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           +H  VGV HRDIK  N+L+
Sbjct: 117 IHK-VGVIHRDIKAANILV 134

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 57.4 bits (138), Expect = 1e-09
 Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 20/148 (13%)

Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIM 184
           G P++ +    +  +G GS G+V  A    TG  VA+KK+  D R + R      E+ IM
Sbjct: 18  GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73

Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
           R  +H NVV +   + S    DEL+  +V+E++          +TRMN+      +    
Sbjct: 74  RDYHHENVVDM---YNSYLVGDELW--VVMEFLEGGALTDIVTHTRMNEE----QIATVC 124

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
             + RAL+YLH+  GV HRDIK  ++L+
Sbjct: 125 LSVLRALSYLHN-QGVIHRDIKSDSILL 151

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.9 bits (138), Expect = 1e-09
 Identities = 36/136 (26%), Positives = 60/136 (44%), Gaps = 18/136 (13%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
           +G G FG V   K      + A+K V          + +   E +I+   NHP +V L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
             F    KD+ Y+ +++EY     ++       R          + Y   +  A  YLH+
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELW----TILRDRGLFDEYTARFYIACVVLAFEYLHN 111

Query: 257 VVGVCHRDIKPQNLLM 272
             G+ +RD+KP+NLL+
Sbjct: 112 R-GIIYRDLKPENLLL 126

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.4 bits (138), Expect = 1e-09
 Identities = 41/137 (29%), Positives = 75/137 (54%), Gaps = 13/137 (9%)

Query: 145 VGTGSFGVVFQAKCLETGDS--VAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFF 200
           VG G++G V++AK  +  D    A+K++          RE+ ++R L HPNV++L+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 201 STTEKDELYLNLVLEYISETVYRVSKHY--TRMNQ---HVPILYVQLYTYQICRALNYLH 255
           S +++    + L+ +Y    ++ + K +  ++ N+    +P   V+   YQI   ++YL 
Sbjct: 69  SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL- 124

Query: 256 HVVGVCHRDIKPQNLLM 272
           H   V HRD+KP N+L+
Sbjct: 125 HANWVLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 45/141 (31%), Positives = 75/141 (53%), Gaps = 22/141 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-------ELQIMRLLNHPNVV 193
           +V+G GSFG VF  + +   D+  +   KVL+    K R       E  I+  +NHP +V
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY--VQLYTYQICRAL 251
            L H  F T  K    L L+L+++     R    +TR+++ V      V+ Y  ++  AL
Sbjct: 62  KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 111

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           ++LH + G+ +RD+KP+N+L+
Sbjct: 112 DHLHSL-GIIYRDLKPENILL 131

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 25/137 (18%)

Query: 148 GSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNH---PNVVSLKHCF 199
           G+FG V+ AK   TGD  AIK      ++   +  N + +   ++     P V  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63

Query: 200 FSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +S   KD  YL LV+EY++     ++        +    +P  + + Y  ++   +  LH
Sbjct: 64  YSFQSKD--YLYLVMEYLNGGDCASL-------IKTLGGLPEDWAKQYIAEVVLGVEDLH 114

Query: 256 HVVGVCHRDIKPQNLLM 272
              G+ HRDIKP+NLL+
Sbjct: 115 QR-GIIHRDIKPENLLI 130

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 16/135 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK--NRELQIMRLLNHPNVVSLKH 197
           +GTGSFG V  AK   TG+  AIK     ++L+ K+ +   +E  I+  L+HP +V++  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
            F    +++ +Y   +LE++      +  H  R     P    + Y  ++  A  YLH  
Sbjct: 86  SF---QDENRVY--FLLEFVVGG--ELFTHL-RKAGRFPNDVAKFYHAELVLAFEYLHS- 136

Query: 258 VGVCHRDIKPQNLLM 272
             + +RD+KP+NLL+
Sbjct: 137 KDIIYRDLKPENLLL 151

Length = 329

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 24/145 (16%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
           +Y+    +G G++  VF+ +   T + VA+K++  +          RE+ +++ L H N+
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTR-----MNQHVPILYVQLYTYQI 247
           V+L H    T +     L LV EY+ + +    K Y       M+ H     V+++ YQI
Sbjct: 67  VTL-HDIVHTDKS----LTLVFEYLDKDL----KQYMDDCGNIMSMH----NVKIFLYQI 113

Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
            R L Y H    V HRD+KPQNLL+
Sbjct: 114 LRGLAYCHRR-KVLHRDLKPQNLLI 137

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 56.4 bits (136), Expect = 2e-09
 Identities = 40/141 (28%), Positives = 69/141 (48%), Gaps = 15/141 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNV 192
           Y   RVVG G+FG+V   +       V IK++  ++  K+       E Q+++LL+HPN+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           +     F          L +V+EY    T+    +   R N  +    +  +  QI  AL
Sbjct: 62  IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLAL 114

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           +++H  + + HRD+K QN+L+
Sbjct: 115 HHVHTKL-ILHRDLKTQNILL 134

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 56.4 bits (136), Expect = 2e-09
 Identities = 44/138 (31%), Positives = 61/138 (44%), Gaps = 16/138 (11%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
           RV+G G FG V   +   TG   A KK L+ KR K R        E QI+  +N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L + +     KD L L L L    +  + +   Y   N          Y  +I   L  L
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    + +RD+KP+N+L+
Sbjct: 119 HR-ERIVYRDLKPENILL 135

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 40/138 (28%), Positives = 72/138 (52%), Gaps = 16/138 (11%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNR----ELQIMRLLNHPNVVSL 195
           +++G G  G VF  +   TG   A+K   K    KR K +    E +I+  L+HP + +L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F + T     YL LV++Y     ++R+ +   +  + +     + Y  ++  AL YL
Sbjct: 67  YASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYL 119

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H ++G+ +RD+KP+N+L+
Sbjct: 120 H-LLGIVYRDLKPENILL 136

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 21/143 (14%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
           Y   +V+G G+FG V   +   +    A+K + +       D  +   E  IM   N P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           VV L  C F    +D+ YL +V+EY+   + V  +S      N  VP  + + YT ++  
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVVL 153

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           AL+ +H + G+ HRD+KP N+L+
Sbjct: 154 ALDAIHSM-GLIHRDVKPDNMLL 175

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.5 bits (134), Expect = 5e-09
 Identities = 46/140 (32%), Positives = 71/140 (50%), Gaps = 22/140 (15%)

Query: 145 VGTGSFGVVFQAKCL------ETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVS 194
           +G G+FG V    C        TG+ VA+KK+        R   RE++I++ L H N+V 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALN 252
            K   +S   ++   L LV+EY+     R  + KH  R++ H  +L   LY  QIC+ + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLD-HRKLL---LYASQICKGME 122

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YL     V HRD+  +N+L+
Sbjct: 123 YLGSKRYV-HRDLATRNILV 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.3 bits (133), Expect = 5e-09
 Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 25/143 (17%)

Query: 143 RVVGTGSFGVV----FQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
           RV+G G FG V    +      TG+ VA+K + ++   +N      E+ I++ L H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRAL 251
             K C    +E+    L L++EY+     R  + KH   + Q      + L+  QIC  +
Sbjct: 70  KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ------LLLFAQQICEGM 120

Query: 252 NYLH--HVVGVCHRDIKPQNLLM 272
            YLH  H +   HRD+  +N+L+
Sbjct: 121 AYLHSQHYI---HRDLAARNVLL 140

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 6e-09
 Identities = 40/143 (27%), Positives = 64/143 (44%), Gaps = 32/143 (22%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQ---IMRLLNHPNVVSLKH 197
           VG G +G VF AK  +TG+ VA+K     +L         L    I+       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 198 CFFSTTEKDELYLNLVLEYISETVYR--------VSKHYTRMNQHVPILYVQLYTYQICR 249
            F     +D+ YL L +EY+    +R        +S+ + R            Y  ++  
Sbjct: 69  AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR-----------FYMAEMFE 112

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           A++ LH + G  HRD+KP+N L+
Sbjct: 113 AVDALHEL-GYIHRDLKPENFLI 134

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.0 bits (132), Expect = 9e-09
 Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 21/143 (14%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
           Y   +V+G G+FG V   +   T    A+K + +       D  +   E  IM   N P 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           VV L + F     +D+ YL +V+EY+   + V  +S      N  VP  + + YT ++  
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVL 153

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           AL+ +H + G  HRD+KP N+L+
Sbjct: 154 ALDAIHSM-GFIHRDVKPDNMLL 175

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 21/139 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
           +V+G G+FG V   +   +    A+K + + +  K         E  IM   N   +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 196 KHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
            H  F    +D+ YL +V+EY+   + V  +S      N  +P  + + YT ++  AL+ 
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDIPEKWARFYTAEVVLALDA 157

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           +H + G  HRD+KP N+L+
Sbjct: 158 IHSM-GFIHRDVKPDNMLL 175

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 40/138 (28%), Positives = 68/138 (49%), Gaps = 19/138 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNRE--LQ---IMRLLNHPNVVS 194
           R +G G FG V+Q   +   +   +VA+K          RE  LQ   IMR  +HP++V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNY 253
           L         ++ +++ + L  + E      + Y ++N++ + +  + LY+YQ+  AL Y
Sbjct: 72  L----IGVITENPVWIVMELAPLGEL-----RSYLQVNKYSLDLASLILYSYQLSTALAY 122

Query: 254 LHHVVGVCHRDIKPQNLL 271
           L     V HRDI  +N+L
Sbjct: 123 LESKRFV-HRDIAARNVL 139

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 53.3 bits (128), Expect = 2e-08
 Identities = 38/147 (25%), Positives = 70/147 (47%), Gaps = 26/147 (17%)

Query: 145 VGTGSFGVVFQAKCLETGDS-VAIKKVL-------QDKRYKNR-------ELQIMR-LLN 188
           +G+G+FG V++ +    G + +A+K++        +DKR +++       E+ I++  L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM---NQHVPILYVQLYTY 245
           HPN+V     F    E D LY+  V++ I        +H+  +    Q      +     
Sbjct: 68  HPNIVRYYKTF---LENDRLYI--VMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120

Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+  AL YLH    + HRD+ P N+++
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIML 147

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 2e-08
 Identities = 35/139 (25%), Positives = 69/139 (49%), Gaps = 24/139 (17%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
           VGTG+FG V   +   +    A+K +       L+ +++ + E ++++ ++HP ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 198 CFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
                TE D+ +L +++EY+      +  R S  ++             Y  +I  AL Y
Sbjct: 68  ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG-------LFYASEIVCALEY 116

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH    + +RD+KP+N+L+
Sbjct: 117 LHSK-EIVYRDLKPENILL 134

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 42/147 (28%), Positives = 64/147 (43%), Gaps = 26/147 (17%)

Query: 144 VVGTGSFGVVFQAK----CLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVV 193
            +G G FG VF AK      E G+++ + K LQ  + +N      REL + R L+H NVV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYT--YQI 247
            L        E +  Y  ++LEY      +   R +K      +  P+   Q      QI
Sbjct: 72  RL---LGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLM 272
              +++L     V   HRD+  +N L+
Sbjct: 127 ALGMDHLSNARFV---HRDLAARNCLV 150

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 47/141 (33%), Positives = 67/141 (47%), Gaps = 23/141 (16%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY--KNRELQIMRLLN-------HPNVV 193
           +V+G GSFG V  A+        A+K VLQ K    K  E  IM   N       HP +V
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            L H  F T +K    L  VL+YI+  E  Y + +    +         + Y  +I  AL
Sbjct: 60  GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPRA-----RFYAAEIASAL 109

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            YLH +  + +RD+KP+N+L+
Sbjct: 110 GYLHSL-NIVYRDLKPENILL 129

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 40/138 (28%), Positives = 70/138 (50%), Gaps = 18/138 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR------ELQIMRLLNHPNVVSL 195
           +++  G++G V+  +  ET    A+KK+  Q+   +N+      E  I+    +P VVS+
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66

Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
             C F T      +L +V+EY+       + K+   +    P+   ++Y  +   AL YL
Sbjct: 67  -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGAL----PVDMARMYFAETVLALEYL 117

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H+  G+ HRD+KP NLL+
Sbjct: 118 HNY-GIVHRDLKPDNLLI 134

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 24/143 (16%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLL---NHPN 191
           +G G++G V++A+   +G  VA+K V    R +           RE+ +++ L   +HPN
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM--NQHVPILYVQLYTYQICR 249
           +V L     ++    E  + LV E++ + +    + Y        +P   ++    Q  R
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQDL----RTYLDKVPPPGLPAETIKDLMRQFLR 119

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
            L++L H   + HRD+KP+N+L+
Sbjct: 120 GLDFL-HANCIVHRDLKPENILV 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 16/137 (11%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
           R +G GSFG V+ A+ +   + VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           + C+       E    LV+EY   +   + + + +  Q V I  V   T+   + L YLH
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132

Query: 256 HVVGVCHRDIKPQNLLM 272
               + HRD+K  N+L+
Sbjct: 133 S-HNMIHRDVKAGNILL 148

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 52.9 bits (127), Expect = 5e-08
 Identities = 40/138 (28%), Positives = 71/138 (51%), Gaps = 19/138 (13%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKK----VLQDKR---YKNRELQIMRLLNHPNVVSLK 196
           +VG G FG V   +   TGD  A+K     VL  +    +   E  I+ + N P +  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 197 HCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           + F    +KD LYL  V+EY    + +  ++++  + ++ +     Q Y  ++  A++ +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G  HRDIKP+N+L+
Sbjct: 119 HQM-GYVHRDIKPENVLI 135

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 52.7 bits (126), Expect = 5e-08
 Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 16/135 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKH 197
           +G GSFG V+ A    T + VA+KK+    +  N       +E++ ++ L HPN +  K 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
           C+       E    LV+EY   +   + + + +  Q V I  +   T+   + L YLH  
Sbjct: 89  CYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHSH 140

Query: 258 VGVCHRDIKPQNLLM 272
             + HRDIK  N+L+
Sbjct: 141 NMI-HRDIKAGNILL 154

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 52.6 bits (126), Expect = 5e-08
 Identities = 43/140 (30%), Positives = 73/140 (52%), Gaps = 21/140 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYK--NRELQIMRLL-NHPNVVS 194
           RV+G GSFG V  A+  E+G   A+K      +LQD   +    E +I+ L  NHP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L +C F T ++    L  V+E+++  + ++ + K   R ++       + Y  +I  AL 
Sbjct: 61  L-YCCFQTPDR----LFFVMEFVNGGDLMFHIQKS-RRFDEA----RARFYAAEITSALM 110

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +LH   G+ +RD+K  N+L+
Sbjct: 111 FLHD-KGIIYRDLKLDNVLL 129

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 52.4 bits (125), Expect = 6e-08
 Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 16/137 (11%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
           R +G GSFG V+ A+ + T + VAIKK+    +  N       +E++ ++ + HPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           K C+       E    LV+EY   +   + + + +  Q V I  +   T+   + L YLH
Sbjct: 91  KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142

Query: 256 HVVGVCHRDIKPQNLLM 272
               + HRDIK  N+L+
Sbjct: 143 S-HNMIHRDIKAGNILL 158

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 52.0 bits (124), Expect = 6e-08
 Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 13/132 (9%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
           +G+G++G V++A+ + TG+  AIK +     +D     +E+ +M+   H N+V+    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
           S   +D+L++   +E+      +   H T       I YV   T Q    L YLH   G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127

Query: 261 CHRDIKPQNLLM 272
            HRDIK  N+L+
Sbjct: 128 MHRDIKGANILL 139

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 21/140 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYK--NRELQIMRLL-NHPNVVS 194
           +V+G GSFG V  A+   T +  A+K      +LQD   +    E +++ L   HP +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L H  F T  KD L+   V+EY++  + ++ + +   R ++     Y      +I   L 
Sbjct: 61  L-HSCFQT--KDRLF--FVMEYVNGGDLMFHIQR-SGRFDEPRARFYAA----EIVLGLQ 110

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +LH   G+ +RD+K  N+L+
Sbjct: 111 FLHE-RGIIYRDLKLDNVLL 129

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 43/141 (30%), Positives = 70/141 (49%), Gaps = 23/141 (16%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ---------IMRLLNHPNVV 193
           +V+G GSFG V  AK    G   A+K VLQ K    ++ Q         +++ L HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            L H  F T EK    L  VL+Y++  E  + + +    +         + Y  ++  A+
Sbjct: 60  GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPRA-----RFYAAEVASAI 109

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            YLH +  + +RD+KP+N+L+
Sbjct: 110 GYLHSL-NIIYRDLKPENILL 129

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.4 bits (123), Expect = 1e-07
 Identities = 39/144 (27%), Positives = 67/144 (46%), Gaps = 21/144 (14%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN--RELQIMRLLNHPNV 192
           Y+  + +G GSFG     K  E G    IK++    +  K  +   +E+ ++  + HPN+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY----VQLYTYQIC 248
           V  +  F    E   LY  +V++Y           Y ++N    +L+    +  +  QIC
Sbjct: 62  VQYQESF---EENGNLY--IVMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            AL ++H    + HRDIK QN+ +
Sbjct: 112 LALKHVHD-RKILHRDIKSQNIFL 134

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 39/139 (28%), Positives = 70/139 (50%), Gaps = 18/139 (12%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---------ELQIMRLLNHPNVV 193
           +++G G+FG V+     +TG  +A+K+V  D   +           E+Q+++ L H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 194 SLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
               C     EK    L++ +EY+   ++    K Y  + ++V     + YT QI + ++
Sbjct: 68  QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120

Query: 253 YLHHVVGVCHRDIKPQNLL 271
           YLH  + + HRDIK  N+L
Sbjct: 121 YLHSNM-IVHRDIKGANIL 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 20/148 (13%)

Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIM 184
           G P+  +    +  +G GS G+V  A    +G  VA+KK+  D R + R      E+ IM
Sbjct: 16  GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIM 71

Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
           R   H NVV + + +      DEL++  V+E++          +TRMN+      +    
Sbjct: 72  RDYQHENVVEMYNSYLV---GDELWV--VMEFLEGGALTDIVTHTRMNEE----QIAAVC 122

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
             + +AL+ LH   GV HRDIK  ++L+
Sbjct: 123 LAVLKALSVLH-AQGVIHRDIKSDSILL 149

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 44/143 (30%), Positives = 67/143 (46%), Gaps = 24/143 (16%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAI--KKVLQ---------DKRYKNRELQIMRLLNHPN 191
           +V+G G +G VFQ + +   D+  I   KVL+         D  +   E  I+  + HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           +V L    F T  K  LYL  +LEY+S  E    + +    M           Y  +I  
Sbjct: 62  IVDL-IYAFQTGGK--LYL--ILEYLSGGELFMHLEREGIFMED-----TACFYLSEISL 111

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           AL +LH   G+ +RD+KP+N+L+
Sbjct: 112 ALEHLHQQ-GIIYRDLKPENILL 133

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 14/141 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A     G +VA+KK+    Q++ +  R   EL +++ +NH N+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           +SL + F      +E   + LV+E +   + +V  H    ++ +  L      YQ+   +
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGI 136

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            +LH   G+ HRD+KP N+++
Sbjct: 137 KHLHSA-GIIHRDLKPSNIVV 156

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 35/135 (25%), Positives = 72/135 (53%), Gaps = 16/135 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKN----RELQIMRLLNH--PNVVSLKH 197
           +G+G+ G V++ +  +TG  +A+K++ +   + +N     +L ++ L +H  P +V    
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV-LKSHDCPYIVKCYG 81

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
            F + ++     + + +E +S  + ++ K   R+   +P   +   T  I +AL+YL   
Sbjct: 82  YFITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMTVAIVKALHYLKEK 133

Query: 258 VGVCHRDIKPQNLLM 272
            GV HRD+KP N+L+
Sbjct: 134 HGVIHRDVKPSNILL 148

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 34/135 (25%), Positives = 64/135 (47%), Gaps = 17/135 (12%)

Query: 146 GTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQIMRLLNHPNVVSLK--HCFF 200
           G G++GVV + + + TG  +A+K++   +  +  K       RLL   ++ S++   C +
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-------RLLMDLDI-SMRSVDCPY 61

Query: 201 STTEKDELYLN----LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
           + T    L+      + +E +  ++ +  K        +P   +      I +AL YLH 
Sbjct: 62  TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 257 VVGVCHRDIKPQNLL 271
            + V HRD+KP N+L
Sbjct: 122 KLSVIHRDVKPSNVL 136

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 49.9 bits (119), Expect = 3e-07
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 16/146 (10%)

Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
           G PK+   Y     +G G+ G V+ A  + TG  VAIK++ LQ +  K     E+ +MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
             HPN+V+    +      DEL+  +V+EY++          T M++      +     +
Sbjct: 73  NKHPNIVNYLDSYLVG---DELW--VVMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 123

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
             +AL +L H   V HRDIK  N+L+
Sbjct: 124 CLQALEFL-HSNQVIHRDIKSDNILL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 41/138 (29%), Positives = 60/138 (43%), Gaps = 16/138 (11%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
           RV+G G FG V   +   TG   A K+ L+ KR K R        E QI+  +N   VV+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L + +     KD L L L +    +  + +   Y   N          Y  +I   L  L
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H      +RD+KP+N+L+
Sbjct: 119 HRE-NTVYRDLKPENILL 135

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 49.6 bits (118), Expect = 4e-07
 Identities = 36/138 (26%), Positives = 68/138 (49%), Gaps = 17/138 (12%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLK 196
           + +G GSFG ++ AK     +   IK++      +++K    +E+ ++  + HPN+V+  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64

Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
             F S  E   L+  +V+EY    + + R+++    +     IL    +  QI   L ++
Sbjct: 65  --FASFQENGRLF--IVMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHI 117

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    + HRDIK QN+ +
Sbjct: 118 HD-RKILHRDIKSQNIFL 134

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 49.7 bits (119), Expect = 4e-07
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 20/139 (14%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNRELQ----IMRLLNHPNVVSLKHC 198
           +G G+FG V +     +G  +A+K++    D++ + R L     +MR  + P +V     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 199 FFSTTEKD-----ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
            F   E D     EL +++ L+   + VY V      +   +P   +        +ALNY
Sbjct: 72  LF--REGDCWICMEL-MDISLDKFYKYVYEV------LKSVIPEEILGKIAVATVKALNY 122

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           L   + + HRD+KP N+L+
Sbjct: 123 LKEELKIIHRDVKPSNILL 141

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.8 bits (119), Expect = 5e-07
 Identities = 41/140 (29%), Positives = 69/140 (49%), Gaps = 21/140 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVA---IKKVL----QDKRYKNRELQIMRLL-NHPNVVS 194
           RV+G GS+  V   +  +T    A   IKK L    +D  +   E  +     NHP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L  CF + +      L  V+E++S  + ++    H  R  + +P  + + Y+ +I  ALN
Sbjct: 61  LHSCFQTESR-----LFFVIEFVSGGDLMF----HMQR-QRKLPEEHARFYSAEISLALN 110

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +LH   G+ +RD+K  N+L+
Sbjct: 111 FLHE-RGIIYRDLKLDNVLL 129

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.2 bits (117), Expect = 5e-07
 Identities = 41/144 (28%), Positives = 71/144 (49%), Gaps = 18/144 (12%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPN 191
           +Y   RVVG GS+G V   +    G    IKK+       ++++   +E Q++  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           +V+ +  +    E ++  L +V+ +     +Y   K   +  + +P   V  +  QI  A
Sbjct: 61  IVAYRESW----EGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114

Query: 251 LNYLH--HVVGVCHRDIKPQNLLM 272
           L YLH  H++   HRD+K QN+ +
Sbjct: 115 LQYLHEKHIL---HRDLKTQNVFL 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 49.0 bits (117), Expect = 6e-07
 Identities = 36/135 (26%), Positives = 63/135 (46%), Gaps = 15/135 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQ--DKRYKN---RELQIMRLLNHPNVVSLKHC 198
           +G GSFGVVF+          A+K++ L   ++R +     E +++  L+   ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
           F      D+  LN+V+EY     ++++ K      + +P   V  +  QI   L +LH  
Sbjct: 68  FL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS- 119

Query: 258 VGVCHRDIKPQNLLM 272
             + HRDIK  NL +
Sbjct: 120 KKILHRDIKSLNLFL 134

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 49.2 bits (117), Expect = 6e-07
 Identities = 36/141 (25%), Positives = 67/141 (47%), Gaps = 16/141 (11%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           Y   RVVG GSFG     + + +    A+K++   K         +E  ++  + HPN+V
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           + K  F     + + +L +V+EY    + + ++     ++     IL  Q +  Q+C  +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTIL--QWFV-QMCLGV 113

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            ++H    V HRDIK +N+ +
Sbjct: 114 QHIHE-KRVLHRDIKSKNIFL 133

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 48.8 bits (116), Expect = 7e-07
 Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 26/141 (18%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSLK 196
           +G G FG V   +   TG   A KK L  KR K +        E +I+  +N P +V+L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 197 HCFFSTTEKDELYLNLVLEYISET-----VYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           + F S T     +L LV+  ++       +Y V +    M +      V  Y+ QI   +
Sbjct: 60  YAFESKT-----HLCLVMSLMNGGDLKYHIYNVGERGLEMER------VIHYSAQITCGI 108

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            +LH +  + +RD+KP+N+L+
Sbjct: 109 LHLHSM-DIVYRDMKPENVLL 128

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 48.9 bits (116), Expect = 7e-07
 Identities = 44/138 (31%), Positives = 61/138 (44%), Gaps = 16/138 (11%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
           RV+G G FG V   +   TG   A KK L+ KR K R        E QI+  +N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L + +     KD L L L L    +  + +   Y              Y  +IC  L  L
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    + +RD+KP+N+L+
Sbjct: 119 HQ-ERIVYRDLKPENILL 135

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.1 bits (117), Expect = 8e-07
 Identities = 39/138 (28%), Positives = 71/138 (51%), Gaps = 18/138 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR----LL---NHPNVVSL 195
           +V+G G+FG V   +  +TG   A+K +L+ + +K  +L  ++    +L   + P VVSL
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 196 KHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
            + F     +D  YL L++E++    +  +   Y   ++ V     + Y  +   A+  +
Sbjct: 67  YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAV 117

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G  HRDIKP N+L+
Sbjct: 118 HKL-GFIHRDIKPDNILI 134

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 48.6 bits (116), Expect = 9e-07
 Identities = 40/163 (24%), Positives = 65/163 (39%), Gaps = 35/163 (21%)

Query: 133 PKQTISYMAERVVGTGSFGVVFQAKC--LETGDS---VAIKKVLQD------KRYKNREL 181
            + TI     R +G G+FG VF  +C  LE  +    VA+ K L++      ++   RE 
Sbjct: 3   QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59

Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRM----N 232
           +++    H N+V         TE D     +V EY     +++ +         +    +
Sbjct: 60  ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 233 QHVPILYVQLY--TYQICRALNYL--HHVVGVCHRDIKPQNLL 271
               +   QL     QI   + YL   H V   HRD+  +N L
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV---HRDLATRNCL 154

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 48.9 bits (116), Expect = 9e-07
 Identities = 36/140 (25%), Positives = 71/140 (50%), Gaps = 21/140 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNH--------PNVVS 194
           RV+G GS+  V   +  +     A+K V ++  + + ++  ++   H        P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L  CF +T+      L LV+EY++  + ++ + +      + +P  + + Y  +IC ALN
Sbjct: 61  LHSCFQTTSR-----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +LH   G+ +RD+K  N+L+
Sbjct: 111 FLHE-RGIIYRDLKLDNVLL 129

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 48.6 bits (116), Expect = 9e-07
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 18/137 (13%)

Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFF 200
           G G+ G V + +   TG   A+K +  D     ++   REL+I +    P +V     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68

Query: 201 STTEKDELYLNLVLEYIS----ETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
              ++    + + +EY      +++Y +V K   R+ + V +  +      + + L+YLH
Sbjct: 69  --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV-LGKI---AESVLKGLSYLH 122

Query: 256 HVVGVCHRDIKPQNLLM 272
               + HRDIKP N+L+
Sbjct: 123 SR-KIIHRDIKPSNILL 138

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 40/141 (28%), Positives = 73/141 (51%), Gaps = 14/141 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           +SL + F      +E   + LV+E +   + +V +       H  + Y+    YQ+   +
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYL---LYQMLCGI 132

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            +LH   G+ HRD+KP N+++
Sbjct: 133 KHLHS-AGIIHRDLKPSNIVV 152

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 18/145 (12%)

Query: 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---------ELQIMRLL 187
           I++   +++G G+FG V+    ++TG  +A K+V  D               E+Q+++ L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
            H  +V    C     EK    L + +EY+   +V    K Y  + + V     + YT Q
Sbjct: 62  QHERIVQYYGCLRDRAEKT---LTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLL 271
           I   ++YLH  + + HRDIK  N+L
Sbjct: 115 ILEGMSYLHSNM-IVHRDIKGANIL 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 41/149 (27%), Positives = 75/149 (50%), Gaps = 16/149 (10%)

Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQI 183
           R+  P +    + E  +G G+FG V++AK  ETG ++A  KV++ K  +       E++I
Sbjct: 6   RDLDPNEVWEIIGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEI 62

Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
           +   NHP +V L   F+   +     L +++E+       V      +++ +    +Q+ 
Sbjct: 63  LATCNHPYIVKLLGAFYWDGK-----LWIMIEFCPGGA--VDAIMLELDRGLTEPQIQVI 115

Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q+  AL YLH  + + HRD+K  N+L+
Sbjct: 116 CRQMLEALQYLHS-MKIIHRDLKAGNVLL 143

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 36/139 (25%), Positives = 66/139 (47%), Gaps = 20/139 (14%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYK--NRELQIMRLLNHPNVV 193
           V+G G++G V+       G  +A+K+V  D        K Y+    E+ +++ L H N+V
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
                 +  T  D+  +++ +E++      +S    R       ++ + YT QI   + Y
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPGG--SISSILNRFGPLPEPVFCK-YTKQILDGVAY 117

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH+   V HRDIK  N+++
Sbjct: 118 LHNNC-VVHRDIKGNNVML 135

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 38/141 (26%), Positives = 72/141 (51%), Gaps = 23/141 (16%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE----LQIMRLL-----NHPNVV 193
           RV+G GS+  V   + L+  + +   KV++ +   + E    +Q  + +     NHP +V
Sbjct: 1   RVIGRGSYAKVLLVR-LKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            L  CF     + E  L  V+EY++  + ++ + +      + +P  + + Y+ +I  AL
Sbjct: 60  GLHSCF-----QTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLAL 109

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           NYLH   G+ +RD+K  N+L+
Sbjct: 110 NYLHE-RGIIYRDLKLDNVLL 129

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 37/139 (26%), Positives = 68/139 (48%), Gaps = 18/139 (12%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---------ELQIMRLLNHPNVV 193
           +++G G+FG V+     +TG  +A+K+V  D               E+Q+++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
               C     E+    L++ +E++   ++    K Y  + ++V     + YT QI   ++
Sbjct: 68  QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120

Query: 253 YLHHVVGVCHRDIKPQNLL 271
           YLH  + + HRDIK  N+L
Sbjct: 121 YLHSNM-IVHRDIKGANIL 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 36/139 (25%), Positives = 57/139 (41%), Gaps = 17/139 (12%)

Query: 143 RVVGTGSFG--VVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVS 194
            ++G       +V  AK   T   VA+KK+  D   K        E+   R L HPN++ 
Sbjct: 4   TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 195 LKHCFFSTTEKDELYLNLVL-EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
               F       ELY+   L  Y S     +  H+    + +P L +      +  AL+Y
Sbjct: 64  YVTSF---IVDSELYVVSPLMAYGSCEDL-LKTHF---PEGLPELAIAFILKDVLNALDY 116

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           +H   G  HR +K  ++L+
Sbjct: 117 IHS-KGFIHRSVKASHILL 134

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 47.4 bits (112), Expect = 2e-06
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 16/146 (10%)

Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRL 186
           G PK+   Y     +G G+ G VF A  + TG  VAIK++   K+ K      E+ +M+ 
Sbjct: 15  GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
           L +PN+V+    F      DEL+  +V+EY++          T M++      +     +
Sbjct: 73  LKNPNIVNFLDSFLV---GDELF--VVMEYLAGGSLTDVVTETCMDE----AQIAAVCRE 123

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
             +AL +L H   V HRDIK  N+L+
Sbjct: 124 CLQALEFL-HANQVIHRDIKSDNVLL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 39/143 (27%), Positives = 59/143 (41%), Gaps = 30/143 (20%)

Query: 145 VGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSL- 195
           +G GSFGVV + +   +G     VA+K +  DK         +E  IM  L+H N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 196 ----KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
                H     TE   L    +L+       R+ K       H  I  +  Y  QI   +
Sbjct: 63  GVVLTHPLMMVTELAPL--GSLLD-------RLRKDALG---HFLISTLCDYAVQIANGM 110

Query: 252 NYLH--HVVGVCHRDIKPQNLLM 272
            YL     +   HRD+  +N+L+
Sbjct: 111 RYLESKRFI---HRDLAARNILL 130

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 47.1 bits (112), Expect = 3e-06
 Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 17/139 (12%)

Query: 142 ERVV-GTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK---NRELQIMRLLNHPNVVSLK 196
           ERVV G G++G+V+ A+ L T   +AIK++  +D RY    + E+ +   L H N+V   
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 197 HCFFSTTEKDELYLNLVLEYI---SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
                 +E    +  + +E +   S +    SK     +    I++   YT QI   L Y
Sbjct: 72  GSD---SENG--FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF---YTKQILEGLKY 123

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH    + HRDIK  N+L+
Sbjct: 124 LHD-NQIVHRDIKGDNVLV 141

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 33/136 (24%), Positives = 58/136 (42%), Gaps = 18/136 (13%)

Query: 145 VGTGSFGVVFQAKCLETGDS---VAIK-----KVLQDKRYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V +   L        VA+K      +   K+   RE  +M  L+HP +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
                  + + L   LV+E            Y +  + +P+  ++   +Q+   + YL  
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLGPLL---KYLKKRREIPVSDLKELAHQVAMGMAYLES 113

Query: 257 VVGVCHRDIKPQNLLM 272
              V HRD+  +N+L+
Sbjct: 114 KHFV-HRDLAARNVLL 128

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 46.5 bits (110), Expect = 5e-06
 Identities = 42/146 (28%), Positives = 78/146 (53%), Gaps = 29/146 (19%)

Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----------KVLQDKRYKNRELQIMRLLN 188
           +V+GTG++G VF  + +   ++G   A+K           K  +  R + + L+ +R   
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--Q 63

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
            P +V+L + F + T+     L+L+L+YI+  E    +S+   R  +      VQ+Y+ +
Sbjct: 64  SPFLVTLHYAFQTDTK-----LHLILDYINGGELFTHLSQR-ERFKEQ----EVQIYSGE 113

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           I  AL +LH + G+ +RDIK +N+L+
Sbjct: 114 IVLALEHLHKL-GIIYRDIKLENILL 138

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.6 bits (111), Expect = 5e-06
 Identities = 40/152 (26%), Positives = 66/152 (43%), Gaps = 46/152 (30%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNR------ELQIMRLLNHPNVVSL 195
           +V+G G+FG V   +  +TG   A+KK+ + +   K +      E  I+   ++P VV L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 196 KHCFFSTTEKDELYLNLVLEYI---------------SETVYRVSKHYTRMNQHVPILYV 240
            + F     +DE YL L++EY+               +E                     
Sbjct: 67  YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE------------------T 103

Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           + Y  +   A++ +H  +G  HRDIKP NLL+
Sbjct: 104 RFYIAETILAIDSIHK-LGYIHRDIKPDNLLL 134

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 7e-06
 Identities = 39/139 (28%), Positives = 66/139 (47%), Gaps = 19/139 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR-----LLNHPN--VVSL 195
           +V+G G+FG V   K   TG   A+K + + +  K  E    R     L+N     + +L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
            + F     +DE  L LV++Y    + +  +SK        +P    + Y  ++  A++ 
Sbjct: 67  HYAF-----QDENNLYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDS 117

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           +H + G  HRDIKP N+L+
Sbjct: 118 VHQL-GYVHRDIKPDNVLL 135

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (109), Expect = 7e-06
 Identities = 39/137 (28%), Positives = 66/137 (48%), Gaps = 20/137 (14%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSLKH 197
           +G GSFG V Q +  +T    A+K + +       E+        ++  +N P +V LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 198 CFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
             FS    ++LYL  VL +I+  E  + + +   R +        + YT ++  AL  LH
Sbjct: 60  --FSFQSPEKLYL--VLAFINGGELFHHLQRE-GRFDLS----RARFYTAELLCALENLH 110

Query: 256 HVVGVCHRDIKPQNLLM 272
               V +RD+KP+N+L+
Sbjct: 111 KF-NVIYRDLKPENILL 126

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.5 bits (110), Expect = 7e-06
 Identities = 48/193 (24%), Positives = 82/193 (42%), Gaps = 19/193 (9%)

Query: 84  LPKEMNEMRIRDEKNVNHDDKDLEPSIVN----GNGTEAGQVIATTVGGRNGQPKQTISY 139
            P EMN   I  + +  ++DK ++  I +     + ++A   +A     R G  K   S 
Sbjct: 38  FPSEMNP-GIESDDDCLYEDKHMDIDIFDIFADEDESDADASLALCAEARAGIEKAGFSI 96

Query: 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCF 199
           +       G+ G  F     +T + V IK     +     E  I+R +NHP+++ LK  F
Sbjct: 97  L--ETFTPGAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF 152

Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
             T  K   +  L+L      +Y     Y    +++ I  +      + RA+ YLH    
Sbjct: 153 --TYNK---FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHE-NR 202

Query: 260 VCHRDIKPQNLLM 272
           + HRDIK +N+ +
Sbjct: 203 IIHRDIKAENIFI 215

Length = 391

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.2 bits (109), Expect = 8e-06
 Identities = 38/141 (26%), Positives = 72/141 (51%), Gaps = 14/141 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           + L + F      +E   + +V+E +   + +V +       H  + Y+    YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL---DHERMSYL---LYQMLCGI 139

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            +LH   G+ HRD+KP N+++
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVV 159

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 35/139 (25%), Positives = 64/139 (46%), Gaps = 20/139 (14%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL-------QIMRLLNHPNVVSL 195
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           K+ F      D   L  V+EY +  E  + +S+              + Y  +I  AL Y
Sbjct: 61  KYSF---QTHD--RLCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSALGY 110

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH    V +RD+K +NL++
Sbjct: 111 LHSC-DVVYRDLKLENLML 128

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 45.2 bits (107), Expect = 1e-05
 Identities = 42/144 (29%), Positives = 76/144 (52%), Gaps = 25/144 (17%)

Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----KVLQDKR---YKNRELQIMRLLNH-P 190
           RV+GTG++G VF  + +   + G   A+K      ++Q  +   +   E Q++  +   P
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQIC 248
            +V+L H  F T  K    L+L+L+Y+        + +T + Q  H     V++Y  +I 
Sbjct: 66  FLVTL-HYAFQTDTK----LHLILDYV-----NGGELFTHLYQREHFTESEVRVYIAEIV 115

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            AL++LH + G+ +RDIK +N+L+
Sbjct: 116 LALDHLHQL-GIIYRDIKLENILL 138

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 43/136 (31%), Positives = 68/136 (50%), Gaps = 22/136 (16%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVSLKHC 198
           +G GS G+V  A+   +G  VA+K  + D R + R      E+ IMR   H NVV +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRALNYLHH 256
           + S    +EL++  ++E++           TR+N+       Q+ T    + +AL YLH 
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEE------QIATVCESVLQALCYLH- 134

Query: 257 VVGVCHRDIKPQNLLM 272
             GV HRDIK  ++L+
Sbjct: 135 SQGVIHRDIKSDSILL 150

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 36/137 (26%), Positives = 67/137 (48%), Gaps = 24/137 (17%)

Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCFF 200
           G G+FG V++A+  ETG   A  K++Q +  +       E+ I+    HPN+V L   +F
Sbjct: 14  GDGAFGKVYKAQHKETG-LFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 201 STTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
               +++L++  ++E+     +   +  + +  T          ++    Q+  ALN+LH
Sbjct: 73  Y---ENKLWI--LIEFCDGGALDSIMLELERGLTEP-------QIRYVCRQMLEALNFLH 120

Query: 256 HVVGVCHRDIKPQNLLM 272
               V HRD+K  N+L+
Sbjct: 121 SHK-VIHRDLKAGNILL 136

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 13/132 (9%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
           VG+G++G V++A+ L TG+  A+K +      D     +E+ +++   H N+V+    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
           S   +++L+  + +EY      +   H T     + I YV   T Q    L YL H  G 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYL-HSKGK 127

Query: 261 CHRDIKPQNLLM 272
            HRDIK  N+L+
Sbjct: 128 MHRDIKGANILL 139

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 41/138 (29%), Positives = 61/138 (44%), Gaps = 16/138 (11%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
           RV+G G FG V   +   TG   A KK L+ KR K R        E +I+  +N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L + +     KD L L L +    +  + +   Y   N          Y  ++C  L  L
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118

Query: 255 HHVVGVCHRDIKPQNLLM 272
                + +RD+KP+N+L+
Sbjct: 119 QR-ERIVYRDLKPENILL 135

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 44.3 bits (104), Expect = 3e-05
 Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 16/146 (10%)

Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
           G PK+   Y     +G G+ G V+ A  + TG  VAIK++ LQ +  K     E+ +MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
             +PN+V+    +      DEL+  +V+EY++          T M++      +     +
Sbjct: 73  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 123

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
             +AL++LH    V HRDIK  N+L+
Sbjct: 124 CLQALDFLHS-NQVIHRDIKSDNILL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 29/146 (19%)

Query: 143 RVVGTGSFGVVF--------------QAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLN 188
           +V+GTG++G VF                K L+    V   K ++  R +   L+ +R   
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQ 246
            P +V+L H  F T  K    L+L+L+Y+S       + +T + Q  +     V+ Y+ +
Sbjct: 64  SPFLVTL-HYAFQTEAK----LHLILDYVSG-----GEMFTHLYQRDNFSEDEVRFYSGE 113

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           I  AL +LH + G+ +RDIK +N+L+
Sbjct: 114 IILALEHLHKL-GIVYRDIKLENILL 138

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.1 bits (104), Expect = 3e-05
 Identities = 36/139 (25%), Positives = 66/139 (47%), Gaps = 15/139 (10%)

Query: 143 RVVGTGSFGVV----FQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           R +G G FG V    +  +   TG+ VA+K +  +    +     +E++I+R L H N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
             K      TE     + L++E++      + ++  R    + +     Y  QIC+ ++Y
Sbjct: 70  KYKGI---CTEDGGNGIKLIMEFLPSG--SLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           L     V HRD+  +N+L+
Sbjct: 125 LGSRQYV-HRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 29/149 (19%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNR---ELQIMRLLNHPNVVSL 195
           R++G G  G V+ A        VA+KK+ +D       K R   E +I   L HP +V +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 196 KHCFFSTTEKDELYLNL------VLEYISETVYR---VSKHY---TRMNQHVPILYVQLY 243
              +   ++ D +Y  +       L+ + ++V++   +SK     T +   + I +    
Sbjct: 68  ---YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH---- 120

Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             +IC  + Y+H   GV HRD+KP N+L+
Sbjct: 121 --KICATIEYVHSK-GVLHRDLKPDNILL 146

Length = 932

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 43.9 bits (103), Expect = 4e-05
 Identities = 38/133 (28%), Positives = 65/133 (48%), Gaps = 14/133 (10%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVSLKHCF 199
           +G G+FG V++A+  ETG  +A  KV+  K  +       E+ I+   +HPN+V L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
           +      E  L +++E+ +     V      + + +    +++   Q   ALNYLH    
Sbjct: 72  YY-----ENNLWILIEFCAGGA--VDAVMLELERPLTEPQIRVVCKQTLEALNYLHE-NK 123

Query: 260 VCHRDIKPQNLLM 272
           + HRD+K  N+L 
Sbjct: 124 IIHRDLKAGNILF 136

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.3 bits (103), Expect = 5e-05
 Identities = 32/135 (23%), Positives = 60/135 (44%), Gaps = 31/135 (22%)

Query: 148 GSFGVVFQAKCLETGDS-VAIKKVLQDKRYKNREL---QIMRLLNHPNVVSLKHCFFSTT 203
           G FG V   K        + ++K+++ K +   E    Q+M+  ++PN + L +    TT
Sbjct: 27  GKFGKVSVLK--HKPTQKLFVQKIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSV--TT 80

Query: 204 EKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--H 256
            K  +   L+++YI      + +        +    +    V+    Q+  ALN LH  +
Sbjct: 81  LKGHV---LIMDYIKDGDLFDLL--------KKEGKLSEAEVKKIIRQLVEALNDLHKHN 129

Query: 257 VVGVCHRDIKPQNLL 271
           ++   H DIK +N+L
Sbjct: 130 II---HNDIKLENVL 141

Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 43.3 bits (102), Expect = 6e-05
 Identities = 40/141 (28%), Positives = 62/141 (43%), Gaps = 24/141 (17%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSLK 196
           +G G FG V   +   TG   A KK L  KR K R        E +I+  ++   +VSL 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 197 HCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           + F + T+     L LV+       +   +Y V +      +     Y    T QI   L
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY----TAQIISGL 110

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            +LH    + +RD+KP+N+L+
Sbjct: 111 EHLHQR-RIIYRDLKPENVLL 130

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 42.7 bits (100), Expect = 8e-05
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 8/134 (5%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ----IMRLL-NHPNVVSLKHCF 199
           +G G++G V++    + G S+A  K+L      + E++    I++ L NHPNVV     F
Sbjct: 30  IGKGTYGKVYKVTNKKDG-SLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 200 FSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
           +   +     L LVLE  +  +V  + K      Q +    +    Y     L +LH+  
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147

Query: 259 GVCHRDIKPQNLLM 272
            + HRD+K  N+L+
Sbjct: 148 RIIHRDVKGNNILL 161

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 42.4 bits (100), Expect = 9e-05
 Identities = 35/137 (25%), Positives = 53/137 (38%), Gaps = 24/137 (17%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---ELQIMRLLNHPNVVSLKHCFFS 201
           +G G FG V        G  VA+K +  D         E  +M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 202 TTEKDELYLNLVLEYISETVY------RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
             + + LY  +V EY+++         R     T   Q         +   +C  + YL 
Sbjct: 71  --QGNPLY--IVTEYMAKGSLVDYLRSRGRAVITLAQQL-------GFALDVCEGMEYLE 119

Query: 256 HVVGVCHRDIKPQNLLM 272
               V HRD+  +N+L+
Sbjct: 120 EKNFV-HRDLAARNVLV 135

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 42.9 bits (101), Expect = 9e-05
 Identities = 41/140 (29%), Positives = 72/140 (51%), Gaps = 21/140 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNR--ELQIMRL-LNHPNVVS 194
           +V+G GSFG V  A+   T +  AIK      +LQD        E +I+ L   HP + +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L HC F T ++    L  V+EY++  + ++++ +   + ++       + Y  ++  AL 
Sbjct: 61  L-HCCFQTKDR----LFFVMEYVNGGDLMFQIQRS-RKFDEP----RSRFYAAEVTLALM 110

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +LH   GV +RD+K  N+L+
Sbjct: 111 FLHR-HGVIYRDLKLDNILL 129

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 42.4 bits (99), Expect = 1e-04
 Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 16/146 (10%)

Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
           G PK+   Y     +G G+ G V+ A  + TG  VAI+++ LQ +  K     E+ +MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
             +PN+V+    +      DEL+  +V+EY++          T M++      +     +
Sbjct: 74  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 124

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
             +AL +LH    V HRDIK  N+L+
Sbjct: 125 CLQALEFLHS-NQVIHRDIKSDNILL 149

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 33/139 (23%), Positives = 65/139 (46%), Gaps = 19/139 (13%)

Query: 144 VVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSL 195
           V+G G      V  A+   TG+ V ++++  +        +   EL + +L NHPN+V  
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           +  F +  E     L +V  +++    +  +  H+      + I Y+      + +AL+Y
Sbjct: 65  RATFIADNE-----LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKALDY 116

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           +HH +G  HR +K  ++L+
Sbjct: 117 IHH-MGYVHRSVKASHILI 134

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 19/138 (13%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNR--ELQIMRLLNHPNVVSLK 196
           V+G GSFG V  A+   T +  AIK      V+QD   +    E +++ L + P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           H  F T   D LY   V+EY++  + +Y    H  ++ +      V  Y  +I   L +L
Sbjct: 67  HSCFQTV--DRLY--FVMEYVNGGDLMY----HIQQVGKFKEPQAV-FYAAEISVGLFFL 117

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ +RD+K  N+++
Sbjct: 118 HR-RGIIYRDLKLDNVML 134

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 42.2 bits (99), Expect = 1e-04
 Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 23/140 (16%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE----------LQIMRLLNHPNVVS 194
           +G G+FG V+Q +  +T    A+K + + +    +E          L    L   P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           LK   FS     +LY  LV +Y+S  E  + + K              + Y  ++  AL 
Sbjct: 61  LK---FSFQTDSDLY--LVTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALE 110

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +LH    + +RD+KP+N+L+
Sbjct: 111 HLHK-YDIVYRDLKPENILL 129

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 1e-04
 Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 11/125 (8%)

Query: 148 GSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207
           GS G VF A      D V +K  +  K     E  +++ +NHP+V+ +K    S      
Sbjct: 77  GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGA---- 130

Query: 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267
               +VL + S  +Y    + T+ ++ +PI    +   QI   L YLH    + HRD+K 
Sbjct: 131 -ITCMVLPHYSSDLY---TYLTKRSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKT 185

Query: 268 QNLLM 272
           +N+ +
Sbjct: 186 ENIFI 190

Length = 357

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 16/150 (10%)

Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ----IMRLL- 187
           P  + ++     +G G++G VF+    + G   A+K +L      + E++    I++ L 
Sbjct: 14  PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72

Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQL 242
           +HPNVV     ++    K+   L LVLE      +++ V    K   RM +  PI+   L
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEE--PIIAYIL 130

Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             ++    L +L HV    HRD+K  N+L+
Sbjct: 131 --HEALMGLQHL-HVNKTIHRDVKGNNILL 157

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 36/133 (27%), Positives = 60/133 (45%), Gaps = 15/133 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
           +G G+ G V + K + TG  +A K V    +        RELQIM     P +VS    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
            +     E  + + +E++   ++ R+ K    +   +    +      +   L YL++V 
Sbjct: 73  LN-----ENNICMCMEFMDCGSLDRIYKKGGPIPVEI----LGKIAVAVVEGLTYLYNVH 123

Query: 259 GVCHRDIKPQNLL 271
            + HRDIKP N+L
Sbjct: 124 RIMHRDIKPSNIL 136

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 23/141 (16%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM----RLLN----HPNVVS 194
           +++G GSFG VF A+   T    AIK + +D    + +++      R+L+    HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRV-SKHYTRMNQHVPILYVQLYTYQICRAL 251
           L +C F T E     L  V+EY++  + ++ + S H   + +         Y  +I   L
Sbjct: 61  L-YCTFQTKE----NLFFVMEYLNGGDLMFHIQSCHKFDLPR------ATFYAAEIICGL 109

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            +LH   G+ +RD+K  N+L+
Sbjct: 110 QFLHS-KGIVYRDLKLDNILL 129

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 40/142 (28%), Positives = 67/142 (47%), Gaps = 25/142 (17%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNV 192
           +++G G+FG V   K   TG   A+K + ++             +NR LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
            +LK+ F  T ++    L  V+EY +  E  + +S+              + Y  +I  A
Sbjct: 58  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSA 107

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L+YLH    V +RD+K +NL++
Sbjct: 108 LDYLHSEKNVVYRDLKLENLML 129

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 44/168 (26%), Positives = 70/168 (41%), Gaps = 43/168 (25%)

Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIK--------KVLQDKRYKNR 179
           P   + ++ E  +G G+FG V++ +        +  SVAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKH------- 227
           E ++M  L HPN+V    C      K++    L  EY++     E + R S H       
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 228 YTRMNQHV--PILYVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLL 271
                +       ++ +   QI   + YL  HH V   HRD+  +N L
Sbjct: 113 GDETVKSSLDCSDFLHI-AIQIAAGMEYLSSHHFV---HRDLAARNCL 156

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.2 bits (96), Expect = 3e-04
 Identities = 41/138 (29%), Positives = 67/138 (48%), Gaps = 18/138 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
           + +G G+FG V  A  ++T    A+K  L+ K   NR        E  I+   ++  VV 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   ++S  +KD LY   V++YI      +     RM +  P +  + Y  ++  A+  +
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGG--DMMSLLIRM-EVFPEVLARFYIAELTLAIESV 117

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G  HRDIKP N+L+
Sbjct: 118 HKM-GFIHRDIKPDNILI 134

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 36/134 (26%), Positives = 65/134 (48%), Gaps = 15/134 (11%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDK-RYKN---RELQIMRLLNHPNVVSLKHC 198
            +G G+ GVV +     +G  +A K + L+ K   +N   REL+++   N P +V     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
           F+S  E     +++ +E++   ++ +V K   R    +P   +   +  + R L YL   
Sbjct: 68  FYSDGE-----ISICMEHMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTYLREK 118

Query: 258 VGVCHRDIKPQNLL 271
             + HRD+KP N+L
Sbjct: 119 HKIMHRDVKPSNIL 132

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 25/144 (17%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYK-NRELQIMRLLN-HPNVVSLKHC 198
            VVG G++G V++ + ++TG   AIK   V +D+  +   E+ +++  + H N+ +    
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 199 FFSTT---EKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           F   +     D+L+  LV+E+     +++ V     +  + +      ++     +I R 
Sbjct: 82  FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKED------WIAYICREILRG 133

Query: 251 LNYL--HHVVGVCHRDIKPQNLLM 272
           L +L  H V+   HRDIK QN+L+
Sbjct: 134 LAHLHAHKVI---HRDIKGQNVLL 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 13/136 (9%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFST 202
           +V+G G+FG V   K   T    A+K + + +  K  E    R     NV+    C + T
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64

Query: 203 TE----KDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
           T     +DE YL LV++Y    + +  +SK   R+ + +   Y+      I  +++ LH+
Sbjct: 65  TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HSIHQLHY 123

Query: 257 VVGVCHRDIKPQNLLM 272
           V    HRDIKP N+L+
Sbjct: 124 V----HRDIKPDNVLL 135

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 40.1 bits (94), Expect = 6e-04
 Identities = 37/143 (25%), Positives = 66/143 (46%), Gaps = 28/143 (19%)

Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           +V+G+G+FG V++   +  G+     VAIK + ++   K       E  +M  ++HP+VV
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 194 SLKH-CFFSTTEKDELYLNL--VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
            L   C  S  +     + L  +L+Y       V  H   +       Y+  +  QI + 
Sbjct: 73  RLLGICLSSQVQLITQLMPLGCLLDY-------VRNHKDNIGS----QYLLNWCVQIAKG 121

Query: 251 LNYL--HHVVGVCHRDIKPQNLL 271
           ++YL    +V   HRD+  +N+L
Sbjct: 122 MSYLEEKRLV---HRDLAARNVL 141

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.0 bits (93), Expect = 7e-04
 Identities = 35/136 (25%), Positives = 67/136 (49%), Gaps = 14/136 (10%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR----LLNHPNVVSLKHC 198
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R    +L   + + +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 199 FFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
           F+S  +K  LYL  ++E++   + +  + K  T   +       Q Y  +   A++ +H 
Sbjct: 67  FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEET-----QFYIAETVLAIDSIHQ 119

Query: 257 VVGVCHRDIKPQNLLM 272
           + G  HRDIKP NLL+
Sbjct: 120 L-GFIHRDIKPDNLLL 134

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.0 bits (93), Expect = 8e-04
 Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 21/140 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMR-----LLNHPN--VVS 194
           +V+G G+FG V   K L+  D V   K+L   +  K  E    R     L+N  N  + +
Sbjct: 7   KVIGRGAFGEVAVVK-LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65

Query: 195 LKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L + F     +DE  L LV++Y    + +  +SK   R+ + +   Y+      I  +++
Sbjct: 66  LHYAF-----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVH 119

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
            LH+V    HRDIKP N+LM
Sbjct: 120 QLHYV----HRDIKPDNILM 135

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.5 bits (94), Expect = 8e-04
 Identities = 39/151 (25%), Positives = 69/151 (45%), Gaps = 24/151 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G G FG VF  K   T +    K +      +R K++   E+ +MR L H N+
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 193 VSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           V     F +   +    L +++E+     +S  + +  K + ++ +H     +   T Q+
Sbjct: 75  VRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA----IVDITRQL 127

Query: 248 CRALNYLHHVVG------VCHRDIKPQNLLM 272
             AL Y H++        V HRD+KPQN+ +
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158

Length = 1021

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 40.2 bits (94), Expect = 9e-04
 Identities = 36/124 (29%), Positives = 53/124 (42%), Gaps = 23/124 (18%)

Query: 160 ETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211
            TG  VAIK +  D         R++ RE  +   L HPN+V+L      + E     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 212 LVLEYIS-ETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268
            V EY+   T+  V                  +L   Q+  AL   H+  G+ HRD+KPQ
Sbjct: 56  AVFEYVPGRTLREVLA-----ADGALPAGETGRLML-QVLDALACAHNQ-GIVHRDLKPQ 108

Query: 269 NLLM 272
           N+++
Sbjct: 109 NIMV 112

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 37/144 (25%), Positives = 70/144 (48%), Gaps = 28/144 (19%)

Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYK-NREL----QIMRLLNHPNVV 193
           +V+G+G+FG V++   +  G+     VAIK++ +    K N+E+     +M  +++P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 194 SLKH-CFFSTTE--KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
            L   C  ST +     +    +L+Y+ E    +   Y  +N          +  QI + 
Sbjct: 73  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LN----------WCVQIAKG 121

Query: 251 LNYLH--HVVGVCHRDIKPQNLLM 272
           +NYL    +V   HRD+  +N+L+
Sbjct: 122 MNYLEERRLV---HRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 35/136 (25%), Positives = 66/136 (48%), Gaps = 14/136 (10%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR----LLNHPNVVSLKHC 198
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R    +L   +   +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 199 FFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
           F+S  +K  LYL  ++E++   + +  + K  T   +       Q Y  +   A++ +H 
Sbjct: 67  FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEAT-----QFYIAETVLAIDAIHQ 119

Query: 257 VVGVCHRDIKPQNLLM 272
           + G  HRDIKP NLL+
Sbjct: 120 L-GFIHRDIKPDNLLL 134

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.5 bits (92), Expect = 0.001
 Identities = 39/134 (29%), Positives = 65/134 (48%), Gaps = 20/134 (14%)

Query: 148 GSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNRELQI------MRLLNHPNVVSLKHCFF 200
           G+FG V+  +        A+K V + D   KN   Q+      + L   P +V L   ++
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL---YY 71

Query: 201 STTEKDELYLNLVLEY-ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVV 258
           S    + +YL  V+EY I   V  +   Y   ++ + + Y+     ++  AL+YLH H  
Sbjct: 72  SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-- 123

Query: 259 GVCHRDIKPQNLLM 272
           G+ HRD+KP N+L+
Sbjct: 124 GIIHRDLKPDNMLI 137

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 34/136 (25%), Positives = 67/136 (49%), Gaps = 19/136 (13%)

Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ++   N P +V    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F+S  E     +++ +E++   ++ +V K   R+ + +    +   +  + + L YL  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121

Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP N+L+
Sbjct: 122 KHKIMHRDVKPSNILV 137

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 38.6 bits (90), Expect = 0.002
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 17/139 (12%)

Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKV-----LQDKRYKNRELQIMRLLNHPNVVS 194
           RV+G G FG V+    +++       A+K +     L++     +E  IM+  +HPNV+S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALNY 253
           L           E    +VL Y+     R   ++ R   H P +   + +  Q+ + + Y
Sbjct: 61  L----LGICLPSEGSPLVVLPYMKHGDLR---NFIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           L     V HRD+  +N ++
Sbjct: 114 LASKKFV-HRDLAARNCML 131

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 38.4 bits (89), Expect = 0.002
 Identities = 35/140 (25%), Positives = 63/140 (45%), Gaps = 21/140 (15%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----------LQIMRLLNHPNV 192
           ++G G FG V+  +  +TG   A+K  L  KR K ++           L ++   + P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           V + + F +    D+L   L L    +  Y +S+H       +     + Y  +I   L 
Sbjct: 60  VCMSYAFHT---PDKLSFILDLMNGGDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           ++H    V +RD+KP N+L+
Sbjct: 112 HMH-NRFVVYRDLKPANILL 130

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 38.1 bits (89), Expect = 0.002
 Identities = 38/150 (25%), Positives = 67/150 (44%), Gaps = 29/150 (19%)

Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH 189
           P++++    ER +G G FG V+      T   VA+K +           +E QIM+ L H
Sbjct: 4   PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60

Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYT 244
             +V L   +   +E++ +Y  +V EY+S     + +        R+ Q V +       
Sbjct: 61  DKLVQL---YAVCSEEEPIY--IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM------A 109

Query: 245 YQICRALNYL---HHVVGVCHRDIKPQNLL 271
            QI   + YL   +++    HRD+  +N+L
Sbjct: 110 AQIAEGMAYLESRNYI----HRDLAARNIL 135

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 38.4 bits (89), Expect = 0.002
 Identities = 39/137 (28%), Positives = 67/137 (48%), Gaps = 16/137 (11%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNR------ELQIMRLLNHPNVVSL 195
           + +G G+FG V  A+ ++T    A+K + + D   +N+      E  I+   ++  VV L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
              ++S  +KD LY   V++YI      +     RM    P    + Y  ++  A+  +H
Sbjct: 67  ---YYSFQDKDNLYF--VMDYIPGG--DMMSLLIRMGI-FPEDLARFYIAELTCAVESVH 118

Query: 256 HVVGVCHRDIKPQNLLM 272
            + G  HRDIKP N+L+
Sbjct: 119 KM-GFIHRDIKPDNILI 134

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 38.1 bits (88), Expect = 0.003
 Identities = 35/140 (25%), Positives = 65/140 (46%), Gaps = 21/140 (15%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----------LQIMRLLNHPNV 192
           ++G G FG V+  +  +TG   A+ K L  KR K ++           L ++   + P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           V + + F +    D+L   L L    +  Y +S+H     +      ++ Y  +I   L 
Sbjct: 60  VCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQHGVFSEKE-----MRFYATEIILGLE 111

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           ++H+   V +RD+KP N+L+
Sbjct: 112 HMHNRF-VVYRDLKPANILL 130

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 38.3 bits (89), Expect = 0.003
 Identities = 32/136 (23%), Positives = 63/136 (46%), Gaps = 18/136 (13%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
           +G G++G V++     TG ++A+K++   L + ++     EL I+     P +V     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 200 FSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           F      E  + + +EY+     + +Y        + + V    ++  TY + + L +L 
Sbjct: 69  FI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV----LRRITYAVVKGLKFLK 119

Query: 256 HVVGVCHRDIKPQNLL 271
               + HRD+KP N+L
Sbjct: 120 EEHNIIHRDVKPTNVL 135

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 38.2 bits (89), Expect = 0.003
 Identities = 35/138 (25%), Positives = 67/138 (48%), Gaps = 19/138 (13%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSLK 196
           V+G GSFG V  A+   T +  AIK + +D   ++ +++       ++ L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           H  F T   D LY   V+EY++  + +Y + +   +  +   + Y      +I   L +L
Sbjct: 67  HSCFQTM--DRLY--FVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAA----EIAIGLFFL 117

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ +RD+K  N+++
Sbjct: 118 HS-KGIIYRDLKLDNVML 134

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 38.3 bits (89), Expect = 0.003
 Identities = 35/132 (26%), Positives = 60/132 (45%), Gaps = 23/132 (17%)

Query: 148 GSFGVVFQAKCLETGDSV---AIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204
           GS G VF   C + GD      I K +   +   RE+ I++ ++H  +++L H +     
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155

Query: 205 KDELYLNLVLEYISETVYRVSKH--YTRMNQHVPILYVQLYTYQ--ICRALNYLHHVVGV 260
               + + V       V    K   +T +++  P+   Q  T Q  +  AL YLH   G+
Sbjct: 156 ---RWKSTVC-----MVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR-GI 206

Query: 261 CHRDIKPQNLLM 272
            HRD+K +N+ +
Sbjct: 207 IHRDVKTENIFL 218

Length = 392

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 38.3 bits (89), Expect = 0.003
 Identities = 36/138 (26%), Positives = 62/138 (44%), Gaps = 18/138 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
           + +G G+FG V   + ++T    A+K  L+      R        E  I+   ++  VV 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVK 65

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   ++S  +KD LY   V++YI      +     R+         + Y  ++  A+  +
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGG--DMMSLLIRLGI-FEEDLARFYIAELTCAIESV 117

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G  HRDIKP N+L+
Sbjct: 118 HKM-GFIHRDIKPDNILI 134

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 38.1 bits (88), Expect = 0.003
 Identities = 34/136 (25%), Positives = 67/136 (49%), Gaps = 19/136 (13%)

Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
           +G G+ GVV + +   +G  +A       IK  ++++    RELQ++   N P +V    
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F+S  E     +++ +E++   ++ +V K   R+ + +    +   +  + R L YL  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE 121

Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP N+L+
Sbjct: 122 KHQIMHRDVKPSNILV 137

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 37.7 bits (88), Expect = 0.004
 Identities = 37/139 (26%), Positives = 59/139 (42%), Gaps = 20/139 (14%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLN---HPNVV 193
           V+G G FG V  A+  +TG+  AIK + +       E++       I    N   HP +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           +L    F T  +D +    V+EY +     +  H    ++         Y   +   L Y
Sbjct: 66  NL-FACFQT--EDHVC--FVMEYAAGGDLMMHIHTDVFSEP----RAVFYAACVVLGLQY 116

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH    + +RD+K  NLL+
Sbjct: 117 LHE-NKIVYRDLKLDNLLL 134

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 37.8 bits (87), Expect = 0.004
 Identities = 39/137 (28%), Positives = 74/137 (54%), Gaps = 13/137 (9%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYK-NRELQIMRLLN-HPNVVSLKHCF 199
           +VG G++G V++ + ++TG   AIK   V  D+  +  +E+ +++  + H N+ +    F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 200 FSTTE---KDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
                    D+L+  LV+E+  + +V  + K+ T+ N  +   ++     +I R L++LH
Sbjct: 73  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKN-TKGNT-LKEEWIAYICREILRGLSHLH 128

Query: 256 HVVGVCHRDIKPQNLLM 272
               V HRDIK QN+L+
Sbjct: 129 Q-HKVIHRDIKGQNVLL 144

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	272
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.98
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.98
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.96
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.96
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.96
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.95
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.95
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.95
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.95
KOG0610	459	consensus Putative serine/threonine protein kinase	99.95
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.95
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.94
KOG0605	550	consensus NDR and related serine/threonine kinases	99.94
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.94
PTZ00036	440	glycogen synthase kinase; Provisional	99.94
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.94
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.94
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.94
KOG0198	313	consensus MEKK and related serine/threonine protei	99.94
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.93
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.93
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.93
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.93
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.93
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.93
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.93
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.93
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.93
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.93
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.93
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.92
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.92
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.92
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.92
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.92
PHA03212	391	serine/threonine kinase US3; Provisional	99.92
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.92
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.92
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.92
PTZ00284	467	protein kinase; Provisional	99.92
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.92
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.92
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.91
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.91
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.91
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.91
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.91
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.91
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.91
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.91
PHA03209	357	serine/threonine kinase US3; Provisional	99.91
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.91
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.91
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.91
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.91
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.91
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.91
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.91
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.91
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.91
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.91
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.91
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.91
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.91
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.91
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.91
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.9
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.9
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.9
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.9
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.9
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.9
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.9
KOG0586	596	consensus Serine/threonine protein kinase [General	99.9
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.9
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.9
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.9
PHA03207	392	serine/threonine kinase US3; Provisional	99.9
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.9
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.9
PTZ00267	478	NIMA-related protein kinase; Provisional	99.9
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.9
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.9
PHA03211	461	serine/threonine kinase US3; Provisional	99.9
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.9
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.9
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.9
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.9
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.9
KOG0589	426	consensus Serine/threonine protein kinase [General	99.9
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.9
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.9
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.89
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.89
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.89
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.89
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.89
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.89
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.89
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.89
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.89
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.89
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.89
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.89
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.89
PTZ00283	496	serine/threonine protein kinase; Provisional	99.89
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.89
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.89
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.89
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.89
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.89
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.89
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.89
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.89
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.89
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.89
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.89
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.89
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.89
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.89
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.89
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.89
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.89
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.89
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.89
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.89
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.89
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.89
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.89
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.89
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.89
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.89
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.89
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.88
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.88
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.88
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.88
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.88
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.88
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.88
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.88
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.88
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.88
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.88
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.88
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.88
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.88
KOG0578	550	consensus p21-activated serine/threonine protein k	99.88
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.88
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.88
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.88
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.88
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.88
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.88
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.88
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.88
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.87
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.87
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.87
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.87
PLN00009	294	cyclin-dependent kinase A; Provisional	99.87
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.87
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.87
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.87
KOG1152	772	consensus Signal transduction serine/threonine kin	99.87
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.87
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.87
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.87
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.87
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.87
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.87
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.87
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.87
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.87
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.87
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.87
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.87
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.87
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.87
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.87
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.87
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.87
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.87
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.87
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.87
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.87
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.87
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.87
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.87
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.87
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.87
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.86
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.86
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.86
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.86
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.86
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.86
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.86
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.86
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.86
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.86
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.86
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.86
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.86
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.86
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.86
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.86
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.86
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.86
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.86
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.86
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.86
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.86
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.86
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.86
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.86
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.86
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.86
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.86
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.86
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.86
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.86
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.86
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.86
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.86
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.86
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.86
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.86
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.86
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.86
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.86
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.86
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.86
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.86
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.86
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.86
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.86
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.86
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.86
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.86
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.85
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.85
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.85
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.85
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.85
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.85
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.85
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.85
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.85
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.85
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.85
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.85
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.85
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.85
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.85
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.85
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.85
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.85
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.85
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.85
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.85
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.85
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.85
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.85
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.85
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.85
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.85
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.85
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.85
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.85
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.85
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.85
PHA03210	501	serine/threonine kinase US3; Provisional	99.85
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.85
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.85
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.85
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.85
KOG0584	632	consensus Serine/threonine protein kinase [General	99.85
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.85
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.84
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.84
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.84
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.84
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.84
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.84
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.84
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.84
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.84
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.84
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.84
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.84
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.84
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.84
PHA02988	283	hypothetical protein; Provisional	99.84
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.84
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.84
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.84
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.84
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.84
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.84
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.84
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.84
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.84
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.84
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.84
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.84
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.84
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.84
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.84
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.84
PHA02882	294	putative serine/threonine kinase; Provisional	99.84
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.84
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.84
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.84
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.84
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.84
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.84
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.84
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.84
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.84
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.84
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.83
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.83
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.83
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.83
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.83
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.83
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.83
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.83
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.83
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.83
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.83
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.83
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.83
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.83
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.83
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.83
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.83
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.83
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.83
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.83
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.83
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.83
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.83
PRK10345	210	hypothetical protein; Provisional	99.83
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.82
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.82
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.82
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.82
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.82
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.82
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.82
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.82
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.82
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.82
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.82
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.82
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.81
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.81
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.81
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.81
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.81
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.81
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.81
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.81
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.81
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.81
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.81
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.81
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.8
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.8
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.8
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.79
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.79
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.78
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.78
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.78
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.78
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.78
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.78
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.78
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.78
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.77
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
smart00090	237	RIO RIO-like kinase.	99.76
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.76
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.75
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.75
KOG3653	534	consensus Transforming growth factor beta/activin	99.75
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.75
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.73
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.73
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.73
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.73
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.72
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.71
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.64
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.63
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.63
PRK12274	218	serine/threonine protein kinase; Provisional	99.62
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.59
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.58
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.56
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.49
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.49
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.47
PLN00181	793	protein SPA1-RELATED; Provisional	99.22
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.21
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.17
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.17
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.16
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.16
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.14
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.11
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.01
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	98.8
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.79
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.65
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.65
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.64
KOG3087	229	consensus Serine/threonine protein kinase [General	98.64
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.5
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.48
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.42
KOG1243	690	consensus Protein kinase [General function predict	98.33
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.32
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.27
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.23
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	98.2
PRK09902	216	hypothetical protein; Provisional	98.07
KOG1266	458	consensus Protein kinase [Signal transduction mech	97.95
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	97.91
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.9
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.89
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.83
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.83
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.76
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.68
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	97.43
KOG2270	520	consensus Serine/threonine protein kinase involved	97.4
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.2
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.0
PF01636	239	APH: Phosphotransferase enzyme family This family	96.91
PLN02876	822	acyl-CoA dehydrogenase	96.9
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	96.84
PRK10593	297	hypothetical protein; Provisional	96.45
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.4
KOG0606	1205	consensus Microtubule-associated serine/threonine	96.17
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.13
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	96.01
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	95.93
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	95.45
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	94.61
PRK05231	319	homoserine kinase; Provisional	94.26
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.12
PRK09550	401	mtnK methylthioribose kinase; Reviewed	94.09
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.09
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.82
KOG2268	465	consensus Serine/threonine protein kinase [Signal	93.74
PHA03111	444	Ser/Thr kinase; Provisional	92.95
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	92.22
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	92.19
PLN02236	344	choline kinase	91.59
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	91.39
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	90.64
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	90.01
COG4248	637	Uncharacterized protein with protein kinase and he	89.94
PLN02756	418	S-methyl-5-thioribose kinase	88.46
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	87.72
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	87.69
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	85.89
PRK12396	409	5-methylribose kinase; Reviewed	84.33
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	80.33

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.98  E-value=9.3e-33  Score=236.34  Aligned_cols=149  Identities=66%  Similarity=1.021  Sum_probs=135.9

Q ss_pred             eeccCCCCCCCCcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeec
Q 024091          123 ATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFST  202 (272)
Q Consensus       123 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  202 (272)
                      .....+..........|...+++|.|+||.||+|....+++.||||.+.+++++..+|+++|+.++|||||+|..+|+..
T Consensus        10 ~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~   89 (364)
T KOG0658|consen   10 QTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSS   89 (364)
T ss_pred             EEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEec
Confidence            33444444555667789999999999999999999999999999999999999999999999999999999999998887


Q ss_pred             ccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          203 TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+.+..|+.+||||++.++++.++++...+..++...++.|++||++||.|||. .+||||||||.|||+
T Consensus        90 ~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLv  158 (364)
T KOG0658|consen   90 TESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLV  158 (364)
T ss_pred             CCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEE
Confidence            766678999999999999999999988889999999999999999999999998 999999999999996

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=6e-32  Score=234.04  Aligned_cols=130  Identities=34%  Similarity=0.624  Sum_probs=112.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...++|.+.+.||.|+|++||+|+++.++..||||.+.+..      .....|+.+|+.|+|||||.|++|+     ...
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~   81 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDD   81 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecC
Confidence            44567999999999999999999999999999999996542      2234799999999999999999998     455


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|||||||.|+.+.   .+....+.+++..++.++.||+.||++||+ ++||||||||.||||
T Consensus        82 ~~i~lVMEyC~gGDLs---~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLL  142 (429)
T KOG0595|consen   82 DFIYLVMEYCNGGDLS---DYIRRRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILL  142 (429)
T ss_pred             CeEEEEEEeCCCCCHH---HHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEe
Confidence            5799999999966554   334445689999999999999999999998 999999999999996

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.5e-30  Score=224.11  Aligned_cols=125  Identities=34%  Similarity=0.539  Sum_probs=105.7

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---------h--hHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------R--YKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------~--~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      .|.+.+.||.|+||.|.+|..+.||+.||||++.+.+         .  ...+|++||++|+|||||+++++|.     .
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~-----~  247 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE-----V  247 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee-----c
Confidence            4888999999999999999999999999999985421         1  1248999999999999999999984     4


Q ss_pred             ceEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+.||||||+.|+ |.+.    .-.++.+.+..-+.+++|+|.|+.|||+ +||+||||||+|||+
T Consensus       248 ~ds~YmVlE~v~GGeLfd~----vv~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl  309 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDK----VVANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILL  309 (475)
T ss_pred             CCceEEEEEEecCccHHHH----HHhccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEe
Confidence            44589999999965 3332    2235567777889999999999999998 899999999999996

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-30  Score=229.52  Aligned_cols=129  Identities=36%  Similarity=0.561  Sum_probs=115.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHH-----HHHHHHHHcC-CCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLN-HPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~-----~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ..+|.+++.||.|+||.||+|+...+++.||||.+++....++     ||+..|++|+ |||||+|++.+.+..    ..
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~   84 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI   84 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence            4579999999999999999999999999999999876544443     8999999999 999999999984332    16


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+|||||+.+|+++++..   +..|++..++.|++||+.||+|+|. +|+.||||||||||+
T Consensus        85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi  143 (538)
T KOG0661|consen   85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILI  143 (538)
T ss_pred             EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEe
Confidence            9999999999999988764   6789999999999999999999998 999999999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.96  E-value=1.2e-29  Score=212.50  Aligned_cols=127  Identities=38%  Similarity=0.638  Sum_probs=113.0

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ++|..+.++|+|+||+||+|+++.||+.||||.+...      ++...+||.+|++|+|+|+|.|+++|     +....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence            3588899999999999999999999999999998643      23345899999999999999999999     666779


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||+|||+.+++..+..+   ...++...++.|++|++.|+.|||. ++||||||||+||||
T Consensus        77 hLVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILi  134 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILI  134 (396)
T ss_pred             EEEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEE
Confidence            999999999988765543   5568999999999999999999998 999999999999996

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=8.6e-29  Score=223.69  Aligned_cols=127  Identities=31%  Similarity=0.514  Sum_probs=112.2

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .+|...++||+|||.+||.+++..+|+.||+|++.+.       .....+||+|.+.|+|||||++|++|     ++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            5699999999999999999999999999999999652       33345899999999999999999999     77888


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||+|+|..+++..+   .+....++|.+++.|++||+.||.|||+ ++|||||||..||||
T Consensus        93 VYivLELC~~~sL~el---~Krrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL  151 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMEL---LKRRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFL  151 (592)
T ss_pred             eEEEEEecCCccHHHH---HHhcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheee
Confidence            9999999996554422   2245789999999999999999999998 999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.7e-29  Score=220.38  Aligned_cols=134  Identities=34%  Similarity=0.516  Sum_probs=115.3

Q ss_pred             CCCcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       132 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      .+.....|..++.||+|+||.||+|++..+|+.||+|.++.+.      ....+||.||++|+|||||+|.+..+..   
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---  188 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---  188 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---
Confidence            3455667999999999999999999999999999999997543      3345899999999999999999987544   


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....+|||+|||+.+|..++..   ..-.|++..+++|++|++.||+|||. +||+|||||.+||||
T Consensus       189 ~~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLi  251 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILI  251 (560)
T ss_pred             CCceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEE
Confidence            3345999999999988765432   34579999999999999999999998 999999999999996

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.5e-28  Score=212.11  Aligned_cols=136  Identities=25%  Similarity=0.412  Sum_probs=119.7

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHH---HHHHHHHHcC--------CCCeeecceeeeec
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLN--------HPNVVSLKHCFFST  202 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~---~E~~~l~~l~--------h~nIv~l~~~~~~~  202 (272)
                      ...++|.+.++||.|.|++||+|++....+.||+|+++....+.+   .||.+|+++.        ..+||+|++.|-..
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            445689999999999999999999999999999999987766554   6999999884        24799999987544


Q ss_pred             ccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          203 TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       ..++.++|||+|+++..|+.+++.+.  .+.++...++.|++|||.||.|||+.+||||-||||+||||
T Consensus       155 -GpNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  155 -GPNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             -CCCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence             47889999999999999999887654  56689999999999999999999987999999999999996

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-28  Score=210.56  Aligned_cols=130  Identities=32%  Similarity=0.467  Sum_probs=112.2

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ....+|.++++||+|+||+||+++...|++.+|+|++++.       ......|..||..++||+||.++-.|     ++
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt   96 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QT   96 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----cc
Confidence            3345799999999999999999999999999999998653       23445799999999999999999888     66


Q ss_pred             ceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+|||+||+.|+-+..   .....+.|++..+++|+.+|+.||.|||+ +|||||||||+||||
T Consensus        97 ~~kLylVld~~~GGeLf~---hL~~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILL  158 (357)
T KOG0598|consen   97 EEKLYLVLDYLNGGELFY---HLQREGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILL  158 (357)
T ss_pred             CCeEEEEEeccCCccHHH---HHHhcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeee
Confidence            667999999999764331   23336789999999999999999999998 999999999999996

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.95  E-value=3.3e-28  Score=208.87  Aligned_cols=129  Identities=29%  Similarity=0.448  Sum_probs=110.2

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .+.+.+..||+|+.|+||++.++.|++.+|+|.|..+     .++..+|+++++.++||+||.+||+|+....    -++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence            3567788999999999999999999999999999432     3445689999999999999999999976652    289


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+++.++.+..   ..+.+++..+..++.+|++||.|||+.++||||||||+||||
T Consensus       155 I~mEYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv  212 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV  212 (364)
T ss_pred             eehhhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee
Confidence            9999999766653322   236799999999999999999999955899999999999996

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.95  E-value=3.3e-28  Score=217.19  Aligned_cols=129  Identities=34%  Similarity=0.570  Sum_probs=113.3

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec-------cchhHHHHHHHHHHc-CCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-------~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  205 (272)
                      +...+|..++.||+|+|++|++|++..+++.||||++.+       ..++..+|-.+|..| .||.|++||..|     +
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence            445679999999999999999999999999999998743       244566899999999 799999999888     5


Q ss_pred             CceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +...+|+|+||++ |.++.++..+    +.|.+.++++|+.||+.||+|||+ +||||||||||||||
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILL  207 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILL  207 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeE
Confidence            5556999999999 6777766654    679999999999999999999998 999999999999996

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.95  E-value=6e-28  Score=198.93  Aligned_cols=127  Identities=34%  Similarity=0.545  Sum_probs=111.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+|...++||+|.||.||+|++..+|+.||||.++..      ....-|||.+|+.++|+||+.++++|     .....+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence            3688899999999999999999999999999999643      22345899999999999999999999     444459


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .||+||++.+|...++..   ...++...++.|+.++++||+|||+ +.|+||||||.|+||
T Consensus        77 ~lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLi  134 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLI  134 (318)
T ss_pred             EEEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEE
Confidence            999999999988776643   4568889999999999999999998 999999999999986

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=6.9e-28  Score=209.14  Aligned_cols=130  Identities=25%  Similarity=0.428  Sum_probs=113.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|++++.||.|.-|+||+++...++..+|+|++.++       ....+.|.+||+.++||.++.||..|     +...
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~  150 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK  150 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence            34699999999999999999999999999999998543       22334699999999999999999999     7777


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |.|+|||||+|+.+..+++ .+....|++..+++|+.+|+.||+|||- .|||+||||||||||
T Consensus       151 ~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILv  212 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILV  212 (459)
T ss_pred             eeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEE
Confidence            8999999999776655544 4557789999999999999999999996 899999999999996

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=210.89  Aligned_cols=131  Identities=34%  Similarity=0.474  Sum_probs=110.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------------------hhHHHHHHHHHHcCCCCeeec
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------------RYKNRELQIMRLLNHPNVVSL  195 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------------~~~~~E~~~l~~l~h~nIv~l  195 (272)
                      ++...|++++.||.|.||+|.+|++..+++.||||++.+..                  ....+||.||++|.|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            55668999999999999999999999999999999985321                  133479999999999999999


Q ss_pred             ceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       196 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~-~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++.....   ..++|||+|||..+-..    +...... +.+..++.|+..++.||+|||. +|||||||||+|+||
T Consensus       174 iEvLDDP~---s~~~YlVley~s~G~v~----w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl  243 (576)
T KOG0585|consen  174 IEVLDDPE---SDKLYLVLEYCSKGEVK----WCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLL  243 (576)
T ss_pred             EEeecCcc---cCceEEEEEeccCCccc----cCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEE
Confidence            99874443   34599999999966443    2333445 8999999999999999999998 999999999999996

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8e-27  Score=208.59  Aligned_cols=129  Identities=33%  Similarity=0.512  Sum_probs=110.1

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---------chhHHHHHHHHHHcC-CCCeeecceeeeecc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTT  203 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~  203 (272)
                      ...++|.+.+.||+|+||+|++|.+..+++.||+|++...         .....+|+.+++.+. ||||+++++++.   
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~---   90 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA---   90 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence            4456799999999999999999999999999999976543         123347999999999 999999999984   


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ....+|+||||+.| .+++.+..    .+++.+..++.++.|++.|++|||+ +||+||||||+|||+
T Consensus        91 --t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENill  153 (370)
T KOG0583|consen   91 --TPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILL  153 (370)
T ss_pred             --cCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEe
Confidence              33449999999996 55554332    5778999999999999999999998 999999999999986

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.94  E-value=7.2e-27  Score=208.45  Aligned_cols=128  Identities=29%  Similarity=0.452  Sum_probs=112.3

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|.++.+||+|+||.||+|+-+.||..+|+|++++.       ......|-.+|...++|+||+||-.|     ++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            456799999999999999999999999999999999753       22334799999999999999999998     788


Q ss_pred             eEEEEEeecccccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|+||||||++||... ++.    ....|++.++++|+.+++.|++-||+ .|||||||||+|+||
T Consensus       214 ~~LYLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLi  274 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLI  274 (550)
T ss_pred             CeeEEEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheee
Confidence            8899999999976443 333    35679999999999999999999998 999999999999996

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.4e-28  Score=204.28  Aligned_cols=134  Identities=34%  Similarity=0.579  Sum_probs=113.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ...|.++++||+|.||.||++.+..+|..||.|.+.-      .....-.|+.+|++|+|||||++|++-+.   ++...
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev   94 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV   94 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence            3469999999999999999999999999999998852      23334479999999999999999984322   22223


Q ss_pred             EEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--cC-CceecCCCCCCeeC
Q 024091          210 LNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH--VV-GVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~--~~-~iiHrDlKp~NILl  272 (272)
                      ++||||||+ |++-.+++++....+.+++..++.++.|+|.||.+||.  .+ -|+||||||.||+|
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl  161 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL  161 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE
Confidence            899999999 77778888988888999999999999999999999996  22 38999999999986

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.94  E-value=3.8e-26  Score=209.86  Aligned_cols=136  Identities=51%  Similarity=0.950  Sum_probs=119.4

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeecc---cCCceEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTT---EKDELYLNL  212 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~~~~~~l  212 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||.+........+|+.+|+.++|||||+++++|+...   .....++++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            34699999999999999999999999999999998777666778999999999999999999875432   123457889


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+++++..++..+......+++..++.++.||+.||.|||+ ++||||||||+||||
T Consensus       145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl  203 (440)
T PTZ00036        145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLI  203 (440)
T ss_pred             EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEE
Confidence            99999999888777666666789999999999999999999998 999999999999986

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.94  E-value=5.5e-27  Score=195.86  Aligned_cols=128  Identities=29%  Similarity=0.492  Sum_probs=111.2

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|..++.||.|+||+|.+++...+|..+|+|++.++       .....+|..+|+.+.||+++++++.|     .+.
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~  116 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDN  116 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccC
Confidence            345799999999999999999999999999999998543       22334799999999999999999888     777


Q ss_pred             eEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++||||||++|+ +..++    +..++|++..+++|+.||+.||+|||+ ++|++||||||||||
T Consensus       117 ~~lymvmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLl  177 (355)
T KOG0616|consen  117 SNLYMVMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLL  177 (355)
T ss_pred             CeEEEEEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeee
Confidence            7899999999965 33333    335679999999999999999999998 999999999999996

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.94  E-value=2.5e-27  Score=200.81  Aligned_cols=132  Identities=28%  Similarity=0.439  Sum_probs=114.0

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchh------HHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY------KNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      .....|..+..|++|+||.||+|++..|++.||+|.++.++..      .-+||.+|.+++|||||.+.++.+...-.  
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d--  150 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD--  150 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc--
Confidence            3445699999999999999999999999999999999765422      24899999999999999999987554432  


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       .+|||||||..++..++..   +.++|....+++++.|++.||+|||. +.|+||||||+|+|+
T Consensus       151 -~iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm  210 (419)
T KOG0663|consen  151 -KIYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLL  210 (419)
T ss_pred             -eeeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheee
Confidence             2999999999988876654   35789999999999999999999998 999999999999986

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.94  E-value=2.3e-26  Score=209.76  Aligned_cols=127  Identities=36%  Similarity=0.567  Sum_probs=114.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHH---HHHHHHHHcC-C-----CCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLN-H-----PNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~---~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~~~  208 (272)
                      +|.+.++||+|+||.|.+|++..|++.||||+++..+.+.+   .|+.||..|+ |     -|||+++++|     ..+.
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence            68999999999999999999999999999999988876654   5899999987 3     4899999999     4555


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||+|++..+|+++++...  ...++...++.|+.|||.||.+||. .+|||.|||||||||
T Consensus       262 HlciVfELL~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL  322 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILL  322 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheee
Confidence            699999999999999887643  3458999999999999999999998 999999999999996

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=4.5e-26  Score=197.33  Aligned_cols=129  Identities=35%  Similarity=0.551  Sum_probs=108.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .+|...+.||+|+||.||++.+..+|+.+|||.+...    .....+|+.+|..|+|||||+++|.......   ..++|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence            3588999999999999999999999999999998655    3446799999999999999999996422221   46899


Q ss_pred             EeecccccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||++++.+. ++..+   ...+++..++.++.||+.||.|||+ +|||||||||+||||
T Consensus        94 ~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl  150 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILL  150 (313)
T ss_pred             eeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEE
Confidence            99999965544 33322   2279999999999999999999998 999999999999996

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.93  E-value=1.2e-26  Score=208.04  Aligned_cols=126  Identities=33%  Similarity=0.555  Sum_probs=112.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch------hHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+|.+.+.||+|+||+||+|+.+.+.+.||||.+.+..+      ...+|++|++.|+|||||.++++|     +...++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence            468899999999999999999999999999999965322      245899999999999999999999     556669


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+|.||+.|.+..++..    ++.+++..++.++++++.||.|||+ .+|+|||+||.||||
T Consensus        77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl  133 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILL  133 (808)
T ss_pred             EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeee
Confidence            99999999988776654    6789999999999999999999998 999999999999996

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2e-25  Score=195.44  Aligned_cols=134  Identities=30%  Similarity=0.537  Sum_probs=116.6

Q ss_pred             CCCCcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       131 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ..+.....|.+..+||.|.-++||+|++..+++.||||++.-+     .....+|++.|+.++||||++++.+|....+ 
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~-   98 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE-   98 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce-
Confidence            3445666899999999999999999999999999999998533     2445689999999999999999999966655 


Q ss_pred             CceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          +|+||.||. |+++++++.+.  ...+.+..+..|+++++.||.|||+ +|.||||||+.||||
T Consensus        99 ----LWvVmpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi  159 (516)
T KOG0582|consen   99 ----LWVVMPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILI  159 (516)
T ss_pred             ----eEEeehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEE
Confidence                999999999 67777776544  3449999999999999999999998 999999999999996

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=8.9e-27  Score=189.41  Aligned_cols=129  Identities=32%  Similarity=0.467  Sum_probs=110.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .++|.+++.||+|-||.||+|+...++-.||+|++.+.       ..+..+|++|...|+||||+++|++|     .+..
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~~   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDSK   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----eccc
Confidence            45799999999999999999999999999999988542       34556899999999999999999999     4445


Q ss_pred             EEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+||++||.+ |.++..++.  .....+.+..+..|..|++.||.|||. ++||||||||+|+|+
T Consensus        96 riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLl  157 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLL  157 (281)
T ss_pred             eeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhcc
Confidence            5999999998 566654442  234568888999999999999999998 999999999999986

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.93  E-value=6.8e-26  Score=194.00  Aligned_cols=135  Identities=30%  Similarity=0.550  Sum_probs=113.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCC-eeecceeeeeccc-CCce
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPN-VVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~-~~~~  208 (272)
                      ..|..+++||+|+||+||+|+...+|+.||+|.+.-+.      ....+|+.+|+.|+|+| |+.|++++..... ....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34777888999999999999999999999999996442      23468999999999999 9999999866542 2233


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|||||+...+...+.........++...++.++.||+.||+|||+ ++|+||||||.||||
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi  153 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLI  153 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEE
Confidence            599999999998877666544332457778899999999999999998 999999999999996

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=1e-26  Score=201.67  Aligned_cols=127  Identities=31%  Similarity=0.491  Sum_probs=111.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|.+.+.||+|+||+|-+|+....|+.||||.|++++       -..++||+||..|+||||+.+|++|     .+..
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkd  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKD  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCc
Confidence            447999999999999999999999999999999997643       2345899999999999999999999     5556


Q ss_pred             EEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+.|||||.. |.|++.+..    .+.+++..+++|++||..|+.|||. ++++|||||.+||||
T Consensus       127 KIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILL  186 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILL  186 (668)
T ss_pred             eEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheee
Confidence            6999999998 566664443    5679999999999999999999998 999999999999996

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.8e-25  Score=201.32  Aligned_cols=125  Identities=28%  Similarity=0.474  Sum_probs=106.9

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||++.+..+++.||||++....       ....+|+++++.++||||++++++|     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence            5999999999999999999999999999999885421       2345799999999999999999988     445569


Q ss_pred             EEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||++++ +..++..    ...+++..++.++.|++.||+|||+ ++|+||||||+||||
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll  134 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILI  134 (377)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEE
Confidence            9999999854 4443332    4568899999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=5.7e-26  Score=206.92  Aligned_cols=127  Identities=35%  Similarity=0.552  Sum_probs=112.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .+-|++++.||.|+-|.|.+|++..||+.+|||+|.+.       ....++||.||+.|.||||+++|+.|     .+..
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence            34599999999999999999999999999999999765       34567899999999999999999999     6666


Q ss_pred             EEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+|+||+++| +++    +....+++++..+.+++.||+.|+.|||. .+||||||||+|+||
T Consensus        86 ~lylvlEyv~gGELFd----ylv~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLL  145 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFD----YLVRKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLL  145 (786)
T ss_pred             eEEEEEEecCCchhHH----HHHhhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhh
Confidence            799999999954 443    34447789999999999999999999998 999999999999986

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=5.1e-25  Score=194.98  Aligned_cols=130  Identities=36%  Similarity=0.613  Sum_probs=111.2

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||||.+...      .....+|+.+|+.++||||+++++++..........+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            589999999999999999999999999999988532      12345799999999999999999988655444445689


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+++++..++..    ...+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll  136 (338)
T cd07859          81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILA  136 (338)
T ss_pred             EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEE
Confidence            9999999887765543    3468999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.3e-25  Score=198.62  Aligned_cols=125  Identities=30%  Similarity=0.464  Sum_probs=107.2

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+|+.++||||++++++|     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence            599999999999999999999999999999998642       12345799999999999999999988     455569


Q ss_pred             EEEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||+.++.+ +++.    ....+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus        77 ~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~  134 (364)
T cd05599          77 YLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLL  134 (364)
T ss_pred             EEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEE
Confidence            999999986544 3332    24568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.93  E-value=3.4e-25  Score=198.69  Aligned_cols=125  Identities=27%  Similarity=0.426  Sum_probs=107.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||+||+|.+..+++.||||++....       ....+|+.++..++|+||++++++|     .+..++
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence            5899999999999999999999999999999986421       2345799999999999999999988     445569


Q ss_pred             EEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||++++ +..++..    ...+++..++.++.||+.||+|||+ ++|+||||||+||||
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi  134 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLL  134 (363)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEE
Confidence            9999999865 4443332    4568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.93  E-value=4.4e-25  Score=198.75  Aligned_cols=125  Identities=25%  Similarity=0.392  Sum_probs=106.9

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|++++.||+|+||.||+|++..+++.||||++...       .....+|+.+|+.+.|+||+++++.|     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence            599999999999999999999999999999998532       22345799999999999999999988     444569


Q ss_pred             EEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||++++ +.+++..    ...+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus        77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill  134 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILI  134 (376)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEE
Confidence            9999999854 4444332    4568899999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.92  E-value=7.2e-25  Score=191.54  Aligned_cols=128  Identities=30%  Similarity=0.478  Sum_probs=110.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++.     ...++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence            357999999999999999999999999999999985321     23457999999999999999999883     44469


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||++++++..+..   ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill  136 (303)
T cd07869          79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLI  136 (303)
T ss_pred             EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            99999999988775543   23568888999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.92  E-value=5.1e-25  Score=198.79  Aligned_cols=125  Identities=26%  Similarity=0.420  Sum_probs=106.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .|.+++.||+|+||+||+|.+..+++.||||++...       .....+|+.+|+.++||||++++++|     .+..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            489999999999999999999999999999998642       12345799999999999999999988     344569


Q ss_pred             EEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||++++ +..++..    ...+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili  134 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILI  134 (381)
T ss_pred             EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEE
Confidence            9999999865 4443332    4568899999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.92  E-value=9.2e-25  Score=189.62  Aligned_cols=128  Identities=29%  Similarity=0.533  Sum_probs=109.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+|.+.+.||.|+||.||+|.+..++..||+|.+...     .....+|+.+++.++||||+++++++     ....+.
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence            34699999999999999999999999999999988532     22345799999999999999999988     444569


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++||||+++++...+..   ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        79 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~  136 (288)
T cd07871          79 TLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLI  136 (288)
T ss_pred             EEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEE
Confidence            99999999987765543   23457888999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.92  E-value=4e-25  Score=196.35  Aligned_cols=126  Identities=32%  Similarity=0.528  Sum_probs=103.7

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCE-EEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDS-VAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~-vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+.+.||.|+||+||+|.+.  |+. ||||.+...      ...+.+|+.+|..|+|||||+|+|++.....    .++
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~  116 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLC  116 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceE
Confidence            455566999999999999984  555 999998643      2356789999999999999999999854431    489


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-ceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-VCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~-iiHrDlKp~NILl  272 (272)
                      |||||++++.+..+.+.. ....+++..+..++.||+.||+|||+ ++ ||||||||+||||
T Consensus       117 iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv  176 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILV  176 (362)
T ss_pred             EEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEE
Confidence            999999966655333322 36779999999999999999999998 88 9999999999996

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.92  E-value=5.9e-25  Score=198.36  Aligned_cols=125  Identities=26%  Similarity=0.398  Sum_probs=106.7

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+++.||+|+||.||+|.+..+++.||||++...       .....+|+.+++.++||||++++++|.     +..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence            589999999999999999999999999999998643       123457999999999999999999983     44469


Q ss_pred             EEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+|||||+++ +..++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl  134 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILI  134 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            9999999864 4443332    3568899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=1.1e-24  Score=197.20  Aligned_cols=126  Identities=25%  Similarity=0.391  Sum_probs=109.1

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||...  .....+|+++|+.|+||||++++++|.     ...+.|+||
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~lv~  162 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCLIL  162 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEEEE
Confidence            3457999999999999999999999999999999753  334568999999999999999999884     334589999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |++.++++..+..    ...+++..++.++.||+.||.|||+ ++||||||||+||||
T Consensus       163 e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll  215 (391)
T PHA03212        163 PRYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFI  215 (391)
T ss_pred             ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEE
Confidence            9999887765433    3468899999999999999999998 899999999999986

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.92  E-value=9.4e-25  Score=195.47  Aligned_cols=126  Identities=37%  Similarity=0.544  Sum_probs=109.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcC-CCCeeecceeeeecccCCc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...|.+.+.||.|.||.||+|+...+|+.+|+|.+.+..       ....+|+++|+.|. |||||.+++.|     .+.
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~~  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----EDP  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----EcC
Confidence            446999999999999999999999999999999996532       25568999999999 99999999998     455


Q ss_pred             eEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++++|||+|.|+ +++.+...     .+++..+..++.||+.++.|||+ .||+||||||+|||+
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~  168 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLL  168 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeee
Confidence            5699999999954 44433322     39999999999999999999998 999999999999985

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.92  E-value=1.5e-24  Score=191.91  Aligned_cols=127  Identities=30%  Similarity=0.459  Sum_probs=107.9

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+|+.++||||++++++|     ....
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence            45799999999999999999999999999999998642       12345799999999999999999988     3444


Q ss_pred             EEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+.++ +...+.    ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        92 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll  151 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLL  151 (329)
T ss_pred             EEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEE
Confidence            699999999865 444333    24568899999999999999999998 999999999999986

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=9.4e-25  Score=189.92  Aligned_cols=125  Identities=24%  Similarity=0.408  Sum_probs=106.7

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence            589999999999999999999999999999998532       22345799999999999999999887     445569


Q ss_pred             EEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.++ +.+++.    ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        77 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli  134 (291)
T cd05612          77 YMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILL  134 (291)
T ss_pred             EEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEE
Confidence            9999999854 444333    24568899999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00284 protein kinase; Provisional

Probab=99.92  E-value=1.6e-23  Score=194.01  Aligned_cols=130  Identities=22%  Similarity=0.312  Sum_probs=106.5

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCC------CeeecceeeeecccC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHP------NVVSLKHCFFSTTEK  205 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~------nIv~l~~~~~~~~~~  205 (272)
                      ...+|.+.++||+|+||+||+|.+..+++.||||+++...   .....|+++++.+.|.      +|+.++++|..    
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----  202 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----  202 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----
Confidence            3467999999999999999999999999999999986432   2345688888887654      58888887742    


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...++|||||+++++++.++..    ...+++..++.|+.||+.||.|||+..+||||||||+||||
T Consensus       203 ~~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl  265 (467)
T PTZ00284        203 ETGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILM  265 (467)
T ss_pred             CCceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE
Confidence            2346899999999888876543    35689999999999999999999962499999999999986

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.92  E-value=3.4e-25  Score=203.37  Aligned_cols=134  Identities=28%  Similarity=0.378  Sum_probs=108.5

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec-----cchhHHHHHHHHHHcCCCCeeecceeeeecc-cCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTT-EKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~~~~~~  211 (272)
                      -|...+.||+|+||.||++++..+|+.||||.+.+     ....+.+|+++|++|+|+|||++++.=.... .--.....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            47888999999999999999999999999998854     3445668999999999999999877531111 00022367


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||||.++.+.-....-.+...+++..++.+...++.||.|||+ +|||||||||+||++
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl  153 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVL  153 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEE
Confidence            899999976655433444556679999999999999999999998 999999999999985

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.92  E-value=2.3e-24  Score=193.91  Aligned_cols=127  Identities=31%  Similarity=0.535  Sum_probs=107.7

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|.+.+.||+|+||.||++.+..+++.||+|++.+.       .....+|+.+++.++||||++++++|     .+.
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD  115 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            345799999999999999999999999999999998532       22345799999999999999999988     445


Q ss_pred             eEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|+||||++++ +..++.     ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl  175 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLL  175 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEE
Confidence            5699999999854 444332     2357889999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.91  E-value=3.8e-24  Score=191.61  Aligned_cols=125  Identities=26%  Similarity=0.402  Sum_probs=106.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||++.+..+++.||||++...       .....+|+.++..++||||++++++|     .+..++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            589999999999999999999999999999998642       12345799999999999999999988     445569


Q ss_pred             EEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||++++ +..++.    ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        77 ~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli  134 (360)
T cd05627          77 YLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLL  134 (360)
T ss_pred             EEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEE
Confidence            9999999865 444332    24568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.5e-24  Score=189.75  Aligned_cols=125  Identities=30%  Similarity=0.460  Sum_probs=106.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+++.++||||++++++|     ....++
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence            599999999999999999999999999999998643       12344799999999999999999988     445569


Q ss_pred             EEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||++++ +..++.    ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        77 ~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~  134 (333)
T cd05600          77 YLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLI  134 (333)
T ss_pred             EEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEE
Confidence            9999999864 444332    24568899999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.1e-24  Score=191.03  Aligned_cols=125  Identities=30%  Similarity=0.486  Sum_probs=107.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||||++...       .....+|+.++..++||||++++++|     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence            599999999999999999999999999999998642       22345799999999999999999988     445569


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.+ ++..++..    ...+++..++.++.||+.||.|||+ +||+||||||+||||
T Consensus        77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll  134 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILI  134 (350)
T ss_pred             EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEE
Confidence            999999985 55444332    3568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.91  E-value=2.6e-24  Score=201.85  Aligned_cols=133  Identities=25%  Similarity=0.417  Sum_probs=111.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcC-CCCeeecce-eeeecccCC-ceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLN-HPNVVSLKH-CFFSTTEKD-ELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~-h~nIv~l~~-~~~~~~~~~-~~~  209 (272)
                      .++++.+.|.+|||+.||+|++...|..||+|.+...    .....+||++|++|. |+|||.|++ ......... ..-
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            3588999999999999999999988899999987432    234468999999998 999999999 433333334 456


Q ss_pred             EEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeC
Q 024091          210 LNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~--iiHrDlKp~NILl  272 (272)
                      ++|+||||. ++|.+++..+..  ..|++.+++.|++++|.|+.+||. +.  |||||||-|||||
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLl  179 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLL  179 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEE
Confidence            889999999 699988775543  449999999999999999999997 65  9999999999996

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.91  E-value=2.9e-24  Score=189.60  Aligned_cols=120  Identities=27%  Similarity=0.389  Sum_probs=101.2

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEee
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      +.||+|+||.||+|.+..+++.||||++....       ....+|+.+|+.++||||++++++|     ....++|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            36999999999999999999999999986431       2234699999999999999999888     44456999999


Q ss_pred             cccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          216 YISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       216 ~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+.++.+ ..+.    ....+++..++.++.||+.||+|||+ ++|+||||||+||||
T Consensus        76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll  128 (323)
T cd05571          76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLML  128 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEE
Confidence            9996544 3322    24568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.1e-24  Score=188.75  Aligned_cols=126  Identities=26%  Similarity=0.430  Sum_probs=106.9

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||++.+..+++.||||++.+.       ...+.+|+.+++.++|+||++++++|     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence            599999999999999999999999999999998642       22345799999999999999999988     444569


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.+ ++..++..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill  135 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLL  135 (331)
T ss_pred             EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEE
Confidence            999999975 54444432   24568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.91  E-value=5.5e-24  Score=184.19  Aligned_cols=126  Identities=38%  Similarity=0.630  Sum_probs=109.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||+|++..+++.||||.+...      .....+|+.+++.++||||++++++|     ....++|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence            699999999999999999999999999999988643      22345799999999999999999988     3445699


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||++++++..+..   ....+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill  133 (287)
T cd07848          77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLI  133 (287)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            9999999887765432   24568899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=9.6e-25  Score=186.92  Aligned_cols=130  Identities=37%  Similarity=0.583  Sum_probs=110.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .|...+.||.|+||.|+.|.+..+|+.||||.+..      ..+..-+|+.+|+.++|+||+.+++.+.......-.-+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            46668999999999999999999999999998852      233345899999999999999999998663333445599


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+|+|+-+|..+++.    +..++...++.+++||++||.|+|+ .+|+||||||.|+|+
T Consensus       103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~  158 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLL  158 (359)
T ss_pred             EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheee
Confidence            9999998877766554    4458999999999999999999998 899999999999986

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=8.4e-24  Score=189.32  Aligned_cols=126  Identities=27%  Similarity=0.392  Sum_probs=108.9

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEee
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|+....  ....|+.+++.++||||++++++|..     ..+.|+|||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e  137 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLP  137 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEE
Confidence            34699999999999999999999999999999975433  33569999999999999999999843     345899999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++.++++.++..   ....+++..++.|+.||+.||.|||+ ++||||||||+|||+
T Consensus       138 ~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill  190 (357)
T PHA03209        138 HYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFI  190 (357)
T ss_pred             ccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            999988775543   34568999999999999999999998 899999999999985

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.9e-24  Score=191.68  Aligned_cols=132  Identities=28%  Similarity=0.415  Sum_probs=106.7

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ..+.+|.-..+||+|+||.||+|... ++..||||.+...    ...+.+|+.+|..++|||+|+|+|||.+...    .
T Consensus        72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~  146 (361)
T KOG1187|consen   72 KATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----H  146 (361)
T ss_pred             HHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----e
Confidence            34567888899999999999999864 4589999988542    3457899999999999999999999965542    3


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--CceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--GVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~--~iiHrDlKp~NILl  272 (272)
                      .+||+||+.+ +|.+.+.. .... .++|.....|+.+++.||+|||...  .||||||||+||||
T Consensus       147 ~~LVYEym~nGsL~d~L~~-~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL  210 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHG-KKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL  210 (361)
T ss_pred             EEEEEEccCCCCHHHHhCC-CCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence            8999999995 44443322 2111 7899999999999999999999744  49999999999996

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.91  E-value=5.6e-24  Score=191.36  Aligned_cols=127  Identities=28%  Similarity=0.497  Sum_probs=107.4

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||++++++|     .+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            345799999999999999999999999999999998532       12345799999999999999999887     455


Q ss_pred             eEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|+||||++++ +..++.     ...+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl  175 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLL  175 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEE
Confidence            5699999999865 444332     2357889999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.1e-24  Score=197.62  Aligned_cols=129  Identities=29%  Similarity=0.414  Sum_probs=111.0

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcC-CCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  205 (272)
                      ....+|.++++||+|+||+|+++..+.+++.+|||+++++.       .....|..|+.... ||+++.++.+|     +
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----Q  439 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----Q  439 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----c
Confidence            44568999999999999999999999999999999997642       33446888887776 99999999999     7


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +..++|+||||+.|+.+.   + ......|++..+++|+.+|+.||.|||+ +|||+||||.+||||
T Consensus       440 T~~~l~fvmey~~Ggdm~---~-~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLL  501 (694)
T KOG0694|consen  440 TKEHLFFVMEYVAGGDLM---H-HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLL  501 (694)
T ss_pred             cCCeEEEEEEecCCCcEE---E-EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEE
Confidence            777799999999987522   1 2224679999999999999999999998 999999999999996

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.91  E-value=1e-23  Score=182.71  Aligned_cols=127  Identities=27%  Similarity=0.366  Sum_probs=105.2

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      |.+.+.||+|+||.||+|.+..+++.||||.+....       ....+|+.+++.++|+||++++++|     ....++|
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence            788999999999999999999999999999885321       1234799999999999999999887     3444699


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.++.+..... ......+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        77 lv~e~~~~g~L~~~~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill  135 (285)
T cd05631          77 LVLTIMNGGDLKFHIY-NMGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILL  135 (285)
T ss_pred             EEEEecCCCcHHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEE
Confidence            9999999665432211 1223468899999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.91  E-value=9.3e-24  Score=187.08  Aligned_cols=126  Identities=25%  Similarity=0.404  Sum_probs=106.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||++++..+++.||+|++.+.       ...+.+|+.++..+.|+||+.++++|     ....++
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            699999999999999999999999999999998542       12245688999999999999999988     445569


Q ss_pred             EEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.++ +..++..   ....+++..++.++.|++.||.|||+ ++|+||||||+||||
T Consensus        77 ~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill  135 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLL  135 (331)
T ss_pred             EEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEE
Confidence            9999999855 4443332   23568899999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.91  E-value=7.1e-24  Score=188.61  Aligned_cols=129  Identities=34%  Similarity=0.495  Sum_probs=106.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCC-CEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETG-DSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ....+|.+.+.||+|+||.||+|.+..++ ..||+|.+...       .....+|+.+++.++||||++++++|     .
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~  101 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----K  101 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----E
Confidence            34557999999999999999999876654 68999988532       12344799999999999999999998     3


Q ss_pred             CceEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...++|+||||+.++ +..++.    ....+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus       102 ~~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl  164 (340)
T PTZ00426        102 DESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLL  164 (340)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEE
Confidence            445699999999854 444333    24568999999999999999999998 999999999999986

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.91  E-value=1.5e-23  Score=187.21  Aligned_cols=126  Identities=29%  Similarity=0.451  Sum_probs=105.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ....+|...+.||+|+||.||+|.+..+++.||||++....     ..+.+|+++|+.++|+||++++++|     ....
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~  145 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNG  145 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCC
Confidence            34456888999999999999999999999999999985432     2345899999999999999999988     3444


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+.++.+.   .    .....+..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       146 ~~~lv~e~~~~~~L~---~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll  201 (353)
T PLN00034        146 EIQVLLEFMDGGSLE---G----THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLI  201 (353)
T ss_pred             eEEEEEecCCCCccc---c----cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEE
Confidence            599999999976543   1    1235677788899999999999998 999999999999986

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.91  E-value=8.5e-24  Score=190.26  Aligned_cols=128  Identities=32%  Similarity=0.525  Sum_probs=107.8

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||++++++|     ..
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~  114 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD  114 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence            3445799999999999999999999999999999998531       12345799999999999999999988     44


Q ss_pred             ceEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++|+||||++++ +..++.     ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll  175 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLL  175 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEE
Confidence            55699999999865 444332     2358889999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.91  E-value=1.2e-23  Score=184.31  Aligned_cols=128  Identities=30%  Similarity=0.538  Sum_probs=109.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+|.+.+.||+|+||.||+|++..+++.||||.+....     ....+|+.+++.++||||+++++++.     ...+.
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   79 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSL   79 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeE
Confidence            356999999999999999999999999999999886321     23457999999999999999999884     33459


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+++++...+..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        80 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill  137 (309)
T cd07872          80 TLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLI  137 (309)
T ss_pred             EEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            99999999887765433   23457888899999999999999998 999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.91  E-value=6.5e-24  Score=187.46  Aligned_cols=121  Identities=27%  Similarity=0.395  Sum_probs=101.0

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEee
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      +.||+|+||.||++.+..+|..||+|++....       ....+|+.+++.++||||++++++|     ....++|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            36999999999999999999999999986431       2234699999999999999999988     34446999999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |++++.+...   ......+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        76 ~~~~~~L~~~---l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll  128 (323)
T cd05595          76 YANGGELFFH---LSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLML  128 (323)
T ss_pred             CCCCCcHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEE
Confidence            9996644321   2224568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=2.2e-24  Score=192.76  Aligned_cols=126  Identities=25%  Similarity=0.371  Sum_probs=106.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      .+.+++.||+|.||.||+|.+..+ ..||+|.++..   ...+.+|+++|++|+|+|||+||+++....     -+||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEE
Confidence            356778999999999999998542 36999988652   345568999999999999999999985433     399999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||. |+|+++++.  .....+.......++.|||.||+||.+ +++|||||.++||||
T Consensus       281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV  336 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILV  336 (468)
T ss_pred             EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheee
Confidence            9999 677776664  335668888899999999999999998 899999999999996

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.91  E-value=8.8e-24  Score=187.42  Aligned_cols=133  Identities=23%  Similarity=0.369  Sum_probs=104.1

Q ss_pred             cccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeecc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTT  203 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  203 (272)
                      ...+|.+.+.||+|+||.||+|.+.     .++..||||.+....     ....+|+.+|+.+ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-   83 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-   83 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence            3457999999999999999999753     345689999986432     2345799999999 899999999987432 


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhhh----------------------------------------------------
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYTR----------------------------------------------------  230 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------  230 (272)
                         ...++++|||+++ ++.+++.....                                                    
T Consensus        84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence               2348999999995 45444432111                                                    


Q ss_pred             ------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          231 ------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       231 ------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                            ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~  207 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILL  207 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEE
Confidence                  02347788889999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.91  E-value=1.4e-23  Score=185.69  Aligned_cols=126  Identities=29%  Similarity=0.471  Sum_probs=107.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||++.+..+++.||||++....       ....+|+.+++.++|+||++++++|     ....++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence            5999999999999999999999999999999986432       2345799999999999999999887     344569


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+++ .+..++..   ....+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus        77 ~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll  135 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLI  135 (330)
T ss_pred             EEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEE
Confidence            999999985 44444332   23568999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.91  E-value=2.1e-23  Score=180.44  Aligned_cols=132  Identities=27%  Similarity=0.472  Sum_probs=109.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHc---CCCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.+   +||||++++++|.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4889999999999999999999999999999886421      2334678777765   699999999988655444556


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++++|||+++++..++....  ...+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili  141 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILV  141 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            789999999988776654322  3458999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.91  E-value=1.2e-23  Score=189.26  Aligned_cols=129  Identities=32%  Similarity=0.468  Sum_probs=108.7

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      |.+.+.||+|+||.||++.+..+++.||||.+...      .....+|+.+|+.++|+||+++++++.........++|+
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            77889999999999999999999999999988532      123457999999999999999999885443222236899


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+.+++...+.    ....+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        82 v~e~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili  136 (372)
T cd07853          82 VTELMQSDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLV  136 (372)
T ss_pred             EeeccccCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEE
Confidence            99999988766443    24568999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.90  E-value=9.7e-24  Score=186.77  Aligned_cols=121  Identities=26%  Similarity=0.395  Sum_probs=101.1

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEee
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      +.||+|+||.||++.+..+++.||||++....       ....+|+.+|+.++||||++++++|     ....++|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            36899999999999999999999999986431       2334799999999999999999887     44456999999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |++++.+..   +......+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        76 y~~~g~L~~---~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll  128 (328)
T cd05593          76 YVNGGELFF---HLSRERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLML  128 (328)
T ss_pred             CCCCCCHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEE
Confidence            999654432   12224568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.90  E-value=2.5e-24  Score=168.77  Aligned_cols=126  Identities=33%  Similarity=0.557  Sum_probs=109.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .|...++||+|+||+||+|++..+++.||+|.++-+      ....-+||.+|+.|+|.|||++++....     ...+-
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----CceeE
Confidence            477778999999999999999999999999998643      2345689999999999999999998733     33488


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+|||...+..   .+...++.+....++.++.|+++||.|||+ +++.||||||.|+||
T Consensus        78 lvfe~cdqdlkk---yfdslng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnlli  134 (292)
T KOG0662|consen   78 LVFEFCDQDLKK---YFDSLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLI  134 (292)
T ss_pred             EeHHHhhHHHHH---HHHhcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEe
Confidence            999999988765   445567889999999999999999999998 999999999999986

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.5e-23  Score=180.38  Aligned_cols=128  Identities=28%  Similarity=0.354  Sum_probs=106.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .|++.++||+|+||.||++.+..+++.||||++....       ....+|+.+++.++||||++++++|     ....++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            3888999999999999999999899999999885421       2234799999999999999999988     444569


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.++.+..... ......+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        76 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~  135 (285)
T cd05605          76 CLVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILL  135 (285)
T ss_pred             EEEEeccCCCcHHHHHH-hcCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEE
Confidence            99999998654432221 1223468999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.90  E-value=2.5e-23  Score=180.28  Aligned_cols=132  Identities=33%  Similarity=0.517  Sum_probs=106.9

Q ss_pred             CeeeeEEeccCCceEEEEEEECC-CCCEEEEEEeeccc------hhHHHHHHHHHHc---CCCCeeecceeeeecccCCc
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~------~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~  207 (272)
                      +|.+.+.||+|+||.||+|.+.. ++..||||.+....      ....+|+.+++.+   .||||++++++|........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            59999999999999999999864 46889999885321      2334678777766   69999999998854443445


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+++||||+++++..++...  ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~  143 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILV  143 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEE
Confidence            568999999998887765432  23458899999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.90  E-value=2.3e-23  Score=186.42  Aligned_cols=130  Identities=27%  Similarity=0.437  Sum_probs=108.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc-CCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~  208 (272)
                      ..+|.+.+.||+|+||.||++.+..+++.||||.+...      .....+|+.+++.++||||++++++|..... ....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            45799999999999999999999999999999998532      2234579999999999999999998754321 1223


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|+||||+++++...+.      ..+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus       100 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~  156 (359)
T cd07876         100 DVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVV  156 (359)
T ss_pred             eeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEE
Confidence            589999999988766432      247888899999999999999998 999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.90  E-value=2.5e-23  Score=183.82  Aligned_cols=122  Identities=27%  Similarity=0.374  Sum_probs=100.6

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEee
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      +.||+|+||.||++.+..+++.||+|++....       ....+|+++++.++||||++++++|     ....++|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            36999999999999999999999999986431       2234689999999999999999887     34456999999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |++++.+..   +......+++..++.++.||+.||.|||+..+|+||||||+||||
T Consensus        76 ~~~~~~L~~---~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll  129 (325)
T cd05594          76 YANGGELFF---HLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML  129 (325)
T ss_pred             CCCCCcHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE
Confidence            999765432   122245689999999999999999999952699999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.6e-23  Score=184.02  Aligned_cols=118  Identities=30%  Similarity=0.438  Sum_probs=99.3

Q ss_pred             eccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          145 VGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       145 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      ||+|+||.||+|.+..+++.||+|++...       .....+|+.+|+.++||||++++++|     ....++|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            79999999999999999999999998642       12234799999999999999999887     3445699999999


Q ss_pred             cccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          218 SETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++.+ ..+.    ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        76 ~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili  126 (312)
T cd05585          76 NGGELFHHLQ----REGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILL  126 (312)
T ss_pred             CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEE
Confidence            86543 3332    24568999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=1.6e-23  Score=189.78  Aligned_cols=130  Identities=32%  Similarity=0.434  Sum_probs=110.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+.|.+...||.|.|+.|.+|++..++..||||.+.+..      ....+|+++|+.|+|||||++|.+....     
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-----  127 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-----  127 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----
Confidence            45567999999999999999999999999999999986531      2245899999999999999999987433     


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+|+||||+.++-+.   .+...++.+.+..++.++.|++.|++|||+ +.|||||||++||||
T Consensus       128 ~~lylV~eya~~ge~~---~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL  188 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELF---DYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILL  188 (596)
T ss_pred             ceeEEEEEeccCchhH---HHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccc
Confidence            3399999999865332   344556677788999999999999999998 999999999999986

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.90  E-value=2.4e-23  Score=178.49  Aligned_cols=128  Identities=20%  Similarity=0.259  Sum_probs=104.7

Q ss_pred             cCeeeeEEeccCCceEEEEEEEC---CCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .+|.+.+.||+|+||.||+|.+.   ..+..||+|.++...     ..+.+|+.+++.++||||+++++++.     ...
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence            36999999999999999999865   346789999886432     23457999999999999999999884     334


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||++++++..+..  .....+++..++.++.||+.||+|||+ ++|+||||||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~--~~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili  140 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLR--KHEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLV  140 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEE
Confidence            5899999999765542221  123468899999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=3.5e-23  Score=201.46  Aligned_cols=136  Identities=27%  Similarity=0.391  Sum_probs=112.7

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....+|.+++.||+|+||.||+|.+..+++.||+|++...      ...+..|+.+|+.|.|||||+++++|+...   .
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~---~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA---N   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---C
Confidence            4455799999999999999999999999999999988532      223457999999999999999999885432   2


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc------CCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV------VGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~------~~iiHrDlKp~NILl  272 (272)
                      ..+||||||+++ +|..++.........+++..++.|+.||+.||.|||+.      .+||||||||+||||
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL  158 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL  158 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence            358999999984 66666655444456799999999999999999999972      249999999999986

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4e-24  Score=190.26  Aligned_cols=130  Identities=31%  Similarity=0.455  Sum_probs=111.4

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      +..+-|.+.+.||+|.|.+|.+|++.-||+.||||++.+.+      .....|+..|+.++|||||+||++.     ..+
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQ   89 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQ   89 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----ccc
Confidence            44456999999999999999999999999999999996532      3445899999999999999999987     445


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+|||+|+-++ ++++++...   ...+.+..++.|+.||+.|+.|||+ ..+|||||||+|+++
T Consensus        90 TKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVF  151 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVF  151 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEE
Confidence            559999999985 666655432   4568999999999999999999998 899999999999964

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=8.8e-23  Score=184.96  Aligned_cols=126  Identities=23%  Similarity=0.399  Sum_probs=107.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEEC--CCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ..+|.+.+.||+|+||.||+|...  .++..||+|.+... ....+|+.+|+.|+||||++++++|     ....++|++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence            346999999999999999999764  35678999987644 3456899999999999999999988     344469999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++.++++.++.    ....+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       165 ~e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill  218 (392)
T PHA03207        165 MPKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFL  218 (392)
T ss_pred             ehhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEE
Confidence            9999988876552    24578999999999999999999998 999999999999986

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.90  E-value=3.2e-23  Score=183.04  Aligned_cols=125  Identities=26%  Similarity=0.368  Sum_probs=102.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCC-CeeecceeeeecccCCceE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHP-NVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~~~~  209 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||||++....       .....|+.++..+.|+ +|+.++++|     ....+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence            4889999999999999999999999999999986431       2234688899999765 577888877     33445


Q ss_pred             EEEEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+.++.+ ..+.    ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill  134 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVML  134 (324)
T ss_pred             EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEE
Confidence            9999999986544 3332    24568899999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.90  E-value=2.5e-23  Score=200.03  Aligned_cols=126  Identities=25%  Similarity=0.386  Sum_probs=107.5

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++....       .....|+.+++.++||||+++++++     ....+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            46999999999999999999999999999999986432       3456799999999999999999887     34446


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||||+.+ .|..++..    ...+++..++.|+.||+.||.|||. ++||||||||+||||
T Consensus        79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl  137 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLI  137 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEE
Confidence            9999999975 55554432    3458888999999999999999998 899999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=3.3e-23  Score=192.36  Aligned_cols=129  Identities=26%  Similarity=0.314  Sum_probs=107.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCC-CCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLET-GDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~-~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .|.+.+.||+|+||.||+|.+..+ ++.||+|.+...    .....+|+.+|+.++|||||+++++|.     ...++||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence            499999999999999999998877 788999976432    223457999999999999999999984     3345999


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+.+ +|...+........++++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll  202 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFL  202 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEE
Confidence            9999985 5555544444445678899999999999999999998 999999999999986

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.90  E-value=2.5e-23  Score=183.65  Aligned_cols=124  Identities=29%  Similarity=0.412  Sum_probs=101.5

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHH---HHcCCCCeeecceeeeecccCCce
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIM---RLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      |.+.+.||+|+||.||+|.+..+++.||||++....       ....+|+.++   +.++||||++++++|     ....
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            678899999999999999999999999999986431       2233565554   566799999999988     3444


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+.++.+.....    ...+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus        76 ~~~lv~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill  134 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLL  134 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEE
Confidence            6999999999765432221    3468999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.90  E-value=3.3e-23  Score=179.13  Aligned_cols=122  Identities=29%  Similarity=0.357  Sum_probs=101.0

Q ss_pred             eccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       145 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      ||+|+||+||++.+..+++.||||.+....       .....|+.+++.++|+||++++++|     ....++|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999999999999999985421       2234699999999999999999887     3445599999999


Q ss_pred             cccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          218 SETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~~l~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++.+. .+.........+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili  130 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLL  130 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            865543 332223334568999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=3.7e-23  Score=190.48  Aligned_cols=126  Identities=25%  Similarity=0.359  Sum_probs=108.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEee
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      ...|.+.+.||+|+||.||+|.+..+++.||||...  .....+|+++|+.|+|+|||++++++..     ..+.|+|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEE
Confidence            346999999999999999999999999999999643  2335689999999999999999998743     334899999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++.++++.++..   ....+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       241 ~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl  293 (461)
T PHA03211        241 KYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLV  293 (461)
T ss_pred             ccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEE
Confidence            999888775543   23468999999999999999999998 999999999999986

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.90  E-value=5.1e-23  Score=182.39  Aligned_cols=126  Identities=25%  Similarity=0.398  Sum_probs=106.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||++.+..+++.||+|++.+.       ......|+.++..+.|+||++++++|     .+..++
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence            599999999999999999999999999999998532       12245788999999999999999988     344569


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.+ ++.+++..   ....+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        77 ~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili  135 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILM  135 (332)
T ss_pred             EEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEE
Confidence            999999985 55444432   23568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.90  E-value=5.7e-23  Score=179.53  Aligned_cols=131  Identities=21%  Similarity=0.296  Sum_probs=102.9

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECC----------------CCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeee
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLE----------------TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVS  194 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~----------------~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~  194 (272)
                      ..+|.+.+.||+|+||.||+|.+..                ++..||+|.+....     ..+.+|+.+|+.+.||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3469999999999999999997532                34579999886432     23457999999999999999


Q ss_pred             cceeeeecccCCceEEEEEeecccc-cHHHHHHHhhh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 024091          195 LKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTR---------------MNQHVPILYVQLYTYQICRALNYLHHVV  258 (272)
Q Consensus       195 l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~  258 (272)
                      ++++|...     ..+|+||||+.+ ++.+++.....               ....+++..+..++.||+.||.|||+ .
T Consensus        84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~  157 (304)
T cd05096          84 LLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-L  157 (304)
T ss_pred             EEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-C
Confidence            99988433     348999999985 55544432110               11246778889999999999999998 8


Q ss_pred             CceecCCCCCCeeC
Q 024091          259 GVCHRDIKPQNLLM  272 (272)
Q Consensus       259 ~iiHrDlKp~NILl  272 (272)
                      +|+||||||+||||
T Consensus       158 ~ivH~dlkp~Nill  171 (304)
T cd05096         158 NFVHRDLATRNCLV  171 (304)
T ss_pred             CccccCcchhheEE
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.90  E-value=6.6e-23  Score=178.90  Aligned_cols=128  Identities=30%  Similarity=0.544  Sum_probs=109.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+|.+.+.||.|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++.     ...++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence            457999999999999999999999999999999885321     23457999999999999999999983     44459


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+++++...+..   ....+++..++.++.||+.||.|||+ .+|+|+||||+|||+
T Consensus        80 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~  137 (301)
T cd07873          80 TLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLI  137 (301)
T ss_pred             EEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEE
Confidence            99999999887765543   23458889999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.90  E-value=3.2e-23  Score=183.46  Aligned_cols=120  Identities=30%  Similarity=0.499  Sum_probs=100.6

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ++||+|+||.||+|.+..+++.||||+++...       .....|+.++..+ +||||++++++|     ....++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            46999999999999999999999999986431       2345788999888 699999999988     3445699999


Q ss_pred             ecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++.+ ..+.    ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili  129 (329)
T cd05588          76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLL  129 (329)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEE
Confidence            99986544 3222    24579999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-23  Score=171.78  Aligned_cols=136  Identities=29%  Similarity=0.404  Sum_probs=118.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|++.+.||+|||+.||+++...++..+|+|.+.-.    .....+|++..++++||||++++++............|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            44799999999999999999999999999999998533    33445899999999999999999887655544566799


Q ss_pred             EEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeC
Q 024091          212 LVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~--iiHrDlKp~NILl  272 (272)
                      |+++|.. |++++.+.........+++..+..|+.+||+||++||. ..  +.||||||.|||+
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILl  162 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILL  162 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEe
Confidence            9999887 67888777766666689999999999999999999998 77  9999999999986

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=7.9e-24  Score=188.39  Aligned_cols=130  Identities=28%  Similarity=0.405  Sum_probs=110.7

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+|..++++|+|+||.+++.++...+..+++|.+.-      .++....|+.+++++.|||||.+++.|+    .++.++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence            469999999999999999999999999999999843      2345568999999999999999999985    455679


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+||+|+.+.-.....+ ...|++..+..|+.|++.|+.|||+ ++|+|||||+.||++
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifl  139 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFL  139 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhc
Confidence            99999999765543322222 4679999999999999999999998 999999999999985

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.90  E-value=7.7e-23  Score=181.16  Aligned_cols=128  Identities=25%  Similarity=0.364  Sum_probs=107.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+|.+.+.||+|+||.||++.+..++..||+|.+....     ..+.+|+++|+.++||||++++++|...     ..+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEE
Confidence            347999999999999999999999999999999886432     2355899999999999999999988433     348


Q ss_pred             EEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++||||++++ +.+++..    ...+++..+..++.|++.||.|||+..+|+||||||+|||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~  137 (331)
T cd06649          79 SICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV  137 (331)
T ss_pred             EEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE
Confidence            9999999965 4443322    34688999999999999999999972369999999999986

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.90  E-value=3.5e-23  Score=187.25  Aligned_cols=126  Identities=19%  Similarity=0.361  Sum_probs=102.6

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+...++..||.|.||+||+|.+-   -.||||.+..      ....+++|+.++++-+|.||+-+.|||..+.     
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~-----  461 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP-----  461 (678)
T ss_pred             CHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-----
Confidence            3345668899999999999999983   3599999853      2345678999999999999999999985443     


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       +.||.-+|.|..+..+.+  .....|.....+.|++||+.||.|||. ++|||||||..||+|
T Consensus       462 -~AIiTqwCeGsSLY~hlH--v~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl  521 (678)
T KOG0193|consen  462 -LAIITQWCEGSSLYTHLH--VQETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFL  521 (678)
T ss_pred             -eeeeehhccCchhhhhcc--chhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEE
Confidence             489999999865442222  223568888899999999999999997 999999999999986

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-24  Score=182.88  Aligned_cols=125  Identities=28%  Similarity=0.427  Sum_probs=109.6

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc--hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeec
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      |.++.+||+|+||.||+|.++.+|..+|||.+.-+.  ...-.||.||++++.|++|++||.|+....     +||||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehhh
Confidence            888999999999999999999999999999986543  344579999999999999999999987765     9999999


Q ss_pred             cc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          217 IS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       217 ~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+ |+.-++++.   .+.++.+..+..+++..+.||+|||. ..-||||||..||||
T Consensus       110 CGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILL  162 (502)
T KOG0574|consen  110 CGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILL  162 (502)
T ss_pred             cCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEE
Confidence            99 555555443   25679999999999999999999998 688999999999996

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.89  E-value=6.8e-23  Score=181.37  Aligned_cols=125  Identities=29%  Similarity=0.490  Sum_probs=103.0

Q ss_pred             CeeeeEEeccCCceEEEEEEEC---CCCCEEEEEEeeccc--------hhHHHHHHHHHHcC-CCCeeecceeeeecccC
Q 024091          138 SYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~~--------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  205 (272)
                      +|.+.+.||+|+||.||++++.   .+++.||+|++.+..        .....|+.+++.+. |+||++++++|     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4889999999999999999874   478999999986421        22346999999994 99999999887     4


Q ss_pred             CceEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...++|+||||+.++ +...+.    ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili  138 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILL  138 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEE
Confidence            445699999999864 444332    24568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.89  E-value=5.2e-23  Score=180.73  Aligned_cols=127  Identities=31%  Similarity=0.525  Sum_probs=104.0

Q ss_pred             eEEeccCCceEEEEEEEC--CCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          142 ERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      ..+||+|+||.||+|.+.  .+++.||+|.+...  .....+|+.+|+.++||||++++++|....   ..++|++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEecc
Confidence            467999999999999975  36789999988643  234568999999999999999999875332   34589999999


Q ss_pred             cccHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          218 SETVYRVSKHYTR-----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~~l~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++++..++.....     ....+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~  141 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILV  141 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEE
Confidence            9988776543211     12358899999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.89  E-value=1e-22  Score=178.36  Aligned_cols=131  Identities=34%  Similarity=0.567  Sum_probs=110.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECC--CCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLE--TGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~--~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      +|.+.+.||+|+||.||+|.+..  ++..||||.+....       ....+|+.+++.++||||++++++|...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            48899999999999999999988  89999999986522       2345799999999999999999988433   224


Q ss_pred             EEEEEeecccccHHHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMN-QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||++++++.++....... ..+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~  141 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILV  141 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEE
Confidence            699999999988887665443333 378999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.89  E-value=5.9e-23  Score=183.47  Aligned_cols=130  Identities=28%  Similarity=0.440  Sum_probs=108.3

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc-CCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~  208 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||.+...      .....+|+.+++.++||||++++++|..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            45799999999999999999999999999999988532      1233479999999999999999998754321 1224


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|+||||+++++...+.      ..+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill  152 (355)
T cd07874          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVV  152 (355)
T ss_pred             eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEE
Confidence            589999999988766443      247888899999999999999998 999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.89  E-value=5.7e-23  Score=181.18  Aligned_cols=120  Identities=31%  Similarity=0.463  Sum_probs=98.9

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ++||+|+||.||+|++..+++.||||++....       .....|..++..+ +||||++++++|     ....++|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            36999999999999999999999999986431       1234688888866 799999999998     3444599999


Q ss_pred             ecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++.+ ..+.    ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        76 E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill  129 (321)
T cd05591          76 EYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILL  129 (321)
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEE
Confidence            99996544 3322    24568899999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.89  E-value=8.8e-23  Score=173.54  Aligned_cols=124  Identities=36%  Similarity=0.624  Sum_probs=106.8

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchh------HHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY------KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      |++.+.||+|+||+||++.+..+++.||+|.+......      ..+|+.+++.++||||+++++++..     ..++++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            78999999999999999999999999999998654221      1248999999999999999998844     445899


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+.+ ++..++.    ....+++..+..++.||+.||.|||+ .+|+|+||||+|||+
T Consensus        76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~  131 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILL  131 (260)
T ss_dssp             EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEE
T ss_pred             ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccc
Confidence            9999997 6665554    24568999999999999999999998 999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.89  E-value=1.4e-22  Score=174.99  Aligned_cols=128  Identities=33%  Similarity=0.569  Sum_probs=109.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||||.+...      .....+|+.+++.++||||+++++++.     ...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            488999999999999999999999999999988532      133567999999999999999999984     344599


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+++..++... .....+++..++.++.||+.||.|||+ .+|+|+||||+|||+
T Consensus        76 ~v~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~  134 (285)
T cd07861          76 LIFEFLSMDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLI  134 (285)
T ss_pred             EEEecCCCCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEE
Confidence            99999998877655432 223568999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.89  E-value=6.1e-23  Score=180.94  Aligned_cols=121  Identities=28%  Similarity=0.464  Sum_probs=97.3

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHH-HHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNREL-QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ++||+|+||.||+|++..+++.||||++....       .....|+ .+++.++||||++++++|     .+..++|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            36999999999999999999999999986421       1122344 467889999999999887     3444599999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++.+...   ......+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus        76 e~~~~~~L~~~---l~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll  129 (321)
T cd05603          76 DYVNGGELFFH---LQRERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILL  129 (321)
T ss_pred             cCCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEE
Confidence            99996544321   1224568899999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.89  E-value=9.1e-23  Score=180.92  Aligned_cols=127  Identities=25%  Similarity=0.389  Sum_probs=106.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .+|.+.+.||+|+||.||++.+..++..+|+|.+....     ..+.+|+++++.++||||++++++|...     .++|
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   79 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEIS   79 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEEE
Confidence            46999999999999999999999999999999876432     2355899999999999999999998543     3599


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ +|.+++..    ...+++..+..++.|++.||.|||+..+|+||||||+|||+
T Consensus        80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili  137 (333)
T cd06650          80 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV  137 (333)
T ss_pred             EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE
Confidence            99999986 44444332    45688899999999999999999973479999999999985

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.89  E-value=1.1e-22  Score=179.64  Aligned_cols=125  Identities=26%  Similarity=0.367  Sum_probs=102.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHc-CCCCeeecceeeeecccCCceE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||||++.+..       .....|..++..+ .|++|+.++++|     ....+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            4889999999999999999999999999999986432       1223577777776 488999998887     34446


Q ss_pred             EEEEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||++++.+ ..+.    ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill  134 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVML  134 (323)
T ss_pred             EEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEE
Confidence            9999999985543 3322    24568899999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.89  E-value=5.7e-23  Score=183.38  Aligned_cols=123  Identities=29%  Similarity=0.502  Sum_probs=106.4

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeec------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEee
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      .++||.|.||+||-|.++.+|+.||||+|.+      +....++|++||+.+.||.||.|--.|     +....+++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence            5789999999999999999999999999853      345667899999999999999986555     33334999999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      -+.|+.+..+...  ..+.+++...+++..||+.||.|||. ++|+|.||||+||||
T Consensus       644 Kl~GDMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLL  697 (888)
T KOG4236|consen  644 KLHGDMLEMILSS--EKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLL  697 (888)
T ss_pred             hhcchHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheee
Confidence            9999988866543  35679999999999999999999998 999999999999996

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.89  E-value=7.2e-23  Score=180.23  Aligned_cols=120  Identities=30%  Similarity=0.500  Sum_probs=99.2

Q ss_pred             EEeccCCceEEEEEEEC---CCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          143 RVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      +.||+|+||.||++.+.   .+|+.||+|++....      ....+|+++|+.++||||++++++|.     ...++|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence            57999999999999863   578999999986421      22346999999999999999999883     44469999


Q ss_pred             eeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+.++ +...+    .....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        77 ~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~  131 (318)
T cd05582          77 LDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILL  131 (318)
T ss_pred             EcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEE
Confidence            9999854 44333    224568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.5e-22  Score=188.55  Aligned_cols=136  Identities=26%  Similarity=0.350  Sum_probs=111.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc---CC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KD  206 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~  206 (272)
                      ..+|.+.+.||+|+||+||+|.+..+++.||||.+...      .....+|+.++..++|+||+++++.|.....   ..
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            34799999999999999999999999999999998542      2234579999999999999999887644322   22


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++++||||+.+ +|.+.+.........+++..+..++.|++.||.|||+ .+|+||||||+||||
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl  176 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILL  176 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEE
Confidence            2357899999984 5655555444445678999999999999999999998 999999999999986

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.89  E-value=6.3e-23  Score=181.21  Aligned_cols=121  Identities=29%  Similarity=0.493  Sum_probs=97.5

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHH-HHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQ-IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||+||+|.+..+|+.||||++....       .....|.. +++.++||||++++++|     ....++|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            36999999999999999999999999986431       11223443 57789999999999887     3344599999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++.+..   +......+++..++.++.||+.||.|||+ .||+||||||+||||
T Consensus        76 e~~~~~~L~~---~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll  129 (325)
T cd05604          76 DFVNGGELFF---HLQRERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILL  129 (325)
T ss_pred             cCCCCCCHHH---HHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEE
Confidence            9999654432   12234578999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.89  E-value=2.4e-22  Score=173.74  Aligned_cols=138  Identities=24%  Similarity=0.348  Sum_probs=113.8

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHc-CCCCeeecceeeeecccCCceE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ....+|.+.+.||+|+||.||++.+..+++.+|+|++....   ....+|+.+++.+ +||||++++++|+......+.+
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            45567999999999999999999999999999999875422   3456799999999 6999999999886554455667


Q ss_pred             EEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++||||++++ +..++.........+++..+..++.|++.||.|||+ .+|+||||||+||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili  157 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILL  157 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEE
Confidence            99999999855 444444333334568889999999999999999998 899999999999985

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.89  E-value=7.9e-23  Score=180.65  Aligned_cols=124  Identities=24%  Similarity=0.442  Sum_probs=102.3

Q ss_pred             eeEEeccC--CceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          141 AERVVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       141 ~~~~lG~G--~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ++++||+|  +|++||++.+..+|+.||||.+....      ....+|+.+++.++||||++++++|...     .++|+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence            45789999  78999999999999999999986431      2445799999999999999999988433     35899


Q ss_pred             Eeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+.++ +.+++...  ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        77 v~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~  134 (327)
T cd08227          77 VTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILI  134 (327)
T ss_pred             EEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEE
Confidence            99999954 44444321  13458899999999999999999998 999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.89  E-value=7.2e-23  Score=181.29  Aligned_cols=121  Identities=31%  Similarity=0.512  Sum_probs=99.7

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||.||+|.+..+++.||+|++.+..       ....+|+.++..+ +||||++++++|.     ...++|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986431       2234688888766 7999999999883     344599999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++.+...   ......+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        76 E~~~~~~L~~~---~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili  129 (329)
T cd05618          76 EYVNGGDLMFH---MQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLL  129 (329)
T ss_pred             eCCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEE
Confidence            99996644321   2224568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.89  E-value=8.4e-23  Score=179.84  Aligned_cols=120  Identities=28%  Similarity=0.415  Sum_probs=97.3

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHH-cCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ++||+|+||.||+|.+..+++.||||+++...       .....|..++.. +.||||++++++|     ....++|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            36999999999999999999999999986432       122346666664 4799999999887     3445699999


Q ss_pred             ecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++.+ ..+.    ....+++..+..++.||+.||.|||+ .+|+||||||+||||
T Consensus        76 e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill  129 (316)
T cd05592          76 EYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLL  129 (316)
T ss_pred             cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEE
Confidence            99986544 3322    24568999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.89  E-value=8.2e-23  Score=180.20  Aligned_cols=121  Identities=31%  Similarity=0.489  Sum_probs=99.1

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||.||+|.+..+++.||||++....       .....|+.++..+ .||||++++++|     ....++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            36999999999999999999999999986431       2234678888776 699999999988     3444599999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++.+..   +......+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        76 Ey~~~g~L~~---~i~~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli  129 (320)
T cd05590          76 EFVNGGDLMF---HIQKSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLL  129 (320)
T ss_pred             cCCCCchHHH---HHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEE
Confidence            9999654432   12224568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.89  E-value=8.3e-23  Score=180.36  Aligned_cols=120  Identities=31%  Similarity=0.450  Sum_probs=98.7

Q ss_pred             EEeccCCceEEEEEEEC---CCCCEEEEEEeeccc--------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          143 RVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~~--------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +.||+|+||.||++++.   .+++.||||++....        ....+|+.+|+.++||||++++++|.     ...++|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence            67999999999999864   468899999986421        22347999999999999999999883     344599


Q ss_pred             EEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.++.+ ..+.    ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        77 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~  133 (323)
T cd05584          77 LILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILL  133 (323)
T ss_pred             EEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEE
Confidence            99999996544 3322    24567888899999999999999998 999999999999986

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.89  E-value=7.9e-23  Score=180.59  Aligned_cols=121  Identities=28%  Similarity=0.454  Sum_probs=96.4

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHH-HHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNREL-QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||.||+|.+..+++.||+|++....       .....|. .+++.+.||||++++++|     ....++|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            36999999999999999999999999986421       1112233 456789999999999988     3444599999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++.+...   ......+++..++.++.||+.||.|||+ .||+||||||+||||
T Consensus        76 e~~~~~~L~~~---~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili  129 (325)
T cd05602          76 DYINGGELFYH---LQRERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILL  129 (325)
T ss_pred             eCCCCCcHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEE
Confidence            99996544321   2224568888999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.89  E-value=7.4e-23  Score=180.60  Aligned_cols=120  Identities=30%  Similarity=0.489  Sum_probs=97.0

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHH-HHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQ-IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||+||+|.+..+++.||||++....       .....|.. +++.++||||++++++|.     ...++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence            36999999999999999999999999986431       11223433 567899999999998883     344589999


Q ss_pred             ecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++.+ ..+.    ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll  129 (323)
T cd05575          76 DYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILL  129 (323)
T ss_pred             cCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEE
Confidence            99996544 3222    24568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.89  E-value=2.1e-22  Score=174.62  Aligned_cols=128  Identities=30%  Similarity=0.517  Sum_probs=109.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+|.+.+.||.|+||.||+|.+..+++.||||.+....     ....+|+.+++.++|+||+++++++     ....+.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL   78 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence            356999999999999999999998899999999985432     2345799999999999999999987     344569


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+++++..++...   ...+++..++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus        79 ~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~  136 (291)
T cd07844          79 TLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLI  136 (291)
T ss_pred             EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEE
Confidence            999999998877654432   3468899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.89  E-value=9e-23  Score=179.64  Aligned_cols=120  Identities=25%  Similarity=0.417  Sum_probs=98.5

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHH-cCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||.||+|.+..+++.||||.+....       .....|..++.. ++||||++++++|     ....++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999986431       223457777765 4899999999988     4445699999


Q ss_pred             ecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++.+ ..+.    ....+++..+..++.||+.||+|||+ ++|+||||||+|||+
T Consensus        76 E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~  129 (316)
T cd05620          76 EFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVML  129 (316)
T ss_pred             CCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEE
Confidence            99986543 3322    24568899999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.89  E-value=2e-22  Score=172.36  Aligned_cols=130  Identities=32%  Similarity=0.556  Sum_probs=108.5

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .+|.+.+.||+|+||.||+|++..+++.||||.+...       ...+.+|+.+++.++||||++++++|...     .+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence            3699999999999999999999999999999977431       12345799999999999999999988433     35


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+++|||+++ ++..++.........+++..+..++.||+.||.|||+ ++|+|+||||+|||+
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~  139 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFI  139 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEE
Confidence            8999999995 5555554444445568899999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.89  E-value=8.3e-23  Score=181.62  Aligned_cols=130  Identities=31%  Similarity=0.478  Sum_probs=108.5

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeeccc-CCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  209 (272)
                      .+|.+.+.||.|+||.||+|.+..+++.||||.+....      ....+|+.+|+.++||||++++++|..... .....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            46999999999999999999999999999999885421      234479999999999999999998743321 22245


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|++||++++.+..++.     ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~  151 (343)
T cd07878          95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAV  151 (343)
T ss_pred             EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEE
Confidence            79999999887765443     3468999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.89  E-value=1.3e-22  Score=179.10  Aligned_cols=125  Identities=26%  Similarity=0.372  Sum_probs=101.3

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      |...+.||+|+||.||+|.+..+++.||||++....       .....|+.+++.+. |++|++++++|     ....++
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~   76 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDRL   76 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCEE
Confidence            778899999999999999999999999999986431       22346888888886 56777888877     334459


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||++++.+..   +......+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        77 ~lv~Ey~~~g~L~~---~i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill  134 (323)
T cd05615          77 YFVMEYVNGGDLMY---HIQQVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVML  134 (323)
T ss_pred             EEEEcCCCCCcHHH---HHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEE
Confidence            99999998654331   22234568999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.89  E-value=5.8e-23  Score=185.88  Aligned_cols=128  Identities=30%  Similarity=0.406  Sum_probs=102.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCC---E-EEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeeccc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGD---S-VAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~-vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  204 (272)
                      ..+..+.++||+|+||.||+|.....+.   . ||||..+.+       ...+.+|+++|++++|||||++||+..... 
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~-  234 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE-  234 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-
Confidence            3345567899999999999998865422   3 899987631       223447999999999999999999874443 


Q ss_pred             CCceEEEEEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          205 KDELYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          -++||||+|.|+.+ +.++.   ....++......++.+.+.||+|||+ +++|||||..+|+|+
T Consensus       235 ----Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~  295 (474)
T KOG0194|consen  235 ----PLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLY  295 (474)
T ss_pred             ----ccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHhee
Confidence                39999999996544 33332   23368999999999999999999998 999999999999996

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.89  E-value=1.1e-22  Score=179.91  Aligned_cols=121  Identities=29%  Similarity=0.518  Sum_probs=100.1

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||.||+|.+..+++.||+|++....       ....+|+.++..+ .||||+.++++|     ....++|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999997432       2244788888887 599999999988     3444599999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++.+...   ......+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        76 e~~~~~~L~~~---~~~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili  129 (327)
T cd05617          76 EYVNGGDLMFH---MQRQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLL  129 (327)
T ss_pred             eCCCCCcHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEE
Confidence            99986544321   1224568999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.89  E-value=1.4e-22  Score=182.62  Aligned_cols=131  Identities=20%  Similarity=0.285  Sum_probs=103.9

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCC-----CCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeeccc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  204 (272)
                      ..+|.+.+.||+|+||.||+|.+..+     +..||||.+....     ..+.+|+++++.+ .|+|||+++++|.    
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~----  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT----  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec----
Confidence            44699999999999999999986543     3579999986432     2345799999999 8999999999884    


Q ss_pred             CCceEEEEEeecccc-cHHHHHHHhhh-----------------------------------------------------
Q 024091          205 KDELYLNLVLEYISE-TVYRVSKHYTR-----------------------------------------------------  230 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------------------  230 (272)
                       ....+|+||||+.+ ++.+++.....                                                     
T Consensus       113 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         113 -HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             -CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence             33459999999984 55554432110                                                     


Q ss_pred             -------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          231 -------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       231 -------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                                   ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~  245 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLL  245 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEE
Confidence                         11247788889999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.89  E-value=1.6e-22  Score=181.30  Aligned_cols=130  Identities=26%  Similarity=0.428  Sum_probs=108.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc-CCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~  208 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||.+...      .....+|+.+++.++||||++++++|..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            45799999999999999999999999999999988532      1234579999999999999999988743321 2234


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|+||||+++++...+.      ..+++..+..++.|++.||.|||+ ++|+||||||+||||
T Consensus       103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll  159 (364)
T cd07875         103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVV  159 (364)
T ss_pred             eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEE
Confidence            589999999998776543      247788899999999999999998 999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.89  E-value=3.5e-22  Score=173.42  Aligned_cols=134  Identities=28%  Similarity=0.474  Sum_probs=111.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||||.+....      ....+|+.+++.+. ||||+++++++..........+
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            5899999999999999999999999999999875321      23457999999995 6999999998865544344568


Q ss_pred             EEEeecccccHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRM-NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+++++..++...... ...+++..++.++.||+.||.|||+ .+|+||||||+||++
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~  143 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLV  143 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEE
Confidence            999999999887765543222 3568999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.89  E-value=3.2e-22  Score=173.60  Aligned_cols=128  Identities=29%  Similarity=0.473  Sum_probs=108.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||.+....     ....+|+++++.++|+||+++++++.     ...+.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~   78 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL   78 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeE
Confidence            356999999999999999999999999999999885321     23457999999999999999999873     34468


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||++++++..+..   ....+++..++.++.||+.||.|||+ .+|+|+||||+|||+
T Consensus        79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~  136 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLI  136 (291)
T ss_pred             EEEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEE
Confidence            99999999887765432   23457788889999999999999998 899999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.89  E-value=1.7e-22  Score=174.55  Aligned_cols=126  Identities=33%  Similarity=0.540  Sum_probs=108.7

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|.+...      .....+|+++++.++||||+++++++     .+..++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            488999999999999999999999999999988532      12345799999999999999999988     3445699


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||++++++..+..   ....+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~  132 (284)
T cd07839          76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLI  132 (284)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEE
Confidence            9999999887765443   24568999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.89  E-value=7.6e-25  Score=179.00  Aligned_cols=126  Identities=31%  Similarity=0.450  Sum_probs=107.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .+.|.+.++||+|.|+.||++.+..+|+.||+|++..      +....++|+.|-+.|+|||||+|.+.+     ....+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence            3469999999999999999999999999999998732      234456899999999999999998887     66678


Q ss_pred             EEEEeecccccHHH--HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~--~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|||+|++.|+-+-  +...     .-+++..+-++++||+.+|.|||. ++|||||+||+|+||
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllL  143 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLL  143 (355)
T ss_pred             eEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheee
Confidence            99999999976542  1221     346788899999999999999998 999999999999986

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.89  E-value=2.1e-22  Score=195.16  Aligned_cols=130  Identities=28%  Similarity=0.410  Sum_probs=105.7

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ++|.+.++||+|+||.||+|.+..+++.||||++...       ...+.+|+.+++.++||||+++++++.     +...
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            4799999999999999999999999999999998642       123457999999999999999999873     3445


Q ss_pred             EEEEeeccccc-HHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISET-VYRVSKHYTR-------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~-l~~~~~~~~~-------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|++|||++|+ +.+++.....       ....++...+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILL  146 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILL  146 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEE
Confidence            89999999864 4444432211       12335566778899999999999998 899999999999985

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.89  E-value=3.1e-22  Score=173.45  Aligned_cols=127  Identities=27%  Similarity=0.344  Sum_probs=105.3

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      |+..+.||+|+||+||+|.+..+++.||+|.+....       ....+|+++|+.++|+||+.++++|     ....++|
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence            778899999999999999999999999999885421       1234799999999999999998887     3445699


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||+.++.+..... ......+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        77 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili  135 (285)
T cd05632          77 LVLTIMNGGDLKFHIY-NMGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILL  135 (285)
T ss_pred             EEEEeccCccHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEE
Confidence            9999999765442221 1223468999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.89  E-value=2.6e-22  Score=173.15  Aligned_cols=129  Identities=26%  Similarity=0.396  Sum_probs=107.5

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch-----hHHHHHH-HHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQ-IMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-----~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||++.+..+|+.||||.+.....     ....|+. .++.++||||+++++++..     ...+|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcEE
Confidence            58999999999999999999999999999998864321     2224555 4677889999999998843     33489


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~-~iiHrDlKp~NILl  272 (272)
                      ++|||+++++..++.........+++..++.++.||+.||.|||+ + +|+||||||+|||+
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~  137 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLI  137 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEE
Confidence            999999998877766544445678999999999999999999997 6 99999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.89  E-value=1.1e-22  Score=183.22  Aligned_cols=131  Identities=21%  Similarity=0.324  Sum_probs=103.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEE-----CCCCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeeccc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  204 (272)
                      ..+|.+.+.||+|+||.||+|.+     ..++..||||+++...     ..+.+|+.+|+.+ +||||++++++|     
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----  108 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-----  108 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence            34699999999999999999974     3456789999886432     2345799999999 899999999988     


Q ss_pred             CCceEEEEEeeccc-ccHHHHHHHhhh-----------------------------------------------------
Q 024091          205 KDELYLNLVLEYIS-ETVYRVSKHYTR-----------------------------------------------------  230 (272)
Q Consensus       205 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  230 (272)
                      ....+.++||||++ |+++.++.....                                                     
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            33445899999998 455555432110                                                     


Q ss_pred             ------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          231 ------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       231 ------------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                                        ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill  247 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILL  247 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEE
Confidence                              01246788889999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.89  E-value=4.7e-22  Score=171.66  Aligned_cols=126  Identities=36%  Similarity=0.608  Sum_probs=107.7

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++|+||++++++|.     ...+++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEEE
Confidence            6999999999999999999999899999999875321      23457999999999999999999884     344589


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||++++++..+.   .....+++..++.++.||+.||.|||+ .+|+|+||||+||++
T Consensus        77 ~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~  133 (286)
T cd07847          77 LVFEYCDHTVLNELE---KNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILI  133 (286)
T ss_pred             EEEeccCccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEE
Confidence            999999988766432   224468999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.88  E-value=1.6e-22  Score=178.10  Aligned_cols=120  Identities=28%  Similarity=0.442  Sum_probs=97.8

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHH-cCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||.||+|.+..+++.||||++....       .....|..++.. ++||||++++++|.     ...++|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence            36999999999999999999999999986531       123357777775 58999999999883     344599999


Q ss_pred             eccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++ +...+..    ...+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~  129 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILL  129 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEE
Confidence            999854 4433322    3468889999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.88  E-value=1.7e-22  Score=177.98  Aligned_cols=121  Identities=28%  Similarity=0.465  Sum_probs=99.8

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||.||+|.+..+++.||||++.+..       ....+|+.+++.+ .||||++++++|     ....++|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            36999999999999999999999999986431       2234688888887 699999999988     3444699999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++.+...   ......+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        76 e~~~~~~L~~~---~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill  129 (318)
T cd05570          76 EYVNGGDLMFH---IQRSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLL  129 (318)
T ss_pred             cCCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEE
Confidence            99986544321   2224468999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.88  E-value=4.4e-22  Score=172.59  Aligned_cols=126  Identities=29%  Similarity=0.375  Sum_probs=104.6

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      |+..+.||+|+||.||++.+..+++.||||.+....       ....+|+.+++.++|+||+.+++.+     ....++|
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence            778899999999999999999999999999885421       2234699999999999999999887     3444699


Q ss_pred             EEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.++.+ ..+..  .....+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        77 lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~  135 (285)
T cd05630          77 LVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILL  135 (285)
T ss_pred             EEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEE
Confidence            99999986544 33322  223458899999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.88  E-value=3.3e-22  Score=175.27  Aligned_cols=126  Identities=25%  Similarity=0.368  Sum_probs=106.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +|.+.+.||+|+||.||++.+..++..+|+|.+....     ....+|+++++.++||||++++++|..     ..++|+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEEE
Confidence            5899999999999999999999999999999885431     234579999999999999999999843     345999


Q ss_pred             Eeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||++++ +..++..    ...+++..+..++.||+.||.|||+..+|+|+||||+|||+
T Consensus        77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~  133 (308)
T cd06615          77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV  133 (308)
T ss_pred             EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE
Confidence            99999864 4443332    35689999999999999999999963589999999999985

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.88  E-value=4.2e-22  Score=171.87  Aligned_cols=128  Identities=30%  Similarity=0.515  Sum_probs=109.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +|.+.+.||.|+||.||+|.+..+++.||||.+...     .....+|+.+++.++|+||++++++|..     ..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence            488999999999999999999999999999988643     2234579999999999999999999843     345899


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+++++..++.... ....+++..+..++.||+.||.|||+ .+|+|+||||+||++
T Consensus        76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~  133 (284)
T cd07836          76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLI  133 (284)
T ss_pred             EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEE
Confidence            99999998877654322 23468999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.88  E-value=1.8e-23  Score=176.15  Aligned_cols=130  Identities=32%  Similarity=0.536  Sum_probs=109.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCC----CEEEEEEeeccch------hHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~----~~vAvK~i~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      .|.+...||+|+||.||+|....+.    +.+|||.++.++.      ...+|+.+++.|+||||+.|..+|...    .
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----d  100 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----D  100 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----C
Confidence            5899999999999999999765543    3799999876533      345899999999999999999988653    3


Q ss_pred             eEEEEEeecccccHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++|++||.+.+|+.++++... ....++...++.|+.||+.|+.|||+ +=|+||||||.||||
T Consensus       101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlv  165 (438)
T KOG0666|consen  101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILV  165 (438)
T ss_pred             ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEE
Confidence            34999999999999998875432 23468899999999999999999998 889999999999986

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.88  E-value=4.1e-22  Score=174.83  Aligned_cols=127  Identities=31%  Similarity=0.540  Sum_probs=103.6

Q ss_pred             eEEeccCCceEEEEEEECC--CCCEEEEEEeeccc--hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          142 ERVVGTGSFGVVFQAKCLE--TGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~--~~~~vAvK~i~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      ..+||+|+||.||+|.+..  ++..||+|.+....  ....+|+.+|+.++||||++++++|....   ..++|+||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEEEeee
Confidence            4689999999999999754  56889999886432  24568999999999999999999875432   34589999999


Q ss_pred             cccHHHHHHHhh-----hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          218 SETVYRVSKHYT-----RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++++.++....     .....+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~  141 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILV  141 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEE
Confidence            998877654321     112358889999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.88  E-value=4.2e-22  Score=173.27  Aligned_cols=126  Identities=34%  Similarity=0.566  Sum_probs=106.7

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch---------hHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||||.+.....         ....|+++++.++|+||+++++++.     +..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence            48889999999999999999998999999999864321         2346999999999999999999983     345


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++++||||+.+++..++...   ...+++..+..++.||+.||.|||+ ++|+|+||||+|||+
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill  135 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLI  135 (298)
T ss_pred             EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEE
Confidence            69999999976666654321   1368999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.88  E-value=4e-22  Score=172.12  Aligned_cols=120  Identities=27%  Similarity=0.373  Sum_probs=98.7

Q ss_pred             eccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          145 VGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       145 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      ||+|+||.||++.+..+|+.||+|.+...       ......|+++++.++||||++++++|     ....++|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            79999999999999999999999988532       12234699999999999999999887     4455699999999


Q ss_pred             cccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          218 SETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++.+ .++..  .....+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus        76 ~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili  128 (277)
T cd05607          76 NGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLL  128 (277)
T ss_pred             CCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEE
Confidence            86544 33322  223457888889999999999999998 999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.88  E-value=1e-22  Score=172.07  Aligned_cols=123  Identities=26%  Similarity=0.438  Sum_probs=104.9

Q ss_pred             eee-eEEeccCCceEEEEEEECCCCCEEEEEEeeccc----hhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEEE
Q 024091          139 YMA-ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       139 y~~-~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      |++ .+.||+|+|+.|--+....+|.++|||+|.+..    ....+|++++..++ |+||++|++||     ++....||
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYL  153 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYL  153 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEE
Confidence            444 578999999999999999999999999996642    34458999999986 99999999998     56666999


Q ss_pred             Eeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCee
Q 024091          213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL  271 (272)
Q Consensus       213 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NIL  271 (272)
                      |||-|.|+ ++..+.    ....|++.++..+.+.|+.||.|||. +||.||||||+|||
T Consensus       154 VfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiL  208 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENIL  208 (463)
T ss_pred             EEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCcccee
Confidence            99999865 443332    24579999999999999999999998 99999999999998

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.88  E-value=7.5e-22  Score=168.57  Aligned_cols=130  Identities=34%  Similarity=0.606  Sum_probs=109.6

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec-------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.++.       ......+|+.+++.++|+||++++++|..     ..+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            469999999999999999999998999999998752       12344579999999999999999999843     345


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++||||+++ ++..++.........+++..+..++.|++.||.|||+ .+|+|+||||+||++
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~  139 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFI  139 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEE
Confidence            8999999985 5555554444445568999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.88  E-value=4.5e-22  Score=172.74  Aligned_cols=125  Identities=30%  Similarity=0.525  Sum_probs=106.7

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||++.+..+++.||+|.+...       .....+|+++++.+.||||+++++++     ....++
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCeE
Confidence            599999999999999999999999999999988542       22345799999999999999999988     344569


Q ss_pred             EEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||++ +.+.+.+..    ...+++..+..++.||+.||.|||+ .+|+|+||+|+||||
T Consensus        77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili  134 (290)
T cd05580          77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLL  134 (290)
T ss_pred             EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEE
Confidence            99999996 555544332    3568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.88  E-value=3.4e-22  Score=171.05  Aligned_cols=126  Identities=26%  Similarity=0.414  Sum_probs=106.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|++...    .....+|+.+++.++||||++++++|..     ..++|+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEE
Confidence            3699999999999999999999999999999988543    2234579999999999999999998843     345899


Q ss_pred             Eeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||++++ +..++..    ...+++..+..++.|++.||.|||+ .+|+||||||+||++
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill  139 (267)
T cd06646          84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILL  139 (267)
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEE
Confidence            99999965 4443322    3568899999999999999999998 899999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.88  E-value=4.3e-22  Score=176.63  Aligned_cols=130  Identities=32%  Similarity=0.506  Sum_probs=110.0

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||.+...     .....+|+.+++.++|+||+++++++.........++|
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            4699999999999999999999999999999988531     12234699999999999999999987554434445689


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||+++.+...+.     ...+++..++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus        85 lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill  139 (336)
T cd07849          85 IVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL  139 (336)
T ss_pred             EEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEE
Confidence            999999987765443     3468999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=7.1e-23  Score=184.13  Aligned_cols=125  Identities=30%  Similarity=0.470  Sum_probs=107.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec----cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .|.....||+|+-|.||.|....+++.||||.+..    .+....+|+.+|+.++|+|||.+++.|+..++     +|+|
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWVV  348 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWVV  348 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEEE
Confidence            47778899999999999999999999999999843    23445689999999999999999999976654     9999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||.|+.+..+-.    ...+++..+..|++++|.||+|||. +||||||||.+|||+
T Consensus       349 MEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL  402 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILL  402 (550)
T ss_pred             EeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEe
Confidence            99999765542221    2348899999999999999999998 999999999999986

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=3.1e-22  Score=177.08  Aligned_cols=118  Identities=27%  Similarity=0.421  Sum_probs=95.7

Q ss_pred             eccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHc---CCCCeeecceeeeecccCCceEEEEEe
Q 024091          145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       145 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ||+|+||+||+|.+..+++.||||++....       .....|..++..+   .||||++++++|     ....++|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            799999999999999999999999985421       1122466666655   699999999988     4445599999


Q ss_pred             ecccccH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++. ...+.    ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili  129 (330)
T cd05586          76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILL  129 (330)
T ss_pred             cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEE
Confidence            9998654 33332    24568999999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.88  E-value=4.9e-22  Score=171.56  Aligned_cols=122  Identities=24%  Similarity=0.420  Sum_probs=104.5

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +|.+.++||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||++++++|...     .+.++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEE
Confidence            4788899999999999999999999999999885431     2344799999999999999999998443     34889


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||++++.+...       ..+++..+..++.|++.||.|||+ .+|+|+||||+|||+
T Consensus        77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill  128 (279)
T cd06619          77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLV  128 (279)
T ss_pred             EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEE
Confidence            9999998766432       246888899999999999999998 999999999999985

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.88  E-value=5.3e-22  Score=180.18  Aligned_cols=132  Identities=23%  Similarity=0.353  Sum_probs=103.7

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCC-----CCEEEEEEeeccc-----hhHHHHHHHHHHcC-CCCeeecceeeeecc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFSTT  203 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAvK~i~~~~-----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~  203 (272)
                      ...+|+++++||+|+||.||+|.+...     +..||||.+....     ..+.+|+++|+.+. ||||++++++|    
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~----  110 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC----  110 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE----
Confidence            345799999999999999999987432     3479999986432     23457999999996 99999999998    


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhhh----------------------------------------------------
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYTR----------------------------------------------------  230 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------  230 (272)
                       ....++|||||||.+ +|.+++.....                                                    
T Consensus       111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         111 -TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             -ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence             344459999999985 55444432110                                                    


Q ss_pred             ----------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 024091          231 ----------------------------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL  270 (272)
Q Consensus       231 ----------------------------------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NI  270 (272)
                                                              ....+++..+..++.||+.||.|||+ .+|+||||||+||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Ni  268 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhE
Confidence                                                    11247788888999999999999998 8999999999999


Q ss_pred             eC
Q 024091          271 LM  272 (272)
Q Consensus       271 Ll  272 (272)
                      |+
T Consensus       269 ll  270 (400)
T cd05105         269 LL  270 (400)
T ss_pred             EE
Confidence            85

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.88  E-value=1.7e-21  Score=169.04  Aligned_cols=138  Identities=26%  Similarity=0.355  Sum_probs=113.5

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHc-CCCCeeecceeeeecccCCceE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ...++|.+...||.|+||.||++.+..+++.+|+|.+...   .....+|+.+++.+ +||||++++++|.........+
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~   98 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ   98 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence            3456799999999999999999999999999999988543   23345799999998 7999999999987654444556


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+++ ++.+++.........+++..++.++.|++.||.|||+ .+|+|+||||+||++
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili  161 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILL  161 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEE
Confidence            8999999986 4444444333344568999999999999999999998 899999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.88  E-value=1e-21  Score=169.77  Aligned_cols=128  Identities=30%  Similarity=0.492  Sum_probs=104.3

Q ss_pred             CeeeeEEeccCCceEEEEEEE----CCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          138 SYMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~----~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      +|++.+.||+|+||.||++..    ..++..||||.+....    ..+.+|+++++.++||||++++++++...   ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~   81 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RRN   81 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CCc
Confidence            689999999999999999974    4578899999986432    24467999999999999999998765432   234


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+++ ++.+++..   ....+++..+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili  141 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILV  141 (284)
T ss_pred             eEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEE
Confidence            8999999985 55544432   23458889999999999999999998 999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.88  E-value=5.8e-22  Score=169.50  Aligned_cols=125  Identities=28%  Similarity=0.481  Sum_probs=105.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----------hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      +|...+.||+|+||.||++.+..+++.||+|.+....          ..+.+|+.+++.++|+||+++++++     ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            3788899999999999999999999999999885422          2345799999999999999999998     344


Q ss_pred             eEEEEEeecccccH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++++||||+.++. .+++..    ...+++..+..++.||+.||.|||+ ++|+|+||||+||++
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~  136 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLI  136 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            45899999999654 444332    3468899999999999999999998 999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.88  E-value=5.3e-22  Score=174.48  Aligned_cols=126  Identities=22%  Similarity=0.454  Sum_probs=102.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCE----EEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~----vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.    ||||.+....     ..+.+|+.+++.++||||+++++++...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            4699999999999999999998766554    8999885332     2345799999999999999999987532     


Q ss_pred             eEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       ..++++||+. +.+++.+..   ....+++..+..++.||+.||+|||+ ++|+||||||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill  142 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLV  142 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEe
Confidence             2678999988 455554432   23457888899999999999999998 999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=9.2e-22  Score=167.78  Aligned_cols=125  Identities=30%  Similarity=0.475  Sum_probs=105.5

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---------hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+....         ....+|+++++.++||||+++++++.     ...
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~   77 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DDE   77 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cCC
Confidence            5899999999999999999999999999999875321         23457999999999999999999883     344


Q ss_pred             EEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++++||||++++ +.+.+..    ...+++..+..++.|++.||.|||+ .+|+|+||+|+||++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv  137 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILR  137 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            699999999864 4443332    3468889999999999999999998 899999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.87  E-value=9.8e-22  Score=169.63  Aligned_cols=126  Identities=34%  Similarity=0.568  Sum_probs=108.2

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||.|+||.||+|.+..++..||||.+....      ....+|+.+++.++||||+++++++     ....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            4889999999999999999999899999999886432      2455799999999999999999988     3455699


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+++++..++...   ...+++..++.++.||+.||.|||+ .+|+|+||||+||++
T Consensus        76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~  132 (286)
T cd07832          76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLI  132 (286)
T ss_pred             EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEE
Confidence            99999977776654432   3568999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.87  E-value=1.3e-21  Score=171.32  Aligned_cols=131  Identities=30%  Similarity=0.462  Sum_probs=110.1

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++|+||+++++++....   ..
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~   81 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LD   81 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CC
Confidence            3457999999999999999999999999999999885321      12347999999999999999999875322   23


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+++||||+++++..++...   ...+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus        82 ~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~  141 (309)
T cd07845          82 SIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLL  141 (309)
T ss_pred             eEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            48999999998877665432   3568999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.87  E-value=3.1e-22  Score=172.63  Aligned_cols=121  Identities=16%  Similarity=0.220  Sum_probs=95.8

Q ss_pred             EeccCCceEEEEEEECCC------------------------CCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeec
Q 024091          144 VVGTGSFGVVFQAKCLET------------------------GDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSL  195 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~~~~------------------------~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l  195 (272)
                      .||+|+||.||+|....+                        ...||+|.+....    ..+.+|+.+++.+.||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            589999999999975321                        2358899875432    233468889999999999999


Q ss_pred             ceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       196 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++++...     .+.|+||||++++.+..+..  .....+++.++..++.||+.||+|||+ ++|+||||||+|||+
T Consensus        82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill  150 (274)
T cd05076          82 HGVCVRG-----SENIMVEEFVEHGPLDVCLR--KEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILL  150 (274)
T ss_pred             EEEEEeC-----CceEEEEecCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEE
Confidence            9988543     34899999999776543322  224568899999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=3.9e-22  Score=172.50  Aligned_cols=130  Identities=23%  Similarity=0.364  Sum_probs=106.5

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +|.+++.||+|+||.||++.+..++..||+|.+....     ..+.+|+.+++.++|+||++++++|.     ...++|+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEEE
Confidence            5889999999999999999999899999999886431     23447999999999999999999884     3446999


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||++++.+..+.........+++..+..++.||+.||.|||+..+|+|+||||+|||+
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~  136 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV  136 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE
Confidence            999999755442222222234689999999999999999999963599999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.87  E-value=1.7e-21  Score=169.24  Aligned_cols=128  Identities=31%  Similarity=0.511  Sum_probs=107.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||.+...      .....+|+++++.++||||+++++++.     ...++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence            3699999999999999999999989999999987532      133557999999999999999999983     44569


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||++++++..+...  ....+++..++.++.||+.||.|||+ ++|+|+||+|+||++
T Consensus        77 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill  135 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLI  135 (294)
T ss_pred             EEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEE
Confidence            999999998877654332  22336788888999999999999998 899999999999985

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.87  E-value=6.3e-22  Score=167.99  Aligned_cols=121  Identities=21%  Similarity=0.347  Sum_probs=100.3

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      +.||+|+||.||+|.+..+++.||+|.+...     ...+.+|+++++.++||||++++++|.     ...++|+||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence            3689999999999999989999999987543     233557999999999999999999883     334589999999


Q ss_pred             ccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          218 SET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++ +.+++.   .....+++..++.++.|++.||.|||+ .+|+|+||||+|||+
T Consensus        76 ~~~~L~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~  127 (252)
T cd05084          76 QGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLV  127 (252)
T ss_pred             cCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEE
Confidence            864 443332   223458899999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.87  E-value=8.4e-22  Score=174.88  Aligned_cols=131  Identities=31%  Similarity=0.542  Sum_probs=110.6

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||.+...      .....+|+.+++.++|+||+++++++.........++
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            3699999999999999999999999999999987532      2234479999999999999999998754433333468


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||++++++.++..    ...+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus        85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~  141 (337)
T cd07858          85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLL  141 (337)
T ss_pred             EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEE
Confidence            99999999887765432    4568999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.87  E-value=2.1e-21  Score=165.08  Aligned_cols=127  Identities=27%  Similarity=0.466  Sum_probs=106.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +|.+.+.||+|+||.||++.+..+++.||+|.+...     .....+|+.+++.++|+||++++++|     ....++|+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            488999999999999999999999999999987532     22345799999999999999999988     34456999


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||+++ .+..++..  .....+++..+..++.||+.||.|||+ ++|+|+||||+|||+
T Consensus        76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili  133 (255)
T cd08219          76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFL  133 (255)
T ss_pred             EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEE
Confidence            9999985 45443332  123457889999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.87  E-value=2.2e-22  Score=181.21  Aligned_cols=133  Identities=27%  Similarity=0.417  Sum_probs=114.2

Q ss_pred             CCCcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHH------------HHHHHHHHcC---CCCeeecc
Q 024091          132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------------RELQIMRLLN---HPNVVSLK  196 (272)
Q Consensus       132 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~------------~E~~~l~~l~---h~nIv~l~  196 (272)
                      .+++..+|..++.||+|+||.|++|.++.....|.||.|.+++-...            .||+||..|+   |+||++++
T Consensus       556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL  635 (772)
T KOG1152|consen  556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL  635 (772)
T ss_pred             eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence            34566679999999999999999999999999999999876532211            5999999998   99999999


Q ss_pred             eeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       197 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|     ++..|+||+||-.+.+ ++++ .+...+..+.+..+..|+.||..|+++||+ +||||||||-+|+++
T Consensus       636 dfF-----Eddd~yyl~te~hg~g-IDLF-d~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenviv  703 (772)
T KOG1152|consen  636 DFF-----EDDDYYYLETEVHGEG-IDLF-DFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIV  703 (772)
T ss_pred             hee-----ecCCeeEEEecCCCCC-cchh-hhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEE
Confidence            999     7888899999988865 3443 345557789999999999999999999998 999999999999975

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.87  E-value=9.4e-22  Score=168.56  Aligned_cols=127  Identities=25%  Similarity=0.408  Sum_probs=103.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCC---CEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .+|++.+.||+|+||.||+|.+..++   ..+|+|.+...     ...+.+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            36899999999999999999886544   37999988542     223457999999999999999999873     334


Q ss_pred             EEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||++++ +.+++..   ....+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili  139 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILV  139 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEE
Confidence            589999999865 4443322   23468889999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.5e-23  Score=186.06  Aligned_cols=125  Identities=30%  Similarity=0.471  Sum_probs=107.4

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeec----cchhH---HHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYK---NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~----~~~~~---~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      |.-++.||.|+||-||-|++..+.+.||||.+.-    ....|   -.|+.+|+.|+|||+|.|.+||.-...     .|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----aW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----AW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----HH
Confidence            7777899999999999999999999999998843    22223   269999999999999999999964443     89


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||-|+--+++...   ..++.+..+..|+.+.+.||.|||+ .+.||||||..||||
T Consensus       103 LVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILL  159 (948)
T KOG0577|consen  103 LVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILL  159 (948)
T ss_pred             HHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEe
Confidence            99999998776665543   4578889999999999999999998 999999999999996

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.87  E-value=6e-22  Score=169.43  Aligned_cols=129  Identities=36%  Similarity=0.604  Sum_probs=108.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||.|+||.||++.+..+++.||||.+...       ...+.+|+.+++.+.|+||++++++|..     ..+.
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~   77 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNEL   77 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCeE
Confidence            588999999999999999999989999999987531       1234479999999999999999998843     3358


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++|||+.+ .+.+++.........+++..+..++.||+.||.|||+ .+|+|+||||+||++
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili  139 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFI  139 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            999999985 5555554434345568999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.87  E-value=1.2e-21  Score=171.37  Aligned_cols=132  Identities=24%  Similarity=0.421  Sum_probs=105.0

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCE--EEEEEeecc-----chhHHHHHHHHHHc-CCCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--vAvK~i~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|.+.+.||+|+||.||+|.+..++..  +|+|.+...     .....+|+.++..+ +|+||+++++++     ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~   79 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH   79 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CC
Confidence            345799999999999999999998777754  577766432     12345799999999 899999999988     34


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++|+||||+++ ++.+++.....            ....+++..++.++.||+.||+|||+ ++|+||||||+|||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili  157 (303)
T cd05088          80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV  157 (303)
T ss_pred             CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEe
Confidence            4459999999984 55555543221            12357889999999999999999998 999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.87  E-value=4.4e-22  Score=170.39  Aligned_cols=126  Identities=23%  Similarity=0.402  Sum_probs=106.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.++...    ....+|+.+++.++||||+++++++..     ..++|+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEEE
Confidence            46999999999999999999999999999999886432    234579999999999999999998743     345899


Q ss_pred             Eeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||++++ +.+++.    ....+++..++.++.|++.||.|||+ .+|+|+||||+||++
T Consensus        84 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili  139 (267)
T cd06645          84 CMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILL  139 (267)
T ss_pred             EEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            99999964 444332    24568999999999999999999998 899999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.87  E-value=1.6e-21  Score=166.88  Aligned_cols=127  Identities=28%  Similarity=0.400  Sum_probs=104.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      +|.+.+.||+|+||.||++.+..++..||||.+...         .....+|+.+++.+.||||+++++++...   ...
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~   79 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---MER   79 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CCc
Confidence            589999999999999999999999999999987532         12345799999999999999999986322   124


Q ss_pred             EEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++++|||++++ +.+.+.    ....+++..+..++.|++.||.|||+ ++|+|+||||+|||+
T Consensus        80 ~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~  139 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILR  139 (265)
T ss_pred             eEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEe
Confidence            588999999865 443332    23457888899999999999999998 899999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.87  E-value=1.2e-21  Score=168.29  Aligned_cols=130  Identities=25%  Similarity=0.301  Sum_probs=104.6

Q ss_pred             cCeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      .+|.+.+.||.|+||.||+|+...     ..+.||+|.+....     ..+.+|+++++.+.|+||+++++++     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            468999999999999999999753     34679999875432     2356799999999999999999987     44


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRM-----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+.|+||||+++ .+.+++......     ...+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili  150 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLV  150 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEE
Confidence            4558999999985 555544332211     1258899999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.87  E-value=1.2e-21  Score=174.86  Aligned_cols=130  Identities=29%  Similarity=0.478  Sum_probs=108.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc-CCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~  208 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||.+...      .....+|+.+++.++||||++++++|..... .+..
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            45799999999999999999999999999999988532      1233479999999999999999998753321 2234


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+.+++...+..      .+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        95 ~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~  151 (353)
T cd07850          95 DVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVV  151 (353)
T ss_pred             cEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEE
Confidence            5899999999887765432      27888899999999999999998 899999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.87  E-value=1.5e-21  Score=170.67  Aligned_cols=125  Identities=29%  Similarity=0.512  Sum_probs=106.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||++.+..+++.||||.+....       ..+.+|+.+++.++||||+++++.|     ....++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence            5899999999999999999999999999999886432       2334799999999999999999887     344569


Q ss_pred             EEEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.++.+ .++..    ...+++..+..++.|++.||.|||+ .+|+||||||+||||
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll  134 (305)
T cd05609          77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLI  134 (305)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEE
Confidence            999999986544 43322    3568999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.87  E-value=1.4e-21  Score=168.84  Aligned_cols=127  Identities=33%  Similarity=0.590  Sum_probs=107.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||.|+||.||+|.+..+++.||||.+....      ....+|+++++.++||||+++++++     .+..+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            3889999999999999999999999999999885321      2355799999999999999999987     3444599


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+++..++...  ....+++..+..++.|++.||.|||+ .+|+|+||+|+||++
T Consensus        76 ~v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill  133 (284)
T cd07860          76 LVFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLI  133 (284)
T ss_pred             EEeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            99999988776654332  23568899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=3e-21  Score=165.27  Aligned_cols=138  Identities=30%  Similarity=0.431  Sum_probs=114.5

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHc-CCCCeeecceeeeeccc-CCce
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~-~~~~  208 (272)
                      ...++|.+.+.||.|+||.||+|.+..+++.+|+|.+....   ..+.+|+.+++.+ .|+||++++++|..... ....
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            45578999999999999999999998889999999886432   3456799999999 69999999999866543 3456


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+.+ ++.+++.........+++..++.++.|++.||.|||+ .+|+|+||+|+||++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~  146 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILL  146 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEE
Confidence            78999999996 4444444333335678999999999999999999998 999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.87  E-value=1.1e-21  Score=174.65  Aligned_cols=132  Identities=22%  Similarity=0.345  Sum_probs=102.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeeccc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  204 (272)
                      .++|++.+.||+|+||.||+|.+.     .+++.||||.++...     ....+|+.+|..+ +||||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence            347999999999999999999853     457889999986432     2244799999999 689999999987433  


Q ss_pred             CCceEEEEEeecccc-cHHHHHHHhhh-----------------------------------------------------
Q 024091          205 KDELYLNLVLEYISE-TVYRVSKHYTR-----------------------------------------------------  230 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------------------  230 (272)
                        ...++++|||+++ ++.+++.....                                                     
T Consensus        84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence              2348899999995 44444432110                                                     


Q ss_pred             ----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          231 ----------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       231 ----------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                                ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~  212 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL  212 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEE
Confidence                      01236778888999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5.1e-23  Score=196.78  Aligned_cols=127  Identities=31%  Similarity=0.521  Sum_probs=111.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec-------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|.++++||+|+||.|.+++++.+++.||+|++.+       +...+..|-.+|..-+.+.|+.++-.|     ++..
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~  148 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER  148 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence            4479999999999999999999999999999998854       233456799999999999999998888     8888


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||||++| +++.++..+    .++|+.++++|+..|+.||.-||+ .|+|||||||+||||
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLl  208 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLL  208 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEe
Confidence            99999999985 555555443    279999999999999999999999 899999999999996

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.87  E-value=2.5e-21  Score=169.04  Aligned_cols=134  Identities=28%  Similarity=0.431  Sum_probs=110.8

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeeccc---C
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE---K  205 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~  205 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+....      ....+|+.+++.++||||+++++++.....   .
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999999999999999885321      123479999999999999999998754432   2


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+.++||||+++++...+..   ....+++..++.++.||+.||.|||+ .+|+|+||||+|||+
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~  152 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILI  152 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEE
Confidence            3346799999999887765432   23468999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=7.9e-22  Score=170.07  Aligned_cols=128  Identities=27%  Similarity=0.383  Sum_probs=107.1

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .+|.+.+.||.|+||.||++.+..++..||+|.+....    ..+.+|+.+++.++||||+++++.|.     ...++|+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEEE
Confidence            46999999999999999999998899999999885432    23457999999999999999999884     3445899


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||++++.+..+.  ......+++..++.++.|++.||.|||+ .+|+|+||||+||++
T Consensus        80 v~e~~~~~~L~~~~--~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili  136 (280)
T cd06611          80 LIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILL  136 (280)
T ss_pred             EeeccCCCcHHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEE
Confidence            99999975544221  1223568999999999999999999998 899999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.87  E-value=1.1e-21  Score=173.78  Aligned_cols=130  Identities=29%  Similarity=0.522  Sum_probs=110.0

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+|.+.+.||.|+||.||+|.+..+++.||+|.+...      .....+|+.+|+.++||||++++++|.... ....++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            4699999999999999999999999999999988543      123457999999999999999999875433 345578


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.+++..++.    ....+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        84 ~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~  140 (334)
T cd07855          84 YVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLV  140 (334)
T ss_pred             EEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            9999999887665433    24558999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.87  E-value=1.6e-21  Score=173.54  Aligned_cols=130  Identities=31%  Similarity=0.485  Sum_probs=108.2

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCC------
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD------  206 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~------  206 (272)
                      .+|.+.+.||.|+||.||+|.+..+++.||+|.+...    .....+|+++++.++||||+++++++.......      
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            4799999999999999999999999999999988543    233457999999999999999998764432211      


Q ss_pred             ---ceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ---ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                         ..++|+||||+++++..++.     ...+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        85 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili  147 (342)
T cd07854          85 LTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFI  147 (342)
T ss_pred             ccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEE
Confidence               13589999999987655432     2458899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.3e-23  Score=180.54  Aligned_cols=125  Identities=26%  Similarity=0.413  Sum_probs=106.5

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .|...++||+|.||.||+|.+..+++.||||++.-+     ....++|+.+|..++++||.++|+.|+....     +|+
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lwi   88 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LWI   88 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HHH
Confidence            588889999999999999999999999999998532     3345689999999999999999999966554     999


Q ss_pred             EeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||.|+.. ++++    ....+.+..+..++++++.||.|||. ++.+|||||+.||||
T Consensus        89 iMey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~  144 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILL  144 (467)
T ss_pred             HHHHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeE
Confidence            9999996544 3332    23445778888899999999999998 999999999999986

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.87  E-value=2.2e-21  Score=165.14  Aligned_cols=125  Identities=23%  Similarity=0.355  Sum_probs=102.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      .|.+.+.||+|+||.||++.+. .+..+|+|.+...   ...+.+|+.+|+.++||||++++++|.     ....+|+||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv~   78 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIVT   78 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEEE
Confidence            5888999999999999999875 4567999987643   234567999999999999999999873     334589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+++ .+.+++..   ....+++..+..++.|++.||.|||+ .+|+||||||+||++
T Consensus        79 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i  133 (256)
T cd05114          79 EFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLV  133 (256)
T ss_pred             EcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEE
Confidence            99985 44443322   22458889999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.87  E-value=1.4e-21  Score=168.72  Aligned_cols=126  Identities=36%  Similarity=0.602  Sum_probs=107.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++||||++++++|     ....+.|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            5899999999999999999998899999999875321      2345799999999999999999998     4455699


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.++++..+..   ....+++..+..++.||+.||.|||+ .+|+|+||+|+||++
T Consensus        77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~  133 (286)
T cd07846          77 LVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILV  133 (286)
T ss_pred             EEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEE
Confidence            9999999877653322   23458899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=3e-21  Score=169.46  Aligned_cols=127  Identities=28%  Similarity=0.530  Sum_probs=107.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||||.+....       .....|+++++.++|+||+++++.+     ....+.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            5999999999999999999999999999999886432       2345799999999999999999887     445569


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.+ .+..++..  .....+++..+..++.||+.||.|||+ .+|+|+||||+||+|
T Consensus        77 ~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili  136 (316)
T cd05574          77 CLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILL  136 (316)
T ss_pred             EEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEE
Confidence            999999985 55444332  123568999999999999999999998 899999999999986

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.87  E-value=1.3e-21  Score=166.70  Aligned_cols=126  Identities=33%  Similarity=0.470  Sum_probs=106.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+.+.       ...+.+|+++++.++||||++++++|     ....++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            488999999999999999999889999999988642       23345799999999999999999987     455569


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.++.+....   .....+++..+..++.||+.||.|||+ ++|+|+||+|+||++
T Consensus        76 ~lv~e~~~~~~L~~~l---~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~  133 (258)
T cd05578          76 YLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILL  133 (258)
T ss_pred             EEEEeCCCCCCHHHHH---HhcCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEE
Confidence            9999999865443221   123578899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.87  E-value=1e-21  Score=173.58  Aligned_cols=122  Identities=22%  Similarity=0.407  Sum_probs=99.8

Q ss_pred             EEeccC--CceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G--~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ..||+|  +||+||++.+..+++.||||++....      ....+|+.+++.++||||++++++|     ....++|+||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence            346666  99999999999999999999985432      2345789999999999999999998     3445589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.+ ++..++....  ...+++..+..++.||+.||+|||+ ++|+||||||+|||+
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill  134 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILI  134 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            99995 5554444322  3358899999999999999999998 999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.87  E-value=2.3e-21  Score=166.13  Aligned_cols=133  Identities=20%  Similarity=0.325  Sum_probs=104.3

Q ss_pred             eeeeEEeccCCceEEEEEEECC---CCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeeccc-CCce
Q 024091          139 YMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~  208 (272)
                      |.+.+.||+|+||.||+|....   ++..||||.+..+.      ..+.+|+.+++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999998764   34789999886432      234579999999999999999998755443 2334


Q ss_pred             EEEEEeecccccHH-HHHHHh--hhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVY-RVSKHY--TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~-~~~~~~--~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +.+++|||+.++.+ .++...  ......+++..+..++.|++.||.|||+ .+|+||||||+||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~  146 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCML  146 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEE
Confidence            58999999995444 333221  1123468899999999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.87  E-value=2.1e-21  Score=168.58  Aligned_cols=128  Identities=27%  Similarity=0.398  Sum_probs=107.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..|++.+.||.|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++|+||++++++|...     .++|+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEEE
Confidence            45999999999999999999999999999999986432    2344699999999999999999988433     35999


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||++++.+..+.  ......+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        87 v~e~~~~~~l~~~~--~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili  143 (292)
T cd06644          87 MIEFCPGGAVDAIM--LELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLL  143 (292)
T ss_pred             EEecCCCCcHHHHH--HhhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEE
Confidence            99999977654222  1223468899999999999999999998 999999999999985

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.87  E-value=3e-21  Score=165.09  Aligned_cols=127  Identities=23%  Similarity=0.362  Sum_probs=106.2

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+..+.   ..+.+|+++++.++|+||+++++++..     ...++++|
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~   81 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYIIT   81 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEEEE
Confidence            5889999999999999999999999999999886543   234579999999999999999998743     33489999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+++ ++.+++..  .....+++..++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus        82 e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~  137 (263)
T cd05052          82 EFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV  137 (263)
T ss_pred             EeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEE
Confidence            99985 45444432  123458888999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.86  E-value=2.9e-21  Score=165.63  Aligned_cols=126  Identities=23%  Similarity=0.400  Sum_probs=103.9

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCC---EEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .|.+.+.||+|+||.||+|.+..+++   .||||.+...     ...+..|+.+++.+.||||+++++++     .....
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~   79 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRP   79 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCc
Confidence            58899999999999999999877664   6999988643     22445799999999999999999987     33445


Q ss_pred             EEEEeecccccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++||||++++.+. ++..   ....+++..++.++.|++.||.|||+ ++++|+||||+|||+
T Consensus        80 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili  139 (269)
T cd05065          80 VMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILV  139 (269)
T ss_pred             eEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEE
Confidence            89999999865443 3322   23468889999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.86  E-value=2.3e-21  Score=167.54  Aligned_cols=130  Identities=20%  Similarity=0.293  Sum_probs=103.0

Q ss_pred             cCeeeeEEeccCCceEEEEEEEC----CCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~----~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ..|++.+.||+|+||.||+|.+.    ..+..||+|.+....     ..+.+|+.+++.+.||||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence            45889999999999999999863    356789999886421     23457999999999999999999873     33


Q ss_pred             eEEEEEeecccc-cHHHHHHHhh-------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYT-------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~-------------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...|+||||+++ ++.+++....             .....+++..+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili  157 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILI  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEE
Confidence            448999999985 5544432111             012347788889999999999999998 999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.86  E-value=1.6e-21  Score=166.73  Aligned_cols=125  Identities=30%  Similarity=0.488  Sum_probs=104.2

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------------hhHHHHHHHHHHcCCCCeeecceeeeeccc
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  204 (272)
                      +|.+...||.|+||.||+|.+..+++.||+|.+....             ....+|+.+++.++||||+++++++..   
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence            4788899999999999999998889999999875321             234579999999999999999998743   


Q ss_pred             CCceEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          205 KDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ..+.+++|||++++ +..++.    ....+++..+..++.|++.||.|||+ .+|+|+||+|+|||+
T Consensus        78 --~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~  139 (267)
T cd06628          78 --ADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILV  139 (267)
T ss_pred             --CCccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEE
Confidence              34589999999864 444332    23568888899999999999999998 899999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.86  E-value=2.4e-22  Score=193.46  Aligned_cols=133  Identities=29%  Similarity=0.447  Sum_probs=107.0

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeeccc-------
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-------  204 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-------  204 (272)
                      .+|+.+++||+||||.||+++++-+|+.||||.|.-..     ....+|+.+|++|+|||||+||..|++...       
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            45788899999999999999999999999999986432     223479999999999999999987652000       


Q ss_pred             --------------------------------------------------------------------------------
Q 024091          205 --------------------------------------------------------------------------------  204 (272)
Q Consensus       205 --------------------------------------------------------------------------------  204 (272)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             -------------------C--------CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 024091          205 -------------------K--------DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV  257 (272)
Q Consensus       205 -------------------~--------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~  257 (272)
                                         .        ...++||-||||...+++.+........  ....++.+++||+.||.|+|+ 
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~-  715 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD-  715 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh-
Confidence                               0        0157899999999888876554332211  467789999999999999998 


Q ss_pred             CCceecCCCCCCeeC
Q 024091          258 VGVCHRDIKPQNLLM  272 (272)
Q Consensus       258 ~~iiHrDlKp~NILl  272 (272)
                      .|||||||||.||+|
T Consensus       716 ~giIHRDLKP~NIFL  730 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFL  730 (1351)
T ss_pred             CceeeccCCcceeEE
Confidence            899999999999986

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.86  E-value=1.6e-21  Score=167.21  Aligned_cols=133  Identities=20%  Similarity=0.301  Sum_probs=102.3

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCC--EEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccC-CceE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGD--SVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELY  209 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~--~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~~~~  209 (272)
                      |.+.+.||+|+||.||+|.+..++.  .||+|.++..      ...+.+|+++++.++|+||++++++++..... ....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999999877665  6999987532      22345799999999999999999876543321 2235


Q ss_pred             EEEEeecccc-cHHHHHHHh--hhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHY--TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+++|||+.+ ++..++...  ......+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~  145 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCML  145 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEE
Confidence            7899999985 444433221  1123457899999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=4.8e-21  Score=163.12  Aligned_cols=128  Identities=27%  Similarity=0.434  Sum_probs=107.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .+|.+.+.||.|+||.||+|.+..+++.+|+|.+...    .....+|+.+++.++||||+++++++.     ...++|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-----RRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-----eCCEEEE
Confidence            4699999999999999999999889999999988643    234568999999999999999999874     3445999


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||++++.+..+..  .....+++..+..++.|++.||.|||+ ++|+|+||||+||++
T Consensus        78 ~~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i  134 (262)
T cd06613          78 VMEYCGGGSLQDIYQ--VTRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILL  134 (262)
T ss_pred             EEeCCCCCcHHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEE
Confidence            999999755442221  222568899999999999999999998 999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.86  E-value=2.8e-21  Score=168.55  Aligned_cols=127  Identities=28%  Similarity=0.376  Sum_probs=106.4

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|.+.+.||.|+||.||++.+..+++.||+|.+...    .....+|+.+++.++|+||++++++|.     ...+.|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence            35799999999999999999999999999999988532    233457999999999999999999884     344599


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||++++.+..+..    ...+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        93 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili  148 (297)
T cd06656          93 VVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILL  148 (297)
T ss_pred             EeecccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            9999998654432221    2457888899999999999999998 899999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.86  E-value=3.1e-21  Score=165.87  Aligned_cols=131  Identities=21%  Similarity=0.216  Sum_probs=104.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCC-----CCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ..+|.+.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.+.||||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence            44799999999999999999988643     4789999985432     23457999999999999999999883     


Q ss_pred             CceEEEEEeeccc-ccHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYIS-ETVYRVSKHYTR------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+.|+||||++ +++..++.....      ....+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill  152 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMV  152 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEE
Confidence            3345899999998 555555443221      12246788889999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.86  E-value=3e-21  Score=165.24  Aligned_cols=127  Identities=22%  Similarity=0.327  Sum_probs=103.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCC---CCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .+|.+.+.||+|+||.||+|.+..+   ...||||.+....     ..+.+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence            3589999999999999999988643   4579999885432     23446999999999999999999873     334


Q ss_pred             EEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..|++|||+.++ +.+++..   ....+++..+..++.|++.||.|||+ .+|+|+||||+|||+
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili  139 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILV  139 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEE
Confidence            489999999864 4443322   23468899999999999999999998 999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.86  E-value=2.7e-21  Score=165.95  Aligned_cols=125  Identities=29%  Similarity=0.497  Sum_probs=104.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc--------------hhHHHHHHHHHHcCCCCeeecceeeeecc
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------RYKNRELQIMRLLNHPNVVSLKHCFFSTT  203 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  203 (272)
                      +|.+.+.||.|+||.||+|.+..+++.||||.+....              ....+|+.+++.++||||+++++++.   
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET---   78 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence            5889999999999999999998899999999874210              12346999999999999999999873   


Q ss_pred             cCCceEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ....+++||||+.++ +...+..    ...+++..++.++.||+.||.|||+ .+++|+||+|+||++
T Consensus        79 --~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~  141 (272)
T cd06629          79 --TEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLV  141 (272)
T ss_pred             --cCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEE
Confidence              344589999999865 4443332    3568889999999999999999998 899999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.86  E-value=2.3e-21  Score=176.07  Aligned_cols=133  Identities=22%  Similarity=0.341  Sum_probs=103.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeeccc-----hhHHHHHHHHHHcC-CCCeeecceeeeec
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFST  202 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~  202 (272)
                      ....+|.+.+.||+|+||.||+|.+.     ..++.||||++....     ..+.+|+.+|..+. |||||+++++|.. 
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-  112 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-  112 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-
Confidence            33446889999999999999999864     345689999986432     23457999999998 9999999998843 


Q ss_pred             ccCCceEEEEEeeccc-ccHHHHHHHhhh---------------------------------------------------
Q 024091          203 TEKDELYLNLVLEYIS-ETVYRVSKHYTR---------------------------------------------------  230 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---------------------------------------------------  230 (272)
                          ...+|+||||+. |+|.+++.....                                                   
T Consensus       113 ----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         113 ----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             ----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence                334899999999 455555433210                                                   


Q ss_pred             -------------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 024091          231 -------------------------------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP  267 (272)
Q Consensus       231 -------------------------------------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp  267 (272)
                                                                 ....+++..++.|+.||+.||.|||+ .+|+||||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp  267 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAA  267 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCc
Confidence                                                       01235677788899999999999998 8999999999


Q ss_pred             CCeeC
Q 024091          268 QNLLM  272 (272)
Q Consensus       268 ~NILl  272 (272)
                      +|||+
T Consensus       268 ~NiLl  272 (401)
T cd05107         268 RNVLI  272 (401)
T ss_pred             ceEEE
Confidence            99985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.86  E-value=4.2e-21  Score=166.46  Aligned_cols=133  Identities=19%  Similarity=0.239  Sum_probs=103.2

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeeccch-----hHHHHHHHHHHcCCCCeeecceeeeecc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTT  203 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~  203 (272)
                      ....+|.+.+.||+|+||.||+|.+..     .+..||+|.+.....     ...+|+.+++.++||||+++++++.   
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---   79 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS---   79 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence            345579999999999999999997642     345799998754321     2346899999999999999999873   


Q ss_pred             cCCceEEEEEeeccc-ccHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYIS-ETVYRVSKHYTRM------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ...+.|+||||++ +++.+++......      ...+....+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus        80 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili  152 (288)
T cd05061          80 --KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMV  152 (288)
T ss_pred             --CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEE
Confidence              3345899999998 5555555432211      1234567788899999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.86  E-value=4.3e-21  Score=167.56  Aligned_cols=133  Identities=29%  Similarity=0.489  Sum_probs=111.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc---CC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KD  206 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~  206 (272)
                      ..+|.+.+.||.|+||.||+|.+..+++.||||.+...      .....+|+++++.++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            56899999999999999999999999999999988532      1234579999999999999999998755432   23


Q ss_pred             ceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++|+||||+.+++...+..   ....+++..+..++.||+.||.|||+ .+|+|+||||+|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~  148 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILI  148 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            456899999999877664432   24468999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.86  E-value=1.8e-21  Score=168.98  Aligned_cols=129  Identities=29%  Similarity=0.434  Sum_probs=108.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+|.+.+.||.|+||.||+|.+..+++.||||.++...      ....+|+.+++.+.||||+++++++....   ..++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence            36999999999999999999999899999999986321      12347999999999999999999875432   2459


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+++++..++...   ...+++..++.++.||+.||.|||+ ++|+|+||||+|||+
T Consensus        82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili  139 (293)
T cd07843          82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLL  139 (293)
T ss_pred             EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEE
Confidence            999999998777655432   2368999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.86  E-value=3.7e-21  Score=164.46  Aligned_cols=124  Identities=26%  Similarity=0.443  Sum_probs=102.9

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----------hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      +|++.+.||.|+||.||+|.. .+++.+|||.+....          ....+|+++++.++|+||++++++|     ...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence            488889999999999999986 478899999875321          2345799999999999999999988     344


Q ss_pred             eEEEEEeecccccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|++|||+.++.+. ++.    ....+++..+..++.|++.||.|||+ .+|+|+||+|+||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~  135 (265)
T cd06631          75 NTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVML  135 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEE
Confidence            5699999999865443 332    23568899999999999999999998 899999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.86  E-value=7.3e-21  Score=164.90  Aligned_cols=131  Identities=24%  Similarity=0.379  Sum_probs=108.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +|...+.||.|+||.||++.+..+++.||+|.+....     ..+.+|+++++.++||||++++++|....   ...+|+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEEE
Confidence            5889999999999999999999999999999886432     23458999999999999999999874332   235899


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+++ ++.+++.........+++..+..++.||+.||.|||+ .+++|+||+|+||++
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~  138 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILL  138 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            9999985 5544444433345568899999999999999999998 999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.86  E-value=4.1e-21  Score=165.48  Aligned_cols=132  Identities=20%  Similarity=0.251  Sum_probs=103.1

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeeccc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  204 (272)
                      ...+|++.+.||+|+||.||+|.+..     ++..||||.+....     ..+.+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            34579999999999999999998642     35679999875422     2244799999999999999999987     


Q ss_pred             CCceEEEEEeecccc-cHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          205 KDELYLNLVLEYISE-TVYRVSKHYTRM------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....+.++||||+++ ++.+++......      ...+++..+..++.|++.||.|||+ .+++|+||||+|||+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~  152 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMV  152 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEE
Confidence            344458999999985 454444332111      1235677888899999999999998 899999999999986

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.86  E-value=3.4e-21  Score=164.25  Aligned_cols=125  Identities=24%  Similarity=0.315  Sum_probs=102.5

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +|.+.+.||+|+||.||++.+.. +..+|||.+....   ..+.+|+.+++.++||||+++++++.     ...++|++|
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~   78 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIVT   78 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEEE
Confidence            58999999999999999998754 4569999886432   33567999999999999999999873     334489999


Q ss_pred             eccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++ +.+++..   ....+++..++.++.||+.||.|||+ .+|+|+||||+|||+
T Consensus        79 e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili  133 (256)
T cd05113          79 EYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLV  133 (256)
T ss_pred             EcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEE
Confidence            999854 4443332   12368899999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.86  E-value=3.2e-21  Score=167.50  Aligned_cols=131  Identities=21%  Similarity=0.295  Sum_probs=104.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCC----------------CEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeee
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETG----------------DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVS  194 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~----------------~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~  194 (272)
                      ..+|.+.+.||+|+||.||+|.+..++                ..||+|.+....     ..+.+|+++++.+.||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            346999999999999999999876543                458999886432     23457999999999999999


Q ss_pred             cceeeeecccCCceEEEEEeecccc-cHHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCC
Q 024091          195 LKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTR-------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK  266 (272)
Q Consensus       195 l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlK  266 (272)
                      ++++|.     ...+++++|||+.+ ++..++.....       ....+++..++.++.|++.||.|||+ .+|+|||||
T Consensus        84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlk  157 (296)
T cd05051          84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLA  157 (296)
T ss_pred             EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccc
Confidence            999883     33458999999985 55544433221       11258899999999999999999998 999999999


Q ss_pred             CCCeeC
Q 024091          267 PQNLLM  272 (272)
Q Consensus       267 p~NILl  272 (272)
                      |+|||+
T Consensus       158 p~Nili  163 (296)
T cd05051         158 TRNCLV  163 (296)
T ss_pred             hhceee
Confidence            999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.86  E-value=3.3e-21  Score=167.89  Aligned_cols=134  Identities=32%  Similarity=0.460  Sum_probs=110.6

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecc-----
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTT-----  203 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----  203 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+....      ....+|+++++.++||||+++++++....     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            3457999999999999999999999999999999985421      23357999999999999999999875432     


Q ss_pred             cCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .....++|+||||++++++..+..   ....+++..++.++.||+.||.|||+ .+|+|+||||+||++
T Consensus        85 ~~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili  149 (302)
T cd07864          85 KKDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILL  149 (302)
T ss_pred             cccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            012336999999999887765432   23468999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.86  E-value=3.8e-21  Score=167.62  Aligned_cols=126  Identities=28%  Similarity=0.403  Sum_probs=106.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.+.|+||++++++|..     ..+.|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEE
Confidence            34799999999999999999999999999999988542    2334579999999999999999998843     34599


Q ss_pred             EEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.++ +..++.     ...+++..+..++.|++.||.|||+ .+|+|+||||+|||+
T Consensus        94 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill  149 (296)
T cd06654          94 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILL  149 (296)
T ss_pred             EeecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            999999865 444332     2357888899999999999999998 899999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.86  E-value=4.8e-21  Score=163.53  Aligned_cols=128  Identities=23%  Similarity=0.301  Sum_probs=104.9

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..+|.+.+.||+|+||.||+|.+. .++.||||.+...   ...+.+|+.+++.++||||+++++++.     ....+|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCeee
Confidence            346999999999999999999864 4578999998653   234567999999999999999999873     3344899


Q ss_pred             Eeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||+. +++.+++....  ...+++..+..++.|++.||.|||+ .+|+|+||||+|||+
T Consensus        79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~  136 (261)
T cd05068          79 VTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLV  136 (261)
T ss_pred             eeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEE
Confidence            999996 56655443321  3468899999999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.86  E-value=2.3e-21  Score=165.98  Aligned_cols=122  Identities=18%  Similarity=0.217  Sum_probs=96.2

Q ss_pred             EEeccCCceEEEEEEECC------------CCCEEEEEEeeccch----hHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          143 RVVGTGSFGVVFQAKCLE------------TGDSVAIKKVLQDKR----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~------------~~~~vAvK~i~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      +.||+|+||.||+|....            ....||+|.+.....    .+.+|+.+++.++||||+++++++...    
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~----   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD----   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            368999999999997532            223588898754322    334688999999999999999987433    


Q ss_pred             ceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       ...+++|||++++.+..+..  .....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        77 -~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill  138 (262)
T cd05077          77 -VENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILL  138 (262)
T ss_pred             -CCCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEE
Confidence             33789999999776654332  223568999999999999999999998 999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.86  E-value=1.8e-21  Score=172.93  Aligned_cols=132  Identities=23%  Similarity=0.353  Sum_probs=103.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeeccc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  204 (272)
                      ..+|++.+.||+|+||.||+|.+..     +++.||+|.+....     .....|++++..+ .|+||++++++|...  
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence            3479999999999999999997543     45789999886422     2234699999999 799999999987533  


Q ss_pred             CCceEEEEEeecccc-cHHHHHHHhhh-----------------------------------------------------
Q 024091          205 KDELYLNLVLEYISE-TVYRVSKHYTR-----------------------------------------------------  230 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------------------  230 (272)
                        ..+++++|||+++ ++..++.....                                                     
T Consensus        84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence              2358899999995 44444432110                                                     


Q ss_pred             ----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          231 ----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       231 ----~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          ....+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill  206 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILL  206 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEE
Confidence                12367889999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=4.2e-21  Score=164.25  Aligned_cols=127  Identities=28%  Similarity=0.449  Sum_probs=104.7

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+...         ...+.+|+++++.++|+||+++++++...   ...
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~~   79 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EEK   79 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CCC
Confidence            599999999999999999999999999999987421         12345799999999999999999987432   223


Q ss_pred             EEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++++|||++++ +.+.+.    ....+++..++.++.||+.||.|||+ ++|+|+||||+||++
T Consensus        80 ~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i  139 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILR  139 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEE
Confidence            578999999865 444332    23457888999999999999999998 999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.86  E-value=3.5e-21  Score=166.52  Aligned_cols=127  Identities=25%  Similarity=0.411  Sum_probs=102.7

Q ss_pred             eeeeEEeccCCceEEEEEEE----CCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          139 YMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~----~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      |++.+.||+|+||.||+|.+    ..++..||+|.+...     ...+.+|+++++.+.||||+++++++...   +..+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGNG   82 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCCc
Confidence            78899999999999999975    356889999998533     12345799999999999999999887432   2245


Q ss_pred             EEEEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++||||++++.+ .++..   ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        83 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~  142 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLV  142 (284)
T ss_pred             eEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEE
Confidence            8999999985544 33322   23357889999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=4.6e-23  Score=187.30  Aligned_cols=127  Identities=25%  Similarity=0.387  Sum_probs=109.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .|.++..||.|+||+||+|..+.++-..|-|+|....    ....-||+||..++||+||+|++.||..+.     +||+
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwil  107 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWIL  107 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEEE
Confidence            4889999999999999999999999888889885322    223359999999999999999999976654     9999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|||+||-.+-+.  ......+.+..++.+++|+|.||.|||+ ++|||||||+.|||+
T Consensus       108 iEFC~GGAVDaim--lEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~  163 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIM--LELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILL  163 (1187)
T ss_pred             EeecCCchHhHHH--HHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEE
Confidence            9999987666332  3456789999999999999999999998 999999999999985

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.86  E-value=4.6e-21  Score=170.63  Aligned_cols=131  Identities=30%  Similarity=0.506  Sum_probs=108.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccC-Cce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~~~  208 (272)
                      ..+|.+.+.||+|+||.||++.+..++..||||.+...      .....+|+.+|+.++||||++++++|...... ...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            44699999999999999999999999999999988532      12345799999999999999999987543221 123


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +.|+||||+++.+..++.     ...+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill  151 (343)
T cd07880          94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAV  151 (343)
T ss_pred             eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            478999999777655432     2468999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.86  E-value=8.3e-21  Score=161.36  Aligned_cols=127  Identities=32%  Similarity=0.516  Sum_probs=106.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|...+.||.|+||.||.+.+..+++.+++|.+...      ...+.+|+++++.++|+||++++++|.     ...+++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence            489999999999999999999999999999987532      123457999999999999999999984     344599


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||+++ ++..++...  ....+++..+..++.|++.||.|||+ .+++|+||||+||++
T Consensus        76 ~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~  134 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFL  134 (256)
T ss_pred             EEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEE
Confidence            99999985 555544321  13468899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.86  E-value=4.2e-21  Score=168.07  Aligned_cols=132  Identities=22%  Similarity=0.376  Sum_probs=104.3

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECC-------CCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeee
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS  201 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~  201 (272)
                      ...+|.+.+.||+|+||.||++.+..       +...+|+|.+....     ....+|+.+++.+ +||||+++++++. 
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-   94 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-   94 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-
Confidence            34579999999999999999998643       23569999886432     2344699999999 7999999999883 


Q ss_pred             cccCCceEEEEEeecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 024091          202 TTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ  268 (272)
Q Consensus       202 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~  268 (272)
                          ...++|+||||+++ ++.+++.....            ....+++..+..++.||+.||.|||+ .+|+||||||+
T Consensus        95 ----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~  169 (307)
T cd05098          95 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAAR  169 (307)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHH
Confidence                33458999999985 55555543211            12347888899999999999999998 89999999999


Q ss_pred             CeeC
Q 024091          269 NLLM  272 (272)
Q Consensus       269 NILl  272 (272)
                      |||+
T Consensus       170 Nill  173 (307)
T cd05098         170 NVLV  173 (307)
T ss_pred             heEE
Confidence            9985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.86  E-value=8.9e-21  Score=160.92  Aligned_cols=127  Identities=27%  Similarity=0.382  Sum_probs=105.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||+|.+..+++.|++|.+...      .....+|+.+++.++||||+++++++.     ...+.|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            378889999999999999999999999999987532      233447999999999999999999883     345699


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+++...  ....+++..+..++.|++.||.|||+ .+|+|+||||+||++
T Consensus        76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili  134 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFL  134 (256)
T ss_pred             EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEE
Confidence            99999975 554444332  23568888899999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.86  E-value=4.3e-21  Score=162.92  Aligned_cols=125  Identities=32%  Similarity=0.519  Sum_probs=104.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---------hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+....         ..+.+|+.+++.++|+||+++++++     ....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            4778899999999999999998889999999875322         2345799999999999999999987     3344


Q ss_pred             EEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|++|||++++ +..++.    ....+++..+..++.||+.||.|||+ .+|+|+||+|+||++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~  135 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILV  135 (258)
T ss_pred             eEEEEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            589999999864 444332    23458888999999999999999998 899999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.86  E-value=3.9e-21  Score=165.57  Aligned_cols=127  Identities=34%  Similarity=0.572  Sum_probs=105.7

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch-----hHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-----~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      |.+.+.||+|+||.||+|.+..+++.||+|.+.....     ...+|+.++..+. |+||+++++++...   ...++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            6788999999999999999999999999998864321     1236888888885 99999999987533   1135899


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||++++++..+...   ...+++..+..++.||+.||.|||+ .+|+||||||+||++
T Consensus        78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l  133 (282)
T cd07831          78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILI  133 (282)
T ss_pred             EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEE
Confidence            9999998887755432   3468999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.86  E-value=4.6e-21  Score=163.08  Aligned_cols=131  Identities=25%  Similarity=0.380  Sum_probs=108.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||.|+||.||++.+..+++.||+|.+...      ......|+++++.++|+||+++++++...   ....+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence            488999999999999999999999999999988532      22344699999999999999999876432   234589


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-----HVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH-----~~~~iiHrDlKp~NILl  272 (272)
                      ++|||+++ ++..++.........+++..++.++.||+.||.|||     . .+|+|+||||+||++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili  143 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFL  143 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEE
Confidence            99999985 565665554444567899999999999999999999     7 799999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.86  E-value=4.5e-21  Score=165.62  Aligned_cols=126  Identities=28%  Similarity=0.415  Sum_probs=105.6

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      |++.+.||.|+||.||++.+..++..+|+|.+....    ....+|+++++.++||||++++++|..     ..+.|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEEE
Confidence            788899999999999999999999999999885432    234579999999999999999998843     34589999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++.+.....  .....+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus        82 e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili  136 (282)
T cd06643          82 EFCAGGAVDAVML--ELERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILF  136 (282)
T ss_pred             EecCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEE
Confidence            9999766543221  224568999999999999999999998 899999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.9e-21  Score=171.73  Aligned_cols=119  Identities=22%  Similarity=0.321  Sum_probs=92.5

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECC-CCCEEEEEEeecc---------chhHHHHHHHHHHcCCCCeee-cceeeeec
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVS-LKHCFFST  202 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vAvK~i~~~---------~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~  202 (272)
                      ....+|.+.+.||+|+||+||+|++.. +++.||||.+...         ...+.+|+++|+.|.|+||+. ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            334579999999999999999999876 6788899986422         223568999999999999985 4331    


Q ss_pred             ccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCC-CCCCeeC
Q 024091          203 TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDI-KPQNLLM  272 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDl-Kp~NILl  272 (272)
                      .     ..||||||+.|..+...   .    ...   ...++.|++.||.|||+ .||+|||| ||+|||+
T Consensus        91 ~-----~~~LVmE~~~G~~L~~~---~----~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv  145 (365)
T PRK09188         91 G-----KDGLVRGWTEGVPLHLA---R----PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLM  145 (365)
T ss_pred             C-----CcEEEEEccCCCCHHHh---C----ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEE
Confidence            1     27899999997765421   1    111   14567899999999998 99999999 9999985

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.86  E-value=4.4e-21  Score=165.79  Aligned_cols=126  Identities=29%  Similarity=0.480  Sum_probs=101.8

Q ss_pred             Ce-eeeEEeccCCceEEEEEEE----CCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          138 SY-MAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       138 ~y-~~~~~lG~G~fg~V~~~~~----~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      +| .+.+.||+|+||+||++..    ..++..||+|.+....     ..+.+|+++|+.++||||+++++++...   ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence            45 8899999999999988653    3467899999986432     2345799999999999999999986432   23


Q ss_pred             eEEEEEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+++++|||+.++.+ +++.     ...+++..++.++.|++.||.|||+ ++|+||||||+|||+
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili  140 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLL  140 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEE
Confidence            458999999996544 3332     2358999999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.86  E-value=3.3e-21  Score=167.75  Aligned_cols=130  Identities=22%  Similarity=0.317  Sum_probs=102.2

Q ss_pred             cCeeeeEEeccCCceEEEEEEECC----------------CCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeec
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLE----------------TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSL  195 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~----------------~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l  195 (272)
                      .+|++.+.||+|+||.||++.+..                +...||+|.+....     ..+.+|+++|+.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            369999999999999999986432                34469999886432     234579999999999999999


Q ss_pred             ceeeeecccCCceEEEEEeecccc-cHHHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 024091          196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRM-------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP  267 (272)
Q Consensus       196 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp  267 (272)
                      ++++..     ..++|++|||+.+ ++..++......       ...+++..+..++.||+.||.|||+ .+|+|+||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp  158 (296)
T cd05095          85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence            998843     3348999999985 555544332111       1246778899999999999999998 8999999999


Q ss_pred             CCeeC
Q 024091          268 QNLLM  272 (272)
Q Consensus       268 ~NILl  272 (272)
                      +|||+
T Consensus       159 ~Nili  163 (296)
T cd05095         159 RNCLV  163 (296)
T ss_pred             heEEE
Confidence            99985

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.86  E-value=4.4e-21  Score=164.49  Aligned_cols=134  Identities=25%  Similarity=0.401  Sum_probs=108.9

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHc-CCCCeeecceeeeecccC-CceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK-DELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~-~~~~~  210 (272)
                      .+.|.+.+.||+|+||.||+|.+..+++.||+|.+...   .....+|+.+++.+ +|+||++++++|...... ...++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            34688999999999999999999999999999998543   23456799999998 699999999988654321 23568


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |++|||+++ .+..++..  .....+++..+..++.|++.||.|||+ ++|+|+||||+||++
T Consensus        85 ~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili  144 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLL  144 (272)
T ss_pred             EEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEE
Confidence            999999986 44444332  123468899999999999999999998 899999999999985

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.86  E-value=4.9e-21  Score=165.45  Aligned_cols=126  Identities=37%  Similarity=0.605  Sum_probs=108.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||+|.+..+++.||||.+...      .....+|+++++.+.|+||++++++|..     ...++
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            699999999999999999999999999999987532      2345589999999999999999999844     34599


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||++++++..+..   ....+++..+..++.||+.||.|||+ .+|+|+||+|+||++
T Consensus        77 iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~  133 (288)
T cd07833          77 LVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILV  133 (288)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEE
Confidence            9999999887764332   23458899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.86  E-value=6.5e-21  Score=165.41  Aligned_cols=132  Identities=22%  Similarity=0.379  Sum_probs=105.1

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCC-----CCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeecc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTT  203 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  203 (272)
                      ...+|.+.+.||+|+||.||++.+...     ...+|+|.+....     ....+|+.+++.+ +|+||+++++++..  
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence            345699999999999999999987643     3689999886432     2244799999999 79999999998733  


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL  270 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NI  270 (272)
                         ...+|++|||+++ ++..++....            .....+++..+..++.||+.||.|||+ .+|+||||||+||
T Consensus        88 ---~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Ni  163 (293)
T cd05053          88 ---EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNV  163 (293)
T ss_pred             ---CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeE
Confidence               3348999999985 5544443211            224568889999999999999999998 9999999999999


Q ss_pred             eC
Q 024091          271 LM  272 (272)
Q Consensus       271 Ll  272 (272)
                      |+
T Consensus       164 l~  165 (293)
T cd05053         164 LV  165 (293)
T ss_pred             EE
Confidence            85

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.86  E-value=5.1e-21  Score=163.88  Aligned_cols=127  Identities=29%  Similarity=0.453  Sum_probs=105.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      +|...+.||+|+||.||+|.+..++..||+|.+...         .....+|+.+++.++||||+++++++...   ...
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AEK   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CCC
Confidence            588999999999999999999999999999987532         12345799999999999999999887432   234


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++++|||+++ .+...+..    ...+++...+.++.|++.||.|||+ .+|+|+||||+||++
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~  139 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILR  139 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEE
Confidence            58899999985 45443332    3457888899999999999999998 999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.86  E-value=1.7e-21  Score=166.02  Aligned_cols=128  Identities=23%  Similarity=0.346  Sum_probs=106.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|.+.+.||.|+||.||+|.+.. +..+|+|.+....    .....|+.+++.++|+||+++++++.     ...+.+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence            4469999999999999999999877 8899999986432    34557999999999999999999873     334589


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+++ ++.+++...  ....+++..+..++.||+.||.|||+ .+|+|+||||+||||
T Consensus        79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv  137 (261)
T cd05148          79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILV  137 (261)
T ss_pred             EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEE
Confidence            99999985 555544322  23457888999999999999999998 899999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.86  E-value=2e-21  Score=168.10  Aligned_cols=128  Identities=27%  Similarity=0.375  Sum_probs=106.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .+|++.+.||+|+||.||++.+..+++.||+|++....     ..+.+|+++++.++||||+++++++.     ...++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence            46899999999999999999999999999999875432     33457999999999999999999984     334699


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||++++.+...   ....+.+++..++.++.|++.||.|||+..+|+||||||+||++
T Consensus        80 lv~e~~~~~~L~~~---~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~  137 (284)
T cd06620          80 MCMEFMDCGSLDRI---YKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV  137 (284)
T ss_pred             EEEecCCCCCHHHH---HHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE
Confidence            99999997655422   12245689999999999999999999963589999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.86  E-value=7.3e-21  Score=162.27  Aligned_cols=128  Identities=22%  Similarity=0.332  Sum_probs=104.3

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..+|++.+.||+|+||.||+|.+. ++..||+|.+...   .....+|+.+++.++|+||+++++++     ....+.++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence            457999999999999999999864 5677999987643   23445799999999999999999887     33445899


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||+.+ ++.+++...  ....+++..+..++.|++.||.|||+ .+++||||||+|||+
T Consensus        79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili  136 (261)
T cd05072          79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLV  136 (261)
T ss_pred             EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEe
Confidence            9999985 555544321  23457888889999999999999998 899999999999986

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.86  E-value=3.6e-21  Score=163.91  Aligned_cols=125  Identities=26%  Similarity=0.386  Sum_probs=102.9

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +|.+.+.||+|+||.||++.+. ++..+|+|.+...   ...+.+|+.+++.++||||+++++++     ....+.|+||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence            4888999999999999999875 4668999988643   22455799999999999999999887     3444589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+++ .+.+++..   ....+++..+..++.||+.||.|||+ .+|+||||||+||++
T Consensus        79 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i  133 (256)
T cd05059          79 EYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLV  133 (256)
T ss_pred             ecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEE
Confidence            99975 45544332   23468899999999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.86  E-value=3.2e-21  Score=167.75  Aligned_cols=130  Identities=23%  Similarity=0.325  Sum_probs=102.1

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCC--------------CEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecce
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETG--------------DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKH  197 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~--------------~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~  197 (272)
                      .+|.+.+.||+|+||.||+|++..++              ..||||.+....     ..+.+|+++++.++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            47999999999999999999875432              359999886532     23457999999999999999999


Q ss_pred             eeeecccCCceEEEEEeecccc-cHHHHHHHhhh--------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 024091          198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTR--------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ  268 (272)
Q Consensus       198 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~  268 (272)
                      ++.     ....+|+||||+.+ ++.+++.....        ....+++..+..++.|++.||.|||+ .+|+|+||||+
T Consensus        85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~  158 (295)
T cd05097          85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATR  158 (295)
T ss_pred             EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChh
Confidence            884     33458999999985 44444432110        01236788889999999999999998 99999999999


Q ss_pred             CeeC
Q 024091          269 NLLM  272 (272)
Q Consensus       269 NILl  272 (272)
                      |||+
T Consensus       159 Nill  162 (295)
T cd05097         159 NCLV  162 (295)
T ss_pred             hEEE
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.86  E-value=6.6e-21  Score=165.25  Aligned_cols=131  Identities=23%  Similarity=0.359  Sum_probs=104.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ..+|.+.+.||+|+||.||++.+.     .++..+|+|.+...    ...+.+|+++++.+.||||+++++++.     .
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence            346999999999999999999853     34567999988643    223567999999999999999999884     3


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhh---------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYT---------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~---------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++|+||||+.+ ++.+++....         .....+++..+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili  153 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLV  153 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEE
Confidence            4458999999985 5544443221         112348999999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.86  E-value=3.6e-21  Score=163.62  Aligned_cols=121  Identities=22%  Similarity=0.271  Sum_probs=97.1

Q ss_pred             EEeccCCceEEEEEEECCCC----------CEEEEEEeeccc---hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          143 RVVGTGSFGVVFQAKCLETG----------DSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~----------~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      +.||+|+||.||+|.+..++          ..+++|.+....   ..+.+|+.+++.++||||+++++++.. .     .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-----E   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C-----C
Confidence            36899999999999997766          358888765432   345579999999999999999998754 2     2


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++||||++++.+..+..  .....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill  134 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLH--REKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILV  134 (259)
T ss_pred             cEEEEEcCCCCcHHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEE
Confidence            689999999665542221  112268889999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.86  E-value=1.3e-20  Score=160.05  Aligned_cols=128  Identities=30%  Similarity=0.494  Sum_probs=105.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|++.+.||+|+||.||++.+..+++.||+|.+...      .....+|+++++.++|+||+++++.|.    ....++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            489999999999999999999989999999988532      223457999999999999999988763    2234589


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||+++ .+.+.+..  .....+++..+..++.|++.||.|||+ .+|+|+||||+||++
T Consensus        77 lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~  135 (257)
T cd08223          77 IVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFL  135 (257)
T ss_pred             EEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEE
Confidence            99999985 45444432  123458999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.86  E-value=4.7e-21  Score=169.76  Aligned_cols=126  Identities=30%  Similarity=0.434  Sum_probs=106.4

Q ss_pred             cCee-eeEEeccCCceEEEEEEECCCCCEEEEEEeeccch------------------hHHHHHHHHHHcCCCCeeecce
Q 024091          137 ISYM-AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------YKNRELQIMRLLNHPNVVSLKH  197 (272)
Q Consensus       137 ~~y~-~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------------------~~~~E~~~l~~l~h~nIv~l~~  197 (272)
                      .+|. +.+.||.|+||.||+|.+..+++.||||.+.....                  ...+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4575 45789999999999999999999999998853211                  2457999999999999999999


Q ss_pred             eeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       198 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|.     ...+.|+||||+.+++..++..    ...+++..+..++.|++.||.|||+ .+|+|+||||+|||+
T Consensus        88 ~~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill  152 (335)
T PTZ00024         88 VYV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFI  152 (335)
T ss_pred             EEe-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEE
Confidence            883     3446999999999887765543    3458899999999999999999998 999999999999985

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.85  E-value=7.2e-21  Score=164.01  Aligned_cols=131  Identities=23%  Similarity=0.281  Sum_probs=105.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ..+|.+.+.||+|+||.||+|.+..     ++..||+|.+....     ..+.+|+.+++.++|+||+++++++...   
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER---   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence            4569999999999999999999976     67889999875332     2345799999999999999999987433   


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        .+.++||||+.+ ++..++.....   ....+++..+..++.||+.||.|||+ ++++||||||+|||+
T Consensus        82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~  149 (277)
T cd05036          82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLL  149 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEE
Confidence              337899999975 55555443221   11358889999999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.85  E-value=5.2e-21  Score=166.69  Aligned_cols=130  Identities=24%  Similarity=0.391  Sum_probs=103.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCC--EEEEEEeecc-----chhHHHHHHHHHHc-CCCCeeecceeeeecccCCce
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGD--SVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~--~vAvK~i~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .+|.+.+.||+|+||.||+|....++.  .+|+|.++..     ...+.+|+++++++ +||||+++++++     ....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence            358999999999999999999877664  4788877532     12345799999999 799999999987     3344


Q ss_pred             EEEEEeeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYIS-ETVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|++|||++ +++.+++.....            ....+++..++.++.||+.||+|||+ ++|+||||||+|||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill  152 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLV  152 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEE
Confidence            5899999998 456555543211            11357889999999999999999998 999999999999986

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.85  E-value=4.6e-21  Score=166.30  Aligned_cols=129  Identities=23%  Similarity=0.419  Sum_probs=101.5

Q ss_pred             CeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....     ..+.+|+.+++.+.||||++++++|.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            37888999999999999998753     23579999876432     23457999999999999999999873     33


Q ss_pred             eEEEEEeecccc-cHHHHHHHhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYT--------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK  266 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~--------------------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlK  266 (272)
                      ...+++|||+.+ .+.+++....                    .....+++..+..++.|++.||.|||+ .+|+|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence            448999999995 4444433211                    112357888899999999999999998 999999999


Q ss_pred             CCCeeC
Q 024091          267 PQNLLM  272 (272)
Q Consensus       267 p~NILl  272 (272)
                      |+||||
T Consensus       155 p~nill  160 (290)
T cd05045         155 ARNVLV  160 (290)
T ss_pred             hheEEE
Confidence            999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.85  E-value=1.1e-20  Score=164.89  Aligned_cols=127  Identities=29%  Similarity=0.411  Sum_probs=107.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|.+.+.||.|+||.||+|.+..+++.||||.+...    .....+|+.+++.++||||++++++|.     ....+|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~   92 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELF   92 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEE
Confidence            34699999999999999999999999999999988532    233457999999999999999999884     334599


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.++.+.....    ...+++..+..++.|++.||.|||+ .+|+|+||||+||++
T Consensus        93 lv~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili  148 (296)
T cd06655          93 VVMEYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLL  148 (296)
T ss_pred             EEEEecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            9999999765543222    2358899999999999999999998 899999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.85  E-value=4.7e-21  Score=164.30  Aligned_cols=123  Identities=23%  Similarity=0.297  Sum_probs=95.1

Q ss_pred             EeccCCceEEEEEEECC--CCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeec
Q 024091          144 VVGTGSFGVVFQAKCLE--TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~~~--~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      .||+|+||.||+|....  ....+|+|.+....     ..+.+|+.+++.++|+||+++++.+.     ....+|+||||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e~   76 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLEF   76 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEEe
Confidence            58999999999996532  34578999775332     23457999999999999999999884     33448999999


Q ss_pred             ccc-cHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          217 ISE-TVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       217 ~~~-~l~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +.+ ++.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill  133 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQL  133 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEe
Confidence            985 55554433221 12335677788999999999999998 899999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.85  E-value=1.1e-20  Score=167.33  Aligned_cols=128  Identities=36%  Similarity=0.623  Sum_probs=107.5

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ...+|.+.+.||.|+||.||+|.+..+++.||||.+...      ......|+.+++.++||||++++++|....    .
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~   83 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL----E   83 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC----C
Confidence            345799999999999999999999999999999987431      234457999999999999999999875322    2


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|++|||+++++..++.     ...+++..+..++.|++.||.|||+ .+|+||||+|.|||+
T Consensus        84 ~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili  141 (328)
T cd07856          84 DIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILI  141 (328)
T ss_pred             cEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeE
Confidence            488999999887665443     2457888888999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.85  E-value=6.2e-21  Score=166.65  Aligned_cols=132  Identities=23%  Similarity=0.392  Sum_probs=103.6

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECC-------CCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeee
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS  201 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~  201 (272)
                      ...+|.+.+.||+|+||.||+|++..       .+..||+|.+....     ....+|+.+++.+ .||||+++++++. 
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-   91 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-   91 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe-
Confidence            34569999999999999999997532       34579999875421     2345799999999 7999999999873 


Q ss_pred             cccCCceEEEEEeecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 024091          202 TTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ  268 (272)
Q Consensus       202 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~  268 (272)
                          ...++|++|||+.+ ++..++.....            ....+++..+..++.||+.||.|||+ ++|+||||||+
T Consensus        92 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~  166 (304)
T cd05101          92 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAAR  166 (304)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccc
Confidence                33458999999985 55544443211            12347788889999999999999998 89999999999


Q ss_pred             CeeC
Q 024091          269 NLLM  272 (272)
Q Consensus       269 NILl  272 (272)
                      |||+
T Consensus       167 Nili  170 (304)
T cd05101         167 NVLV  170 (304)
T ss_pred             eEEE
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.85  E-value=8.3e-21  Score=162.56  Aligned_cols=128  Identities=22%  Similarity=0.307  Sum_probs=103.7

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCC---EEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .+|...+.||+|+||.||+|.+..++.   .+|+|.+....     .....|+++++.+.|+||+++++++.     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence            358889999999999999999876554   79999885431     23457999999999999999999873     334


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +.|+||||++++.+....  ......+++..+..++.|++.||.|||+ .+|+|+||||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~~--~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili  140 (268)
T cd05063          80 PAMIITEYMENGALDKYL--RDHDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILV  140 (268)
T ss_pred             CcEEEEEcCCCCCHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEE
Confidence            589999999965544222  1223568888999999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.85  E-value=7.6e-21  Score=163.93  Aligned_cols=127  Identities=22%  Similarity=0.393  Sum_probs=103.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCC----EEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ..+|.+.+.||+|+||+||+|.+..+++    .||+|.+....     ....+|+.+++.+.||||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence            3469999999999999999999877766    48999875421     2344789999999999999999987422    


Q ss_pred             ceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ..+++|||++ +++++++..   ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        82 --~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~  142 (279)
T cd05109          82 --TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLV  142 (279)
T ss_pred             --CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEE
Confidence              2678999998 555544332   23468999999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.85  E-value=8.4e-22  Score=184.55  Aligned_cols=129  Identities=24%  Similarity=0.356  Sum_probs=106.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      +.+..+.||+|+||+||+|+...     ....||||.++...     ..+++|+++|..|+|||||+|+|.|.....   
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P---  563 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP---  563 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe---
Confidence            45667899999999999997643     34679999997543     346799999999999999999999955443   


Q ss_pred             eEEEEEeeccc-ccHHHHHHHhhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYIS-ETVYRVSKHYTRM----------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~-~~l~~~~~~~~~~----------~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        +|||+|||. |+|..+++.....          ..+++..+.+.|+.||+.||+||-+ +.+|||||..+|+||
T Consensus       564 --~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  564 --LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLV  636 (774)
T ss_pred             --eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhcee
Confidence              999999999 6666666543211          2237888999999999999999998 899999999999996

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.85  E-value=8.1e-21  Score=163.89  Aligned_cols=126  Identities=33%  Similarity=0.553  Sum_probs=106.7

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      |.+.+.||.|++|.||+|.+..+|..||||.+....      ....+|+++++.++||||+++++++     ....+.|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence            567889999999999999999999999999885331      2345799999999999999999988     34456999


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||+++++..++....  ...+++..+..++.|++.||.|||+ .+++|+||+|+||++
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~  132 (283)
T cd07835          76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLI  132 (283)
T ss_pred             EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEE
Confidence            99999887766544321  2368899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.85  E-value=1.8e-20  Score=159.89  Aligned_cols=128  Identities=32%  Similarity=0.461  Sum_probs=106.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +|.+.+.||.|+||.||+|.+..++..+|+|++...     .....+|+.+++.++|+||+++++.+..     ..+.|+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~i   76 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELWL   76 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEEE
Confidence            589999999999999999999889999999988532     2334579999999999999999988743     345899


Q ss_pred             EeecccccH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||++.++. ..++.. ......+++..+..++.|++.||.|||+ .+|+|+||||+||++
T Consensus        77 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~  135 (267)
T cd06610          77 VMPYLSGGSLLDIMKS-SYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILL  135 (267)
T ss_pred             EEeccCCCcHHHHHHH-hcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEE
Confidence            999998654 443332 2223468899999999999999999998 999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.85  E-value=9.5e-21  Score=161.12  Aligned_cols=126  Identities=24%  Similarity=0.400  Sum_probs=104.9

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch---hHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .+|.+.+.||.|+||.||+|..  .++.||||.+.....   ...+|+.+++.++|+||+++++++..     ....|+|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEE
Confidence            3688999999999999999987  478999999865533   45579999999999999999998743     3448999


Q ss_pred             eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+++ .+.+++...  ....+++..+..++.|++.||.|||+ .+|+|+||||+||++
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili  135 (256)
T cd05039          79 TEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLV  135 (256)
T ss_pred             EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEE
Confidence            999995 555544322  12368899999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=1.8e-21  Score=159.19  Aligned_cols=119  Identities=18%  Similarity=0.267  Sum_probs=90.3

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeeccch------------------------------hHHHHHHHHHHcCCCC
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------------------YKNRELQIMRLLNHPN  191 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------------------------------~~~~E~~~l~~l~h~n  191 (272)
                      ...||+|+||.||+|.+. +|+.||||+++....                              ...+|+++|..|.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999986 899999999864311                              1124999999998887


Q ss_pred             eeecceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCceecCCCCCCe
Q 024091          192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL-HHVVGVCHRDIKPQNL  270 (272)
Q Consensus       192 Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yl-H~~~~iiHrDlKp~NI  270 (272)
                      +...+...  ..  .   .+|||||++++.+....   .....+++..+..++.|++.+|.|| |+ .||+||||||+||
T Consensus        81 v~~p~~~~--~~--~---~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI  149 (190)
T cd05147          81 IPCPEPIL--LK--S---HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL  149 (190)
T ss_pred             CCCCcEEE--ec--C---CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence            74433221  11  1   37999999976443111   1134688889999999999999999 67 8999999999999


Q ss_pred             eC
Q 024091          271 LM  272 (272)
Q Consensus       271 Ll  272 (272)
                      |+
T Consensus       150 li  151 (190)
T cd05147         150 LY  151 (190)
T ss_pred             EE
Confidence            86

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.85  E-value=1.2e-20  Score=160.10  Aligned_cols=127  Identities=30%  Similarity=0.455  Sum_probs=106.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||++.+..+++.+|||.+...      .....+|+.+++.++||||+++++.+.     ...+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            488999999999999999999999999999988532      223457999999999999999999873     344599


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+++ .+.+++...  ....+++..+..++.|++.||.|||+ ++|+|+||||+||++
T Consensus        76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~  134 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILL  134 (256)
T ss_pred             EEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            99999985 555544321  23458899999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.85  E-value=1.5e-20  Score=161.14  Aligned_cols=125  Identities=26%  Similarity=0.405  Sum_probs=101.5

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.....||+|+||.||+|.+..++..||+|.+...    ...+.+|+.+++.++|+||+++++++.     ...+.+++|
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~   84 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFM   84 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEE
Confidence            33446899999999999999989999999987543    224558999999999999999999883     445699999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~--~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.+ ++..++...   ...+  ++..+..++.||+.||.|||+ .+|+||||||+||++
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~  141 (268)
T cd06624          85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLV  141 (268)
T ss_pred             ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEE
Confidence            99985 444443321   1234  778888999999999999998 999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.85  E-value=1.1e-20  Score=162.86  Aligned_cols=126  Identities=24%  Similarity=0.443  Sum_probs=103.5

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCC----EEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      .+|.+.+.||+|+||.||+|.+..+++    .||+|.+....     ....+|+.+++.+.||||+++++++..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            469999999999999999999876654    58999875442     234479999999999999999998754      


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...++||||+.+ .+.+.+.   .....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~  142 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVR---NHKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLV  142 (279)
T ss_pred             CceEEEEecCCCCcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEE
Confidence            238899999985 5544332   223458899999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.85  E-value=8.2e-21  Score=166.22  Aligned_cols=127  Identities=28%  Similarity=0.437  Sum_probs=107.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ..|.+.+.||.|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||++++++|...     ..
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----Ce
Confidence            35999999999999999999998899999999885321       2345799999999999999999998543     34


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|+||||+.+++..++..   ....+++..+..++.|++.||.|||+ .+|+|+||+|+||++
T Consensus        90 ~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~  148 (307)
T cd06607          90 AWLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILL  148 (307)
T ss_pred             EEEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEE
Confidence            899999999887765432   23468899999999999999999998 899999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.85  E-value=1.2e-20  Score=167.20  Aligned_cols=131  Identities=22%  Similarity=0.378  Sum_probs=102.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCC-------CCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeec
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLET-------GDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST  202 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~-------~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  202 (272)
                      ..+|.+.+.||+|+||.||+|.+...       ...||+|.+....     ....+|+++++++ .||||++++++|.  
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence            34699999999999999999987532       2368999876422     2345799999999 7999999999884  


Q ss_pred             ccCCceEEEEEeecccc-cHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 024091          203 TEKDELYLNLVLEYISE-TVYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN  269 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~N  269 (272)
                         ...+++++|||+++ ++.+++....            .....+++..+..++.||+.||.|||+ ++|+||||||+|
T Consensus        89 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N  164 (334)
T cd05100          89 ---QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARN  164 (334)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccce
Confidence               33458999999985 5555443321            112347778888999999999999998 999999999999


Q ss_pred             eeC
Q 024091          270 LLM  272 (272)
Q Consensus       270 ILl  272 (272)
                      ||+
T Consensus       165 ill  167 (334)
T cd05100         165 VLV  167 (334)
T ss_pred             EEE
Confidence            986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.85  E-value=1.5e-20  Score=167.54  Aligned_cols=131  Identities=31%  Similarity=0.464  Sum_probs=107.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeeccc-CCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~  208 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++||||++++++|..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            457999999999999999999999999999999885421      234479999999999999999998743321 1223


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..|++++++++.+..++.     ...+++..++.++.||+.||.|||+ .+|+||||||+||++
T Consensus        96 ~~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll  153 (345)
T cd07877          96 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAV  153 (345)
T ss_pred             cEEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEE
Confidence            478999999877765443     2358899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.85  E-value=9.4e-22  Score=169.54  Aligned_cols=129  Identities=26%  Similarity=0.464  Sum_probs=111.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhH---HHHHHHHHHcCC--C----CeeecceeeeecccCC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLLNH--P----NVVSLKHCFFSTTEKD  206 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~---~~E~~~l~~l~h--~----nIv~l~~~~~~~~~~~  206 (272)
                      ..+|.+...+|+|+||+|..+.+..++..||||+++...++.   .-|+++|.++.+  |    -+|.+.+||     ..
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence            567999999999999999999999999999999997655443   359999999953  2    277888888     66


Q ss_pred             ceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++.|||+|.++-++++++...  ...+++...++.+++|+|.++.|||+ .+++|-||||||||+
T Consensus       163 rghiCivfellG~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILf  225 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILF  225 (415)
T ss_pred             cCceEEEEeccChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEE
Confidence            7779999999999998877643  35679999999999999999999998 899999999999986

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.85  E-value=1.5e-21  Score=175.63  Aligned_cols=117  Identities=27%  Similarity=0.519  Sum_probs=100.0

Q ss_pred             eeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeeccc-c
Q 024091          141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-E  219 (272)
Q Consensus       141 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~  219 (272)
                      -++-||.|+.|.||+|+.  .++.||||.+++   ..+.+|.-|++|+|||||.|.|+|     ....++|||||||. |
T Consensus       128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeeccccc
Confidence            356699999999999987  678999997743   334689999999999999999999     44456999999999 6


Q ss_pred             cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          220 TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       220 ~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|+.+++.    ...++...+..|..+|+.||.|||. +.|||||||.-||||
T Consensus       198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLI  245 (904)
T KOG4721|consen  198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILI  245 (904)
T ss_pred             cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEe
Confidence            66666554    5668888889999999999999998 999999999999996

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.85  E-value=7e-21  Score=164.90  Aligned_cols=131  Identities=24%  Similarity=0.317  Sum_probs=104.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ..+|.+.+.||+|+||.||+|.+..     ++..||+|.+...     ...+.+|+.+++.+.||||+++++++.     
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence            3469999999999999999998743     5788999988643     233557999999999999999999873     


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhh------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYT------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK  266 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~------------------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlK  266 (272)
                      .....|++|||+++ ++..++....                  .....+++..+..++.||+.||.|||+ .+++|||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~  157 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLA  157 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeeccccc
Confidence            33458999999995 5555443211                  111246788889999999999999998 899999999


Q ss_pred             CCCeeC
Q 024091          267 PQNLLM  272 (272)
Q Consensus       267 p~NILl  272 (272)
                      |+|||+
T Consensus       158 p~nil~  163 (288)
T cd05050         158 TRNCLV  163 (288)
T ss_pred             HhheEe
Confidence            999985

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.85  E-value=1.2e-20  Score=161.33  Aligned_cols=127  Identities=26%  Similarity=0.347  Sum_probs=102.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..+|.+.+.||+|+||.||+|.+..+ ..||+|.+....   ..+.+|+++++.++||||+++++.+..      .+.|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcEE
Confidence            34699999999999999999988655 459999886432   345689999999999999999886521      23789


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+++ ++.+++...  ....+++..+..++.|++.||.|||+ .+|+|+||||+|||+
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill  135 (262)
T cd05071          78 VTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILV  135 (262)
T ss_pred             EEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEE
Confidence            9999985 555544321  23457888899999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.85  E-value=1.3e-20  Score=160.72  Aligned_cols=125  Identities=29%  Similarity=0.529  Sum_probs=104.9

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||++.+..+++.||+|.+....      ....+|+.+++.++|+||+++++++     .....++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            5889999999999999999998899999999986432      2345799999999999999999987     3344589


Q ss_pred             EEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||++++.+ +++.    ....+++..++.++.|++.||.|||+ .+|+|+||+|+||++
T Consensus        76 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~  132 (264)
T cd06626          76 IFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFL  132 (264)
T ss_pred             EEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            99999985544 3332    23457888899999999999999998 999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.85  E-value=4.5e-21  Score=165.12  Aligned_cols=131  Identities=21%  Similarity=0.345  Sum_probs=104.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ..+|.+.+.||+|+||.||+|.+..     ++..||||.+...     ...+.+|+++|+.+.|+||+++++++...   
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence            3458899999999999999998743     4678999988643     23455799999999999999999988443   


Q ss_pred             CceEEEEEeeccccc-HHHHHHHhh----------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISET-VYRVSKHYT----------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~-l~~~~~~~~----------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        .++|+||||++++ +..++....          .....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili  155 (280)
T cd05049          81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLV  155 (280)
T ss_pred             --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEE
Confidence              4499999999854 444433221          112447888899999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.85  E-value=1.2e-20  Score=167.10  Aligned_cols=129  Identities=31%  Similarity=0.453  Sum_probs=106.5

Q ss_pred             CeeeeEEeccCCceEEEEEEECCC--CCEEEEEEeecc------chhHHHHHHHHHHc-CCCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLET--GDSVAIKKVLQD------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~--~~~vAvK~i~~~------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      +|.+.+.||+|+||.||++.+..+  +..||||.+...      .....+|+.+++.+ .||||+++++++.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            488999999999999999999887  899999988642      12345799999999 5999999998754332 2334


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|++|||+++++...+.    ....+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        80 ~~~~~~e~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili  138 (332)
T cd07857          80 ELYLYEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLV  138 (332)
T ss_pred             cEEEEEecccCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEE
Confidence            588999999988776543    24568999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.85  E-value=1.9e-20  Score=159.10  Aligned_cols=127  Identities=28%  Similarity=0.504  Sum_probs=106.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||.|+||.||++.+..+++.||+|.+...      .....+|+.+++.++||||++++++|     ....+.|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            488999999999999999999999999999988532      22455799999999999999999988     4445699


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ .+...+..  .....+++..+..++.|++.||.|||+ ++++|+||+|+|||+
T Consensus        76 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~  134 (256)
T cd08218          76 IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFL  134 (256)
T ss_pred             EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEE
Confidence            99999985 55444332  123357888999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.85  E-value=1.9e-21  Score=165.91  Aligned_cols=121  Identities=21%  Similarity=0.286  Sum_probs=96.3

Q ss_pred             EEeccCCceEEEEEEECCCCC-------EEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          143 RVVGTGSFGVVFQAKCLETGD-------SVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~-------~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +.||.|+||.||+|.+...+.       .||+|.+....    ..+..|+.+++.+.||||+++++++....     +.+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence            368999999999998865443       48888775432    23457899999999999999999985433     388


Q ss_pred             EEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||++++.+ .++..   ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        76 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili  133 (258)
T cd05078          76 MVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLL  133 (258)
T ss_pred             EEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEE
Confidence            99999996544 33322   23357888899999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.85  E-value=7.5e-21  Score=167.93  Aligned_cols=130  Identities=34%  Similarity=0.510  Sum_probs=109.7

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||.|+||.||+|.+..+++.||||.+...      .....+|+.+++.++|+||+++++++..........+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            588999999999999999999888999999988542      23455799999999999999999988555423334689


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||+++++..++..    ...+++..++.++.||+.||.|||+ .||+|+||||+|||+
T Consensus        81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili  136 (330)
T cd07834          81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILV  136 (330)
T ss_pred             EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            9999999876654432    3478999999999999999999998 899999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.85  E-value=1.2e-20  Score=162.54  Aligned_cols=123  Identities=24%  Similarity=0.375  Sum_probs=103.7

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      |.+.+.||.|+||.||+|.+..+++.||||.+....     ..+.+|+.+++.++||||++++++|.     ...+.|+|
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv   80 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWII   80 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEEE
Confidence            778899999999999999998899999999875321     23457999999999999999999883     34458999


Q ss_pred             eecccccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||++++.+. ++.     ...+++..+..++.|++.||.|||+ .+|+|+||||+||++
T Consensus        81 ~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i  134 (277)
T cd06641          81 MEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLL  134 (277)
T ss_pred             EEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEE
Confidence            9999965443 322     2457889999999999999999998 999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.85  E-value=9.8e-21  Score=163.38  Aligned_cols=130  Identities=23%  Similarity=0.334  Sum_probs=104.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCC-----CEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      .+|.+.+.||+|+||.||+|.+...+     ..||+|.+....     ..+.+|+.+++.+.||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            46889999999999999999876554     679999886432     23457999999999999999999873     3


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....|++|||+.+ ++.+++.....            ....+++..+..++.|++.||.|||+ .+|+|+||||+|||+
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~  157 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLV  157 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEE
Confidence            3448999999985 55554443211            11457888899999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.85  E-value=1.6e-20  Score=159.50  Aligned_cols=127  Identities=25%  Similarity=0.430  Sum_probs=106.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||.|+||.||++.+..++..||+|.+..      ......+|+++++.++|+||+++++++     ....++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            48899999999999999999999999999998853      223455899999999999999999987     3444699


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||+.+ .+...+..  .....+++..+..++.|++.||.|||+ .+|+|+||||+||++
T Consensus        76 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~  134 (257)
T cd08225          76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFL  134 (257)
T ss_pred             EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEE
Confidence            99999985 54443332  112357889999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.85  E-value=1.8e-20  Score=164.64  Aligned_cols=132  Identities=22%  Similarity=0.379  Sum_probs=103.8

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECC-------CCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeee
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS  201 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~  201 (272)
                      ...+|.+.+.||+|+||.||++.+..       ....+|+|.+....     .....|+++++.+ .||||+++++++. 
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-   88 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-   88 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc-
Confidence            34579999999999999999998642       34579999886432     1244799999999 5999999999873 


Q ss_pred             cccCCceEEEEEeecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 024091          202 TTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ  268 (272)
Q Consensus       202 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~  268 (272)
                          ...++|++|||+++ ++..++.....            ....+++..+..++.||+.||.|||+ +||+||||||+
T Consensus        89 ----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~  163 (314)
T cd05099          89 ----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAAR  163 (314)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccce
Confidence                33458999999985 55555443211            12357888899999999999999998 99999999999


Q ss_pred             CeeC
Q 024091          269 NLLM  272 (272)
Q Consensus       269 NILl  272 (272)
                      |||+
T Consensus       164 Nill  167 (314)
T cd05099         164 NVLV  167 (314)
T ss_pred             eEEE
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.85  E-value=4.7e-21  Score=178.85  Aligned_cols=131  Identities=18%  Similarity=0.264  Sum_probs=97.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCC-CCEEEEE------------------Eeecc---chhHHHHHHHHHHcCCCCee
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLET-GDSVAIK------------------KVLQD---KRYKNRELQIMRLLNHPNVV  193 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~vAvK------------------~i~~~---~~~~~~E~~~l~~l~h~nIv  193 (272)
                      ..+|.+++.||+|+||+||+|..... +..+++|                  .+...   ...+.+|+.+|+.++|||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            45799999999999999999876432 2222222                  11111   22345799999999999999


Q ss_pred             ecceeeeecccCCceEEEEEeecccccHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYT-RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       194 ~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++++++.     ...+.|+|||++.+.++..+.... ..........++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       227 ~l~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEILR-----SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEEE-----ECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            9999883     334589999999988876543221 112233456678899999999999998 999999999999986

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.85  E-value=1.1e-20  Score=165.14  Aligned_cols=130  Identities=22%  Similarity=0.345  Sum_probs=103.7

Q ss_pred             cccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeecc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTT  203 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  203 (272)
                      ...+|.+.+.||+|+||.||++.+.     .++..||||.+....     ..+.+|+++++.+ +||||++++++|..  
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  110 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--  110 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence            3446999999999999999999752     345689999886432     2345799999999 79999999998843  


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                         ...+|++|||+.+ ++..++...  ....+++..+..++.||+.||.|||+ ++|+|+||||+|||+
T Consensus       111 ---~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~  174 (302)
T cd05055         111 ---GGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLL  174 (302)
T ss_pred             ---CCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEE
Confidence               3348999999985 554444321  12337899999999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.85  E-value=1.3e-20  Score=161.61  Aligned_cols=123  Identities=21%  Similarity=0.177  Sum_probs=96.2

Q ss_pred             EeccCCceEEEEEEEC--CCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeec
Q 024091          144 VVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      .||+|+||.||+|...  .++..+|+|.+....     ..+.+|+.+++.++||||+++++++.     ...++++||||
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   76 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVMEF   76 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEEC
Confidence            5899999999999864  345679999886432     23457999999999999999999873     33448999999


Q ss_pred             ccc-cHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          217 ISE-TVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       217 ~~~-~l~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++ ++.+++..... .....++..++.++.|++.||.|||+ .+|+||||||+||++
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~  133 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLL  133 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEE
Confidence            995 55444433221 12345667788899999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.85  E-value=1.1e-21  Score=164.64  Aligned_cols=134  Identities=28%  Similarity=0.382  Sum_probs=109.2

Q ss_pred             cccCeee-eEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEE
Q 024091          135 QTISYMA-ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       135 ~~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .+++|.+ -++||-|-.|+|..|.++.|++.||+|++.. ....++|+++.-.. .|||||.++++|-.. ..+..++.+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rkcLLi  136 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENS-YQGRKCLLI  136 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCceeeEe
Confidence            3456766 4789999999999999999999999997754 34456799886665 499999999987433 356778999


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+|.|+-+ +.+...+..+.|++..+..|+.||+.|+.|||+ .+|.||||||+|+|.
T Consensus       137 VmE~meGGeL-fsriq~~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLy  194 (400)
T KOG0604|consen  137 VMECMEGGEL-FSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLY  194 (400)
T ss_pred             eeecccchHH-HHHHHHcccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheee
Confidence            9999996643 223334556779999999999999999999998 899999999999983

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.85  E-value=2.4e-20  Score=158.97  Aligned_cols=129  Identities=26%  Similarity=0.351  Sum_probs=105.3

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ...+|.+.+.||+|+||.||+|.+. .+..||||.+...   .....+|+.+++.++|+||+++++++.     ....++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIY   77 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceE
Confidence            3457999999999999999999875 4577999988643   234568999999999999999999873     334489


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ .+.+++..  .....+++..+..++.|++.||.|||+ .+|+|+||||+||++
T Consensus        78 ~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili  136 (261)
T cd05034          78 IVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILV  136 (261)
T ss_pred             EEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEE
Confidence            99999985 55444332  123468899999999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.85  E-value=1.1e-21  Score=178.18  Aligned_cols=127  Identities=27%  Similarity=0.452  Sum_probs=104.5

Q ss_pred             eeeEEeccCCceEEEEEEECCCCCEEEEEEeec-----c---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----D---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       140 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +...+||+|+|-+||+|.|..+|..||.-.++-     .   ...+..|+++|+.|+|||||++|+.|.....   .++.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            345789999999999999999999999765531     1   2345579999999999999999999865543   4588


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~-~~iiHrDlKp~NILl  272 (272)
                      +|.|++..|.+.   .|.+..+.+....++.|++||+.||.|||+. -.|||||||-+||+|
T Consensus       120 ~iTEL~TSGtLr---~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFi  178 (632)
T KOG0584|consen  120 FITELFTSGTLR---EYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFV  178 (632)
T ss_pred             eeeecccCCcHH---HHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEE
Confidence            999999966544   4555567788999999999999999999971 369999999999986

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.85  E-value=1.9e-20  Score=161.55  Aligned_cols=134  Identities=26%  Similarity=0.391  Sum_probs=108.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHc-CCCCeeecceeeeeccc-CCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE-KDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~-~~~~~~  210 (272)
                      .+.|++.+.||.|+||.||+|.+..+++.||+|.+....   .....|+.+++.+ +|+||++++++|+.... ....++
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            456999999999999999999999999999999875432   2345788888888 69999999998864321 234579


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |++|||+++ .+..++...  ....+++..+..++.||+.||.|||+ .+|+|+||||+||++
T Consensus        95 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili  154 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLL  154 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            999999986 454444321  23457888899999999999999998 999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.84  E-value=1.4e-20  Score=163.13  Aligned_cols=125  Identities=29%  Similarity=0.509  Sum_probs=103.0

Q ss_pred             CeeeeEEeccCCceEEEEEEEC---CCCCEEEEEEeecc--------chhHHHHHHHHHHc-CCCCeeecceeeeecccC
Q 024091          138 SYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~--------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  205 (272)
                      +|.+.+.||.|+||.||++.+.   .+|+.||+|.+...        .....+|+++++.+ +|+||++++++|     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            3888999999999999999875   47899999988642        12345799999999 599999999887     3


Q ss_pred             CceEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...++|+||||++++ +.+.+.    ....+++..+..++.||+.||.|||+ .+++||||||+|||+
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~  138 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILL  138 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEE
Confidence            445689999999964 433332    23568889999999999999999998 999999999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.2e-20  Score=154.28  Aligned_cols=129  Identities=25%  Similarity=0.407  Sum_probs=109.9

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch--hHHHHHHHHHHcCC-CCeeecceeeeecccCCceEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--YKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..++|.+++.||.|+||.+|+|.....|+.||||.-....+  ....|..+.+.|.+ ..|..++.++     ..+.|-.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccce
Confidence            34579999999999999999999999999999998755433  44579999999985 5677766655     5556788


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||++++.++.+++..+   ...++...++.++.|++.-++|+|. +++|||||||+|+|+
T Consensus        88 lVMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLM  144 (341)
T KOG1163|consen   88 LVMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLM  144 (341)
T ss_pred             eeeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceee
Confidence            99999999999987765   4568899999999999999999998 999999999999985

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.84  E-value=1.8e-20  Score=161.53  Aligned_cols=127  Identities=31%  Similarity=0.518  Sum_probs=107.1

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      |.+.+.||.|+||.||+|.+..+++.+|+|.+....      ....+|+.+++.+.|+||+++++++....   ..++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            678899999999999999999999999999986542      23457999999999999999999874331   245999


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+++++..++...   ...+++..++.++.||+.||.|||+ .+++|+||||+|||+
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~  133 (287)
T cd07840          78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILI  133 (287)
T ss_pred             EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEE
Confidence            9999998776654322   2468899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.84  E-value=2.1e-20  Score=159.50  Aligned_cols=127  Identities=22%  Similarity=0.317  Sum_probs=103.3

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..+|.+.++||+|+||.||+|... +++.||+|.+....   ..+.+|+.+++.++|+||+++++++. .     .++|+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~-----~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-Q-----EPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-c-----CCcEE
Confidence            346999999999999999999854 57889999886532   34568999999999999999988752 1     23889


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||+.+ ++.+++..  .....+++..+..++.|++.||+|||+ .+|+|+||||+||++
T Consensus        78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i  135 (260)
T cd05067          78 ITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILV  135 (260)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEE
Confidence            9999984 55554432  223468888899999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.84  E-value=5.4e-21  Score=164.69  Aligned_cols=125  Identities=23%  Similarity=0.359  Sum_probs=104.5

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .|...+.||.|+||.||+|.+..+++.||+|.+....     ..+.+|+.+++.+.||||++++++|.     ...+.|+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence            3777889999999999999998899999999876322     23457999999999999999999883     4445999


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||++++.+.....    ...+++..++.++.|++.||.|||+ .+|+|+||+|+||++
T Consensus        80 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i  134 (277)
T cd06642          80 IMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLL  134 (277)
T ss_pred             EEEccCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEE
Confidence            999999654432211    3468889999999999999999998 999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.84  E-value=6.1e-21  Score=164.79  Aligned_cols=129  Identities=22%  Similarity=0.309  Sum_probs=102.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCC-----CCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      +|.+.+.||+|+||.||+|.+..+     +..||||.+....     ..+.+|+.++..++||||+++++++.     ..
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----KE   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC
Confidence            588889999999999999987543     5789999986432     23457999999999999999999883     33


Q ss_pred             eEEEEEeeccccc-HHHHHHHh------------hhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISET-VYRVSKHY------------TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~-l~~~~~~~------------~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+++++||+.++ +..++...            ......+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~  157 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLV  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEe
Confidence            3489999999854 44433211            0112357888899999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.84  E-value=3.2e-20  Score=157.98  Aligned_cols=127  Identities=24%  Similarity=0.371  Sum_probs=103.7

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc--hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      .+|.+.+.||+|+||.||++..  .+..||+|.+....  ..+.+|+.+++.+.|+||++++++++..    ...++++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEE
Confidence            4699999999999999999976  47889999886543  2355899999999999999999876433    23489999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+++ .+.+++...  ....+++..+..++.||+.||.|||+ ++|+||||||+||++
T Consensus        80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~  135 (256)
T cd05082          80 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLV  135 (256)
T ss_pred             ECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEE
Confidence            99985 555544321  22347888999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.84  E-value=1.6e-20  Score=161.22  Aligned_cols=123  Identities=19%  Similarity=0.285  Sum_probs=94.8

Q ss_pred             EeccCCceEEEEEEECCC--CCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeec
Q 024091          144 VVGTGSFGVVFQAKCLET--GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~~~~--~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      .||+|+||.||++.....  ...+++|.+...     ...+.+|+.+++.++||||++++++|.     ...+.|+||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence            589999999999975433  345667766432     234457899999999999999999884     33458999999


Q ss_pred             ccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          217 ISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       217 ~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +.+ ++..++.........+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~  132 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFL  132 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEE
Confidence            995 5545444322223456777788999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.84  E-value=4.9e-22  Score=161.19  Aligned_cols=127  Identities=28%  Similarity=0.543  Sum_probs=108.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-chhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ..+|++.+++|+|-++.||.|.+..+.+.++||+++.. ++...+|+.||..|. |||||+|++.......+.   ..|+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt---paLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT---PSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC---chhH
Confidence            44799999999999999999999999999999999764 445679999999998 999999999875444333   7799


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||+.+.....      ....++...++.++.|++.||.|||+ .||+|||+||.|++|
T Consensus       114 FE~v~n~Dfk~------ly~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmI  165 (338)
T KOG0668|consen  114 FEYVNNTDFKQ------LYPTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMI  165 (338)
T ss_pred             hhhhccccHHH------HhhhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeee
Confidence            99999764332      23457788899999999999999998 899999999999985

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.84  E-value=1.9e-20  Score=159.83  Aligned_cols=119  Identities=25%  Similarity=0.332  Sum_probs=95.7

Q ss_pred             EeccCCceEEEEEEEC--CCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeec
Q 024091          144 VVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      .||+|+||.||+|.+.  .++..||+|++....     ..+.+|+.+++.++||||+++++++.     . .+.++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence            3899999999999775  445679999886432     23457999999999999999998762     1 237899999


Q ss_pred             ccccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          217 ISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       217 ~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++++.+. ++.   .....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        76 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~  128 (257)
T cd05115          76 ASGGPLNKFLS---GKKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLL  128 (257)
T ss_pred             CCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEE
Confidence            9865443 332   224568999999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.84  E-value=2e-20  Score=162.40  Aligned_cols=130  Identities=24%  Similarity=0.358  Sum_probs=104.0

Q ss_pred             cCeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      .+|.+.+.||+|+||.||+|.+..     ++..+|+|.+....    ..+.+|+++++.++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            458999999999999999998643     45679999875432    34568999999999999999999883     34


Q ss_pred             eEEEEEeecccc-cHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+.++||||+++ ++.+++....            .....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEE
Confidence            458999999984 5544443221            112347889999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.84  E-value=1.5e-20  Score=161.96  Aligned_cols=128  Identities=27%  Similarity=0.467  Sum_probs=103.9

Q ss_pred             CeeeeEEeccCCceEEEEEEEC----CCCCEEEEEEeeccch-----hHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~----~~~~~vAvK~i~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .|.+.+.||+|+||.||++...    .+++.||||.+.....     .+.+|+.+++.+.|+||+++++++...   ...
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~~   81 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GGR   81 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CCC
Confidence            4778899999999999999864    3478999999864432     456899999999999999999877332   244


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +.+++|||+++ ++..++..   ....+++..+..++.|++.||.|||+ .+|+|+||||+|||+
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~  142 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILV  142 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEE
Confidence            58999999985 55444332   12358889999999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.84  E-value=3.2e-20  Score=157.74  Aligned_cols=126  Identities=24%  Similarity=0.361  Sum_probs=103.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +|.+.+.||.|+||.||++.+. .+..+|+|.+...   ...+.+|+++++.+.||||+++++++     ....+.|+||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~   78 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLVF   78 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEEE
Confidence            5889999999999999999875 4678999988643   23456799999999999999999987     3344589999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++.+....  ......+++..+..++.|++.||.|||+ .+|+|+||||+||++
T Consensus        79 e~~~~~~L~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i  133 (256)
T cd05112          79 EFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLV  133 (256)
T ss_pred             EcCCCCcHHHHH--HhCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEE
Confidence            999965443221  1223457888899999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.84  E-value=1e-20  Score=163.71  Aligned_cols=130  Identities=21%  Similarity=0.335  Sum_probs=105.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|...+.||+|+||.||++.+..+++.||||.+...     .....+|+.++..+. |+||+++++++...     ...+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEE
Confidence            466778999999999999999999999999988542     223457899999986 99999999987543     3388


Q ss_pred             EEeecccccHHHHHHHh-hhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHY-TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||++.++..+.... ......+++..+..++.|++.||+|||+..+|+||||||+|||+
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~  141 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL  141 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE
Confidence            99999997765544322 22346789999999999999999999973599999999999985

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.84  E-value=1.3e-20  Score=162.78  Aligned_cols=126  Identities=21%  Similarity=0.346  Sum_probs=99.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCC----EEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      .+|++.+.||+|+||.||+|.+..+++    .+|+|.+....     .....|+.+++.+.||||+++++++..      
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence            468899999999999999999987776    47777764321     223457778899999999999997621      


Q ss_pred             eEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+++|||++ +++.+++..   ....+++..+..++.||+.||.|||+ .+++||||||+|||+
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili  142 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILL  142 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEE
Confidence            12678999998 555554432   23468899999999999999999998 899999999999986

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.84  E-value=2e-20  Score=158.81  Aligned_cols=124  Identities=28%  Similarity=0.453  Sum_probs=102.4

Q ss_pred             EEeccCCceEEEEEEECCC---CCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||.||+|.+...   +..||+|.+....     ....+|+.+++.+.|+||+++++++..     ...++++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            3689999999999999865   8899999986432     344579999999999999999998843     44599999


Q ss_pred             eccc-ccHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYIS-ETVYRVSKHYTRM-----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+. +++.+++......     ...+++..+..++.|++.||.|||+ ++|+|+||||+||++
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili  138 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLV  138 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEE
Confidence            9996 5665554432111     3678999999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PHA02988 hypothetical protein; Provisional

Probab=99.84  E-value=2.3e-20  Score=161.84  Aligned_cols=123  Identities=13%  Similarity=0.224  Sum_probs=99.4

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEee
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      ..||+|++|.||+|.+  +|+.||||.+....       ..+.+|+.+|+.++||||++++++|.... ....++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5799999999999988  78999999986431       23448999999999999999999885421 22345899999


Q ss_pred             cccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          216 YISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       216 ~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+.++.+ +++.    ....+++.....++.|++.||.|||+..+++||||||+|||+
T Consensus       103 y~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill  156 (283)
T PHA02988        103 YCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV  156 (283)
T ss_pred             eCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE
Confidence            9996644 3332    245688888899999999999999973489999999999985

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.84  E-value=7.9e-22  Score=163.68  Aligned_cols=125  Identities=23%  Similarity=0.462  Sum_probs=106.2

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------------chhHHHHHHHHHHcC-CCCeeecceeeeeccc
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTE  204 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~  204 (272)
                      .|.-.+.||.|..++|.++.+..++..+|+|++...            ......|+.||+++. ||+|+.+.++|     
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-----   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-----   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence            577788999999999999999999999999988421            112236999999985 99999999998     


Q ss_pred             CCceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          205 KDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       205 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +...++++|+|+|+ |.|.+.+.    ..-.+++...+.|++|++.|++|||. ++||||||||+|||+
T Consensus        93 es~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILl  156 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILL  156 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheee
Confidence            66677999999999 66655433    24568999999999999999999998 999999999999985

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.84  E-value=1.8e-20  Score=161.55  Aligned_cols=126  Identities=37%  Similarity=0.599  Sum_probs=106.2

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch-----hHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-----~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      |.+.+.||.|+||.||+|....+++.||||.+.....     ...+|+..++.+. |+||++++++|..     ....|+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            6788999999999999999988999999998754321     2346899999999 9999999999843     445899


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||++++++..+....  ...+++..+..++.|++.+|.|||+ ++|+|+||+|+||++
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i  132 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLV  132 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEE
Confidence            99999888776554322  2468899999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.84  E-value=1.2e-20  Score=160.75  Aligned_cols=129  Identities=22%  Similarity=0.379  Sum_probs=104.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      +|.+.+.||+|+||.||++.+..++..+++|.++..         ......|+.+++.++||||+++++++..     ..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence            588999999999999999999877777777765421         1123468999999999999999998743     33


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++||||+++ ++..++..+......+++..++.++.|++.||.|||+ .+|+|+||||+||++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili  139 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFL  139 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEe
Confidence            48999999985 5444444444445678999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.84  E-value=2.8e-20  Score=160.43  Aligned_cols=132  Identities=19%  Similarity=0.271  Sum_probs=105.3

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECC----CCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLE----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ..+|.+.+.||+|+||.||+|.+..    ++..||+|.+....     ....+|+.+++.+.|+||++++++++..    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            3469999999999999999999865    35789999886432     2345799999999999999999987543    


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRM----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....++++||+++ .+..++......    ...+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~  150 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVI  150 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEE
Confidence            2347899999984 554444332211    1468899999999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.84  E-value=2.7e-20  Score=162.04  Aligned_cols=127  Identities=29%  Similarity=0.409  Sum_probs=105.5

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ...+|.+.+.||.|+||.||++.+..++..||+|.+...    ...+.+|+.+++.+.||||+++++.|..     ..+.
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~   91 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDEL   91 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcE
Confidence            345799999999999999999999889999999987532    2234579999999999999999998843     3348


Q ss_pred             EEEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.++.+ .++.     ...+++..+..++.|++.||.|||+ .+++|+||||+||++
T Consensus        92 ~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili  148 (293)
T cd06647          92 WVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILL  148 (293)
T ss_pred             EEEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEE
Confidence            999999986544 3322     2347888899999999999999998 899999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.84  E-value=1.5e-20  Score=164.24  Aligned_cols=127  Identities=24%  Similarity=0.404  Sum_probs=102.3

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCC----EEEEEEeeccch-----hHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ..+|+..+.||+|+||.||+|.+..++.    .||+|.+.....     ...+|+.+++.+.||||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence            3468899999999999999999887776    478887754321     345799999999999999999987432    


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ..++++||+++ .+.+.+..   ....+++..+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus        82 --~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill  142 (303)
T cd05110          82 --TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLV  142 (303)
T ss_pred             --CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeee
Confidence              25689999984 55544332   23457888899999999999999998 999999999999986

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.84  E-value=4.6e-20  Score=156.18  Aligned_cols=129  Identities=29%  Similarity=0.498  Sum_probs=108.2

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||.|+||.||++.+..++..||+|.+...      .....+|+++++.++|+|++++++.+..     ..+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence            488999999999999999999889999999998543      2234579999999999999999998743     35699


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||+++ ++...+.........+++..+..++.|++.||.|||+ .+++|+||+|+||++
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~  136 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFL  136 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEE
Confidence            99999986 5555444332224678999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.84  E-value=2.1e-20  Score=161.13  Aligned_cols=124  Identities=24%  Similarity=0.379  Sum_probs=104.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .|...+.||.|+||.||+|.+..++..||||.+....     ..+.+|+.+++.+.|+||+++++++.     +..+.|+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            4788899999999999999999899999999886432     23457999999999999999999884     3445999


Q ss_pred             EeecccccH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||++++. .+++.     ...+++..+..++.|++.||.|||+ .+++|+||+|+||++
T Consensus        80 v~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~  134 (277)
T cd06640          80 IMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLL  134 (277)
T ss_pred             EEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEE
Confidence            999998654 43332     2457888899999999999999998 899999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.84  E-value=2.5e-20  Score=164.04  Aligned_cols=125  Identities=29%  Similarity=0.467  Sum_probs=106.3

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      |...+.||+|+||.||++.+..++..||+|.+....       ....+|+++++.++|||++++++++...     ...|
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~  101 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTAW  101 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeEE
Confidence            888899999999999999999899999999885321       1344799999999999999999988433     3489


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+++++++..   ....+++..+..++.||+.||.|||+ .+|+|+||+|+||++
T Consensus       102 lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~  158 (317)
T cd06635         102 LVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILL  158 (317)
T ss_pred             EEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEE
Confidence            9999999887765432   23458899999999999999999998 999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=6.5e-21  Score=174.92  Aligned_cols=122  Identities=25%  Similarity=0.421  Sum_probs=104.3

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeeccc
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS  218 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~  218 (272)
                      -+||+|+||+||-|++..+....|||.+....    .....||.+.+.|+|.|||+++|++     ...+|+-|.||-++
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVP  655 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCC
Confidence            36999999999999999999999999996432    2345899999999999999999997     55568999999999


Q ss_pred             ccHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          219 ETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       219 ~~l~~~~~~~~~~~~~~--~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+++.-+..  ...+++  .+..+-+|.+||+.||.|||+ +.|||||||-+|+||
T Consensus       656 GGSLSsLLr--skWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLv  708 (1226)
T KOG4279|consen  656 GGSLSSLLR--SKWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLV  708 (1226)
T ss_pred             CCcHHHHHH--hccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEE
Confidence            877664332  235566  788999999999999999998 899999999999986

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.84  E-value=2.1e-20  Score=161.59  Aligned_cols=120  Identities=22%  Similarity=0.346  Sum_probs=94.1

Q ss_pred             EeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHH---HcCCCCeeecceeeeecccCCceEEEEE
Q 024091          144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMR---LLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      +||+|+||.||++.+..+++.+|||.+....       ....+|..+++   ...||||+.++++|..     ..+.|+|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            4899999999999999999999999885421       11223444333   3479999999888743     3458999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+.++.+...   ......+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        76 ~e~~~~~~L~~~---i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~  130 (279)
T cd05633          76 LDLMNGGDLHYH---LSQHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILL  130 (279)
T ss_pred             EecCCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEE
Confidence            999996654321   2224568999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.84  E-value=2.3e-20  Score=160.82  Aligned_cols=120  Identities=27%  Similarity=0.352  Sum_probs=98.8

Q ss_pred             eccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          145 VGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       145 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      ||+|+||+||+|.+..+++.||+|.+...       ......|+++|+.++||||+++++.|     ....+.|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            69999999999999999999999988532       12234799999999999999999887     3444589999999


Q ss_pred             ccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          218 SET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++ +...+...  ....+++..+..++.|++.||.|||+ .+|+|+||+|+|||+
T Consensus        76 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~  128 (277)
T cd05577          76 NGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLL  128 (277)
T ss_pred             CCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEE
Confidence            964 43333221  22468999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.84  E-value=9.2e-21  Score=164.95  Aligned_cols=125  Identities=30%  Similarity=0.381  Sum_probs=104.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .|.....||+|+||.||++.+..++..||||.+...    ...+.+|+.+++.+.|+||+++++.|.     ...+.|+|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence            356667899999999999999889999999987532    223457999999999999999999884     34458999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||++++.+..+..    ...+++..+..++.||+.||.|||+ .+|+||||||+||++
T Consensus        98 ~e~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill  151 (292)
T cd06658          98 MEFLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILL  151 (292)
T ss_pred             EeCCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEE
Confidence            99999765543221    2458889999999999999999998 899999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=1.8e-20  Score=161.17  Aligned_cols=124  Identities=27%  Similarity=0.417  Sum_probs=105.2

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++|+||++++++|...     .++|+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEEE
Confidence            5888999999999999999999999999999885432     2345799999999999999999987433     45999


Q ss_pred             Eeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||++++ +.+++..     ..+++..+..++.|++.||.|||+ .+|+|+||+|+||++
T Consensus        77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i  131 (274)
T cd06609          77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILL  131 (274)
T ss_pred             EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEE
Confidence            99999865 4443321     268899999999999999999998 899999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1e-21  Score=172.37  Aligned_cols=133  Identities=29%  Similarity=0.424  Sum_probs=111.5

Q ss_pred             CCcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchh-----------HHHHHHHHHHcCCCCeeecceeeee
Q 024091          133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-----------KNRELQIMRLLNHPNVVSLKHCFFS  201 (272)
Q Consensus       133 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-----------~~~E~~~l~~l~h~nIv~l~~~~~~  201 (272)
                      +....+|.++.+||+|+|+.||+|.+....+.||||+-.-.+.+           ..+|-.|.+.|+||-||++|++|..
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            34456799999999999999999999999999999976433222           2379999999999999999999966


Q ss_pred             cccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCCeeC
Q 024091          202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLM  272 (272)
Q Consensus       202 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~-~~iiHrDlKp~NILl  272 (272)
                      +++.    +|-|+|||+|+.++++   .+.+..+++..++.|+.||+.||.||... ..|||-||||.||||
T Consensus       539 Dtds----FCTVLEYceGNDLDFY---LKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILL  603 (775)
T KOG1151|consen  539 DTDS----FCTVLEYCEGNDLDFY---LKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILL  603 (775)
T ss_pred             cccc----ceeeeeecCCCchhHH---HHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEE
Confidence            5543    8999999999877743   34466789999999999999999999962 479999999999986

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.84  E-value=1.1e-20  Score=167.71  Aligned_cols=129  Identities=29%  Similarity=0.511  Sum_probs=107.0

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHc-CCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+...      .....+|+.+++.+ +||||++++++|...   +.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence            345799999999999999999999889999999987432      22344799999999 999999999987432   23


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|+||||+++++...+..     ..+.+..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill  140 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILL  140 (337)
T ss_pred             ceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            45899999999877654432     267788888999999999999998 899999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.84  E-value=4e-20  Score=161.08  Aligned_cols=130  Identities=18%  Similarity=0.336  Sum_probs=98.1

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCC---CCEEEEEEeeccchhHH---------------HHHHHHHHcCCCCeeeccee
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDKRYKN---------------RELQIMRLLNHPNVVSLKHC  198 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~~~~~---------------~E~~~l~~l~h~nIv~l~~~  198 (272)
                      .+|.+.++||+|+||.||+|.+..+   +..+|+|..........               .+...+..+.|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4699999999999999999998877   66788886432221111               12234456689999999987


Q ss_pred             eeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       199 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +.... ....+.+++||++...+..++..    ....++..++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus        92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill  159 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMV  159 (294)
T ss_pred             eeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            64433 33456788999988776654433    2235778889999999999999998 899999999999985

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.84  E-value=4.9e-20  Score=157.31  Aligned_cols=126  Identities=24%  Similarity=0.321  Sum_probs=102.2

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .+|.+.+.||+|+||.||+|.+..+ ..+|+|.+....   ..+.+|+++++.+.|+||+++++++. .     .+.|++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~-----~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-E-----EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-C-----CCcEEE
Confidence            4699999999999999999987654 469999876432   23457999999999999999988762 1     237899


Q ss_pred             eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+.+ ++.+++...  ....+++..+..++.|++.||.|||+ .+|+|+||||+||++
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill  135 (260)
T cd05069          79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILV  135 (260)
T ss_pred             EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEE
Confidence            999985 566655432  23457888899999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.84  E-value=4.1e-20  Score=157.76  Aligned_cols=127  Identities=21%  Similarity=0.347  Sum_probs=103.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..+|.+.+.||+|+||.||++.+. .+..+|+|.+....   ..+.+|+.+++.++|+||+++++++..      ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence            457999999999999999999854 45679999886532   345579999999999999999888732      33789


Q ss_pred             Eeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||++ +++.+++...  ....+++..+..++.|++.||.|||+ .+++|+||||+||++
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i  135 (260)
T cd05073          78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILV  135 (260)
T ss_pred             EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEE
Confidence            999998 4665554332  23457788888999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.84  E-value=3.1e-20  Score=157.57  Aligned_cols=127  Identities=30%  Similarity=0.428  Sum_probs=107.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      .+|.+.+.||.|+||.||+|.+..++..||+|.+...  .....+|+.+++.++|+||+++++++..     ..++|++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEE
Confidence            3699999999999999999999888999999988644  2345689999999999999999998843     34599999


Q ss_pred             ecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++.+ +++.   .....+++..++.++.|++.||.|||+ .+|+|+||+|+||++
T Consensus        78 e~~~~~~L~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~  132 (256)
T cd06612          78 EYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILL  132 (256)
T ss_pred             ecCCCCcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEE
Confidence            99996544 3332   224568999999999999999999998 899999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.84  E-value=3.2e-20  Score=158.36  Aligned_cols=127  Identities=23%  Similarity=0.330  Sum_probs=102.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..+|.+.+.||+|+||.||+|.+. .+..||+|.+...   ...+.+|+.+++.++|+||+++++++. .     ...|+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~-----~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-E-----EPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-C-----CCcEE
Confidence            346999999999999999999765 5667999988643   234568999999999999999998752 1     12789


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||+++ ++.+++..  .....+++..++.++.|++.||.|||+ .+|+||||||+||++
T Consensus        78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili  135 (260)
T cd05070          78 VTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILV  135 (260)
T ss_pred             EEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEE
Confidence            9999985 55544432  123458899999999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.7e-21  Score=165.25  Aligned_cols=129  Identities=28%  Similarity=0.376  Sum_probs=108.5

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhH-------HHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~-------~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|..+++||+|.||+|.+++.+.+++.+|||+++++.-..       ..|-.+|+..+||++..|.-.|     +..
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence            4567899999999999999999999999999999987653322       2577899999999999998777     555


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+|+||||..|+-+-+  + ......+++..+++|..+|+.||.|||+ ++||.||||.+|+||
T Consensus       241 drlCFVMeyanGGeLf~--H-Lsrer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlL  301 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFF--H-LSRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLL  301 (516)
T ss_pred             ceEEEEEEEccCceEee--e-hhhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhhee
Confidence            56999999999764322  2 2225669999999999999999999998 999999999999986

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.84  E-value=3.1e-20  Score=159.47  Aligned_cols=123  Identities=26%  Similarity=0.453  Sum_probs=97.6

Q ss_pred             EeccCCceEEEEEEECCCCC--EEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEEee
Q 024091          144 VVGTGSFGVVFQAKCLETGD--SVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~~~~~~--~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      .||+|+||.||+|.+..++.  .+|+|.+....     ....+|++++..+ .||||++++++|.     ...++|+|||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~e   76 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAIE   76 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEEE
Confidence            68999999999999887775  46888876321     2344799999999 7999999999883     3345899999


Q ss_pred             ccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          216 YIS-ETVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       216 ~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |++ +++.+++.....            ....+++..++.++.|++.||+|||+ .+|+||||||+|||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili  145 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV  145 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEE
Confidence            998 455555443211            12347888999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.84  E-value=4.4e-20  Score=162.24  Aligned_cols=126  Identities=29%  Similarity=0.458  Sum_probs=106.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .|...+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++++..     ..+.
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   96 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTA   96 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence            3777788999999999999999999999999885321       223479999999999999999998843     3458


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.++++.++..   ....+++..+..++.||+.||.|||+ .+|+|+||+|+||++
T Consensus        97 ~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili  154 (313)
T cd06633          97 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILL  154 (313)
T ss_pred             EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEE
Confidence            99999999887765543   23568889999999999999999998 899999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=5e-20  Score=155.88  Aligned_cols=125  Identities=37%  Similarity=0.614  Sum_probs=105.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||.|+||.||++.+..+++.||+|.+....      ....+|+++++.+.|+||+++++++.     ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            4888999999999999999999899999999885442      23457999999999999999999873     345699


Q ss_pred             EEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||+.+. +.+++..    ...+++..+..++.|++.||.|||+ .+|+|+||||+||++
T Consensus        76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i  132 (254)
T cd06627          76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILT  132 (254)
T ss_pred             EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEE
Confidence            999999864 4333322    3568999999999999999999998 999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.84  E-value=5.3e-20  Score=172.57  Aligned_cols=135  Identities=26%  Similarity=0.395  Sum_probs=115.3

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+-|.+.++||.|.+|+||+++.+.+++..|+|+...+   ....+.|.++|+.+ .|||++.+|++|+......+..+
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            344599999999999999999999999999999987543   33455678888887 49999999999988777777789


Q ss_pred             EEEeecccccH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||||++++ -++.+...  ...+.|.++..|++.+|.||.+||+ ..+||||||-.|||+
T Consensus        97 WLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLL  156 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLL  156 (953)
T ss_pred             EEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEE
Confidence            99999999554 45555444  7789999999999999999999998 899999999999996

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.84  E-value=2.5e-20  Score=160.43  Aligned_cols=125  Identities=35%  Similarity=0.641  Sum_probs=106.6

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+....      ....+|+++++.++|+||+++++++.     ....+++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence            567789999999999999998899999999885432      23457999999999999999999873     3355999


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||+++++...+...   ...+++..+..++.||+.||.|||+ .+|+|+||||+||++
T Consensus        76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili  131 (283)
T cd05118          76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLI  131 (283)
T ss_pred             EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEE
Confidence            9999998877655432   3568899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.83  E-value=2.6e-20  Score=160.03  Aligned_cols=125  Identities=34%  Similarity=0.551  Sum_probs=106.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcC-CCCeeecceeeeecccCCceE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      +|.+.+.||.|+||.||++.+..+++.||+|++...       .....+|+++++.+. ||||++++++|     .....
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence            599999999999999999999999999999988542       123457899999999 99999999988     34455


Q ss_pred             EEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++|||++. +++.+++..    ...+++..++.++.|++.||.|||+ .+++|+||+|+||++
T Consensus        77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i  135 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILL  135 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEE
Confidence            999999996 555554433    3468999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.83  E-value=3.1e-20  Score=157.51  Aligned_cols=125  Identities=28%  Similarity=0.442  Sum_probs=102.4

Q ss_pred             eeeEEeccCCceEEEEEEECCCC----CEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          140 MAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       140 ~~~~~lG~G~fg~V~~~~~~~~~----~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+.+.||.|+||.||++.+...+    ..||+|.+....     .....|+.+++.++|+||+++++++..     ....
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCee
Confidence            46688999999999999998766    899999986443     244579999999999999999998843     3459


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |++|||+.+ ++.+++....  ...+++..+..++.|++.||.|||+ .+++|+||||+||++
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~  136 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLV  136 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEE
Confidence            999999985 5544443211  1128999999999999999999998 899999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.83  E-value=4.7e-20  Score=158.15  Aligned_cols=126  Identities=27%  Similarity=0.378  Sum_probs=101.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCC---CCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .+|.+.+.||+|+||.||+|.+...   ...||||......     ..+.+|+.+++.+.||||+++++++..      .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence            3588999999999999999987544   4569999875432     234579999999999999999987632      1


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..|+||||+.+ ++.+++..   ....+++..+..++.|++.||.|||+ .+++|+||||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili  140 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLV  140 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEE
Confidence            26799999985 45444332   23358899999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.83  E-value=5.4e-20  Score=155.99  Aligned_cols=129  Identities=27%  Similarity=0.450  Sum_probs=107.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||++.+..+++.+|+|.+...      .....+|+.+++.++|+||+++++++..     ....|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence            488999999999999999999999999999988542      1223478999999999999999998843     35599


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+++ ++...+.........+++..+..++.|++.||.|||+ .+++|+||+|+||++
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~  136 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILL  136 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEE
Confidence            99999975 5555554433334568889999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.83  E-value=4.5e-20  Score=157.84  Aligned_cols=125  Identities=30%  Similarity=0.435  Sum_probs=99.0

Q ss_pred             eeeEEeccCCceEEEEEEEC----CCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          140 MAERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       140 ~~~~~lG~G~fg~V~~~~~~----~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+.+.||.|.||.||+|.+.    ..+..|+||.+...     ...+.+|+++++.++||||+++++++.....     +
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            46789999999999999987    34678999999542     2344579999999999999999999863332     8


Q ss_pred             EEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++||||+. +++.+.+...  ....+++.....++.||+.||.|||+ ++|+|+||+++||||
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill  136 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILL  136 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEE
T ss_pred             ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccc
Confidence            99999998 4565554432  23568899999999999999999998 899999999999985

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.83  E-value=3.7e-20  Score=159.87  Aligned_cols=120  Identities=22%  Similarity=0.350  Sum_probs=94.7

Q ss_pred             EeccCCceEEEEEEECCCCCEEEEEEeeccch-------hHHHHH---HHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNREL---QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-------~~~~E~---~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      +||+|+||.||+|.+..+++.||||.+.+...       ....|.   .+++...||||++++++|     ....++|+|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            48999999999999999999999998854211       112333   344456799999999887     344459999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+.++.+...   ......+++..++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus        76 ~e~~~g~~L~~~---l~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili  130 (278)
T cd05606          76 LDLMNGGDLHYH---LSQHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILL  130 (278)
T ss_pred             EecCCCCcHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEE
Confidence            999997655422   2234568999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.83  E-value=3.9e-20  Score=157.27  Aligned_cols=125  Identities=25%  Similarity=0.442  Sum_probs=102.6

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      .+|.+.+.||+|+||.||++..  +++.||+|.+...  .....+|+.+++.++||||+++++++...      ..+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEEEE
Confidence            4699999999999999999864  7888999988643  23456799999999999999999887321      268999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.+ ++..++...  ....+++..+..++.|++.||.|||+ .+++||||||+|||+
T Consensus        78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili  133 (254)
T cd05083          78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILV  133 (254)
T ss_pred             ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEE
Confidence            99984 665554432  23357888899999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.83  E-value=4.6e-20  Score=157.08  Aligned_cols=119  Identities=27%  Similarity=0.397  Sum_probs=97.1

Q ss_pred             EEeccCCceEEEEEEECCCC---CEEEEEEeeccch-----hHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETG---DSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~---~~vAvK~i~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ++||+|+||.||+|.+..++   ..||+|.+.....     ...+|+++++.+.|+||+++++++.      ....++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            36999999999999876544   7899998864432     3457999999999999999998752      12378999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.+ .+.+++..    ...+++..+..++.|++.||.|||. .+|+|+||||+|||+
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili  128 (257)
T cd05060          75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLL  128 (257)
T ss_pred             EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEE
Confidence            99985 55554432    3368899999999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.83  E-value=3.1e-20  Score=165.26  Aligned_cols=131  Identities=32%  Similarity=0.513  Sum_probs=109.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc-CCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~  208 (272)
                      ..+|.+...||+|+||.||+|.+..+++.||||.+...      .....+|+.+++.+.||||+++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            44699999999999999999999999999999987532      1223469999999999999999987744332 2334


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|+|+||+++++.+++..     ..+++..++.++.||+.||.|||+ .+|+||||||+||++
T Consensus        94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill  151 (343)
T cd07851          94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAV  151 (343)
T ss_pred             cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEE
Confidence            5899999998887765442     468999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.83  E-value=4.7e-20  Score=156.18  Aligned_cols=120  Identities=22%  Similarity=0.373  Sum_probs=96.9

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      ++||.|+||.||+|... ++..+|+|.+....     ..+.+|+++++.++||||+++++++.     .....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence            36899999999999854 67899999875432     23457999999999999999999873     333489999999


Q ss_pred             ccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          218 SET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++ +..++.   .....+.+..+..++.|++.||.|||+ .+++|+||||+||++
T Consensus        75 ~~~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili  126 (250)
T cd05085          75 PGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLV  126 (250)
T ss_pred             CCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEE
Confidence            855 433322   223457888899999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.2e-20  Score=171.77  Aligned_cols=125  Identities=25%  Similarity=0.387  Sum_probs=107.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      -|..++.||-|+||.|.++....|...+|+|.+++.       ....+.|..||...+++.||+||-.|     ++...+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnL  704 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL  704 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCce
Confidence            378889999999999999999999999999988653       22234799999999999999999888     666679


Q ss_pred             EEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||+|++|+ +..++..    .+-|++..+++|+.++.+|+++.|. .|+|||||||+||||
T Consensus       705 YFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILI  762 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILI  762 (1034)
T ss_pred             EEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEE
Confidence            9999999965 4444333    3568999999999999999999998 799999999999996

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.83  E-value=3.2e-20  Score=158.18  Aligned_cols=118  Identities=25%  Similarity=0.369  Sum_probs=95.9

Q ss_pred             EeccCCceEEEEEEE--CCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEee
Q 024091          144 VVGTGSFGVVFQAKC--LETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~--~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      .||+|+||.||+|.+  ..++..+|+|++....      ..+.+|+.+++.+.||||+++++++.     . ...++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~-~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----A-ESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----C-CCcEEEEe
Confidence            589999999999965  4567899999885432      23457899999999999999998762     1 23689999


Q ss_pred             ccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          216 YISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       216 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |++++ +.+++.    ....+++..+..++.|++.||.|||+ ++|+||||||.|||+
T Consensus        76 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill  128 (257)
T cd05116          76 LAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLL  128 (257)
T ss_pred             cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEE
Confidence            99965 444432    23468899999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=4.1e-20  Score=159.01  Aligned_cols=125  Identities=29%  Similarity=0.502  Sum_probs=103.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcC---CCCeeecceeeeecccCCceE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .|.+.+.||.|+||.||+|.+..+++.||+|.+...     .....+|+.+++.+.   ||||++++++|..     ..+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence            377889999999999999999999999999987532     223557999999997   9999999998743     345


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|+||||+.++.+..+..    ...+++..+..++.|++.||.|||+ .+|+|+||+|+||++
T Consensus        77 ~~lv~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i  134 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILV  134 (277)
T ss_pred             EEEEEecCCCCcHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEE
Confidence            899999998654432221    2368899999999999999999998 899999999999985

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.83  E-value=1.1e-19  Score=156.73  Aligned_cols=131  Identities=31%  Similarity=0.508  Sum_probs=107.0

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHc---CCCCeeecceeeeecccCCceE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      |.+.+.||.|+||.||+|.+..+++.||+|.+....      ....+|+.+++.+   +|+||++++++|..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999998889999999986321      1234687777666   5999999999986654434456


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++++|||+.+.+..++....  ...+++..++.++.||+.||.|||+ .+|+|+||+|+|||+
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili  140 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILV  140 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEE
Confidence            89999999988776554322  2358999999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.83  E-value=2.8e-20  Score=158.23  Aligned_cols=118  Identities=33%  Similarity=0.499  Sum_probs=99.3

Q ss_pred             eccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       145 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      ||.|+||.||++.+..+++.||+|.+....       ....+|+++++.+.||||+++++.+     ....+.|++|||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            689999999999999899999999885432       2345789999999999999999887     3445699999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          218 SE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+ .+..++..    ...+++..+..++.||+.||.|||+ .+|+|+||+|+||++
T Consensus        76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~  126 (265)
T cd05579          76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILI  126 (265)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEE
Confidence            85 55444432    2368999999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.83  E-value=1.9e-20  Score=187.49  Aligned_cols=122  Identities=24%  Similarity=0.356  Sum_probs=102.7

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      .|....+||+|+||.||+|.+..++..||||.+.........|++++++++|||||+++++|...     ...|+||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence            35566789999999999999988999999999876555556789999999999999999998443     3489999999


Q ss_pred             cccH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hcCCceecCCCCCCeeC
Q 024091          218 SETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH---HVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~~l-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH---~~~~iiHrDlKp~NILl  272 (272)
                      +++. .+++.       .+++.....++.||+.||.|||   + .+|+||||||+|||+
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~  816 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIII  816 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEE
Confidence            9554 44332       3778889999999999999999   5 699999999999985

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.83  E-value=5.3e-20  Score=157.89  Aligned_cols=133  Identities=22%  Similarity=0.327  Sum_probs=101.4

Q ss_pred             eeeeEEeccCCceEEEEEEEC---CCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCc-e
Q 024091          139 YMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE-L  208 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~-~  208 (272)
                      |.+.+.||+|+||.||+|.+.   .+++.||||++..+.      ..+.+|+++++.++||||+++++++......+. .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999864   357899999886432      234579999999999999999998754432222 2


Q ss_pred             EEEEEeecccccHH-HHHHHh--hhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVY-RVSKHY--TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~-~~~~~~--~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++++||+.++.+ .++...  ......+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili  146 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCML  146 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEE
Confidence            35788999985443 332211  1112357888899999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.83  E-value=4.5e-20  Score=159.40  Aligned_cols=130  Identities=23%  Similarity=0.370  Sum_probs=102.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      .+|.+.+.||+|+||.||++...     .++..+|+|.+...    ...+.+|+++++.+.|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence            35888999999999999999753     34678999987543    234568999999999999999998873     33


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTR-----------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...|++|||+++ ++.+++.....           ....+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~  155 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLV  155 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEE
Confidence            458999999985 55544433211           01347888999999999999999998 999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.83  E-value=5.5e-20  Score=156.38  Aligned_cols=121  Identities=29%  Similarity=0.384  Sum_probs=98.5

Q ss_pred             EEeccCCceEEEEEEECC-CC--CEEEEEEeeccch-----hHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLE-TG--DSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~-~~--~~vAvK~i~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||.||+|.+.. .+  ..||||.+.....     .+.+|+.+++.++||||+++++.+..      .++++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            368999999999999865 33  3699999865433     34579999999999999999998743      4589999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+. +++...+.....  ..+++..++.++.|++.||.|||+ .+++|+||||+|||+
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~  130 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILL  130 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEE
Confidence            9997 555554443221  468899999999999999999998 999999999999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.83  E-value=4.7e-21  Score=168.48  Aligned_cols=133  Identities=29%  Similarity=0.404  Sum_probs=109.8

Q ss_pred             CCcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       133 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      +.....|..-++||+|+||.||-++.+.||+.+|+|.+.+.       .....+|-.||.+++.++||.+--+|     +
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----e  255 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----E  255 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----c
Confidence            34445688889999999999999999999999999987432       22234799999999999999997777     3


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +...+|+||..|.|+.+.+.. +.-.+..|++..+++|+.+|+.||++||+ .+||.|||||+||||
T Consensus       256 Tkd~LClVLtlMNGGDLkfHi-yn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILL  320 (591)
T KOG0986|consen  256 TKDALCLVLTLMNGGDLKFHI-YNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILL  320 (591)
T ss_pred             CCCceEEEEEeecCCceeEEe-eccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheee
Confidence            444499999999988665432 33334579999999999999999999998 999999999999996

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.83  E-value=2.5e-20  Score=162.54  Aligned_cols=124  Identities=27%  Similarity=0.355  Sum_probs=102.5

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      |.....||+|+||.||++.+..+++.||||.+...    .....+|+.+++.+.||||++++++|..     ..+.|++|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEE
Confidence            44556799999999999999889999999988532    2334579999999999999999998843     34589999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++.+..+..    ...+++..++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus        98 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill  150 (297)
T cd06659          98 EFLQGGALTDIVS----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILL  150 (297)
T ss_pred             ecCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEE
Confidence            9999665442221    2458899999999999999999998 899999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.83  E-value=8.9e-20  Score=162.26  Aligned_cols=129  Identities=32%  Similarity=0.527  Sum_probs=106.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc-CCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  209 (272)
                      .+|.+...||+|+||.||+|.+..+++.||||.+...      .....+|+.+++.+.||||++++++|..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4799999999999999999999989999999988532      1234579999999999999999998754321 12234


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+...+..+.      ...+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll  150 (342)
T cd07879          95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAV  150 (342)
T ss_pred             EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            7899999987654321      2358889999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.83  E-value=1.3e-19  Score=153.22  Aligned_cols=127  Identities=35%  Similarity=0.525  Sum_probs=105.9

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +|.+.+.||+|+||.||+|.+..++..|++|.+....      ....+|+.+++.++|+||+++++++....   ...++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            4788899999999999999999899999999885433      34457999999999999999998874331   24589


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||+.+ ++.+++..    ...+++..+..++.|++.||.|||+ .+++|+||+|+||++
T Consensus        78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i  134 (260)
T cd06606          78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILV  134 (260)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEE
Confidence            99999964 54444332    2378999999999999999999998 999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=8.8e-20  Score=150.96  Aligned_cols=118  Identities=19%  Similarity=0.248  Sum_probs=88.6

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHc-----CCCCeeecceeeeecccCCceE-EE
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLL-----NHPNVVSLKHCFFSTTEKDELY-LN  211 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~~~~~~~-~~  211 (272)
                      .++||+|+||.||.  +..++.. +||++...    .....+|+.+++.|     .||||+++|+++.+..  ...+ +.
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~~   81 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVYD   81 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEEE
Confidence            47899999999995  6667665 69987643    34566899999999     6799999999874432  2234 44


Q ss_pred             EEeeccc---ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYIS---ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL-NYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~---~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L-~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||++   ++|.+++..     ..+++.  ..++.|++.++ +|||+ ++||||||||+|||+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl  138 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILC  138 (210)
T ss_pred             EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEE
Confidence            7899955   466555532     235554  35577888888 99998 999999999999986

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.82  E-value=6.4e-20  Score=155.46  Aligned_cols=120  Identities=22%  Similarity=0.389  Sum_probs=98.4

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      ++||+|+||.||++.+.. ++.||+|.+...     ...+.+|+++++.+.|+||+++++++.     ...+.|+||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence            368999999999999877 999999987643     223457999999999999999999874     334489999999


Q ss_pred             ccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          218 SET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++ +.+++..   ....+++..+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus        75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili  126 (251)
T cd05041          75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLV  126 (251)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEE
Confidence            855 4443322   23457888889999999999999998 899999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.82  E-value=6.8e-20  Score=156.38  Aligned_cols=118  Identities=29%  Similarity=0.473  Sum_probs=98.6

Q ss_pred             eccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       145 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      ||.|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++.+.     +..++|++|||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence            699999999999999889999999985422       23457999999999999999999873     334589999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          218 SE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++ ++.+++..    ...+++..+..++.||+.||.|||+ ++++|+||+|+||++
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv  126 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLL  126 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEE
Confidence            85 44443322    3458889999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.82  E-value=1e-19  Score=158.34  Aligned_cols=131  Identities=24%  Similarity=0.381  Sum_probs=105.7

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcC-CCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....+|.+.+.||.|+||.||+|.+..+++.||||.+....     .....|+.++..+. ||||++++++|.     ..
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~   86 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TD   86 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cC
Confidence            34457999999999999999999999889999999986431     12235666666664 999999999984     34


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|++|||+++.+..+....   ...+++..+..++.||+.||.|||+..+|+||||+|+|||+
T Consensus        87 ~~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill  148 (296)
T cd06618          87 SDVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL  148 (296)
T ss_pred             CeEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE
Confidence            459999999988766654432   34788899999999999999999963599999999999985

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.82  E-value=1.3e-19  Score=154.30  Aligned_cols=126  Identities=34%  Similarity=0.527  Sum_probs=106.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +|.+.+.||.|+||.||+|.+..+++.||||.+...     ...+.+|+.++..++|+||+++++++..     ...+++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEEE
Confidence            588999999999999999999999999999988654     2345589999999999999999998843     345999


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+++ ++..++..    ...+++..+..++.|++.||.|||+..+++|+||+|+||++
T Consensus        77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~  133 (264)
T cd06623          77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI  133 (264)
T ss_pred             EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE
Confidence            9999995 55444332    35689999999999999999999952799999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.82  E-value=6.8e-20  Score=157.70  Aligned_cols=125  Identities=34%  Similarity=0.555  Sum_probs=106.5

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      |.+.+.||+|+||.||+|.+..+++.||+|.+....      .....|+.+++.++|+||+++++++..     ..++++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence            567789999999999999999999999999886431      233479999999999999999998843     345999


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+++++..++...   ...+++..+..++.|++.||.|||+ .+|+|+||+|+||++
T Consensus        76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~  131 (282)
T cd07829          76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILI  131 (282)
T ss_pred             EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEE
Confidence            9999998877665432   2468899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.82  E-value=5.4e-20  Score=157.02  Aligned_cols=127  Identities=25%  Similarity=0.435  Sum_probs=105.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +|...+.||.|+||.||++.+..+++.||+|.+....     ..+.+|+++++.+.||||+++++++..     ..++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence            4778899999999999999999999999999886432     234579999999999999999998843     355999


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||+++ ++.+++..   ....+++..+..++.|++.||.|||+..+++|+||||+||++
T Consensus        77 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~  134 (265)
T cd06605          77 CMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV  134 (265)
T ss_pred             EEEecCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE
Confidence            9999994 55444332   126788999999999999999999963799999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.82  E-value=8.7e-20  Score=155.55  Aligned_cols=120  Identities=33%  Similarity=0.473  Sum_probs=95.3

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccch-------hHHHHHHH-HHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQI-MRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-------~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||.|+||.||+|.+..+++.||||.+.....       ....|..+ ...+.|+||++++++|.     ...++|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence            568999999999999999999999998854311       11234433 44558999999999883     344699999


Q ss_pred             ecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++.+ .++..    ...+++..+..++.||+.||.|||+ .+|+|+||+|+|||+
T Consensus        77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~  130 (260)
T cd05611          77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLI  130 (260)
T ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEE
Confidence            99986544 43332    3468899999999999999999998 899999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=7.4e-20  Score=149.69  Aligned_cols=120  Identities=18%  Similarity=0.261  Sum_probs=90.8

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeeccch------------------------------hHHHHHHHHHHcCCCC
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------------------YKNRELQIMRLLNHPN  191 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------------------------------~~~~E~~~l~~l~h~n  191 (272)
                      .+.||+|+||.||+|.+. +|+.||||++.....                              ....|...+..+.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 899999999864310                              1246889999999998


Q ss_pred             eeecceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCee
Q 024091          192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL  271 (272)
Q Consensus       192 Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NIL  271 (272)
                      |.....+..  . .    .||||||+++..+....  . ....++...+..++.|++.+|.|||+..||+||||||+|||
T Consensus        81 i~~p~~~~~--~-~----~~lVmE~~~g~~~~~~~--l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl  150 (190)
T cd05145          81 VPVPEPILL--K-K----NVLVMEFIGDDGSPAPR--L-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL  150 (190)
T ss_pred             CCCceEEEe--c-C----CEEEEEEecCCCchhhh--h-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence            855443321  1 1    47999999976322110  1 12356778889999999999999996369999999999998


Q ss_pred             C
Q 024091          272 M  272 (272)
Q Consensus       272 l  272 (272)
                      +
T Consensus       151 l  151 (190)
T cd05145         151 Y  151 (190)
T ss_pred             E
Confidence            5

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.82  E-value=9.7e-20  Score=159.61  Aligned_cols=126  Identities=28%  Similarity=0.460  Sum_probs=105.9

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .|...+.||+|+||.||+|.+..+++.||||.+....       ....+|+++++.++|+|++++++++..     ....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence            4888899999999999999999899999999885321       123469999999999999999998843     3458


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.+++..++..   ....+++..+..++.|++.||.|||+ .+++||||||+|||+
T Consensus        91 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~  148 (308)
T cd06634          91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILL  148 (308)
T ss_pred             EEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEE
Confidence            99999999887665432   23458889999999999999999998 899999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.82  E-value=1.3e-19  Score=155.14  Aligned_cols=129  Identities=24%  Similarity=0.402  Sum_probs=102.5

Q ss_pred             eeeeEEeccCCceEEEEEEECC-CCCEEEEEEeeccc--------------hhHHHHHHHHHH-cCCCCeeecceeeeec
Q 024091          139 YMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK--------------RYKNRELQIMRL-LNHPNVVSLKHCFFST  202 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~--------------~~~~~E~~~l~~-l~h~nIv~l~~~~~~~  202 (272)
                      |.+.+.||+|+||.||++.+.. +++.+|+|.+....              ....+|+.++.. ++||||++++++|.  
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~--   79 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL--   79 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc--
Confidence            7888999999999999999887 68899999874211              112357777764 78999999999883  


Q ss_pred             ccCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                         ...+.|++|||+.+ ++.+++.........+++..++.++.|++.||.|||+..+|+|+||+|+|||+
T Consensus        80 ---~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~  147 (269)
T cd08528          80 ---ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML  147 (269)
T ss_pred             ---cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE
Confidence               34469999999985 55555544334455689999999999999999999953689999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.82  E-value=1.3e-19  Score=157.03  Aligned_cols=125  Identities=29%  Similarity=0.487  Sum_probs=101.7

Q ss_pred             CeeeeEEeccCCceEEEEEEEC---CCCCEEEEEEeecc--------chhHHHHHHHHHHc-CCCCeeecceeeeecccC
Q 024091          138 SYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~--------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  205 (272)
                      +|.+.+.||+|+||.||++.+.   .+++.||||.++..        .....+|++++..+ +||||++++++|     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            3888999999999999999864   46788999988642        12234799999999 599999999887     3


Q ss_pred             CceEEEEEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....+|+||||+.++.+ ..+.    ....+++..++.++.|++.||.|||+ .+++|+||||+|||+
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~  138 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILL  138 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEE
Confidence            44458999999986543 3222    23568889999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.82  E-value=5.9e-20  Score=157.23  Aligned_cols=123  Identities=20%  Similarity=0.323  Sum_probs=97.3

Q ss_pred             EeccCCceEEEEEEECCCC------CEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          144 VVGTGSFGVVFQAKCLETG------DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~~~~~------~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .||+|+||.||+|.+....      +.+|||.+...     ...+.+|+++++.++||||++++++|..     ..+.++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQYI   76 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeEE
Confidence            6899999999999876433      68999987543     2234579999999999999999998743     334899


Q ss_pred             Eeecccc-cHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+++ .+...+.....   ....+++..+..++.|++.||.|||+ .+++|+||||+|||+
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~  139 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLV  139 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEE
Confidence            9999985 55554433211   12347788899999999999999998 899999999999985

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.82  E-value=1.2e-19  Score=154.79  Aligned_cols=122  Identities=24%  Similarity=0.380  Sum_probs=94.5

Q ss_pred             EEeccCCceEEEEEEECC---CCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~---~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||.||+|.+..   .+..||||.+...     ...+.+|+.+++.++||||+++++++...    ....+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            368999999999998754   3457999987432     12345799999999999999999876432    22378999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.+ ++..++..   ....+.+..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus        77 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili  131 (262)
T cd05058          77 PYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCML  131 (262)
T ss_pred             ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEE
Confidence            99985 44444332   23345677788899999999999998 899999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.82  E-value=7.5e-21  Score=184.22  Aligned_cols=129  Identities=29%  Similarity=0.531  Sum_probs=107.0

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....+|.-..+||.|.||.||-|.+..+|+..|+|.++-+      ...+.+|..++..|+|||+|++||+-.....   
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek--- 1308 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK--- 1308 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH---
Confidence            3345788889999999999999999999999999987532      3345689999999999999999997543333   


Q ss_pred             eEEEEEeecccccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ++|.||||.++.+. ++.+    .+..++...+.|..|++.|+.|||+ .|||||||||+||||
T Consensus      1309 --v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~L 1367 (1509)
T KOG4645|consen 1309 --VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILL 1367 (1509)
T ss_pred             --HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceee
Confidence              89999999966554 3332    4457778888899999999999998 999999999999986

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.81  E-value=1.9e-19  Score=154.70  Aligned_cols=124  Identities=23%  Similarity=0.284  Sum_probs=97.2

Q ss_pred             CeeeeEEe--ccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVV--GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~l--G~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      .|.+.+.+  |.|+||.||++.+..++..+|+|.+..... ...|+.+...+ +||||++++++|..     ..++|+||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~iv~   88 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVLIM   88 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEEEE
Confidence            35555554  999999999999999999999998864321 12244444333 69999999999843     33599999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+++ ++..++..    ...+++..+..++.||+.||.|||+ .+|+||||||+||++
T Consensus        89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~  142 (267)
T PHA03390         89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLY  142 (267)
T ss_pred             EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEE
Confidence            99985 55544432    3378999999999999999999998 899999999999985

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.81  E-value=3.6e-19  Score=149.94  Aligned_cols=126  Identities=30%  Similarity=0.488  Sum_probs=106.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .|.+.+.||.|+||.||++.+..+++.|++|.+....    ....+|+.+++.+.|+||++++++|...     ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence            3788899999999999999998889999999986543    3456899999999999999999987433     448999


Q ss_pred             eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+++ ++.+++..   ....+++..+..++.|++.||.|||+ .+++|+||+|+||++
T Consensus        76 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i  131 (253)
T cd05122          76 MEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILL  131 (253)
T ss_pred             EecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEE
Confidence            999995 44443322   12568999999999999999999998 999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.81  E-value=2.7e-19  Score=154.78  Aligned_cols=128  Identities=29%  Similarity=0.413  Sum_probs=108.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ...|.....||.|+||.||++.+..++..||+|.+....   ..+.+|+++++.++|+||++++++|...     .+.|+
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l   92 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWV   92 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEE
Confidence            345888899999999999999998889999999986543   3455799999999999999999988543     45999


Q ss_pred             Eeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||++ +++.+++...   ...+++..+..++.|++.||.|||+ .||+|+||+|+||++
T Consensus        93 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i  149 (286)
T cd06614          93 VMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILL  149 (286)
T ss_pred             EEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEE
Confidence            999999 5555544432   1368899999999999999999998 999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.81  E-value=1.1e-19  Score=158.16  Aligned_cols=124  Identities=27%  Similarity=0.346  Sum_probs=102.2

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      |.....||+|+||.||++....+++.||||.+...    ...+.+|+.+++.++|+||++++++|.     ...+.|++|
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEE
Confidence            33346799999999999999999999999987432    223457999999999999999999884     344599999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++.+..+..    ...+++..+..++.|++.||.|||+ .+|+|+||+|+||++
T Consensus        97 e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv  149 (292)
T cd06657          97 EFLEGGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILL  149 (292)
T ss_pred             ecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            9999765542221    3457889999999999999999998 899999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.81  E-value=1.3e-19  Score=152.82  Aligned_cols=114  Identities=23%  Similarity=0.304  Sum_probs=94.2

Q ss_pred             CCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecccc-cHHHHHH
Q 024091          148 GSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSK  226 (272)
Q Consensus       148 G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~  226 (272)
                      |.||.||++++..+++.||+|.+.... ...+|...+....||||+++++++.     ...++|++|||+.+ .+.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence            899999999999999999999986543 2345666666678999999999883     34459999999995 4544443


Q ss_pred             HhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          227 HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       227 ~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .    ...+++..+..++.|++.||.|||+ .+|+||||||+||++
T Consensus        78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~  118 (237)
T cd05576          78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILL  118 (237)
T ss_pred             H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEE
Confidence            2    2358899999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.81  E-value=4.2e-20  Score=153.46  Aligned_cols=131  Identities=24%  Similarity=0.391  Sum_probs=105.4

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchh-----HHHHHHHHHHc-CCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-----KNRELQIMRLL-NHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-----~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ........+..||.|+.|.||+++.+.+|..+|||.+......     ....+.++.+. +.|+||+.+|+|+....   
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d---  165 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD---  165 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch---
Confidence            3344566778899999999999999999999999999653221     12344444443 48999999999987766   


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        +++.||+|......+++.   ..+++|+..+.++...++.||.||...++|||||+||+||||
T Consensus       166 --V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl  225 (391)
T KOG0983|consen  166 --VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL  225 (391)
T ss_pred             --HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE
Confidence              899999998666555443   356799999999999999999999976899999999999996

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.81  E-value=1.9e-19  Score=157.85  Aligned_cols=123  Identities=24%  Similarity=0.356  Sum_probs=94.7

Q ss_pred             eeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       140 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .+.+.+|.|  |.||++++..+++.||||.+...      ...+.+|+.+++.++|+||++++++|..     ..+.|++
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~   77 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVV   77 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEE
Confidence            344444444  55566666669999999998543      1245689999999999999999998843     3448999


Q ss_pred             eeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||++++ +..++...  ....+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        78 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili  134 (314)
T cd08216          78 SPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILL  134 (314)
T ss_pred             EeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEE
Confidence            9999955 44444322  23458899999999999999999998 899999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=2e-19  Score=153.05  Aligned_cols=128  Identities=24%  Similarity=0.374  Sum_probs=111.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEee--ccchhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL--QDKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      -..|+++++||+|+||.+++|.+.-+++.||||.-.  .+..+...|-...+.|. .++|..+|-+-     ..+.|-.|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNIL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhh
Confidence            346999999999999999999999999999999753  34566778999999886 68888876433     55667789


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+++.+|.+++..|   ...|+...+..++.|++.-++|+|. +.+|.|||||+|+||
T Consensus       102 VidLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLI  157 (449)
T KOG1165|consen  102 VIDLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLI  157 (449)
T ss_pred             hhhhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceee
Confidence            9999999999988766   4679999999999999999999998 999999999999996

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.81  E-value=4.3e-19  Score=153.80  Aligned_cols=123  Identities=29%  Similarity=0.419  Sum_probs=101.8

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      |.....||+|+||.||++.+..+++.+|+|.+...    .....+|+.+++.+.||||++++++|.     ...+.|+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v~   95 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVVM   95 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEEE
Confidence            55567999999999999999889999999987532    223457999999999999999999874     334589999


Q ss_pred             ecccccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++.+. ++..     ..+++..+..++.|++.||.|||+ .+|+||||+|+||++
T Consensus        96 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~  148 (285)
T cd06648          96 EFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILL  148 (285)
T ss_pred             eccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEE
Confidence            999865443 3221     457888999999999999999998 999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.81  E-value=2.1e-19  Score=162.33  Aligned_cols=126  Identities=24%  Similarity=0.349  Sum_probs=99.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ...+.++||+|-||.|.+|.- ..+..||||.++.+     ...+.+||++|.+|+|||||.|+++|..+..     +||
T Consensus       539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----icm  612 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LCM  612 (807)
T ss_pred             heehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hHH
Confidence            467789999999999999985 33689999999753     3455689999999999999999999976665     999


Q ss_pred             Eeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++||+..+ +-.++.... ... +.......|+.||+.||.||.+ .++|||||.+.|||+
T Consensus       613 I~EYmEnGDLnqFl~ahe-apt-~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv  670 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHE-LPT-AETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLV  670 (807)
T ss_pred             HHHHHhcCcHHHHHHhcc-Ccc-cccchhHHHHHHHHHHHHHHHh-hchhhccccccceee
Confidence            99999954 433333221 111 2223344589999999999998 999999999999996

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.81  E-value=4.6e-20  Score=147.63  Aligned_cols=132  Identities=21%  Similarity=0.423  Sum_probs=111.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHH-HHcCCCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .+....+..||+|++|.|-+-++..+|...|+|.++...     +..-+|+.+. +...+|++|++||.++....     
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-----  119 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-----  119 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-----
Confidence            334555678999999999999999999999999986422     2223566654 44569999999999866554     


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||.||.|.-++..+.++.....+.+++..+..|+..|+.||+|||+...|||||+||+||||
T Consensus       120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI  182 (282)
T KOG0984|consen  120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI  182 (282)
T ss_pred             EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE
Confidence            999999999988888888888889999999999999999999999986799999999999996

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.81  E-value=3e-19  Score=151.00  Aligned_cols=118  Identities=34%  Similarity=0.544  Sum_probs=99.7

Q ss_pred             eccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecc
Q 024091          145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       145 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      ||.|+||.||++.+..+++.||+|.+....       .....|+.+++.+.|+||+++++.+     ....++|++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            699999999999998889999999886432       2455799999999999999999887     4555699999999


Q ss_pred             c-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          218 S-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       218 ~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      . +.+.+.+..    ...+++..+..++.|++.||.|||+ .+++|+||+|+||++
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~  126 (250)
T cd05123          76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILL  126 (250)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEE
Confidence            6 555544332    3468899999999999999999998 999999999999985

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.80  E-value=2.2e-19  Score=173.79  Aligned_cols=131  Identities=23%  Similarity=0.394  Sum_probs=106.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCC-C----CEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLET-G----DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~----~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      .....+.+.||+|+||.||.|+.... +    ..||||.+...     ...+-+|..+|+.++|||||+++|.++.... 
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC-
Confidence            34577889999999999999988653 2    24999988653     3345589999999999999999999976443 


Q ss_pred             CceEEEEEeeccc-ccHHHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYIS-ETVYRVSKHYTRM---NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          .+|++|||. |+|+.+++.....   ...++...+..++.+|++|+.||++ +++|||||..+|+||
T Consensus       770 ----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL  835 (1025)
T KOG1095|consen  770 ----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLL  835 (1025)
T ss_pred             ----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheee
Confidence                889999999 5666666543111   3457888999999999999999998 899999999999996

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=2.7e-19  Score=157.08  Aligned_cols=128  Identities=26%  Similarity=0.398  Sum_probs=103.9

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEee-ccchhHHHHHHHHH--HcCCCCeeecceeeeecccCCceEEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQIMR--LLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~-~~~~~~~~E~~~l~--~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ....+.+.||+|.||.||+|.+  .|+.||||++. .+...+.+|.+|.+  .|+|+||+.|++.=..++ ..-..+|||
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwLv  287 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWLV  287 (513)
T ss_pred             heeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEEe
Confidence            3578899999999999999998  68999999984 35566777777766  579999999887643333 344569999


Q ss_pred             eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-------cCCceecCCCCCCeeC
Q 024091          214 LEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-------VVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~-------~~~iiHrDlKp~NILl  272 (272)
                      .+|.+ |+|++++..     ..++......++..++.||.+||-       .-.|.|||||..||||
T Consensus       288 TdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV  349 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV  349 (513)
T ss_pred             eecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence            99999 676665543     458888899999999999999994       1259999999999996

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.80  E-value=7.3e-21  Score=157.34  Aligned_cols=130  Identities=25%  Similarity=0.417  Sum_probs=106.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHH-HHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQI-MRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +.+-+..||.|+||+|++-.++.+|+.+|||.|+...     ..+..|.+. ++.-+.||||++||..|..+.     .|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----cW  139 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----CW  139 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----ee
Confidence            3445678999999999999999999999999996432     223346654 455579999999999877665     89


Q ss_pred             EEeecccccHHHHHHH-hhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKH-YTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |.||+|+-++..+.+. +......+++..+..|+..++.||+||.....|||||+||+||||
T Consensus       140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl  201 (361)
T KOG1006|consen  140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL  201 (361)
T ss_pred             eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE
Confidence            9999999887766553 344456799999999999999999999976799999999999996

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=1.7e-21  Score=160.14  Aligned_cols=131  Identities=31%  Similarity=0.495  Sum_probs=108.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--c----hhHHHHHHHHHHcCCCCeeecceeeee---cccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--K----RYKNRELQIMRLLNHPNVVSLKHCFFS---TTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~----~~~~~E~~~l~~l~h~nIv~l~~~~~~---~~~~~~~  208 (272)
                      .|.-..+||+|.||.||+|+...+|+.||+|++..+  +    ...-+|+.+|..|+|+|++.+++.|-.   ....+..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            477788999999999999999999999999976432  1    123489999999999999988887632   3333455


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+||||.+|..++..++..   ....++...+..++.+++.||.|+|+ ..|+|||+||+|+||
T Consensus        98 t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLI  157 (376)
T KOG0669|consen   98 TFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLI  157 (376)
T ss_pred             eeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEE
Confidence            6999999999887765433   34578999999999999999999999 899999999999986

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.79  E-value=5e-19  Score=166.90  Aligned_cols=134  Identities=24%  Similarity=0.318  Sum_probs=90.2

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCC----CCEEEEEEeeccchhHHHHHHHHH---HcCCCCeeecceeeeeccc-CC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLET----GDSVAIKKVLQDKRYKNRELQIMR---LLNHPNVVSLKHCFFSTTE-KD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~----~~~vAvK~i~~~~~~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~-~~  206 (272)
                      ...+|.+.+.||+|+||.||+|++..+    +..||||.+.....   .|+.+..   ...+.+++.++..|..... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            456799999999999999999999888    89999998753221   2222222   2233444444333322111 34


Q ss_pred             ceEEEEEeeccccc-HHHHHHHhhh----------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 024091          207 ELYLNLVLEYISET-VYRVSKHYTR----------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN  269 (272)
Q Consensus       207 ~~~~~lv~e~~~~~-l~~~~~~~~~----------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~N  269 (272)
                      ...++|||||++++ +.+++.....                .........+..++.||+.||.|||+ ++||||||||+|
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~N  285 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQN  285 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHH
Confidence            45589999999954 5444432110                00011234466799999999999998 999999999999


Q ss_pred             eeC
Q 024091          270 LLM  272 (272)
Q Consensus       270 ILl  272 (272)
                      |||
T Consensus       286 ILl  288 (566)
T PLN03225        286 IIF  288 (566)
T ss_pred             EEE
Confidence            985

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=1.4e-18  Score=156.17  Aligned_cols=125  Identities=24%  Similarity=0.379  Sum_probs=101.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .|.+++.||.||.+.||++.... ...+|+|.+...      .....+|+.+|.+|+ |.+||+||++-+     ...|+
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-----~d~~l  435 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-----TDGYL  435 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-----cCceE
Confidence            49999999999999999998543 455666655321      223458999999997 999999999863     35679


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||-+.+|-.++....   ...+..++++|.+|+|.|+.++|+ .||||.||||.|+||
T Consensus       436 YmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLl  493 (677)
T KOG0596|consen  436 YMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLL  493 (677)
T ss_pred             EEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEE
Confidence            9999999988887776543   334445899999999999999998 999999999999985

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=1.5e-18  Score=153.41  Aligned_cols=128  Identities=23%  Similarity=0.285  Sum_probs=106.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCC-CEEEEEEeeccc----hhHHHHHHHHHHcCC----CCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETG-DSVAIKKVLQDK----RYKNRELQIMRLLNH----PNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~-~~vAvK~i~~~~----~~~~~E~~~l~~l~h----~nIv~l~~~~~~~~~~~~~  208 (272)
                      +|.+.+.||+|+||.||++.+..++ ..+|+|......    .....|+.++..+..    +++..+++.+.    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999987774 679999775431    146689999999873    57777766552    3556


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |-||||+.++.+|.++.....  .+.++...+..++.|++.+|++||+ .|+|||||||+|+++
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~  155 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVV  155 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeee
Confidence            789999999999988665443  5789999999999999999999998 999999999999975

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.78  E-value=4.6e-19  Score=161.19  Aligned_cols=125  Identities=30%  Similarity=0.515  Sum_probs=100.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCC--C--CEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLET--G--DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~--~--~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ...+.++||+|-||.||+|.+...  |  -.||||.-+.+     ...+..|.-+|+.++|||||+|+|.+....     
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-----  464 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-----  464 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-----
Confidence            455678899999999999987543  3  35888876542     333457999999999999999999984433     


Q ss_pred             EEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       +|||||+++-+ |-.+++   .....++...+..|++|||.||.|||+ ..+|||||..+||||
T Consensus       465 -~WivmEL~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLV  524 (974)
T KOG4257|consen  465 -MWIVMELAPLGELREYLQ---QNKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILV  524 (974)
T ss_pred             -eeEEEecccchhHHHHHH---hccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheee
Confidence             89999999944 433332   334568888899999999999999998 999999999999996

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.78  E-value=4.8e-19  Score=158.15  Aligned_cols=128  Identities=34%  Similarity=0.464  Sum_probs=112.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchh---HHHHHHHHHHcC------CCCeeecceeeeecccCCce
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY---KNRELQIMRLLN------HPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~---~~~E~~~l~~l~------h~nIv~l~~~~~~~~~~~~~  208 (272)
                      +|.+....|+|-|+.|..|.+...|..||||+|....-.   -..|++||++|+      --++++|+..|     ...+
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hkn  507 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHKN  507 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhcc
Confidence            688888899999999999999999999999999865433   347999999996      34789998888     5666


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||+|-+..+|-.+++.+...- .+.+..++.|+.|+..||..|.. +||+|.||||.||||
T Consensus       508 HLClVFE~LslNLRevLKKyG~nv-GL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLV  569 (752)
T KOG0670|consen  508 HLCLVFEPLSLNLREVLKKYGRNV-GLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILV  569 (752)
T ss_pred             eeEEEehhhhchHHHHHHHhCccc-ceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEe
Confidence            799999999999999998887643 48889999999999999999998 999999999999996

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.78  E-value=3.5e-20  Score=169.42  Aligned_cols=128  Identities=26%  Similarity=0.413  Sum_probs=110.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|.++..+|.|+||.||+|++..+++..|+|+++-+    ....+.|+-+++.++|||||.|++.|....     .+|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcE
Confidence            34699999999999999999999999999999999753    334568999999999999999999984443     399


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++||||+++.++   ......+++++..+.+..++.+.||.|||+ .|-+|||||-.|||+
T Consensus        89 icMEycgggslQ---diy~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanill  145 (829)
T KOG0576|consen   89 ICMEYCGGGSLQ---DIYHVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILL  145 (829)
T ss_pred             EEEEecCCCccc---ceeeecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceee
Confidence            999999976654   233447789999999999999999999998 899999999999986

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.78  E-value=3.3e-19  Score=162.13  Aligned_cols=127  Identities=23%  Similarity=0.394  Sum_probs=109.0

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.....+||-|.||.||.|.|+.-...||||.++.+   ...+..|+.+|+.++|||+|+|+|+|....     -+|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PFYIiT  342 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PFYIIT  342 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----CeEEEE
Confidence            345567899999999999999988889999999765   345568999999999999999999994433     389999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||. |+|++.++.+.+  ..++...++.++.||..||+||.. +++|||||..+|+||
T Consensus       343 EfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLV  398 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV  398 (1157)
T ss_pred             ecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccc
Confidence            9998 899988877653  446777788899999999999998 999999999999986

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.5e-20  Score=156.26  Aligned_cols=130  Identities=31%  Similarity=0.464  Sum_probs=103.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      +..-.+.||.|+||.||-.++..+|+.||+|.+..-      -+...+|+.+|..++|.|++..++......-..-..+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            445568899999999999999999999999987532      23345899999999999999888765322211111267


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++.|+|..++..+    ....++++...++-+.+||++||.|||+ .+|.||||||.|+|+
T Consensus       134 V~TELmQSDLHKI----IVSPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLV  189 (449)
T KOG0664|consen  134 VLTELMQSDLHKI----IVSPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLV  189 (449)
T ss_pred             HHHHHHHhhhhhe----eccCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEe
Confidence            8888888776543    3346788889999999999999999998 899999999999986

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=2.5e-20  Score=165.83  Aligned_cols=126  Identities=24%  Similarity=0.366  Sum_probs=106.1

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .++..+..||-|+||.|-+.........+|+|++++.       ......|-+||..+..|+||++|..|     ++..|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence            3577788899999999998887655556999988542       22334799999999999999999998     88899


Q ss_pred             EEEEeecc-cccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||+||-| +|.++.+++.    .+.|....+++|+.+++.|++|||+ +|||.|||||+|+||
T Consensus       495 vYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllL  553 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLL  553 (732)
T ss_pred             hhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheee
Confidence            99999965 5777776655    4668888999999999999999998 999999999999986

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.77  E-value=2.4e-19  Score=164.81  Aligned_cols=126  Identities=26%  Similarity=0.369  Sum_probs=104.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCC-C--CEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLET-G--DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~-~--~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ...+.++||+|.||.|++|.|... |  -.||||+++.+     ...+.+|+.+|.+|+|+|+|+|||.....      -
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------P  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------h
Confidence            466778999999999999998653 3  36999999754     34466899999999999999999987432      2


Q ss_pred             EEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +.||||++. |+|++.+..  .....|....+..|+.||+.||.||.. +++|||||..+||||
T Consensus       185 ~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlll  245 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLL  245 (1039)
T ss_pred             hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhhee
Confidence            789999999 666665544  345678888889999999999999998 999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.77  E-value=5.2e-18  Score=157.07  Aligned_cols=137  Identities=24%  Similarity=0.310  Sum_probs=96.0

Q ss_pred             cccCeeeeEEeccCCceEEEEEEEC----------------CCCCEEEEEEeeccc------------------hhHHHH
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCL----------------ETGDSVAIKKVLQDK------------------RYKNRE  180 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~----------------~~~~~vAvK~i~~~~------------------~~~~~E  180 (272)
                      ...+|.+.++||+|+||.||+|.+.                ..++.||||.+....                  .....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4567999999999999999999753                234679999875321                  111246


Q ss_pred             HHHHHHcCCCCe-----eecceeeeeccc---CCceEEEEEeecccc-cHHHHHHHhh-----------h---------c
Q 024091          181 LQIMRLLNHPNV-----VSLKHCFFSTTE---KDELYLNLVLEYISE-TVYRVSKHYT-----------R---------M  231 (272)
Q Consensus       181 ~~~l~~l~h~nI-----v~l~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~~~~~~-----------~---------~  231 (272)
                      +.++..+.|.++     ++++++|.....   ......||||||+++ ++.+++....           .         .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776654     667776643211   122348999999995 4444433210           0         0


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       232 ~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+.+..++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl  342 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLV  342 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEE
Confidence            1234567788899999999999998 899999999999985

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.7e-18  Score=158.10  Aligned_cols=128  Identities=28%  Similarity=0.436  Sum_probs=105.9

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ....|.+...+|.|+|+.|..+.+..+++.+|+|++.+......+|+.++... .||||+++.+.|     .+..++|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence            35678888999999999999999999999999999987766777888666555 699999999998     667779999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++.|+.+-  .. ......+. ..+..|+.||+.|+.|||. +|||||||||+|||+
T Consensus       395 ~e~l~g~ell--~r-i~~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~  448 (612)
T KOG0603|consen  395 MELLDGGELL--RR-IRSKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILL  448 (612)
T ss_pred             ehhccccHHH--HH-HHhcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheee
Confidence            9999976542  11 11122233 6778899999999999998 999999999999996

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=2.5e-18  Score=145.24  Aligned_cols=124  Identities=17%  Similarity=0.149  Sum_probs=91.3

Q ss_pred             CeeeeEEeccCCceEEEEEE-ECCCCCEEEEEEeeccc----------------------------hhHHHHHHHHHHcC
Q 024091          138 SYMAERVVGTGSFGVVFQAK-CLETGDSVAIKKVLQDK----------------------------RYKNRELQIMRLLN  188 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~-~~~~~~~vAvK~i~~~~----------------------------~~~~~E~~~l~~l~  188 (272)
                      -|.+.+.||+|+||.||+|. +..+|+.||||++....                            ....+|+++++.+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            38889999999999999998 66789999999886321                            11347999999997


Q ss_pred             CCCeeecceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-ceecCCCC
Q 024091          189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-VCHRDIKP  267 (272)
Q Consensus       189 h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~-iiHrDlKp  267 (272)
                      +.+ +.+...+.. . .    .++||||+++..+...   ......+....+..++.||+.+|.|||+ .| |+||||||
T Consensus       109 ~~~-i~~p~~~~~-~-~----~~lV~E~~~g~~L~~~---~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp  177 (237)
T smart00090      109 EAG-VPVPKPIAW-R-R----NVLVMEFIGGDGLPAP---RLKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE  177 (237)
T ss_pred             hcC-CCCCeeeEe-c-C----ceEEEEEecCCccccc---ccccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence            633 222222211 1 1    4799999998654321   1112345556677899999999999998 89 99999999


Q ss_pred             CCeeC
Q 024091          268 QNLLM  272 (272)
Q Consensus       268 ~NILl  272 (272)
                      +|||+
T Consensus       178 ~NIli  182 (237)
T smart00090      178 YNILV  182 (237)
T ss_pred             hhEEE
Confidence            99985

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.76  E-value=8.1e-19  Score=153.14  Aligned_cols=125  Identities=29%  Similarity=0.522  Sum_probs=104.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECC---CCCEEEEEEeec--cchhHHHHHHHHHHcC-CCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQ--DKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vAvK~i~~--~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ...|....+||+|+|++||++.+..   ..+.||+|.+..  ......+|+++|..+. +.||+++.+++     +....
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd~  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNNDQ  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCCe
Confidence            3458999999999999999998877   788999998843  3455678999999986 99999999998     66667


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++||||++..-..-+      ...++...++.|++.++.||.|+|. +|||||||||.|+|.
T Consensus       110 v~ivlp~~~H~~f~~l------~~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~  165 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDL------YRSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLY  165 (418)
T ss_pred             eEEEecccCccCHHHH------HhcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCcccccc
Confidence            9999999996432211      1236678899999999999999998 999999999999984

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.75  E-value=1.3e-18  Score=161.64  Aligned_cols=127  Identities=24%  Similarity=0.385  Sum_probs=104.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCC---CEEEEEEeec-----cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~---~~vAvK~i~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ...+.++||.|.||.|++|+.+..+   ..||||.++.     ++..+..|+.||-+++||||++|-|+..     ...-
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT-----ks~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT-----KSKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe-----cCce
Confidence            3568899999999999999987655   4699999964     3445557999999999999999999873     3334


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +.||.|||.++.++-+..  ...+.|+...+.-+++.|+.||.||-+ .++|||||.++||||
T Consensus       705 vMIiTEyMENGsLDsFLR--~~DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILV  764 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLR--QNDGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILV  764 (996)
T ss_pred             eEEEhhhhhCCcHHHHHh--hcCCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheee
Confidence            899999999665553322  234668888888899999999999998 799999999999996

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=3e-18  Score=146.16  Aligned_cols=130  Identities=28%  Similarity=0.482  Sum_probs=108.8

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHc-CCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  205 (272)
                      ....+|.++++||+|+|.+|.+++...|.+.+|+|+++++       -.+.+.|-.+.... +||++|-|..||     +
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----q  321 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----Q  321 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----c
Confidence            4455799999999999999999999999999999998653       23344566666554 699999999998     5


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+..+++|.||++|+.+-+.   ......+|+..+++|..+|+.||.|||+ +|||.||||.+|+||
T Consensus       322 tesrlffvieyv~ggdlmfh---mqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvll  384 (593)
T KOG0695|consen  322 TESRLFFVIEYVNGGDLMFH---MQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLL  384 (593)
T ss_pred             ccceEEEEEEEecCcceeee---hhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEE
Confidence            55669999999998755432   2335679999999999999999999998 999999999999986

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.75  E-value=1.5e-18  Score=153.49  Aligned_cols=127  Identities=24%  Similarity=0.341  Sum_probs=101.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec-cchhHHHHHHHHHH--cCCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNRELQIMRL--LNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ...+.++||+|.||.||+|..  +++.||||++.. ++..+.+|-+|.+.  +.|+||++|+++--..+ .++.-++||+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEe
Confidence            466788999999999999987  569999999964 45667788888775  57999999887642222 1234589999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCceecCCCCCCeeC
Q 024091          215 EYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV--------VGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~--------~~iiHrDlKp~NILl  272 (272)
                      ||.+ |+|.++++.     ..+++....+++..+++||.|||..        ..|+|||||..||||
T Consensus       288 ~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv  349 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV  349 (534)
T ss_pred             eeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE
Confidence            9999 666665554     3488999999999999999999951        369999999999996

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.75  E-value=1.5e-18  Score=162.29  Aligned_cols=126  Identities=29%  Similarity=0.473  Sum_probs=99.4

Q ss_pred             eeeeEEeccCCce-EEEEEEECCCCCEEEEEEeeccch-hHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEEEEee
Q 024091          139 YMAERVVGTGSFG-VVFQAKCLETGDSVAIKKVLQDKR-YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       139 y~~~~~lG~G~fg-~V~~~~~~~~~~~vAvK~i~~~~~-~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      |.-.+++|.|+-| .||+|..  .|+.||||.+..+-. ..++||++|+.-+ |||||++|+.     ++++.|+||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEeh
Confidence            4445779999987 5699988  678999998876543 6789999999885 9999997754     378889999999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|..+|.+++...............+.+..|++.||.+||+ .+||||||||.||||
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI  639 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILI  639 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEE
Confidence            99999988776521101111113456778899999999998 999999999999996

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.73  E-value=3e-18  Score=159.98  Aligned_cols=124  Identities=26%  Similarity=0.454  Sum_probs=102.7

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCC----EEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .+..++||.|+||+||+|.+...|+    +||||++...     ...+-.|+-+|..|+|||+++|++++....      
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence            4556889999999999999876554    6899987532     233457999999999999999999985443      


Q ss_pred             EEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +.||++|++ |.|++.++.   ....+.....+.|.+||++||.|||. ++++||||..+|+||
T Consensus       772 ~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLV  831 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLV  831 (1177)
T ss_pred             HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheee
Confidence            779999999 677665544   34568888899999999999999998 999999999999996

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=1.3e-18  Score=151.77  Aligned_cols=128  Identities=27%  Similarity=0.373  Sum_probs=103.9

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch-------hHHHHHHHHHHcC-CCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|..+.+||+|+||+|.+|..+.+.+.+|||+++++.-       -...|-.+|+... -|.+++++.||     +.
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QT  421 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QT  421 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hh
Confidence            34468889999999999999999999999999999876432       1235777777764 67899999988     44


Q ss_pred             ceEEEEEeecccccHHHH-HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISETVYRV-SKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      -..+|+||||+.|+.+-. +++    -+.+.+..+.+|+.+|+-||-+||+ +|||.||||.+||||
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmL  483 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVML  483 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEe
Confidence            444999999999765432 222    3557788899999999999999998 999999999999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.73  E-value=5.4e-17  Score=134.51  Aligned_cols=124  Identities=35%  Similarity=0.591  Sum_probs=103.8

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      |.+.+.||.|+||.||++.+..+++.+|+|.+...     .....+|++.++.++|+|++++++++...     ...+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence            56778999999999999999888999999998643     33455799999999999999999987433     448999


Q ss_pred             eecccc-cHHHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISE-TVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~-~l~~~~~~~~~~~~~-~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|++++ .+..++..    ... +++..+..++.+++.+|.|||+ .+++|+||+|.||++
T Consensus        76 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v  131 (225)
T smart00221       76 MEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILL  131 (225)
T ss_pred             EeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            999997 55554433    222 7888899999999999999998 899999999999985

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.73  E-value=9.2e-17  Score=130.78  Aligned_cols=119  Identities=36%  Similarity=0.565  Sum_probs=100.3

Q ss_pred             eccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeeccc-
Q 024091          145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-  218 (272)
Q Consensus       145 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-  218 (272)
                      ||+|.+|.||++....+++.+++|.+....     ....+|+++++.+.|++|+++++++...     ...+++||+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence            689999999999998889999999986553     3467899999999999999999988433     45899999999 


Q ss_pred             ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          219 ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       219 ~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +.+..++...   ...+++..+..++.+++.+|.|||+ .+++|+||+|.||++
T Consensus        76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~  125 (215)
T cd00180          76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILL  125 (215)
T ss_pred             CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEE
Confidence            5555443321   1457888999999999999999998 899999999999985

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.72  E-value=3e-18  Score=142.36  Aligned_cols=127  Identities=20%  Similarity=0.310  Sum_probs=101.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +.|.+.+.||+|.||.+.+|+++.+...+++|.+...   .+.+.+|...--.| .|.||+.-|+.-+    +...++.+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF----qt~d~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF----QTSDAYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh----hcCceEEE
Confidence            3599999999999999999999999999999988643   34455676654444 4899998887654    33446889


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||++.+.+.   . .-....+.+.....++.|++.|++|+|+ +++||||||.+||||
T Consensus       100 ~qE~aP~gdL~---s-nv~~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLi  154 (378)
T KOG1345|consen  100 VQEFAPRGDLR---S-NVEAAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILI  154 (378)
T ss_pred             eeccCccchhh---h-hcCcccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEE
Confidence            99999955443   1 1123457888899999999999999998 999999999999996

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.71  E-value=6.6e-17  Score=134.75  Aligned_cols=123  Identities=14%  Similarity=0.130  Sum_probs=93.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----ch---------hHHHHHHHHHHcCCCCeeecceeeeec
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KR---------YKNRELQIMRLLNHPNVVSLKHCFFST  202 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~  202 (272)
                      .++|++.++||.|+||.||++..  ++..+|||++...    ..         +..+|+..+..|.|++|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            44799999999999999999755  4668999998532    11         145789999999999999998886543


Q ss_pred             ccC---CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          203 TEK---DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       203 ~~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...   .....+|+|||++|..+.-.   .    .+++    ....+++.+|..||+ .|++|+||||+|||+
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~---~----~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili  168 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDM---P----EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIV  168 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHh---h----hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEE
Confidence            211   12348899999998644321   1    1222    235599999999998 999999999999985

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.69  E-value=1.7e-17  Score=140.59  Aligned_cols=129  Identities=28%  Similarity=0.453  Sum_probs=104.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec------cchhHHHHHHHHHHcCCCCeeecceeeeeccc-CCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~  208 (272)
                      ..+|.-+..+|.|.- .|.-|.+.-.++.||+|.+..      ..+...+|..++..+.|+||++++.+|..... ....
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            347999999999998 788888888899999998743      23445689999999999999999998843221 1223


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|+|||+|..++-..+.      -.+.-..+..+++|+|+|+.|||+ .||+||||||+||++
T Consensus        95 e~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv  151 (369)
T KOG0665|consen   95 EVYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVV  151 (369)
T ss_pred             hHHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCccccee
Confidence            489999999988876554      125567789999999999999998 899999999999986

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=2.5e-16  Score=130.47  Aligned_cols=114  Identities=20%  Similarity=0.325  Sum_probs=86.9

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc------------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      +.||+|++|.||+|.+  .+..|++|......            ....+|+.++..+.|++|.....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5799999999999987  67789999754211            12347999999999999877665553332     26


Q ss_pred             EEEeecccccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++|||++|..+. ++..    .   .. ....++.+++.+|.+||+ .+++|+|++|+|||+
T Consensus        75 ~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~  128 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMIL  128 (211)
T ss_pred             EEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEE
Confidence            8999999875443 3221    1   11 567889999999999998 999999999999985

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.66  E-value=8.6e-16  Score=128.29  Aligned_cols=114  Identities=38%  Similarity=0.601  Sum_probs=95.6

Q ss_pred             CceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecccc-cHH
Q 024091          149 SFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVY  222 (272)
Q Consensus       149 ~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~  222 (272)
                      +||.||+|.+..+++.+|+|++...     .....+|++.++.++|+||+++++++...     ...+++|||+++ ++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence            5899999999888999999998643     34556899999999999999999988443     458999999997 655


Q ss_pred             HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++..    ...++...+..++.+++.+|.|||+ .+|+|+||+|.||++
T Consensus        76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~  120 (244)
T smart00220       76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILL  120 (244)
T ss_pred             HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEE
Confidence            54432    2237888999999999999999998 899999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=8.4e-16  Score=126.23  Aligned_cols=111  Identities=16%  Similarity=0.281  Sum_probs=80.6

Q ss_pred             EeccCCceEEEEEEECCCCCEEEEEEeecc------------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .||+|+||.||++..  ++..|++|.....            .....+|++++..+.|+++....-++....     ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence            489999999999985  6788999985421            122347999999999887654443333222     267


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||++|..+.-....   ..       ..++.|++.+|.+||+ .+++|+|++|+|||+
T Consensus        74 lv~e~~~g~~l~~~~~~---~~-------~~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~  123 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEE---GN-------DELLREIGRLVGKLHK-AGIVHGDLTTSNIIV  123 (199)
T ss_pred             EEEEEECCccHHHHHhh---cH-------HHHHHHHHHHHHHHHH-CCeecCCCCcceEEE
Confidence            99999987654321110   10       0678899999999998 999999999999985

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.64  E-value=6.2e-16  Score=127.20  Aligned_cols=114  Identities=18%  Similarity=0.170  Sum_probs=85.4

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc--------------------------hhHHHHHHHHHHcCCCC-
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------------------RYKNRELQIMRLLNHPN-  191 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--------------------------~~~~~E~~~l~~l~h~n-  191 (272)
                      |.+.+.||.|+||.||++... +|+.||||++....                          .....|+.++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            788899999999999999864 79999999864321                          11346888999998874 


Q ss_pred             -eeecceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 024091          192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL  270 (272)
Q Consensus       192 -Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NI  270 (272)
                       ++.+++.    .     ..++||||+++..+..+..         ......++.+++.++.++|+ .+|+|+||||+||
T Consensus        96 ~v~~~~~~----~-----~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Ni  156 (198)
T cd05144          96 PVPKPIDW----N-----RHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNI  156 (198)
T ss_pred             CCCceeec----C-----CceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccE
Confidence             3333321    1     1589999999865432111         02355678899999999998 9999999999999


Q ss_pred             eC
Q 024091          271 LM  272 (272)
Q Consensus       271 Ll  272 (272)
                      +|
T Consensus       157 ll  158 (198)
T cd05144         157 LV  158 (198)
T ss_pred             EE
Confidence            86

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.63  E-value=1.8e-15  Score=142.38  Aligned_cols=116  Identities=15%  Similarity=0.228  Sum_probs=85.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEee-cc-----------chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QD-----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~-~~-----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      .|...+.||+|+||.||++.+...  .+++|... +.           .....+|+++++.+.|++|+..+.++....  
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--  409 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--  409 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--
Confidence            456789999999999999987443  34444321 11           122457999999999999987765553322  


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                         ..++||||+++..+.-...           ....++.|++.+|.|||+ .+|+||||||+|||+
T Consensus       410 ---~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl  461 (535)
T PRK09605        410 ---EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIV  461 (535)
T ss_pred             ---CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEE
Confidence               2679999999765432111           245688899999999998 999999999999985

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.63  E-value=1.5e-15  Score=144.63  Aligned_cols=129  Identities=25%  Similarity=0.427  Sum_probs=103.2

Q ss_pred             CeeeeEEeccCCceEEEEEEECC-------CCCEEEEEEeecc-----chhHHHHHHHHHHcC-CCCeeecceeeeeccc
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQD-----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTE  204 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~  204 (272)
                      +..+.+.||+|.||.|++|....       ....||||.++..     ......|+++|+.+. |+||+.+.+++..   
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---  373 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---  373 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence            34566799999999999997531       1456999988643     344568999999985 9999999999844   


Q ss_pred             CCceEEEEEeeccc-ccHHHHHHHhh---hcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCee
Q 024091          205 KDELYLNLVLEYIS-ETVYRVSKHYT---RMN---------QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL  271 (272)
Q Consensus       205 ~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~---------~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NIL  271 (272)
                        ...+++|+||+. |.++.+++...   ...         ..++...+..++.||+.||+||++ .++|||||..+|||
T Consensus       374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVL  450 (609)
T ss_pred             --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEE
Confidence              445999999999 77777766544   111         138889999999999999999998 89999999999999


Q ss_pred             C
Q 024091          272 M  272 (272)
Q Consensus       272 l  272 (272)
                      |
T Consensus       451 i  451 (609)
T KOG0200|consen  451 I  451 (609)
T ss_pred             e
Confidence            6

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.62  E-value=2.5e-15  Score=123.08  Aligned_cols=111  Identities=22%  Similarity=0.277  Sum_probs=83.5

Q ss_pred             eeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch--------hHHHHHHHHHHcC-CCCeeecceeeeecccCCceEE
Q 024091          140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       140 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+...|+.|+||+||++..  .+..|+.+.+.....        .+.+|+++|+.|. |++|++++++.     .    .
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----R   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----E
Confidence            4567899999999998765  677788776643322        3568999999996 57888887752     1    6


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCC-CCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDI-KPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDl-Kp~NILl  272 (272)
                      |++|||+.|..+..  . .      +.. ...++.|++.+|.|||+ +||+|||| ||+|||+
T Consensus        74 ~lvmeyI~G~~L~~--~-~------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv  125 (218)
T PRK12274         74 HLDRSYLAGAAMYQ--R-P------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLV  125 (218)
T ss_pred             EEEEeeecCccHHh--h-h------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEE
Confidence            89999999875531  1 1      111 13467899999999998 99999999 7999985

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=2.8e-15  Score=145.43  Aligned_cols=125  Identities=27%  Similarity=0.448  Sum_probs=95.2

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhH-HHHHHHHHHcC---CCCeeecceeeeecccCCceEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-NRELQIMRLLN---HPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~-~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..|.|.+.||+|+||+||+|.+.. |+.||||+-+....+- .-=.+++.+|+   -+.|..++.++...+.     -+|
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-----S~l  771 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA-----SVL  771 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc-----cee
Confidence            358899999999999999999877 9999999765432211 11233444554   3455555555544443     678


Q ss_pred             Eeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||.+ |+|++++.    ..+.+++..+.++..|+|..++.||. .+|||+||||+|+||
T Consensus       772 v~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll  827 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLL  827 (974)
T ss_pred             eeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEe
Confidence            999999 77777554    45668888899999999999999998 899999999999986

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.58  E-value=7.3e-15  Score=119.40  Aligned_cols=115  Identities=22%  Similarity=0.195  Sum_probs=77.9

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeeccchh----------------------------HHHHHHHHHHcCCCC--
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY----------------------------KNRELQIMRLLNHPN--  191 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~----------------------------~~~E~~~l~~l~h~n--  191 (272)
                      .+.||+|+||.||+|.+. +++.||||++......                            ...|...+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999876 7899999987642110                            023555555554433  


Q ss_pred             eeecceeeeecccCCceEEEEEeecccccHHH--HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 024091          192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN  269 (272)
Q Consensus       192 Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~--~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~N  269 (272)
                      +.+++++.         ..++||||++++...  .+....     .. ..++.++.+++.++.++|...+|+|+||||+|
T Consensus        81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N  145 (187)
T cd05119          81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN  145 (187)
T ss_pred             CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence            33333221         158999999973211  111111     01 45778899999999999964799999999999


Q ss_pred             eeC
Q 024091          270 LLM  272 (272)
Q Consensus       270 ILl  272 (272)
                      |++
T Consensus       146 ili  148 (187)
T cd05119         146 ILV  148 (187)
T ss_pred             EEE
Confidence            985

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.56  E-value=5.2e-14  Score=121.32  Aligned_cols=122  Identities=39%  Similarity=0.516  Sum_probs=99.1

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCC-CeeecceeeeecccCCceEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHP-NVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~~~~~  210 (272)
                      |.+...||.|+||.||++.+.   ..+|+|.+...       ...+.+|+.+++.+.|+ +|+++++.+.     .....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence            778899999999999999986   78999988543       22345799999999988 7999999882     22237


Q ss_pred             EEEeecccccHHHHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMN---QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~---~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++++++.+..+..+   ....   ..+....+..++.|++.++.|+|+ .+++||||||+|||+
T Consensus        74 ~~~~~~~~~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~  134 (384)
T COG0515          74 YLVMEYVDGGSLEDL---LKKIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILL  134 (384)
T ss_pred             EEEEecCCCCcHHHH---HHhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeee
Confidence            899999997655411   1112   268889999999999999999998 899999999999985

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.49  E-value=3.8e-14  Score=123.38  Aligned_cols=133  Identities=20%  Similarity=0.259  Sum_probs=102.9

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCC-----CCEEEEEEeeccchhHH-----HHHHHHHHcCCCCeeecceeeeeccc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAvK~i~~~~~~~~-----~E~~~l~~l~h~nIv~l~~~~~~~~~  204 (272)
                      ...++++..++-+|+||.||.|.++..     .+.|-+|.+++.....+     .|..++..+.|||+..+.+...+...
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            345688889999999999999977643     24466777766554443     58888888899999999998866443


Q ss_pred             CCceEEEEEeeccc-ccHHHHHHHhh----hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          205 KDELYLNLVLEYIS-ETVYRVSKHYT----RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       205 ~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          ..++++.+++ |++..++..+.    ...+.++...+..++.|++.|++|||+ ++|||.||..+|++|
T Consensus       362 ----~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvI  429 (563)
T KOG1024|consen  362 ----TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVI  429 (563)
T ss_pred             ----cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhccee
Confidence                3778889998 67766665433    123446677788899999999999998 999999999999985

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.49  E-value=1.6e-13  Score=106.38  Aligned_cols=115  Identities=19%  Similarity=0.256  Sum_probs=88.7

Q ss_pred             eeEEeccCCceEEEEEEECCCCCEEEEEEeeccc--hhHHHHHHHHHHcCC--CCeeecceeeeecccCCceEEEEEeec
Q 024091          141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNH--PNVVSLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       141 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      +.+.||.|.++.||++...  +..+++|......  .....|+.+++.+.|  .++++++.++.     .....+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEEe
Confidence            3578999999999999874  3789999886554  256789999999987  48888877652     22458999999


Q ss_pred             ccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc--CCceecCCCCCCeeC
Q 024091          217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV--VGVCHRDIKPQNLLM  272 (272)
Q Consensus       217 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~--~~iiHrDlKp~NILl  272 (272)
                      +.+..+..+          +......++.+++.+|.+||..  .+++|+||+|+|||+
T Consensus        75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~  122 (155)
T cd05120          75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV  122 (155)
T ss_pred             cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE
Confidence            987644311          3445566788999999999973  269999999999985

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.47  E-value=6.3e-13  Score=112.52  Aligned_cols=117  Identities=15%  Similarity=0.213  Sum_probs=80.3

Q ss_pred             EEec-cCCceEEEEEEECCCCCEEEEEEeecc-----------------chhHHHHHHHHHHcCCCCe--eecceeeeec
Q 024091          143 RVVG-TGSFGVVFQAKCLETGDSVAIKKVLQD-----------------KRYKNRELQIMRLLNHPNV--VSLKHCFFST  202 (272)
Q Consensus       143 ~~lG-~G~fg~V~~~~~~~~~~~vAvK~i~~~-----------------~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~  202 (272)
                      ..|| .|+.|+||.+..  .+..++||.+...                 .....+|++++..|.|++|  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 788888888876  3778999876321                 1223579999999998885  5555543322


Q ss_pred             ccCCceEEEEEeecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          203 TEKDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      . ......++|||+++|  .+..++.     ...+++..    +.||+.+|.+||+ .||+||||||+|||+
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv  175 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQ-----EAPLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILL  175 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEE
Confidence            1 111224699999996  3433322     22345432    5689999999998 999999999999985

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.22  E-value=5.3e-12  Score=124.28  Aligned_cols=82  Identities=20%  Similarity=0.177  Sum_probs=63.0

Q ss_pred             cCC-CCeeecceeeeeccc--CCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceec
Q 024091          187 LNH-PNVVSLKHCFFSTTE--KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHR  263 (272)
Q Consensus       187 l~h-~nIv~l~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHr  263 (272)
                      +.| +||..++++|.....  .....++++|||++++|..++..   ....+++..++.|+.||+.||.|||+ +|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeeec
Confidence            345 577888887622221  11124778899999988876542   24568999999999999999999998 999999


Q ss_pred             CCCCCCeeC
Q 024091          264 DIKPQNLLM  272 (272)
Q Consensus       264 DlKp~NILl  272 (272)
                      ||||+||||
T Consensus       105 DlKP~NiLl  113 (793)
T PLN00181        105 NVRPSCFVM  113 (793)
T ss_pred             cCCchhEEE
Confidence            999999996

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.21  E-value=1.4e-11  Score=114.77  Aligned_cols=122  Identities=16%  Similarity=0.205  Sum_probs=72.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchh--------------------------------------H--
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY--------------------------------------K--  177 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~--------------------------------------~--  177 (272)
                      .|.. +.||.|++|+||+|+...+|+.||||+++.....                                      .  
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3555 7899999999999998888999999998643100                                      0  


Q ss_pred             ----HHHHHHHHHcC----CCCeeecceeeeecccCCceEEEEEeecccccHHHHHHHhhhcC---CCCCHHHHHHHHHH
Q 024091          178 ----NRELQIMRLLN----HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN---QHVPILYVQLYTYQ  246 (272)
Q Consensus       178 ----~~E~~~l~~l~----h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~---~~~~~~~~~~i~~q  246 (272)
                          .+|+..+..+.    +.+.+.+-..|+....    ..+|||||+.|..+.-+.......   ..+.+..+..++.|
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st----~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS----ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCC----CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence                12333333332    3333433333322111    157999999976543221111111   12333334444445


Q ss_pred             HHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          247 ICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       247 i~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++       . .|++|+|+||.||++
T Consensus       276 if-------~-~GffHaDpHPGNIlv  293 (537)
T PRK04750        276 VF-------R-DGFFHADMHPGNIFV  293 (537)
T ss_pred             HH-------h-CCeeeCCCChHHeEE
Confidence            43       4 799999999999986

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=2.3e-11  Score=106.56  Aligned_cols=79  Identities=28%  Similarity=0.443  Sum_probs=60.5

Q ss_pred             CCCCeeecceeeeecc----------------------cCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHH
Q 024091          188 NHPNVVSLKHCFFSTT----------------------EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY  245 (272)
Q Consensus       188 ~h~nIv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~  245 (272)
                      +|||||++.++|...-                      -.....+|+||.-...++-.++.     ....+......++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~-----~~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLW-----TRHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHh-----cCCCchHHHHHHHH
Confidence            5999999998875311                      11233589999988877665433     23455566777888


Q ss_pred             HHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          246 QICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       246 qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |++.|+.|||+ +||.|||||.+||||
T Consensus       349 QlLEav~hL~~-hgvAhRDlKSDNiL~  374 (598)
T KOG4158|consen  349 QLLEAVTHLHK-HGVAHRDLKSDNILL  374 (598)
T ss_pred             HHHHHHHHHHH-ccchhhcccccceEE
Confidence            99999999998 999999999999996

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=1.4e-11  Score=116.68  Aligned_cols=123  Identities=28%  Similarity=0.426  Sum_probs=90.2

Q ss_pred             eeeEEeccCCceEEEEEEECCCCCEEEEEEee----ccc---hh---HHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDK---RY---KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       140 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~----~~~---~~---~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ....++|.|++|.|+.+......+.++.|...    ...   .+   ...|..+-..|.|+||+.....++....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            45688999999999888887767666666543    111   11   1236666677899999877666543322     


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+-.||||+++++.++..    ...+....+..++.|++.|+.|||. .||.||||||+|||+
T Consensus       396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~  453 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLV  453 (601)
T ss_pred             chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEE
Confidence            333499999966554443    2357778899999999999999998 899999999999985

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.16  E-value=2e-10  Score=105.37  Aligned_cols=120  Identities=20%  Similarity=0.251  Sum_probs=72.2

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeeccch-h-------------------------------------------H
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-Y-------------------------------------------K  177 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~-------------------------------------------~  177 (272)
                      .+.||.|++|+||+|+. .+|+.||||+.+.... .                                           .
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            36799999999999985 4789999998754210 0                                           0


Q ss_pred             HHHHHHHHHc----CCCCeeecceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHH-HHH
Q 024091          178 NRELQIMRLL----NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR-ALN  252 (272)
Q Consensus       178 ~~E~~~l~~l----~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~-~L~  252 (272)
                      .+|+..+..+    .|.+-+.+-..|+....    ..+|||||++|..+.-......  ....   ...++.+++. .+.
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~  271 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLN  271 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHH
Confidence            1344444444    23222333333322111    1589999999755432221111  1111   2345555555 467


Q ss_pred             HHHhcCCceecCCCCCCeeC
Q 024091          253 YLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       253 ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|. .|++|+|+||.||++
T Consensus       272 ql~~-~g~~H~D~hPgNilv  290 (437)
T TIGR01982       272 QVLR-DGFFHADLHPGNIFV  290 (437)
T ss_pred             HHHh-CCceeCCCCcccEEE
Confidence            8898 899999999999985

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.16  E-value=1.1e-10  Score=93.06  Aligned_cols=110  Identities=15%  Similarity=0.191  Sum_probs=78.2

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCee-ecceeeeecccCCceEEEEEeecc
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      .+.|+.|.++.||++..  .+..|++|......   .....|+.+++.+.+.+++ +++.+.  .   ..  -++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~---~~--~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--P---ET--GVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--C---CC--CeEEEEec
Confidence            36789999999999986  47889999875442   3356899999998765554 343322  1   11  36899999


Q ss_pred             cccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCc-----eecCCCCCCeeC
Q 024091          218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV-----CHRDIKPQNLLM  272 (272)
Q Consensus       218 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~i-----iHrDlKp~NILl  272 (272)
                      +|..+...        ..   ....++.+++.+|..||. .++     +|+|++|.||++
T Consensus        74 ~G~~l~~~--------~~---~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~  121 (170)
T cd05151          74 EGSELLTE--------DF---SDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLL  121 (170)
T ss_pred             CCCccccc--------cc---cCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEE
Confidence            98643210        01   113456789999999997 664     999999999985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.14  E-value=1.8e-10  Score=94.04  Aligned_cols=115  Identities=20%  Similarity=0.241  Sum_probs=80.0

Q ss_pred             EEeccCCceEEEEEEECC------CCCEEEEEEeec--------------cch----------------hHHHHHHHHHH
Q 024091          143 RVVGTGSFGVVFQAKCLE------TGDSVAIKKVLQ--------------DKR----------------YKNRELQIMRL  186 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~------~~~~vAvK~i~~--------------~~~----------------~~~~E~~~l~~  186 (272)
                      ..||.|--+.||.|....      .+..+|||+.+.              +.+                +.++|...|+.
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997643      357899997632              100                11269999998


Q ss_pred             cCC--CCeeecceeeeecccCCceEEEEEeecccccHHH--HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCce
Q 024091          187 LNH--PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL-HHVVGVC  261 (272)
Q Consensus       187 l~h--~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~--~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yl-H~~~~ii  261 (272)
                      |..  -++..++++.     .    -+|||||++++.+.  .++     ...++...+..+..+++.+|.+| |+ .|||
T Consensus        83 l~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~-~glV  147 (197)
T cd05146          83 MQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKE-CNLV  147 (197)
T ss_pred             HHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHh-CCee
Confidence            864  3455555431     2    47899999864221  111     12344455667788999999999 77 8999


Q ss_pred             ecCCCCCCeeC
Q 024091          262 HRDIKPQNLLM  272 (272)
Q Consensus       262 HrDlKp~NILl  272 (272)
                      |+||++.|||+
T Consensus       148 HGDLs~~NIL~  158 (197)
T cd05146         148 HADLSEYNMLW  158 (197)
T ss_pred             cCCCCHHHEEE
Confidence            99999999985

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.11  E-value=7.6e-10  Score=95.25  Aligned_cols=133  Identities=23%  Similarity=0.366  Sum_probs=79.3

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch-------hHHHHHHHHHHcCC----------------CCeeec
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLLNH----------------PNVVSL  195 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-------~~~~E~~~l~~l~h----------------~nIv~l  195 (272)
                      +...+.||.|+|+.||.+++..|++.+|||+......       ..++|.-....+.+                --++++
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            6778999999999999999999999999998743211       11223222222111                111111


Q ss_pred             ce--eeeecccCCce----EEEEEeecccccHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhcCCceecCCC
Q 024091          196 KH--CFFSTTEKDEL----YLNLVLEYISETVYRVSKHYTRMNQH---VPILYVQLYTYQICRALNYLHHVVGVCHRDIK  266 (272)
Q Consensus       196 ~~--~~~~~~~~~~~----~~~lv~e~~~~~l~~~~~~~~~~~~~---~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlK  266 (272)
                      -+  -++........    ..+++|+-+.+++..++.........   +....-..+..|+++.+++||. .||+|+|||
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEecccc
Confidence            10  01111111111    24778998888887765543222222   2222223455899999999998 999999999


Q ss_pred             CCCeeC
Q 024091          267 PQNLLM  272 (272)
Q Consensus       267 p~NILl  272 (272)
                      |+|+|+
T Consensus       173 ~~nfll  178 (288)
T PF14531_consen  173 PENFLL  178 (288)
T ss_dssp             GGGEEE
T ss_pred             eeeEEE
Confidence            999985

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.01  E-value=6.5e-11  Score=114.69  Aligned_cols=122  Identities=25%  Similarity=0.456  Sum_probs=91.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----h-hHH--HHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----R-YKN--RELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~-~~~--~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .|...+.||.+.|=+|.+|++..  ..|+||++.+..     + +.+  .|++ ...+++||++.+.-+.     .....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e--G~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE--GLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC--ceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            47777999999999999998743  349999885432     1 112  3555 6677899999976543     23334


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|||-+|+..+|++.+.-    ..-+...+-+.|+-|++.||.-||. .||+|+|||.|||||
T Consensus        96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILi  153 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILI  153 (1431)
T ss_pred             HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEE
Confidence            788999999998874321    2224556677889999999999998 999999999999996

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=98.80  E-value=7.5e-10  Score=101.99  Aligned_cols=120  Identities=27%  Similarity=0.428  Sum_probs=91.8

Q ss_pred             EeccCCceEEEEEEE---CCCCCEEEEEEeecc------chhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEEEE
Q 024091          144 VVGTGSFGVVFQAKC---LETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~---~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ++|+|+||.|++++-   ...+..+|+|+..+.      +.....|..++..++ ||.+|++.-+|...+     -++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-----kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-----KLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-----chhHh
Confidence            379999999987643   235778898877432      112335888999988 999999988884444     38999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|..++.+-  .+ ......+.+..+..+...++.+++++|+ .+|+|||+|++||++
T Consensus        76 ld~~rgg~lf--t~-l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enill  130 (612)
T KOG0603|consen   76 LDFLRGGDLF--TR-LSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLL  130 (612)
T ss_pred             hhhcccchhh--hc-cccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceee
Confidence            9999876332  22 2234457788888999999999999998 999999999999985

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.79  E-value=4.8e-08  Score=80.94  Aligned_cols=106  Identities=14%  Similarity=0.109  Sum_probs=65.0

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCC--eeecceeeeecccCCceEEEEEee
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      +.|+.|.++.||++.... |+.+++|.....     ......|+++++.+.+.+  +.+++.+....  ......++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence            578999999999998643 578999987543     235568999999997643  45555543211  11123679999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 024091          216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH  255 (272)
Q Consensus       216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH  255 (272)
                      |++|..+...   .. ...+++.....++.+++.+|.+||
T Consensus        81 ~i~G~~l~~~---~~-~~~~~~~~~~~i~~~i~~~l~~lH  116 (223)
T cd05154          81 RVDGRVLRDR---LL-RPELSPEERRALARALADTLAALH  116 (223)
T ss_pred             EeCCEecCCC---CC-CCCCCHHHHHHHHHHHHHHHHHHh
Confidence            9987643210   00 022344444445555555555555

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.65  E-value=7.1e-07  Score=76.72  Aligned_cols=93  Identities=13%  Similarity=0.151  Sum_probs=62.3

Q ss_pred             HHHHHHHHHHcCCCCeeec--ceeeeecccCCceEEEEEeeccccc--HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 024091          177 KNRELQIMRLLNHPNVVSL--KHCFFSTTEKDELYLNLVLEYISET--VYRVSKHYTRMNQHVPILYVQLYTYQICRALN  252 (272)
Q Consensus       177 ~~~E~~~l~~l~h~nIv~l--~~~~~~~~~~~~~~~~lv~e~~~~~--l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~  252 (272)
                      ..+|...+..|..-+|...  ..++..........-+||||++++.  +.+++..+.  ...........++.+++..+.
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~  152 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVR  152 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHH
Confidence            5689998888864444332  3332111111123367999999974  444443221  233455667788999999999


Q ss_pred             HHHhcCCceecCCCCCCeeC
Q 024091          253 YLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       253 ylH~~~~iiHrDlKp~NILl  272 (272)
                      -||+ .||+|+||++.||||
T Consensus       153 ~LH~-~Gi~HgDL~~~NiLl  171 (268)
T PRK15123        153 DMHA-AGINHRDCYICHFLL  171 (268)
T ss_pred             HHHH-CcCccCCCChhhEEE
Confidence            9998 999999999999986

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.65  E-value=2.2e-08  Score=91.96  Aligned_cols=129  Identities=22%  Similarity=0.199  Sum_probs=97.1

Q ss_pred             cccCeeeeEEeccCCceEEEEEEEC-CCCCEEEEEEeeccchhH------HHHHHHHHHcC-CCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCL-ETGDSVAIKKVLQDKRYK------NRELQIMRLLN-HPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~~~~------~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|.++..||.|.|+.|+..... .++..+++|.+.+.....      -.|+.+...+. |.+++.++..|+....  
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--  340 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--  340 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc--
Confidence            3456888999999999999987655 578889999876543222      24666666664 9999998877754432  


Q ss_pred             ceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                         .|+-.|||.+....+...   ...-+.+...+.+..|++.++.++|+ ..++|+|+||+||++
T Consensus       341 ---~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i  399 (524)
T KOG0601|consen  341 ---GYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILI  399 (524)
T ss_pred             ---ccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceee
Confidence               669999998766554332   22335566678888999999999998 899999999999985

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.64  E-value=2.6e-07  Score=84.13  Aligned_cols=120  Identities=23%  Similarity=0.351  Sum_probs=91.6

Q ss_pred             eEEEEEEECCCCCEEEEEEeeccch----hHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeeccc--ccHHHH
Q 024091          151 GVVFQAKCLETGDSVAIKKVLQDKR----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV  224 (272)
Q Consensus       151 g~V~~~~~~~~~~~vAvK~i~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~  224 (272)
                      .+.|+++...+|..|++|.+.-++.    ..-.-++.++++.|+|||+|.++|.... -+...+++|++|.+  .+|+++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHHH
Confidence            4679999989999999999832211    1124578999999999999999986433 34455899999998  466653


Q ss_pred             HHHhh-----------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          225 SKHYT-----------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       225 ~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .-...           ..+...++..+|.|+.|+..||.++|+ .|+.-+-|-|.+||+
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv  426 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILV  426 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEe
Confidence            32111           112357889999999999999999998 899999999999985

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.64  E-value=3.7e-07  Score=72.97  Aligned_cols=122  Identities=16%  Similarity=0.222  Sum_probs=81.4

Q ss_pred             eeEEeccCCceEEEEEEECCCCCEEEEEEeec------------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       141 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .+.+|-+|+-+.|+++.+  .|+...||.-..            .+....+|+.+|.++.--.|.-..-+|.... .   
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~-~---   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY-G---   84 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-C---
Confidence            567888999999999987  678888885321            1223347999999887444432222232222 1   


Q ss_pred             EEEEEeecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       -+|+|||++|  .+.+++....  ...........++.+|-..+.-||. .+|||+||-.+||||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill  146 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILL  146 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEE
Confidence             4688999998  4444433222  2222223336678888889999998 999999999999985

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.50  E-value=4e-07  Score=74.09  Aligned_cols=105  Identities=21%  Similarity=0.252  Sum_probs=64.6

Q ss_pred             EEEEEEECCCCCEEEEEEeecc--------------c----------------hhHHHHHHHHHHcCCC--Ceeecceee
Q 024091          152 VVFQAKCLETGDSVAIKKVLQD--------------K----------------RYKNRELQIMRLLNHP--NVVSLKHCF  199 (272)
Q Consensus       152 ~V~~~~~~~~~~~vAvK~i~~~--------------~----------------~~~~~E~~~l~~l~h~--nIv~l~~~~  199 (272)
                      -||.|.. ..|..+|||+.+..              .                ...++|...|..+..-  ++.+++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3888876 45779999987421              0                1123699999999866  455665432


Q ss_pred             eecccCCceEEEEEeeccc--ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH-HHhcCCceecCCCCCCeeC
Q 024091          200 FSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY-LHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       200 ~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~y-lH~~~~iiHrDlKp~NILl  272 (272)
                           .    -+|||||++  |..+..+....     +.......++.+++..+.. +|. .||||+||.+.|||+
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv  140 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILV  140 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEE
T ss_pred             -----C----CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEe
Confidence                 2    369999999  65443333221     1122345566788886666 467 899999999999985

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.50  E-value=1.2e-07  Score=87.21  Aligned_cols=126  Identities=25%  Similarity=0.313  Sum_probs=99.6

Q ss_pred             CeeeeEEecc--CCceEEEEEEE--CCCCCEEEEEEee------ccchhHHHHHHHHHHcC-CCCeeecceeeeecccCC
Q 024091          138 SYMAERVVGT--GSFGVVFQAKC--LETGDSVAIKKVL------QDKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       138 ~y~~~~~lG~--G~fg~V~~~~~--~~~~~~vAvK~i~------~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~  206 (272)
                      .+.+...+|.  |.+|.||.+..  ..++..+|+|.-+      .......+|+.-.++++ |+|.++.+..|     ..
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e~  189 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----EG  189 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----cc
Confidence            4666788999  99999999988  7888999999632      22333457887777776 99999988877     45


Q ss_pred             ceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR----ALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~----~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+|+-+|+|+..+..   .+......++...++.++.+...    ||.++|. .+|+|-|+||+||++
T Consensus       190 ~~~lfiqtE~~~~sl~~---~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~  255 (524)
T KOG0601|consen  190 SGILFIQTELCGESLQS---YCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFT  255 (524)
T ss_pred             CCcceeeeccccchhHH---hhhcccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheec
Confidence            55699999999977654   33333445788888888888888    9999998 999999999999974

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.48  E-value=1.4e-06  Score=69.74  Aligned_cols=112  Identities=16%  Similarity=0.277  Sum_probs=72.8

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeecc------------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+.+|+-..+|.+.+  -|..+.+|.-...            .....+|+.+|.++.--.|...+=+++....     .
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-----~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-----G   74 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----C
Confidence            3578899999998866  3445666743211            1223479999998875554433323333332     5


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|+|||++|.++.-...   ..   .    ..++..+-.-+.-||. .||||+||-++||+|
T Consensus        75 ~I~me~I~G~~lkd~l~---~~---~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl  125 (204)
T COG3642          75 LIVMEYIEGELLKDALE---EA---R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIIL  125 (204)
T ss_pred             EEEEEEeCChhHHHHHH---hc---c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEE
Confidence            69999999987652211   11   1    2344556666888998 899999999999985

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.42  E-value=2.1e-07  Score=90.62  Aligned_cols=96  Identities=26%  Similarity=0.484  Sum_probs=63.6

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ...+|..++.|-.|+||.||+.+++.+.+.||+|+ .++.-..++   |+.....|++|                     
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilRn---ilt~a~npfvv---------------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILRN---ILTFAGNPFVV---------------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhhc---cccccCCccee---------------------
Confidence            34579999999999999999999999999999964 333222222   22222333332                     


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          |+--.+    .+.-++++..        .+.+++|||+ .+|+|||+||+|+||
T Consensus       136 ----gDc~tl----lk~~g~lPvd--------mvla~Eylh~-ygivhrdlkpdnllI  176 (1205)
T KOG0606|consen  136 ----GDCATL----LKNIGPLPVD--------MVLAVEYLHS-YGIVHRDLKPDNLLI  176 (1205)
T ss_pred             ----chhhhh----cccCCCCcch--------hhHHhHhhcc-CCeecCCCCCCccee
Confidence                111111    1112334432        3778999998 999999999999986

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.33  E-value=2e-06  Score=80.50  Aligned_cols=105  Identities=22%  Similarity=0.260  Sum_probs=76.3

Q ss_pred             EEEECCCCCEEEEEEeeccch----hHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecccccHHHHHHHhhh
Q 024091          155 QAKCLETGDSVAIKKVLQDKR----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTR  230 (272)
Q Consensus       155 ~~~~~~~~~~vAvK~i~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~  230 (272)
                      .|..+.++.+|.|...+....    ...+-++.|+.|+||||++|++.+..     ...+|||+|-+..-- ..++.   
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-----~~~~ylvTErV~Pl~-~~lk~---  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-----EGTLYLVTERVRPLE-TVLKE---  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-----cCceEEEeeccccHH-HHHHH---
Confidence            456677888888887754332    24567888999999999999998843     335999999886321 11122   


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       231 ~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          +....+..-+.||+.||.|||+.++++|.+|--.-|+|
T Consensus       101 ----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV  138 (690)
T KOG1243|consen  101 ----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV  138 (690)
T ss_pred             ----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE
Confidence                22455667788999999999865899999997776653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.32  E-value=6.5e-08  Score=91.98  Aligned_cols=127  Identities=28%  Similarity=0.334  Sum_probs=93.7

Q ss_pred             CeeeeEEeccCCceEEEEEEEC-CCCCEEEEEEeecc---chhH---HHHHHHHHHcC-CCCeeecceeeeecccCCceE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCL-ETGDSVAIKKVLQD---KRYK---NRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~-~~~~~vAvK~i~~~---~~~~---~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .|.+.+.||+|+|+.|-++... .....+|+|.+...   ....   ..|..+-+.+. |+|++.+++..     ....+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCcc
Confidence            4888888999999999888764 34456777765322   2222   24777888887 99999999887     55556


Q ss_pred             EEEEeecccccHHHHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHH-hcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRALNYLH-HVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~-~~~~~~~~~i~~qi~~~L~ylH-~~~~iiHrDlKp~NILl  272 (272)
                      .+++++|..++.+-  ........ ..+...+..++.|+..++.|+| . .++.||||||+|.++
T Consensus        96 ~~~~~~~s~g~~~f--~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l  157 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLF--SKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLL  157 (601)
T ss_pred             cccccCcccccccc--cccccCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchh
Confidence            89999997765432  11102222 4566778899999999999999 7 899999999999875

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.27  E-value=3.9e-06  Score=71.10  Aligned_cols=115  Identities=19%  Similarity=0.167  Sum_probs=78.1

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--------------------------chhHHHHHHHHHHcCCC--
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------------------------KRYKNRELQIMRLLNHP--  190 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--------------------------~~~~~~E~~~l~~l~h~--  190 (272)
                      +.++..||.|--+.||.|.+. .|.++|||.-+-.                          ....++|.++|..|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            457789999999999999864 6889999965321                          11224799999998755  


Q ss_pred             CeeecceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 024091          191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL  270 (272)
Q Consensus       191 nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NI  270 (272)
                      .|.+.+++-         .-.+||||+.|-.+.-+.        +.......++..|+.-+.-+-. .||||+|+.+=||
T Consensus       172 ~VP~P~~~n---------RHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNI  233 (304)
T COG0478         172 KVPKPIAWN---------RHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNI  233 (304)
T ss_pred             CCCCccccc---------cceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH-cCccccCCchheE
Confidence            666665532         257999999985443111        1122233444455555554445 7999999999999


Q ss_pred             eC
Q 024091          271 LM  272 (272)
Q Consensus       271 Ll  272 (272)
                      |+
T Consensus       234 lV  235 (304)
T COG0478         234 LV  235 (304)
T ss_pred             EE
Confidence            86

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.23  E-value=1.6e-05  Score=65.81  Aligned_cols=91  Identities=15%  Similarity=0.214  Sum_probs=61.1

Q ss_pred             hHHHHHHHHHHcCCCCee--ecceeeeecccCCceEEEEEeeccccc--HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Q 024091          176 YKNRELQIMRLLNHPNVV--SLKHCFFSTTEKDELYLNLVLEYISET--VYRVSKHYTRMNQHVPILYVQLYTYQICRAL  251 (272)
Q Consensus       176 ~~~~E~~~l~~l~h~nIv--~l~~~~~~~~~~~~~~~~lv~e~~~~~--l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L  251 (272)
                      ...+|...+..|..-+|.  ..+.+..... ......+||+|++++.  +..++....    ..+......++.++...+
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI  131 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence            345788888877644443  3333332221 1123468999999863  444333211    144556678889999999


Q ss_pred             HHHHhcCCceecCCCCCCeeC
Q 024091          252 NYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       252 ~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .-||+ .||+|+|++|.|||+
T Consensus       132 ~~lH~-~gi~H~Dl~~~NILv  151 (206)
T PF06293_consen  132 AKLHD-AGIYHGDLNPSNILV  151 (206)
T ss_pred             HHHHH-CcCCCCCCCcccEEE
Confidence            99998 999999999999996

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=98.20  E-value=3.4e-07  Score=77.12  Aligned_cols=114  Identities=18%  Similarity=0.299  Sum_probs=83.1

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeec------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..+.-+|.+...|..|+|++-  |..++.|++.-      -.+.++.|.-.|+.+.||||+.+++.|-..     .++.+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~  264 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVI  264 (448)
T ss_pred             hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceE
Confidence            445677899999999999984  44455565521      234566788899999999999999998444     34889


Q ss_pred             Eeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCce
Q 024091          213 VLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC  261 (272)
Q Consensus       213 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~ii  261 (272)
                      +..||+ ++++.++....  .-.+....+..++..|++|+.|||+...+|
T Consensus       265 isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~i  312 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMI  312 (448)
T ss_pred             eeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhh
Confidence            999999 66666554322  223455678889999999999999733333

>PRK09902 hypothetical protein; Provisional

Probab=98.07  E-value=0.00012  Score=60.37  Aligned_cols=122  Identities=13%  Similarity=0.059  Sum_probs=79.3

Q ss_pred             eccCCceEEEEEEECCCCCEEEEEEee----------ccchhHHHHHHHHHHcCCCC--eeecceeeeecccCCceEEEE
Q 024091          145 VGTGSFGVVFQAKCLETGDSVAIKKVL----------QDKRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       145 lG~G~fg~V~~~~~~~~~~~vAvK~i~----------~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~~~~~~l  212 (272)
                      -|+||.+-|+....  .|+.+-+|.-.          .....+.+|+..|..|..-+  +.++. ++-.........-+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            36688888887654  34467777542          12345568999999886433  33333 221111123345788


Q ss_pred             Eeeccc--ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+|-++  .+|.+++....  -.+.+...-..+..+|...+.-||+ .|+.|+|+-+.|||+
T Consensus       103 VTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll  161 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYV  161 (216)
T ss_pred             EEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheee
Confidence            999888  45544432211  1234555556788899999999998 999999999999985

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.95  E-value=8.2e-06  Score=70.67  Aligned_cols=120  Identities=19%  Similarity=0.262  Sum_probs=84.3

Q ss_pred             EEEEEEECCCCCEEEEEEeec----cchh--HHHH--HHHHHHcCCCCeeecceeeeecccCCceEEEEEeeccc-ccHH
Q 024091          152 VVFQAKCLETGDSVAIKKVLQ----DKRY--KNRE--LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVY  222 (272)
Q Consensus       152 ~V~~~~~~~~~~~vAvK~i~~----~~~~--~~~E--~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~l~  222 (272)
                      .||++.+...|.+|..-.+..    +.+.  ..++  ..-|-.+.|.|||+++.+|......+.....++.||+. +.+.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            567777777776665443321    1110  0112  23345667999999988875544445556888999999 6777


Q ss_pred             HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCCee
Q 024091          223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLL  271 (272)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~-~~iiHrDlKp~NIL  271 (272)
                      .+++...+....+......+|+-||+.||.|||+. -.|+|..+-.+-|+
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tif  210 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIF  210 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhhee
Confidence            77777777777888888899999999999999971 36999998776665

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=97.91  E-value=1.7e-05  Score=73.03  Aligned_cols=81  Identities=21%  Similarity=0.367  Sum_probs=64.4

Q ss_pred             HHHcCCCCeeecceeeeecccCCceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcee
Q 024091          184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCH  262 (272)
Q Consensus       184 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiH  262 (272)
                      |+.+.|.|+.+++|.++....     .++|.+||. |++.+++..   ....+.+.....+.+.|+.||.|||......|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~-----~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPE-----MIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecCCc-----eEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence            457889999999999876633     899999999 666665443   34557777777888999999999998333399


Q ss_pred             cCCCCCCeeC
Q 024091          263 RDIKPQNLLM  272 (272)
Q Consensus       263 rDlKp~NILl  272 (272)
                      .-|+..|+++
T Consensus        73 g~l~s~nClv   82 (484)
T KOG1023|consen   73 GALKSSNCLV   82 (484)
T ss_pred             eeecccccee
Confidence            9999999985

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.90  E-value=0.00025  Score=58.84  Aligned_cols=122  Identities=17%  Similarity=0.212  Sum_probs=70.9

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhH-------------HHHHHHHHHcCCCCeeecceeeeec-
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------------NRELQIMRLLNHPNVVSLKHCFFST-  202 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~-------------~~E~~~l~~l~h~nIv~l~~~~~~~-  202 (272)
                      ..|.+.+++-......|.+-.-  .|+.+.+|..+...+..             .+++..+..+...++..+-..+... 
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            3577777777777776666543  67889999765432221             1344444444322222221111111 


Q ss_pred             --ccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          203 --TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       203 --~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ...-....+|+|||++|-.+.-+.       .+++    .++..|..++.-||. .|+.|+|..|.|+++
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv  168 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLV  168 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEE
Confidence              111123366899999986432111       1222    234567778999998 999999999999985

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.89  E-value=3.2e-05  Score=72.18  Aligned_cols=29  Identities=24%  Similarity=0.298  Sum_probs=25.0

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeec
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ  172 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~  172 (272)
                      ..|+.++-|+||+|+.. +|+.||||+.+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrP  159 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRP  159 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCC
Confidence            57899999999999865 499999998754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.83  E-value=0.00022  Score=58.59  Aligned_cols=116  Identities=20%  Similarity=0.303  Sum_probs=73.9

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccc--------------------hhHHHHHHHHHHcC------CCCeeecc
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------------RYKNRELQIMRLLN------HPNVVSLK  196 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--------------------~~~~~E~~~l~~l~------h~nIv~l~  196 (272)
                      ..||.|+.-.||.-  + ......||++....                    +...+|+.....+.      +.+|.++|
T Consensus         7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            57999999999963  2 34456889886554                    34446777666665      78899999


Q ss_pred             eeeeecccCCceEEEEEeeccc---ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          197 HCFFSTTEKDELYLNLVLEYIS---ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       197 ~~~~~~~~~~~~~~~lv~e~~~---~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+..     +...+-+|+|.+.   |..-..+..+.. ...++. .+.   ..+-.-..||-+ .+|+.+||+|.||++
T Consensus        84 G~ve-----T~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~---~~L~~f~~~l~~-~~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   84 GFVE-----TNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELR---QALDEFKRYLLD-HHIVIRDLNPHNIVV  151 (199)
T ss_pred             EEEe-----cCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHH---HHHHHHHHHHHH-cCCeecCCCcccEEE
Confidence            9873     3333778888764   222222222222 233444 222   233344557777 899999999999985

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.83  E-value=0.00017  Score=60.59  Aligned_cols=117  Identities=17%  Similarity=0.184  Sum_probs=75.9

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeeccch----------------------------hHHHHHHHHHHcC--CCCe
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR----------------------------YKNRELQIMRLLN--HPNV  192 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~----------------------------~~~~E~~~l~~l~--h~nI  192 (272)
                      ..|..|--..||+|.. ..+..||+|+.+....                            +...|..-|+.+.  +-.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            4677788889999974 5688999998753211                            1125777777775  3344


Q ss_pred             eecceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       193 v~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+-+.++     +    -.|||||++...+.   .-.-..-.+....+..+..+++..+.-|-...++||.||..=|||+
T Consensus       133 P~Pi~~~-----~----nVLvMEfIg~~g~p---AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~  200 (268)
T COG1718         133 PEPIAFR-----N----NVLVMEFIGDDGLP---APRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV  200 (268)
T ss_pred             CCceeec-----C----CeEEEEeccCCCCC---CCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence            5555554     2    46899999854111   0000011223335667777888888877654799999999999985

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.76  E-value=0.00034  Score=57.30  Aligned_cols=116  Identities=23%  Similarity=0.295  Sum_probs=79.8

Q ss_pred             cCeeeeEEeccCCc-eEEEEEEECCCCCEEEEEEeec-------------cc------------hhHHHHHHHHHHc---
Q 024091          137 ISYMAERVVGTGSF-GVVFQAKCLETGDSVAIKKVLQ-------------DK------------RYKNRELQIMRLL---  187 (272)
Q Consensus       137 ~~y~~~~~lG~G~f-g~V~~~~~~~~~~~vAvK~i~~-------------~~------------~~~~~E~~~l~~l---  187 (272)
                      .+++.++.||.|.- |.||+++.  .|..+|||....             ..            ..+..|......|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            45888999999999 99999987  678999998321             00            1123566654444   


Q ss_pred             CCCCe--eecceeeeecc-c------------CCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 024091          188 NHPNV--VSLKHCFFSTT-E------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN  252 (272)
Q Consensus       188 ~h~nI--v~l~~~~~~~~-~------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~  252 (272)
                      .+.++  |+.+||+.... .            .......||.||+....            .+...    -+.+|+.-|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHH
Confidence            56677  89999886552 1            11223567888777542            11212    2347888899


Q ss_pred             HHHhcCCceecCCCCCCee
Q 024091          253 YLHHVVGVCHRDIKPQNLL  271 (272)
Q Consensus       253 ylH~~~~iiHrDlKp~NIL  271 (272)
                      .+|. .||+-+|+|+.|..
T Consensus       179 ~~~k-~gI~~~Dv~~~ny~  196 (207)
T PF13095_consen  179 ILHK-LGIVPRDVKPRNYR  196 (207)
T ss_pred             HHHH-CCeeeccCcccccc
Confidence            9998 89999999999963

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.68  E-value=0.00016  Score=67.50  Aligned_cols=30  Identities=27%  Similarity=0.378  Sum_probs=25.4

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeec
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ  172 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~  172 (272)
                      .+.||.-+.|.||+|+.+. |+.||||+-+.
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P  195 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHP  195 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCc
Confidence            3679999999999998665 99999997643

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=97.43  E-value=7.6e-05  Score=68.20  Aligned_cols=61  Identities=26%  Similarity=0.447  Sum_probs=47.8

Q ss_pred             ceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..|+||.|++|. ..+.+++.. .+.....+....+.++.|+..|++|    ++.+|||+||.||++
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~  389 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFF  389 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh----ccchhhhcccccccc
Confidence            347999999999 565566543 2334456677788999999999999    589999999999974

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.40  E-value=0.00089  Score=59.53  Aligned_cols=121  Identities=20%  Similarity=0.262  Sum_probs=80.2

Q ss_pred             eeEEeccCCceEEEEEEECCCCCEEEEEEeecc------------------------------chhHHHHHHHHHHcCCC
Q 024091          141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------------------------KRYKNRELQIMRLLNHP  190 (272)
Q Consensus       141 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------------------------------~~~~~~E~~~l~~l~h~  190 (272)
                      +..+|..|--.-||.|. ..+|..+|||+.+..                              +-+.+.|+.-|+.|+..
T Consensus       148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            45678888889999987 457888999987421                              11223688888888765


Q ss_pred             CeeecceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 024091          191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL  270 (272)
Q Consensus       191 nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NI  270 (272)
                      .|...--.+ ...      -.|||+|++..-+-   .-....-.++...+..+-.|++.-|.-|.+.+++||.||.-=|+
T Consensus       227 GIP~PePIl-Lk~------hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~  296 (520)
T KOG2270|consen  227 GIPCPEPIL-LKN------HVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL  296 (520)
T ss_pred             CCCCCCcee-eec------ceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence            543221111 111      35899999944221   01111334666677777778888888887668999999998888


Q ss_pred             eC
Q 024091          271 LM  272 (272)
Q Consensus       271 Ll  272 (272)
                      |+
T Consensus       297 Ly  298 (520)
T KOG2270|consen  297 LY  298 (520)
T ss_pred             eE
Confidence            74

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.20  E-value=0.0045  Score=51.89  Aligned_cols=69  Identities=19%  Similarity=0.155  Sum_probs=46.1

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCe--eecceeeeecccCCceEEEEEeeccc
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNV--VSLKHCFFSTTEKDELYLNLVLEYIS  218 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~~~~~~~~~~lv~e~~~  218 (272)
                      ..||.|..+.||+.    .+..+++|.....  .....+|.++++.+..-++  .+.+++.     .......+|||++.
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            57899999999984    2456788976543  2345689999988864433  3444433     22222678999999


Q ss_pred             cc
Q 024091          219 ET  220 (272)
Q Consensus       219 ~~  220 (272)
                      |.
T Consensus        78 G~   79 (226)
T TIGR02172        78 GK   79 (226)
T ss_pred             Cc
Confidence            84

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.00  E-value=0.0024  Score=51.09  Aligned_cols=72  Identities=24%  Similarity=0.340  Sum_probs=52.4

Q ss_pred             eeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCee-ecceeeeecccCCceEEEEEeec
Q 024091          140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       140 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      ...+.|++|++|.||++.+  .|..+|+|+-+.+  +..+..|+++|..+.-.++- ++|.+-     .    .++.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg-----~----~~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG-----E----DFIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec-----h----hhhhhhh
Confidence            3467899999999999988  5678999976544  34456899999999876664 333221     1    4566999


Q ss_pred             ccccHH
Q 024091          217 ISETVY  222 (272)
Q Consensus       217 ~~~~l~  222 (272)
                      +.|-.+
T Consensus        94 i~G~~L   99 (201)
T COG2112          94 IDGRPL   99 (201)
T ss_pred             hcCcch
Confidence            998433

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.91  E-value=0.014  Score=48.26  Aligned_cols=78  Identities=17%  Similarity=0.152  Sum_probs=52.3

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCC--eeecceeeeecccCCceEEEEEeecc
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      ++.|+.|..+.||+.....  ..+++|.....  .....+|..+++.|....  +.+++.+..  ......+.+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~--~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDT--SDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEE--ETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecc--cccccccceEEEEEe
Confidence            4679999999999998744  58999987554  344567999988886443  445554321  112333478999999


Q ss_pred             cccHHH
Q 024091          218 SETVYR  223 (272)
Q Consensus       218 ~~~l~~  223 (272)
                      +|..+.
T Consensus        78 ~g~~~~   83 (239)
T PF01636_consen   78 PGRPLD   83 (239)
T ss_dssp             SSEEHH
T ss_pred             cccccc
Confidence            976443

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=96.90  E-value=0.0093  Score=59.48  Aligned_cols=108  Identities=17%  Similarity=0.159  Sum_probs=66.2

Q ss_pred             eEEeccCCceEEEEEEECCCC--CEEEEEEeecc-----chhHHHHHHHHHHcC-CCCe--eecceeeeecccCCceEEE
Q 024091          142 ERVVGTGSFGVVFQAKCLETG--DSVAIKKVLQD-----KRYKNRELQIMRLLN-HPNV--VSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~--~~vAvK~i~~~-----~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~~~~~~~~~~  211 (272)
                      ...|+.|.+..+|+......+  ..+++|.....     .....+|+.+|+.|. |.+|  .+++.++...  ......|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence            467899999999998764332  36777765432     234668999999996 6665  5555443211  1123468


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH  256 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~  256 (272)
                      +||||++|..+.   .  .....++......++.+++..|..||+
T Consensus       121 lVME~v~G~~~~---~--~~~~~~~~~~r~~l~~~l~~~La~LH~  160 (822)
T PLN02876        121 YIMEYLEGRIFV---D--PKLPGVAPERRRAIYRATAKVLAALHS  160 (822)
T ss_pred             EEEEecCCcccC---C--ccCCCCCHHHHHHHHHHHHHHHHHHhC
Confidence            999999986421   0  001123344455566677777777764

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=96.84  E-value=0.01  Score=50.04  Aligned_cols=71  Identities=14%  Similarity=0.055  Sum_probs=44.3

Q ss_pred             eccCCc-eEEEEEEECCCCCEEEEEEeecc-chhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEEEEeecccccH
Q 024091          145 VGTGSF-GVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYISETV  221 (272)
Q Consensus       145 lG~G~f-g~V~~~~~~~~~~~vAvK~i~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l  221 (272)
                      |-.|.. ..||+...  .+..+.||..... .....+|+++++.+. +--+.+++++...     ....++|||+++|..
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~e~i~G~~   78 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLTSAVPGVP   78 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEEEeeCCcc
Confidence            444555 78898864  2467888876432 234567999998885 3334455554421     123678999998754


Q ss_pred             H
Q 024091          222 Y  222 (272)
Q Consensus       222 ~  222 (272)
                      +
T Consensus        79 l   79 (244)
T cd05150          79 A   79 (244)
T ss_pred             H
Confidence            4

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PRK10593 hypothetical protein; Provisional

Probab=96.45  E-value=0.038  Score=48.35  Aligned_cols=76  Identities=8%  Similarity=0.004  Sum_probs=51.4

Q ss_pred             eeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCC---CCeeecceeeeecccCCceEEEEEee
Q 024091          141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNH---PNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       141 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      -.+.||.|..+.||..... .+ .+.+|..+..  ...+..|...|+.|.-   -.+.++++++...  ......+||||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEEEEe
Confidence            3567999999999998542 23 4677875442  3467789999998863   3466766654221  11233789999


Q ss_pred             ccccc
Q 024091          216 YISET  220 (272)
Q Consensus       216 ~~~~~  220 (272)
                      ++.+.
T Consensus        94 ~i~G~   98 (297)
T PRK10593         94 RLRGV   98 (297)
T ss_pred             ccCCE
Confidence            99975

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.40  E-value=0.00076  Score=63.56  Aligned_cols=115  Identities=17%  Similarity=0.066  Sum_probs=74.9

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCC-eeecceeeeecccCCceEEEEEeecc
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPN-VVSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      |....-+++|+++++++.+...+...+ .+.+.+. ....-++++|.+++||| .+.+++-+     +.+.+.+++|+++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRIC  316 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhhh
Confidence            344556899999999999876665555 6766544 33456899999999999 55544443     6667899999999


Q ss_pred             ccc--HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 024091          218 SET--VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD  264 (272)
Q Consensus       218 ~~~--l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrD  264 (272)
                      +++  ...   ........+.+.....+.+.-+.+|+|+|+ .--+|||
T Consensus       317 s~~rs~~~---~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d  361 (829)
T KOG0576|consen  317 STGRSSAL---EMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD  361 (829)
T ss_pred             cCCccccc---cCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc
Confidence            865  111   000001112222333444556778999997 4458998

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=96.17  E-value=0.00074  Score=66.71  Aligned_cols=127  Identities=20%  Similarity=0.152  Sum_probs=85.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .+.+.+.+-+-.|.|+.++.+.-..+|..+++|.....       -.....+-.++-...+|.++...--|     ....
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs  877 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS  877 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence            44577888999999999999988888877777755322       12222344444445567777654333     2233


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      -.+|+|+|+++ ++...+..    -......-++-+...+..+++|||. ..++|||++|.|+|+
T Consensus       878 P~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~  937 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLI  937 (1205)
T ss_pred             CcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhh
Confidence            38999999985 43333222    2234445566677788999999997 669999999999873

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.13  E-value=0.077  Score=44.30  Aligned_cols=70  Identities=21%  Similarity=0.307  Sum_probs=44.6

Q ss_pred             eEEeccCCceEEEEEEECC-CCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCe-eecceeeeecccCCceEEEEEeec
Q 024091          142 ERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      .+.|..|-...+|+..... .++.|.+|+.....   ....+|+.+++.+...++ ++++..+     ..    .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence            3567788888999987533 35678899764332   123479999998864433 3443322     11    379999


Q ss_pred             cccc
Q 024091          217 ISET  220 (272)
Q Consensus       217 ~~~~  220 (272)
                      ++|.
T Consensus        74 i~G~   77 (235)
T cd05157          74 IPGR   77 (235)
T ss_pred             eCCC
Confidence            8864

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=96.01  E-value=0.036  Score=46.55  Aligned_cols=71  Identities=13%  Similarity=0.094  Sum_probs=39.9

Q ss_pred             EEeccCCce-EEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCC---CeeecceeeeecccCCceEEEEEeec
Q 024091          143 RVVGTGSFG-VVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHP---NVVSLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       143 ~~lG~G~fg-~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      +.|+.|+.. .||+.     +..+.+|.....  .....+|.++|..|...   -+..+++..  .......+.|++|++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~--~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKG--EPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecC--CCccCCCcceEEEEe
Confidence            457766665 58875     234677865432  23456899999888632   223332211  111111245789999


Q ss_pred             cccc
Q 024091          217 ISET  220 (272)
Q Consensus       217 ~~~~  220 (272)
                      ++|.
T Consensus        76 i~G~   79 (235)
T cd05155          76 LEGE   79 (235)
T ss_pred             ecCC
Confidence            8863

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=95.93  E-value=0.017  Score=47.00  Aligned_cols=85  Identities=20%  Similarity=0.192  Sum_probs=60.5

Q ss_pred             HHHHHHHHHcCC-CCeeecceeeeecccCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 024091          178 NRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH  255 (272)
Q Consensus       178 ~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH  255 (272)
                      +.|.-+|+.+.+ +++++++|.|     .    -+++.||++. .++.... ........++.....|+.+++..+++|+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHh
Confidence            358889999986 6999999987     2    3568899984 3321100 0001123678888999999999999998


Q ss_pred             hc--CCceecCCCCCCeeC
Q 024091          256 HV--VGVCHRDIKPQNLLM  272 (272)
Q Consensus       256 ~~--~~iiHrDlKp~NILl  272 (272)
                      +.  ..+.-.|++|+|+-+
T Consensus        77 ~~~~~~~~lcDv~~~nfgv   95 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGV   95 (188)
T ss_pred             cCCCCcEEEeecchHHeEE
Confidence            51  247779999999853

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=95.45  E-value=0.058  Score=45.84  Aligned_cols=66  Identities=17%  Similarity=0.181  Sum_probs=41.4

Q ss_pred             eccCCceEEEEEEECCCCCEEEEEEeeccch----hHHHHHHHHHHcCCCCee-ecceeeeecccCCceEEEEEeecccc
Q 024091          145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKR----YKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLVLEYISE  219 (272)
Q Consensus       145 lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~----~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~~lv~e~~~~  219 (272)
                      +..|-...+|+..  .+++.+++|.......    ...+|..+++.+...+++ +++..+     .    -++||||++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence            4556777888876  3566788887543321    246799999998754443 333221     1    2589999987


Q ss_pred             cH
Q 024091          220 TV  221 (272)
Q Consensus       220 ~l  221 (272)
                      ..
T Consensus        73 ~~   74 (256)
T TIGR02721        73 EV   74 (256)
T ss_pred             cc
Confidence            43

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.75  E-value=0.13  Score=46.76  Aligned_cols=58  Identities=29%  Similarity=0.288  Sum_probs=34.4

Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..|+-+|..| ++..+++     ....++.....++.--..||.-+--..+++|.|+.|.||++
T Consensus       320 ~vl~E~~~~Gl~v~~~v~-----~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVli  378 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVK-----WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLI  378 (565)
T ss_pred             ceeeeeccccccHHhhhh-----cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEE
Confidence            3445556654 3333322     23345555555665555565544434689999999999985

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=94.61  E-value=0.0064  Score=55.92  Aligned_cols=70  Identities=23%  Similarity=0.469  Sum_probs=55.4

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchh-----HHHHHHHHHHcCCCCeeecceeeeecc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-----KNRELQIMRLLNHPNVVSLKHCFFSTT  203 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-----~~~E~~~l~~l~h~nIv~l~~~~~~~~  203 (272)
                      .....|..+.++|.|+||+|+.+....++..+|||.|......     ..+|+.-+..+.|++|+++...|....
T Consensus        46 r~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~  120 (516)
T KOG1033|consen   46 REANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYERP  120 (516)
T ss_pred             hhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecCC
Confidence            4445688899999999999999998888878999988543222     235777788999999999988876554

>PRK05231 homoserine kinase; Provisional

Probab=94.26  E-value=0.58  Score=41.02  Aligned_cols=73  Identities=8%  Similarity=-0.010  Sum_probs=40.5

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeec-cchhHHHHHHHHHHcCCCC--eeecce----eeeecccCCceEEEEEee
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNRELQIMRLLNHPN--VVSLKH----CFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-~~~~~~~E~~~l~~l~h~n--Iv~l~~----~~~~~~~~~~~~~~lv~e  215 (272)
                      +.|+.|....+|+....  +..+.+|+... .......|+.++..|...+  +.+++.    .++.   ......+++||
T Consensus        28 ~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~---~~~g~~~~l~~  102 (319)
T PRK05231         28 KGIAEGIENSNFFLTTT--QGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALG---ELAGKPAAIVT  102 (319)
T ss_pred             chhccccccceEEEEeC--CCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEee---eeCCEEEEEEE
Confidence            45677777889987642  33688897641 2223345667776664222  223221    1111   11223688999


Q ss_pred             ccccc
Q 024091          216 YISET  220 (272)
Q Consensus       216 ~~~~~  220 (272)
                      |++|.
T Consensus       103 ~l~G~  107 (319)
T PRK05231        103 FLEGK  107 (319)
T ss_pred             ecCCC
Confidence            99875

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.12  E-value=0.3  Score=42.30  Aligned_cols=77  Identities=6%  Similarity=-0.072  Sum_probs=45.2

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeec-cchhHHHHHHHHHHcCCCC--eeecceeeeec-ccCCceEEEEEeecc
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNRELQIMRLLNHPN--VVSLKHCFFST-TEKDELYLNLVLEYI  217 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~-~~~~~~~~~lv~e~~  217 (272)
                      .+.|..|....+|+...  .+..+++|+... .......|+.++..|.+.+  +.+++...... ........++||+++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            45677787788998754  345688898763 2334457888888885433  33433210000 001112367899999


Q ss_pred             ccc
Q 024091          218 SET  220 (272)
Q Consensus       218 ~~~  220 (272)
                      +|.
T Consensus        97 ~G~   99 (296)
T cd05153          97 AGE   99 (296)
T ss_pred             CCC
Confidence            864

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=94.09  E-value=0.66  Score=42.34  Aligned_cols=71  Identities=24%  Similarity=0.309  Sum_probs=48.1

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeec-----------cchhHHHHHHHHHHcC---CCCeeecceeeeecccCCc
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----------DKRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----------~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~  207 (272)
                      .+.||.|.+..||++.....++.|.||+-..           .......|.+.|+.+.   -..+++++.+-  .     
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~-----  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E-----  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C-----
Confidence            3679999999999998754335899997431           1122346888888763   34566776542  1     


Q ss_pred             eEEEEEeecccc
Q 024091          208 LYLNLVLEYISE  219 (272)
Q Consensus       208 ~~~~lv~e~~~~  219 (272)
                      ...++|||++++
T Consensus       104 ~~~~lVME~L~~  115 (401)
T PRK09550        104 ELAVTVMEDLSD  115 (401)
T ss_pred             CCCEEEEecCCC
Confidence            115799999985

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.09  E-value=0.42  Score=41.81  Aligned_cols=77  Identities=6%  Similarity=-0.080  Sum_probs=43.8

Q ss_pred             eeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCC--eeecceeeeec-ccCCceEEEEEee
Q 024091          141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPN--VVSLKHCFFST-TEKDELYLNLVLE  215 (272)
Q Consensus       141 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~-~~~~~~~~~lv~e  215 (272)
                      ..+.++.|.-..+|+... . +..+.+|+....  ......|++++..|...+  +.+++...... ........+++||
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             eccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            346677777788998764 2 335778876542  234456788887775322  33333211000 0011234689999


Q ss_pred             cccc
Q 024091          216 YISE  219 (272)
Q Consensus       216 ~~~~  219 (272)
                      |++|
T Consensus       104 ~i~G  107 (307)
T TIGR00938       104 FLQG  107 (307)
T ss_pred             eCCC
Confidence            9886

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.82  E-value=0.89  Score=39.56  Aligned_cols=63  Identities=13%  Similarity=0.119  Sum_probs=35.7

Q ss_pred             EEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCC--eeeccee----eeecccCCceEEEEEeecccc
Q 024091          152 VVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPN--VVSLKHC----FFSTTEKDELYLNLVLEYISE  219 (272)
Q Consensus       152 ~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~----~~~~~~~~~~~~~lv~e~~~~  219 (272)
                      .||+...  .+..+++|...........|+.++..|...+  ++.++..    ++..   .+...++++||++|
T Consensus        11 ~v~~v~t--~~g~~~LK~~~~~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~---~~~~~~~l~~~i~G   79 (313)
T TIGR02906        11 NVYKVET--DSGNKCLKKINYPPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVK---YNGDLYVLTEWIEG   79 (313)
T ss_pred             cEEEEEe--CCCCeEEEEcCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE---ECCEEEEEehhccC
Confidence            4787763  2336889987544444556777777765333  2232211    1111   12357899999986

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=93.74  E-value=0.049  Score=48.03  Aligned_cols=114  Identities=16%  Similarity=0.173  Sum_probs=70.6

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeec----------cch----------------hHHHHHHHHHHcC-CCC
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----------DKR----------------YKNRELQIMRLLN-HPN  191 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~----------~~~----------------~~~~E~~~l~~l~-h~n  191 (272)
                      +.++..||-|--+-||.+.+ ..|.+.++|.-+-          .+.                ...+|.+.|+.|. |.+
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            56778899999999999875 3578888885421          111                1126999999886 332


Q ss_pred             -eeecceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 024091          192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL  270 (272)
Q Consensus       192 -Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NI  270 (272)
                       |.+.+++.         .-|+|||++.+-.+....+      ...   +..+...++.-+--|-. +|+||+|..-=||
T Consensus       173 pVPkpiD~~---------RH~Vvmelv~g~Pl~~v~~------v~d---~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNi  233 (465)
T KOG2268|consen  173 PVPKPIDHN---------RHCVVMELVDGYPLRQVRH------VED---PPTLYDDLMGLIVRLAN-HGLIHGDFNEFNI  233 (465)
T ss_pred             CCCCccccc---------ceeeHHHhhcccceeeeee------cCC---hHHHHHHHHHHHHHHHH-cCceecccchhee
Confidence             33444332         2679999998754432211      111   12222333333444556 8999999988888


Q ss_pred             eC
Q 024091          271 LM  272 (272)
Q Consensus       271 Ll  272 (272)
                      +|
T Consensus       234 mv  235 (465)
T KOG2268|consen  234 MV  235 (465)
T ss_pred             EE
Confidence            75

>PHA03111 Ser/Thr kinase; Provisional

Probab=92.95  E-value=0.18  Score=44.62  Aligned_cols=62  Identities=16%  Similarity=0.271  Sum_probs=35.4

Q ss_pred             EEEeecccccHHHHHH-HhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---cCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSK-HYTRMNQHVPILYVQLYTYQICRALNYLHH---VVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~---~~~iiHrDlKp~NILl  272 (272)
                      .+|+++.-++...+-. .....+-.--...+++++.||+.-.-++-.   ....+|-||||.||||
T Consensus       251 IIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILi  316 (444)
T PHA03111        251 IIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILI  316 (444)
T ss_pred             EEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEE
Confidence            4677765543332211 112222222345678888888654433322   2469999999999996

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=92.22  E-value=1.7  Score=37.70  Aligned_cols=69  Identities=19%  Similarity=0.243  Sum_probs=42.0

Q ss_pred             EEeccCCceEEEEEEECC------CCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCee-ecceeeeecccCCceEEEE
Q 024091          143 RVVGTGSFGVVFQAKCLE------TGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~------~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~~l  212 (272)
                      +.|..|--..||+.....      .++.+++|+.....   ....+|..+++.+...++. +++.++     .+    .+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~~----~~   74 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF-----PN----GR   74 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe-----CC----Cc
Confidence            445566666888876432      25789999865432   2345798899888644433 444333     11    24


Q ss_pred             Eeeccccc
Q 024091          213 VLEYISET  220 (272)
Q Consensus       213 v~e~~~~~  220 (272)
                      |+||++|.
T Consensus        75 v~e~i~G~   82 (302)
T cd05156          75 IEEFIPSR   82 (302)
T ss_pred             hhheeCCC
Confidence            78887753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=92.19  E-value=0.064  Score=40.19  Aligned_cols=44  Identities=23%  Similarity=0.299  Sum_probs=32.7

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeeccch-hHHHHHHHHHH
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YKNRELQIMRL  186 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~E~~~l~~  186 (272)
                      ...||.|+.|+||+|+.. +|+.||||+.+.... .....+.+|+.
T Consensus        16 ~~PlasASiaQVh~a~l~-~g~~VaVKV~rP~i~~~i~~Dl~~l~~   60 (119)
T PF03109_consen   16 PEPLASASIAQVHRARLK-DGEEVAVKVQRPGIEEQIEADLRILRR   60 (119)
T ss_pred             cchhhheehhhheeeeec-ccchhhhhhcchHHHHHHHHHHHHHHH
Confidence            357999999999999864 499999998866543 34455666654

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PLN02236 choline kinase

Probab=91.59  E-value=0.87  Score=40.66  Aligned_cols=69  Identities=17%  Similarity=0.158  Sum_probs=41.2

Q ss_pred             eEEeccCCceEEEEEEECC----CCCEEEEEEeeccch---hHHHHHHHHHHcCCCCee-ecceeeeecccCCceEEEEE
Q 024091          142 ERVVGTGSFGVVFQAKCLE----TGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~----~~~~vAvK~i~~~~~---~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ...|-.|-.-.+|++....    .++.|.+|+......   ...+|..+++.+..-++. ++++.|     .++    .|
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~-----~~g----~v  111 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF-----PNG----RV  111 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE-----CCc----eE
Confidence            3445457777888876432    246788997644322   125699999888754443 444444     221    46


Q ss_pred             eecccc
Q 024091          214 LEYISE  219 (272)
Q Consensus       214 ~e~~~~  219 (272)
                      .+|+.+
T Consensus       112 ~efi~g  117 (344)
T PLN02236        112 EEFIHA  117 (344)
T ss_pred             EEeeCC
Confidence            777764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=91.39  E-value=0.83  Score=39.48  Aligned_cols=42  Identities=17%  Similarity=0.082  Sum_probs=25.9

Q ss_pred             ccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcC
Q 024091          146 GTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLN  188 (272)
Q Consensus       146 G~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~  188 (272)
                      +.|--..||... ...|..+++|.-+..  .....+|..+|+.|.
T Consensus        20 ~~g~~~~v~~i~-~~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~   63 (276)
T cd05152          20 ESGLDFQVVFAK-DTDGVPWVLRIPRRPDVSERAAAEKRVLALVR   63 (276)
T ss_pred             CCcceeEEEEEE-cCCCCeEEEEecCCHHHHHHHHHHHHHHHHHH
Confidence            444344555542 234778888876432  234568999999886

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=90.64  E-value=0.34  Score=43.12  Aligned_cols=60  Identities=22%  Similarity=0.416  Sum_probs=35.2

Q ss_pred             EEEeecccccHHHHHH-HhhhcCCCCCHHHHHHHHHHHHHHHHHHH--h---cCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSK-HYTRMNQHVPILYVQLYTYQICRALNYLH--H---VVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~qi~~~L~ylH--~---~~~iiHrDlKp~NILl  272 (272)
                      .+|+++.-++...+-. .+...+-..-...+++++.||+  |-|+-  .   ....+|-||||+||||
T Consensus       247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILi  312 (434)
T PF05445_consen  247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILI  312 (434)
T ss_pred             EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEE
Confidence            3788876654433211 1222222233456778888865  44421  1   2469999999999996

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=90.01  E-value=3.1  Score=36.37  Aligned_cols=65  Identities=14%  Similarity=0.303  Sum_probs=36.3

Q ss_pred             ceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCC---CCeeecce----eeeecccCCceEEEEEeecccc
Q 024091          150 FGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNH---PNVVSLKH----CFFSTTEKDELYLNLVLEYISE  219 (272)
Q Consensus       150 fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h---~nIv~l~~----~~~~~~~~~~~~~~lv~e~~~~  219 (272)
                      -|.||++.-  ++..+++|.+..........+.++..|..   +.+++++-    ..+.   ..+...|++|++++|
T Consensus        19 ~~~v~~v~T--~~G~~~Lk~~~~~~~~l~~~~~~~~~L~~~G~~~~~~~~~t~~G~~~~---~~~~~~~~L~~wi~G   90 (309)
T TIGR02904        19 TGKLFKVYT--DQGVFALKKLYADRNTIESFVSQIQVLSEKGFSRIVPVYPTKDGSYYL---FHGHFLYYLMPWLDI   90 (309)
T ss_pred             cCcEEEEEe--CCCCEEEEEeccchHhHHHHHHHHHHHHHcCCCcCCceeecCCCCeee---EECCEEEEEeCCccc
Confidence            458888764  34468999886554444455666666643   33444321    1110   112235889999876

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=89.94  E-value=1.9  Score=39.64  Aligned_cols=127  Identities=13%  Similarity=0.169  Sum_probs=74.6

Q ss_pred             eeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-hhHHHHHHHHHHc-CCCCeeeccee----eeecccCCceEEEEE
Q 024091          140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLL-NHPNVVSLKHC----FFSTTEKDELYLNLV  213 (272)
Q Consensus       140 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~E~~~l~~l-~h~nIv~l~~~----~~~~~~~~~~~~~lv  213 (272)
                      ...+.||+|+-+.+|-.-  .-+..|| |+...-. .....-++.|... .||-+-.=+.|    .+..  +.+..+-++
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VA-KIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVA-KIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG--RRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhh-eeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC--CccceeEEe
Confidence            345789999999998532  1234455 6553321 1112223334333 35543320111    1111  222336778


Q ss_pred             eecccc--cHHHHHHH--hhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISE--TVYRVSKH--YTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~--~l~~~~~~--~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |..+.+  .+..++.-  ..+......+..+...++.++.+..-||. .|.+-+|+.++|||+
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lV  150 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLV  150 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceee
Confidence            888875  33322221  11222346788899999999999999998 899999999999986

>PLN02756 S-methyl-5-thioribose kinase

Probab=88.46  E-value=5.3  Score=36.62  Aligned_cols=69  Identities=20%  Similarity=0.257  Sum_probs=46.0

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeec-----------cchhHHHHHHHHHHcC---CCCeeecceeeeecccCCc
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----------DKRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----------~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~  207 (272)
                      .+.||.|....||+..+  .+..|.||+-..           .......|...|+.+.   -..+.++|.+.     .+.
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~  109 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM  109 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence            56789999999999876  345689997541           1222235777776654   24677777654     111


Q ss_pred             eEEEEEeecccc
Q 024091          208 LYLNLVLEYISE  219 (272)
Q Consensus       208 ~~~~lv~e~~~~  219 (272)
                        -+++||++++
T Consensus       110 --~vlvME~L~~  119 (418)
T PLN02756        110 --ALIGMRYLEP  119 (418)
T ss_pred             --CEEEEeecCC
Confidence              4678999986

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=87.72  E-value=5  Score=35.55  Aligned_cols=69  Identities=17%  Similarity=0.292  Sum_probs=39.9

Q ss_pred             EEeccCCceEEEEEEECCC---CCEEEEEEeeccch---hHHHHHHHHHHcCCCCee-ecceeeeecccCCceEEEEEee
Q 024091          143 RVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~~---~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      +.|-.|=.-.+|+......   +..|.+|+......   ...+|..+++.+..-++- ++++++     .++    +|.+
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~-----~~G----~i~~   90 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF-----GNG----MIQS   90 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe-----CCc----Eeeh
Confidence            3444466677888764332   23788887643322   235799999988755553 444433     221    4677


Q ss_pred             ccccc
Q 024091          216 YISET  220 (272)
Q Consensus       216 ~~~~~  220 (272)
                      |+.+.
T Consensus        91 fi~g~   95 (330)
T PLN02421         91 FINAR   95 (330)
T ss_pred             hhcCC
Confidence            77643

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=87.69  E-value=5  Score=34.93  Aligned_cols=74  Identities=15%  Similarity=0.128  Sum_probs=43.9

Q ss_pred             eeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-chhHHHHHHHHHHcC---CCCeeecceeeeecccCCceEEEEEee
Q 024091          140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       140 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      .-.+.|+.|....+|+..  .+++.+.||.-... ...+..|.+-|+.|.   --.+.+++.+....+.     -|||||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-----~fLlle   92 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-----AFLLLE   92 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-----CEEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-----ceEEEE
Confidence            345678989999999876  57788999977633 445778999888884   3345566665432221     489999


Q ss_pred             ccccc
Q 024091          216 YISET  220 (272)
Q Consensus       216 ~~~~~  220 (272)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99855

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=85.89  E-value=8.5  Score=34.71  Aligned_cols=69  Identities=25%  Similarity=0.258  Sum_probs=44.4

Q ss_pred             EeccCCceEEEEEEECCCCCEEEEEEeec-----------cchhHHHHHHHHHHcC--CC-CeeecceeeeecccCCceE
Q 024091          144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----------DKRYKNRELQIMRLLN--HP-NVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----------~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~~~~  209 (272)
                      .||.|....||++.....++.|.||+-..           .......|...|+...  -| .+.++|.+  ..    . .
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~----e-~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DT----E-M   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cc----c-c
Confidence            47999999999999754346899997532           1122245888887664  23 45556543  11    1 1


Q ss_pred             EEEEeecccc
Q 024091          210 LNLVLEYISE  219 (272)
Q Consensus       210 ~~lv~e~~~~  219 (272)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            4589999975

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=84.33  E-value=6.6  Score=35.89  Aligned_cols=71  Identities=20%  Similarity=0.217  Sum_probs=47.2

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeec----------cchhHHHHHHHHHHcC--CC-CeeecceeeeecccCCce
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----------DKRYKNRELQIMRLLN--HP-NVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~----------~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~~~  208 (272)
                      .+.||.|.-..||++.+...++.|.||+-..          .......|.++|+.+.  -| .+.++|.+  ...     
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e-----  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSV-----  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcH-----
Confidence            5678999999999998743457899997532          1222345888888764  34 45566543  111     


Q ss_pred             EEEEEeecccc
Q 024091          209 YLNLVLEYISE  219 (272)
Q Consensus       209 ~~~lv~e~~~~  219 (272)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            15689999975

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=80.33  E-value=2.8  Score=43.05  Aligned_cols=78  Identities=15%  Similarity=0.240  Sum_probs=49.1

Q ss_pred             HHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 024091          178 NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH  256 (272)
Q Consensus       178 ~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~  256 (272)
                      +.|...+.++.|+|++.++.|-...-... ..+.+.-|+|.. .+...+.    .-..++...++.+..+++.||.|+|.
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH
Confidence            34677788889999999887654332211 112223345543 2222222    23567888899999999999999997


Q ss_pred             cCCce
Q 024091          257 VVGVC  261 (272)
Q Consensus       257 ~~~ii  261 (272)
                       ....
T Consensus       305 -~~l~  308 (1351)
T KOG1035|consen  305 -LSLE  308 (1351)
T ss_pred             -hccc
Confidence             4333

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	272
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-50
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-50
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-50
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-50
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-50
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-50
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-50
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-50
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-50
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-50
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-49
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-49
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-49
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-48
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-48
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-48
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-48
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-48
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-47
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-47
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-47
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-46
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-30
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-28
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-14
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		9e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-07
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-07
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-07
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-07
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-07
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-07
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-07
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-07
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-07
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-07
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-06
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-06
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-05
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-05
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		4e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-05
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-05
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-05
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		6e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-05
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		9e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-04
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-04
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-04
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-04
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-04
3soa_A	444	Full-Length Human Camkii Length = 444		1e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-04
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-04
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-04
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		7e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		7e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-04
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-04
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-04

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  196 bits (498), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 99/211 (46%), Positives = 139/211 (65%), Gaps = 20/211 (9%)
Query: 63  PVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVI 122
           P+ S+    T +  E     Q P     M++  +K+                G++   V+
Sbjct: 2   PLGSSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKD----------------GSKVTTVV 45
Query: 123 ATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ 182
           AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQDKR+KNRELQ
Sbjct: 46  ATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 103
Query: 183 IMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
           IMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R  Q +P++YV+
Sbjct: 104 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 163
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 164 LYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 193

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  194 bits (493), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 91/162 (56%), Positives = 126/162 (77%), Gaps = 4/162 (2%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
           + +G++   V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 172 QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTR 230
           QDKR+KNRELQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q +P++YV+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 189

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  194 bits (492), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 91/162 (56%), Positives = 126/162 (77%), Gaps = 4/162 (2%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
           + +G++   V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 172 QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTR 230
           QDKR+KNRELQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q +P++YV+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 189

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  194 bits (492), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 91/160 (56%), Positives = 125/160 (78%), Gaps = 4/160 (2%)
Query: 114 NGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD 173
           +G++   V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQD
Sbjct: 35  DGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD 92
Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMN 232
           KR+KNRELQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R  
Sbjct: 93  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 152
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q +P++YV+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 153 QTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 191

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  193 bits (491), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 91/160 (56%), Positives = 125/160 (78%), Gaps = 4/160 (2%)
Query: 114 NGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD 173
           +G++   V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQD
Sbjct: 78  DGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD 135
Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMN 232
           KR+KNRELQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R  
Sbjct: 136 KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 195
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q +P++YV+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 196 QTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 234

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  193 bits (491), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 91/162 (56%), Positives = 126/162 (77%), Gaps = 4/162 (2%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
           + +G++   V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVL
Sbjct: 25  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 82
Query: 172 QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTR 230
           QDKR+KNRELQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R
Sbjct: 83  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 142
Query: 231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q +P++YV+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 143 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 183

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  193 bits (491), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 91/162 (56%), Positives = 126/162 (77%), Gaps = 4/162 (2%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
           + +G++   V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 172 QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTR 230
           QDKR+KNRELQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q +P++YV+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 167

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  193 bits (490), Expect = 9e-50,   Method: Compositional matrix adjust.
 Identities = 91/162 (56%), Positives = 126/162 (77%), Gaps = 4/162 (2%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
           + +G++   V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 172 QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTR 230
           QDKR+KNRELQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q +P++YV+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 167

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  193 bits (490), Expect = 9e-50,   Method: Compositional matrix adjust.
 Identities = 91/162 (56%), Positives = 126/162 (77%), Gaps = 4/162 (2%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
           + +G++   V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 172 QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTR 230
           QDKR+KNRELQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q +P++YV+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 163

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  193 bits (490), Expect = 9e-50,   Method: Compositional matrix adjust.
 Identities = 91/162 (56%), Positives = 126/162 (77%), Gaps = 4/162 (2%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
           + +G++   V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 172 QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTR 230
           QDKR+KNRELQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q +P++YV+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 174

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  193 bits (490), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 91/162 (56%), Positives = 126/162 (77%), Gaps = 4/162 (2%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
           + +G++   V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 172 QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTR 230
           QDKR+KNRELQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q +P++YV+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 168

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  192 bits (487), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 91/159 (57%), Positives = 124/159 (77%), Gaps = 4/159 (2%)
Query: 115 GTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK 174
           G++   V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQDK
Sbjct: 4   GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK 61
Query: 175 RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQ 233
           R+KNRELQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R  Q
Sbjct: 62  RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ 121
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            +P++YV+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 122 TLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 159

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  190 bits (483), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 90/153 (58%), Positives = 121/153 (79%), Gaps = 4/153 (2%)
Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
           V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQDKR+KNRE
Sbjct: 11  VVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE 68
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           LQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R  Q +P++Y
Sbjct: 69  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 128
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           V+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 129 VKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 160

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 90/153 (58%), Positives = 121/153 (79%), Gaps = 4/153 (2%)
Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
           V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQDKR+KNRE
Sbjct: 6   VVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE 63
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           LQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R  Q +P++Y
Sbjct: 64  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           V+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 155

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 90/153 (58%), Positives = 121/153 (79%), Gaps = 4/153 (2%)
Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
           V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQDKR+KNRE
Sbjct: 6   VVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE 63
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           LQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R  Q +P++Y
Sbjct: 64  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           V+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 155

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  189 bits (480), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 90/153 (58%), Positives = 121/153 (79%), Gaps = 4/153 (2%)
Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
           V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQDKR+KNRE
Sbjct: 6   VVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE 63
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           LQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R  Q +P++Y
Sbjct: 64  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           V+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 155

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  189 bits (480), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 90/153 (58%), Positives = 121/153 (79%), Gaps = 4/153 (2%)
Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
           V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQDKR+KNRE
Sbjct: 7   VVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE 64
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           LQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R  Q +P++Y
Sbjct: 65  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 124
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           V+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 125 VKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 156

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  187 bits (474), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 88/146 (60%), Positives = 118/146 (80%), Gaps = 4/146 (2%)
Query: 128 GRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL 187
           G+ G+ ++ I+Y   +V+G GSFGVVFQAK +E+ D VAIKKVLQDKR+KNRELQIMR++
Sbjct: 32  GKTGE-QREIAYTNCKVIGNGSFGVVFQAKLVES-DEVAIKKVLQDKRFKNRELQIMRIV 89
Query: 188 NHPNVVSLKHCFFSTTEK-DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
            HPNVV LK  F+S  +K DE++LNLVLEY+ ETVYR S+HY ++ Q +P+L ++LY YQ
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           + R+L Y+H  +G+CHRDIKPQNLL+
Sbjct: 150 LLRSLAYIHS-IGICHRDIKPQNLLL 174

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 89/153 (58%), Positives = 120/153 (78%), Gaps = 4/153 (2%)
Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
           V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQDKR+KNRE
Sbjct: 6   VVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE 63
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           LQIMR L+H N+V L++ F+S+ E KD +YLNLVL+Y+ ETVYRV++HY+R  Q +P++Y
Sbjct: 64  LQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           V+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 155

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  184 bits (466), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 88/153 (57%), Positives = 119/153 (77%), Gaps = 4/153 (2%)
Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
           V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQ K +KNRE
Sbjct: 6   VVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE 63
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           LQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R  Q +P++Y
Sbjct: 64  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           V+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 155

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  184 bits (466), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 88/153 (57%), Positives = 119/153 (77%), Gaps = 4/153 (2%)
Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
           V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQ K +KNRE
Sbjct: 6   VVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE 63
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           LQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R  Q +P++Y
Sbjct: 64  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           V+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 155

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  181 bits (460), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 87/153 (56%), Positives = 118/153 (77%), Gaps = 4/153 (2%)
Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
           V+AT   G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQ K +KNRE
Sbjct: 6   VVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE 63
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           LQIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+  TVYRV++HY+R  Q +P++Y
Sbjct: 64  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIY 123
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           V+LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 155

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  127 bits (318), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 63/145 (43%), Positives = 99/145 (68%), Gaps = 6/145 (4%)
Query: 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR---LLNHP 190
           K+   +  ER+ G G+FG V   K   TG SVAIKKV+QD R++NRELQIM+   +L+HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 191 NVVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           N+V L+  F++  E+D  ++YLN+V+EY+ +T++R  ++Y R     P + ++++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 249 RALNYLH-HVVGVCHRDIKPQNLLM 272
           R++  LH   V VCHRDIKP N+L+
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLV 164

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 60/167 (35%), Positives = 98/167 (58%), Gaps = 34/167 (20%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHC 198
           Y   + +GTGSFG+V +   +E+G   A+KKVLQD RYKNREL IM++L+H N++ L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 199 FFSTTEKDEL---------------------------------YLNLVLEYISETVYRVS 225
           F++T +++                                   YLN+++EY+ +T+++V 
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 226 KHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           K + R  + +P+  + +Y YQ+ RA+ ++H  +G+CHRDIKPQNLL+
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLV 174

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/143 (34%), Positives = 77/143 (53%), Gaps = 14/143 (9%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHP 190
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+ +++ LNHP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           NV+     F    E     LN+VLE   +  + R+ KH+ +  + +P   V  Y  Q+C 
Sbjct: 93  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           AL ++H    V HRDIKP N+ +
Sbjct: 148 ALEHMHS-RRVMHRDIKPANVFI 169

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/134 (36%), Positives = 75/134 (55%), Gaps = 15/134 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHC 198
           +G GS+GVVF+ +  +TG  VAIKK L+       K+   RE+++++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
           F     + +  L+LV EY   TV      Y R    VP   V+  T+Q  +A+N+ H   
Sbjct: 71  F-----RRKRRLHLVFEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHK-H 121
Query: 259 GVCHRDIKPQNLLM 272
              HRD+KP+N+L+
Sbjct: 122 NCIHRDVKPENILI 135

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 83/152 (54%), Gaps = 16/152 (10%)
Query: 128 GRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------REL 181
           G  G P+   ++     +G G++GVV++A+   TG+ VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            +++ LNHPN+V L     +   +++LY  LV E++ + + +           +P+  ++
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIK 113
Query: 242 LYTYQICRALNYLH-HVVGVCHRDIKPQNLLM 272
            Y +Q+ + L + H H   V HRD+KPQNLL+
Sbjct: 114 SYLFQLLQGLAFCHSH--RVLHRDLKPQNLLI 143

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 83/152 (54%), Gaps = 16/152 (10%)
Query: 128 GRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------REL 181
           G  G P+   ++     +G G++GVV++A+   TG+ VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            +++ LNHPN+V L     +   +++LY  LV E++ + + +           +P+  ++
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIK 113
Query: 242 LYTYQICRALNYLH-HVVGVCHRDIKPQNLLM 272
            Y +Q+ + L + H H   V HRD+KPQNLL+
Sbjct: 114 SYLFQLLQGLAFCHSH--RVLHRDLKPQNLLI 143

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 78/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L++ H H 
Sbjct: 71  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLSFCHSH- 122
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 123 -RVLHRDLKPQNLLI 136

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 71  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 123 -RVLHRDLKPQNLLI 136

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 75  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 126
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 127 -RVLHRDLKPQNLLI 140

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 74  IHT---ENKLY--LVFEHVDQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 126 -RVLHRDLKPQNLLI 139

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 72  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 124 -RVLHRDLKPQNLLI 137

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 74  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 126 -RVLHRDLKPQNLLI 139

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 71  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 123 -RVLHRDLKPQNLLI 136

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 74  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 126 -RVLHRDLKPQNLLI 139

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 73  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 125 -RVLHRDLKPQNLLI 138

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 73  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 125 -RVLHRDLKPQNLLI 138

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 75  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 126
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 127 -RVLHRDLKPQNLLI 140

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 71  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 123 -RVLHRDLKPQNLLI 136

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 72  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 124 -RVLHRDLKPQNLLI 137

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 71  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 123 -RVLHRDLKPQNLLI 136

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 70  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 122 -RVLHRDLKPQNLLI 135

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 71  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 123 -RVLHRDLKPQNLLI 136

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 70  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 122 -RVLHRDLKPQNLLI 135

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 72  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 124 -RVLHRDLKPQNLLI 137

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 71  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 123 -RVLHRDLKPQNLLI 136

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 70  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 122 -RVLHRDLKPQNLLI 135

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 70  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 122 -RVLHRDLKPQNLLI 135

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 71  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 123 -RVLHRDLKPQNLLI 136

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 79/137 (57%), Gaps = 20/137 (14%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQICRALNYLH- 255
             +   +++LY  LV E++S  +    K +   +    +P+  ++ Y +Q+ + L + H 
Sbjct: 73  IHT---ENKLY--LVFEFLSMDL----KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 256 HVVGVCHRDIKPQNLLM 272
           H   V HRD+KPQNLL+
Sbjct: 124 H--RVLHRDLKPQNLLI 138

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 79/137 (57%), Gaps = 20/137 (14%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQICRALNYLH- 255
             +   +++LY  LV E++S  +    K +   +    +P+  ++ Y +Q+ + L + H 
Sbjct: 74  IHT---ENKLY--LVFEFLSMDL----KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 256 HVVGVCHRDIKPQNLLM 272
           H   V HRD+KPQNLL+
Sbjct: 125 H--RVLHRDLKPQNLLI 139

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++S  + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 74  IHT---ENKLY--LVFEFLSMDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KP+NLL+
Sbjct: 126 -RVLHRDLKPENLLI 139

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 74/135 (54%), Gaps = 12/135 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKK------VLQDKRYKNRELQIMRLLNHPNVVSLKHC 198
           +G G++GVV  A+   TG  VAIKK      V+ + +   REL+I++   H N++++K  
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 199 FFSTTEKDEL-YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
              T    E   + +VL+ +   ++++       +Q + + +V+ + YQ+ R L Y+H  
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQI----IHSSQPLTLEHVRYFLYQLLRGLKYMHS- 177
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KP NLL+
Sbjct: 178 AQVIHRDLKPSNLLV 192

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 74/135 (54%), Gaps = 12/135 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKK------VLQDKRYKNRELQIMRLLNHPNVVSLKHC 198
           +G G++GVV  A+   TG  VAIKK      V+ + +   REL+I++   H N++++K  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 199 FFSTTEKDEL-YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
              T    E   + +VL+ +   ++++       +Q + + +V+ + YQ+ R L Y+H  
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQI----IHSSQPLTLEHVRYFLYQLLRGLKYMHS- 176
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KP NLL+
Sbjct: 177 AQVIHRDLKPSNLLV 191

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++S  + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 72  IHT---ENKLY--LVFEFLSMDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KP+NLL+
Sbjct: 124 -RVLHRDLKPENLLI 137

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 79/139 (56%), Gaps = 24/139 (17%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH----VPILYVQLYTYQICRALNYL 254
             +   +++LY  LV E++ + +       T M+      +P+  ++ Y +Q+ + L + 
Sbjct: 74  IHT---ENKLY--LVFEFLHQDL------KTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 255 H-HVVGVCHRDIKPQNLLM 272
           H H   V HRD+KPQNLL+
Sbjct: 123 HSH--RVLHRDLKPQNLLI 139

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 73  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KP+NLL+
Sbjct: 125 -RVLHRDLKPENLLI 138

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 77/135 (57%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 72  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KP+NLL+
Sbjct: 124 -RVLHRDLKPENLLI 137

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 79/139 (56%), Gaps = 24/139 (17%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH----VPILYVQLYTYQICRALNYL 254
             +   +++LY  LV E++ + +       T M+      +P+  ++ Y +Q+ + L + 
Sbjct: 70  IHT---ENKLY--LVFEHVHQDL------KTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 255 H-HVVGVCHRDIKPQNLLM 272
           H H   V HRD+KPQNLL+
Sbjct: 119 HSH--RVLHRDLKPQNLLI 135

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 76/135 (56%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+ K+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 71  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 123 -RVLHRDLKPQNLLI 136

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 76/135 (56%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+ K+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
             +   +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H H 
Sbjct: 70  IHT---ENKLY--LVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 258 VGVCHRDIKPQNLLM 272
             V HRD+KPQNLL+
Sbjct: 122 -RVLHRDLKPQNLLI 135

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 79/137 (57%), Gaps = 20/137 (14%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQICRALNYLH- 255
             +   +++LY  LV E++ + +    K +   +    +P+  ++ Y +Q+ + L + H 
Sbjct: 71  IHT---ENKLY--LVFEFLHQDL----KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 256 HVVGVCHRDIKPQNLLM 272
           H   V HRD+KP+NLL+
Sbjct: 122 H--RVLHRDLKPENLLI 136

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 80/158 (50%), Gaps = 17/158 (10%)
Query: 127 GGRNGQ-PKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---- 179
           GGR+   P QT     M ER+ GTG FG V +    +TG+ VAIK+  Q+   KNR    
Sbjct: 3   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 61
Query: 180 -ELQIMRLLNHPNVVSLKHC--FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVP 236
            E+QIM+ LNHPNVVS +           ++L L L +EY      R  K+  +      
Sbjct: 62  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLR--KYLNQFENCCG 118
Query: 237 ILYVQLYTY--QICRALNYLHHVVGVCHRDIKPQNLLM 272
           +    + T    I  AL YLH    + HRD+KP+N+++
Sbjct: 119 LKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVL 155

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 80/158 (50%), Gaps = 17/158 (10%)
Query: 127 GGRNGQ-PKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---- 179
           GGR+   P QT     M ER+ GTG FG V +    +TG+ VAIK+  Q+   KNR    
Sbjct: 2   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60
Query: 180 -ELQIMRLLNHPNVVSLKHC--FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVP 236
            E+QIM+ LNHPNVVS +           ++L L L +EY      R  K+  +      
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLR--KYLNQFENCCG 117
Query: 237 ILYVQLYTY--QICRALNYLHHVVGVCHRDIKPQNLLM 272
           +    + T    I  AL YLH    + HRD+KP+N+++
Sbjct: 118 LKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVL 154

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 15/155 (9%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHP 190
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 191 N--------VVSLKHCF-----FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPI 237
           N         +   H       F+    + +++ +V E + E +  + K Y   ++ +P+
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 130
Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +YV+  + Q+   L+Y+H   G+ H DIKP+N+LM
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 15/155 (9%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHP 190
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 191 N--------VVSLKHCF-----FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPI 237
           N         +   H       F+    + +++ +V E + E +  + K Y   ++ +P+
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 130
Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +YV+  + Q+   L+Y+H   G+ H DIKP+N+LM
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 13/133 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNVVSLKHC 198
           VG+G++G V  A    TG  VAIKK+    Q + +  R   EL++++ + H NV+ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 199 FFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
           F      D+     LV+ ++   + ++ KH  ++ +      +Q   YQ+ + L Y+H  
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGED----RIQFLVYQMLKGLRYIH-A 146
Query: 258 VGVCHRDIKPQNL 270
            G+ HRD+KP NL
Sbjct: 147 AGIIHRDLKPGNL 159

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 23/149 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVV- 193
           YM  + +G G  G+VF A   +    VAIKK++    Q  ++  RE++I+R L+H N+V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 194 ----------SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
                      L     S TE + +Y  +V EY+   +  V +    + +H      +L+
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVY--IVQEYMETDLANVLEQGPLLEEH-----ARLF 125
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            YQ+ R L Y+H    V HRD+KP NL +
Sbjct: 126 MYQLLRGLKYIHS-ANVLHRDLKPANLFI 153

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 74/134 (55%), Gaps = 16/134 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
           +GTG+FGVV +     TG++ A K V+     DK    +E+Q M +L HP +V+L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 201 STTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
               +D+  + ++ E++S  E   +V+  + +M++   + Y++    Q+C+ L ++H   
Sbjct: 224 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHE-N 274
Query: 259 GVCHRDIKPQNLLM 272
              H D+KP+N++ 
Sbjct: 275 NYVHLDLKPENIMF 288

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 74/134 (55%), Gaps = 16/134 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
           +GTG+FGVV +     TG++ A K V+     DK    +E+Q M +L HP +V+L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 201 STTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
               +D+  + ++ E++S  E   +V+  + +M++   + Y++    Q+C+ L ++H   
Sbjct: 118 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHE-N 168
Query: 259 GVCHRDIKPQNLLM 272
              H D+KP+N++ 
Sbjct: 169 NYVHLDLKPENIMF 182

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 70/134 (52%), Gaps = 15/134 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++G VF+AK  ET + VA+K+V  D   +       RE+ +++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
             S  +     L LV E+  +    + K++   N  +    V+ + +Q+ + L + H   
Sbjct: 70  LHSDKK-----LTLVFEFCDQD---LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120
Query: 259 GVCHRDIKPQNLLM 272
            V HRD+KPQNLL+
Sbjct: 121 NVLHRDLKPQNLLI 134

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 70/134 (52%), Gaps = 15/134 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++G VF+AK  ET + VA+K+V  D   +       RE+ +++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
             S  +     L LV E+  +    + K++   N  +    V+ + +Q+ + L + H   
Sbjct: 70  LHSDKK-----LTLVFEFCDQD---LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120
Query: 259 GVCHRDIKPQNLLM 272
            V HRD+KPQNLL+
Sbjct: 121 NVLHRDLKPQNLLI 134

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 65/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 101
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L  CF    + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 102 LYFCF---QDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 153
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 154 HGK-GIIHRDLKPENILL 170

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 75/135 (55%), Gaps = 18/135 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           VG G++GVV++AK    G  VA+K++  D   +       RE+ +++ L+HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 199 FFSTTEKDELYLNLVLEYISETVYRV-SKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
             S     E  L LV E++ + + +V  ++ T +        +++Y YQ+ R + + H  
Sbjct: 88  IHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDS----QIKIYLYQLLRGVAHCHQ- 137
Query: 258 VGVCHRDIKPQNLLM 272
             + HRD+KPQNLL+
Sbjct: 138 HRILHRDLKPQNLLI 152

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 75/135 (55%), Gaps = 18/135 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           VG G++GVV++AK    G  VA+K++  D   +       RE+ +++ L+HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 199 FFSTTEKDELYLNLVLEYISETVYRV-SKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
             S     E  L LV E++ + + +V  ++ T +        +++Y YQ+ R + + H  
Sbjct: 88  IHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDS----QIKIYLYQLLRGVAHCHQ- 137
Query: 258 VGVCHRDIKPQNLLM 272
             + HRD+KPQNLL+
Sbjct: 138 HRILHRDLKPQNLLI 152

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 65/135 (48%), Gaps = 13/135 (9%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLK 196
           R VG+G++G V  A        VA+KK+      L   R   REL++++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 197 HCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
             F   T  ++   + LV   +   +  + K     ++HV     Q   YQ+ R L Y+H
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHV-----QFLVYQLLRGLKYIH 148
Query: 256 HVVGVCHRDIKPQNL 270
              G+ HRD+KP N+
Sbjct: 149 SA-GIIHRDLKPSNV 162

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 76/141 (53%), Gaps = 16/141 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIM-RLLNHPN 191
           Y   + +G G++G+V+++    TG+ VA+KK+        D +   RE+ I+  L  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           +V+L +   +  ++D   + LV +Y+   ++ V     R N   P+ + Q   YQ+ + +
Sbjct: 71  IVNLLNVLRADNDRD---VYLVFDYMETDLHAV----IRANILEPV-HKQYVVYQLIKVI 122
Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            YLH   G+ HRD+KP N+L+
Sbjct: 123 KYLHS-GGLLHRDMKPSNILL 142

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 149 HGK-GIIHRDLKPENILL 165

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 149 HGK-GIIHRDLKPENILL 165

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 65/135 (48%), Gaps = 13/135 (9%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLK 196
           R VG+G++G V  A        VA+KK+      L   R   REL++++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 197 HCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
             F   T  ++   + LV   +   +  + K     ++HV     Q   YQ+ R L Y+H
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHV-----QFLVYQLLRGLKYIH 148
Query: 256 HVVGVCHRDIKPQNL 270
              G+ HRD+KP N+
Sbjct: 149 SA-GIIHRDLKPSNV 162

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 97
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 98  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 149
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 150 HGK-GIIHRDLKPENILL 166

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 147 HGK-GIIHRDLKPENILL 163

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 97
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 98  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 149
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 150 HGK-GIIHRDLKPENILL 166

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 75/141 (53%), Gaps = 22/141 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-------ELQIMRLLNHPNVV 193
           +V+G GSFG VF  K +   D+  +   KVL+    K R       E  I+  +NHP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY--VQLYTYQICRAL 251
            L + F     + E  L L+L+++     R    +TR+++ V      V+ Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           ++LH + G+ +RD+KP+N+L+
Sbjct: 140 DHLHSL-GIIYRDLKPENILL 159

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 149 HGK-GIIHRDLKPENILL 165

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 174

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 79/151 (52%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY++     +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 174

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 99
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 100 L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 151
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 152 HGK-GIIHRDLKPENILL 168

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 149 HGK-GIIHRDLKPENILL 165

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 149 HGK-GIIHRDLKPENILL 165

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 75/141 (53%), Gaps = 22/141 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-------ELQIMRLLNHPNVV 193
           +V+G GSFG VF  K +   D+  +   KVL+    K R       E  I+  +NHP +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY--VQLYTYQICRAL 251
            L + F     + E  L L+L+++     R    +TR+++ V      V+ Y  ++  AL
Sbjct: 91  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           ++LH + G+ +RD+KP+N+L+
Sbjct: 141 DHLHSL-GIIYRDLKPENILL 160

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 147 HGK-GIIHRDLKPENILL 163

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 147 HGK-GIIHRDLKPENILL 163

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 69/140 (49%), Gaps = 14/140 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN---RELQIMRLLNHPN 191
           +Y++   VG+G++G V  A    +G+ VAIKK+    Q + +     REL +++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 192 VVSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           V+ L   F   +     Y   LV+ ++   + ++      M        +Q   YQ+ + 
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKI------MGMEFSEEKIQYLVYQMLKG 156
Query: 251 LNYLHHVVGVCHRDIKPQNL 270
           L Y+H   GV HRD+KP NL
Sbjct: 157 LKYIHS-AGVVHRDLKPGNL 175

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 75/141 (53%), Gaps = 22/141 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-------ELQIMRLLNHPNVV 193
           +V+G GSFG VF  K +   D+  +   KVL+    K R       E  I+  +NHP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY--VQLYTYQICRAL 251
            L + F     + E  L L+L+++     R    +TR+++ V      V+ Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           ++LH + G+ +RD+KP+N+L+
Sbjct: 140 DHLHSL-GIIYRDLKPENILL 159

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 73/136 (53%), Gaps = 17/136 (12%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKH 197
           +VG GS+G+V + +  +TG  VAIKK L+       K+   RE+++++ L H N+V+L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHH 256
                 +K   Y  LV E++  T+    + +   ++  V    VQ Y +QI   + + H 
Sbjct: 92  V---CKKKKRWY--LVFEFVDHTILDDLELFPNGLDYQV----VQKYLFQIINGIGFCHS 142
Query: 257 VVGVCHRDIKPQNLLM 272
              + HRDIKP+N+L+
Sbjct: 143 -HNIIHRDIKPENILV 157

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 28/147 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
           Y  +RV+G GSFG V   K   TG   A+K + +       DK    RE+Q+++ L+HPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 192 VVSLKHCFFSTTEKDELYLNLV------LEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
           ++ L   F     +D+ Y  LV       E   E + R  K ++ ++    I        
Sbjct: 112 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARII-------R 157
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+   + Y+H    + HRD+KP+NLL+
Sbjct: 158 QVLSGITYMHK-NKIVHRDLKPENLLL 183

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 65/135 (48%), Gaps = 13/135 (9%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLK 196
           R VG+G++G V  A        VA+KK+      L   R   REL++++ L H NV+ L 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 197 HCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
             F   T  ++   + LV   +   +  + K     ++HV     Q   YQ+ R L Y+H
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHV-----QFLVYQLLRGLKYIH 140
Query: 256 HVVGVCHRDIKPQNL 270
              G+ HRD+KP N+
Sbjct: 141 SA-GIIHRDLKPSNV 154

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 28/147 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
           Y  +RV+G GSFG V   K   TG   A+K + +       DK    RE+Q+++ L+HPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 192 VVSLKHCFFSTTEKDELYLNLV------LEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
           ++ L   F     +D+ Y  LV       E   E + R  K ++ ++    I        
Sbjct: 111 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARII-------R 156
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+   + Y+H    + HRD+KP+NLL+
Sbjct: 157 QVLSGITYMHK-NKIVHRDLKPENLLL 182

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 73
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 74  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 125
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 126 HGK-GIIHRDLKPENILL 142

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 71
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 72  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 123
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 124 HGK-GIIHRDLKPENILL 140

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 174

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEP-HAR 145
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 146 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 175

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 74
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 75  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 126
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 127 HGK-GIIHRDLKPENILL 143

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 174

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 73  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 125 HGK-GIIHRDLKPENILL 141

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 145
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 146 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 175

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKXQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 145
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 146 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 175

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 21/144 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHP 190
            Y   +V+G G+FG V   +   T    A+K + +       D  +   E  IM   N P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
            VV L + F     +D+ YL +V+EY+   + V  +S      N  VP  + + YT ++ 
Sbjct: 130 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVV 178
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            AL+ +H + G  HRD+KP N+L+
Sbjct: 179 LALDAIHSM-GFIHRDVKPDNMLL 201

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 21/144 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHP 190
            Y   +V+G G+FG V   +   T    A+K + +       D  +   E  IM   N P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
            VV L + F     +D+ YL +V+EY+   + V  +S      N  VP  + + YT ++ 
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVV 183
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            AL+ +H + G  HRD+KP N+L+
Sbjct: 184 LALDAIHSM-GFIHRDVKPDNMLL 206

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 174

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 174

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 21/144 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHP 190
            Y   +V+G G+FG V   +   T    A+K + +       D  +   E  IM   N P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
            VV L + F     +D+ YL +V+EY+   + V  +S      N  VP  + + YT ++ 
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVV 183
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            AL+ +H + G  HRD+KP N+L+
Sbjct: 184 LALDAIHSM-GFIHRDVKPDNMLL 206

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 28/147 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
           Y  +RV+G GSFG V   K   TG   A+K + +       DK    RE+Q+++ L+HPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 192 VVSLKHCFFSTTEKDELYLNLV------LEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
           ++ L   F     +D+ Y  LV       E   E + R  K ++ ++    I        
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARII-------R 133
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+   + Y+H    + HRD+KP+NLL+
Sbjct: 134 QVLSGITYMHK-NKIVHRDLKPENLLL 159

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKSQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 78
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 79  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 130
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 131 HGK-GIIHRDLKPENILL 147

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELR 93
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 94  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 146
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 147 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 176

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 174

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELR 93
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 94  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 146
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 147 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 176

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELR 92
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 93  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 145
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 146 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 175

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKXQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 32/145 (22%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 195 LKHCFFSTTEKDELYLNL-------VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           L   +F+  + ++LY  L       +L+YI + +    +  TR            YT +I
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGCLLKYIRK-IGSFDETCTR-----------FYTAEI 141
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
             AL YLH   G+ HRD+KP+N+L+
Sbjct: 142 VSALEYLHGK-GIIHRDLKPENILL 165

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 174

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 94  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 145
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 146 HGK-GIIHRDLKPENILL 162

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 174

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 94  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 145
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 146 HGK-GIIHRDLKPENILL 162

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELR 83
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 84  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 136
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 137 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 166

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELR 69
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCAKLTDDH----- 122
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 123 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 152

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K  ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L++ F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 174

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELR 69
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 122
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 123 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 152

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K  ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L++ F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 174

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 19  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 78
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 79  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 130
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 131 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 160

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELR 69
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 122
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 123 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 152

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K  ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L++ F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 174

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELR 79
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 132
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+ H   + HRD+KP NL
Sbjct: 133 VQFLIYQILRGLKYI-HSADIIHRDLKPSNL 162

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 75
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 128
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 129 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 158

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 79
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 132
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 133 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 162

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 84
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 85  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 137
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 138 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 167

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 69/140 (49%), Gaps = 14/140 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN---RELQIMRLLNHPN 191
           +Y++   VG+G++G V  A    +G+ VAIKK+    Q + +     REL +++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 192 VVSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           V+ L   F   +     Y   LV+ ++   + ++      M        +Q   YQ+ + 
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKI------MGLKFSEEKIQYLVYQMLKG 138
Query: 251 LNYLHHVVGVCHRDIKPQNL 270
           L Y+H   GV HRD+KP NL
Sbjct: 139 LKYIHS-AGVVHRDLKPGNL 157

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 85
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 86  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 138
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 139 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 168

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 85
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 86  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 138
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 139 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 168

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 20/149 (13%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  +  +++G  +A+KK       ++  KR   REL+
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELR 102
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
           +++ + H NV+ L   F   T  +E   + LV   +   +  + K     + H     VQ
Sbjct: 103 LLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQ 157
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNL 270
              YQI R L Y+H    + HRD+KP NL
Sbjct: 158 FLIYQILRGLKYIHS-ADIIHRDLKPSNL 185

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELR 85
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 86  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 138
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 139 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 168

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 78
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 131
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 132 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 161

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K +E++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY       +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NL++
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLMI 174

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 80
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 133
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 134 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 163

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 93
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 94  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 146
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 147 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 176

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 92
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 93  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 145
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 146 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 175

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 80
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 133
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 134 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 163

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLNHPNVVS 194
           +++G GSF     A+ L T    AIK +L+ +         Y  RE  +M  L+HP  V 
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   +F+  + ++LY  L      E +      Y R          + YT +I  AL YL
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ HRD+KP+N+L+
Sbjct: 147 HGK-GIIHRDLKPENILL 163

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 96
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 97  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 149
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 150 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 179

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K +E++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY       +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NL++
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLMI 174

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 75
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 128
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 129 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 158

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 96
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 97  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 149
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 150 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 179

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 84
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 85  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 137
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 138 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 167

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 80
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 133
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 134 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 163

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 79
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 132
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 133 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 162

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 80
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 133
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 134 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 163

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 75
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 128
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 129 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 158

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 71
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 72  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 124
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 125 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 154

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 70
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 71  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 123
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 124 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 153

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 78
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 131
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 132 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 161

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 72
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 73  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 125
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 126 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 155

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      +G+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 78
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 131
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 132 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 161

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 78
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 131
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 132 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 161

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 73
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 127 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 156

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 75
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 128
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 129 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 158

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 69
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 122
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 123 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 152

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 70
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 71  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 123
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 124 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 153

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 11/139 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKN----RELQIMRLLNHPNVV 193
           +  + ++G G++GVV  A    TG+ VAIKK+   DK        RE++I++   H N++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           ++    F+    D  + N    YI + + +   H     Q +   ++Q + YQ  RA+  
Sbjct: 73  TI----FNIQRPDS-FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH    V HRD+KP NLL+
Sbjct: 128 LHG-SNVIHRDLKPSNLLI 145

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 74/141 (52%), Gaps = 22/141 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-------ELQIMRLLNHPNVV 193
           +V+G GSFG VF  + +   DS  +   KVL+    K R       E  I+  +NHP VV
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY--VQLYTYQICRAL 251
            L + F     + E  L L+L+++     R    +TR+++ V      V+ Y  ++   L
Sbjct: 94  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           ++LH + G+ +RD+KP+N+L+
Sbjct: 144 DHLHSL-GIIYRDLKPENILL 163

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 135 QTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQ 182
           +TI  + ER      VG+G++G V  A   +TG  VA+KK       ++  KR   REL+
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELR 79
Query: 183 IMRLLNHPNVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           +++ + H NV+ L   F    S  E +++Y  LV   +   +  + K     + H     
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH----- 132
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
           VQ   YQI R L Y+H    + HRD+KP NL
Sbjct: 133 VQFLIYQILRGLKYIHS-ADIIHRDLKPSNL 162

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 78/149 (52%), Gaps = 22/149 (14%)
Query: 131 GQPKQTISYMAERV-VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQI 183
           G P++   Y+A  + +G GS G+V  A    TG  VA+KK+  D R + R      E+ I
Sbjct: 41  GDPRE---YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVI 95
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
           MR  +H NVV +   + S    DEL+  +V+E++          +TRMN+      +   
Sbjct: 96  MRDYHHDNVVDM---YSSYLVGDELW--VVMEFLEGGALTDIVTHTRMNEE----QIATV 146
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
              + RAL+YLH+  GV HRDIK  ++L+
Sbjct: 147 CLSVLRALSYLHN-QGVIHRDIKSDSILL 174

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  +R ++     Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 129 HSK-RVIHRDIKPENLLL 145

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 11/139 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKN----RELQIMRLLNHPNVV 193
           +  + ++G G++GVV  A    TG+ VAIKK+   DK        RE++I++   H N++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           ++    F+    D  + N    YI + + +   H     Q +   ++Q + YQ  RA+  
Sbjct: 73  TI----FNIQRPDS-FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH    V HRD+KP NLL+
Sbjct: 128 LHG-SNVIHRDLKPSNLLI 145

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 11/139 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKN----RELQIMRLLNHPNVV 193
           +  + ++G G++GVV  A    TG+ VAIKK+   DK        RE++I++   H N++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           ++    F+    D  + N    YI + + +   H     Q +   ++Q + YQ  RA+  
Sbjct: 73  TI----FNIQRPDS-FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH    V HRD+KP NLL+
Sbjct: 128 LHG-SNVIHRDLKPSNLLI 145

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 28/147 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
           Y  +RV+G GSFG V   K   TG   A+K + +       DK    RE+Q+++ L+HPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 192 VVSLKHCFFSTTEKDELYLNLV------LEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
           ++ L   F     +D+ Y  LV       E   E + R  K ++ ++    I        
Sbjct: 94  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIR------- 139
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+   + Y+H    + HRD+KP+NLL+
Sbjct: 140 QVLSGITYMHK-NKIVHRDLKPENLLL 165

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 23/142 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK--------NRELQIMRLLNHPNVV 193
           E ++G G FG V++A     GD VA+K    D             +E ++  +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           +L+          E  L LV+E+     + RV        + +P   +  +  QI R +N
Sbjct: 70  ALRGVCLK-----EPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 253 YLHH--VVGVCHRDIKPQNLLM 272
           YLH   +V + HRD+K  N+L+
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILI 141

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K  ETG+  A+K + + K  K ++++      
Sbjct: 54  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 114 RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 165
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 166 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 195

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 131 GQPKQT-ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIM 184
           GQP      Y   + +G G++G+V  A        VAIKK+   + + Y  R   E+QI+
Sbjct: 36  GQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQIL 95
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
               H NV+ ++    ++T +    + +V + +   +Y++ K     N H  I Y   + 
Sbjct: 96  LRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDH--ICY---FL 150
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
           YQI R L Y+H    V HRD+KP NLL+
Sbjct: 151 YQILRGLKYIHS-ANVLHRDLKPSNLLI 177

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K  ETG+  A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 145
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 146 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 175

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K  ETG+  A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 145
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 146 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 175

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K  ETG+  A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 145
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 146 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 175

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 69/147 (46%), Gaps = 28/147 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
           Y  +RV+G GSFG V   K   TG   A+K + +       DK    RE+Q+++ L+HPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 192 VVSLKHCFFSTTEKDELYLNLV------LEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
           +  L   F     +D+ Y  LV       E   E + R  K ++ ++    I        
Sbjct: 88  IXKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARII-------R 133
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+   + Y H    + HRD+KP+NLL+
Sbjct: 134 QVLSGITYXHK-NKIVHRDLKPENLLL 159

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  +R ++     Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 129 HSK-RVIHRDIKPENLLL 145

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K  ETG+  A+K + + K  K ++++      
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 86  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEP-HAR 137
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 138 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 167

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 74/144 (51%), Gaps = 21/144 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNH 189
           +Y  ++ +G G+F  V  A+ + TG  VA+K +  DK   N        RE++IM++LNH
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           PN+V L    F   E ++  L LV+EY S   V+     + RM +       +    QI 
Sbjct: 74  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIV 124
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            A+ Y H    + HRD+K +NLL+
Sbjct: 125 SAVQYCHQKY-IVHRDLKAENLLL 147

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFAEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY       +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG--EMFSHLRRIGRFXEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NL++
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLMI 174

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 17/140 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN------RELQIMRLLN---HPNVVS 194
           +G G++G VF+A+ L+ G   VA+K+V      +       RE+ ++R L    HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 195 LKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALN 252
           L   C  S T++ E  L LV E++ + +   + +  ++ +  VP   ++   +Q+ R L+
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +LH    V HRD+KPQN+L+
Sbjct: 135 FLHSH-RVVHRDLKPQNILV 153

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 151 HSK-RVIHRDIKPENLLL 167

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K  ETG+  A+K + + K  K ++++      
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY+      +  H  R+ +     + +
Sbjct: 86  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEP-HAR 137
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 138 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 167

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 128 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEP-HARFYAAQIVLTFEYLH 179
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 180 S-LDLIYRDLKPENLLI 195

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    R +GTGSFG V   K  ETG+  A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I + +N P +V L+  F     KD   L +VLEY       +  H  R+ +     + +
Sbjct: 94  RIQQAVNFPFLVKLEFSF-----KDNSNLYMVLEYAPGG--EMFSHLRRIGRFSEP-HAR 145
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NLL+
Sbjct: 146 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLI 175

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 151 HSK-RVIHRDIKPENLLL 167

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY       +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NL++
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLMI 174

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY       +  H  R+ +     + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEP-HAR 144
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NL++
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLMI 174

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 91  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 141
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 142 HSK-RVIHRDIKPENLLL 158

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 79/141 (56%), Gaps = 19/141 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN------RELQIMRLLN---HPNVVS 194
           +G G++G VF+A+ L+ G   VA+K+V      +       RE+ ++R L    HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 195 LKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALN 252
           L   C  S T++ E  L LV E++ + +   + +  ++ +  VP   ++   +Q+ R L+
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 253 YLH-HVVGVCHRDIKPQNLLM 272
           +LH H   V HRD+KPQN+L+
Sbjct: 135 FLHSH--RVVHRDLKPQNILV 153

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 128 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 179
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 180 S-LDLIYRDLKPENLLI 195

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 79/141 (56%), Gaps = 19/141 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN------RELQIMRLLN---HPNVVS 194
           +G G++G VF+A+ L+ G   VA+K+V      +       RE+ ++R L    HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 195 LKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALN 252
           L   C  S T++ E  L LV E++ + +   + +  ++ +  VP   ++   +Q+ R L+
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 253 YLH-HVVGVCHRDIKPQNLLM 272
           +LH H   V HRD+KPQN+L+
Sbjct: 135 FLHSH--RVVHRDLKPQNILV 153

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 126 HSK-RVIHRDIKPENLLL 142

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 108 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 159
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 160 S-LDLIYRDLKPENLLI 175

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 102 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEP-HARFYAAQIVLTFEYLH 153
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 154 S-LDLIYRDLKPENLLI 169

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 71/144 (49%), Gaps = 21/144 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHP 190
            Y   +V+G G+FG V   +   +    A+K + +       D  +   E  IM   N P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
            VV L  C F    +D+ YL +V+EY+   + V  +S      N  VP  + + YT ++ 
Sbjct: 136 WVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVV 184
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            AL+ +H + G+ HRD+KP N+L+
Sbjct: 185 LALDAIHSM-GLIHRDVKPDNMLL 207

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 130 HSK-RVIHRDIKPENLLL 146

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 128 HSK-RVIHRDIKPENLLL 144

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 128 HSKR-VIHRDIKPENLLL 144

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 130 H-SKRVIHRDIKPENLLL 146

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 127 HSK-RVIHRDIKPENLLL 143

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 127 HSK-RVIHRDIKPENLLL 143

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 125 HSK-RVIHRDIKPENLLL 141

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 126 HSK-RVIHRDIKPENLLL 142

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 125 HSK-RVIHRDIKPENLLL 141

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 126 HSK-RVIHRDIKPENLLL 142

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 94  EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 145
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 146 S-LDLIYRDLKPENLLI 161

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 130 HSK-RVIHRDIKPENLLL 146

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 125 HSK-RVIHRDIKPENLLL 141

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 128 HSK-RVIHRDIKPENLLL 144

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 128
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 129 HSK-RVIHRDIKPENLLL 145

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 128 HSK-RVIHRDIKPENLLL 144

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 125 HSK-RVIHRDIKPENLLL 141

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 125 HSK-RVIHRDIKPENLLL 141

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 128 HSK-RVIHRDIKPENLLL 144

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 73  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 123
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 124 HSK-RVIHRDIKPENLLL 140

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 128 HSK-RVIHRDIKPENLLL 144

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 73/144 (50%), Gaps = 21/144 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNH 189
           +Y   + +G G+F  V  A+ + TG  VA+K +  DK   N        RE++IM++LNH
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           PN+V L    F   E ++  L LV+EY S   V+     + RM +       +    QI 
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHGRMKEKE----ARAKFRQIV 123
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            A+ Y H    + HRD+K +NLL+
Sbjct: 124 SAVQYCHQKF-IVHRDLKAENLLL 146

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 19/145 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVS 194
           Y+  + +G G F  V   + L  G   A+K++L    QD+    RE  + RL NHPN++ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 195 L-KHCFFSTTEKDELYLNLVLEYISETVY------RVSKHYTRMNQHVPILYVQLYTYQI 247
           L  +C      K E +L L   +   T++      +   ++   +Q   IL++ L    I
Sbjct: 91  LVAYCLRERGAKHEAWLLLPF-FKRGTLWNEIERLKDKGNFLTEDQ---ILWLLL---GI 143
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
           CR L  + H  G  HRD+KP N+L+
Sbjct: 144 CRGLEAI-HAKGYAHRDLKPTNILL 167

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 125 HSK-RVIHRDIKPENLLL 141

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+   +   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F  +T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 74  YGYFHDSTR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 125 HSK-KVIHRDIKPENLLL 141

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 125 HSK-RVIHRDIKPENLLL 141

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 73/144 (50%), Gaps = 21/144 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNH 189
           +Y   + +G G+F  V  A+ + TG  VA+K +  DK   N        RE++IM++LNH
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           PN+V L    F   E ++  L LV+EY S   V+     + RM +       +    QI 
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHGRMKEKE----ARAKFRQIV 123
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            A+ Y H    + HRD+K +NLL+
Sbjct: 124 SAVQYCHQKF-IVHRDLKAENLLL 146

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 73/144 (50%), Gaps = 21/144 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNH 189
           +Y   + +G G+F  V  A+ + TG  VA+K +  DK   N        RE++IM++LNH
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           PN+V L    F   E ++  L LV+EY S   V+     + RM +       +    QI 
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHGRMKEKE----ARAKFRQIV 123
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            A+ Y H    + HRD+K +NLL+
Sbjct: 124 SAVQYCHQKF-IVHRDLKAENLLL 146

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 22/154 (14%)
Query: 128 GRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------R 179
           G + QP    +Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        R
Sbjct: 4   GSDEQP-HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFR 60
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPIL 238
           E++IM++LNHPN+V L    F   E ++  L L++EY S   V+     + RM +     
Sbjct: 61  EVRIMKILNHPNIVKL----FEVIETEKT-LYLIMEYASGGEVFDYLVAHGRMKEK---- 111
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             +    QI  A+ Y H    + HRD+K +NLL+
Sbjct: 112 EARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLL 144

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 16/134 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++G V++A    T ++VAIK++  +   +       RE+ +++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
                      L+L+ EY    +    K Y   N  V +  ++ + YQ+   +N+ H   
Sbjct: 102 IHHNHR-----LHLIFEYAENDL----KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR- 151
Query: 259 GVCHRDIKPQNLLM 272
              HRD+KPQNLL+
Sbjct: 152 RCLHRDLKPQNLLL 165

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAI----KKVLQDKRYKN---RELQIMRLLNHP 190
           +Y   + +G GSFG V  A    TG  VA+    KKVL     +    RE+  +RLL HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           +++ L     S   KDE+   +V+EY    ++       +M++     + Q    QI  A
Sbjct: 75  HIIKLYDVIKS---KDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQ----QIISA 125
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           + Y H    + HRD+KP+NLL+
Sbjct: 126 VEYCHR-HKIVHRDLKPENLLL 146

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAI----KKVLQDKRYKN---RELQIMRLLNHP 190
           +Y   + +G GSFG V  A    TG  VA+    KKVL     +    RE+  +RLL HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           +++ L     S   KDE+   +V+EY    ++       +M++     + Q    QI  A
Sbjct: 74  HIIKLYDVIKS---KDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQ----QIISA 124
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           + Y H    + HRD+KP+NLL+
Sbjct: 125 VEYCHR-HKIVHRDLKPENLLL 145

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K ++++       I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F     KD   L +V+EY++     +  H  R+ +     + + Y  QI     YLH
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NL++
Sbjct: 159 S-LDLIYRDLKPENLII 174

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +  L+  F     KD   L +V+EY       +  H  R+ +     + +
Sbjct: 94  RILQAVNFPFLTKLEFSF-----KDNSNLYMVMEYAPGG--EMFSHLRRIGRFXEP-HAR 145
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NL++
Sbjct: 146 FYAAQIVLTFEYLHS-LDLIYRDLKPENLMI 175

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------------LQDKRYKNRELQIMRL 186
           Y  +R + +GS+G V  A     G  VAIK+V            L D     R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAV-CAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 187 LNH---PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPI--LYVQ 241
           LNH   PN++ L+  F    E     L LV E +   + +V       +Q + I   ++Q
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            + Y I   L+ LH   GV HRD+ P N+L+
Sbjct: 138 YFMYHILLGLHVLHE-AGVVHRDLHPGNILL 167

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 68/134 (50%), Gaps = 16/134 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVSLKHCF 199
           ++G G FG V + +   TG  +A K +    ++DK     E+ +M  L+H N++ L   F
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 200 FSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
            S  +     + LV+EY+   E   R+      + +   IL+++    QIC  + ++H +
Sbjct: 156 ESKND-----IVLVMEYVDGGELFDRIIDESYNLTELDTILFMK----QICEGIRHMHQM 206
Query: 258 VGVCHRDIKPQNLL 271
             + H D+KP+N+L
Sbjct: 207 Y-ILHLDLKPENIL 219

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 24/145 (16%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
           +Y+    +G G++  V++ K   T + VA+K++  +          RE+ +++ L H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTR-----MNQHVPILYVQLYTYQI 247
           V+L       TEK    L LV EY+ + +    K Y       +N H     V+L+ +Q+
Sbjct: 63  VTLHDIIH--TEKS---LTLVFEYLDKDL----KQYLDDCGNIINMH----NVKLFLFQL 109
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
            R L Y H    V HRD+KPQNLL+
Sbjct: 110 LRGLAYCHRQ-KVLHRDLKPQNLLI 133

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------------LQDKRYKNRELQIMRL 186
           Y  +R + +GS+G V  A     G  VAIK+V            L D     R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAV-CAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 187 LNH---PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPI--LYVQ 241
           LNH   PN++ L+  F    E     L LV E +   + +V       +Q + I   ++Q
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            + Y I   L+ LH   GV HRD+ P N+L+
Sbjct: 138 YFMYHILLGLHVLHE-AGVVHRDLHPGNILL 167

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAI----KKVLQDKRYKN---RELQIMRLLNHP 190
           +Y   + +G GSFG V  A    TG  VA+    KKVL     +    RE+  +RLL HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           +++ L     S   KDE+   +V+EY    ++       +M++     + Q    QI  A
Sbjct: 65  HIIKLYDVIKS---KDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQ----QIISA 115
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           + Y H    + HRD+KP+NLL+
Sbjct: 116 VEYCHR-HKIVHRDLKPENLLL 136

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAI----KKVLQDKRYKN---RELQIMRLLNHP 190
           +Y   + +G GSFG V  A    TG  VA+    KKVL     +    RE+  +RLL HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           +++ L     S   KDE+   +V+EY    ++       +M++     + Q    QI  A
Sbjct: 69  HIIKLYDVIKS---KDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQ----QIISA 119
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           + Y H    + HRD+KP+NLL+
Sbjct: 120 VEYCHR-HKIVHRDLKPENLLL 140

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 75/147 (51%), Gaps = 24/147 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------------NRELQIMR 185
           Y+  + +G+G+ G V  A   +T   VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
            LNHP ++ +K+ F    + ++ Y+ L L    E   +V       N+ +     +LY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+  A+ YLH   G+ HRD+KP+N+L+
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLL 147

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +  L+  F     KD   L +V+EY       +  H  R+ +     + +
Sbjct: 94  RILQAVNFPFLTKLEFSF-----KDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEP-HAR 145
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NL++
Sbjct: 146 FYAAQIVLTFEYLHS-LDLIYRDLKPENLMI 175

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K +ETG+  A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +  L+  F     KD   L +V+EY       +  H  R+ +     + +
Sbjct: 94  RILQAVNFPFLTKLEFSF-----KDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEP-HAR 145
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NL++
Sbjct: 146 FYAAQIVLTFEYLHS-LDLIYRDLKPENLMI 175

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 75/147 (51%), Gaps = 24/147 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------------NRELQIMR 185
           Y+  + +G+G+ G V  A   +T   VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
            LNHP ++ +K+ F    + ++ Y+ L L    E   +V       N+ +     +LY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+  A+ YLH   G+ HRD+KP+N+L+
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLL 147

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 75/147 (51%), Gaps = 24/147 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------------NRELQIMR 185
           Y+  + +G+G+ G V  A   +T   VAIK ++  +++                E++I++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
            LNHP ++ +K+ F    + ++ Y+ L L    E   +V       N+ +     +LY Y
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 127
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+  A+ YLH   G+ HRD+KP+N+L+
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLL 153

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 75/147 (51%), Gaps = 24/147 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------------NRELQIMR 185
           Y+  + +G+G+ G V  A   +T   VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
            LNHP ++ +K+ F    + ++ Y+ L L    E   +V       N+ +     +LY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+  A+ YLH   G+ HRD+KP+N+L+
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLL 147

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 75/147 (51%), Gaps = 24/147 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------------NRELQIMR 185
           Y+  + +G+G+ G V  A   +T   VAIK ++  +++                E++I++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
            LNHP ++ +K+ F    + ++ Y+ L L    E   +V       N+ +     +LY Y
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 120
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+  A+ YLH   G+ HRD+KP+N+L+
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLL 146

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 73/144 (50%), Gaps = 21/144 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNH 189
           +Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        RE++IM++LNH
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           PN+V L    F   E ++  L L++EY S   V+     + RM +       +    QI 
Sbjct: 74  PNIVKL----FEVIETEKT-LYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFRQIV 124
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            A+ Y H    + HRD+K +NLL+
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLL 147

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 20/151 (13%)
Query: 133 PKQTISYMAE----RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ------ 182
           P Q  +++ +    + +GTGSFG V   K  ETG+  A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ +N P +V L+  F     KD   L +V+EY       +  H  R+ +     + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEP-HAR 145
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  QI     YLH  + + +RD+KP+NL++
Sbjct: 146 FYAAQIVLTFEYLHS-LDLIYRDLKPENLMI 175

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 21/144 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNH 189
           +Y   + +G G+F  V  A+ + TG  VA++ +  DK   N        RE++IM++LNH
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           PN+V L    F   E ++  L LV+EY S   V+     + RM +       +    QI 
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHGRMKEKE----ARAKFRQIV 123
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            A+ Y H    + HRD+K +NLL+
Sbjct: 124 SAVQYCHQKF-IVHRDLKAENLLL 146

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 72/144 (50%), Gaps = 16/144 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           Y  + V+G+G+  VV  A C    + VAIK++  +K   +     +E+Q M   +HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICR--- 249
           S    + S   KDEL+  LV++ +S  +V  + KH     +H   +  +     I R   
Sbjct: 77  SY---YTSFVVKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 250 -ALNYLHHVVGVCHRDIKPQNLLM 272
             L YLH   G  HRD+K  N+L+
Sbjct: 132 EGLEYLHK-NGQIHRDVKAGNILL 154

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 21/141 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQDKRYKNRELQIMRLLNHPNVV 193
           YM    +G G FG+V   +C+ET       +  +K    D+    +E+ I+ +  H N++
Sbjct: 7   YMIAEDLGRGEFGIV--HRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            L   F S  E     L ++ E+IS  +   R++     +N+   + YV    +Q+C AL
Sbjct: 65  HLHESFESMEE-----LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 252 NYLH-HVVGVCHRDIKPQNLL 271
            +LH H +G  H DI+P+N++
Sbjct: 116 QFLHSHNIG--HFDIRPENII 134

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 21/144 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNH 189
           +Y   + +G G+F  V  A+ + TG  VA++ +  DK   N        RE++IM++LNH
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           PN+V L    F   E ++  L LV+EY S   V+     + RM +       +    QI 
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHGRMKEKE----ARAKFRQIV 123
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            A+ Y H    + HRD+K +NLL+
Sbjct: 124 SAVQYCHQKF-IVHRDLKAENLLL 146

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 72/139 (51%), Gaps = 19/139 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYKNRELQIMRLLNHPNVVSLK 196
           +  E  +G G+  +V++ K   T    A+K  K   DK+    E+ ++  L+HPN++ LK
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYTRMNQHVPILYVQLYTYQICRALN 252
             F + TE     ++LVLE ++  E   R+ +  +Y+  +    +        QI  A+ 
Sbjct: 115 EIFETPTE-----ISLVLELVTGGELFDRIVEKGYYSERDAADAV-------KQILEAVA 162
Query: 253 YLHHVVGVCHRDIKPQNLL 271
           YLH   G+ HRD+KP+NLL
Sbjct: 163 YLHE-NGIVHRDLKPENLL 180

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 69/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  +    +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY    TVYR  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 71  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 121
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 122 HSK-RVIHRDIKPENLLL 138

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 74/146 (50%), Gaps = 25/146 (17%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNH 189
           +Y   + +G G+F  V  A+ + TG  VA+K +  DK   N        RE++IM++LNH
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETV-YRVSKHYTRMNQHVPILYVQLYTYQ 246
           PN+V L    F   E ++  L LV+EY S  E   Y V+  + +  +       +    Q
Sbjct: 66  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHGWMKEKE------ARAKFRQ 114
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           I  A+ Y H    + HRD+K +NLL+
Sbjct: 115 IVSAVQYCHQKF-IVHRDLKAENLLL 139

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 72/144 (50%), Gaps = 16/144 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           Y  + V+G+G+  VV  A C    + VAIK++  +K   +     +E+Q M   +HPN+V
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICR--- 249
           S    + S   KDEL+  LV++ +S  +V  + KH     +H   +  +     I R   
Sbjct: 72  SY---YTSFVVKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 250 -ALNYLHHVVGVCHRDIKPQNLLM 272
             L YLH   G  HRD+K  N+L+
Sbjct: 127 EGLEYLHK-NGQIHRDVKAGNILL 149

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 56/99 (56%), Gaps = 9/99 (9%)
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY--TRMNQ--- 233
           RE+ ++R L HPNV+SL+  F S  ++    + L+ +Y    ++ + K +  ++ N+   
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            +P   V+   YQI   ++YL H   V HRD+KP N+L+
Sbjct: 124 QLPRGMVKSLLYQILDGIHYL-HANWVLHRDLKPANILV 161

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 85  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 137
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 138 -GTKRYIHRDLATRNILV 154

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 71/135 (52%), Gaps = 20/135 (14%)
Query: 145 VGTGSFGVVFQAKCLETGDS-VAIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHC 198
           +G+G+FGVV   +C+E     V + K +      DK     E+ IM  L+HP +++L   
Sbjct: 59  LGSGAFGVV--HRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 199 FFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
           F     +D+  + L+LE++S  E   R++    +M++   I Y++    Q C  L ++H 
Sbjct: 117 F-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHE 167
Query: 257 VVGVCHRDIKPQNLL 271
              + H DIKP+N++
Sbjct: 168 H-SIVHLDIKPENIM 181

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 133
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 134 -GTKRYIHRDLATRNILV 150

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 109 GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 161
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 162 -GTKRYIHRDLATRNILV 178

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 26/169 (15%)
Query: 108 PSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAI 167
           PS+   +G E   V+   VG         IS+  + V+G G+ G +      +  D VA+
Sbjct: 5   PSLEQDDGDEETSVV--IVG--------KISFCPKDVLGHGAEGTIVYRGMFDNRD-VAV 53
Query: 168 KKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYISETV--YR 223
           K++L +   + +RE+Q++R  + HPNV+      +  TEKD  +  + +E  + T+  Y 
Sbjct: 54  KRILPECFSFADREVQLLRESDEHPNVIR-----YFCTEKDRQFQYIAIELCAATLQEYV 108
Query: 224 VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             K +  +    PI  +Q    Q    L +LH  + + HRD+KP N+L+
Sbjct: 109 EQKDFAHLGLE-PITLLQ----QTTSGLAHLH-SLNIVHRDLKPHNILI 151

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 83  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 135
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 136 -GTKRYIHRDLATRNILV 152

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 74/142 (52%), Gaps = 21/142 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRLLNHPNVV 193
           +++   V+G+G+F  VF  K   TG   A+K + +   +++     E+ +++ + H N+V
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKH--YTRMNQHVPILYVQLYTYQICR 249
           +L+  + STT     +  LV++ +S  E   R+ +   YT  +         L   Q+  
Sbjct: 70  TLEDIYESTT-----HYYLVMQLVSGGELFDRILERGVYTEKD-------ASLVIQQVLS 117
Query: 250 ALNYLHHVVGVCHRDIKPQNLL 271
           A+ YLH   G+ HRD+KP+NLL
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLL 138

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 148
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 149 -GTKRYIHRDLATRNILV 165

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 130
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 131 -GTKRYIHRDLATRNILV 147

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 69/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY     VY+  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 130 HSK-RVIHRDIKPENLLL 146

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 84  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 136
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 137 -GTKRYIHRDLATRNILV 153

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 82  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 134
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 135 -GTKRYIHRDLATRNILV 151

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 130
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 131 -GTKRYIHRDLATRNILV 147

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 76  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 128
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 129 -GTKRYIHRDLATRNILV 145

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 18/140 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYK-NRELQIMRLLNHPNVV 193
           Y    V+GTG+F  V  A+   T   VAIK    K L+ K      E+ ++  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSK--HYTRMNQHVPILYVQLYTYQICRAL 251
           +L   + S      LYL + L    E   R+ +   YT  +    I       +Q+  A+
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRLI-------FQVLDAV 129
Query: 252 NYLHHVVGVCHRDIKPQNLL 271
            YLH + G+ HRD+KP+NLL
Sbjct: 130 KYLHDL-GIVHRDLKPENLL 148

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 77  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 129
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 130 -GTKRYIHRDLATRNILV 146

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 69/138 (50%), Gaps = 18/138 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   T      + L+LEY     VY+  +  ++ ++     Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 130 HSK-RVIHRDIKPENLLL 146

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 18/140 (12%)
Query: 143 RVVGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVS 194
           R +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALN 252
            K   +S   ++   L L++E++     R  + KH  R++ H+ +L    YT QIC+ + 
Sbjct: 79  YKGVCYSAGRRN---LKLIMEFLPYGSLREYLQKHKERID-HIKLLQ---YTSQICKGME 131
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YL       HRD+  +N+L+
Sbjct: 132 YL-GTKRYIHRDLATRNILV 150

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 130
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 131 -GTKRYIHRDLATRNILV 147

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 148
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 149 -GTKRYIHRDLATRNILV 165

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 16/136 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVSLKHC 198
           +G GSFG V +A+    G  VA+K +++   +  R      E+ IM+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
            F         L++V EY+S  ++YR+  H +   + +         Y + + +NYLH+ 
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 258 -VGVCHRDIKPQNLLM 272
              + HRD+K  NLL+
Sbjct: 157 NPPIVHRDLKSPNLLV 172

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 75/147 (51%), Gaps = 24/147 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------------NRELQIMR 185
           Y+  + +G+G+ G V  A   +T   VAI+ ++  +++                E++I++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
            LNHP ++ +K+ F    + ++ Y+ L L    E   +V       N+ +     +LY Y
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 246
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+  A+ YLH   G+ HRD+KP+N+L+
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLL 272

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 75/147 (51%), Gaps = 24/147 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------------NRELQIMR 185
           Y+  + +G+G+ G V  A   +T   VAI+ ++  +++                E++I++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
            LNHP ++ +K+ F    + ++ Y+ L L    E   +V       N+ +     +LY Y
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 260
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+  A+ YLH   G+ HRD+KP+N+L+
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLL 286

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 83/167 (49%), Gaps = 19/167 (11%)
Query: 114 NGTEAGQVIATTVGGRNGQPK-QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ 172
           +G+   Q    T+GG+  Q +   +  + E  +G+G+ G V++ +  +TG  +A+K++  
Sbjct: 3   SGSSGKQTGYLTIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM-- 58
Query: 173 DKRYKNRELQIMRLLNHPNVVSLKH-------CFFSTTEKDELYLNLVLEYISETVYRVS 225
            +R  N+E +  R+L   +VV   H       CF +     ++++   +E +     ++ 
Sbjct: 59  -RRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI--AMELMGTCAEKLK 114
Query: 226 KHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           K   RM   +P   +   T  I +AL YL    GV HRD+KP N+L+
Sbjct: 115 K---RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL 158

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 71/137 (51%), Gaps = 12/137 (8%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-NRELQIMR-LLNHPNVVSL 195
            Y   R +G G +  VF+A  +   + V +K +   K+ K  RE++I+  L   PN+++L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
                    +      LV E+++ T ++      ++ Q +    ++ Y Y+I +AL+Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 256 HVVGVCHRDIKPQNLLM 272
             +G+ HRD+KP N+++
Sbjct: 149 -SMGIMHRDVKPHNVMI 164

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 74/140 (52%), Gaps = 21/140 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM----RLL----NHPNVVS 194
           RV+G GSFG V  A+  ETGD  A+K + +D   ++ +++      R+L    NHP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L  C F T ++    L  V+E+++  + ++ + K   R ++       + Y  +I  AL 
Sbjct: 89  L-FCCFQTPDR----LFFVMEFVNGGDLMFHIQKS-RRFDE----ARARFYAAEIISALM 138
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +LH   G+ +RD+K  N+L+
Sbjct: 139 FLHD-KGIIYRDLKLDNVLL 157

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 149 VLHRDLKPSNLLL 161

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + LV   +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 165 VLHRDLKPSNLLL 177

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 73/149 (48%), Gaps = 19/149 (12%)
Query: 133 PKQTI-SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIM 184
           PK ++  +   R +GTGSFG V   +    G   A+K +       L+   + N E  ++
Sbjct: 1   PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLY 243
            ++ HP ++ +   F     +D   + ++++YI    ++ +     R +Q  P    + Y
Sbjct: 61  SIVTHPFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSL----LRKSQRFPNPVAKFY 111
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             ++C AL YLH    + +RD+KP+N+L+
Sbjct: 112 AAEVCLALEYLHS-KDIIYRDLKPENILL 139

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 71/142 (50%), Gaps = 22/142 (15%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLL---NHPN 191
           +G G++G V++A+   +G  VA+K V    R  N          RE+ ++R L    HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 192 VVSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           VV L   C  S T++ E+ + LV E++ + +             +P   ++    Q  R 
Sbjct: 68  VVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRG 124
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L++LH    + HRD+KP+N+L+
Sbjct: 125 LDFLHANC-IVHRDLKPENILV 145

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
           R +G GSFG V+ A+ +   + VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           + C+       E    LV+EY   +   + + + +  Q V I  V   T+   + L YLH
Sbjct: 120 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 171
Query: 256 HVVGVCHRDIKPQNLLM 272
               + HRD+K  N+L+
Sbjct: 172 S-HNMIHRDVKAGNILL 187

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 19/147 (12%)
Query: 133 PKQTISYMAERV-VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMR 185
           P    SY+   + +G GS G+V  A    +G  VA+KK+  D R + R      E+ IMR
Sbjct: 146 PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 203
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
              H NVV + + +      DEL++  V+E++          +TRMN+      +     
Sbjct: 204 DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEE----QIAAVCL 254
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
            + +AL+ LH   GV HRDIK  ++L+
Sbjct: 255 AVLQALSVLH-AQGVIHRDIKSDSILL 280

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 71/142 (50%), Gaps = 22/142 (15%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLL---NHPN 191
           +G G++G V++A+   +G  VA+K V    R  N          RE+ ++R L    HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 192 VVSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           VV L   C  S T++ E+ + LV E++ + +             +P   ++    Q  R 
Sbjct: 68  VVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRG 124
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L++LH    + HRD+KP+N+L+
Sbjct: 125 LDFLHANC-IVHRDLKPENILV 145

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 147 VLHRDLKPSNLLL 159

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPNVVSL 195
           R +G GSFG V   +  +T    A+K     K ++    +N  +ELQIM+ L HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
            + F     +DE  + +V++ +     R   ++ + N H     V+L+  ++  AL+YL 
Sbjct: 81  WYSF-----QDEEDMFMVVDLLLGGDLR---YHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 256 HVVGVCHRDIKPQNLLM 272
           +   + HRD+KP N+L+
Sbjct: 133 N-QRIIHRDMKPDNILL 148

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 71/142 (50%), Gaps = 22/142 (15%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLL---NHPN 191
           +G G++G V++A+   +G  VA+K V    R  N          RE+ ++R L    HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 192 VVSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           VV L   C  S T++ E+ + LV E++ + +             +P   ++    Q  R 
Sbjct: 68  VVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRG 124
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L++LH    + HRD+KP+N+L+
Sbjct: 125 LDFLHANC-IVHRDLKPENILV 145

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 15/142 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNV 192
           Y    ++GTGS+G V +A        VAIKK+L+      D +   RE+ I+  LNH +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 193 VS-LKHCFFSTTEK-DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           V  L        EK DELY+  VLE I+++ +   K   R   ++  L+++   Y +   
Sbjct: 115 VKVLDIVIPKDVEKFDELYV--VLE-IADSDF---KKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           + Y+H   G+ HRD+KP N L+
Sbjct: 169 VKYVHSA-GILHRDLKPANCLV 189

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 18/135 (13%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHC 198
           V+GTG+F  V  A+   T   VAIK + ++     +     E+ ++  + HPN+V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSK--HYTRMNQHVPILYVQLYTYQICRALNYLHH 256
           + S      LYL + L    E   R+ +   YT  +    I       +Q+  A+ YLH 
Sbjct: 85  YESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRLI-------FQVLDAVKYLHD 134
Query: 257 VVGVCHRDIKPQNLL 271
           + G+ HRD+KP+NLL
Sbjct: 135 L-GIVHRDLKPENLL 148

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 147 VLHRDLKPSNLLL 159

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 18/135 (13%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHC 198
           V+GTG+F  V  A+   T   VAIK + ++     +     E+ ++  + HPN+V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSK--HYTRMNQHVPILYVQLYTYQICRALNYLHH 256
           + S      LYL + L    E   R+ +   YT  +    I       +Q+  A+ YLH 
Sbjct: 85  YESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRLI-------FQVLDAVKYLHD 134
Query: 257 VVGVCHRDIKPQNLL 271
           + G+ HRD+KP+NLL
Sbjct: 135 L-GIVHRDLKPENLL 148

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 18/135 (13%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHC 198
           V+GTG+F  V  A+   T   VAIK + ++     +     E+ ++  + HPN+V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSK--HYTRMNQHVPILYVQLYTYQICRALNYLHH 256
           + S      LYL + L    E   R+ +   YT  +    I       +Q+  A+ YLH 
Sbjct: 85  YESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRLI-------FQVLDAVKYLHD 134
Query: 257 VVGVCHRDIKPQNLL 271
           + G+ HRD+KP+NLL
Sbjct: 135 L-GIVHRDLKPENLL 148

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 67/144 (46%), Gaps = 21/144 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
           Y+  + +G GSFG     K  E G    IK++       +++    RE+ ++  + HPN+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY----VQLYTYQIC 248
           V  +  F    E   LY  +V++Y           + R+N    +L+    +  +  QIC
Sbjct: 86  VQYRESF---EENGSLY--IVMDYCEG-----GDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            AL ++H    + HRDIK QN+ +
Sbjct: 136 LALKHVHD-RKILHRDIKSQNIFL 158

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
           R +G GSFG V+ A+ +   + VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           + C+       E    LV+EY   +   + + + +  Q V I  V   T+   + L YLH
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 256 HVVGVCHRDIKPQNLLM 272
               + HRD+K  N+L+
Sbjct: 133 S-HNMIHRDVKAGNILL 148

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 145 VLHRDLKPSNLLL 157

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  +  H  R++ H+ +L    YT QIC+ + YL
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQAHAERID-HIKLLQ---YTSQICKGMEYL 133
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 134 -GTKRYIHRDLATRNILV 150

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 23/138 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLKHC 198
           +G G+F VV +   + TG   A K +       +D +   RE +I RLL HPN+V L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 70
Query: 199 FFSTTEKDELYLNLVL----EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
             S +E+   YL   L    E   + V R  ++Y+  +    I        QI  ++N+ 
Sbjct: 71  --SISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILESVNHC 119
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRD+KP+NLL+
Sbjct: 120 H-LNGIVHRDLKPENLLL 136

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 19/147 (12%)
Query: 133 PKQTISYMAERV-VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMR 185
           P    SY+   + +G GS G+V  A    +G  VA+KK+  D R + R      E+ IMR
Sbjct: 69  PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 126
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
              H NVV + + +      DEL++  V+E++          +TRMN+      +     
Sbjct: 127 DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEE----QIAAVCL 177
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
            + +AL+ LH   GV HRDIK  ++L+
Sbjct: 178 AVLQALSVLH-AQGVIHRDIKSDSILL 203

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 145 VLHRDLKPSNLLL 157

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 152
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 153 VLHRDLKPSNLLL 165

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 145 VLHRDLKPSNLLL 157

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 165 VLHRDLKPSNLLL 177

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 145 VLHRDLKPSNLLL 157

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 149 VLHRDLKPSNLLL 161

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 19/147 (12%)
Query: 133 PKQTISYMAERV-VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMR 185
           P    SY+   + +G GS G+V  A    +G  VA+KK+  D R + R      E+ IMR
Sbjct: 26  PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 83
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
              H NVV + + +      DEL++  V+E++          +TRMN+      +     
Sbjct: 84  DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEE----QIAAVCL 134
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
            + +AL+ LH   GV HRDIK  ++L+
Sbjct: 135 AVLQALSVLH-AQGVIHRDIKSDSILL 160

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 147 VLHRDLKPSNLLL 159

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 149 VLHRDLKPSNLLL 161

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 150 VLHRDLKPSNLLL 162

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 150 VLHRDLKPSNLLL 162

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 143 VLHRDLKPSNLLL 155

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 150
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 151 VLHRDLKPSNLLL 163

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 141
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 142 VLHRDLKPSNLLL 154

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 149 VLHRDLKPSNLLL 161

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 145 VLHRDLKPSNLLL 157

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 68/136 (50%), Gaps = 16/136 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVSLKHC 198
           +G GSFG V +A+    G  VA+K +++   +  R      E+ IM+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
            F         L++V EY+S  ++YR+  H +   + +         Y + + +NYLH+ 
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRL-LHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 258 -VGVCHRDIKPQNLLM 272
              + HR++K  NLL+
Sbjct: 157 NPPIVHRNLKSPNLLV 172

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 143 VLHRDLKPSNLLL 155

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 22/149 (14%)
Query: 131 GQPKQTISYMAERV-VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQI 183
           G P+   SY+   + +G GS G+V  A    +G  VA+KK+  D R + R      E+ I
Sbjct: 16  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 70
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
           MR   H NVV + + +      DEL++  V+E++          +TRMN+      +   
Sbjct: 71  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEE----QIAAV 121
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
              + +AL+ LH   GV HRDIK  ++L+
Sbjct: 122 CLAVLQALSVLH-AQGVIHRDIKSDSILL 149

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 22/148 (14%)
Query: 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNH 189
           QP++    + +  +G GS+G V++A   ETG  VAIK+V  +   +   +E+ IM+  + 
Sbjct: 26  QPEEVFDVLEK--LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS 83
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYT 244
           P+VV     +F  T+     L +V+EY     +S+ +   +K  T  ++   IL   L  
Sbjct: 84  PHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTE-DEIATILQSTL-- 135
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
               + L YLH +  + HRDIK  N+L+
Sbjct: 136 ----KGLEYLHFMRKI-HRDIKAGNILL 158

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 19/147 (12%)
Query: 133 PKQTISYMAERV-VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMR 185
           P    SY+   + +G GS G+V  A    +G  VA+KK+  D R + R      E+ IMR
Sbjct: 24  PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 81
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
              H NVV + + +      DEL++  V+E++          +TRMN+      +     
Sbjct: 82  DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEE----QIAAVCL 132
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
            + +AL+ LH   GV HRDIK  ++L+
Sbjct: 133 AVLQALSVLH-AQGVIHRDIKSDSILL 158

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 19/147 (12%)
Query: 133 PKQTISYMAERV-VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMR 185
           P    SY+   + +G GS G+V  A    +G  VA+KK+  D R + R      E+ IMR
Sbjct: 19  PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 76
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
              H NVV + + +      DEL++  V+E++          +TRMN+      +     
Sbjct: 77  DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEE----QIAAVCL 127
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
            + +AL+ LH   GV HRDIK  ++L+
Sbjct: 128 AVLQALSVLH-AQGVIHRDIKSDSILL 153

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVV----FQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V    +      TG+ VA+KK+        R   RE++I++ L H N+V  K
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +S   ++   L L++EY+     R  + KH  R++ H+ +L    YT QIC+ + YL
Sbjct: 79  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERID-HIKLLQ---YTSQICKGMEYL 131
Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HR++  +N+L+
Sbjct: 132 -GTKRYIHRNLATRNILV 148

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 67/141 (47%), Gaps = 23/141 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY--KNRELQIMRLLN-------HPNVV 193
           +V+G GSFG V  A+        A+K VLQ K    K  E  IM   N       HP +V
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            L    FS    D+LY   VL+YI+  E  Y + +    +         + Y  +I  AL
Sbjct: 103 GLH---FSFQTADKLYF--VLDYINGGELFYHLQRERCFLEPRA-----RFYAAEIASAL 152
Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            YLH +  + +RD+KP+N+L+
Sbjct: 153 GYLHSL-NIVYRDLKPENILL 172

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 23/138 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLKHC 198
           +G G+F VV +   + TG   A K +       +D +   RE +I RLL HPN+V L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 70
Query: 199 FFSTTEKDELYLNLVL----EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
             S +E+   YL   L    E   + V R  ++Y+  +    I        QI  ++N+ 
Sbjct: 71  --SISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILESVNHC 119
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRD+KP+NLL+
Sbjct: 120 H-LNGIVHRDLKPENLLL 136

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 68/138 (49%), Gaps = 18/138 (13%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVVS 194
            +G G F  V++A+   T   VAIKK+    R +          RE+++++ L+HPN++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   F   +      ++LV +++   +  + K  + +   +   +++ Y     + L YL
Sbjct: 77  LLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYL 128
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    + HRD+KP NLL+
Sbjct: 129 HQ-HWILHRDLKPNNLLL 145

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 27/158 (17%)
Query: 130 NGQPKQTISYMAERV---------VGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRY 176
           NG+   +    AE +         +GTG+F  V  A+   TG   A+K    K L+ K  
Sbjct: 6   NGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES 65
Query: 177 K-NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSK--HYTRMNQ 233
               E+ ++R + H N+V+L+  + S    + LYL + L    E   R+ +   YT  + 
Sbjct: 66  SIENEIAVLRKIKHENIVALEDIYESP---NHLYLVMQLVSGGELFDRIVEKGFYTEKDA 122
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
              I        Q+  A+ YLH + G+ HRD+KP+NLL
Sbjct: 123 STLIR-------QVLDAVYYLHRM-GIVHRDLKPENLL 152

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 17/141 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
           Y+    +G GSFG V  A   +T   VA+K + +    K+       RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           ++ L     + T+     + +V+EY    ++       RM +     + Q    QI  A+
Sbjct: 71  IIKLYDVITTPTD-----IVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQ----QIICAI 121
Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            Y H    + HRD+KP+NLL+
Sbjct: 122 EYCHRH-KIVHRDLKPENLLL 141

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 13/135 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
           +G G++  V++     TG  VA+K+V  D          RE+ +M+ L H N+V L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 200 FSTTEKDELYLNLVLEYISETV--YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
            +  +     L LV E++   +  Y  S+      + + +  V+ + +Q+ + L + H  
Sbjct: 73  HTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 258 VGVCHRDIKPQNLLM 272
             + HRD+KPQNLL+
Sbjct: 128 -KILHRDLKPQNLLI 141

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 25/145 (17%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------------RELQIMRLL---N 188
           +G G++G V++A+   +G  VA+K V    R  N             RE+ ++R L    
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 189 HPNVVSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           HPNVV L   C  S T++ E+ + LV E++ + +             +P   ++    Q 
Sbjct: 73  HPNVVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQF 129
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
            R L++LH    + HRD+KP+N+L+
Sbjct: 130 LRGLDFLHANC-IVHRDLKPENILV 153

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--ELQIMRLLNHPNVVSLKHCF 199
           E VVG G+FGVV +AK       VAIK++  +   K    EL+ +  +NHPN+V L    
Sbjct: 14  EEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 200 FSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV- 257
            +        + LV+EY    ++Y V  H      +    +   +  Q  + + YLH + 
Sbjct: 72  LNP-------VCLVMEYAEGGSLYNV-LHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 258 -VGVCHRDIKPQNLLM 272
              + HRD+KP NLL+
Sbjct: 124 PKALIHRDLKPPNLLL 139

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 68/137 (49%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  +    +A+K + + +  K        RE++I   L HPN++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
            + F    ++  +YL L      E    + KH  R ++     +++    ++  AL+Y H
Sbjct: 81  YNYF---HDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFME----ELADALHYCH 132
Query: 256 HVVGVCHRDIKPQNLLM 272
               V HRDIKP+NLLM
Sbjct: 133 ER-KVIHRDIKPENLLM 148

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----CQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 149 VLHRDLKPSNLLL 161

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 68/137 (49%), Gaps = 16/137 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  +    +A+K + + +  K        RE++I   L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
            + F    ++  +YL L      E    + KH  R ++     +++    ++  AL+Y H
Sbjct: 80  YNYF---HDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFME----ELADALHYCH 131
Query: 256 HVVGVCHRDIKPQNLLM 272
               V HRDIKP+NLLM
Sbjct: 132 ER-KVIHRDIKPENLLM 147

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--ELQIMRLLNHPNVVSLKHCF 199
           E VVG G+FGVV +AK       VAIK++  +   K    EL+ +  +NHPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 200 FSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV- 257
            +        + LV+EY    ++Y V  H      +    +   +  Q  + + YLH + 
Sbjct: 71  LNP-------VCLVMEYAEGGSLYNV-LHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 258 -VGVCHRDIKPQNLLM 272
              + HRD+KP NLL+
Sbjct: 123 PKALIHRDLKPPNLLL 138

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNR---ELQIMRLLNHPNVVSLKHCF 199
           +G G++G+V  A        VAI+K+   + + Y  R   E++I+    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            + T +    + +V + +   +Y++ K      QH+   ++  + YQI R L Y+H    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 260 VCHRDIKPQNLLM 272
           V HRD+KP NLL+
Sbjct: 149 VLHRDLKPSNLLL 161

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 78/143 (54%), Gaps = 18/143 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRLLN-HPNVVSLKH 197
           RV+  G F  V++A+ + +G   A+K++L ++  KNR    E+  M+ L+ HPN+V  + 
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV--QF 91
Query: 198 CFFSTTEKDELYLN----LVLEYISETVYRVSKHYTRMNQHVPI---LYVQLYTYQICRA 250
           C  ++  K+E        L+L  + +   ++ +   +M    P+     ++++ YQ CRA
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKG--QLVEFLKKMESRGPLSCDTVLKIF-YQTCRA 148
Query: 251 LNYLH-HVVGVCHRDIKPQNLLM 272
           + ++H     + HRD+K +NLL+
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLL 171

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 75/149 (50%), Gaps = 16/149 (10%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQI 183
           R+  P +    + E  +G G+FG V++AK  ETG ++A  KV++ K  +       E++I
Sbjct: 13  RDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEI 69
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
           +   +HP +V L   ++   +     L +++E+       V      +++ +    +Q+ 
Sbjct: 70  LATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGA--VDAIMLELDRGLTEPQIQVV 122
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q+  ALN+LH    + HRD+K  N+LM
Sbjct: 123 CRQMLEALNFLHS-KRIIHRDLKAGNVLM 150

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 75/149 (50%), Gaps = 16/149 (10%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQI 183
           R+  P +    + E  +G G+FG V++AK  ETG ++A  KV++ K  +       E++I
Sbjct: 5   RDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEI 61
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
           +   +HP +V L   ++   +     L +++E+       V      +++ +    +Q+ 
Sbjct: 62  LATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGA--VDAIMLELDRGLTEPQIQVV 114
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q+  ALN+LH    + HRD+K  N+LM
Sbjct: 115 CRQMLEALNFLHS-KRIIHRDLKAGNVLM 142

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 69/145 (47%), Gaps = 23/145 (15%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNH 189
           +Y   + +G G+F  V  A+ + TG  VA+K +  DK   N        RE++I ++LNH
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           PN+V L    F   E ++  L LV EY S  E    +  H     +     +      QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVXEYASGGEVFDYLVAHGRXKEKEARAKF-----RQI 122
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
             A+ Y H    + HRD+K +NLL+
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLL 146

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 24/143 (16%)
Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIKKV--------LQDKRYKNRELQIMRLLNHPN 191
           RV+G G +G VFQ + +    TG   A+K +         +D  +   E  I+  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           +V L + F +  +     L L+LEY+S  E   ++ +    M           Y  +I  
Sbjct: 83  IVDLIYAFQTGGK-----LYLILEYLSGGELFMQLEREGIFMED-----TACFYLAEISM 132
Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           AL +LH   G+ +RD+KP+N+++
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIML 154

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 24/143 (16%)
Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIKKV--------LQDKRYKNRELQIMRLLNHPN 191
           RV+G G +G VFQ + +    TG   A+K +         +D  +   E  I+  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           +V L + F +  +     L L+LEY+S  E   ++ +    M           Y  +I  
Sbjct: 83  IVDLIYAFQTGGK-----LYLILEYLSGGELFMQLEREGIFMED-----TACFYLAEISM 132
Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           AL +LH   G+ +RD+KP+N+++
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIML 154

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 78/146 (53%), Gaps = 29/146 (19%)
Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----------KVLQDKRYKNRELQIMRLLN 188
           +V+GTG++G VF  + +   +TG   A+K           K  +  R + + L+ +R   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--Q 117
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
            P +V+L + F + T+     L+L+L+YI+  E    +S+   R  +H     VQ+Y  +
Sbjct: 118 SPFLVTLHYAFQTETK-----LHLILDYINGGELFTHLSQR-ERFTEH----EVQIYVGE 167
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           I  AL +LH + G+ +RDIK +N+L+
Sbjct: 168 IVLALEHLHKL-GIIYRDIKLENILL 192

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 62/133 (46%), Gaps = 12/133 (9%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVSLKHCF 199
           V+G G FG   +    ETG+ + +K+++    + +R   +E+++MR L HPNV+     F
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----F 72
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
                KD+  LN + EYI     R       M+   P      +   I   + YLH  + 
Sbjct: 73  IGVLYKDK-RLNFITEYIKGGTLR--GIIKSMDSQYPWSQRVSFAKDIASGMAYLHS-MN 128
Query: 260 VCHRDIKPQNLLM 272
           + HRD+   N L+
Sbjct: 129 IIHRDLNSHNCLV 141

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 69/146 (47%), Gaps = 21/146 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL---QIMR------LLNHPNVV 193
           + +G G FGVVF+AK      + AIK++    R  NREL   ++MR       L HP +V
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 194 SLKHCFF--STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPI----LYVQLYTY-Q 246
              + +   +TTEK +     V  YI   + R       MN    I      V L+ + Q
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           I  A+ +LH   G+ HRD+KP N+  
Sbjct: 127 IAEAVEFLHS-KGLMHRDLKPSNIFF 151

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 XGIKHLHS-AGIIHRDLKPSNIVV 159

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 22/154 (14%)
Query: 131 GQPKQTIS---YMAERVVGTGSFGVVFQAKCL-ETGD--SVAIKKVLQDKRYKNRE---- 180
           G P+  I+    +  R++G G FG V++       G+  +VA+K   +D    N+E    
Sbjct: 15  GSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 74
Query: 181 -LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPIL 238
              IM+ L+HP++V L        E++  ++ + L    E       HY   N++ + +L
Sbjct: 75  EAVIMKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGEL-----GHYLERNKNSLKVL 125
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            + LY+ QIC+A+ YL  +  V HRDI  +N+L+
Sbjct: 126 TLVLYSLQICKAMAYLESINCV-HRDIAVRNILV 158

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 33/145 (22%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQIMRLLNHPNVVSLK 196
           ++G GSF  V++A+ + TG  VAIK + +   YK         E++I   L HP+++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 197 HCFFSTTEKDELYLNLVLE---------YISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           + F     +D  Y+ LVLE         Y+   V   S++  R   H           QI
Sbjct: 78  NYF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-----------QI 121
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
              + YL H  G+ HRD+   NLL+
Sbjct: 122 ITGMLYL-HSHGILHRDLTLSNLLL 145

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 XGIKHLHS-AGIIHRDLKPSNIVV 159

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 76/148 (51%), Gaps = 13/148 (8%)
Query: 133 PKQTISYMAE--RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNH- 189
           P   ++Y  E  +V+G GSFG V +A   +    VA+K V  +KR+  +  + +R+L H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 190 -----PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
                 N +++ H   + T ++  ++ +  E +S  +Y + K        +P+  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
           + I + L+ LH    + H D+KP+N+L+
Sbjct: 207 HSILQCLDALHKNR-IIHCDLKPENILL 233

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 76/148 (51%), Gaps = 13/148 (8%)
Query: 133 PKQTISYMAE--RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNH- 189
           P   ++Y  E  +V+G GSFG V +A   +    VA+K V  +KR+  +  + +R+L H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 190 -----PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
                 N +++ H   + T ++  ++ +  E +S  +Y + K        +P+  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
           + I + L+ LH    + H D+KP+N+L+
Sbjct: 207 HSILQCLDALHKNR-IIHCDLKPENILL 233

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 27/144 (18%)
Query: 143 RVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
           R +G G FG V    C +     TG+ VA+K +  D   ++R     E+ I+R L H ++
Sbjct: 37  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRA 250
           +  K C     +     L LV+EY+     R  + +H   + Q      + L+  QIC  
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ------LLLFAQQICEG 146
Query: 251 LNYLH--HVVGVCHRDIKPQNLLM 272
           + YLH  H +   HRD+  +N+L+
Sbjct: 147 MAYLHAQHYI---HRDLAARNVLL 167

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 68/133 (51%), Gaps = 16/133 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLLNHPNVVSLKHCFFS 201
           +G+G+FGV    +  ++ + VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 202 TTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            T     +L +V+EY S  E   R+  +  R ++     + Q    Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQ----QLISGVSYCH-AMQ 135
Query: 260 VCHRDIKPQNLLM 272
           VCHRD+K +N L+
Sbjct: 136 VCHRDLKLENTLL 148

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 72/139 (51%), Gaps = 19/139 (13%)
Query: 143 RVVGTGSFGVVFQAKCL-ETGD--SVAIKKVLQDKRYKNRE-----LQIMRLLNHPNVVS 194
           R++G G FG V++       G+  +VA+K   +D    N+E       IM+ L+HP++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNY 253
           L        E++  ++ + L    E       HY   N++ + +L + LY+ QIC+A+ Y
Sbjct: 78  L----IGIIEEEPTWIIMELYPYGEL-----GHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 254 LHHVVGVCHRDIKPQNLLM 272
           L  +  V HRDI  +N+L+
Sbjct: 129 LESINCV-HRDIAVRNILV 146

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 68/133 (51%), Gaps = 16/133 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLLNHPNVVSLKHCFFS 201
           +G+G+FGV    +  ++ + VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 202 TTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            T     +L +V+EY S  E   R+  +  R ++     + Q    Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQ----QLISGVSYCH-AMQ 135
Query: 260 VCHRDIKPQNLLM 272
           VCHRD+K +N L+
Sbjct: 136 VCHRDLKLENTLL 148

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLL---------YQML 129
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 130 XGIKHLHS-AGIIHRDLKPSNIVV 152

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 68/133 (51%), Gaps = 16/133 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLLNHPNVVSLKHCFFS 201
           +G+G+FGV    +  ++ + VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 202 TTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            T     +L +V+EY S  E   R+  +  R ++     + Q    Q+   ++Y H  + 
Sbjct: 86  PT-----HLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQ----QLISGVSYCH-AMQ 134
Query: 260 VCHRDIKPQNLLM 272
           VCHRD+K +N L+
Sbjct: 135 VCHRDLKLENTLL 147

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 67/134 (50%), Gaps = 11/134 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-----LQDKRYKNRELQI-MRLLNHPNVVSLKHC 198
           +G G++GVV + + + +G  +A+K++      Q+++    +L I MR ++ P  V+    
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
            F   +     + + +E +  ++ +  K      Q +P   +      I +AL +LH  +
Sbjct: 119 LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 259 GVCHRDIKPQNLLM 272
            V HRD+KP N+L+
Sbjct: 174 SVIHRDVKPSNVLI 187

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 63/139 (45%), Gaps = 15/139 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
           Y  E  +G GS+G V  A    T    A KK+    ++D     +E++IM+ L+HPN++ 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           L   F   T   ++YL + L    E   R V K   R +    I+   L     C  LN 
Sbjct: 71  LYETFEDNT---DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN- 126
Query: 254 LHHVVGVCHRDIKPQNLLM 272
                 V HRD+KP+N L 
Sbjct: 127 ------VAHRDLKPENFLF 139

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 68/133 (51%), Gaps = 16/133 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLLNHPNVVSLKHCFFS 201
           +G+G+FGV    +  ++ + VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 202 TTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            T     +L +V+EY S  E   R+  +  R ++     + Q    Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQ----QLISGVSYCH-AMQ 135
Query: 260 VCHRDIKPQNLLM 272
           VCHRD+K +N L+
Sbjct: 136 VCHRDLKLENTLL 148

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHP 190
           Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           +++ L     + T+       +V+EY+S  E    + KH  R+ +    +  +    QI 
Sbjct: 72  HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-GRVEE----MEARRLFQQIL 121
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            A++Y H  + V HRD+KP+N+L+
Sbjct: 122 SAVDYCHRHM-VVHRDLKPENVLL 144

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHP 190
           Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           +++ L     + T+       +V+EY+S  E    + KH  R+ +    +  +    QI 
Sbjct: 72  HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-GRVEE----MEARRLFQQIL 121
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            A++Y H  + V HRD+KP+N+L+
Sbjct: 122 SAVDYCHRHM-VVHRDLKPENVLL 144

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 63/139 (45%), Gaps = 15/139 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
           Y  E  +G GS+G V  A    T    A KK+    ++D     +E++IM+ L+HPN++ 
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           L   F   T   ++YL + L    E   R V K   R +    I+   L     C  LN 
Sbjct: 88  LYETFEDNT---DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN- 143
Query: 254 LHHVVGVCHRDIKPQNLLM 272
                 V HRD+KP+N L 
Sbjct: 144 ------VAHRDLKPENFLF 156

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 72/139 (51%), Gaps = 19/139 (13%)
Query: 143 RVVGTGSFGVVFQAKCL-ETGD--SVAIKKVLQDKRYKNRE-----LQIMRLLNHPNVVS 194
           R++G G FG V++       G+  +VA+K   +D    N+E       IM+ L+HP++V 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNY 253
           L        E++  ++ + L    E       HY   N++ + +L + LY+ QIC+A+ Y
Sbjct: 74  L----IGIIEEEPTWIIMELYPYGEL-----GHYLERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 254 LHHVVGVCHRDIKPQNLLM 272
           L  +  V HRDI  +N+L+
Sbjct: 125 LESINCV-HRDIAVRNILV 142

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 18/161 (11%)
Query: 123 ATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ 182
           A TV  R G   + I      ++G+G FG VF+AK    G +  IK+V  +     RE++
Sbjct: 2   AHTVDKRFGMDFKEIE-----LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK 56
Query: 183 IMRLLNHPNVVSLKHCFFS------TTEKDELY-----LNLVLEYISETVYRVSKHYTRM 231
            +  L+H N+V    C+        T+ K+        L + +E+  +          R 
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            +   +L ++L+  QI + ++Y+H    + +RD+KP N+ +
Sbjct: 117 EKLDKVLALELFE-QITKGVDYIHS-KKLINRDLKPSNIFL 155

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 67/134 (50%), Gaps = 11/134 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-----LQDKRYKNRELQI-MRLLNHPNVVSLKHC 198
           +G G++GVV + + + +G  +A+K++      Q+++    +L I MR ++ P  V+    
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
            F   +     + + +E +  ++ +  K      Q +P   +      I +AL +LH  +
Sbjct: 75  LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 259 GVCHRDIKPQNLLM 272
            V HRD+KP N+L+
Sbjct: 130 SVIHRDVKPSNVLI 143

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 CGIKHLHS-AGIIHRDLKPSNIVV 159

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 14/141 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A     G +VA+KK+    Q++ +  R   EL +++ +NH N+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           +SL + F      +E   + LV+E +   + +V  H    ++ +  L      YQ+   +
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 137
Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            +LH   G+ HRD+KP N+++
Sbjct: 138 KHLHSA-GIIHRDLKPSNIVV 157

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 38/57 (66%), Gaps = 6/57 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
           +G G+FG VF+A+  +TG  VA+KKVL +   +       RE++I++LL H NVV+L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 82

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+++NH N+
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 VGIKHLHSA-GIIHRDLKPSNIVV 159

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 27/144 (18%)
Query: 143 RVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
           R +G G FG V    C +     TG+ VA+K +  D   ++R     E+ I+R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRA 250
           +  K C     EK    L LV+EY+     R  + +H   + Q      + L+  QIC  
Sbjct: 79  IKYKGCCEDQGEKS---LQLVMEYVPLGSLRDYLPRHSIGLAQ------LLLFAQQICEG 129
Query: 251 LNYLH--HVVGVCHRDIKPQNLLM 272
           + YLH  H +   HR++  +N+L+
Sbjct: 130 MAYLHAQHYI---HRNLAARNVLL 150

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 27/144 (18%)
Query: 143 RVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
           R +G G FG V    C +     TG+ VA+K +  D   ++R     E+ I+R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRA 250
           +  K C     EK    L LV+EY+     R  + +H   + Q      + L+  QIC  
Sbjct: 79  IKYKGCCEDQGEKS---LQLVMEYVPLGSLRDYLPRHSIGLAQ------LLLFAQQICEG 129
Query: 251 LNYLH--HVVGVCHRDIKPQNLLM 272
           + YLH  H +   HR++  +N+L+
Sbjct: 130 MAYLHSQHYI---HRNLAARNVLL 150

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 136 TISYMAER-----VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------RYKNRELQ 182
           T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE Q
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQ 64
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
               LNHP +V++     + T    L   +V+EY+     R   H        P   +++
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTE--GPMTPKRAIEV 121
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
                C+ALN+ H   G+ HRD+KP N+L+
Sbjct: 122 IA-DACQALNFSHQN-GIIHRDVKPANILI 149

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPN 191
           +Y+ + ++G GS+G V+ A    T  +VAIKKV      L D +   RE+ I+  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 192 VVSLKHCFFSTT--EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           ++ L          + DELY  +VLE     + ++ K    + +     +++   Y +  
Sbjct: 87  IIRLYDLIIPDDLLKFDELY--IVLEIADSDLKKLFKTPIFLTEE----HIKTILYNLLL 140
Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
             N++H   G+ HRD+KP N L+
Sbjct: 141 GENFIHE-SGIIHRDLKPANCLL 162

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 38/57 (66%), Gaps = 6/57 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
           +G G+FG VF+A+  +TG  VA+KKVL +   +       RE++I++LL H NVV+L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 81

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 38/57 (66%), Gaps = 6/57 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
           +G G+FG VF+A+  +TG  VA+KKVL +   +       RE++I++LL H NVV+L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 82

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 174
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 175 CGIKHLHS-AGIIHRDLKPSNIVV 197

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 121 HGI-GITHRDIKPENLLL 137

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 70/140 (50%), Gaps = 21/140 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRL--------LNHPNVVS 194
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          NHP +V 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L  CF     + E  L  V+EY++  + ++ + +      + +P  + + Y+ +I  ALN
Sbjct: 86  LHSCF-----QTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 135
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH   G+ +RD+K  N+L+
Sbjct: 136 YLHE-RGIIYRDLKLDNVLL 154

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 14/141 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A     G +VA+KK+    Q++ +  R   EL +++ +NH N+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           +SL + F      +E   + LV+E +   + +V  H    ++ +  L      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 139
Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            +LH   G+ HRD+KP N+++
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVV 159

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 38/57 (66%), Gaps = 6/57 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
           +G G+FG VF+A+  +TG  VA+KKVL +   +       RE++I++LL H NVV+L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 82

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 23/138 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLKHC 198
           +G G+F VV +   +  G   A K +       +D +   RE +I RLL HPN+V L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 88
Query: 199 FFSTTEKDELYLNLVL----EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
             S +E+   YL   L    E   + V R  ++Y+  +    I        QI  A+ + 
Sbjct: 89  --SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILEAVLHC 137
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + GV HRD+KP+NLL+
Sbjct: 138 HQM-GVVHRDLKPENLLL 154

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 69
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 122 HGI-GITHRDIKPENLLL 138

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 68/139 (48%), Gaps = 19/139 (13%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLL-NHPNVVSL 195
           + ++ +G GSF +    KC+    + A    +  KR +    +E+  ++L   HPN+V L
Sbjct: 14  LKDKPLGEGSFSIC--RKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
              F      D+L+  LV+E ++  E   R+ K      +H           ++  A+++
Sbjct: 72  HEVF-----HDQLHTFLVMELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSH 121
Query: 254 LHHVVGVCHRDIKPQNLLM 272
           +H V GV HRD+KP+NLL 
Sbjct: 122 MHDV-GVVHRDLKPENLLF 139

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 122 HGI-GITHRDIKPENLLL 138

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 121 HGI-GITHRDIKPENLLL 137

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 121 HGI-GITHRDIKPENLLL 137

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 137
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 138 CGIKHLHS-AGIIHRDLKPSNIVV 160

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 137
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 138 CGIKHLHS-AGIIHRDLKPSNIVV 160

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 CGIKHLHS-AGIIHRDLKPSNIVV 159

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 CGIKHLHS-AGIIHRDLKPSNIVV 159

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 77/143 (53%), Gaps = 22/143 (15%)
Query: 140 MAERVVGTGSFG-VVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL----NHPNVVS 194
           ++E+++G GS G VVFQ      G  VA+K++L D  + +  L  ++LL    +HPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 91
Query: 195 LKHCFFSTTEKDELYL-----NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
             +C  S T    LY+     NL L+ + E+     ++     ++ PI  ++    QI  
Sbjct: 92  Y-YC--SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR----QIAS 144
Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
            + +LH +  + HRD+KPQN+L+
Sbjct: 145 GVAHLHSL-KIIHRDLKPQNILV 166

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 136 TISYMAER-----VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------RYKNRELQ 182
           T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE Q
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQ 64
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
               LNHP +V++     + T    L   +V+EY+     R   H        P   +++
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTE--GPMTPKRAIEV 121
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
                C+ALN+ H   G+ HRD+KP N+++
Sbjct: 122 IA-DACQALNFSHQN-GIIHRDVKPANIMI 149

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 21/140 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVA---IKKVL----QDKRYKNRELQIM-RLLNHPNVVS 194
           RV+G GS+  V   +  +T    A   +KK L    +D  +   E  +  +  NHP +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L  CF     + E  L  V+EY++  + ++ + +      + +P  + + Y+ +I  ALN
Sbjct: 118 LHSCF-----QTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 167
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH   G+ +RD+K  N+L+
Sbjct: 168 YLHE-RGIIYRDLKLDNVLL 186

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 84
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 85  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 135
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 136 CGIKHLHS-AGIIHRDLKPSNIVV 158

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 174
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 175 CGIKHLHS-AGIIHRDLKPSNIVV 197

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 130
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 131 CGIKHLHS-AGIIHRDLKPSNIVV 153

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 75/148 (50%), Gaps = 13/148 (8%)
Query: 133 PKQTISYMAE--RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNH- 189
           P   ++Y  E  +V+G G FG V +A   +    VA+K V  +KR+  +  + +R+L H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 190 -----PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
                 N +++ H   + T ++  ++ +  E +S  +Y + K        +P+  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
           + I + L+ LH    + H D+KP+N+L+
Sbjct: 207 HSILQCLDALHKNR-IIHCDLKPENILL 233

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 CGIKHLHS-AGIIHRDLKPSNIVV 159

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 77/143 (53%), Gaps = 22/143 (15%)
Query: 140 MAERVVGTGSFG-VVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL----NHPNVVS 194
           ++E+++G GS G VVFQ      G  VA+K++L D  + +  L  ++LL    +HPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 91
Query: 195 LKHCFFSTTEKDELYL-----NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
             +C  S T    LY+     NL L+ + E+     ++     ++ PI  ++    QI  
Sbjct: 92  Y-YC--SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR----QIAS 144
Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
            + +LH +  + HRD+KPQN+L+
Sbjct: 145 GVAHLHSL-KIIHRDLKPQNILV 166

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR--------LLNHPNVVS 194
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          NHP +V 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L  CF     + E  L  V+EY++     +  H  R  + +P  + + Y+ +I  ALNYL
Sbjct: 71  LHSCF-----QTESRLFFVIEYVNGG--DLMFHMQRQRK-LPEEHARFYSAEISLALNYL 122
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ +RD+K  N+L+
Sbjct: 123 HE-RGIIYRDLKLDNVLL 139

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 130
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 131 CGIKHLHS-AGIIHRDLKPSNIVV 153

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 136 TISYMAER-----VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------RYKNRELQ 182
           T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE Q
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQ 64
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
               LNHP +V++     + T    L   +V+EY+     R   H        P   +++
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTE--GPMTPKRAIEV 121
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
                C+ALN+ H   G+ HRD+KP N+++
Sbjct: 122 IA-DACQALNFSHQN-GIIHRDVKPANIMI 149

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 19/139 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR-----LLNHPN--VVSL 195
           +V+G G+F  V   K  +TG   A+K + +    K  E+   R     L+N     +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 196 KHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
              F     +DE YL LV+EY    + +  +SK      + +P    + Y  +I  A++ 
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLTLLSK----FGERIPAEMARFYLAEIVMAIDS 177
Query: 254 LHHVVGVCHRDIKPQNLLM 272
           +H + G  HRDIKP N+L+
Sbjct: 178 VHRL-GYVHRDIKPDNILL 195

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           +SL + F      +E   + LV+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 129
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 130 CGIKHLHS-AGIIHRDLKPSNIVV 152

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 62/149 (41%), Gaps = 36/149 (24%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVVS 194
           V+G G+F VV +    ETG   A+K V   K   +         RE  I  +L HP++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 195 LKHCF---------FSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLY 243
           L   +         F   +  +L   +V    +  VY   V+ HY R             
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR------------- 137
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             QI  AL Y H    + HRD+KP+N+L+
Sbjct: 138 --QILEALRYCHDN-NIIHRDVKPENVLL 163

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 122 HGI-GITHRDIKPENLLL 138

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 122 HGI-GITHRDIKPENLLL 138

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 122 HGI-GITHRDIKPENLLL 138

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+++NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 VGIKHLHSA-GIIHRDLKPSNIVV 159

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRL--------LNHPNVVS 194
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          NHP +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L  CF     + E  L  V+EY++     +  H  R  + +P  + + Y+ +I  ALNYL
Sbjct: 75  LHSCF-----QTESRLFFVIEYVNGG--DLMFHMQRQRK-LPEEHARFYSAEISLALNYL 126
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H   G+ +RD+K  N+L+
Sbjct: 127 HE-RGIIYRDLKLDNVLL 143

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 121 HGI-GITHRDIKPENLLL 137

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 14/98 (14%)
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY----ISETVYRVSKHYTRMNQH 234
           +E+Q++R L H NV+ L    ++  EK ++Y+  V+EY    + E +  V +      + 
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNE-EKQKMYM--VMEYCVCGMQEMLDSVPE------KR 105
Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            P+     Y  Q+   L YLH   G+ H+DIKP NLL+
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLL 142

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+++NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 VGIKHLHSA-GIIHRDLKPSNIVV 159

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 77/143 (53%), Gaps = 22/143 (15%)
Query: 140 MAERVVGTGSFG-VVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL----NHPNVVS 194
           ++E+++G GS G VVFQ      G  VA+K++L D  + +  L  ++LL    +HPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 195 LKHCFFSTTEKDELYL-----NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
             +C  S T    LY+     NL L+ + E+     ++     ++ PI  ++    QI  
Sbjct: 74  Y-YC--SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR----QIAS 126
Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
            + +LH +  + HRD+KPQN+L+
Sbjct: 127 GVAHLHSL-KIIHRDLKPQNILV 148

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 136 TISYMAER-----VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------RYKNRELQ 182
           T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE Q
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQ 64
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
               LNHP +V++     + T    L   +V+EY+     R   H        P   +++
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTE--GPMTPKRAIEV 121
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
                C+ALN+ H   G+ HRD+KP N+++
Sbjct: 122 IA-DACQALNFSHQN-GIIHRDVKPANIMI 149

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 77/143 (53%), Gaps = 22/143 (15%)
Query: 140 MAERVVGTGSFG-VVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL----NHPNVVS 194
           ++E+++G GS G VVFQ      G  VA+K++L D  + +  L  ++LL    +HPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 195 LKHCFFSTTEKDELYL-----NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
             +C  S T    LY+     NL L+ + E+     ++     ++ PI  ++    QI  
Sbjct: 74  Y-YC--SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR----QIAS 126
Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
            + +LH +  + HRD+KPQN+L+
Sbjct: 127 GVAHLHSL-KIIHRDLKPQNILV 148

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHP 190
           Y+    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           +++ L     + ++     + +V+EY+S  E    + K+  R+++       Q    QI 
Sbjct: 77  HIIKLYQVISTPSD-----IFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQ----QIL 126
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             ++Y H  + V HRD+KP+N+L+
Sbjct: 127 SGVDYCHRHM-VVHRDLKPENVLL 149

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 121 HGI-GITHRDIKPENLLL 137

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 65/116 (56%), Gaps = 13/116 (11%)
Query: 162 GDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SET 220
            D ++IK    D  +KN ELQI+  + +   ++   C    T  DE+Y+  + EY+ +++
Sbjct: 78  NDKISIKSKYDD--FKN-ELQIITDIKNEYCLT---CEGIITNYDEVYI--IYEYMENDS 129
Query: 221 VYRVSKHYTRMNQH----VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           + +  +++  ++++    +PI  ++     +  + +Y+H+   +CHRD+KP N+LM
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 68/147 (46%), Gaps = 23/147 (15%)
Query: 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNH 189
           T  Y     +G G+F VV +   L TG   A K +       +D +   RE +I RLL H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVL----EYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
            N+V L     S +E+   YL   L    E   + V R  ++Y+  +    I        
Sbjct: 63  SNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------Q 110
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           QI  A+ + H + GV HRD+KP+NLL+
Sbjct: 111 QILEAVLHCHQM-GVVHRDLKPENLLL 136

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 67
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 68  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 120 HGI-GITHRDIKPENLLL 136

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 46/171 (26%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------- 179
           R  + K   SY   R +G+G++G V   K        AIK + + +  K R         
Sbjct: 28  RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIE 87
Query: 180 --------ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM 231
                   E+ +++ L+HPN++ L   F     +D+ Y  LV E+     Y   + + ++
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEF-----YEGGELFEQI 137
Query: 232 -NQHVPILYVQLYTYQICRALNYLHHVV-GVC--------HRDIKPQNLLM 272
            N+H          +  C A N +  ++ G+C        HRDIKP+N+L+
Sbjct: 138 INRH---------KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILL 179

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 121 HGI-GITHRDIKPENLLL 137

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 136 TISYMAER-----VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------RYKNRELQ 182
           T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE Q
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQ 64
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
               LNHP +V++     + T    L   +V+EY+     R   H        P   +++
Sbjct: 65  NAAALNHPAIVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTE--GPMTPKRAIEV 121
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
                C+ALN+ H   G+ HRD+KP N+++
Sbjct: 122 IA-DACQALNFSHQN-GIIHRDVKPANIMI 149

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 121 HGI-GITHRDIKPENLLL 137

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 121 HGI-GITHRDIKPENLLL 137

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 122 HGI-GITHRDIKPENLLL 138

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 121 HGI-GITHRDIKPENLLL 137

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 18/137 (13%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYK---NRELQIMRLLNHPNVVSLKHCF 199
           V+G G++G+V+  + L     +AIK++ + D RY    + E+ + + L H N+V     F
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 200 FSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
                 +  ++ + +E +       + R      + N+      +  YT QI   L YLH
Sbjct: 89  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT----IGFYTKQILEGLKYLH 139
Query: 256 HVVGVCHRDIKPQNLLM 272
               + HRDIK  N+L+
Sbjct: 140 DNQ-IVHRDIKGDNVLI 155

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+++NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVV 159

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 27/144 (18%)
Query: 143 RVVGTGSFGVVFQAKCLE-----TGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPNV 192
           R +G G FG V    C +     TG+ VA+K +      Q +    RE++I+R L H ++
Sbjct: 15  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRA 250
           V  K C     EK    + LV+EY+     R  + +H   + Q      + L+  QIC  
Sbjct: 74  VKYKGCCEDQGEKS---VQLVMEYVPLGSLRDYLPRHCVGLAQ------LLLFAQQICEG 124
Query: 251 LNYLH--HVVGVCHRDIKPQNLLM 272
           + YLH  H +   HR +  +N+L+
Sbjct: 125 MAYLHAQHYI---HRALAARNVLL 145

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 68/153 (44%), Gaps = 26/153 (16%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCF--FS 201
           ++G+G FG VF+AK    G +  I++V  +     RE++ +  L+H N+V    C+  F 
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 78
Query: 202 ---TTEKDEL-------------------YLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
               T  D L                    L + +E+  +          R  +   +L 
Sbjct: 79  YDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 138
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           ++L+  QI + ++Y+H    + HRD+KP N+ +
Sbjct: 139 LELFE-QITKGVDYIHS-KKLIHRDLKPSNIFL 169

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 27/144 (18%)
Query: 143 RVVGTGSFGVVFQAKCLE-----TGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPNV 192
           R +G G FG V    C +     TG+ VA+K +      Q +    RE++I+R L H ++
Sbjct: 14  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRA 250
           V  K C     EK    + LV+EY+     R  + +H   + Q      + L+  QIC  
Sbjct: 73  VKYKGCCEDQGEKS---VQLVMEYVPLGSLRDYLPRHCVGLAQ------LLLFAQQICEG 123
Query: 251 LNYLH--HVVGVCHRDIKPQNLLM 272
           + YLH  H +   HR +  +N+L+
Sbjct: 124 MAYLHAQHYI---HRALAARNVLL 144

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 121 HGI-GITHRDIKPENLLL 137

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 136 TISYMAER-----VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------RYKNRELQ 182
           T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE Q
Sbjct: 23  TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQ 81
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
               LNHP +V++     + T    L   +V+EY+     R   H        P   +++
Sbjct: 82  NAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTE--GPMTPKRAIEV 138
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
                C+ALN+ H   G+ HRD+KP N+++
Sbjct: 139 IA-DACQALNFSHQN-GIIHRDVKPANIMI 166

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 121 HGI-GITHRDIKPENLLL 137

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 122 HGI-GITHRDIKPENLLL 138

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 65/142 (45%), Gaps = 20/142 (14%)
Query: 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVS 194
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++I+ R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 195 LKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           LK  +      D  Y+ +V E      + + + R      R    V      L+T  I +
Sbjct: 81  LKDVY-----DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAV------LFT--ITK 127
Query: 250 ALNYLHHVVGVCHRDIKPQNLL 271
            + YLH   GV HRD+KP N+L
Sbjct: 128 TVEYLH-AQGVVHRDLKPSNIL 148

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 16/140 (11%)
Query: 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVS 194
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++I+ R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 195 LKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKH-YTRMNQHVPILYVQLYTYQICRAL 251
           LK  +      D  Y+ +V E +   E + ++ +  +    +   +L+       I + +
Sbjct: 81  LKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT------ITKTV 129
Query: 252 NYLHHVVGVCHRDIKPQNLL 271
            YLH   GV HRD+KP N+L
Sbjct: 130 EYLH-AQGVVHRDLKPSNIL 148

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 16/134 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+    G++ A+KK+  +K  +       RE+ I++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
             +        L LV E++ + +    K        +  +  + +  Q+   + Y H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDL---KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 259 GVCHRDIKPQNLLM 272
            V HRD+KPQNLL+
Sbjct: 120 RVLHRDLKPQNLLI 133

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 16/134 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+    G++ A+KK+  +K  +       RE+ I++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
             +        L LV E++ + +    K        +  +  + +  Q+   + Y H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDL---KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 259 GVCHRDIKPQNLLM 272
            V HRD+KPQNLL+
Sbjct: 120 RVLHRDLKPQNLLI 133

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 16/134 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+    G++ A+KK+  +K  +       RE+ I++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
             +        L LV E++ + +    K        +  +  + +  Q+   + Y H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDL---KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 259 GVCHRDIKPQNLLM 272
            V HRD+KPQNLL+
Sbjct: 120 RVLHRDLKPQNLLI 133

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----LQI 183
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +  E     + I
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
           +   +HPN+V L   F+      E  L +++E+ +     V      + + +    +Q+ 
Sbjct: 88  LASCDHPNIVKLLDAFYY-----ENNLWILIEFCAGGA--VDAVMLELERPLTESQIQVV 140
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q   ALNYLH    + HRD+K  N+L 
Sbjct: 141 CKQTLDALNYLHD-NKIIHRDLKAGNILF 168

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----LQI 183
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +  E     + I
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
           +   +HPN+V L   F+      E  L +++E+ +     V      + + +    +Q+ 
Sbjct: 88  LASCDHPNIVKLLDAFYY-----ENNLWILIEFCAGGA--VDAVMLELERPLTESQIQVV 140
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q   ALNYLH    + HRD+K  N+L 
Sbjct: 141 CKQTLDALNYLHD-NKIIHRDLKAGNILF 168

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----LQI 183
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +  E     + I
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
           +   +HPN+V L   F+      E  L +++E+ +     V      + + +    +Q+ 
Sbjct: 88  LASCDHPNIVKLLDAFYY-----ENNLWILIEFCAGGA--VDAVMLELERPLTESQIQVV 140
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q   ALNYLH    + HRD+K  N+L 
Sbjct: 141 CKQTLDALNYLHD-NKIIHRDLKAGNILF 168

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 18/137 (13%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYK---NRELQIMRLLNHPNVVSLKHCF 199
           V+G G++G+V+  + L     +AIK++ + D RY    + E+ + + L H N+V     F
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 200 FSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
                 +  ++ + +E +       + R      + N+      +  YT QI   L YLH
Sbjct: 75  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT----IGFYTKQILEGLKYLH 125
Query: 256 HVVGVCHRDIKPQNLLM 272
               + HRDIK  N+L+
Sbjct: 126 DNQ-IVHRDIKGDNVLI 141

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 64/136 (47%), Gaps = 17/136 (12%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLK 196
           ++G GSFG V + K   T    A+K V+     KN       RE+++++ L+HPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
              F   E    +  +   Y    ++       R ++H     ++    Q+   + Y+H 
Sbjct: 87  ---FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QVFSGITYMHK 139
Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP+N+L+
Sbjct: 140 H-NIVHRDLKPENILL 154

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL--------NHP 190
           Y   R +G G F  V+ +  ++    VA+K V   + Y    L  +RLL        N P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 191 N---VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN-QHVPILYVQLYTYQ 246
           N   VV L   F   +  +  ++ +V E +    + + K   + N Q +P+  V+    Q
Sbjct: 99  NREMVVQLLDDF-KISGVNGTHICMVFEVLG---HHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           + + L+YLH    + H DIKP+N+L+
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILL 180

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVV 159

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 16/146 (10%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
           G PK+   Y     +G G+ G V+ A  + TG  VAI+++ LQ +  K     E+ +MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
             +PN+V+    +      DEL+  +V+EY++          T M++      +     +
Sbjct: 74  NKNPNIVNYLDSYLVG---DELW--VVMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 124
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
             +AL +LH    V HRDIK  N+L+
Sbjct: 125 CLQALEFLHS-NQVIHRDIKSDNILL 149

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 72/144 (50%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+            YQ+ 
Sbjct: 88  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 138
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 139 CGIKHLHSA-GIIHRDLKPSNIVV 161

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 16/146 (10%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
           G PK+   Y     +G G+ G V+ A  + TG  VAI+++ LQ +  K     E+ +MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
             +PN+V+    +      DEL+  +V+EY++          T M++      +     +
Sbjct: 74  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 124
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
             +AL +LH    V HRDIK  N+L+
Sbjct: 125 CLQALEFLHS-NQVIHRDIKSDNILL 149

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 16/146 (10%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
           G PK+   Y     +G G+ G V+ A  + TG  VAI+++ LQ +  K     E+ +MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
             +PN+V+    +      DEL+  +V+EY++          T M++      +     +
Sbjct: 75  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 125
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
             +AL +LH    V HRDIK  N+L+
Sbjct: 126 CLQALEFLHS-NQVIHRDIKSDNILL 150

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 16/146 (10%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
           G PK+   Y     +G G+ G V+ A  + TG  VAI+++ LQ +  K     E+ +MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
             +PN+V+    +      DEL+  +V+EY++          T M++      +     +
Sbjct: 74  NKNPNIVNYLDSYLVG---DELW--VVMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 124
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
             +AL +LH    V HRDIK  N+L+
Sbjct: 125 CLQALEFLHS-NQVIHRDIKSDNILL 149

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVV 159

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G++G V  A    T ++VA+K ++  KR  +      +E+ I  +LNH NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINAMLNHENVVK-- 69
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 122 HGI-GITHRDIKPENLLL 138

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 18/143 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVV 193
           ++ +R +G+G+FG V   +   +G    IK + +D+          E+++++ L+HPN++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 194 SLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            +   F     +D   + +V+E     E + R+     R  + +   YV     Q+  AL
Sbjct: 84  KIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNAL 137
Query: 252 NYLH--HVVGVCHRDIKPQNLLM 272
            Y H  HVV   H+D+KP+N+L 
Sbjct: 138 AYFHSQHVV---HKDLKPENILF 157

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL--------NHP 190
           Y   R +G G F  V+ +  ++    VA+K V   + Y    L  +RLL        N P
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 82
Query: 191 N---VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN-QHVPILYVQLYTYQ 246
           N   VV L   F   +  +  ++ +V E +    + + K   + N Q +P+  V+    Q
Sbjct: 83  NREMVVQLLDDF-KISGVNGTHICMVFEVLG---HHLLKWIIKSNYQGLPLPCVKKIIQQ 138
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           + + L+YLH    + H DIKP+N+L+
Sbjct: 139 VLQGLDYLHTKCRIIHTDIKPENILL 164

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVV 159

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVV 159

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 16/133 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLLNHPNVVSLKHCFFS 201
           +G G+FGV    +  +  + VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 202 TTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
            T     +L +V+EY S  E   R+  +  R ++     + Q    Q+   ++Y  H + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQ----QLISGVSYA-HAMQ 135
Query: 260 VCHRDIKPQNLLM 272
           V HRD+K +N L+
Sbjct: 136 VAHRDLKLENTLL 148

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 14/132 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLLNHPNVVSLKHCFFS 201
           +G+G+FGV    +   T + VA+K + +         RE+   R L HPN+V  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 202 TTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
            T     +L +++EY S   +Y    +  R ++     + Q    Q+   ++Y H +  +
Sbjct: 88  PT-----HLAIIMEYASGGELYERICNAGRFSEDEARFFFQ----QLLSGVSYCHSM-QI 137
Query: 261 CHRDIKPQNLLM 272
           CHRD+K +N L+
Sbjct: 138 CHRDLKLENTLL 149

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 68/138 (49%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDS----VAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V   +    GD+    VA+K++       +R   RE+QI++ L+   +V  +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +     +   L LV+EY+     R  + +H  R++       + LY+ QIC+ + YL
Sbjct: 75  GVSYGPGRPE---LRLVMEYLPSGCLRDFLQRHRARLDAS----RLLLYSSQICKGMEYL 127
Query: 255 HHVVGVCHRDIKPQNLLM 272
                V HRD+  +N+L+
Sbjct: 128 GSRRCV-HRDLAARNILV 144

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVV 159

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---------YQML 137
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 138 CGIKHLHSA-GIIHRDLKPSNIVV 160

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ++   N P +V    
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 133
Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F+S  E     +++ +E++   ++ +V K   R+ + +    +   +  + + L YL  
Sbjct: 134 AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 184
Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP N+L+
Sbjct: 185 KHKIMHRDVKPSNILV 200

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 20/138 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
           + +G G+ G V  A    T ++VA+K ++  KR  +      +E+ I ++LNH NVV   
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYL 254
             F+    +  +   L LEY S       + + R+   +  P    Q + +Q+   + YL
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSG-----GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + G+ HRDIKP+NLL+
Sbjct: 121 HGI-GITHRDIKPENLLL 137

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL--------NHP 190
           Y   R +G G F  V+    ++    VA+K V   + Y    L  ++LL        + P
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDP 92
Query: 191 N---VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN-QHVPILYVQLYTYQ 246
           N   VV L    F  +  + +++ +V E +    + + K   + N Q +P+  V+    Q
Sbjct: 93  NKDMVVQLID-DFKISGMNGIHVCMVFEVLG---HHLLKWIIKSNYQGLPVRCVKSIIRQ 148
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           + + L+YLH    + H DIKP+N+LM
Sbjct: 149 VLQGLDYLHSKCKIIHTDIKPENILM 174

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 64/136 (47%), Gaps = 20/136 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   VA+K + + +  K        RE++I   L+HPN++ L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
            + F+     D   + L+LEY    E    + K  T   Q    +  +L       AL Y
Sbjct: 89  YNYFY-----DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL-----ADALMY 138
Query: 254 LHHVVGVCHRDIKPQN 269
            H    V HRDIKP+N
Sbjct: 139 CHGK-KVIHRDIKPEN 153

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 91  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---------YQML 141
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 142 CGIKHLHSA-GIIHRDLKPSNIVV 164

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVV 159

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---------YQML 136
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVV 159

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 19/148 (12%)
Query: 134 KQTISYMAERV--VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMR 185
           K  +S M +RV  +G+G++G V   +   T    AIK + +     +       E+ +++
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK 91
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLE-YISETVYRVSKHYTRMNQHVPILYVQLYT 244
           LL+HPN++ L   F     +D+    LV+E Y    ++    H  + N+    + ++   
Sbjct: 92  LLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK--- 143
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Q+   + YLH    + HRD+KP+NLL+
Sbjct: 144 -QVLSGVTYLHKH-NIVHRDLKPENLLL 169

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 18/154 (11%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---ELQIMR 185
           +NG+ K    Y  + ++G GSFG V +A      + VAIK +   K + N+   E++++ 
Sbjct: 28  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 186 LLNHPN------VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           L+N  +      +V LK  F         +L LV E +S  +Y + ++     + V +  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRNTNF--RGVSLNL 139
Query: 240 VQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLM 272
            + +  Q+C AL +L    + + H D+KP+N+L+
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILL 173

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 18/154 (11%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---ELQIMR 185
           +NG+ K    Y  + ++G GSFG V +A      + VAIK +   K + N+   E++++ 
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 186 LLNHPN------VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           L+N  +      +V LK  F         +L LV E +S  +Y + ++     + V +  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRNTNF--RGVSLNL 158
Query: 240 VQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLM 272
            + +  Q+C AL +L    + + H D+KP+N+L+
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 18/154 (11%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---ELQIMR 185
           +NG+ K    Y  + ++G GSFG V +A      + VAIK +   K + N+   E++++ 
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 186 LLNHPN------VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
           L+N  +      +V LK  F         +L LV E +S  +Y + ++     + V +  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRNTNF--RGVSLNL 158
Query: 240 VQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLM 272
            + +  Q+C AL +L    + + H D+KP+N+L+
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+    Q++ +  R   EL +M+ +NH N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSK---HYTRMNQHVPILYVQLYTYQIC 248
           + L + F      +E   + +V+E +   + +V +    + RM+  +         YQ+ 
Sbjct: 80  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---------YQML 130
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + +LH   G+ HRD+KP N+++
Sbjct: 131 CGIKHLHSA-GIIHRDLKPSNIVV 153

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 67/145 (46%), Gaps = 22/145 (15%)
Query: 140 MAER-----VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLL 187
            AER     ++G GSFG V + K   T    A+K V+     KN       RE+++++ L
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKL 78
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           +HPN++ L    F   E    +  +   Y    ++       R ++H     ++    Q+
Sbjct: 79  DHPNIMKL----FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QV 130
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
              + Y+H    + HRD+KP+N+L+
Sbjct: 131 FSGITYMHKH-NIVHRDLKPENILL 154

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 67/145 (46%), Gaps = 22/145 (15%)
Query: 140 MAER-----VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLL 187
            AER     ++G GSFG V + K   T    A+K V+     KN       RE+++++ L
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKL 78
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           +HPN++ L    F   E    +  +   Y    ++       R ++H     ++    Q+
Sbjct: 79  DHPNIMKL----FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QV 130
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
              + Y+H    + HRD+KP+N+L+
Sbjct: 131 FSGITYMHKH-NIVHRDLKPENILL 154

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 68/138 (49%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDS----VAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V   +    GD+    VA+K++       +R   RE+QI++ L+   +V  +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +    +    L LV+EY+     R  + +H  R++       + LY+ QIC+ + YL
Sbjct: 78  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDAS----RLLLYSSQICKGMEYL 130
Query: 255 HHVVGVCHRDIKPQNLLM 272
                V HRD+  +N+L+
Sbjct: 131 GSRRCV-HRDLAARNILV 147

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 68/138 (49%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDS----VAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V   +    GD+    VA+K++       +R   RE+QI++ L+   +V  +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +    +    L LV+EY+     R  + +H  R++       + LY+ QIC+ + YL
Sbjct: 91  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDASR----LLLYSSQICKGMEYL 143
Query: 255 HHVVGVCHRDIKPQNLLM 272
                V HRD+  +N+L+
Sbjct: 144 GSRRCV-HRDLAARNILV 160

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 60/135 (44%), Gaps = 16/135 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKH 197
           +G G    V+ A+       VAIK +    R K        RE+     L+H N+VS+  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
                 E+D+ Y  LV+EYI          Y   +  + +     +T QI   + + H +
Sbjct: 77  --IDVDEEDDCYY-LVMEYIEGPTL---SEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 258 VGVCHRDIKPQNLLM 272
             + HRDIKPQN+L+
Sbjct: 131 -RIVHRDIKPQNILI 144

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 68/138 (49%), Gaps = 18/138 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDS----VAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLK 196
           +G G+FG V   +    GD+    VA+K++       +R   RE+QI++ L+   +V  +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              +    +    L LV+EY+     R  + +H  R++       + LY+ QIC+ + YL
Sbjct: 79  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDAS----RLLLYSSQICKGMEYL 131
Query: 255 HHVVGVCHRDIKPQNLLM 272
                V HRD+  +N+L+
Sbjct: 132 GSRRCV-HRDLAARNILV 148

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 23/138 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAI------KKVLQDKRYKNRELQIMRLLNHPNVVSLKHC 198
           +G G+F VV +   +  G   A       K   +D +   RE +I RLL HPN+V L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 77
Query: 199 FFSTTEKDELYLNLVL----EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
             S +E+   YL   L    E   + V R  ++Y+  +    I        QI  A+ + 
Sbjct: 78  --SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILEAVLHC 126
Query: 255 HHVVGVCHRDIKPQNLLM 272
           H + GV HR++KP+NLL+
Sbjct: 127 HQM-GVVHRNLKPENLLL 143

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ++   N P +V    
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 98
Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F+S  E     +++ +E++   ++ +V K   R+ + +    +   +  + + L YL  
Sbjct: 99  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 149
Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP N+L+
Sbjct: 150 KHKIMHRDVKPSNILV 165

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 75/181 (41%), Gaps = 47/181 (25%)
Query: 119 GQVIATTVGGR----------NGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK 168
           G  +A+  GG+          N   K + +Y  +  +G G+F VV +     TG   A  
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-A 59
Query: 169 KVLQDKRYKNRELQ-------IMRLLNHPNVV---------SLKHCFFSTTEKDELYLNL 212
           K++  K+   R+ Q       I R L HPN+V         S  +  F      EL+ ++
Sbjct: 60  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 119
Query: 213 VL-EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
           V  E+ SE     + H  +               QI  ++ Y H   G+ HR++KP+NLL
Sbjct: 120 VAREFYSEAD---ASHCIQ---------------QILESIAYCHSN-GIVHRNLKPENLL 160
Query: 272 M 272
           +
Sbjct: 161 L 161

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPN 191
           +Y  + ++G GS+G V+ A       +VAIKKV      L D +   RE+ I+  L    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 192 VVSLKHCFF--STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           ++ L          + DELY  +VLE     + ++ K    + +     +V+   Y +  
Sbjct: 89  IIRLHDLIIPEDLLKFDELY--IVLEIADSDLKKLFKTPIFLTEQ----HVKTILYNLLL 142
Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
              ++H   G+ HRD+KP N L+
Sbjct: 143 GEKFIHE-SGIIHRDLKPANCLL 164

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ++   N P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F+S  E     +++ +E++   ++ +V K   R+ + +    +   +  + + L YL  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 122
Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP N+L+
Sbjct: 123 KHKIMHRDVKPSNILV 138

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 33/152 (21%)
Query: 136 TISYMAERVVGTGSFGVV-----------FQAKCLETGDSVAIKKVLQDKRYKNRELQIM 184
           T  Y     +G G+F VV           + AK + T    A     +D +   RE +I 
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA-----RDHQKLEREARIC 84
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVL----EYISETVYRVSKHYTRMNQHVPILYV 240
           RLL HPN+V L     S +E+   YL   L    E   + V R  ++Y+  +    I   
Sbjct: 85  RLLKHPNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI--- 136
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
               +QI  ++N++H    + HRD+KP+NLL+
Sbjct: 137 ----HQILESVNHIHQ-HDIVHRDLKPENLLL 163

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ++   N P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F+S  E     +++ +E++   ++ +V K   R+ + +    +   +  + + L YL  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 122
Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP N+L+
Sbjct: 123 KHKIMHRDVKPSNILV 138

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ++   N P +V    
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 74
Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F+S  E     +++ +E++   ++ +V K   R+ + +    +   +  + + L YL  
Sbjct: 75  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 125
Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP N+L+
Sbjct: 126 KHKIMHRDVKPSNILV 141

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ++   N P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F+S  E     +++ +E++   ++ +V K   R+ + +    +   +  + + L YL  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 122
Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP N+L+
Sbjct: 123 KHKIMHRDVKPSNILV 138

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNHPNVV 193
           ++   ++G G+   VF+ +  +TGD  AIK       L+    + RE ++++ LNH N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
            L      TT + ++   L++E+    ++Y V +  +     +P     +    +   +N
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMN 126
Query: 253 YLHHVVGVCHRDIKPQNLL 271
           +L    G+ HR+IKP N++
Sbjct: 127 HLRE-NGIVHRNIKPGNIM 144

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 73/152 (48%), Gaps = 17/152 (11%)
Query: 133 PKQTISYMAERV-----VGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQ--- 182
           P+Q   + AE +     +G G++G V +     +G  +A+K++    D++ + + L    
Sbjct: 13  PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLD 72
Query: 183 -IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKH-YTRMNQHVPILYV 240
            +MR  + P +V      F   +       + +E +S +  +  K+ Y+ ++  +P   +
Sbjct: 73  VVMRSSDCPYIVQFYGALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEIL 127
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
              T    +ALN+L   + + HRDIKP N+L+
Sbjct: 128 GKITLATVKALNHLKENLKIIHRDIKPSNILL 159

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 72/146 (49%), Gaps = 23/146 (15%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM----RLLN----H 189
            ++  +++G GSFG VF A+  +T    AIK + +D    + +++      R+L+    H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV-SKHYTRMNQHVPILYVQLYTYQ 246
           P +  +  C F T E     L  V+EY++  + +Y + S H   +++         Y  +
Sbjct: 78  PFLTHM-FCTFQTKEN----LFFVMEYLNGGDLMYHIQSCHKFDLSR------ATFYAAE 126
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           I   L +LH   G+ +RD+K  N+L+
Sbjct: 127 IILGLQFLHS-KGIVYRDLKLDNILL 151

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 68/137 (49%), Gaps = 12/137 (8%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ--IMRLLNHPNVVSL 195
            Y   R +G G +  VF+A  +   + VA+K +   K+ K +     +  L   PN+++L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
                    +      LV E+++ T ++      ++ Q +    ++ Y Y+I +AL+Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 256 HVVGVCHRDIKPQNLLM 272
             +G+ HRD+KP N+L+
Sbjct: 149 -SMGIMHRDVKPHNVLI 164

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ++   N P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F+S  E     +++ +E++   ++ +V K   R+ + +    +   +  + + L YL  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 122
Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP N+L+
Sbjct: 123 KHKIMHRDVKPSNILV 138

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ++   N P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F+S  E     +++ +E++   ++ +V K   R+ + +    +   +  + + L YL  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 122
Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP N+L+
Sbjct: 123 KHKIMHRDVKPSNILV 138

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 20/143 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-------ELQIMRLLNHPN 191
           Y   + +G+G++G V   K   TG   AIK + +              E+ +++ L+HPN
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTR--MNQHVPILYVQLYTYQICR 249
           ++ L   F     +D+    LV+E     VYR  + +    + Q    +   +   Q+  
Sbjct: 66  IMKLYEFF-----EDKRNYYLVME-----VYRGGELFDEIILRQKFSEVDAAVIMKQVLS 115
Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
              YLH    + HRD+KP+NLL+
Sbjct: 116 GTTYLHKH-NIVHRDLKPENLLL 137

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 22/156 (14%)
Query: 128 GRNGQPKQTISYMAERV--VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ 179
           GR     Q +S   +RV  +G+G++G V   K   TG   AIK + +             
Sbjct: 10  GRENLYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL 69
Query: 180 -ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTR--MNQHVP 236
            E+ +++ L+HPN++ L   F     +D+    LV+E     VYR  + +    + Q   
Sbjct: 70  DEVAVLKQLDHPNIMKLYEFF-----EDKRNYYLVME-----VYRGGELFDEIILRQKFS 119
Query: 237 ILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            +   +   Q+     YLH    + HRD+KP+NLL+
Sbjct: 120 EVDAAVIMKQVLSGTTYLHKH-NIVHRDLKPENLLL 154

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 63/134 (47%), Gaps = 11/134 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-----LQDKRYKNRELQI-MRLLNHPNVVSLKHC 198
           +G G++GVV + + + +G   A+K++      Q+++    +L I  R ++ P  V+    
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
            F   +     + +  E    ++ +  K      Q +P   +      I +AL +LH  +
Sbjct: 102 LFREGD-----VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 259 GVCHRDIKPQNLLM 272
            V HRD+KP N+L+
Sbjct: 157 SVIHRDVKPSNVLI 170

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 68/140 (48%), Gaps = 23/140 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F +V + +   TG   A  K ++ +R  +           RE+ I+R + HPN++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           +L   F + T+     + L+LE +S   ++        + +     +++    QI   ++
Sbjct: 72  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 122
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH    + H D+KP+N+++
Sbjct: 123 YLHS-KRIAHFDLKPENIML 141

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 64/136 (47%), Gaps = 22/136 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVSLKHC 198
           +G GS G+V  A+   +G  VA+K  + D R + R      E+ IMR   H NVV +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRALNYLHH 256
           +    E     L +++E++            R+N+       Q+ T    + +AL YLH 
Sbjct: 111 YLVGEE-----LWVLMEFLQGGALTDIVSQVRLNEE------QIATVCEAVLQALAYLH- 158
Query: 257 VVGVCHRDIKPQNLLM 272
             GV HRDIK  ++L+
Sbjct: 159 AQGVIHRDIKSDSILL 174

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 10/135 (7%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLK 196
            Y+ +  +G GS+    +     T    A+K + + KR  + E++I+ R   HPN+++LK
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
             +    +   +YL   L    E + ++ +      +    +   L+T  I + + YLH 
Sbjct: 88  DVY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV---LHT--IGKTVEYLHS 139
Query: 257 VVGVCHRDIKPQNLL 271
             GV HRD+KP N+L
Sbjct: 140 Q-GVVHRDLKPSNIL 153

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/91 (26%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
           Q +  + HP++V + +    T    +    +V+EY+     + SK      Q +P+    
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAI 185
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            Y  +I  AL+YLH + G+ + D+KP+N+++
Sbjct: 186 AYLLEILPALSYLHSI-GLVYNDLKPENIML 215

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ++   N P +V    
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 90
Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
            F+S  E     +++ +E++   ++ +V K   R+ + +    +   +  + + L YL  
Sbjct: 91  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 141
Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP N+L+
Sbjct: 142 KHKIMHRDVKPSNILV 157

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
           Y+ +  +G GS+    +     T    A+K + + KR  + E++I+ R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
            +    +   +YL   L    E + ++ +      +    +   L+T  I + + YLH  
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV---LHT--IGKTVEYLHSQ 140
Query: 258 VGVCHRDIKPQNLL 271
            GV HRD+KP N+L
Sbjct: 141 -GVVHRDLKPSNIL 153

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 16/146 (10%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
           G PK+   Y     +G G+ G V+ A  + TG  VAI+++ LQ +  K     E+ +MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
             +PN+V+    +      DEL+  +V+EY++          T M++      +     +
Sbjct: 75  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 125
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
             +AL +LH    V HR+IK  N+L+
Sbjct: 126 CLQALEFLHS-NQVIHRNIKSDNILL 150

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 59/149 (39%), Gaps = 36/149 (24%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVVS 194
           V+G G F VV +    ETG   A+K V   K   +         RE  I  +L HP++V 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 195 LKHCF---------FSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLY 243
           L   +         F   +  +L   +V    +  VY   V+ HY R             
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR------------- 139
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             QI  AL Y H    + HRD+KP  +L+
Sbjct: 140 --QILEALRYCHD-NNIIHRDVKPHCVLL 165

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 68/140 (48%), Gaps = 23/140 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F +V + +   TG   A  K ++ +R  +           RE+ I+R + HPN++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           +L   F + T+     + L+LE +S   ++        + +     +++    QI   ++
Sbjct: 93  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 143
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH    + H D+KP+N+++
Sbjct: 144 YLHS-KRIAHFDLKPENIML 162

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 68/141 (48%), Gaps = 16/141 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCFF 200
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  LNH  VV     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 201 S--------TTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
                    T  K +  L + +EY  + T+Y +  H   +NQ     Y +L+  QI  AL
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI-HSENLNQQRD-EYWRLFR-QILEAL 129
Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           +Y+H   G+ HRD+KP N+ +
Sbjct: 130 SYIHSQ-GIIHRDLKPMNIFI 149

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 68/140 (48%), Gaps = 23/140 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F +V + +   TG   A  K ++ +R  +           RE+ I+R + HPN++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           +L   F + T+     + L+LE +S   ++        + +     +++    QI   ++
Sbjct: 79  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 129
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH    + H D+KP+N+++
Sbjct: 130 YLHS-KRIAHFDLKPENIML 148

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 59/149 (39%), Gaps = 36/149 (24%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVVS 194
           V+G G F VV +    ETG   A+K V   K   +         RE  I  +L HP++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 195 LKHCF---------FSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLY 243
           L   +         F   +  +L   +V    +  VY   V+ HY R             
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR------------- 137
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             QI  AL Y H    + HRD+KP  +L+
Sbjct: 138 --QILEALRYCHD-NNIIHRDVKPHCVLL 163

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 63/140 (45%), Gaps = 14/140 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCFF 200
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  LNH  VV     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 201 S--------TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
                    T  K +  L + +EY          H   +NQ     Y +L+  QI  AL+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD-EYWRLFR-QILEALS 130
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           Y+H   G+ HRD+KP N+ +
Sbjct: 131 YIHSQ-GIIHRDLKPMNIFI 149

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 25/142 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK------VLQDK----RYKNRELQIMRLLNHPNV 192
           +++G G+FG V   K   TG   A+K       V +D+      +NR LQ  R   HP +
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 213
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
            +LK+ F  T ++    L  V+EY +  E  + +S+              + Y  +I  A
Sbjct: 214 TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSA 263
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L+YLH    V +RD+K +NL++
Sbjct: 264 LDYLHSEKNVVYRDLKLENLML 285

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 25/142 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK------VLQDK----RYKNRELQIMRLLNHPNV 192
           +++G G+FG V   K   TG   A+K       V +D+      +NR LQ  R   HP +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 210
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
            +LK+ F  T ++    L  V+EY +  E  + +S+              + Y  +I  A
Sbjct: 211 TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSA 260
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L+YLH    V +RD+K +NL++
Sbjct: 261 LDYLHSEKNVVYRDLKLENLML 282

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
           +E+ I++ L+HPNVV L        E D LY+  V E +++           +++     
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNE-DHLYM--VFELVNQGPVMEVPTLKPLSEDQARF 141
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           Y Q     + + + YLH+   + HRDIKP NLL+
Sbjct: 142 YFQ----DLIKGIEYLHYQ-KIIHRDIKPSNLLV 170

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 56/182 (30%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN 188
           Y  +  +G GS+GVV  A   +T    AIK + ++K          R K  E+++M+ L+
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLE-------------YISETVYRVSKHYTRMNQHV 235
           HPN+  L   +     +DE Y+ LV+E             +I ++  + +    +  Q  
Sbjct: 87  HPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK-TQIC 140
Query: 236 P-------------------ILYVQL------YTYQICRALNYLHHVVGVCHRDIKPQNL 270
           P                   + +VQ          QI  AL+YLH+  G+CHRDIKP+N 
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENF 199
Query: 271 LM 272
           L 
Sbjct: 200 LF 201

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 15/137 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------RYKNRELQIMRLLNHPNVVSLK 196
           +G GSF  V++    ET   VA  + LQD+        R+K  E + ++ L HPN+V   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCE-LQDRKLTKSERQRFKE-EAEXLKGLQHPNIVRFY 91
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
             + ST  K +  + LV E  +       K Y +  +   I  ++ +  QI + L +LH 
Sbjct: 92  DSWESTV-KGKKCIVLVTELXTSGTL---KTYLKRFKVXKIKVLRSWCRQILKGLQFLHT 147
Query: 256 HVVGVCHRDIKPQNLLM 272
               + HRD+K  N+ +
Sbjct: 148 RTPPIIHRDLKCDNIFI 164

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 25/147 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----------LQIMRLL 187
           +   R++G G FG V+  +  +TG   A+ K L  KR K ++           L ++   
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVSTG 248
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKH--YTRMNQHVPILYVQLYTY 245
           + P +V + + F +    D+L   L L    +  Y +S+H  ++  +       ++ Y  
Sbjct: 249 DCPFIVCMSYAFHTP---DKLSFILDLMNGGDLHYHLSQHGVFSEAD-------MRFYAA 298
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           +I   L ++H+   V +RD+KP N+L+
Sbjct: 299 EIILGLEHMHNRF-VVYRDLKPANILL 324

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 25/147 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----------LQIMRLL 187
           +   R++G G FG V+  +  +TG   A+ K L  KR K ++           L ++   
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKH--YTRMNQHVPILYVQLYTY 245
           + P +V + + F +    D+L   L L    +  Y +S+H  ++  +       ++ Y  
Sbjct: 250 DCPFIVCMSYAFHTP---DKLSFILDLMNGGDLHYHLSQHGVFSEAD-------MRFYAA 299
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           +I   L ++H+   V +RD+KP N+L+
Sbjct: 300 EIILGLEHMHNRF-VVYRDLKPANILL 325

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNHPNVV 193
           ++   ++G G+   VF+ +  +TGD  AIK       L+    + RE ++++ LNH N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
            L      TT + ++   L++E+    ++Y V +  +     +P     +    +   +N
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMN 126
Query: 253 YLHHVVGVCHRDIKPQNLL 271
           +L    G+ HR+IKP N++
Sbjct: 127 HLRE-NGIVHRNIKPGNIM 144

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 143 RVVGTGSFGVV----FQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           R +G G FG V    +  +   TG+ VA+K +  +    +     +E++I+R L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
             K      TE     + L++E++        K Y   N++   L  QL Y  QIC+ ++
Sbjct: 87  KYKGI---CTEDGGNGIKLIMEFLPSGSL---KEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YL     V HRD+  +N+L+
Sbjct: 141 YLGSRQYV-HRDLAARNVLV 159

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 25/142 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK------VLQDK----RYKNRELQIMRLLNHPNV 192
           +++G G+FG V   K   TG   A+K       V +D+      +NR LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 72
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
            +LK+ F  T ++    L  V+EY +  E  + +S+              + Y  +I  A
Sbjct: 73  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSA 122
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L+YLH    V +RD+K +NL++
Sbjct: 123 LDYLHSEKNVVYRDLKLENLML 144

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 25/147 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----------LQIMRLL 187
           +   R++G G FG V+  +  +TG   A+ K L  KR K ++           L ++   
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKH--YTRMNQHVPILYVQLYTY 245
           + P +V + + F +    D+L   L L    +  Y +S+H  ++  +       ++ Y  
Sbjct: 250 DCPFIVCMSYAFHTP---DKLSFILDLMNGGDLHYHLSQHGVFSEAD-------MRFYAA 299
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           +I   L ++H+   V +RD+KP N+L+
Sbjct: 300 EIILGLEHMHNRF-VVYRDLKPANILL 325

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 25/147 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----------LQIMRLL 187
           +   R++G G FG V+  +  +TG   A+ K L  KR K ++           L ++   
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKH--YTRMNQHVPILYVQLYTY 245
           + P +V + + F +    D+L   L L    +  Y +S+H  ++  +       ++ Y  
Sbjct: 250 DCPFIVCMSYAFHTP---DKLSFILDLMNGGDLHYHLSQHGVFSEAD-------MRFYAA 299
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           +I   L ++H+   V +RD+KP N+L+
Sbjct: 300 EIILGLEHMHNRF-VVYRDLKPANILL 325

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 25/142 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK------VLQDK----RYKNRELQIMRLLNHPNV 192
           +++G G+FG V   K   TG   A+K       V +D+      +NR LQ  R   HP +
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 71
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
            +LK+ F  T ++    L  V+EY +  E  + +S+              + Y  +I  A
Sbjct: 72  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSA 121
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L+YLH    V +RD+K +NL++
Sbjct: 122 LDYLHSEKNVVYRDLKLENLML 143

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 25/142 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK------VLQDK----RYKNRELQIMRLLNHPNV 192
           +++G G+FG V   K   TG   A+K       V +D+      +NR LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 70
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
            +LK+ F  T ++    L  V+EY +  E  + +S+              + Y  +I  A
Sbjct: 71  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSA 120
Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L+YLH    V +RD+K +NL++
Sbjct: 121 LDYLHSEKNVVYRDLKLENLML 142

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 69/140 (49%), Gaps = 23/140 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F VV + +   TG   A  K ++ +R K+           RE+ I++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           +L   + + T+     + L+LE ++   ++        + +     +++    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH  + + H D+KP+N+++
Sbjct: 129 YLHS-LQIAHFDLKPENIML 147

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 70/141 (49%), Gaps = 23/141 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM----RLLN----HPNVVS 194
           +++G GSFG VF A+  +T    AIK + +D    + +++      R+L+    HP +  
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRV-SKHYTRMNQHVPILYVQLYTYQICRAL 251
           +  C F T E     L  V+EY++  + +Y + S H   +++         Y  +I   L
Sbjct: 84  M-FCTFQTKEN----LFFVMEYLNGGDLMYHIQSCHKFDLSR------ATFYAAEIILGL 132
Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            +LH   G+ +RD+K  N+L+
Sbjct: 133 QFLHS-KGIVYRDLKLDNILL 152

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 143 RVVGTGSFGVV----FQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           R +G G FG V    +  +   TG+ VA+K +  +    +     +E++I+R L H N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
             K      TE     + L++E++        K Y   N++   L  QL Y  QIC+ ++
Sbjct: 75  KYKGI---CTEDGGNGIKLIMEFLPSGSL---KEYLPKNKNKINLKQQLKYAVQICKGMD 128
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YL     V HRD+  +N+L+
Sbjct: 129 YLGSRQYV-HRDLAARNVLV 147

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 69/140 (49%), Gaps = 23/140 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F VV + +   TG   A  K ++ +R K+           RE+ I++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           +L   + + T+     + L+LE ++   ++        + +     +++    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH  + + H D+KP+N+++
Sbjct: 129 YLHS-LQIAHFDLKPENIML 147

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 31/144 (21%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F VV + +   TG   A  K ++ +R K+           RE+ I++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 194 SLKHCFFSTTEKDELYLNLV-----LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           +L   + + T+   L L LV      ++++E      +  T             +  QI 
Sbjct: 78  TLHEVYENKTDVI-LILELVAGGELFDFLAEKESLTEEEATE------------FLKQIL 124
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + YLH  + + H D+KP+N+++
Sbjct: 125 NGVYYLHS-LQIAHFDLKPENIML 147

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 69/140 (49%), Gaps = 23/140 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F VV + +   TG   A  K ++ +R K+           RE+ I++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           +L   + + T+     + L+LE ++   ++        + +     +++    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH  + + H D+KP+N+++
Sbjct: 129 YLHS-LQIAHFDLKPENIML 147

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 31/144 (21%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F VV + +   TG   A  K ++ +R K+           RE+ I++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 194 SLKHCFFSTTEKDELYLNLV-----LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           +L   + + T+   L L LV      ++++E      +  T             +  QI 
Sbjct: 78  TLHEVYENKTDVI-LILELVAGGELFDFLAEKESLTEEEATE------------FLKQIL 124
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + YLH  + + H D+KP+N+++
Sbjct: 125 NGVYYLHS-LQIAHFDLKPENIML 147

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 70/141 (49%), Gaps = 21/141 (14%)
Query: 142 ERV--VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNV 192
           ER+  +G G+ GVV + +   +G  +A       IK  ++++    RELQ++   N P +
Sbjct: 19  ERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYI 76
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           V     F+S  E     +++ +E++   ++ +V K   R+ + +    +   +  + R L
Sbjct: 77  VGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGL 127
Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            YL     + HRD+KP N+L+
Sbjct: 128 AYLREKHQIMHRDVKPSNILV 148

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 28/143 (19%)
Query: 145 VGTGSFGVVFQAKCLE---TGDSVAIKKVLQDKRY---KNRELQIMRLLN--HPNVVSLK 196
           +G G+FG V   +C++    G  VA+K V    RY      E+Q++  LN   PN     
Sbjct: 22  LGEGAFGKV--VECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNST--- 76
Query: 197 HCFFSTTEKDELY-----LNLVLEYISETVYRVSKHYTRMNQHVP--ILYVQLYTYQICR 249
              F   +  E +     + +V E +  + Y     + + N  +P  + +++   YQIC+
Sbjct: 77  ---FRCVQMLEWFEHHGHICIVFELLGLSTYD----FIKENGFLPFRLDHIRKMAYQICK 129
Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           ++N+L H   + H D+KP+N+L 
Sbjct: 130 SVNFL-HSNKLTHTDLKPENILF 151

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/139 (23%), Positives = 68/139 (48%), Gaps = 21/139 (15%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----------ELQIMRLLNHPNVVS 194
           +G+G F +V + +   TG   A K + + +   +R          E+ I+R + HPN+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           L   + + T+     + L+LE +S   ++        +++     +++    QI   +NY
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 254 LHHVVGVCHRDIKPQNLLM 272
           L H   + H D+KP+N+++
Sbjct: 131 L-HTKKIAHFDLKPENIML 148

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/137 (23%), Positives = 62/137 (45%), Gaps = 15/137 (10%)
Query: 144 VVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSL 195
           V+G G      V  A+   TG+ V ++++  +        +   EL + +L NHPN+V  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F +    +EL++             +  H+      + I Y+      + +AL+Y+H
Sbjct: 92  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 256 HVVGVCHRDIKPQNLLM 272
           H +G  HR +K  ++L+
Sbjct: 146 H-MGYVHRSVKASHILI 161

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 31/144 (21%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F VV + +   TG   A  K ++ +R K+           RE+ I++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 194 SLKHCFFSTTEKDELYLNLV-----LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           +L   + + T+   L L LV      ++++E      +  T             +  QI 
Sbjct: 78  TLHEVYENKTDVI-LILELVAGGELFDFLAEKESLTEEEATE------------FLKQIL 124
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + YLH  + + H D+KP+N+++
Sbjct: 125 NGVYYLHS-LQIAHFDLKPENIML 147

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/137 (23%), Positives = 62/137 (45%), Gaps = 15/137 (10%)
Query: 144 VVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSL 195
           V+G G      V  A+   TG+ V ++++  +        +   EL + +L NHPN+V  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F +    +EL++             +  H+      + I Y+      + +AL+Y+H
Sbjct: 76  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 256 HVVGVCHRDIKPQNLLM 272
           H +G  HR +K  ++L+
Sbjct: 130 H-MGYVHRSVKASHILI 145

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 31/144 (21%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F VV + +   TG   A  K ++ +R K+           RE+ I++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 194 SLKHCFFSTTEKDELYLNLV-----LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           +L   + + T+   L L LV      ++++E      +  T             +  QI 
Sbjct: 77  TLHEVYENKTDVI-LILELVAGGELFDFLAEKESLTEEEATE------------FLKQIL 123
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + YLH  + + H D+KP+N+++
Sbjct: 124 NGVYYLHS-LQIAHFDLKPENIML 146

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 31/144 (21%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F VV + +   TG   A  K ++ +R K+           RE+ I++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 194 SLKHCFFSTTEKDELYLNLV-----LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           +L   + + T+   L L LV      ++++E      +  T             +  QI 
Sbjct: 78  TLHEVYENKTDVI-LILELVAGGELFDFLAEKESLTEEEATE------------FLKQIL 124
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + YLH  + + H D+KP+N+++
Sbjct: 125 NGVYYLHS-LQIAHFDLKPENIML 147

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 20/61 (32%), Positives = 37/61 (60%), Gaps = 7/61 (11%)
Query: 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
           LV EYI+ T ++      ++ Q +    ++ Y Y++ +AL+Y H   G+ HRD+KP N++
Sbjct: 112 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCH-SKGIMHRDVKPHNVM 164
Query: 272 M 272
           +
Sbjct: 165 I 165

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 69/140 (49%), Gaps = 23/140 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F VV + +   TG   A  K ++ +R K+           RE+ I++ + HPNV+
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           +L   + + T+     + L+LE ++   ++        + +     +++    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH  + + H D+KP+N+++
Sbjct: 129 YLHS-LQIAHFDLKPENIML 147

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 28/143 (19%)
Query: 145 VGTGSFGVVFQAKCLE---TGDSVAIKKVLQDKRY---KNRELQIMRLLN--HPNVVSLK 196
           +G G+FG V   +C++    G  VA+K V    RY      E+Q++  LN   PN     
Sbjct: 22  LGEGAFGKV--VECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNST--- 76
Query: 197 HCFFSTTEKDELY-----LNLVLEYISETVYRVSKHYTRMNQHVP--ILYVQLYTYQICR 249
              F   +  E +     + +V E +  + Y     + + N  +P  + +++   YQIC+
Sbjct: 77  ---FRCVQMLEWFEHHGHICIVFELLGLSTYD----FIKENGFLPFRLDHIRKMAYQICK 129
Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           ++N+L H   + H D+KP+N+L 
Sbjct: 130 SVNFL-HSNKLTHTDLKPENILF 151

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 31/144 (21%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F VV + +   TG   A  K ++ +R K+           RE+ I++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 194 SLKHCFFSTTEKDELYLNLV-----LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           +L   + + T+   L L LV      ++++E      +  T             +  QI 
Sbjct: 77  TLHEVYENKTDVI-LILELVAGGELFDFLAEKESLTEEEATE------------FLKQIL 123
Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + YLH  + + H D+KP+N+++
Sbjct: 124 NGVYYLHS-LQIAHFDLKPENIML 146

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 69/140 (49%), Gaps = 23/140 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F VV + +   TG   A  K ++ +R K+           RE+ I++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           +L   + + T+     + L+LE ++   ++        + +     +++    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH  + + H D+KP+N+++
Sbjct: 129 YLHS-LQIAHFDLKPENIML 147

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 69/140 (49%), Gaps = 23/140 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHPNVV 193
           +G+G F VV + +   TG   A  K ++ +R K+           RE+ I++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           +L   + + T+     + L+LE ++   ++        + +     +++    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH  + + H D+KP+N+++
Sbjct: 129 YLHS-LQIAHFDLKPENIML 147

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 20/61 (32%), Positives = 37/61 (60%), Gaps = 7/61 (11%)
Query: 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
           LV EYI+ T ++      ++ Q +    ++ Y Y++ +AL+Y H   G+ HRD+KP N++
Sbjct: 117 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCH-SKGIMHRDVKPHNVM 169
Query: 272 M 272
           +
Sbjct: 170 I 170

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	272
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-86
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-82
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-79
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-71
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-33
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-29
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-29
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-29
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-29
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-28
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-28
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-28
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-28
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-28
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-28
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-28
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-28
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-27
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-27
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-27
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-27
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-27
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-26
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-26
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-26
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-26
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-26
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-26
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-26
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-26
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-26
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-25
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-25
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-25
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-24
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-24
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-23
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-22
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-22
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-21
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-20
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-20
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-20
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-19
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-19
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-19
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-19
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-19
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-19
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-18
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-18
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-18
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-17
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-17
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-17
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-17
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-17
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-16
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-16
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-16
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-16
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-16
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-15
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-15
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-15
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-15
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-15
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-14
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-14
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-12
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-11
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-11
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-11
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-11
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-11
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-11
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-11
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-11
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-11
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-10
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-10
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-10
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-10
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-10
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-10
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-10
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-10
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-10
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-10
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-10
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-10
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-10
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-10
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-10
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-09
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-09
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-09
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-09
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-09
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-09
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-09
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-09
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-09
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-09
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-09
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-08
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-08
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-08
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-08
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-08
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-08
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-08
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-08
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-08
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-08
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-08
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-08
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-08
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-08
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-08
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-07
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-07
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-07
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-04

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  262 bits (671), Expect = 4e-86
 Identities = 97/207 (46%), Positives = 136/207 (65%), Gaps = 20/207 (9%)

Query: 67  TSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTV 126
           +    T +  E     Q P     M++  +K+                G++   V+AT  
Sbjct: 2   SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKD----------------GSKVTTVVATP- 44

Query: 127 GGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRL 186
            G+     Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQDKR+KNRELQIMR 
Sbjct: 45  -GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 103

Query: 187 LNHPNVVSLKHCFFSTTEK-DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
           L+H N+V L++ F+S+ EK DE+YLNLVL+Y+ ETVYRV++HY+R  Q +P++YV+LY Y
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 164 QLFRSLAYIHS-FGICHRDIKPQNLLL 189

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  251 bits (642), Expect = 4e-82
 Identities = 89/175 (50%), Positives = 123/175 (70%), Gaps = 4/175 (2%)

Query: 98  NVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAK 157
           +    +  L    +N        +      G+ G+ ++ I+Y   +V+G GSFGVVFQAK
Sbjct: 2   SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAK 60

Query: 158 CLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELYLNLVLEY 216
            +E+ + VAIKKVLQDKR+KNRELQIMR++ HPNVV LK  F+S  +K DE++LNLVLEY
Sbjct: 61  LVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119

Query: 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
           + ETVYR S+HY ++ Q +P+L ++LY YQ+ R+L Y+H  +G+CHRDIKPQNLL
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLL 173

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  243 bits (623), Expect = 1e-79
 Identities = 66/165 (40%), Positives = 102/165 (61%), Gaps = 8/165 (4%)

Query: 113 GNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ 172
           G G+      A     R+   K+   +  ER+ G G+FG V   K   TG SVAIKKV+Q
Sbjct: 1   GPGSMMSLNAAAAADERS--RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ 58

Query: 173 DKRYKNRELQIMRLL---NHPNVVSLKHCFFSTTEK--DELYLNLVLEYISETVYRVSKH 227
           D R++NRELQIM+ L   +HPN+V L+  F++  E+   ++YLN+V+EY+ +T++R  ++
Sbjct: 59  DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN 118

Query: 228 YTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLL 271
           Y R     P + ++++ +Q+ R++  LH   V VCHRDIKP N+L
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL 163

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  223 bits (569), Expect = 2e-71
 Identities = 61/175 (34%), Positives = 99/175 (56%), Gaps = 34/175 (19%)

Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHP 190
           G    +  Y   + +GTGSFG+V +   +E+G   A+KKVLQD RYKNREL IM++L+H 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 191 NVVSLKHCFFSTTEK---------------------------------DELYLNLVLEYI 217
           N++ L   F++T ++                                    YLN+++EY+
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            +T+++V K + R  + +P+  + +Y YQ+ RA+ ++H  +G+CHRDIKPQNLL+
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLV 174

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  121 bits (306), Expect = 5e-33
 Identities = 48/134 (35%), Positives = 73/134 (54%), Gaps = 15/134 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G GS+GVVF+ +  +TG  VAIKK L+ +          RE+++++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
           F     K  L+  LV EY   TV        R  + VP   V+  T+Q  +A+N+ H   
Sbjct: 71  F---RRKRRLH--LVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHK-H 121

Query: 259 GVCHRDIKPQNLLM 272
              HRD+KP+N+L+
Sbjct: 122 NCIHRDVKPENILI 135

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  120 bits (304), Expect = 2e-32
 Identities = 42/134 (31%), Positives = 68/134 (50%), Gaps = 15/134 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           VG GS+G+V + +  +TG  VAIKK L+    K       RE+++++ L H N+V+L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
                +K   Y  LV E++  T+    +        +    VQ Y +QI   + + H   
Sbjct: 93  C---KKKKRWY--LVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHS-H 143

Query: 259 GVCHRDIKPQNLLM 272
            + HRDIKP+N+L+
Sbjct: 144 NIIHRDIKPENILV 157

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  117 bits (294), Expect = 3e-31
 Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 19/160 (11%)

Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QD 173
            G ++   +  ++        Y+  + +G G F  V   + L  G   A+K++L    QD
Sbjct: 20  QGHMV--IIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD 69

Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFF-STTEKDELYLNLVLEYISE-TVYRVSKHYTRM 231
           +    RE  + RL NHPN++ L          K E +  L+L +    T++   +     
Sbjct: 70  REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDK 127

Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
              +    +      ICR L  +H   G  HRD+KP N+L
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNIL 166

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  113 bits (286), Expect = 4e-30
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 15/170 (8%)

Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV 170
            G               R      T++ +  E+ +G G F  V++A CL  G  VA+KKV
Sbjct: 6   QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65

Query: 171 -------LQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVY 222
                   + +    +E+ +++ LNHPNV+     F    E +EL   +VLE      + 
Sbjct: 66  QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI---EDNELN--IVLELADAGDLS 120

Query: 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           R+ KH+ +  + +P   V  Y  Q+C AL ++H    V HRDIKP N+ +
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFI 169

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  113 bits (285), Expect = 6e-30
 Identities = 33/141 (23%), Positives = 62/141 (43%), Gaps = 13/141 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNHPNVV 193
           ++   ++G G+   VF+ +  +TGD  AIK       L+    + RE ++++ LNH N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            L      TT        L++E+         + +        +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKV--LIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           N+L    G+ HR+IKP N++ 
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMR 145

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  112 bits (282), Expect = 7e-30
 Identities = 35/145 (24%), Positives = 61/145 (42%), Gaps = 14/145 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
           Y     +GTGS+G   + +    G  +  K++        +K+    E+ ++R L HPN+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           V          ++    L +V+EY     +  V    T+  Q++   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 252 NYLH----HVVGVCHRDIKPQNLLM 272
              H        V HRD+KP N+ +
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFL 149

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  111 bits (280), Expect = 2e-29
 Identities = 37/148 (25%), Positives = 58/148 (39%), Gaps = 18/148 (12%)

Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKN---RELQIMR 185
           P+    Y+  R +G G F   F+    +T +  A K     +L     +     E+ I R
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70

Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT 244
            L H +VV     F      D ++  +VLE     ++  + K    + +       + Y 
Sbjct: 71  SLAHQHVVGFHGFFED---NDFVF--VVLELCRRRSLLELHKRRKALTEPE----ARYYL 121

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
            QI     YLH    V HRD+K  NL +
Sbjct: 122 RQIVLGCQYLHR-NRVIHRDLKLGNLFL 148

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  111 bits (279), Expect = 3e-29
 Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 20/152 (13%)

Query: 131 GQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQ 182
               + I  +    ++G GSF  V++A+ + TG  VAIK + +   YK         E++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYV 240
           I   L HP+++ L + F      + +Y  LVLE     E    +       +++      
Sbjct: 64  IHCQLKHPSILELYNYFED---SNYVY--LVLEMCHNGEMNRYLKNRVKPFSENE----A 114

Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           + + +QI   + YLH   G+ HRD+   NLL+
Sbjct: 115 RHFMHQIITGMLYLHS-HGILHRDLTLSNLLL 145

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  111 bits (280), Expect = 4e-29
 Identities = 37/148 (25%), Positives = 58/148 (39%), Gaps = 18/148 (12%)

Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKN---RELQIMR 185
           P+    Y+  R +G G F   F+    +T +  A K     +L     +     E+ I R
Sbjct: 37  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96

Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT 244
            L H +VV     F      D ++  +VLE     ++  + K    + +       + Y 
Sbjct: 97  SLAHQHVVGFHGFFED---NDFVF--VVLELCRRRSLLELHKRRKALTEPE----ARYYL 147

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
            QI     YLH    V HRD+K  NL +
Sbjct: 148 RQIVLGCQYLHR-NRVIHRDLKLGNLFL 174

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  111 bits (280), Expect = 5e-29
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 16/134 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++G V++A    T ++VAIK++  +   +       RE+ +++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
                    L+  L+ EY    +    K Y   N  V +  ++ + YQ+   +N+ H   
Sbjct: 102 I---HHNHRLH--LIFEYAENDL----KKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151

Query: 259 GVCHRDIKPQNLLM 272
              HRD+KPQNLL+
Sbjct: 152 RCLHRDLKPQNLLL 165

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  111 bits (280), Expect = 5e-29
 Identities = 37/137 (27%), Positives = 66/137 (48%), Gaps = 18/137 (13%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVVSL 195
           +G G F  V++A+   T   VAIKK+    R +          RE+++++ L+HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
              F     K  +   LV +++   +  + K     +  +   +++ Y     + L YLH
Sbjct: 78  LDAF---GHKSNIS--LVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 256 HVVGVCHRDIKPQNLLM 272
               + HRD+KP NLL+
Sbjct: 130 Q-HWILHRDLKPNNLLL 145

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  112 bits (281), Expect = 6e-29
 Identities = 33/141 (23%), Positives = 62/141 (43%), Gaps = 13/141 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNHPNVV 193
           ++   ++G G+   VF+ +  +TGD  AIK       L+    + RE ++++ LNH N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            L      TT        L++E+         + +        +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKV--LIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           N+L    G+ HR+IKP N++ 
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMR 145

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  109 bits (276), Expect = 7e-29
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 18/138 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK--NRELQIMRLLNHPNVVSL 195
           R +G G FG V+ A+  ++   +A+K     ++ +        RE++I   L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F      D   + L+LEY    TVYR  +  ++ ++         Y  ++  AL+Y 
Sbjct: 75  YGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQR----TATYITELANALSYC 125

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIKP+NLL+
Sbjct: 126 HS-KRVIHRDIKPENLLL 142

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  109 bits (275), Expect = 8e-29
 Identities = 30/144 (20%), Positives = 60/144 (41%), Gaps = 11/144 (7%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHC 198
           +    ++G+G FG VF+AK    G +  IK+V  +     RE++ +  L+H N+V    C
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 199 FFSTTEKDELYLNLVLEYISETVYRV----------SKHYTRMNQHVPILYVQLYTYQIC 248
           +       E          ++ ++                 R  + +  +       QI 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
           + ++Y+H    + +RD+KP N+ +
Sbjct: 133 KGVDYIHS-KKLINRDLKPSNIFL 155

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  109 bits (276), Expect = 9e-29
 Identities = 42/134 (31%), Positives = 75/134 (55%), Gaps = 14/134 (10%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
                 +++LY  LV E++ + + +           +P+  ++ Y +Q+ + L + H   
Sbjct: 71  I---HTENKLY--LVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122

Query: 259 GVCHRDIKPQNLLM 272
            V HRD+KPQNLL+
Sbjct: 123 RVLHRDLKPQNLLI 136

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  109 bits (276), Expect = 9e-29
 Identities = 41/134 (30%), Positives = 68/134 (50%), Gaps = 15/134 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++G VF+AK  ET + VA+K+V  D   +       RE+ +++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
                   +L   LV E+       + K++   N  +    V+ + +Q+ + L + H   
Sbjct: 70  L---HSDKKLT--LVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120

Query: 259 GVCHRDIKPQNLLM 272
            V HRD+KPQNLL+
Sbjct: 121 NVLHRDLKPQNLLI 134

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  112 bits (281), Expect = 1e-28
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 19/143 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
           Y    ++GTGS+G V +A        VAIKK+L+        KR    RE+ I+  LNH 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 191 NVVSLKHCFFSTTEK--DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           +VV +         +  DELY  +VLE       ++     R   ++  L+++   Y + 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKL----FRTPVYLTELHIKTLLYNLL 166

Query: 249 RALNYLHHVVGVCHRDIKPQNLL 271
             + Y+H   G+ HRD+KP N L
Sbjct: 167 VGVKYVHS-AGILHRDLKPANCL 188

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  110 bits (277), Expect = 1e-28
 Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 19/142 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-----LQD-KR-YKNRELQIMRLLNHPN 191
           +  + ++G G++GVV  A    TG+ VAIKK+          R    RE++I++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 192 VVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           ++++ +     + ++  E+Y  ++ E +   ++RV       + H     +Q + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVY--IIQELMQTDLHRVISTQMLSDDH-----IQYFIYQTLR 123

Query: 250 ALNYLHHVVGVCHRDIKPQNLL 271
           A+  LH    V HRD+KP NLL
Sbjct: 124 AVKVLHG-SNVIHRDLKPSNLL 144

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  109 bits (275), Expect = 2e-28
 Identities = 36/136 (26%), Positives = 71/136 (52%), Gaps = 14/136 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNRELQIMR-LLNHPNVVSL 195
           Y   R +G G +  VF+A  +   + V +K +  ++ K+ K RE++I+  L   PN+++L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
                    +       V E+++ T ++      ++ Q +    ++ Y Y+I +AL+Y H
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH 147

Query: 256 HVVGVCHRDIKPQNLL 271
             +G+ HRD+KP N++
Sbjct: 148 S-MGIMHRDVKPHNVM 162

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  109 bits (274), Expect = 2e-28
 Identities = 41/179 (22%), Positives = 71/179 (39%), Gaps = 16/179 (8%)

Query: 101 HDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLE 160
                L+P  V+  G  +  + +        +     S+     +G GS+G VF+ +  E
Sbjct: 21  QSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKE 80

Query: 161 TGDSVAIKKVL------QDKRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNLV 213
            G   A+K+ +      +D+  K  E+    ++  HP  V L+  +    E   LY  L 
Sbjct: 81  DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE---EGGILY--LQ 135

Query: 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            E    ++    +H       +P   V  Y      AL +LH   G+ H D+KP N+ +
Sbjct: 136 TELCGPSLQ---QHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFL 190

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (272), Expect = 2e-28
 Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 19/157 (12%)

Query: 125 TVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK- 177
           T      + K TI  +   R +G G FG V+ A+  +    +A+K     ++ ++     
Sbjct: 1   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60

Query: 178 -NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHV 235
             RE++I   L HPN++ + + F     +  +Y  L+LE+     +Y+  + + R ++  
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHD---RKRIY--LMLEFAPRGELYKELQKHGRFDEQR 115

Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
                  +  ++  AL+Y H    V HRDIKP+NLLM
Sbjct: 116 ----SATFMEELADALHYCHE-RKVIHRDIKPENLLM 147

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  108 bits (273), Expect = 3e-28
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 27/150 (18%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQD----KR-YKNRELQIMRLLNHPNV 192
           YM  + +G G  G+VF A   +    VAIKK+ L D    K     RE++I+R L+H N+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 193 VSLKHCF-----------FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
           V +                S TE + +Y  +V EY+   +  V +    + +H      +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVY--IVQEYMETDLANVLEQGPLLEEH-----AR 123

Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
           L+ YQ+ R L Y+H    V HRD+KP NL 
Sbjct: 124 LFMYQLLRGLKYIHS-ANVLHRDLKPANLF 152

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  110 bits (277), Expect = 3e-28
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 19/143 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQD-KR-YKNRELQIMRLLNHP 190
           Y+ + ++G GS+G V+ A    T  +VAIKKV      L D KR    RE+ I+  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 191 NVVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
            ++ L             ELY  +VLE     + ++     +    +   +++   Y + 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELY--IVLEIADSDLKKL----FKTPIFLTEEHIKTILYNLL 139

Query: 249 RALNYLHHVVGVCHRDIKPQNLL 271
              N++H   G+ HRD+KP N L
Sbjct: 140 LGENFIHE-SGIIHRDLKPANCL 161

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  108 bits (273), Expect = 4e-28
 Identities = 36/139 (25%), Positives = 67/139 (48%), Gaps = 21/139 (15%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVVSL 195
           +G G++  V++     TG  VA+K+V    +  +         RE+ +M+ L H N+V L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 196 KHCFFSTTEKDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
                    +++L   LV E++      Y  S+      + + +  V+ + +Q+ + L +
Sbjct: 69  YDVI---HTENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 254 LHHVVGVCHRDIKPQNLLM 272
            H    + HRD+KPQNLL+
Sbjct: 124 CHE-NKILHRDLKPQNLLI 141

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  107 bits (270), Expect = 4e-28
 Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 23/151 (15%)

Query: 131 GQPKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQIM 184
           G  K  I+  Y  E  +G GS+G V  A    T    A K      ++D     +E++IM
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYV 240
           + L+HPN++ L   F     +D   + LV+E  +  E   RV   + +            
Sbjct: 61  KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108

Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
                 +  A+ Y H  + V HRD+KP+N L
Sbjct: 109 ARIMKDVLSAVAYCHK-LNVAHRDLKPENFL 138

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  107 bits (270), Expect = 7e-28
 Identities = 38/142 (26%), Positives = 68/142 (47%), Gaps = 19/142 (13%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLN---HPNV 192
           +G G++G V++A+   +G  VA+K V                 RE+ ++R L    HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY--TRMNQHVPILYVQLYTYQICRA 250
           V L     ++    E+ + LV E++ + +    + Y        +P   ++    Q  R 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDL----RTYLDKAPPPGLPAETIKDLMRQFLRG 132

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L++LH    + HRD+KP+N+L+
Sbjct: 133 LDFLHA-NCIVHRDLKPENILV 153

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  107 bits (270), Expect = 9e-28
 Identities = 39/144 (27%), Positives = 71/144 (49%), Gaps = 22/144 (15%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLN 188
           +Y+    +G G++  V++ K   T + VA+K++    R ++         RE+ +++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           H N+V+L         +  L   LV EY+      + ++       + +  V+L+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLT--LVFEYLD---KDLKQYLDDCGNIINMHNVKLFLFQLL 110

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
           R L Y H    V HRD+KPQNLL+
Sbjct: 111 RGLAYCHR-QKVLHRDLKPQNLLI 133

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  106 bits (268), Expect = 2e-27
 Identities = 41/145 (28%), Positives = 67/145 (46%), Gaps = 22/145 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN---RELQIMRLLNHP 190
           Y+   ++G GS+G V +    ET    A+K     K+ +    +    +E+Q++R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
           NV+ L    ++  ++  +Y  +V+EY      E +  V +   R        Y      Q
Sbjct: 67  NVIQLVDVLYNEEKQK-MY--MVMEYCVCGMQEMLDSVPEK--RFPVCQAHGYFC----Q 117

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLL 271
           +   L YLH   G+ H+DIKP NLL
Sbjct: 118 LIDGLEYLHS-QGIVHKDIKPGNLL 141

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  107 bits (270), Expect = 2e-27
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 15/138 (10%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLK- 196
           +G G+FG VF+A+  +TG  VA+KKVL +   K        RE++I++LL H NVV+L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIE 83

Query: 197 --HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
                 S   + +  + LV ++     + ++   + +     +  ++     +   L Y+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    + HRD+K  N+L+
Sbjct: 141 HR-NKILHRDMKAANVLI 157

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  107 bits (269), Expect = 2e-27
 Identities = 38/153 (24%), Positives = 68/153 (44%), Gaps = 16/153 (10%)

Query: 128 GRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRE 180
           G      Q++  Y+  + +G GSFG     K  E G    IK++       +++    RE
Sbjct: 14  GTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRRE 73

Query: 181 LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILY 239
           + ++  + HPN+V  +  F    E   LY  +V++Y     +++      +         
Sbjct: 74  VAVLANMKHPNIVQYRESFE---ENGSLY--IVMDYCEGGDLFKRINA--QKGVLFQEDQ 126

Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +  +  QIC AL ++H    + HRDIK QN+ +
Sbjct: 127 ILDWFVQICLALKHVHD-RKILHRDIKSQNIFL 158

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  107 bits (269), Expect = 2e-27
 Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 21/144 (14%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQD----KR-YKNRELQIMRLLNHP 190
           Y   + VG+G++G V  A    TG  VAIKK+    Q     KR Y  REL++++ + H 
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84

Query: 191 NVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           NV+ L   F    +  +  + Y  LV+ ++   + ++ KH            +Q   YQ+
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFY--LVMPFMGTDLGKLMKHEKLGEDR-----IQFLVYQM 137

Query: 248 CRALNYLHHVVGVCHRDIKPQNLL 271
            + L Y+H   G+ HRD+KP NL 
Sbjct: 138 LKGLRYIHA-AGIIHRDLKPGNLA 160

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  107 bits (269), Expect = 3e-27
 Identities = 40/142 (28%), Positives = 67/142 (47%), Gaps = 19/142 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQD----KR-YKNRELQIMRLLNHPN 191
           Y     +G G++G+V  A        VAIKK+   +     +R    RE++I+    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 192 VVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           ++ +     + T +   ++Y  +V + +   +Y++ K     N H     +  + YQI R
Sbjct: 87  IIGINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDH-----ICYFLYQILR 139

Query: 250 ALNYLHHVVGVCHRDIKPQNLL 271
            L Y+H    V HRD+KP NLL
Sbjct: 140 GLKYIHS-ANVLHRDLKPSNLL 160

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  105 bits (265), Expect = 3e-27
 Identities = 37/164 (22%), Positives = 68/164 (41%), Gaps = 28/164 (17%)

Query: 124 TTVGGRNGQPKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRY 176
            + G  N   + TI   ++ +R +G+G+FG V   +   +G    IK     +       
Sbjct: 7   HSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ 66

Query: 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--------ETVYRVSKHY 228
              E+++++ L+HPN++ +   F     +D   + +V+E            +     K  
Sbjct: 67  IEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKAL 121

Query: 229 TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +         YV     Q+  AL Y H    V H+D+KP+N+L 
Sbjct: 122 SEG-------YVAELMKQMMNALAYFHS-QHVVHKDLKPENILF 157

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  105 bits (264), Expect = 4e-27
 Identities = 32/141 (22%), Positives = 55/141 (39%), Gaps = 14/141 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQ----IMRLLNHPN 191
           +     +G+G FG VF+      G   AIK+    L     +   L+       L  H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           VV     +    E D +   +  EY +  ++        R+  +     ++    Q+ R 
Sbjct: 73  VVRYFSAWA---EDDHML--IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 251 LNYLHHVVGVCHRDIKPQNLL 271
           L Y+H  + + H DIKP N+ 
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIF 147

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  107 bits (268), Expect = 8e-27
 Identities = 39/138 (28%), Positives = 68/138 (49%), Gaps = 14/138 (10%)

Query: 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMR-LLNHPNVVS 194
           IS+  + V+G G+ G +   + +     VA+K++L +   + +RE+Q++R    HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
                   TEKD  +  + +E  + T+   V +         PI  +Q    Q    L +
Sbjct: 83  YFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133

Query: 254 LHHVVGVCHRDIKPQNLL 271
           LH +  + HRD+KP N+L
Sbjct: 134 LHSL-NIVHRDLKPHNIL 150

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  105 bits (265), Expect = 1e-26
 Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 28/152 (18%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------------RELQI 183
           Y  +R + +GS+G V        G  VAIK+V                       RE+++
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 184 MRLLNHPNVVSLKHCF--FSTTEKDELYLNLVLEYISETVYRV--SKHYTRMNQHVPILY 239
           +   +HPN++ L+  F  F      +LY  LV E +   + +V   +      QH     
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLY--LVTELMRTDLAQVIHDQRIVISPQH----- 135

Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
           +Q + Y I   L+ LH   GV HRD+ P N+L
Sbjct: 136 IQYFMYHILLGLHVLHE-AGVVHRDLHPGNIL 166

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  104 bits (261), Expect = 1e-26
 Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 16/134 (11%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
           +G G++GVV++A+    G++ A+KK+  +K  +       RE+ I++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
                 K  L L  V E++ + + ++          +  +  + +  Q+   + Y H   
Sbjct: 69  I---HTKKRLVL--VFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 259 GVCHRDIKPQNLLM 272
            V HRD+KPQNLL+
Sbjct: 120 RVLHRDLKPQNLLI 133

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  105 bits (263), Expect = 1e-26
 Identities = 38/190 (20%), Positives = 76/190 (40%), Gaps = 19/190 (10%)

Query: 85  PKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS-YMAER 143
                    +   + +   + L P   +      G ++   +   + + ++ +     + 
Sbjct: 9   QAHSLASLAKTWSSGSAKLQRLGPETED----NEGVLLTEKLKPVDYEYREEVHWMTHQP 64

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNRELQIMRLLNHPNVVSLKHCFFST 202
            VG GSFG V + K  +TG   A+KKV L+   ++  EL     L+ P +V L       
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYGA---- 118

Query: 203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
             ++  ++N+ +E +   ++ ++ K    + +         Y  Q    L YLH    + 
Sbjct: 119 -VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQALEGLEYLHT-RRIL 172

Query: 262 HRDIKPQNLL 271
           H D+K  N+L
Sbjct: 173 HGDVKADNVL 182

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  103 bits (260), Expect = 1e-26
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 18/140 (12%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           +   + +G G++G V  A    T ++VA+K V   +         +E+ I ++LNH NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
                     E +  Y  L LEY S  E   R+      M +     +      Q+   +
Sbjct: 69  KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-IGMPEPDAQRFFH----QLMAGV 118

Query: 252 NYLHHVVGVCHRDIKPQNLL 271
            YLH  +G+ HRDIKP+NLL
Sbjct: 119 VYLHG-IGITHRDIKPENLL 137

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  105 bits (263), Expect = 1e-26
 Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 22/144 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQD----KR-YKNRELQIMRLLNHP 190
           Y++   VG+G++G V  A    +G+ VAIKK+    Q     KR Y  REL +++ + H 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83

Query: 191 NVVSLKHCFFSTTEKD---ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           NV+ L   F   +      + Y  LV+ ++   + ++        +      +Q   YQ+
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFY--LVMPFMQTDLQKIMGL-KFSEEK-----IQYLVYQM 135

Query: 248 CRALNYLHHVVGVCHRDIKPQNLL 271
            + L Y+H   GV HRD+KP NL 
Sbjct: 136 LKGLKYIHS-AGVVHRDLKPGNLA 158

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  107 bits (268), Expect = 2e-26
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 17/157 (10%)

Query: 127 GGRNGQPKQTI--SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----R 179
           GGR+          +  +  +GTG FG V +    +TG+ VAIK+  Q+   KN      
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61

Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN-LVLEYIS--ETVYRVSKH--YTRMNQH 234
           E+QIM+ LNHPNVVS +       +     L  L +EY    +    +++      + + 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121

Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
                +      I  AL YLH    + HRD+KP+N++
Sbjct: 122 PIRTLLS----DISSALRYLHE-NRIIHRDLKPENIV 153

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  104 bits (261), Expect = 2e-26
 Identities = 28/142 (19%), Positives = 55/142 (38%), Gaps = 19/142 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN--RELQIMRLLNHPN- 191
           Y   + +G+G    VFQ    E     AIK V      ++   +   E+  +  L   + 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
            ++ L           + Y+ +V+E  +  +    K    ++        + Y   +  A
Sbjct: 89  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWE----RKSYWKNMLEA 139

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           ++ +H   G+ H D+KP N L+
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLI 160

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  103 bits (260), Expect = 2e-26
 Identities = 36/146 (24%), Positives = 58/146 (39%), Gaps = 18/146 (12%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL 195
           +    V+G G+FG V +A+        AIKK+   +   +    E+ ++  LNH  VV  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 196 KHCF--------FSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTY 245
              +          T  K +  L + +EY         +       N +           
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFR 123

Query: 246 QICRALNYLHHVVGVCHRDIKPQNLL 271
           QI  AL+Y+H   G+ HRD+KP N+ 
Sbjct: 124 QILEALSYIHS-QGIIHRDLKPMNIF 148

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  104 bits (261), Expect = 3e-26
 Identities = 39/158 (24%), Positives = 67/158 (42%), Gaps = 21/158 (13%)

Query: 123 ATTVGGRNGQPKQTI-SYMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRY 176
             T G  +         Y   + +G+G+FGV    +   T + VA+K       + +   
Sbjct: 5   PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64

Query: 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQH 234
             RE+   R L HPN+V  K    +      L   +++EY S  E   R+     R ++ 
Sbjct: 65  --REIINHRSLRHPNIVRFKEVILT---PTHLA--IIMEYASGGELYERICNA-GRFSED 116

Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
               + Q    Q+   ++Y H  + +CHRD+K +N L+
Sbjct: 117 EARFFFQ----QLLSGVSYCHS-MQICHRDLKLENTLL 149

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  104 bits (261), Expect = 5e-26
 Identities = 42/142 (29%), Positives = 77/142 (54%), Gaps = 20/142 (14%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL---QD----KR-YKNRELQIMRLLN-H 189
           Y   + +G G++G+V+++    TG+ VA+KK+    Q+    +R +  RE+ I+  L+ H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
            N+V+L +   +  ++D +Y  LV +Y+   ++ V +       H      Q   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VY--LVFDYMETDLHAVIRANILEPVH-----KQYVVYQLIK 120

Query: 250 ALNYLHHVVGVCHRDIKPQNLL 271
            + YLH   G+ HRD+KP N+L
Sbjct: 121 VIKYLHS-GGLLHRDMKPSNIL 141

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  102 bits (256), Expect = 5e-26
 Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 13/137 (9%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKH 197
            +G GSF  V++    ET   VA  ++   K  K+       E ++++ L HPN+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
            + ST +  +  + LV E ++  T+    K +  M   V    ++ +  QI + L +LH 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTLKTYLKRFKVMKIKV----LRSWCRQILKGLQFLHT 147

Query: 256 HVVGVCHRDIKPQNLLM 272
               + HRD+K  N+ +
Sbjct: 148 RTPPIIHRDLKCDNIFI 164

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  103 bits (259), Expect = 5e-26
 Identities = 27/156 (17%), Positives = 58/156 (37%), Gaps = 33/156 (21%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN----------------REL 181
           R +  G F  +   +  +     A+K      + + + +                   EL
Sbjct: 37  RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVP 236
           QI+  + +   ++      +    DE+Y+  + EY+      +               +P
Sbjct: 95  QIITDIKNEYCLTC-EGIITN--YDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 237 ILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           I  ++     +  + +Y+H+   +CHRD+KP N+LM
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  103 bits (258), Expect = 5e-26
 Identities = 41/135 (30%), Positives = 68/135 (50%), Gaps = 18/135 (13%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKH 197
           VG G++GVV++AK    G  VA+K++  D            RE+ +++ L+HPN+VSL  
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLID 86

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
                  +  L L  V E++      + K        +    +++Y YQ+ R + + H  
Sbjct: 87  VI---HSERCLTL--VFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138

Query: 258 VGVCHRDIKPQNLLM 272
             + HRD+KPQNLL+
Sbjct: 139 -RILHRDLKPQNLLI 152

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  103 bits (259), Expect = 6e-26
 Identities = 45/144 (31%), Positives = 68/144 (47%), Gaps = 21/144 (14%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
           Y     VG+G++G V  A   +TG  VA+KK+ +        KR Y  REL++++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 191 NVVSLKHCFFSTTEKD---ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           NV+ L   F      +   ++Y  LV   +   +  + K     + H     VQ   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQI 141

Query: 248 CRALNYLHHVVGVCHRDIKPQNLL 271
            R L Y+H    + HRD+KP NL 
Sbjct: 142 LRGLKYIHS-ADIIHRDLKPSNLA 164

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  103 bits (259), Expect = 7e-26
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 16/140 (11%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQIMRLLNHPNVVS 194
           Y     +G+G+FGVV +     TG     K        DK     E+ IM  L+HP +++
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L   F     +D+  + L+LE++S  E   R++    +M++   I Y++    Q C  L 
Sbjct: 113 LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLK 163

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           ++H    + H DIKP+N++ 
Sbjct: 164 HMHE-HSIVHLDIKPENIMC 182

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  104 bits (261), Expect = 7e-26
 Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 12/138 (8%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMR-LLNHPNVVSLK 196
            ++E+++G GS G V   +    G  VA+K++L D       E++++    +HPNV+   
Sbjct: 17  VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY 75

Query: 197 HCFFSTTEKDELYLNLVLEYISETVY-RVSKH--YTRMNQHVPILYVQLYTYQICRALNY 253
                 +E  + +L + LE  +  +   V          +            QI   + +
Sbjct: 76  C-----SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 254 LHHVVGVCHRDIKPQNLL 271
           LH +  + HRD+KPQN+L
Sbjct: 131 LHSL-KIIHRDLKPQNIL 147

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  101 bits (255), Expect = 7e-26
 Identities = 33/144 (22%), Positives = 61/144 (42%), Gaps = 23/144 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
           Y    ++G GSFG V + K   T    A+K + +            RE+++++ L+HPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYTRMNQHVPILYVQLYTYQIC 248
           + L         +D     +V E  +  E    + K   ++                Q+ 
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + Y+H    + HRD+KP+N+L+
Sbjct: 132 SGITYMHK-HNIVHRDLKPENILL 154

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  102 bits (255), Expect = 9e-26
 Identities = 33/146 (22%), Positives = 59/146 (40%), Gaps = 15/146 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDKRYKNRELQIMRLLNHPNVV 193
           +   + +G G FGVVF+AK      + AIK++        +    RE++ +  L HP +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 194 SLKHCFF-------STTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTY 245
              + +              ++YL + ++    E +           +            
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFL 125

Query: 246 QICRALNYLHHVVGVCHRDIKPQNLL 271
           QI  A+ +LH   G+ HRD+KP N+ 
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIF 150

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  102 bits (257), Expect = 9e-26
 Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 19/141 (13%)

Query: 145 VGTGSFGVVFQAK-CLETGDSVAIKKVLQDKRYKN-------RELQIMRLLN---HPNVV 193
           +G G++G VF+A+     G  VA+K+V      +        RE+ ++R L    HPNVV
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY--TRMNQHVPILYVQLYTYQICRAL 251
            L      +    E  L LV E++ + +      Y        VP   ++   +Q+ R L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDL----TTYLDKVPEPGVPTETIKDMMFQLLRGL 133

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           ++LH    V HRD+KPQN+L+
Sbjct: 134 DFLHSH-RVVHRDLKPQNILV 153

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  102 bits (257), Expect = 9e-26
 Identities = 28/142 (19%), Positives = 54/142 (38%), Gaps = 19/142 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPN- 191
           Y   + +G+G    VFQ    E     AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
            ++ L           + Y+ +V+E  +  +    K    ++        + Y   +  A
Sbjct: 70  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWE----RKSYWKNMLEA 120

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           ++ +H   G+ H D+KP N L+
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI 141

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (256), Expect = 9e-26
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 18/140 (12%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           +   + +G G++G V  A    T ++VA+K V   +         +E+ I ++LNH NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
                     E +  Y  L LEY S  E   R+      M +     +      Q+   +
Sbjct: 69  KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-IGMPEPDAQRFFH----QLMAGV 118

Query: 252 NYLHHVVGVCHRDIKPQNLL 271
            YLH  +G+ HRDIKP+NLL
Sbjct: 119 VYLHG-IGITHRDIKPENLL 137

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  104 bits (261), Expect = 1e-25
 Identities = 34/144 (23%), Positives = 62/144 (43%), Gaps = 23/144 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNV 192
           Y    ++G GSFG V + K   T    A+K +       +D     RE+++++ L+HPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYTRMNQHVPILYVQLYTYQIC 248
           + L         +D     +V E  +  E    + K   ++                Q+ 
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + Y+H    + HRD+KP+N+L+
Sbjct: 132 SGITYMHK-HNIVHRDLKPENILL 154

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  101 bits (255), Expect = 1e-25
 Identities = 34/139 (24%), Positives = 64/139 (46%), Gaps = 15/139 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVA---IKKVLQDKRYKNRELQIMRLLNHPNVVSL 195
           YM    +G G FG+V +     +  +     +K    D+    +E+ I+ +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
              F     +    L ++ E+IS  +   R++     +N+   + YV     Q+C AL +
Sbjct: 67  HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH----QVCEALQF 117

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH    + H DI+P+N++ 
Sbjct: 118 LHS-HNIGHFDIRPENIIY 135

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  103 bits (258), Expect = 1e-25
 Identities = 39/137 (28%), Positives = 70/137 (51%), Gaps = 13/137 (9%)

Query: 145 VGTGSFGVVFQAKCLE--TGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFF 200
           VG G++G V++AK  +       A+K++       +  RE+ ++R L HPNV+SL+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY-----VQLYTYQICRALNYLH 255
           S  ++    + L+ +Y    ++ + K +     +   +      V+   YQI   ++YLH
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 256 HVVGVCHRDIKPQNLLM 272
               V HRD+KP N+L+
Sbjct: 146 AN-WVLHRDLKPANILV 161

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  101 bits (254), Expect = 2e-25
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 23/143 (16%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----RELQIMRLLNHPNVVS 194
           ++   V+G+G+F  VF  K   TG   A+K + +   +++     E+ +++ + H N+V+
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYR-VSK-HYT-RMNQHVPILYVQLYTYQICR 249
           L+  +         Y  LV++ +S  E   R + +  YT +    V          Q+  
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYTEKDASLV--------IQQVLS 117

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           A+ YLH   G+ HRD+KP+NLL 
Sbjct: 118 AVKYLHE-NGIVHRDLKPENLLY 139

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  102 bits (256), Expect = 2e-25
 Identities = 28/142 (19%), Positives = 54/142 (38%), Gaps = 19/142 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPN- 191
           Y   + +G+G    VFQ    E     AIK V  ++           E+  +  L   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
            ++ L           + Y+ +V+E  +  +    K    ++        + Y   +  A
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWE----RKSYWKNMLEA 167

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           ++ +H   G+ H D+KP N L+
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLI 188

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  103 bits (259), Expect = 2e-25
 Identities = 40/139 (28%), Positives = 74/139 (53%), Gaps = 16/139 (11%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
           Y     +GTG+FGVV +     TG++ A K V      DK    +E+Q M +L HP +V+
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L   F     +D+  + ++ E++S  E   +V+  + +M++   + Y++    Q+C+ L 
Sbjct: 219 LHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269

Query: 253 YLHHVVGVCHRDIKPQNLL 271
           ++H      H D+KP+N++
Sbjct: 270 HMHE-NNYVHLDLKPENIM 287

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  102 bits (257), Expect = 4e-25
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 24/144 (16%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHPN 191
           Y  +RV+G GSFG V   K   TG   A+K +    ++ K  K    RE+Q+++ L+HPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYTYQI 247
           ++ L   F     +D+ Y  LV E  +  E    +   K ++ +              Q+
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135

Query: 248 CRALNYLHHVVGVCHRDIKPQNLL 271
              + Y+H    + HRD+KP+NLL
Sbjct: 136 LSGITYMHK-NKIVHRDLKPENLL 158

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 99.6 bits (249), Expect = 4e-25
 Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 20/155 (12%)

Query: 127 GGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------R 179
           G ++    +   Y+    +G G+FG V   +   TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPI 237
           E+Q ++L  HP+++ L     +     + +  +V+EY+S  E    + KH  R+ +    
Sbjct: 61  EIQNLKLFRHPHIIKLYQVIST---PTDFF--MVMEYVSGGELFDYICKH-GRVEEMEAR 114

Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
              Q    QI  A++Y H    V HRD+KP+N+L+
Sbjct: 115 RLFQ----QILSAVDYCHR-HMVVHRDLKPENVLL 144

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 99.6 bits (249), Expect = 5e-25
 Identities = 34/148 (22%), Positives = 64/148 (43%), Gaps = 27/148 (18%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
           Y     +G+G F +V + +   TG   A K          +    +    RE+ I+R + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
           HPN+++L   F     +++  + L+LE +S  E    +   +  T             + 
Sbjct: 67  HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDE-------ATQFL 114

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
            QI   ++YLH    + H D+KP+N+++
Sbjct: 115 KQILDGVHYLHS-KRIAHFDLKPENIML 141

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (256), Expect = 6e-25
 Identities = 34/144 (23%), Positives = 61/144 (42%), Gaps = 23/144 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNV 192
           Y   + +G+G++G V   +   T    AIK +               E+ +++LL+HPN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYTYQIC 248
           + L   F     +D+    LV+E     E    +     +  +          +   Q+ 
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEV-------DAAVIIKQVL 146

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + YLH    + HRD+KP+NLL+
Sbjct: 147 SGVTYLHK-HNIVHRDLKPENLLL 169

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 99.7 bits (249), Expect = 6e-25
 Identities = 36/141 (25%), Positives = 60/141 (42%), Gaps = 19/141 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
            +  +V+G G  G V Q     T +  A+ K+LQD     RE+++  R    P++V +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 198 CFFSTTEKDELYLNLVLEYIS------ETVYRVSKHYT-RMNQHVPILYVQLYTYQICRA 250
             +         L +V+E +           R  + +T R    +           I  A
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI--------MKSIGEA 129

Query: 251 LNYLHHVVGVCHRDIKPQNLL 271
           + YLH  + + HRD+KP+NLL
Sbjct: 130 IQYLHS-INIAHRDVKPENLL 149

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 99.3 bits (248), Expect = 8e-25
 Identities = 34/137 (24%), Positives = 63/137 (45%), Gaps = 18/137 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
            V+G G++G+V+  + L     +AIK++  +D RY      E+ + + L H N+V     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83

Query: 199 FFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
            +  +  +  ++ + +E +       + R    +  +  +     +  YT QI   L YL
Sbjct: 84  -YLGSFSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQT--IGFYTKQILEGLKYL 138

Query: 255 HHVVGVCHRDIKPQNLL 271
           H    + HRDIK  N+L
Sbjct: 139 HD-NQIVHRDIKGDNVL 154

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  100 bits (251), Expect = 8e-25
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 22/144 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQD----KR-YKNRELQIMRLLNHP 190
           Y   + +G+G+ G+V  A       +VAIKK+    Q+    KR Y  REL +M+ +NH 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 191 NVVSLKHCF---FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           N++ L + F    S  E  ++Y  +V+E +   + +V +     ++      +    YQ+
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVY--IVMELMDANLCQVIQM-ELDHER-----MSYLLYQM 136

Query: 248 CRALNYLHHVVGVCHRDIKPQNLL 271
              + +LH   G+ HRD+KP N++
Sbjct: 137 LCGIKHLHS-AGIIHRDLKPSNIV 159

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 99.8 bits (249), Expect = 2e-24
 Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 16/152 (10%)

Query: 126 VGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNREL 181
           V  + G      +     ++G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILY 239
            +M  L+H N++ L   F     + +  + LV+EY+   E   R+      + +   IL+
Sbjct: 138 SVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192

Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
           ++    QIC  + ++H  + + H D+KP+N+L
Sbjct: 193 MK----QICEGIRHMHQ-MYILHLDLKPENIL 219

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  100 bits (251), Expect = 2e-24
 Identities = 41/147 (27%), Positives = 74/147 (50%), Gaps = 26/147 (17%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------------RELQIMRL 186
           Y+  + +G+G+ G V  A   +T   VAI+ + + K                 E++I++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYT 244
           LNHP ++ +K+ F    + ++ Y  +VLE +   E   +V  +     + +     +LY 
Sbjct: 197 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVGN-----KRLKEATCKLYF 245

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLL 271
           YQ+  A+ YLH   G+ HRD+KP+N+L
Sbjct: 246 YQMLLAVQYLHE-NGIIHRDLKPENVL 271

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 98.9 bits (247), Expect = 2e-24
 Identities = 33/147 (22%), Positives = 63/147 (42%), Gaps = 27/147 (18%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
           Y     +G+G F VV + +   TG   A K          +    +    RE+ I++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
           HPNV++L   +     +++  + L+LE ++  E    +   +  T             + 
Sbjct: 73  HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEE-------ATEFL 120

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLL 271
            QI   + YLH  + + H D+KP+N++
Sbjct: 121 KQILNGVYYLHS-LQIAHFDLKPENIM 146

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 98.5 bits (246), Expect = 2e-24
 Identities = 39/166 (23%), Positives = 67/166 (40%), Gaps = 42/166 (25%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--------------- 178
           Y  +  +G GS+GVV  A         A+K     K+++   +                 
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 179 ----------RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK 226
                     +E+ I++ L+HPNVV L         +D LY  +V E ++    +   + 
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLY--MVFELVNQGPVMEVPTL 131

Query: 227 HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
               +++     Y Q     + + + YLH+   + HRDIKP NLL+
Sbjct: 132 --KPLSEDQARFYFQ----DLIKGIEYLHY-QKIIHRDIKPSNLLV 170

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 98.5 bits (246), Expect = 3e-24
 Identities = 40/148 (27%), Positives = 59/148 (39%), Gaps = 26/148 (17%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNH 189
           Y    V+G G F VV +    ETG   A+K V   K   +         RE  I  +L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILY----VQLY 243
           P++V L   +       +  L +V E++   +  + + K           +Y       Y
Sbjct: 86  PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHY 135

Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLL 271
             QI  AL Y H    + HRD+KP  +L
Sbjct: 136 MRQILEALRYCHD-NNIIHRDVKPHCVL 162

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 97.2 bits (243), Expect = 4e-24
 Identities = 40/145 (27%), Positives = 63/145 (43%), Gaps = 25/145 (17%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
           Y  +  +G G+F VV +     TG   A K +   K          RE +I R L HPN+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYR-VSK-HYT-RMNQHVPILYVQLYTYQI 247
           V L         ++E +  LV + ++  E     V++  Y+     H           QI
Sbjct: 68  VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--------IQQI 114

Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
             ++ Y H   G+ HR++KP+NLL+
Sbjct: 115 LESIAYCHS-NGIVHRNLKPENLLL 138

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 98.1 bits (245), Expect = 4e-24
 Identities = 33/148 (22%), Positives = 62/148 (41%), Gaps = 27/148 (18%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
           Y     +G+G F +V + +   TG   A K          +    +    RE+ I+R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
           H NV++L   +     ++   + L+LE +S  E    +   +  +             + 
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
            QI   +NYLH    + H D+KP+N+++
Sbjct: 122 KQILDGVNYLHT-KKIAHFDLKPENIML 148

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =   99 bits (249), Expect = 4e-24
 Identities = 42/144 (29%), Positives = 74/144 (51%), Gaps = 22/144 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQD----KR-YKNRELQIMRLLNHP 190
           Y   + +G+G+ G+V  A       +VAIKK+    Q+    KR Y  REL +M+ +NH 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 191 NVVSLKHCF---FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           N++SL + F    +  E  ++Y  LV+E +   + +V +     ++      +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVY--LVMELMDANLCQVIQM-ELDHER-----MSYLLYQM 173

Query: 248 CRALNYLHHVVGVCHRDIKPQNLL 271
              + +LH   G+ HRD+KP N++
Sbjct: 174 LCGIKHLHS-AGIIHRDLKPSNIV 196

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 98.2 bits (245), Expect = 4e-24
 Identities = 45/186 (24%), Positives = 79/186 (42%), Gaps = 23/186 (12%)

Query: 96  EKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS--YMAERVVGTGSFGVV 153
             ++  ++   +           G          +G  +  +S  +  E  +G G+  +V
Sbjct: 10  GVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIV 69

Query: 154 FQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211
           ++ K   T    A+K + +    K    E+ ++  L+HPN++ LK  F     +    ++
Sbjct: 70  YRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEIS 124

Query: 212 LVLEYIS--ETVYR-VSK-HYT-RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266
           LVLE ++  E   R V K +Y+ R               QI  A+ YLH   G+ HRD+K
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSERDAADA--------VKQILEAVAYLHE-NGIVHRDLK 175

Query: 267 PQNLLM 272
           P+NLL 
Sbjct: 176 PENLLY 181

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.8 bits (249), Expect = 5e-24
 Identities = 37/154 (24%), Positives = 61/154 (39%), Gaps = 34/154 (22%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------------REL 181
           Y   R +G+G++G V   K        AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYTRMNQHVPI 237
            +++ L+HPN++ L   F     +D+ Y  LV E+    E   ++     +         
Sbjct: 98  SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146

Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
                   QI   + YLH    + HRDIKP+N+L
Sbjct: 147 -DAANIMKQILSGICYLHK-HNIVHRDIKPENIL 178

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 97.7 bits (244), Expect = 6e-24
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 30/149 (20%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKN--------RELQIMRL 186
           Y+  + +G+G+ G V  A   +T   VAIK    +       +          E++I++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQL 242
           LNHP ++ +K+ F    + ++ Y  +VLE +   E   +V  +K              +L
Sbjct: 72  LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVGNKRLKEA-------TCKL 118

Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLL 271
           Y YQ+  A+ YLH   G+ HRD+KP+N+L
Sbjct: 119 YFYQMLLAVQYLHE-NGIIHRDLKPENVL 146

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.9 bits (247), Expect = 7e-24
 Identities = 38/144 (26%), Positives = 60/144 (41%), Gaps = 25/144 (17%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
           Y     +G G+F VV +   +  G   A   +   K          RE +I RLL HPN+
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYT-RMNQHVPILYVQLYTYQI 247
           V L          +E +  L+ + ++  E    +    +Y+     H           QI
Sbjct: 73  VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC--------IQQI 119

Query: 248 CRALNYLHHVVGVCHRDIKPQNLL 271
             A+ + H  +GV HR++KP+NLL
Sbjct: 120 LEAVLHCHQ-MGVVHRNLKPENLL 142

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 98.3 bits (245), Expect = 8e-24
 Identities = 36/141 (25%), Positives = 60/141 (42%), Gaps = 19/141 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
            +  +V+G G  G V Q     T +  A+ K+LQD     RE+++  R    P++V +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 198 CFFSTTEKDELYLNLVLEYIS------ETVYRVSKHYT-RMNQHVPILYVQLYTYQICRA 250
             +         L +V+E +           R  + +T R    +           I  A
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI--------MKSIGEA 173

Query: 251 LNYLHHVVGVCHRDIKPQNLL 271
           + YLH  + + HRD+KP+NLL
Sbjct: 174 IQYLHS-INIAHRDVKPENLL 193

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 97.0 bits (242), Expect = 1e-23
 Identities = 33/148 (22%), Positives = 63/148 (42%), Gaps = 27/148 (18%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
           Y     +G+G F +V + +   TG   A K          +    +    RE+ I+R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
           HPN+++L   +     ++   + L+LE +S  E    +   +  +             + 
Sbjct: 74  HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
            QI   +NYLH    + H D+KP+N+++
Sbjct: 122 KQILDGVNYLHT-KKIAHFDLKPENIML 148

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 97.0 bits (242), Expect = 2e-23
 Identities = 39/145 (26%), Positives = 61/145 (42%), Gaps = 25/145 (17%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
           Y  +  +G G+F VV +     TG   A K +   K          RE +I R L HPN+
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYT-RMNQHVPILYVQLYTYQI 247
           V L         ++E +  LV + ++  E    +     Y+     H           QI
Sbjct: 91  VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--------IQQI 137

Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
             ++ Y H   G+ HR++KP+NLL+
Sbjct: 138 LESIAYCHS-NGIVHRNLKPENLLL 161

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 96.4 bits (240), Expect = 2e-23
 Identities = 40/170 (23%), Positives = 66/170 (38%), Gaps = 22/170 (12%)

Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
                  GQ +   +G               RV+  G F  V++A+ + +G   A+K++L
Sbjct: 13  RDQSDFVGQTV--ELGELR--------LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL 62

Query: 172 ----QDKRYKNRELQIMR-LLNHPNVVSLKHCFFSTTE----KDELYLNLVLEYISETVY 222
               +  R   +E+  M+ L  HPN+V          E        +L L+ E     + 
Sbjct: 63  SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL-LLTELCKGQLV 121

Query: 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVVGVCHRDIKPQNLL 271
              K        +    V    YQ CRA+ ++H     + HRD+K +NLL
Sbjct: 122 EFLKK-MESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 95.8 bits (239), Expect = 3e-23
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 21/143 (14%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPN 191
           Y+    +G GSFG V  A   +T   VA+K      + +   +    RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETV--YRVSKHYTRMNQHVPILYVQLYTYQICR 249
           ++ L     +     ++   +V+EY    +  Y V K   RM +     + Q    QI  
Sbjct: 71  IIKLYDVITT---PTDIV--MVIEYAGGELFDYIVEKK--RMTEDEGRRFFQ----QIIC 119

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           A+ Y H    + HRD+KP+NLL+
Sbjct: 120 AIEYCHR-HKIVHRDLKPENLLL 141

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 95.9 bits (239), Expect = 3e-23
 Identities = 31/138 (22%), Positives = 57/138 (41%), Gaps = 19/138 (13%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFF 200
           ++V+G G  G V +     TG   A+K +L D     +E+    +    P++V +    +
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91

Query: 201 STTEKDELYLNLVLEYIS------ETVYRVSKHYT-RMNQHVPILYVQLYTYQICRALNY 253
                 +  L +++E +           R  + +T R    +           I  A+ +
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI--------MRDIGTAIQF 143

Query: 254 LHHVVGVCHRDIKPQNLL 271
           LH    + HRD+KP+NLL
Sbjct: 144 LHS-HNIAHRDVKPENLL 160

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 95.8 bits (239), Expect = 3e-23
 Identities = 39/139 (28%), Positives = 66/139 (47%), Gaps = 20/139 (14%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
           Y  +  +G GS+ V  +     T    A+K + + KR    E++I+ R   HPN+++LK 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 198 CFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYT-RMNQHVPILYVQLYTYQICRALN 252
            +      D  Y+ +V E +   E + ++   K ++ R    V         + I + + 
Sbjct: 84  VY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV--------LFTITKTVE 130

Query: 253 YLHHVVGVCHRDIKPQNLL 271
           YLH   GV HRD+KP N+L
Sbjct: 131 YLHA-QGVVHRDLKPSNIL 148

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 96.2 bits (239), Expect = 4e-23
 Identities = 20/146 (13%), Positives = 51/146 (34%), Gaps = 17/146 (11%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDS-----VAIK----KVLQDKRYKNRELQIMRLLN 188
                 ++G G+F  V++A   +  D+       +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
               +           ++     LV E  S    +  ++ +     + +P   V  +  +
Sbjct: 126 QHMFMKFYSAHLF---QNGSV--LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           +   +  +H    + H DIKP N ++
Sbjct: 181 MLYMIEQVHD-CEIIHGDIKPDNFIL 205

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.4 bits (238), Expect = 4e-23
 Identities = 50/144 (34%), Positives = 71/144 (49%), Gaps = 23/144 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHP 190
           Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        RE++IM++LNHP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           N+V L       TEK    L L++EY S  E    +  H  RM +       +    QI 
Sbjct: 75  NIVKLFEVI--ETEKT---LYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFR----QIV 124

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            A+ Y H    + HRD+K +NLL+
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLL 147

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 96.8 bits (241), Expect = 5e-23
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 21/160 (13%)

Query: 123 ATTVGGRNGQPKQTI-SYMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRY 176
                 +    +  I  Y+    +G G+FG V   K   TG  VA+K     K+      
Sbjct: 1   GPMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVV 60

Query: 177 KN--RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMN 232
               RE+Q ++L  HP+++ L +   ST    +++  +V+EY+S  E    + K+  R++
Sbjct: 61  GKIRREIQNLKLFRHPHIIKL-YQVIST--PSDIF--MVMEYVSGGELFDYICKN-GRLD 114

Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +       Q    QI   ++Y H    V HRD+KP+N+L+
Sbjct: 115 EKESRRLFQ----QILSGVDYCHR-HMVVHRDLKPENVLL 149

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 95.0 bits (237), Expect = 6e-23
 Identities = 33/146 (22%), Positives = 63/146 (43%), Gaps = 26/146 (17%)

Query: 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNH-PNV 192
           +  + +G G F VV Q     TG   A K + + +R ++       E+ ++ L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS------ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
           ++L   +     ++   + L+LEY +        +  +++  +  +       V     Q
Sbjct: 92  INLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND-------VIRLIKQ 139

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           I   + YLH    + H D+KPQN+L+
Sbjct: 140 ILEGVYYLHQ-NNIVHLDLKPQNILL 164

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 94.9 bits (236), Expect = 8e-23
 Identities = 44/179 (24%), Positives = 70/179 (39%), Gaps = 52/179 (29%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL---------QDKRYKNRELQIMRLLNH 189
           Y  +  +G GS+GVV  A   +T    AIK +          +D      E+++M+ L+H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQL----- 242
           PN+  L   +     +DE Y+ LV+E       + +++           +  V+      
Sbjct: 88  PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 243 ------------------------------YTYQICRALNYLHHVVGVCHRDIKPQNLL 271
                                            QI  AL+YLH+  G+CHRDIKP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFL 200

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 94.4 bits (235), Expect = 1e-22
 Identities = 33/150 (22%), Positives = 63/150 (42%), Gaps = 28/150 (18%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN-------RELQIMRL 186
           Y     +G+G+FG V+ A   E    V +K     KVL+D   ++        E+ I+  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV----YRVSKHYTRMNQHVPILYVQL 242
           + H N++ +    F    +      LV+E     +    +       R+++ +     + 
Sbjct: 86  VEHANIIKVLD-IFEN--QGFFQ--LVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFR- 137

Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
              Q+  A+ YL     + HRDIK +N+++
Sbjct: 138 ---QLVSAVGYLRL-KDIIHRDIKDENIVI 163

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 94.3 bits (235), Expect = 1e-22
 Identities = 36/140 (25%), Positives = 71/140 (50%), Gaps = 21/140 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-NRELQIMRLL-NHPNVVSLK 196
            + ++ +G GSF +  +    ++  + A+K + +       +E+  ++L   HPN+V L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYT-RMNQHVPILYVQLYTYQICRAL 251
             F      D+L+  LV+E ++  E   R+   KH++     ++          ++  A+
Sbjct: 73  EVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI--------MRKLVSAV 119

Query: 252 NYLHHVVGVCHRDIKPQNLL 271
           +++H  VGV HRD+KP+NLL
Sbjct: 120 SHMHD-VGVVHRDLKPENLL 138

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 93.2 bits (232), Expect = 2e-22
 Identities = 43/136 (31%), Positives = 64/136 (47%), Gaps = 15/136 (11%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
           E VVG G+FGVV +AK       VAIK++  +   K    EL+ +  +NHPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-- 256
                     + LV+EY    ++Y V  H      +    +   +  Q  + + YLH   
Sbjct: 70  --CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 257 VVGVCHRDIKPQNLLM 272
              + HRD+KP NLL+
Sbjct: 123 PKALIHRDLKPPNLLL 138

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 92.7 bits (231), Expect = 3e-22
 Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 20/139 (14%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
           +++G GSF  V  A+ L T    AIK      ++++    Y  RE  +M  L+HP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
              F     +D+  L   L Y    E +  + K     ++       + YT +I  AL Y
Sbjct: 96  YFTF-----QDDEKLYFGLSYAKNGELLKYIRK-IGSFDETC----TRFYTAEIVSALEY 145

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH   G+ HRD+KP+N+L+
Sbjct: 146 LHG-KGIIHRDLKPENILL 163

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 92.4 bits (230), Expect = 4e-22
 Identities = 39/151 (25%), Positives = 59/151 (39%), Gaps = 30/151 (19%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN-----RELQIMRLLN 188
           Y    ++G G FG VF    L     VAIK     +VL      +      E+ ++  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 189 ----HPNVVSLKHCFFSTTEKDELYLNLVLEYISETV----YRVSKHYTRMNQHVPILYV 240
               HP V+ L   +F T  ++     LVLE          Y   K    + +     + 
Sbjct: 93  AGGGHPGVIRL-LDWFET--QEGFM--LVLERPLPAQDLFDYITEK--GPLGEGPSRCFF 145

Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
                Q+  A+ + H   GV HRDIK +N+L
Sbjct: 146 G----QVVAAIQHCHS-RGVVHRDIKDENIL 171

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 92.4 bits (230), Expect = 4e-22
 Identities = 36/190 (18%), Positives = 69/190 (36%), Gaps = 30/190 (15%)

Query: 100 NHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS--YMAERVVGTGSFGVVFQAK 157
           +H        +V      A            G+ K+ +   Y    ++G+G FG V+   
Sbjct: 4   SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63

Query: 158 CLETGDSVAIK-----KVLQDKRYKN-----RELQIMRLLNH--PNVVSLKHCFFSTTEK 205
            +     VAIK     ++       N      E+ +++ ++     V+ L   +F     
Sbjct: 64  RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD-WFER--P 120

Query: 206 DELYLNLVLEYISETV----YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
           D     L+LE          +   +    + + +   +      Q+  A+ + H+  GV 
Sbjct: 121 DSFV--LILERPEPVQDLFDFITER--GALQEELARSFFW----QVLEAVRHCHN-CGVL 171

Query: 262 HRDIKPQNLL 271
           HRDIK +N+L
Sbjct: 172 HRDIKDENIL 181

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.0 bits (229), Expect = 6e-22
 Identities = 35/140 (25%), Positives = 60/140 (42%), Gaps = 24/140 (17%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQIM-RLLNHPNVVSLK 196
           E V+G G+   V     L T    A+K    +    +    RE++++ +   H NV+ L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYT-RMNQHVPILYVQLYTYQICRAL 251
             F     ++E    LV E +     +  + K  H+       V           +  AL
Sbjct: 78  EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV--------VQDVASAL 124

Query: 252 NYLHHVVGVCHRDIKPQNLL 271
           ++LH+  G+ HRD+KP+N+L
Sbjct: 125 DFLHNK-GIAHRDLKPENIL 143

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 92.4 bits (229), Expect = 7e-22
 Identities = 28/180 (15%), Positives = 48/180 (26%), Gaps = 34/180 (18%)

Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK------ 177
           TTV     Q ++         +  G   VVF  + +E  +  A+K               
Sbjct: 51  TTVDSLLSQGERK--LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELER 108

Query: 178 -NRELQIMRLLNHPNVVSLKHCF-------------------FSTTEKDELYLNLVLEYI 217
            +        L   +    +                       S  + D    N +L   
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168

Query: 218 S-----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +     E ++              IL + + T Q+ R    L    G+ H    P NL +
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS-KGLVHGHFTPDNLFI 227

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 90.1 bits (224), Expect = 2e-21
 Identities = 32/146 (21%), Positives = 58/146 (39%), Gaps = 27/146 (18%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHP 190
           E+ +G G FG+V + + ++    VAIK ++                  RE+ IM  LNHP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT--YQI 247
           N+V L                +V+E++    +Y         ++  PI +         I
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLL-----DKAHPIKWSVKLRLMLDI 131

Query: 248 CRALNYLH-HVVGVCHRDIKPQNLLM 272
              + Y+      + HRD++  N+ +
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFL 157

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 89.7 bits (223), Expect = 3e-21
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 16/144 (11%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           Y  + V+G+G+  VV  A C    + VAIK++  +K   +     +E+Q M   +HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICR--- 249
           S    F     KDEL+  LV++ +S  +V  + KH     +H   +  +     I R   
Sbjct: 77  SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 250 -ALNYLHHVVGVCHRDIKPQNLLM 272
             L YLH   G  HRD+K  N+L+
Sbjct: 132 EGLEYLHK-NGQIHRDVKAGNILL 154

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 90.5 bits (225), Expect = 4e-21
 Identities = 40/139 (28%), Positives = 72/139 (51%), Gaps = 20/139 (14%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
           R +G GSFG V   +  +T    A+K     K ++    R   +ELQIM+ L HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
            + F     +DE  + +V++ +   +  Y + ++     +      V+L+  ++  AL+Y
Sbjct: 81  WYSF-----QDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEET----VKLFICELVMALDY 130

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           L +   + HRD+KP N+L+
Sbjct: 131 LQN-QRIIHRDMKPDNILL 148

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 88.8 bits (221), Expect = 5e-21
 Identities = 33/135 (24%), Positives = 66/135 (48%), Gaps = 11/135 (8%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQI-MRLLNHPNVVSLKH 197
            +G G++GVV + + + +G  +A+K++   +  +  K    +L I MR ++ P  V+   
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
             F   +     + + +E +  ++ +  K      Q +P   +      I +AL +LH  
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 258 VGVCHRDIKPQNLLM 272
           + V HRD+KP N+L+
Sbjct: 129 LSVIHRDVKPSNVLI 143

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 87.7 bits (218), Expect = 1e-20
 Identities = 30/153 (19%), Positives = 63/153 (41%), Gaps = 33/153 (21%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK------------KVLQDKRYK-NRELQIMR 185
           Y  + ++G G   VV +     T    A+K            + +Q+ R    +E+ I+R
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 186 LLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYT-RMNQHVPILY 239
            ++ HPN++ LK  +     +   +  LV + +   E    +      + +  + +    
Sbjct: 79  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI---- 129

Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
                  +   +  LH +  + HRD+KP+N+L+
Sbjct: 130 ----MRALLEVICALHKL-NIVHRDLKPENILL 157

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 88.6 bits (220), Expect = 2e-20
 Identities = 37/231 (16%), Positives = 85/231 (36%), Gaps = 38/231 (16%)

Query: 66  STSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATT 125
                A          ++  +      +RD+ + + +       + +        +   +
Sbjct: 17  KERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQS 76

Query: 126 VGGRNGQPKQTIS------YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------- 168
           +G  +  P    +      Y  + V+G G   VV +     TG   A+K           
Sbjct: 77  MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSP 136

Query: 169 KVLQDKRYK-NRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV 224
           + L++ R    RE  I+R +  HP++++L   +     +   ++ LV + +   E    +
Sbjct: 137 EQLEEVREATRRETHILRQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYL 191

Query: 225 --SKHYT-RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
                 + +  + +           +  A+++LH    + HRD+KP+N+L+
Sbjct: 192 TEKVALSEKETRSI--------MRSLLEAVSFLHAN-NIVHRDLKPENILL 233

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.7 bits (220), Expect = 3e-20
 Identities = 33/139 (23%), Positives = 64/139 (46%), Gaps = 19/139 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
           +V+G G+FG V   K        A+K     ++L+         E  ++   +   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
            + F     +D+  L LV++Y    + +  +SK   R+ + +     + Y  ++  A++ 
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM----ARFYLAEMVIAIDS 190

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           +H  +   HRDIKP N+LM
Sbjct: 191 VHQ-LHYVHRDIKPDNILM 208

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 87.8 bits (217), Expect = 3e-20
 Identities = 28/182 (15%), Positives = 60/182 (32%), Gaps = 35/182 (19%)

Query: 123 ATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---- 178
              V    G+  +T   +   V+G        +A   ETG+S  +      +R  +    
Sbjct: 61  PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118

Query: 179 ---RELQIMRLL-------------------------NHPNVVSLKHCFFSTTEKDELYL 210
               E+  +RLL                             ++ ++            +L
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178

Query: 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
              ++   +T   V   ++  ++ +        T Q+ R L  LHH  G+ H  ++P ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDI 237

Query: 271 LM 272
           ++
Sbjct: 238 VL 239

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 87.4 bits (217), Expect = 3e-20
 Identities = 32/138 (23%), Positives = 64/138 (46%), Gaps = 16/138 (11%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQI-MRLLNHPNVVSLKH 197
            +G G++G V +     +G  +A+K++   + +K  K    +L + MR  + P +V    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 198 CFFSTTEKDELYLNLVLEYI---SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
             F   +       + +E +    +  Y+    Y+ ++  +P   +   T    +ALN+L
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYK--YVYSVLDDVIPEEILGKITLATVKALNHL 141

Query: 255 HHVVGVCHRDIKPQNLLM 272
              + + HRDIKP N+L+
Sbjct: 142 KENLKIIHRDIKPSNILL 159

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 87.8 bits (218), Expect = 5e-20
 Identities = 38/139 (27%), Positives = 64/139 (46%), Gaps = 19/139 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKR--YKNRELQIMRLLNHPNVVSL 195
           +V+G G+F  V   K  +TG   A+K      +L+         E  ++   +   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
              F     +DE YL LV+EY    + +  +SK   R+   +     + Y  +I  A++ 
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM----ARFYLAEIVMAIDS 177

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           +H  +G  HRDIKP N+L+
Sbjct: 178 VHR-LGYVHRDIKPDNILL 195

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.4 bits (215), Expect = 5e-20
 Identities = 37/139 (26%), Positives = 66/139 (47%), Gaps = 20/139 (14%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
           R +GTGSFG V   +    G   A+K      V++ K   + N E  ++ ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
              F     +D   + ++++YI   E    + K     N        + Y  ++C AL Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCLALEY 121

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH    + +RD+KP+N+L+
Sbjct: 122 LHS-KDIIYRDLKPENILL 139

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 87.3 bits (216), Expect = 6e-20
 Identities = 32/143 (22%), Positives = 66/143 (46%), Gaps = 17/143 (11%)

Query: 139 YMAERVVGTG--SFGVVFQAKCLETGDSVAIKKV----LQDKRYKN--RELQIMRLLNHP 190
           Y    V+G G      V  A+   TG+ V ++++      ++       EL + +L NHP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           N+V  +  F +    +EL+  +V  +++  +   +   +      +  L +      + +
Sbjct: 87  NIVPYRATFIA---DNELW--VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLK 139

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           AL+Y+HH +G  HR +K  ++L+
Sbjct: 140 ALDYIHH-MGYVHRSVKASHILI 161

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 86.6 bits (215), Expect = 8e-20
 Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 20/139 (14%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K     KV++ K   +   E +I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           +  F     KD   L +V+EY++  E        + R        + + Y  QI     Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFS-----HLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH  + + +RD+KP+NLL+
Sbjct: 157 LHS-LDLIYRDLKPENLLI 174

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 85.8 bits (213), Expect = 8e-20
 Identities = 36/142 (25%), Positives = 63/142 (44%), Gaps = 20/142 (14%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVS 194
           +     +G G+FG V++AK  ETG   A K +     ++      E++I+   +HP +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           L   ++   +     L +++E+      + +           Q   I  V     Q+  A
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVV---CRQMLEA 129

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           LN+LH    + HRD+K  N+LM
Sbjct: 130 LNFLHS-KRIIHRDLKAGNVLM 150

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 85.4 bits (212), Expect = 9e-20
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 25/143 (17%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHPNVV 193
           E ++G G FG V++A  +  GD VA+K    D             +E ++  +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 194 SLK-HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           +L+  C     ++  L   LV+E+     + RV        + +P   +  +  QI R +
Sbjct: 70  ALRGVC----LKEPNLC--LVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGM 118

Query: 252 NYLHH--VVGVCHRDIKPQNLLM 272
           NYLH   +V + HRD+K  N+L+
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILI 141

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 39/139 (28%), Positives = 69/139 (49%), Gaps = 21/139 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
           +V+G G+FG V   +   T    A+K     ++++     +   E  IM   N P VV L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
            + F     +D+ YL +V+EY+   + V  +S +   + +       + YT ++  AL+ 
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKW----ARFYTAEVVLALDA 183

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           +H  +G  HRD+KP N+L+
Sbjct: 184 IHS-MGFIHRDVKPDNMLL 201

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 85.9 bits (213), Expect = 1e-19
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 16/141 (11%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
           +   R +G GSFG V+ A+ +   + VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            +  + C+     +   +  LV+EY   +   + + + +  Q V I  V   T+   + L
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGL 167

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            YLH    + HRD+K  N+L+
Sbjct: 168 AYLHS-HNMIHRDVKAGNILL 187

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 85.4 bits (212), Expect = 1e-19
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 26/152 (17%)

Query: 130 NGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMR 185
            G PK+   Y     +G G+ G V+ A  + TG  VAI+++       K     E+ +MR
Sbjct: 15  VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYV 240
              +PN+V+    +      DEL+  +V+EY     +++ V       T M++   I  V
Sbjct: 73  ENKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVV-----TETCMDEGQ-IAAV 121

Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
                +  +AL +LH    V HRDIK  N+L+
Sbjct: 122 ---CRECLQALEFLHS-NQVIHRDIKSDNILL 149

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 85.1 bits (211), Expect = 2e-19
 Identities = 34/135 (25%), Positives = 64/135 (47%), Gaps = 14/135 (10%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQI-MRLLNHPNVVSLKH 197
            +G+G+ G V++ +  +TG  +A+K++      +  K    +L + ++  + P +V    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
            F + T+     + + +E +        K   RM   +P   +   T  I +AL YL   
Sbjct: 92  TFITNTD-----VFIAMELMGTCA---EKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 258 VGVCHRDIKPQNLLM 272
            GV HRD+KP N+L+
Sbjct: 144 HGVIHRDVKPSNILL 158

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 84.3 bits (209), Expect = 3e-19
 Identities = 32/140 (22%), Positives = 61/140 (43%), Gaps = 17/140 (12%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           +     +G GSFG VF+     T   VAIK +  ++         +E+ ++   + P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
                +   T+     L +++EY+   +   + +    +++   I  +     +I + L+
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-GPLDETQ-IATI---LREILKGLD 133

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH      HRDIK  N+L+
Sbjct: 134 YLHS-EKKIHRDIKAANVLL 152

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 85.6 bits (212), Expect = 3e-19
 Identities = 46/208 (22%), Positives = 90/208 (43%), Gaps = 22/208 (10%)

Query: 77  ERSGFDQLPKEMNEM--RIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPK 134
           ER+   + P+E  E    I+   +        E    +G+ ++        V     + +
Sbjct: 85  ERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHR 144

Query: 135 QTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL 186
            T++ +   +++G G+FG V   K   TG   A+K      ++      +   E ++++ 
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204

Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYT 244
             HP + +LK+ F +    D L    V+EY +  E  + +S+      +       + Y 
Sbjct: 205 SRHPFLTALKYSFQT---HDRLCF--VMEYANGGELFFHLSRE-----RVFSEDRARFYG 254

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
            +I  AL+YLH    V +RD+K +NL++
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLML 282

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 83.9 bits (208), Expect = 4e-19
 Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 14/136 (10%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKN--RELQIMRLLNHPNVVSLKH 197
             V+G G FG   +    ETG+ + +K++++  ++  +   +E+++MR L HPNV+    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
                 +   L    + EYI   T+  + K    M+   P      +   I   + YLH 
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 257 VVGVCHRDIKPQNLLM 272
            + + HRD+   N L+
Sbjct: 127 -MNIIHRDLNSHNCLV 141

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 84.0 bits (208), Expect = 4e-19
 Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 18/140 (12%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLK 196
           +     +G GS+G V++A   ETG  VAIK+V  +   +   +E+ IM+  + P+VV   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 197 HCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
             +F  T+     L +V+EY        + R+       ++   I  +        + L 
Sbjct: 91  GSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDE---IATI---LQSTLKGLE 139

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH  +   HRDIK  N+L+
Sbjct: 140 YLHF-MRKIHRDIKAGNILL 158

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 83.2 bits (206), Expect = 9e-19
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 26/153 (16%)

Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIM 184
             G P+      +   +G GS G+V  A+   +G  VA+K +     Q +     E+ IM
Sbjct: 39  DQGDPRLL--LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM 96

Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILY 239
           R   H NVV +   +      +EL+  +++E+     +++ V        R+N+   I  
Sbjct: 97  RDYQHFNVVEMYKSYLV---GEELW--VLMEFLQGGALTDIV-----SQVRLNEEQ-IAT 145

Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           V      + +AL YLH   GV HRDIK  ++L+
Sbjct: 146 V---CEAVLQALAYLHA-QGVIHRDIKSDSILL 174

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 83.2 bits (206), Expect = 9e-19
 Identities = 36/143 (25%), Positives = 69/143 (48%), Gaps = 15/143 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQIMR-LLNHPNVVS 194
           +    +VG G++G V++ + ++TG   AIK +     ++    +E+ +++   +H N+ +
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 195 LKHCFF-STTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
               F        +  L LV+E+        + + +K  T   +   I Y+     +I R
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYI---CREILR 140

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
            L++LH    V HRDIK QN+L+
Sbjct: 141 GLSHLHQ-HKVIHRDIKGQNVLL 162

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 83.1 bits (206), Expect = 1e-18
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 18/140 (12%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
           +  +G GSFG V +A+    G  VA+K +++   +        RE+ IM+ L HPN+V  
Sbjct: 42  KEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 196 K-HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
                   T+   L   +V EY+S  ++YR+  H +   + +         Y + + +NY
Sbjct: 100 MGAV----TQPPNLS--IVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNY 152

Query: 254 LH-HVVGVCHRDIKPQNLLM 272
           LH     + HR++K  NLL+
Sbjct: 153 LHNRNPPIVHRNLKSPNLLV 172

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 83.2 bits (206), Expect = 1e-18
 Identities = 40/147 (27%), Positives = 75/147 (51%), Gaps = 15/147 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLN-----HP 190
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E+++++ +N       
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 191 NVVSLKHC-----FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
           + +   H       F+    + +++ +V E + E +  + K Y   ++ +P++YV+  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138

Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+   L+Y+H   G+ H DIKP+N+LM
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLM 165

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 83.6 bits (206), Expect = 1e-18
 Identities = 33/196 (16%), Positives = 66/196 (33%), Gaps = 41/196 (20%)

Query: 117 EAGQVIATTVGGRNGQPKQTISYMAER--------VVGTGSFGVVFQAKCLETGDSVAIK 168
            A   + +T     GQP +  S + ER        V+G        +A   ETG+S  + 
Sbjct: 50  SAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVH 109

Query: 169 KVLQDKRYKN-------RELQIMRLL-------------------------NHPNVVSLK 196
                +R  +        E+  +RLL                             ++ ++
Sbjct: 110 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 169

Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
                       +L   ++   +T   V   ++  ++ +        T Q+ R L  LHH
Sbjct: 170 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229

Query: 257 VVGVCHRDIKPQNLLM 272
             G+ H  ++P ++++
Sbjct: 230 -YGLVHTYLRPVDIVL 244

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 84.1 bits (208), Expect = 1e-18
 Identities = 43/143 (30%), Positives = 67/143 (46%), Gaps = 24/143 (16%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
           RV+G G FG VF  +   TG   A  K L  KR K R        E +I+  ++   +VS
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYAC-KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPIL---YVQLYTYQICR 249
           L + F +   K +L   LV+  ++  +  Y    H   +++  P         YT QI  
Sbjct: 250 LAYAFET---KTDLC--LVMTIMNGGDIRY----HIYNVDEDNPGFQEPRAIFYTAQIVS 300

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
            L +LH    + +RD+KP+N+L+
Sbjct: 301 GLEHLHQ-RNIIYRDLKPENVLL 322

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 81.5 bits (202), Expect = 2e-18
 Identities = 17/141 (12%), Positives = 50/141 (35%), Gaps = 19/141 (13%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSL 195
              +     G +++ +    G+ + +K +          R  N E   +R+ +HPNV+ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT--YQICRALN 252
                        +  L+  ++   ++Y    +      +  +   Q       + R + 
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLY----NVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 253 YLH-HVVGVCHRDIKPQNLLM 272
           +LH     +    +  +++++
Sbjct: 126 FLHTLEPLIPRHALNSRSVMI 146

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 82.2 bits (203), Expect = 3e-18
 Identities = 32/138 (23%), Positives = 62/138 (44%), Gaps = 21/138 (15%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQIMRLLNHPNVVSLKHC 198
            +G G+ GVVF+     +G  +A K +   ++        RELQ++   N P +V     
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 199 FFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           F+S  E     +++ +E++     + V + +         +P   +   +  + + L YL
Sbjct: 100 FYSDGE-----ISICMEHMDGGSLDQVLKKAGR-------IPEQILGKVSIAVIKGLTYL 147

Query: 255 HHVVGVCHRDIKPQNLLM 272
                + HRD+KP N+L+
Sbjct: 148 REKHKIMHRDVKPSNILV 165

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 83.4 bits (206), Expect = 3e-18
 Identities = 45/246 (18%), Positives = 94/246 (38%), Gaps = 32/246 (13%)

Query: 41  EANLVERSASSLEQHMASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVN 100
           E   +  S    + ++    L      S++A           Q+P ++ +  I +     
Sbjct: 98  EEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQ-- 155

Query: 101 HDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCL 159
               +L   +                         T++ +   R++G G FG V+  +  
Sbjct: 156 ----NLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKA 211

Query: 160 ETGDSVAIKKVLQDKRYKNRE-----------LQIMRLLNHPNVVSLKHCFFSTTEKDEL 208
           +TG   A+ K L  KR K ++           L ++   + P +V + + F +    D+L
Sbjct: 212 DTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---PDKL 267

Query: 209 YLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266
               +L+ ++  +  Y +S+H            ++ Y  +I   L ++H+   V +RD+K
Sbjct: 268 S--FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLK 319

Query: 267 PQNLLM 272
           P N+L+
Sbjct: 320 PANILL 325

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 81.8 bits (202), Expect = 8e-18
 Identities = 46/141 (32%), Positives = 65/141 (46%), Gaps = 22/141 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
           RV+G G FG V   +   TG   A  K L+ KR K R        E QI+  +N   VVS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYAC-KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHV-PILYVQLYTYQICRAL 251
           L + + +   KD L   LVL  ++  +  +    H   M Q   P      Y  +IC  L
Sbjct: 249 LAYAYET---KDALC--LVLTLMNGGDLKF----HIYHMGQAGFPEARAVFYAAEICCGL 299

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
             LH    + +RD+KP+N+L+
Sbjct: 300 EDLHR-ERIVYRDLKPENILL 319

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.8 bits (195), Expect = 4e-17
 Identities = 36/139 (25%), Positives = 66/139 (47%), Gaps = 20/139 (14%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPNVVSL 195
           +++G G+FG V   +   TG   A+K      ++      +   E ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           K+  F T ++  L    V+EY +  E  + +S+      +       + Y  +I  AL Y
Sbjct: 71  KYA-FQTHDR--LC--FVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEY 120

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH    V +RDIK +NL++
Sbjct: 121 LHS-RDVVYRDIKLENLML 138

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 78.2 bits (193), Expect = 5e-17
 Identities = 31/143 (21%), Positives = 60/143 (41%), Gaps = 21/143 (14%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNVVS-LKH 197
              VG G +G V++      G++VA+K    +D++   RE ++    +L H N++  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
              S     +L+L  +  Y    ++Y   +  T     +  +        I   L +LH 
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHI 123

Query: 256 ------HVVGVCHRDIKPQNLLM 272
                     + HRD+K +N+L+
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILV 146

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 78.0 bits (193), Expect = 5e-17
 Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 31/161 (19%)

Query: 122 IATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------- 173
           I   +  R         Y     +G G    V+ A+       VAIK  +          
Sbjct: 5   IGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEET 54

Query: 174 -KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRM 231
            KR++ RE+     L+H N+VS+        E+D+ Y  LV+EYI   T+      Y   
Sbjct: 55  LKRFE-REVHNSSQLSHQNIVSM----IDVDEEDDCYY-LVMEYIEGPTL----SEYIES 104

Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +  + +     +T QI   + + H +  + HRDIKPQN+L+
Sbjct: 105 HGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILI 144

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 78.4 bits (193), Expect = 6e-17
 Identities = 34/191 (17%), Positives = 64/191 (33%), Gaps = 58/191 (30%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           +   + +G G FGVVF+AK      + AIK++    R        RE++ +  L HP +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 194 SLKHCFF------------------------STTEKDELYLNLVLEYISETVYRVSKHYT 229
              + +                          ++       ++ +  +     + +    
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 230 RMNQHVPILYVQL----------------------------YTYQICRALNYLHHVVGVC 261
           + +     LY+Q+                               QI  A+ +LH   G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS-KGLM 186

Query: 262 HRDIKPQNLLM 272
           HRD+KP N+  
Sbjct: 187 HRDLKPSNIFF 197

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 78.5 bits (194), Expect = 6e-17
 Identities = 40/190 (21%), Positives = 75/190 (39%), Gaps = 41/190 (21%)

Query: 94  RDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVV 153
           R+      DD+ +  S   G            +            ++  R +G G+FG V
Sbjct: 11  RENLYFQGDDEIVHFSWKKG----------MLLNNA---------FLVIRKMGDGTFGRV 51

Query: 154 FQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH-----PNVVSLKHCFFSTTEK 205
              + ++     A+K V   K+Y      E  I++ + +      N+V     F      
Sbjct: 52  LLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF------ 105

Query: 206 DELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCH 262
             +Y +   L+ E +  ++Y +            I  ++LY  +I +ALNYL   + + H
Sbjct: 106 --MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK-MSLTH 160

Query: 263 RDIKPQNLLM 272
            D+KP+N+L+
Sbjct: 161 TDLKPENILL 170

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 78.6 bits (194), Expect = 7e-17
 Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 23/146 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH------ 189
           Y   +V+G GSFG V +A   +    VA+K V  +KR+      E++I+  L        
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 190 PNVVSLKHCFFSTTEKDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
            NV+ +   F         + N   +  E +S  +Y + K      Q   +  V+ + + 
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKK--NKFQGFSLPLVRKFAHS 208

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           I + L+ LH    + H D+KP+N+L+
Sbjct: 209 ILQCLDALHK-NRIIHCDLKPENILL 233

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 77.8 bits (192), Expect = 8e-17
 Identities = 30/139 (21%), Positives = 57/139 (41%), Gaps = 21/139 (15%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
             ++G G FG V+  +    G+ VAI+ +  ++  ++      RE+   R   H NVV  
Sbjct: 38  GELIGKGRFGQVYHGRWH--GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 196 K-HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
              C         L   ++       T+Y V +        + +   +    +I + + Y
Sbjct: 95  MGAC----MSPPHLA--IITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH   G+ H+D+K +N+  
Sbjct: 146 LHA-KGILHKDLKSKNVFY 163

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 77.2 bits (191), Expect = 1e-16
 Identities = 43/141 (30%), Positives = 73/141 (51%), Gaps = 22/141 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSV---AIK-----KVLQDKRYKNR-ELQIMRLLNHPNVV 193
           +V+G GSFG VF  K +   D+    A+K      +    R + + E  I+  +NHP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            L +  F T  K  LY  L+L+++   +   R+SK             V+ Y  ++  AL
Sbjct: 90  KLHYA-FQTEGK--LY--LILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALAL 139

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           ++LH  +G+ +RD+KP+N+L+
Sbjct: 140 DHLHS-LGIIYRDLKPENILL 159

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 77.7 bits (192), Expect = 1e-16
 Identities = 39/140 (27%), Positives = 67/140 (47%), Gaps = 21/140 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKR--YKNRELQIMRL-LNHPNVVS 194
           RV+G GS+  V   +  +T    A+K      V  D+   +   E  +     NHP +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L  C F T  +  L+   V+EY++  + ++ + +      +H      + Y+ +I  ALN
Sbjct: 75  LHSC-FQTESR--LF--FVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALN 124

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH   G+ +RD+K  N+L+
Sbjct: 125 YLHE-RGIIYRDLKLDNVLL 143

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 77.1 bits (190), Expect = 1e-16
 Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 21/143 (14%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNVVS-LKH 197
            + +G G +G V+  K    G+ VA+K     ++    RE +I    L+ H N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
               T    +LYL  + +Y    ++Y   K  T     +    +    Y     L +LH 
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHT 152

Query: 256 ------HVVGVCHRDIKPQNLLM 272
                     + HRD+K +N+L+
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILV 175

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 77.2 bits (190), Expect = 1e-16
 Identities = 30/143 (20%), Positives = 56/143 (39%), Gaps = 19/143 (13%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNRELQIMRL--LNHPNVVSLKHC 198
             ++G G +G V++         VA+K     +++    E  I R+  + H N+      
Sbjct: 18  LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLYTYQICRALNYLH-- 255
               T    +   LV+EY        S   Y  ++    +   +L  + + R L YLH  
Sbjct: 76  DERVTADGRMEYLLVMEYYP----NGSLXKYLSLHTSDWVSSCRL-AHSVTRGLAYLHTE 130

Query: 256 ------HVVGVCHRDIKPQNLLM 272
                 +   + HRD+  +N+L+
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLV 153

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 77.4 bits (191), Expect = 2e-16
 Identities = 46/192 (23%), Positives = 81/192 (42%), Gaps = 42/192 (21%)

Query: 94  RDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVV 153
           R   N  +DD + +  + NG               R         Y  + ++G GSFG V
Sbjct: 30  RKVYNDGYDDDNYDYIVKNG----------EKWMDR---------YEIDSLIGKGSFGQV 70

Query: 154 FQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHP------NVVSLKHCFFSTTE 204
            +A      + VAIK +   K + N    E++++ L+N         +V LK  F     
Sbjct: 71  VKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM---- 126

Query: 205 KDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGV 260
               + N   LV E +S  +Y + ++     + V +   + +  Q+C AL +L    + +
Sbjct: 127 ----FRNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSI 180

Query: 261 CHRDIKPQNLLM 272
            H D+KP+N+L+
Sbjct: 181 IHCDLKPENILL 192

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 77.0 bits (190), Expect = 2e-16
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 21/140 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKR--YKNRELQIMRL-LNHPNVVS 194
           RV+G GS+  V   +  +T    A++      V  D+   +   E  +     NHP +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L  C F T  +  L+   V+EY++  + ++ + +      +H      + Y+ +I  ALN
Sbjct: 118 LHSC-FQTESR--LF--FVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALN 167

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YLH   G+ +RD+K  N+L+
Sbjct: 168 YLHE-RGIIYRDLKLDNVLL 186

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.5 bits (189), Expect = 3e-16
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 22/177 (12%)

Query: 107 EPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSV 165
           EP ++N N             G +  P    S +   +V+G GSFG V  A+        
Sbjct: 7   EPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFY 66

Query: 166 AIK-----KVLQDK--RYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217
           A+K      +L+ K  ++   E  ++ + + HP +V L    F T +K  LY   VL+YI
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS-FQTADK--LY--FVLDYI 121

Query: 218 S--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +  E  Y + +      +       + Y  +I  AL YLH  + + +RD+KP+N+L+
Sbjct: 122 NGGELFYHLQRE-RCFLEPR----ARFYAAEIASALGYLHS-LNIVYRDLKPENILL 172

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 75.7 bits (187), Expect = 5e-16
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 24/143 (16%)

Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----KVLQDKRYKNR---ELQIMRLLNHPN 191
           RV+G G +G VFQ + +    TG   A+K      ++++ +       E  I+  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           +V L +  F T  K  LY  L+LEY+S  E   ++ +      +         Y  +I  
Sbjct: 83  IVDLIYA-FQTGGK--LY--LILEYLSGGELFMQLERE-GIFMEDT----ACFYLAEISM 132

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           AL +LH   G+ +RD+KP+N+++
Sbjct: 133 ALGHLHQ-KGIIYRDLKPENIML 154

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 75.6 bits (186), Expect = 5e-16
 Identities = 33/143 (23%), Positives = 61/143 (42%), Gaps = 21/143 (14%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNVVS-LKH 197
           +  +G G FG V++ K    G+ VA+K    +++R   RE +I    +L H N++  +  
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
                    +L+L  V +Y    +++     YT     V +  +          L +LH 
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 157

Query: 256 ------HVVGVCHRDIKPQNLLM 272
                     + HRD+K +N+L+
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILV 180

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 44/140 (31%), Positives = 71/140 (50%), Gaps = 21/140 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL-LNHPNVVS 194
           RV+G GSFG V  A+  ETGD  A+K      +LQD   +    E +I+ L  NHP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L  C F T ++  L+   V+E+++  + ++ + K              + Y  +I  AL 
Sbjct: 89  LFCC-FQTPDR--LF--FVMEFVNGGDLMFHIQKSRRFDEAR-----ARFYAAEIISALM 138

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +LH   G+ +RD+K  N+L+
Sbjct: 139 FLHD-KGIIYRDLKLDNVLL 157

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 35/159 (22%), Positives = 67/159 (42%), Gaps = 29/159 (18%)

Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQD-------KR 175
             V G+         Y  +  +  G  G ++ A      G  V +K  L           
Sbjct: 76  DIVAGQ---------YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAM 125

Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN-LVLEYIS-ETVYRVSKHYTRMNQ 233
               E Q +  + HP++V +   F   T++    +  +V+EY+  +++ R         Q
Sbjct: 126 AM-AERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKR------SKGQ 177

Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            +P+     Y  +I  AL+YLH + G+ + D+KP+N+++
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIML 215

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 73.9 bits (182), Expect = 2e-15
 Identities = 33/147 (22%), Positives = 60/147 (40%), Gaps = 24/147 (16%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN---RELQIMRLLNHP---- 190
           Y     +G G+FG V +      G S VA+K +    +Y+     E+ +++ +       
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 191 --NVVSLKHCFFSTTEKDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
               V +   F         +     +  E + +  +   K      Q  P+ +V+   Y
Sbjct: 81  KFLCVLMSDWF--------NFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAY 130

Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+C AL +LH    + H D+KP+N+L 
Sbjct: 131 QLCHALRFLHE-NQLTHTDLKPENILF 156

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.8 bits (182), Expect = 2e-15
 Identities = 36/140 (25%), Positives = 64/140 (45%), Gaps = 21/140 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL-LNHPNVVS 194
            V+G GSFG V  ++   T +  A+K      V+QD   +    E +++ L    P +  
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L  C F T ++  LY   V+EY++  + +Y + +       H        Y  +I   L 
Sbjct: 86  LHSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLF 135

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +L    G+ +RD+K  N+++
Sbjct: 136 FLQS-KGIIYRDLKLDNVML 154

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.4 bits (181), Expect = 3e-15
 Identities = 38/140 (27%), Positives = 64/140 (45%), Gaps = 21/140 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL-LNHPNVVS 194
           +++G GSFG VF A+  +T    AIK      VL D   +    E +++ L   HP +  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           +    F T E   L+   V+EY++  + +Y +            +     Y  +I   L 
Sbjct: 83  MFCT-FQTKEN--LF--FVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQ 132

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +LH   G+ +RD+K  N+L+
Sbjct: 133 FLHS-KGIVYRDLKLDNILL 151

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 72.7 bits (179), Expect = 3e-15
 Identities = 31/138 (22%), Positives = 58/138 (42%), Gaps = 20/138 (14%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
            + +G+GSFG V++ K    GD VA+K +               E+ ++R   H N++  
Sbjct: 29  GQRIGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
              F   +   +L   +V ++    ++Y    H         +  +     Q  R ++YL
Sbjct: 85  ---FMGYSTAPQLA--IVTQWCEGSSLYH---HLHASETKFEMKKLIDIARQTARGMDYL 136

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    + HRD+K  N+ +
Sbjct: 137 HA-KSIIHRDLKSNNIFL 153

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 73.1 bits (180), Expect = 3e-15
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 24/147 (16%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGD-SVAIKKVLQDKRYKN---RELQIMRLLNHP---- 190
           Y     +G G+FG V +    + G   VA+K V    RY      E+Q++  LN      
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 191 --NVVSLKHCFFSTTEKDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
               V +   F         +     +V E +  + Y   K          + +++   Y
Sbjct: 76  TFRCVQMLEWFE--------HHGHICIVFELLGLSTYDFIKENGF--LPFRLDHIRKMAY 125

Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           QIC+++N+LH    + H D+KP+N+L 
Sbjct: 126 QICKSVNFLHS-NKLTHTDLKPENILF 151

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 72.7 bits (179), Expect = 5e-15
 Identities = 39/163 (23%), Positives = 65/163 (39%), Gaps = 31/163 (19%)

Query: 122 IATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDKRY 176
             + +  R         Y    ++G G    V  A+ L     VA+K VL     +D  +
Sbjct: 6   TPSHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSF 55

Query: 177 KNR---ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN---LVLEYIS-ETVYRVSKHYT 229
             R   E Q    LNHP +V++    + T E +        +V+EY+   T+    +   
Sbjct: 56  YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIV 107

Query: 230 RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
                +            C+ALN+ H   G+ HRD+KP N+++
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMI 149

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 71.9 bits (177), Expect = 7e-15
 Identities = 35/143 (24%), Positives = 57/143 (39%), Gaps = 20/143 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDKRYK---NRELQIMRLLNHP 190
           Y   R+VG G  G V++A+       VA+K ++      D  ++    RE +    L  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           +VV +        E D     + +  I+   +        R    +          QI  
Sbjct: 95  HVVPI----HDFGEIDGQLY-VDMRLINGVDL----AAMLRRQGPLAPPRAVAIVRQIGS 145

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
           AL+  H   G  HRD+KP+N+L+
Sbjct: 146 ALDAAHAA-GATHRDVKPENILV 167

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 36/140 (25%), Positives = 64/140 (45%), Gaps = 21/140 (15%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLN-HPNVVS 194
            V+G GSFG V  ++   T +  A+K      V+QD        E +++ L    P +  
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           L  C F T ++  LY   V+EY++  + +Y + +   R  +         Y  +I   L 
Sbjct: 407 LHSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQV-GRFKEPH----AVFYAAEIAIGLF 456

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           +L    G+ +RD+K  N+++
Sbjct: 457 FLQS-KGIIYRDLKLDNVML 475

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 70.8 bits (174), Expect = 2e-14
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 25/144 (17%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSV---AIK-----KVLQDKRYKNR---ELQIMRLLNH-P 190
           +V+GTG++G VF  + +   D+    A+K      ++Q  +       E Q++  +   P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
            +V+L +  F T  K  L+  L+L+YI+  E    +S+      +      VQ+Y  +I 
Sbjct: 120 FLVTLHYA-FQTETK--LH--LILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIV 169

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
            AL +LH  +G+ +RDIK +N+L+
Sbjct: 170 LALEHLHK-LGIIYRDIKLENILL 192

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 69.7 bits (171), Expect = 5e-14
 Identities = 31/151 (20%), Positives = 63/151 (41%), Gaps = 23/151 (15%)

Query: 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNV 192
           ++      V   G FG V++A+     + VA+K    QDK+    E ++  +  + H N+
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 193 VS-LKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           +  +      T+   +L+  L+  +  + ++      + + N         +    + R 
Sbjct: 81  LQFIGAEKRGTSVDVDLW--LITAFHEKGSLS----DFLKANVVSWNELCHIA-ETMARG 133

Query: 251 LNYLHHVV---------GVCHRDIKPQNLLM 272
           L YLH  +          + HRDIK +N+L+
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 36/145 (24%), Positives = 66/145 (45%), Gaps = 14/145 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLL-----NHP 190
           Y   R +G G F  V+ +  ++    VA+K V   + Y      E+++++ +     N P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 191 N---VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           N   VV L   F  +      ++ +V E +   + +         Q +P+  V+    Q+
Sbjct: 99  NREMVVQLLDDFKISGVNGT-HICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 248 CRALNYLHHVVGVCHRDIKPQNLLM 272
            + L+YLH    + H DIKP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILL 180

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.3 bits (157), Expect = 3e-12
 Identities = 31/137 (22%), Positives = 61/137 (44%), Gaps = 12/137 (8%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNH-PNVVSL 195
           Y   R +G+GSFG ++    +  G+ VAIK      ++     E +I +++     + ++
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           + C       +  Y  +V+E +  +   +   +   ++   +  V L   Q+   + Y+H
Sbjct: 71  RWCG-----AEGDYNVMVMELLGPS---LEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 256 HVVGVCHRDIKPQNLLM 272
                 HRD+KP N LM
Sbjct: 123 S-KNFIHRDVKPDNFLM 138

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 63.9 bits (156), Expect = 6e-12
 Identities = 27/137 (19%), Positives = 58/137 (42%), Gaps = 12/137 (8%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYKNRELQIMRLL-NHPNVVSL 195
           +   + +G G+FG +   K L T + VAIK   +       + E +  + L +   +  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
            +           Y  +VLE +  +   +   +   ++   +  V +   Q+   + Y+H
Sbjct: 71  YYFG-----PCGKYNAMVLELLGPS---LEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 256 HVVGVCHRDIKPQNLLM 272
               + +RD+KP+N L+
Sbjct: 123 S-KNLIYRDVKPENFLI 138

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.1 bits (154), Expect = 8e-12
 Identities = 30/137 (21%), Positives = 57/137 (41%), Gaps = 12/137 (8%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLL-NHPNVVSL 195
           Y   R +G GSFGV+F+   L     VAIK   +         E +  +LL     + ++
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
            +       ++ L+  LV++ +  +   +        +   +  V +   Q+   +  +H
Sbjct: 72  YYFG-----QEGLHNVLVIDLLGPS---LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 256 HVVGVCHRDIKPQNLLM 272
               + +RDIKP N L+
Sbjct: 124 E-KSLVYRDIKPDNFLI 139

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 62.6 bits (153), Expect = 1e-11
 Identities = 38/140 (27%), Positives = 59/140 (42%), Gaps = 26/140 (18%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
            + +G G FG V        G+ VA+K +  D   +    E  +M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 200 FSTTEKDELYLNLVLEYISETVYRVSK----HYTRMNQHVPILYVQL--YTYQICRALNY 253
               EK  LY  +V EY       ++K     Y R      +    L  ++  +C A+ Y
Sbjct: 83  -IVEEKGGLY--IVTEY-------MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132

Query: 254 L--HHVVGVCHRDIKPQNLL 271
           L  ++ V   HRD+  +N+L
Sbjct: 133 LEGNNFV---HRDLAARNVL 149

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 62.5 bits (152), Expect = 1e-11
 Identities = 22/158 (13%), Positives = 38/158 (24%), Gaps = 29/158 (18%)

Query: 123 ATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKN 178
           A    GR         Y      G       +QA        VA+  V            
Sbjct: 26  ARIANGR---------YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQ 76

Query: 179 R---ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQH 234
                   +  ++ P V  +              L +V E+I   ++  V       +  
Sbjct: 77  ETLSRTLRLSRIDKPGVARV----LDVVHTRAGGL-VVAEWIRGGSLQEV------ADTS 125

Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
              +        +  A +  H   GV      P  + +
Sbjct: 126 PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRV 162

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 62.4 bits (152), Expect = 2e-11
 Identities = 38/141 (26%), Positives = 63/141 (44%), Gaps = 21/141 (14%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
            R +G G FG V       T D     VA+K +  D   ++     +E+ I+R L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           +  K C     +     L LV+EY+        + Y   +  + +  + L+  QIC  + 
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRHS-IGLAQLLLFAQQICEGMA 148

Query: 253 YLH--HVVGVCHRDIKPQNLL 271
           YLH  H +   HRD+  +N+L
Sbjct: 149 YLHAQHYI---HRDLAARNVL 166

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 62.4 bits (152), Expect = 2e-11
 Identities = 37/136 (27%), Positives = 58/136 (42%), Gaps = 18/136 (13%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
            + +G G FG V        G+ VA+K +  D   +    E  +M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL--H 255
               EK  LY  +V EY++         Y R      +    L  ++  +C A+ YL  +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 256 HVVGVCHRDIKPQNLL 271
           + V   HRD+  +N+L
Sbjct: 309 NFV---HRDLAARNVL 321

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 61.6 bits (150), Expect = 3e-11
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 23/143 (16%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
            R +G G FG V   +    GD+    VA+K +  +    +     +E++I+R L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
           V  K      TE     + L++E++        K Y   N++  I   Q   Y  QIC+ 
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKN-KINLKQQLKYAVQICKG 138

Query: 251 LNYL--HHVVGVCHRDIKPQNLL 271
           ++YL     V   HRD+  +N+L
Sbjct: 139 MDYLGSRQYV---HRDLAARNVL 158

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 61.2 bits (149), Expect = 4e-11
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 24/143 (16%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
            + +G G+FG V   +     D+    VA+KK LQ    ++     RE++I++ L H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
           V  K             L L++EY+    Y   + Y + ++   I +++L  YT QIC+ 
Sbjct: 74  VKYKGV---CYSAGRRNLKLIMEYLP---YGSLRDYLQKHKE-RIDHIKLLQYTSQICKG 126

Query: 251 LNYL--HHVVGVCHRDIKPQNLL 271
           + YL     +   HRD+  +N+L
Sbjct: 127 MEYLGTKRYI---HRDLATRNIL 146

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 61.7 bits (150), Expect = 4e-11
 Identities = 32/137 (23%), Positives = 60/137 (43%), Gaps = 18/137 (13%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
           +  +G G +G V++    +   +VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
               T +   Y  ++ E+++   Y     Y R      +  V L     QI  A+ YL  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 255 HHVVGVCHRDIKPQNLL 271
            + +   HR++  +N L
Sbjct: 337 KNFI---HRNLAARNCL 350

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 60.7 bits (148), Expect = 5e-11
 Identities = 32/135 (23%), Positives = 55/135 (40%), Gaps = 21/135 (15%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN---RELQIMRLLNHPNVV 193
             V+G G FG V+    L+        A+K    + D    +    E  IM+  +HPNV+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
           SL         +      +VL Y+    +   +++ R   H P +   + +  Q+ + + 
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142

Query: 253 YL--HHVVGVCHRDI 265
           YL     V   HRD+
Sbjct: 143 YLASKKFV---HRDL 154

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 61.1 bits (149), Expect = 5e-11
 Identities = 32/142 (22%), Positives = 65/142 (45%), Gaps = 24/142 (16%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
            +V+G+G+FG V++   +  G+     VAIK++ +    K       E  +M  +++P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
             L            +   L+ + +    +     Y R ++ ++   Y+  +  QI + +
Sbjct: 80  CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 252 NYL--HHVVGVCHRDIKPQNLL 271
           NYL    +V   HRD+  +N+L
Sbjct: 131 NYLEDRRLV---HRDLAARNVL 149

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 60.8 bits (148), Expect = 7e-11
 Identities = 28/142 (19%), Positives = 54/142 (38%), Gaps = 24/142 (16%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
            R++G G FG V +A+  +   S   VA+K +  D    +      RE   M+  +HP+V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 193 VSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV----PILYVQL--YTY 245
             L      S  +       ++L ++    +     +   ++       +    L  +  
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMK---HGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 246 QICRALNYL--HHVVGVCHRDI 265
            I   + YL   + +   HRD+
Sbjct: 145 DIACGMEYLSSRNFI---HRDL 163

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 60.5 bits (147), Expect = 9e-11
 Identities = 31/135 (22%), Positives = 55/135 (40%), Gaps = 21/135 (15%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN---RELQIMRLLNHPNVV 193
             V+G G FG V+    L+        A+K    + D    +    E  IM+  +HPNV+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
           SL         +      +VL Y+    +   +++ R   H P +   + +  Q+ + + 
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206

Query: 253 YL--HHVVGVCHRDI 265
           +L     V   HRD+
Sbjct: 207 FLASKKFV---HRDL 218

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 30/137 (21%), Positives = 62/137 (45%), Gaps = 12/137 (8%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLN-HPNVVSL 195
           +   R +G+GSFG ++    ++T + VAIK      ++     E +I R+L     + ++
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +         +  Y  LV++ +  +   +   +   ++ + +  V +   Q+   + ++H
Sbjct: 69  RWFG-----VEGDYNVLVMDLLGPS---LEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 256 HVVGVCHRDIKPQNLLM 272
                 HRDIKP N LM
Sbjct: 121 S-KSFLHRDIKPDNFLM 136

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 60.0 bits (146), Expect = 1e-10
 Identities = 32/142 (22%), Positives = 60/142 (42%), Gaps = 22/142 (15%)

Query: 140 MAERVVGTGSFGVVFQAKCLETGDS--VAIKKV---LQDKRYKN---RELQIMRLLNHPN 191
           + ++ +G+G+FG V +           VA+K +     D   K+    E  +M+ L++P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           +V +        E +     LV+E            Y + N+HV    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 252 NYL--HHVVGVCHRDIKPQNLL 271
            YL   + V   HRD+  +N+L
Sbjct: 131 KYLEESNFV---HRDLAARNVL 149

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 59.6 bits (145), Expect = 1e-10
 Identities = 33/137 (24%), Positives = 60/137 (43%), Gaps = 18/137 (13%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
           +  +G G +G V++    +   +VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
               T +   Y  ++ E+++   Y     Y R      +  V L     QI  A+ YL  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 255 HHVVGVCHRDIKPQNLL 271
            + +   HRD+  +N L
Sbjct: 130 KNFI---HRDLAARNCL 143

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 59.6 bits (145), Expect = 1e-10
 Identities = 28/140 (20%), Positives = 52/140 (37%), Gaps = 21/140 (15%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
            +++G G FG V +    +   +   VA+K +  D   +        E   M+  +HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQL-YTYQI 247
           + L       + +      ++L ++      T    S+  T        L   L +   I
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET--GPKHIPLQTLLKFMVDI 156

Query: 248 CRALNYL--HHVVGVCHRDI 265
              + YL   + +   HRD+
Sbjct: 157 ALGMEYLSNRNFL---HRDL 173

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 59.7 bits (145), Expect = 1e-10
 Identities = 37/142 (26%), Positives = 68/142 (47%), Gaps = 22/142 (15%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIK--KVLQDKRYKN--RELQIMRLLNHPNVV 193
            + +G G+FG V   +     D+    VA+K  +   ++  ++  RE++I++ L H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRAL 251
             K             L L++EY+     R    Y + ++   I +++L  YT QIC+ +
Sbjct: 106 KYKGV---CYSAGRRNLKLIMEYLPYGSLR---DYLQKHKE-RIDHIKLLQYTSQICKGM 158

Query: 252 NYL--HHVVGVCHRDIKPQNLL 271
            YL     +   HRD+  +N+L
Sbjct: 159 EYLGTKRYI---HRDLATRNIL 177

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 37/151 (24%), Positives = 67/151 (44%), Gaps = 23/151 (15%)

Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN---RELQIM 184
           P + +   ++RV+G G FGVV+  + ++   +    AIK    + + +      RE  +M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76

Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL- 242
           R LNHPNV++L         +   +  ++L Y+           + R  Q  P +   + 
Sbjct: 77  RGLNHPNVLALIGI--MLPPEGLPH--VLLPYMC----HGDLLQFIRSPQRNPTVKDLIS 128

Query: 243 YTYQICRALNYL--HHVVGVCHRDIKPQNLL 271
           +  Q+ R + YL     V   HRD+  +N +
Sbjct: 129 FGLQVARGMEYLAEQKFV---HRDLAARNCM 156

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 31/141 (21%), Positives = 53/141 (37%), Gaps = 25/141 (17%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVSLK 196
              +G G+FG VF  +       VA+K   +      +     E +I++  +HPN+V L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 197 H--CFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL-YTYQICRALN 252
              C    T+K  +Y  +V+E +           + R       +   L         + 
Sbjct: 178 IGVC----TQKQPIY--IVMELVQGG----DFLTFLRTEGARLRVKTLLQMVGDAAAGME 227

Query: 253 YLH--HVVGVCHRDIKPQNLL 271
           YL     +   HRD+  +N L
Sbjct: 228 YLESKCCI---HRDLAARNCL 245

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 59.3 bits (144), Expect = 2e-10
 Identities = 36/142 (25%), Positives = 64/142 (45%), Gaps = 22/142 (15%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
              +G G+FG V   +    GD+    VA+K  LQ           RE+QI++ L+   +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
           V  +   +    +  L   LV+EY+        + + + ++  +    + LY+ QIC+ +
Sbjct: 87  VKYRGVSYGPGRQS-LR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 252 NYL--HHVVGVCHRDIKPQNLL 271
            YL     V   HRD+  +N+L
Sbjct: 141 EYLGSRRCV---HRDLAARNIL 159

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 58.4 bits (142), Expect = 2e-10
 Identities = 34/137 (24%), Positives = 57/137 (41%), Gaps = 20/137 (14%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKH- 197
            + +G+G FG+V     L     VAIK + +    +     E ++M  L+HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY-TYQICRALNYL-- 254
           C     E+  +   LV E++    +     Y R  + +      L     +C  + YL  
Sbjct: 72  C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 255 HHVVGVCHRDIKPQNLL 271
             V+   HRD+  +N L
Sbjct: 123 ACVI---HRDLAARNCL 136

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 58.2 bits (141), Expect = 5e-10
 Identities = 29/172 (16%), Positives = 59/172 (34%), Gaps = 31/172 (18%)

Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK 177
            G+V+    G +         ++  + +G+G FG+++ A      +  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 178 N---RELQIMRLLNHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYISET 220
                EL+  + +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 221 VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +    +  +  N       V     ++   L Y+H      H DIK  NLL+
Sbjct: 138 L----QKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLL 184

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 57.3 bits (139), Expect = 6e-10
 Identities = 29/145 (20%), Positives = 60/145 (41%), Gaps = 27/145 (18%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS-------VAIKKVLQDKRYKN----RELQIMRLLNHP 190
              +G G+F  +F+    E GD        V +K + +  R  +        +M  L+H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 191 NVVSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQIC 248
           ++V     C       DE    LV E++    +     Y + N++   +  +L    Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 249 RALNYL--HHVVGVCHRDIKPQNLL 271
            A+++L  + ++   H ++  +N+L
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNIL 145

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 58.2 bits (141), Expect = 7e-10
 Identities = 27/137 (19%), Positives = 59/137 (43%), Gaps = 20/137 (14%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
           E+ +G G FG V+ A   +    VA+K +            E  +M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
             +   K+ +Y  ++ E+++         + + ++       +L  ++ QI   + ++  
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 255 HHVVGVCHRDIKPQNLL 271
            + +   HRD++  N+L
Sbjct: 303 RNYI---HRDLRAANIL 316

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 57.2 bits (139), Expect = 7e-10
 Identities = 36/137 (26%), Positives = 61/137 (44%), Gaps = 20/137 (14%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKH- 197
            + +GTG FGVV   K     D VAIK + +    ++    E ++M  L+H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY-TYQICRALNYL-- 254
           C    T++  ++  ++ EY++        +Y R  +H       L     +C A+ YL  
Sbjct: 88  C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138

Query: 255 HHVVGVCHRDIKPQNLL 271
              +   HRD+  +N L
Sbjct: 139 KQFL---HRDLAARNCL 152

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 57.7 bits (140), Expect = 7e-10
 Identities = 31/142 (21%), Positives = 53/142 (37%), Gaps = 24/142 (16%)

Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
           E+++G+G  G V   +    G     VAIK +      + R     E  IM   +HPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 194 SLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRAL 251
            L+       T        +V EY+          + R +     +   +     +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164

Query: 252 NYL--HHVVGVCHRDIKPQNLL 271
            YL     V   HRD+  +N+L
Sbjct: 165 RYLSDLGYV---HRDLAARNVL 183

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 57.2 bits (139), Expect = 8e-10
 Identities = 27/138 (19%), Positives = 56/138 (40%), Gaps = 22/138 (15%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
              +G G FG V+          VA+K + Q     +    E  +M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRALNYL- 254
            ++   ++ +Y  ++ EY+       S   + +    + +   +L     QI   + ++ 
Sbjct: 74  -YAVVTQEPIY--IITEYMENG----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 255 -HHVVGVCHRDIKPQNLL 271
             + +   HRD++  N+L
Sbjct: 127 ERNYI---HRDLRAANIL 141

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 57.6 bits (138), Expect = 8e-10
 Identities = 27/170 (15%), Positives = 49/170 (28%), Gaps = 44/170 (25%)

Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----------RELQIMRLL----- 187
           +G G FG VFQ         VAIK + ++     N            E+ I + L     
Sbjct: 28  IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 188 ----NHPNVVSLKHCFFSTTEKDELYLNLVLEYISE--------TVYRVSKHYTRM---- 231
                    + L            L L     Y S           ++  + +  +    
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 232 ---------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
                     +   +   +   +Q+  +L      +   HRD+   N+L+
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 56.8 bits (138), Expect = 9e-10
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 22/138 (15%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKH- 197
            + +G+G FGVV   K     D VA+K + +    ++   +E Q M  L+HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLY-TYQICRALNYL- 254
           C    +++  +Y  +V EYIS         +Y R +         L   Y +C  + +L 
Sbjct: 72  C----SKEYPIY--IVTEYIS----NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 255 -HHVVGVCHRDIKPQNLL 271
            H  +   HRD+  +N L
Sbjct: 122 SHQFI---HRDLAARNCL 136

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 57.0 bits (138), Expect = 1e-09
 Identities = 32/142 (22%), Positives = 64/142 (45%), Gaps = 24/142 (16%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
            +V+G+G+FG V++   +  G+     VAIK++ +    K       E  +M  +++P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
             L            +   L+ + +          Y R ++ ++   Y+  +  QI + +
Sbjct: 80  CRL----LGICLTSTVQ--LITQLMPFGCLL---DYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 252 NYL--HHVVGVCHRDIKPQNLL 271
           NYL    +V   HRD+  +N+L
Sbjct: 131 NYLEDRRLV---HRDLAARNVL 149

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 56.8 bits (138), Expect = 1e-09
 Identities = 36/150 (24%), Positives = 62/150 (41%), Gaps = 42/150 (28%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRLLNHPNVVSL-K 196
           + ++G G FG V++   L  G  VA+K+   +          E++ +    HP++VSL  
Sbjct: 44  KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 197 HCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHY------TRMNQHVPILYVQLYTY 245
            C     E++E+ L  + +Y+        +Y             R+              
Sbjct: 103 FC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL-------------- 142

Query: 246 QIC----RALNYLHHVVGVCHRDIKPQNLL 271
           +IC    R L+YLH    + HRD+K  N+L
Sbjct: 143 EICIGAARGLHYLHTR-AIIHRDVKSINIL 171

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 56.6 bits (137), Expect = 2e-09
 Identities = 35/142 (24%), Positives = 55/142 (38%), Gaps = 24/142 (16%)

Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
           ++VVG G FG V   +         SVAIK +      K R     E  IM   +HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 194 SLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRAL 251
            L+       T+   +   +V EY+          + R +     +   +     I   +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 252 NYL--HHVVGVCHRDIKPQNLL 271
            YL     V   HRD+  +N+L
Sbjct: 161 KYLSDMGYV---HRDLAARNIL 179

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 56.1 bits (136), Expect = 2e-09
 Identities = 31/158 (19%), Positives = 61/158 (38%), Gaps = 36/158 (22%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIM-RLLNHP 190
            + +G G+FG V +A       S     VA+K +     L ++     EL+++  L NH 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS-------------ETVYRVSKHYTRMNQHVPI 237
           N+V+L       T        ++ EY                 +   +      +  + +
Sbjct: 88  NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 238 LYVQLYT--YQICRALNYL--HHVVGVCHRDIKPQNLL 271
               L +  YQ+ + + +L   + +   HRD+  +N+L
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNIL 177

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 27/174 (15%), Positives = 52/174 (29%), Gaps = 32/174 (18%)

Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQA-----KCLETGDSVAIKKVLQ 172
            G++I                +     +G G FG ++ A     + + +     +K    
Sbjct: 25  VGEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS 75

Query: 173 DKRYKNRELQIMRLLNHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYIS 218
           D      EL+  +    P  +                        +  + Y  ++++   
Sbjct: 76  DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135

Query: 219 ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             +    K Y    +      V   + +I   L Y+H      H DIK  NLL+
Sbjct: 136 SDL---QKIYEANAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLL 185

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 55.8 bits (135), Expect = 3e-09
 Identities = 30/142 (21%), Positives = 59/142 (41%), Gaps = 24/142 (16%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
            +V+G+G FG V +   +  G+S    V IK +      ++       +  +  L+H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
           V L            L   LV +Y+          + R ++  +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLPLGSLL---DHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 252 NYL--HHVVGVCHRDIKPQNLL 271
            YL  H +V   HR++  +N+L
Sbjct: 129 YYLEEHGMV---HRNLAARNVL 147

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 55.7 bits (135), Expect = 3e-09
 Identities = 39/141 (27%), Positives = 67/141 (47%), Gaps = 23/141 (16%)

Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
            R++G G FG V++           +VA+K   +D    N+     E  IM+ L+HP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
            L        E++  +  +++E      Y    HY   N++   +   + Y+ QIC+A+ 
Sbjct: 77  KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 253 YL--HHVVGVCHRDIKPQNLL 271
           YL   + V   HRDI  +N+L
Sbjct: 128 YLESINCV---HRDIAVRNIL 145

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 55.7 bits (135), Expect = 3e-09
 Identities = 29/157 (18%), Positives = 54/157 (34%), Gaps = 41/157 (26%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
            + +G G FG V +A             VA+K +       + R    E  +++ +NHP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEY-------------------ISETVYRVSKHYTRMN 232
           V+ L       ++   L   L++EY                      +    +       
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 233 QHVPILYVQL--YTYQICRALNYL--HHVVGVCHRDI 265
               +    L  + +QI + + YL    +V   HRD+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLV---HRDL 176

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 56.1 bits (135), Expect = 3e-09
 Identities = 34/142 (23%), Positives = 58/142 (40%), Gaps = 22/142 (15%)

Query: 140 MAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
           +A+  +G G+FG V Q           VAIK + Q     +      E QIM  L++P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
           V L        + + L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449

Query: 252 NYL--HHVVGVCHRDIKPQNLL 271
            YL   + V   HR++  +N+L
Sbjct: 450 KYLEEKNFV---HRNLAARNVL 468

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 55.9 bits (135), Expect = 4e-09
 Identities = 35/138 (25%), Positives = 59/138 (42%), Gaps = 22/138 (15%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
           E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRALNYL- 254
            ++   ++ +Y  +V EY+S+     S   + +      +   QL     QI   + Y+ 
Sbjct: 245 -YAVVSEEPIY--IVTEYMSKG----SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 255 -HHVVGVCHRDIKPQNLL 271
             + V   HRD++  N+L
Sbjct: 298 RMNYV---HRDLRAANIL 312

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 55.0 bits (133), Expect = 5e-09
 Identities = 29/148 (19%), Positives = 57/148 (38%), Gaps = 27/148 (18%)

Query: 143 RVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPNV 192
           R +G GSFG+V++              VAIK V     ++++     E  +M+  N  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQ---LYTY 245
           V L       ++       +++E ++     +  R  +     N  +    +        
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 246 QICRALNYL--HHVVGVCHRDIKPQNLL 271
           +I   + YL  +  V   HRD+  +N +
Sbjct: 146 EIADGMAYLNANKFV---HRDLAARNCM 170

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 55.3 bits (133), Expect = 6e-09
 Identities = 35/138 (25%), Positives = 59/138 (42%), Gaps = 22/138 (15%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
           E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRALNYL- 254
            ++   ++ +Y  +V EY+S+     S   + +      +   QL     QI   + Y+ 
Sbjct: 328 -YAVVSEEPIY--IVTEYMSKG----SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 255 -HHVVGVCHRDIKPQNLL 271
             + V   HRD++  N+L
Sbjct: 381 RMNYV---HRDLRAANIL 395

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 54.5 bits (132), Expect = 7e-09
 Identities = 36/163 (22%), Positives = 60/163 (36%), Gaps = 34/163 (20%)

Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDS-----VAIKKV----LQDKRYKNRELQI 183
            ++ I     R +G G+FG VF A+C     +     VA+K +    L  ++   RE ++
Sbjct: 13  KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----------ETVYRVSKHYTRMN 232
           +  L H ++V          + D L   +V EY+                 +        
Sbjct: 71  LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 233 QHVPILYVQLY--TYQICRALNYL--HHVVGVCHRDIKPQNLL 271
               +   Q+     QI   + YL   H V   HRD+  +N L
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFV---HRDLATRNCL 165

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 30/143 (20%), Positives = 55/143 (38%), Gaps = 25/143 (17%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
           ++V+G G FG V++     +       VAIK +      K R     E  IM   +H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 193 VSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRA 250
           + L+       ++   +   ++ EY+          + R       +   +     I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 251 LNYL--HHVVGVCHRDIKPQNLL 271
           + YL   + V   HRD+  +N+L
Sbjct: 160 MKYLANMNYV---HRDLAARNIL 179

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 53.8 bits (130), Expect = 1e-08
 Identities = 34/147 (23%), Positives = 54/147 (36%), Gaps = 31/147 (21%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV----LQDKRYKNRELQIMRLLNHPNV 192
           +  +G G+FG VF A+C           VA+K +       ++   RE +++ +L H ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYI----------SETVYRVSKHYTRMNQHVPILYVQL 242
           V         TE   L   +V EY+          S                 P+   QL
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 243 --YTYQICRALNYL--HHVVGVCHRDI 265
                Q+   + YL   H V   HRD+
Sbjct: 161 LAVASQVAAGMVYLAGLHFV---HRDL 184

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 53.8 bits (130), Expect = 1e-08
 Identities = 35/142 (24%), Positives = 58/142 (40%), Gaps = 22/142 (15%)

Query: 140 MAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
           +A+  +G G+FG V Q           VAIK + Q     +      E QIM  L++P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
           V L        + + L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 252 NYL--HHVVGVCHRDIKPQNLL 271
            YL   + V   HRD+  +N+L
Sbjct: 124 KYLEEKNFV---HRDLAARNVL 142

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 53.7 bits (130), Expect = 1e-08
 Identities = 32/153 (20%), Positives = 58/153 (37%), Gaps = 44/153 (28%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVSLK 196
           + ++G G FG V++ + L  G  VA+K++ +++          E++++ +  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 197 -HCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHY------TRMNQHVPILYVQLYT 244
             C        E    LV  Y++       +    +         R              
Sbjct: 94  GFC----MTPTERL--LVYPYMANGSVASCLRERPESQPPLDWPKRQR------------ 135

Query: 245 YQIC----RALNYLHHVVGVC--HRDIKPQNLL 271
             I     R L YLH        HRD+K  N+L
Sbjct: 136 --IALGSARGLAYLHDHCDPKIIHRDVKAANIL 166

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 53.5 bits (129), Expect = 1e-08
 Identities = 30/146 (20%), Positives = 58/146 (39%), Gaps = 24/146 (16%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
            R +G G+FG V++ +     +      VA+K +      QD+     E  I+   NH N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           +V        + +    +  +++E ++     +  R ++        + +L +      I
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 248 CRALNYL--HHVVGVCHRDIKPQNLL 271
                YL  +H +   HRDI  +N L
Sbjct: 150 ACGCQYLEENHFI---HRDIAARNCL 172

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 53.6 bits (129), Expect = 2e-08
 Identities = 31/146 (21%), Positives = 58/146 (39%), Gaps = 24/146 (16%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
            R +G G+FG V++ +     +      VA+K +      QD+     E  I+   NH N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQI 247
           +V        + +    +  ++LE ++     +  R ++        + +L +      I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 248 CRALNYL--HHVVGVCHRDIKPQNLL 271
                YL  +H +   HRDI  +N L
Sbjct: 191 ACGCQYLEENHFI---HRDIAARNCL 213

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 53.0 bits (128), Expect = 2e-08
 Identities = 30/149 (20%), Positives = 57/149 (38%), Gaps = 33/149 (22%)

Query: 143 RVVGTGSFGVVFQAKCL-----ETGDSVAIKKV-----LQDKRYKNRELQIM-RLLNHPN 191
           + +G G+FG V +A         T  +VA+K +       + R    EL+I+  + +H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPILYV 240
           VV+L      T     L   +++E+                +   K          +   
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 241 QL--YTYQICRALNYL--HHVVGVCHRDI 265
            L  Y++Q+ + + +L     +   HRD+
Sbjct: 149 HLICYSFQVAKGMEFLASRKCI---HRDL 174

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 53.7 bits (129), Expect = 2e-08
 Identities = 35/142 (24%), Positives = 59/142 (41%), Gaps = 25/142 (17%)

Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
            R +G G FG V Q   +   +   +VAIK          R     E   MR  +HP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRAL 251
            L         ++ ++  +++E  +       + + ++ +   +    L  Y YQ+  AL
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKF-SLDLASLILYAYQLSTAL 504

Query: 252 NYL--HHVVGVCHRDIKPQNLL 271
            YL     V   HRDI  +N+L
Sbjct: 505 AYLESKRFV---HRDIAARNVL 523

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 34/146 (23%), Positives = 60/146 (41%), Gaps = 31/146 (21%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS--VAIKKV-----LQDKRYKNRELQIM-RLLNHPNVV 193
           + V+G G+FG V +A+  + G     AIK++       D R    EL+++ +L +HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 194 SLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPILYVQL 242
           +L         +  LY  L +EY            S  +          +    +   QL
Sbjct: 90  NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 243 --YTYQICRALNYL--HHVVGVCHRD 264
             +   + R ++YL     +   HRD
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRD 167

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 53.1 bits (128), Expect = 3e-08
 Identities = 33/166 (19%), Positives = 54/166 (32%), Gaps = 43/166 (25%)

Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQ 182
           P+  I Y+  R +G G+FG VFQA+            VA+K +        +    RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-------------------ISETVYR 223
           +M   ++PN+V L            +   L+ EY                          
Sbjct: 103 LMAEFDNPNIVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 224 VSKHYTRMNQHVPILYVQL--YTYQICRALNYL--HHVVGVCHRDI 265
            ++         P+   +      Q+   + YL     V   HRD+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDL 200

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 22/175 (12%), Positives = 56/175 (32%), Gaps = 34/175 (19%)

Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDS--------VAIK- 168
            G V+    G +         +  +      + G++++A    T            ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 169 -----------KVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217
                         Q +  K  ++   + L    ++++  C      +D+    LVL  +
Sbjct: 83  DAKDGRLFNEQNFFQ-RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSL 140

Query: 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             ++        +    +    V     ++  AL +LH      H ++  +N+ +
Sbjct: 141 GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFV 192

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 52.7 bits (127), Expect = 3e-08
 Identities = 36/163 (22%), Positives = 63/163 (38%), Gaps = 41/163 (25%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIM-RLLNHP 190
            +V+G+G+FG V  A       +     VA+K +       ++     EL++M +L +H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEY------------------ISETVYRVSKHYTRMN 232
           N+V+L       T    +Y  L+ EY                    E  Y   K      
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 233 QHVPILYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLL 271
               + +  L  + YQ+ + + +L     V   HRD+  +N+L
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVL 204

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 52.2 bits (126), Expect = 4e-08
 Identities = 35/141 (24%), Positives = 60/141 (42%), Gaps = 23/141 (16%)

Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
            R +G G FG V Q   +   +   +VAIK          R     E   MR  +HP++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
            L         ++ ++  +++E  +       + + ++ ++   L   + Y YQ+  AL 
Sbjct: 80  KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 253 YL--HHVVGVCHRDIKPQNLL 271
           YL     V   HRDI  +N+L
Sbjct: 131 YLESKRFV---HRDIAARNVL 148

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 51.9 bits (125), Expect = 7e-08
 Identities = 31/153 (20%), Positives = 59/153 (38%), Gaps = 30/153 (19%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIM-RLLNHP 190
            + +G G+FG V +A     G       VA+K +       +K     EL+IM  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 191 NVVSLKHCFFSTTEKDELYL--------NLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
           N+V+L       T    + +        +L L ++      +         +       L
Sbjct: 111 NIVNLLGA---CTHGGPVLVITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 243 --YTYQICRALNYL--HHVVGVCHRDIKPQNLL 271
             ++ Q+ + + +L   + +   HRD+  +N+L
Sbjct: 167 LHFSSQVAQGMAFLASKNCI---HRDVAARNVL 196

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 51.4 bits (124), Expect = 7e-08
 Identities = 31/149 (20%), Positives = 44/149 (29%), Gaps = 33/149 (22%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
              +G   FG V++              VAIK +        +     E  +   L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS-----------ETVYRVSKHYTRMNQHVPILYV 240
           VV L       T+   L   ++  Y S                V            +   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 241 QL--YTYQICRALNYL--HHVVGVCHRDI 265
                  QI   + YL  HHVV   H+D+
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVV---HKDL 154

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 51.6 bits (124), Expect = 8e-08
 Identities = 30/152 (19%), Positives = 55/152 (36%), Gaps = 36/152 (23%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS-------VAIKKV-----LQDKRYKNRELQIM-RLLN 188
            + +G G FG V  A+ +            VA+K +      +D      E+++M  +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPI 237
           H N+++L       T+   LY  +++EY                     +         +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 238 LYVQL--YTYQICRALNYL--HHVVGVCHRDI 265
            +  L   TYQ+ R + YL     +   HRD+
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI---HRDL 229

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 51.1 bits (123), Expect = 1e-07
 Identities = 33/143 (23%), Positives = 54/143 (37%), Gaps = 25/143 (17%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
              +G GSFGVV + +          VA+K +  D   +        RE+  M  L+H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRA 250
           ++ L    +       +   +V E              R +Q H  +  +  Y  Q+   
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 251 LNYL--HHVVGVCHRDIKPQNLL 271
           + YL     +   HRD+  +NLL
Sbjct: 134 MGYLESKRFI---HRDLAARNLL 153

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 32/158 (20%), Positives = 59/158 (37%), Gaps = 36/158 (22%)

Query: 142 ERVVGTGSFGVVFQAKCL-------ETGDSVAIKKV-----LQDKRYKNRELQIM-RLLN 188
            + +G G+FG V  A+ +            VA+K +      +D      E+++M  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPI 237
           H N+++L       T+   LY  +++EY                     +    N    +
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 238 LYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLL 271
               L    YQ+ R + YL     +   HRD+  +N+L
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVL 223

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 30/152 (19%), Positives = 56/152 (36%), Gaps = 36/152 (23%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS-------VAIKKV-----LQDKRYKNRELQIM-RLLN 188
            + +G G+FG V  A+ +            VA+K +      +D      E+++M  +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPI 237
           H N+++L       T+   LY  +++EY                     +         +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 238 LYVQL--YTYQICRALNYL--HHVVGVCHRDI 265
            +  L   TYQ+ R + YL     +   HRD+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDL 183

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 43.3 bits (103), Expect = 4e-05
 Identities = 34/153 (22%), Positives = 57/153 (37%), Gaps = 50/153 (32%)

Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSL 195
            +G G FGVV++   +    +VA+KK+                 E+++M    H N+V L
Sbjct: 38  KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 196 K-HCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKH-----YTRMNQHVPILYVQLYT 244
                   ++ D+L   LV  Y+      + +  +        + R              
Sbjct: 96  LGFS----SDGDDLC--LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK------------ 137

Query: 245 YQIC----RALNYLH--HVVGVCHRDIKPQNLL 271
             I       +N+LH  H +   HRDIK  N+L
Sbjct: 138 --IAQGAANGINFLHENHHI---HRDIKSANIL 165

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 22/86 (25%), Positives = 39/86 (45%), Gaps = 15/86 (17%)

Query: 142 ERVVGTGSFGVVFQAKCL-----ETGDSVAIKKV-----LQDKRYKNRELQIMRLL-NHP 190
            + +G G+FG V +A         T  +VA+K +       + R    EL+I+  + +H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEY 216
           NVV+L      T     L   +++E+
Sbjct: 87  NVVNLLGA--CTKPGGPLM--VIVEF 108

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	272
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.98
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.97
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.97
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.97
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.97
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.97
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.97
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.96
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.96
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.96
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.96
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.96
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.96
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.94
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.94
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.94
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.94
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.94
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.94
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.94
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.94
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.94
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.94
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.94
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.94
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.94
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
3uqc_A	286	Probable conserved transmembrane protein; structur	99.94
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.94
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.94
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.94
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.94
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.94
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.94
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.94
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.94
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.94
3niz_A	311	Rhodanese family protein; structural genomics, str	99.94
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.94
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.93
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.93
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.93
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.93
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.93
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.93
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.93
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.93
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.93
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.93
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.93
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.93
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.93
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.93
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.93
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.93
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.93
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.93
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.93
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.93
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.93
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.93
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.93
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.93
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.93
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.93
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.93
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.93
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.93
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.93
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.93
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.93
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.93
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.93
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.93
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.93
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.93
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.93
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.93
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.93
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.93
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.93
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.92
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.92
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.92
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.92
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.92
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.92
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.92
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.92
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.92
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.92
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.92
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.92
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.92
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.92
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.92
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.92
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.92
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.92
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.92
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.92
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.92
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.92
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.92
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.92
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.92
3bhy_A	283	Death-associated protein kinase 3; death associate	99.92
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.92
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.92
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.92
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.92
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.92
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.92
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.92
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.92
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.92
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.92
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.92
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.92
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.92
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.92
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.92
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.92
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.92
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.92
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.92
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.92
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.92
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.92
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.92
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.92
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.92
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.92
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.92
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.92
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.91
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.91
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.91
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.91
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.91
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.91
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.91
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.91
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.91
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.91
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.91
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.91
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.91
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.91
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.91
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.91
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.91
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.91
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.91
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.91
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.91
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.91
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.91
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.91
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.91
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.91
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.91
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.91
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.91
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.91
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.91
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.91
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.91
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.91
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.91
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.91
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.91
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.91
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.91
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.91
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.91
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.91
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.91
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.91
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.91
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.91
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.91
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.91
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.91
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.91
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.9
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.9
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.9
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.9
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.9
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.9
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.9
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.9
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.9
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.9
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.9
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.9
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.9
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.9
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.9
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.9
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.9
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.9
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.9
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.9
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.9
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.9
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.9
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.9
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.9
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.9
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.9
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.9
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.9
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.9
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.89
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.89
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.89
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.89
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.89
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.89
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.89
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.89
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.89
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.89
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.89
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.89
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.89
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.89
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.89
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.89
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.89
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.88
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.88
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.88
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.87
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.87
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.87
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.85
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.84
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.82
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.16
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.91
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.89
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.24
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.06
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.02
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.79
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.76
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.59
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.47
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.44
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.19
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.79
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.69
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.66
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	95.42
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.29
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	95.16
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	94.89
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	94.54
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	94.32
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	93.76
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	90.35
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	88.57
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	82.82

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-33  Score=242.39  Aligned_cols=128  Identities=30%  Similarity=0.489  Sum_probs=108.6

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++.+.       .....+|+++|+.|+|||||+++++|     .+.
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~   85 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSK   85 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence            346799999999999999999999999999999998542       22356899999999999999999998     344


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|||||||+|++++.+..    ...+++..++.|+.||+.||+|||+ ++||||||||+||||
T Consensus        86 ~~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl  145 (275)
T 3hyh_A           86 DEIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLL  145 (275)
T ss_dssp             SEEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEE
T ss_pred             CEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEE
Confidence            56999999999988876654    4579999999999999999999998 999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.2e-33  Score=248.14  Aligned_cols=130  Identities=26%  Similarity=0.438  Sum_probs=105.4

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..++|++++.||+|+||+||+|++..+|+.||||++...      ...+.+|+.+|+.|+|||||+++++|..     ..
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~   96 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NG   96 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CC
Confidence            456899999999999999999999999999999998643      2345689999999999999999999843     34


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||||||.| +|.+++..  .....+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl  158 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFL  158 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEE
T ss_pred             EEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEE
Confidence            59999999985 66565543  224567899999999999999999998 999999999999996

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-33  Score=245.71  Aligned_cols=127  Identities=32%  Similarity=0.515  Sum_probs=111.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .++|.+++.||+|+||+||+|++..+++.||||++.+.       .....+|+++|+.|+|||||+++++|     .+..
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            34699999999999999999999999999999998642       23456899999999999999999998     4455


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||||||.| +|.+++..    .+.+++..++.|+.||+.||+|||+ ++||||||||+||||
T Consensus       106 ~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl  165 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILL  165 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEE
Confidence            69999999985 66555543    3569999999999999999999998 999999999999996

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.2e-33  Score=245.35  Aligned_cols=124  Identities=27%  Similarity=0.366  Sum_probs=108.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec----cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .|.+++.||+|+||+||+|++..+|+.||||++..    ....+.+|+.+|+.|+|||||+++++|...     .++|||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~iv  149 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVV  149 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEE
Confidence            59999999999999999999999999999999853    234467899999999999999999998443     459999


Q ss_pred             eecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||.|+.+ +++.     ...+++..++.|+.||+.||+|||+ ++||||||||+||||
T Consensus       150 mEy~~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl  203 (346)
T 4fih_A          150 MEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILL  203 (346)
T ss_dssp             ECCCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEE
Confidence            999996544 4332     2459999999999999999999998 999999999999996

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.4e-33  Score=244.00  Aligned_cols=125  Identities=28%  Similarity=0.355  Sum_probs=109.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEeec
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      ..|.+.++||+|+||+||+|++..+|+.||||++..+.. ..+|+.+|+.|+|||||+++++|.     +..++||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEec
Confidence            458999999999999999999999999999999975533 357999999999999999999984     34459999999


Q ss_pred             ccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          217 ISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       217 ~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |.| +|.+++..    .+.+++..++.|+.||+.||+|||+ ++||||||||+||||
T Consensus       132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl  183 (336)
T 4g3f_A          132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLL  183 (336)
T ss_dssp             CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEE
T ss_pred             cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEE
Confidence            995 66555543    3569999999999999999999998 999999999999996

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.9e-32  Score=247.47  Aligned_cols=125  Identities=27%  Similarity=0.358  Sum_probs=109.0

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec----cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..|.+++.||+|+||+||+|++..+|+.||||++..    ....+.+|+.+|+.|+|||||+++++|...     .++||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEE
Confidence            469999999999999999999999999999999853    234567899999999999999999998543     45999


Q ss_pred             EeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||.|+.+ +++.     ...+++..++.|+.||+.||+|||+ ++||||||||+||||
T Consensus       226 VmEy~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl  280 (423)
T 4fie_A          226 VMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILL  280 (423)
T ss_dssp             EEECCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEE
T ss_pred             EEeCCCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEE
Confidence            9999996544 4332     2459999999999999999999998 999999999999996

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.98  E-value=4.1e-32  Score=234.72  Aligned_cols=128  Identities=27%  Similarity=0.383  Sum_probs=108.5

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      |++.+.||+|+||+||+|.+..++..||||.+...      ...+.+|+.+|+.|+|||||+++++|.... ....++||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            37788999999999999999999999999998543      233568999999999999999999875433 34567999


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~--iiHrDlKp~NILl  272 (272)
                      |||||++ +|.+++..    ...+++..++.|+.||+.||.|||+ ++  ||||||||+||||
T Consensus       107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl  164 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFI  164 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEE
T ss_pred             EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeE
Confidence            9999995 55554433    3568999999999999999999998 78  9999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.97  E-value=6e-32  Score=243.61  Aligned_cols=131  Identities=31%  Similarity=0.514  Sum_probs=112.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecc-cCCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTT-EKDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~~~~  209 (272)
                      ++|.+++.||+|+||+||+|++..+|+.||||++....      ....+|+++|+.|+|||||+++++|.... ..+..+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            36999999999999999999999999999999996432      23457999999999999999999875432 123456


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||||||+|+++.++.    ..+.+++..++.|+.||+.||.|||+ +|||||||||+||||
T Consensus       134 ~~ivmE~~~g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~  191 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLV  191 (398)
T ss_dssp             EEEEEECCSEEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEE
T ss_pred             EEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCcccccc
Confidence            99999999998776543    25679999999999999999999998 999999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.97  E-value=6.4e-32  Score=234.80  Aligned_cols=134  Identities=24%  Similarity=0.395  Sum_probs=106.0

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeeccc-------
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-------  204 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-------  204 (272)
                      .+|.+++.||+|+||+||+|++..+|+.||||++....     ..+.+|+.+|+.|+|||||+++++|.....       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35999999999999999999999999999999986422     234589999999999999999999865542       


Q ss_pred             CCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....++|||||||.+ ++.+++.... ......+..++.|+.||+.||+|||+ ++||||||||+||||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl  151 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFF  151 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEE
Confidence            234578999999985 5555443321 11234566788999999999999998 999999999999986

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.97  E-value=2.6e-31  Score=230.89  Aligned_cols=132  Identities=23%  Similarity=0.358  Sum_probs=106.7

Q ss_pred             cccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ...+|.+.+.||+|+||+||+|++.     .++..||||.+...    ...+.+|+++|+.|+|||||+++++|....  
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--   88 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD--   88 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--
Confidence            3457999999999999999999875     35788999998643    234568999999999999999999985433  


Q ss_pred             CceEEEEEeeccc-ccHHHHHHHhh---------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYIS-ETVYRVSKHYT---------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                         .+|||||||+ |+|.+++....         .....+++..+..|+.||+.||.|||+ ++||||||||+||||
T Consensus        89 ---~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl  161 (299)
T 4asz_A           89 ---PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLV  161 (299)
T ss_dssp             ---SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             ---EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEE
Confidence               3899999999 56666554321         224569999999999999999999998 999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.97  E-value=3.3e-32  Score=236.60  Aligned_cols=126  Identities=29%  Similarity=0.467  Sum_probs=103.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEEC---CCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      .+|++++.||+|+||+||+|++.   .+++.||||++.+.      .....+|+++|+.|+|||||+++++|..     .
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence            46999999999999999999984   46889999998542      2345689999999999999999999843     3


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|||||||.| +|.+++..    ...+++..++.|+.||+.||+|||+ ++||||||||+||||
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl  159 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILL  159 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEE
Confidence            459999999995 66555543    3569999999999999999999998 999999999999985

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.97  E-value=1.1e-30  Score=229.81  Aligned_cols=131  Identities=22%  Similarity=0.340  Sum_probs=106.9

Q ss_pred             ccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ..+|.+.+.||+|+||+||+|++.     .+++.||||++...    ...+.+|+++|+.|+|||||+++++|...    
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----  115 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG----  115 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS----
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----
Confidence            346899999999999999999875     36789999998643    23456899999999999999999998443    


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhh-----------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYT-----------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       ..+|||||||++ +|.+++....           ....++++..+..|+.||+.||.|||+ ++||||||||+||||
T Consensus       116 -~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl  191 (329)
T 4aoj_A          116 -RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLV  191 (329)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEE
Confidence             349999999995 5555554321           123468999999999999999999998 999999999999996

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.97  E-value=3.8e-30  Score=224.43  Aligned_cols=131  Identities=22%  Similarity=0.305  Sum_probs=106.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ...+++.+.||+|+||+||+|.+.     .+++.||||.+...     ...+.+|+.+|+.|+|||||+++|+|....  
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~--  102 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ--  102 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC--
Confidence            345888999999999999999864     35788999998542     245678999999999999999999985433  


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                         .+|||||||++ +|.+++....            .....+++..+..|+.||+.||.|||+ ++||||||||+||||
T Consensus       103 ---~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          103 ---PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLV  178 (308)
T ss_dssp             ---SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             ---EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEE
Confidence               38999999994 6655554321            112468999999999999999999998 999999999999996

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.96  E-value=4.9e-30  Score=223.31  Aligned_cols=126  Identities=21%  Similarity=0.376  Sum_probs=103.0

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....++.+.+.||+|+||+||+|++.   ..||||+++..      ...+.+|+.+|+.|+|||||++++++.. .    
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~----  104 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D----  104 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S----
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C----
Confidence            33456889999999999999999853   46999998532      2345689999999999999999997632 1    


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       .+|||||||++ +|.+++.   .....+++..+..|+.||+.||.|||+ ++||||||||+||||
T Consensus       105 -~~~iVmEy~~gGsL~~~l~---~~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl  165 (307)
T 3omv_A          105 -NLAIVTQWCEGSSLYKHLH---VQETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFL  165 (307)
T ss_dssp             -SCEEEEECCSSCBHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEE
T ss_pred             -eEEEEEEcCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEE
Confidence             27899999995 5444432   234579999999999999999999998 999999999999996

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.96  E-value=1.1e-29  Score=226.37  Aligned_cols=125  Identities=24%  Similarity=0.471  Sum_probs=105.7

Q ss_pred             cccCeeeeEEeccCCceEEEEEEEC---CCCCEEEEEEeeccc--hhHHHHHHHHHHc-CCCCeeecceeeeecccCCce
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~~--~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..++|++.+.||+|+||+||+|++.   .+++.||||.+....  ....+|+++|+.+ +|||||+++++|.     +..
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~~   93 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KND   93 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ETT
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----ECC
Confidence            3457999999999999999999874   467899999886543  3345899999998 6999999999984     344


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||||||++ ++.+++       ..+++..++.|+.||+.||.|||+ +|||||||||+||||
T Consensus        94 ~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl  150 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLY  150 (361)
T ss_dssp             EEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEE
Confidence            69999999985 554433       248999999999999999999998 999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.96  E-value=1.3e-29  Score=239.39  Aligned_cols=129  Identities=22%  Similarity=0.363  Sum_probs=107.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHH---HHHHHHcCCCCeeecceeeeecc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRE---LQIMRLLNHPNVVSLKHCFFSTT  203 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E---~~~l~~l~h~nIv~l~~~~~~~~  203 (272)
                      ...++|.++++||+|+||+||+|++..+|+.||||++.+..       ....+|   +.+++.++|||||+++++|    
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f----  261 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF----  261 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE----
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE----
Confidence            45668999999999999999999999999999999986421       122233   5566677899999999998    


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       .+..++|||||||.| +|..++..    .+.+++..++.|+.||+.||+|||+ +|||||||||+||||
T Consensus       262 -~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILl  325 (689)
T 3v5w_A          262 -HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILL  325 (689)
T ss_dssp             -ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEE
T ss_pred             -EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEE
Confidence             455569999999995 55554433    3569999999999999999999998 999999999999996

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.96  E-value=2.1e-29  Score=236.94  Aligned_cols=128  Identities=28%  Similarity=0.494  Sum_probs=110.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .++|.+++.||+|+||+||+|.+..+|+.||||++...    .....+|+.+|+.|+|||||+|+++|     .+..++|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            46899999999999999999999999999999998643    23456899999999999999999998     4455699


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||.| +|++.+   ......+++..++.|+.||+.||.|||+ ++|+||||||+||||
T Consensus       231 iv~E~~~gg~L~~~i---~~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill  288 (573)
T 3uto_A          231 MIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMF  288 (573)
T ss_dssp             EEEECCCCCBHHHHH---TCTTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEeecCCCcHHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccc
Confidence            99999985 544433   2234579999999999999999999998 999999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.96  E-value=3.5e-29  Score=218.04  Aligned_cols=126  Identities=22%  Similarity=0.336  Sum_probs=102.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch-hH--HHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YK--NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~--~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +|.+.+.||+|+||+||+|++  +|+.||||++..... ..  +.|+..+..|+|||||++++++.... .....+||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~   80 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEe
Confidence            589999999999999999987  689999999865432 22  34666667889999999999986554 2334589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--------GVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~--------~iiHrDlKp~NILl  272 (272)
                      |||++ +|.+++..     ..+++..+..++.|++.||.|||+ +        +||||||||+||||
T Consensus        81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl  141 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILV  141 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEE
T ss_pred             cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEE
Confidence            99995 55554432     358899999999999999999996 5        89999999999996

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.96  E-value=1.3e-28  Score=218.46  Aligned_cols=133  Identities=21%  Similarity=0.346  Sum_probs=107.4

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCC-----CCEEEEEEeecc-----chhHHHHHHHHHHcCC-CCeeecceeeeecc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQD-----KRYKNRELQIMRLLNH-PNVVSLKHCFFSTT  203 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~  203 (272)
                      ...+|++.+.||+|+||+||+|.+..+     ++.||||.+...     ...+.+|+.+|+.+.| ||||+++++|....
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            345799999999999999999998654     367999998643     2335579999999976 89999999885432


Q ss_pred             cCCceEEEEEeeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 024091          204 EKDELYLNLVLEYIS-ETVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL  270 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NI  270 (272)
                          ..+|||||||+ |+|.++++....            ....+++..+..|+.||+.||.|||+ ++||||||||+||
T Consensus       142 ----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NI  216 (353)
T 4ase_A          142 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI  216 (353)
T ss_dssp             ----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred             ----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccce
Confidence                23899999999 566565554321            13458899999999999999999998 9999999999999


Q ss_pred             eC
Q 024091          271 LM  272 (272)
Q Consensus       271 Ll  272 (272)
                      ||
T Consensus       217 Ll  218 (353)
T 4ase_A          217 LL  218 (353)
T ss_dssp             EE
T ss_pred             ee
Confidence            86

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=1.8e-28  Score=219.90  Aligned_cols=137  Identities=44%  Similarity=0.864  Sum_probs=120.3

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeeccc----------
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE----------  204 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----------  204 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||++..+.....+|+++|+.++||||++++++|+....          
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~   84 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD   84 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence            3457999999999999999999999999999999998777777789999999999999999999876543          


Q ss_pred             -----------------------CCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCce
Q 024091          205 -----------------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC  261 (272)
Q Consensus       205 -----------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~ii  261 (272)
                                             ....++++||||+++++...+..+......+++..++.++.||+.||.|||+ +||+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~  163 (383)
T 3eb0_A           85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGIC  163 (383)
T ss_dssp             -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEE
T ss_pred             ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCc
Confidence                                   3456799999999999888877776777889999999999999999999998 9999


Q ss_pred             ecCCCCCCeeC
Q 024091          262 HRDIKPQNLLM  272 (272)
Q Consensus       262 HrDlKp~NILl  272 (272)
                      ||||||+||||
T Consensus       164 H~Dikp~Nil~  174 (383)
T 3eb0_A          164 HRDIKPQNLLV  174 (383)
T ss_dssp             CSCCCGGGEEE
T ss_pred             cCccCHHHEEE
Confidence            99999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.96  E-value=2.4e-28  Score=221.84  Aligned_cols=137  Identities=63%  Similarity=1.100  Sum_probs=123.0

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeeccc-CCceEEEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLV  213 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~~~lv  213 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+........+|+++|+.|+|||||+++++|+.... .+..++++|
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            3446999999999999999999999999999999998777777789999999999999999999876543 456778999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||++++++.++..+......+++..++.|+.||+.||.|||+ ++|+||||||+||||
T Consensus       132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl  189 (420)
T 1j1b_A          132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL  189 (420)
T ss_dssp             EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEE
T ss_pred             hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEE
Confidence            9999999888877766667889999999999999999999998 999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.95  E-value=1.7e-27  Score=214.48  Aligned_cols=135  Identities=63%  Similarity=1.116  Sum_probs=120.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeeccc-CCceEEEEEe
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVL  214 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~~~lv~  214 (272)
                      ..+|.+.++||+|+||.||+|.+..+++ ||+|.+........+|+++|+.++||||++++++|+.... .+..++|+||
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            4569999999999999999999877665 8999887777777789999999999999999999877654 5667899999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++++..+..+......+++..++.|+.||+.||.|||+ ++|+||||||+||||
T Consensus       118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill  174 (394)
T 4e7w_A          118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLL  174 (394)
T ss_dssp             ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEE
Confidence            999999888777777777889999999999999999999998 999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.94  E-value=6.4e-27  Score=207.55  Aligned_cols=130  Identities=29%  Similarity=0.392  Sum_probs=111.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++...         ...+.+|+.+|+.++||||++++++|..     .
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~   98 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----D   98 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence            4699999999999999999999999999999998532         2345689999999999999999999843     3


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|+||||+.+ ++...+.........+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~  163 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLL  163 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEE
Confidence            459999999984 5555554444445568999999999999999999998 999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.94  E-value=3.2e-27  Score=216.50  Aligned_cols=131  Identities=29%  Similarity=0.400  Sum_probs=105.1

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+|.+++.||+|+||+||+|.+..+++.||||++...      ...+.+|+.+|+.|+|||||+++++|..........+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            4799999999999999999999999999999998542      2334579999999999999999999866554455569


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+++++..++..    ...+++..++.|+.||+.||.|||+ .+||||||||+||||
T Consensus       133 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl  189 (458)
T 3rp9_A          133 YVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLV  189 (458)
T ss_dssp             EEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEE
T ss_pred             EEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEE
Confidence            99999999988776543    4569999999999999999999998 999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.94  E-value=1e-26  Score=200.53  Aligned_cols=127  Identities=33%  Similarity=0.533  Sum_probs=111.0

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+|.+.+.||+|+||+||+|.+..+++.||||++....      ....+|+.+++.++||||++++++|..     ..++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence            46999999999999999999999999999999986432      334579999999999999999999843     3459


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||++++++..+..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~  134 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLI  134 (292)
T ss_dssp             EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            99999999988775543   34679999999999999999999998 899999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.94  E-value=1e-26  Score=205.67  Aligned_cols=127  Identities=28%  Similarity=0.452  Sum_probs=111.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEEe
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++........+|+++|..+ .||||++++++|     .+..++|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEEE
Confidence            4469999999999999999999999999999999987766677899999888 799999999998     4455699999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.+ ++.+.+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus        96 E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~  149 (342)
T 2qr7_A           96 ELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILY  149 (342)
T ss_dssp             CCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEE
Confidence            99985 5555443    24568999999999999999999998 999999999999984

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.94  E-value=1.6e-26  Score=203.40  Aligned_cols=129  Identities=33%  Similarity=0.455  Sum_probs=110.1

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+|+.++||||+++++++.     ..
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~   86 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TE   86 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence            34567999999999999999999999999999999986432      23457999999999999999999983     34


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+|+||||+.+ ++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll  147 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLL  147 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             CEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEE
Confidence            459999999974 65554433    3568999999999999999999998 999999999999985

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.94  E-value=1.2e-26  Score=204.93  Aligned_cols=129  Identities=27%  Similarity=0.455  Sum_probs=112.5

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+|+.++||||++++++|..     
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----   80 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----   80 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----
Confidence            4456899999999999999999999999999999998542       2345689999999999999999999843     


Q ss_pred             ceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+|+||||+++++++.+..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        81 ~~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll  141 (336)
T 3h4j_B           81 PTDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLL  141 (336)
T ss_dssp             SSEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEE
T ss_pred             CCEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEE
Confidence            345999999999888876544    3468999999999999999999998 899999999999985

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.94  E-value=1.4e-26  Score=205.79  Aligned_cols=129  Identities=31%  Similarity=0.464  Sum_probs=107.9

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHc-CCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  205 (272)
                      ....+|.+.++||+|+||+||+|++..+++.||||++.+.       .....+|+.+|+.+ +||||++++++|     .
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~   94 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q   94 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence            3456799999999999999999999999999999998643       22345799999988 699999999998     4


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +..++||||||+.+ .+...+..    ...+++..++.|+.||+.||.|||+ ++|+||||||+||||
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl  157 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLL  157 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEE
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEE
Confidence            44459999999986 55444332    3569999999999999999999998 999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.94  E-value=2.3e-26  Score=204.98  Aligned_cols=128  Identities=25%  Similarity=0.426  Sum_probs=109.8

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----------hhHHHHHHHHHHcCCCCeeecceeeeeccc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  204 (272)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||||++....          ....+|+.+|+.+.||||++++++|     
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----   84 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----   84 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence            3457999999999999999999999999999999986432          3456899999999999999999998     


Q ss_pred             CCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+..++|+||||+.+ ++.+++    .....+++..+..++.||+.||.|||+ +||+||||||+|||+
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll  148 (361)
T 2yab_A           85 ENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIML  148 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHH----TTCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EeCCEEEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            344569999999974 555433    224579999999999999999999998 999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.94  E-value=1.5e-26  Score=202.10  Aligned_cols=135  Identities=24%  Similarity=0.392  Sum_probs=108.3

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeeccc------
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE------  204 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------  204 (272)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++...     .....+|+.+|+.|+||||++++++|.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            34699999999999999999999999999999998632     2345689999999999999999998865432      


Q ss_pred             ----------------------------------------------CCceEEEEEeecccc-cHHHHHHHhhhcCCCCCH
Q 024091          205 ----------------------------------------------KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPI  237 (272)
Q Consensus       205 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~  237 (272)
                                                                    ....++|+||||+.+ ++.+++.. ........+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR-RCSLEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT-CCSGGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc-ccCccchhh
Confidence                                                          223468999999986 55554443 222234566


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       238 ~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       164 ~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll  197 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFF  197 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             HHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEE
Confidence            6788999999999999998 999999999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.94  E-value=2.3e-26  Score=208.14  Aligned_cols=127  Identities=32%  Similarity=0.553  Sum_probs=109.4

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec-------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|.+.++||+|+||+||+|++..+++.||||++.+       ......+|+.+|+.++||||++++++|     .+.
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~  141 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  141 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence            34579999999999999999999999999999999854       233456899999999999999999998     445


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++||||||+++ ++..++..     ..+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl  201 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLL  201 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeE
Confidence            569999999975 55544432     358999999999999999999998 999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.94  E-value=2.2e-26  Score=206.57  Aligned_cols=130  Identities=32%  Similarity=0.426  Sum_probs=110.1

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+|+.++|||||+++++|.     +
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~   86 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----D   86 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            3456799999999999999999999999999999998543       234457999999999999999999983     4


Q ss_pred             ceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+|+||||+.++.+..+   ......+++..++.|+.||+.||.|||+ +|||||||||+||||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~---l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll  148 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYH---LQQNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILL  148 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHH---HHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             CCEEEEEEecCCCCcHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEE
Confidence            4459999999986544322   2234579999999999999999999998 999999999999985

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.94  E-value=2e-26  Score=203.42  Aligned_cols=127  Identities=26%  Similarity=0.386  Sum_probs=108.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|.+++.||+|+||+||+|++..+++.||||++.+.       .....+|+.+|+.++||||++++++|     ....
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence            45799999999999999999999999999999998643       22345799999999999999999998     3444


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+++ .+...+..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll  138 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLML  138 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEE
T ss_pred             EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEE
Confidence            59999999986 44443332    3568999999999999999999998 999999999999985

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.94  E-value=6.2e-26  Score=198.12  Aligned_cols=132  Identities=26%  Similarity=0.376  Sum_probs=110.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+|.+.++||+|+||.||+|.+..+++.||||++...     .....+|+++|+.++||||+++++++....   ..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceE
Confidence            34699999999999999999999999999999998642     233458999999999999999999875433   2348


Q ss_pred             EEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+. +++..++.. ......+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        85 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll  145 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMR  145 (319)
T ss_dssp             EEEEECCTTCBHHHHHHS-GGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEEEeCCCCCCHHHHHHH-hccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEE
Confidence            99999998 466555543 2233448999999999999999999998 999999999999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.94  E-value=3.1e-26  Score=197.68  Aligned_cols=124  Identities=15%  Similarity=0.048  Sum_probs=104.1

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++....       ..+.+|+.+++.+.||||+++++++..     ..+
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence            46999999999999999999999999999999986432       345689999999999999999999843     345


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+.+ ++.+++.     .+ .....+..++.||+.||.|||+ +||+||||||+||||
T Consensus       106 ~~lv~e~~~g~~L~~~l~-----~~-~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll  162 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVAD-----TS-PSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRV  162 (286)
T ss_dssp             EEEEEECCCEEEHHHHHT-----TC-CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEE
T ss_pred             EEEEEEecCCCCHHHHHh-----cC-CChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEE
Confidence            8999999985 4444331     12 3455678899999999999998 999999999999985

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.94  E-value=2.9e-26  Score=206.63  Aligned_cols=129  Identities=29%  Similarity=0.481  Sum_probs=109.2

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHc-CCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  205 (272)
                      ....+|.++++||+|+||+||+|++..+++.||||++.+.       .....+|..+|..+ +||||++++++|     .
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~  123 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q  123 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----E
Confidence            3455799999999999999999999999999999998643       22345799999877 899999999998     3


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +..++||||||+.+ .+...+..    ...+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl  186 (396)
T 4dc2_A          124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLL  186 (396)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEE
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEE
Confidence            44569999999986 44443332    3569999999999999999999998 999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.94  E-value=6e-26  Score=203.65  Aligned_cols=131  Identities=24%  Similarity=0.426  Sum_probs=110.9

Q ss_pred             CcccCeeeeEEeccC--CceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G--~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ...++|.+.+.||+|  +||.||+|++..+++.||||++....      ....+|+.+|+.++|||||+++++|...   
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---   98 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD---   98 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC---
Confidence            445679999999999  99999999999999999999986432      3345799999999999999999998543   


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ..+|+||||+.+ ++.+++...  ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        99 --~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll  161 (389)
T 3gni_B           99 --NELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILI  161 (389)
T ss_dssp             --TEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             --CEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence              349999999985 555544332  23568999999999999999999998 999999999999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.94  E-value=4.6e-26  Score=196.00  Aligned_cols=132  Identities=25%  Similarity=0.422  Sum_probs=114.3

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ..++|.+.+.||+|+||.||+|.+..++..||+|.+....     ....+|+++|+.++||||++++++|     .+...
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   94 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHN   94 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCe
Confidence            3457999999999999999999999999999999986532     3456899999999999999999998     34445


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+.+ ++.+.+.........+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~  157 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILF  157 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEE
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEE
Confidence            9999999985 6766665554556779999999999999999999998 999999999999985

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.94  E-value=3.7e-26  Score=200.40  Aligned_cols=128  Identities=30%  Similarity=0.389  Sum_probs=108.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...     .....+|+.+++.++||||+++++++     ....+.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence            45799999999999999999999999999999998533     23456899999999999999999988     344568


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.++.+.   .+......+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        81 ~lv~e~~~~~~L~---~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll  138 (323)
T 3tki_A           81 YLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLL  138 (323)
T ss_dssp             EEEEECCTTEEGG---GGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEEEEcCCCCcHH---HHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEE
Confidence            9999999864332   233345569999999999999999999998 999999999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.94  E-value=6.3e-26  Score=197.00  Aligned_cols=134  Identities=29%  Similarity=0.463  Sum_probs=112.4

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---------chhHHHHHHHHHHcC---CCCeeecceeeeecc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLN---HPNVVSLKHCFFSTT  203 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~  203 (272)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++...         .....+|+.+++.+.   ||||++++++|....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            45799999999999999999999999999999998632         124557888877765   999999999987766


Q ss_pred             cCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .....++++||||+++++..++...  ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~  153 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILV  153 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEE
T ss_pred             CCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            5556679999999999887765532  22348999999999999999999998 999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.94  E-value=3.8e-26  Score=208.08  Aligned_cols=132  Identities=27%  Similarity=0.373  Sum_probs=113.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+|+.++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            45799999999999999999999999999999998642      233458999999999999999999986554333355


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+++++..++..    ...+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus       105 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl  162 (432)
T 3n9x_A          105 LYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLL  162 (432)
T ss_dssp             EEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEE
Confidence            999999999988776543    4569999999999999999999998 899999999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.94  E-value=4.8e-26  Score=202.74  Aligned_cols=128  Identities=27%  Similarity=0.430  Sum_probs=110.4

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||++...   .....+|+.+++.++||||++++++|.     ...++|
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~   92 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA   92 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence            345799999999999999999999999999999998653   344568999999999999999999984     344599


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++..++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        93 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill  149 (361)
T 3uc3_A           93 IIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLL  149 (361)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEE
T ss_pred             EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            99999975 55554432    3468999999999999999999998 999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.94  E-value=3.4e-26  Score=200.95  Aligned_cols=129  Identities=29%  Similarity=0.509  Sum_probs=111.0

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+|+.++||||++++++|..     .
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----N  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----T
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----C
Confidence            44568999999999999999999999999999999985432      223479999999999999999999843     3


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+|+||||+++++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       106 ~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll  165 (329)
T 3gbz_A          106 HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLL  165 (329)
T ss_dssp             TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEE
Confidence            45999999999988776543    4468999999999999999999998 999999999999985

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.94  E-value=4.6e-26  Score=199.55  Aligned_cols=127  Identities=27%  Similarity=0.542  Sum_probs=109.4

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|.+.+.||+|+||.||+|++..+|+.||||++.+.       .....+|+.+|+.++||||++++++|     .+..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence            45799999999999999999999999999999998643       23345799999999999999999998     3445


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+.+ ++..++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll  139 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILL  139 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEE
T ss_pred             EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEE
Confidence            69999999985 55554433    4568999999999999999999998 999999999999985

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.94  E-value=3.4e-26  Score=199.87  Aligned_cols=130  Identities=28%  Similarity=0.475  Sum_probs=99.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||.+...     .....+|+.+|+.++||||++++++|     .....+|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~   79 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT   79 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence            4699999999999999999999999999999998643     23456899999999999999999998     3445699


Q ss_pred             EEeecccccHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTR--MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+++++.+++.....  ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~  141 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLI  141 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEE
Confidence            9999999988877654332  22458999999999999999999998 999999999999985

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.94  E-value=6e-26  Score=197.89  Aligned_cols=128  Identities=34%  Similarity=0.559  Sum_probs=108.6

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ...+|.+.+.||+|+||.||+|.+. +++.||||++....      ....+|+.+|+.++||||++++++|     .+..
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   92 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSER   92 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCC
Confidence            3457999999999999999999985 58999999985431      2345899999999999999999998     3444


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+++++...+..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        93 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~  152 (311)
T 3niz_A           93 CLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLI  152 (311)
T ss_dssp             CEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEE
Confidence            5999999999988775543   34568999999999999999999998 999999999999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=6e-26  Score=198.93  Aligned_cols=128  Identities=25%  Similarity=0.422  Sum_probs=109.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|.+....   ....+|+.+|+.++||||++++++|..     ..++|+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEE
Confidence            357999999999999999999999999999999986432   334589999999999999999999843     335999


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+.+ ++.+.+   ......+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        79 v~e~~~g~~L~~~l---~~~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~  135 (321)
T 1tki_A           79 IFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIY  135 (321)
T ss_dssp             EECCCCCCBHHHHH---TSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEeCCCCCHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEE
Confidence            9999986 554433   2223468999999999999999999998 999999999999985

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.93  E-value=4.8e-26  Score=202.87  Aligned_cols=127  Identities=28%  Similarity=0.451  Sum_probs=108.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....      ..+.+|+.+|+.|+||||++++++|     .+..+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            346999999999999999999999999999999986432      2345899999999999999999998     34456


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|+||||+.+ .+.+.+.    ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       103 ~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll  161 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLL  161 (362)
T ss_dssp             EEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEE
T ss_pred             EEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEE
Confidence            8999999986 5544332    24568999999999999999999998 999999999999985

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.93  E-value=5.5e-26  Score=199.48  Aligned_cols=127  Identities=24%  Similarity=0.423  Sum_probs=109.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----------chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...          ...+.+|+.+|+.++||||++++++|.     
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----   84 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----   84 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence            44699999999999999999999999999999998642          234568999999999999999999983     


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....+|+||||+.+ ++.+++.    ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll  147 (326)
T 2y0a_A           85 NKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIML  147 (326)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEE
Confidence            34459999999975 5554432    24568999999999999999999998 999999999999985

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.93  E-value=5.2e-26  Score=201.37  Aligned_cols=129  Identities=29%  Similarity=0.483  Sum_probs=109.1

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHc-CCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  205 (272)
                      ....+|.+.+.||+|+||.||+|++..+++.||||++.+..       ....+|+.+++.+ +||||++++++|     .
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~   80 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q   80 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----E
Confidence            34567999999999999999999999999999999986532       2245799999887 899999999998     3


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +..++|+||||+.+ ++..++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll  143 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLL  143 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEE
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEE
Confidence            44569999999985 55444432    3468999999999999999999998 999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.93  E-value=5.2e-26  Score=207.43  Aligned_cols=128  Identities=23%  Similarity=0.381  Sum_probs=109.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|.+.++||+|+||+||+|++..+++.||||++.+.       .....+|+.++..++||||++++++|     .+..
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~  147 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN  147 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence            45799999999999999999999999999999998642       22356899999999999999999998     4445


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++||||||+.+ ++..++..   ....+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl  208 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILM  208 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeE
Confidence            69999999975 55554432   24569999999999999999999998 999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.93  E-value=7e-26  Score=208.18  Aligned_cols=130  Identities=28%  Similarity=0.440  Sum_probs=111.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc-CCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~  208 (272)
                      ..+|.+++.||+|+||.||+|.+..+++.||||++...      .....+|+.+|+.++||||++++++|..... ....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            45799999999999999999999999999999998643      2334589999999999999999999854332 2335


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+||||||++++++..+.      ..+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus       141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll  197 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVV  197 (464)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEE
Confidence            689999999998776442      348899999999999999999998 899999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.93  E-value=6e-26  Score=205.57  Aligned_cols=129  Identities=28%  Similarity=0.455  Sum_probs=110.4

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|.+.++||+|+||.||+|++..+++.||||++.+.       .....+|+.+|..++||||++++++|     .+.
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  133 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE  133 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence            345799999999999999999999999999999998642       23356899999999999999999998     445


Q ss_pred             eEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++||||||+. +++..++...   ...+++..++.|+.||+.||+|||+ ++||||||||+||||
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl  195 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILL  195 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeee
Confidence            56999999997 5655554432   3468999999999999999999998 999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.93  E-value=3.8e-26  Score=197.49  Aligned_cols=131  Identities=29%  Similarity=0.409  Sum_probs=107.7

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------------------------------hhHHHHHHH
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------------------------RYKNRELQI  183 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------------------------~~~~~E~~~  183 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++....                              ..+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            44568999999999999999999999999999999985432                              335689999


Q ss_pred             HHHcCCCCeeecceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceec
Q 024091          184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHR  263 (272)
Q Consensus       184 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHr  263 (272)
                      |+.++||||+++++++...   ...++|+||||++++.+.   .. .....+++..++.++.||+.||.|||+ ++|+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~---~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~  161 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVM---EV-PTLKPLSEDQARFYFQDLIKGIEYLHY-QKIIHR  161 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSC---CS-SCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred             HHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHH---HH-hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecc
Confidence            9999999999999987532   234689999999865432   11 224568999999999999999999998 999999


Q ss_pred             CCCCCCeeC
Q 024091          264 DIKPQNLLM  272 (272)
Q Consensus       264 DlKp~NILl  272 (272)
                      ||||+||||
T Consensus       162 Dlkp~Nil~  170 (298)
T 2zv2_A          162 DIKPSNLLV  170 (298)
T ss_dssp             CCCGGGEEE
T ss_pred             CCCHHHEEE
Confidence            999999985

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.93  E-value=6.4e-26  Score=199.06  Aligned_cols=127  Identities=21%  Similarity=0.298  Sum_probs=110.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++...  ...+.+|+.+++.| .||||+++++++..     ..+.|+|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv   83 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAMV   83 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEEE
Confidence            4699999999999999999999999999999998643  34567899999999 89999999998743     3458999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+++++.+++...   ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill  138 (330)
T 2izr_A           84 LELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLI  138 (330)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeee
Confidence            999987877766543   4579999999999999999999998 999999999999985

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.93  E-value=1.1e-25  Score=199.67  Aligned_cols=129  Identities=26%  Similarity=0.466  Sum_probs=110.9

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcC-----CCCeeecceeeeecccCCc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN-----HPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~-----h~nIv~l~~~~~~~~~~~~  207 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....   .....|+.+++.+.     ||||++++++|...     
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-----  108 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-----  108 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-----
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-----
Confidence            457999999999999999999999999999999986432   33457999999997     99999999998543     


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|+||||+++++.+++....  ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       109 ~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll  170 (360)
T 3llt_A          109 DHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILL  170 (360)
T ss_dssp             TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             CeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEE
Confidence            3599999999888887665422  3458999999999999999999998 999999999999985

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.93  E-value=7.8e-26  Score=193.51  Aligned_cols=132  Identities=23%  Similarity=0.325  Sum_probs=112.8

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHc-CCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+...      .....+|+.++..+ .||||++++++|...     
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----
Confidence            345799999999999999999999999999999998642      22344788899988 899999999998433     


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|+||||+++ ++.+++.........+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~  148 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFI  148 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEE
Confidence            358999999975 7777766655555779999999999999999999998 999999999999985

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.93  E-value=6.1e-26  Score=201.00  Aligned_cols=129  Identities=26%  Similarity=0.437  Sum_probs=108.1

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHc-CCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  205 (272)
                      ....+|.+.+.||+|+||.||+|++..+++.||||++.+.       ......|..+|..+ +||||++++++|     .
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~   88 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----Q   88 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----E
Confidence            3455799999999999999999999999999999998643       22345789999877 899999999998     3


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +..++|+||||+.+ ++..++..    ...+++..++.++.||+.||+|||+ ++|+||||||+||||
T Consensus        89 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll  151 (345)
T 1xjd_A           89 TKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILL  151 (345)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEE
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEE
Confidence            44559999999985 55554433    3468999999999999999999998 999999999999985

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.93  E-value=7.5e-26  Score=200.77  Aligned_cols=128  Identities=30%  Similarity=0.485  Sum_probs=109.7

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|.+++.||+|+||.||+|++..+++.||||++...       .....+|+.+|+.++||||++++++|     .+.
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~  113 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN  113 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence            445799999999999999999999999999999998543       22345799999999999999999988     344


Q ss_pred             eEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|+||||+. +++..++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll  174 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLI  174 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             CEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEE
Confidence            56999999997 465555443    2468999999999999999999998 999999999999985

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.93  E-value=7.8e-26  Score=194.72  Aligned_cols=126  Identities=29%  Similarity=0.506  Sum_probs=108.6

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+|.+.+.||+|+||.||+|.+ .+++.||||.+....      ....+|+.+++.++||||++++++|...     .++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence            4699999999999999999998 678999999985432      3445899999999999999999998433     349


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+++++..++..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~  133 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLI  133 (288)
T ss_dssp             EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            99999999988775543   23568999999999999999999998 999999999999985

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.93  E-value=5.4e-26  Score=196.59  Aligned_cols=127  Identities=28%  Similarity=0.366  Sum_probs=108.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||.+...       ...+.+|+.+++.++||||+++++++     ....
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            35799999999999999999999999999999988432       12345799999999999999999988     3445


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+.+ ++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~  144 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILI  144 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence            69999999986 55554433    3468999999999999999999998 999999999999985

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.93  E-value=7.7e-26  Score=206.77  Aligned_cols=127  Identities=28%  Similarity=0.397  Sum_probs=107.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+|+.|+||||++++++|     ....+
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~   84 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH   84 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence            456999999999999999999999999999999986432      2345899999999999999999998     34456


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+.+ .+.+.+..    ...+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        85 ~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll  143 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLL  143 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEE
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEE
Confidence            9999999985 55554432    4569999999999999999999998 999999999999985

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.93  E-value=8.9e-26  Score=195.56  Aligned_cols=126  Identities=28%  Similarity=0.418  Sum_probs=107.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||.+...    .....+|+.+++.++||||++++++|....     .+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-----EEE
Confidence            45799999999999999999999999999999998532    334568999999999999999999985433     489


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+++..     ..+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~  149 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILL  149 (297)
T ss_dssp             EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEE
Confidence            99999975 55444432     358899999999999999999998 999999999999985

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.93  E-value=2.1e-25  Score=193.94  Aligned_cols=128  Identities=28%  Similarity=0.520  Sum_probs=109.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|.+...    ...+.+|+.+|+.++||||++++++|...     ..+|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence            45799999999999999999999999999999987542    23455899999999999999999998543     3489


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+++..   ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        84 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~  141 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLV  141 (310)
T ss_dssp             EEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEE
T ss_pred             EEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEE
Confidence            99999986 55554432   24568999999999999999999998 999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.93  E-value=4.1e-25  Score=192.41  Aligned_cols=135  Identities=26%  Similarity=0.436  Sum_probs=113.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...    ...+.+|+.+++.++||||+++++++.... .....+|
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence            34699999999999999999999999999999988543    234458999999999999999999886432 3455689


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+++.........+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~  167 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILL  167 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEE
Confidence            99999986 7766666554456779999999999999999999998 899999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.93  E-value=2e-25  Score=200.94  Aligned_cols=132  Identities=26%  Similarity=0.370  Sum_probs=109.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+|.+.++||+|+||.||+|.+..+++.||||++...     .....+|+++|+.++||||+++++++....   ..++
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence            34699999999999999999999999999999998642     233458999999999999999999875432   2348


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.+ ++.+++.. ......+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        85 ~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll  145 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMR  145 (396)
T ss_dssp             EEEECCCTTEEHHHHTTS-GGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEEecCCCCCHHHHHHh-hhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEE
Confidence            999999985 55544332 2223348999999999999999999998 999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.93  E-value=3.2e-25  Score=197.28  Aligned_cols=130  Identities=29%  Similarity=0.459  Sum_probs=112.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||.+....     ....+|+.+|+.++||||+++++++..........+|
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            47999999999999999999999999999999986422     2345799999999999999999998655434445689


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+++++..++..     ..+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       107 iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~  161 (364)
T 3qyz_A          107 IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL  161 (364)
T ss_dssp             EEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEE
Confidence            9999999988876543     358999999999999999999998 999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.93  E-value=2.7e-25  Score=196.90  Aligned_cols=138  Identities=41%  Similarity=0.737  Sum_probs=108.0

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch---hHHHHHHHHHHcCCCCeeecceeeeeccc--CCce
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVSLKHCFFSTTE--KDEL  208 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~~~  208 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++.....   ...+|+..++.++||||++++++|.....  ....
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   99 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI   99 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence            345579999999999999999999999999999998865432   33467777888999999999999876543  4456


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--HVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH--~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||++++++..+..+......+++..++.++.||+.||.|||  + ++|+||||||+||||
T Consensus       100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll  164 (360)
T 3e3p_A          100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLV  164 (360)
T ss_dssp             EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEE
T ss_pred             eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEE
Confidence            78999999999988777666666778999999999999999999999  8 899999999999986

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.93  E-value=2.9e-25  Score=192.80  Aligned_cols=127  Identities=38%  Similarity=0.621  Sum_probs=109.2

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||++++++|..     ...+
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence            46999999999999999999999999999999885432      234479999999999999999999843     3448


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++||||++++++..+.   .....+++..+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus        78 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~  135 (311)
T 4agu_A           78 HLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILI  135 (311)
T ss_dssp             EEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEE
Confidence            9999999988765433   234568999999999999999999998 999999999999985

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.93  E-value=8.4e-26  Score=196.71  Aligned_cols=131  Identities=27%  Similarity=0.368  Sum_probs=110.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....       ..+.+|+.+++.++||||+++++++.... ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            457999999999999999999999999999999986531       23457999999999999999999875544 3445


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+.+ ++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~  149 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMI  149 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEE
Confidence            67999999975 55554432    3468999999999999999999998 999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.93  E-value=2.8e-25  Score=190.84  Aligned_cols=133  Identities=23%  Similarity=0.332  Sum_probs=111.3

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch------hHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++.....      ...++...++.+.||||+++++++....    
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~----   79 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG----   79 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC----
Confidence            345679999999999999999999999999999999864321      1223445578889999999999985433    


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~-~iiHrDlKp~NILl  272 (272)
                       ..|+||||+++++..++.........+++..++.++.||+.||.|||+ + +|+||||||+|||+
T Consensus        80 -~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~  143 (290)
T 3fme_A           80 -DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLI  143 (290)
T ss_dssp             -SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEE
T ss_pred             -CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEE
Confidence             389999999998888777666667789999999999999999999998 7 99999999999985

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=1.8e-25  Score=200.51  Aligned_cols=128  Identities=29%  Similarity=0.528  Sum_probs=102.4

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcC-CCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+|+.+. ||||++++++|....   ..
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~   84 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---DR   84 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---SS
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---CC
Confidence            35799999999999999999999999999999988532      223347999999997 999999999885432   23


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+++++..++..     ..+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus        85 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll  142 (388)
T 3oz6_A           85 DVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILL  142 (388)
T ss_dssp             CEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEE
Confidence            4899999999988776543     368899999999999999999998 999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.93  E-value=2.3e-25  Score=200.21  Aligned_cols=128  Identities=28%  Similarity=0.439  Sum_probs=109.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++...    .....+|+.+|+.|+||||++++++|.     +...+|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence            45799999999999999999999999999999998643    234568999999999999999999983     344599


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+.+   ......+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus       125 lv~E~~~gg~L~~~l---~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll  182 (387)
T 1kob_A          125 LILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMC  182 (387)
T ss_dssp             EEEECCCCCBHHHHT---TCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEEcCCCCcHHHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEE
Confidence            99999985 444432   2234468999999999999999999998 999999999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.93  E-value=1.2e-25  Score=197.09  Aligned_cols=127  Identities=31%  Similarity=0.550  Sum_probs=108.9

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch-----hHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++.....     ...+|+.+|+.++||||++++++|..     ..++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence            469999999999999999999999999999999864322     22369999999999999999999843     33489


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+++++..++...   ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~  133 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLI  133 (324)
T ss_dssp             EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEE
T ss_pred             EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEE
Confidence            99999999888765542   4468999999999999999999998 999999999999985

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.93  E-value=1.8e-25  Score=196.33  Aligned_cols=129  Identities=29%  Similarity=0.436  Sum_probs=105.4

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEEC---CCCCEEEEEEeecc--------chhHHHHHHHHHHcCCCCeeecceeeeec
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFST  202 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  202 (272)
                      ....+|.+.+.||+|+||.||+|++.   .+++.||||++.+.        .....+|+.+|+.++||||++++++|.. 
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   92 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-   92 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-
Confidence            34457999999999999999999985   68999999998643        1234579999999999999999999843 


Q ss_pred             ccCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          ..++|+||||+.+ ++..++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        93 ----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill  154 (327)
T 3a62_A           93 ----GGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIML  154 (327)
T ss_dssp             ----SSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEE
T ss_pred             ----CCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEE
Confidence                3349999999985 55544432    3468899999999999999999998 999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.93  E-value=3.5e-25  Score=198.20  Aligned_cols=133  Identities=24%  Similarity=0.340  Sum_probs=113.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcC--------CCCeeecceeeeeccc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN--------HPNVVSLKHCFFSTTE  204 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~--------h~nIv~l~~~~~~~~~  204 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....   ....+|+.+|+.+.        |+||++++++|.... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence            357999999999999999999999999999999986543   33457999999986        788999999885433 


Q ss_pred             CCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeeC
Q 024091          205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLM  272 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~-~iiHrDlKp~NILl  272 (272)
                      ....++||||||++++++..+...  ....+++..++.++.||+.||.|||+ + +|+||||||+||||
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll  180 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILL  180 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEE
T ss_pred             CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeE
Confidence            355679999999999988765532  23568999999999999999999998 8 99999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.93  E-value=3.4e-25  Score=206.76  Aligned_cols=133  Identities=27%  Similarity=0.341  Sum_probs=111.7

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ....+|.+.++||+|+||.||+|++..+|+.||||++.+..       ....+|+.+|+.++||||++++++|     ..
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  256 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET  256 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence            44567999999999999999999999999999999986431       2345799999999999999999988     34


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++|+||||+.| ++...+.........+++..++.|+.||+.||.|||+ ++|+||||||+||||
T Consensus       257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl  322 (543)
T 3c4z_A          257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLL  322 (543)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEE
Confidence            4559999999985 5544444333334579999999999999999999998 999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.93  E-value=4e-25  Score=196.14  Aligned_cols=132  Identities=30%  Similarity=0.508  Sum_probs=113.9

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---------------hhHHHHHHHHHHcCCCCeeecceeee
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------------RYKNRELQIMRLLNHPNVVSLKHCFF  200 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------------~~~~~E~~~l~~l~h~nIv~l~~~~~  200 (272)
                      ..+|.+.+.||+|+||.||+|.+.. ++.||||.+....               ..+.+|+.+|+.++||||++++++|.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            3579999999999999999998754 8999999884321               34568999999999999999999987


Q ss_pred             ecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       201 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ........++|+||||++++++..+..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILL  167 (362)
T ss_dssp             ECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             eccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEE
Confidence            766566678999999999988876542   34568999999999999999999998 999999999999985

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.93  E-value=4.8e-27  Score=206.74  Aligned_cols=129  Identities=22%  Similarity=0.203  Sum_probs=100.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------------hhHHHHHHHHHHcC---------CCCeee
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLN---------HPNVVS  194 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~E~~~l~~l~---------h~nIv~  194 (272)
                      ..+|.+.+.||+|+||+||+|++  +++.||||++....            ....+|+.+|+.|+         |||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            34699999999999999999998  78999999986542            44568999999886         555555


Q ss_pred             c-----------------ceeeeecc--------cCCceEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHH
Q 024091          195 L-----------------KHCFFSTT--------EKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQIC  248 (272)
Q Consensus       195 l-----------------~~~~~~~~--------~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~  248 (272)
                      +                 +++|....        .....++||||||+.++ ++..+     ....+++..++.|+.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~-----~~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGG-----TTTCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHH-----HhcCCCHHHHHHHHHHHH
Confidence            4                 44442210        00134599999999754 55432     125689999999999999


Q ss_pred             HHHHHHH-hcCCceecCCCCCCeeC
Q 024091          249 RALNYLH-HVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       249 ~~L~ylH-~~~~iiHrDlKp~NILl  272 (272)
                      .||.||| + ++||||||||+||||
T Consensus       172 ~aL~~lH~~-~~ivHrDlKp~NILl  195 (336)
T 2vuw_A          172 ASLAVAEAS-LRFEHRDLHWGNVLL  195 (336)
T ss_dssp             HHHHHHHHH-HCCBCSCCCGGGEEE
T ss_pred             HHHHHHHHh-CCEeECCCCHHHEEE
Confidence            9999999 8 899999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.93  E-value=1.4e-25  Score=199.27  Aligned_cols=128  Identities=23%  Similarity=0.357  Sum_probs=108.1

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHc-CCCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|.+.+.||+|+||.||+|++..+++.||||++.+.       ......|..+|..+ .||||++++++|     .+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence            445799999999999999999999999999999998643       22345789999887 799999999998     44


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++|+||||+.+ ++..++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll  154 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVML  154 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEE
Confidence            4569999999985 55554433    2468999999999999999999998 999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.93  E-value=2.1e-25  Score=205.45  Aligned_cols=129  Identities=28%  Similarity=0.414  Sum_probs=110.1

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||||++...       .....+|+.+|+.++||||+++++++.     .
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~   87 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----T   87 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence            3456799999999999999999999999999999998643       224568999999999999999999984     3


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+|+||||+.+ ++.+++    .....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll  149 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLL  149 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHT----TSSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEE
T ss_pred             CCEEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEE
Confidence            3459999999975 544432    335679999999999999999999998 999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.93  E-value=5.6e-25  Score=194.92  Aligned_cols=126  Identities=27%  Similarity=0.448  Sum_probs=109.8

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .|.+.+.||+|+||.||+|.+..+++.||||++....       ..+.+|+.+|+.++||||++++++|...     ..+
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~  129 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA  129 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CeE
Confidence            5999999999999999999999999999999986431       2345799999999999999999998543     348


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.+++.+++...   ...+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       130 ~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll  187 (348)
T 1u5q_A          130 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILL  187 (348)
T ss_dssp             EEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEE
T ss_pred             EEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEE
Confidence            999999999887765432   4568999999999999999999998 899999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.93  E-value=4.3e-25  Score=197.21  Aligned_cols=131  Identities=23%  Similarity=0.383  Sum_probs=106.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECC-------CCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeec
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST  202 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  202 (272)
                      ..+|.+.+.||+|+||.||+|.+..       ++..||||++....     ..+.+|+.+|+.+ +||||++++++|.. 
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence            4579999999999999999998752       45679999986532     2345899999999 89999999999843 


Q ss_pred             ccCCceEEEEEeecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 024091          203 TEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN  269 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~N  269 (272)
                          ...+|+||||+.+ +|.+++.....            ....+++..+..++.||+.||.|||+ ++|+||||||+|
T Consensus       159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~N  233 (370)
T 2psq_A          159 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN  233 (370)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGG
T ss_pred             ----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchhh
Confidence                3348999999985 66665554321            12458899999999999999999998 999999999999


Q ss_pred             eeC
Q 024091          270 LLM  272 (272)
Q Consensus       270 ILl  272 (272)
                      |||
T Consensus       234 Ill  236 (370)
T 2psq_A          234 VLV  236 (370)
T ss_dssp             EEE
T ss_pred             EEE
Confidence            986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.93  E-value=3.7e-25  Score=192.81  Aligned_cols=127  Identities=27%  Similarity=0.381  Sum_probs=105.5

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch------hHHHHHHHHHHc-CCCCeeecceeeeecccCCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .+|.+.++||+|+||+||+|.+..+++.||||++.....      ....|+..+..+ .||||++++++|.     ...+
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence            469999999999999999999999999999998754221      122455444444 8999999999984     3445


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+++++...+...   ...+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus       132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll  190 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFL  190 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEE
Confidence            9999999999888765443   4569999999999999999999998 899999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.93  E-value=2.1e-25  Score=192.49  Aligned_cols=131  Identities=28%  Similarity=0.490  Sum_probs=108.6

Q ss_pred             cccCeeeeEEeccCCceEEEEEE----ECCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|++.+.||+|+||.||+|+    +..+++.||||.+....    ..+.+|+.+|+.++||||++++++|...... 
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-   86 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR-   86 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT-
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC-
Confidence            34579999999999999999998    45688999999986532    3345899999999999999999987544322 


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ++|+||||+.+ ++.+++...   ...+++..+..++.||+.||.|||+ .+|+||||||+||||
T Consensus        87 --~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~  147 (295)
T 3ugc_A           87 --NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILV  147 (295)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             --ceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEE
Confidence              37899999975 666555432   2358899999999999999999998 999999999999985

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.93  E-value=2.2e-25  Score=195.59  Aligned_cols=125  Identities=28%  Similarity=0.526  Sum_probs=107.1

Q ss_pred             Ceeee---EEeccCCceEEEEEEECCCCCEEEEEEeecc-chhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAE---RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~---~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +|.+.   +.||+|+||.||+|.+..+++.||||++... .....+|+.+++.+. ||||++++++|     .+..++|+
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~l   83 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFL   83 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEEE
Confidence            46654   7899999999999999999999999998654 344568999999997 99999999998     34456999


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+.+ ++.+.+..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll  139 (325)
T 3kn6_A           84 VMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLF  139 (325)
T ss_dssp             EECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEE
Confidence            9999986 55554432    4679999999999999999999998 999999999999985

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.93  E-value=2.5e-25  Score=195.17  Aligned_cols=129  Identities=23%  Similarity=0.383  Sum_probs=107.7

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCC---EEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++   .||||.+...     ...+.+|+.+|+.++||||++++++|.     .
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~  121 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----R  121 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----G
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            34579999999999999999999986655   4999998653     233457999999999999999999983     3


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++|+||||+.+ ++.+++..   ....+++..+..++.||+.||.|||+ .+|+||||||+||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll  184 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLV  184 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             CCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEE
Confidence            4458999999975 55554432   24568999999999999999999998 999999999999985

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.93  E-value=3.9e-25  Score=195.95  Aligned_cols=127  Identities=28%  Similarity=0.417  Sum_probs=104.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...  .....+|+.+|+.+.||||++++++|.     ....+|+|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEEEE
Confidence            45699999999999999999999999999999998653  334567999999999999999999984     33459999


Q ss_pred             eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+.+ ++.+.+.    ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       127 ~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll  181 (349)
T 2w4o_A          127 LELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLY  181 (349)
T ss_dssp             ECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             EEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEE
Confidence            999985 5544332    24568999999999999999999998 999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.92  E-value=3.3e-25  Score=205.56  Aligned_cols=128  Identities=28%  Similarity=0.472  Sum_probs=107.3

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----------------hhHHHHHHHHHHcCCCCeeecce
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----------------RYKNRELQIMRLLNHPNVVSLKH  197 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----------------~~~~~E~~~l~~l~h~nIv~l~~  197 (272)
                      ...+|.+++.||+|+||.||+|.+..+++.||||++....                 ....+|+.+|+.|+||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3457999999999999999999999999999999986421                 23457999999999999999999


Q ss_pred             eeeecccCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       198 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|     .+..++|+|||||.+ .+...+..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~  179 (504)
T 3q5i_A          114 VF-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILL  179 (504)
T ss_dssp             EE-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EE-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEE
Confidence            98     445569999999985 55554433    3468999999999999999999998 999999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.92  E-value=3.8e-25  Score=200.73  Aligned_cols=127  Identities=31%  Similarity=0.479  Sum_probs=107.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------------hhHHHHHHHHHHcCCCCeeecceeeeecc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTT  203 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  203 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....            ..+.+|+.+|+.++||||++++++|.   
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---  210 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---  210 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            457999999999999999999999999999999986432            13468999999999999999999862   


Q ss_pred             cCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        .. .+|+||||+.++.+.   .+......+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       211 --~~-~~~lv~e~~~~g~L~---~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll  272 (419)
T 3i6u_A          211 --AE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLL  272 (419)
T ss_dssp             --SS-EEEEEEECCTTCBGG---GGTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             --cC-ceEEEEEcCCCCcHH---HHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEE
Confidence              11 278999999864332   223345679999999999999999999998 999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.92  E-value=4.2e-25  Score=196.51  Aligned_cols=131  Identities=18%  Similarity=0.242  Sum_probs=107.4

Q ss_pred             ccCeeeeEEeccCCceEEEEE-----EECCCCCEEEEEEeeccc-hhHHHHHHHHHHcC---CCCeeecceeeeecccCC
Q 024091          136 TISYMAERVVGTGSFGVVFQA-----KCLETGDSVAIKKVLQDK-RYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~-----~~~~~~~~vAvK~i~~~~-~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~  206 (272)
                      ..+|.+.+.||+|+||.||+|     .+..+++.||||++.... ....+|+++++.+.   |+||+.+++++....   
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~---  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN---  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS---
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC---
Confidence            346999999999999999999     466789999999986543 34567889998887   999999999985443   


Q ss_pred             ceEEEEEeeccc-ccHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYIS-ETVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ..||||||+. ++|.+++..... ....+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       141 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll  205 (365)
T 3e7e_A          141 --GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFIL  205 (365)
T ss_dssp             --CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEE
T ss_pred             --CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEe
Confidence              3899999998 566666654333 34679999999999999999999998 999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.92  E-value=5e-25  Score=194.84  Aligned_cols=134  Identities=28%  Similarity=0.439  Sum_probs=111.9

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc---C
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE---K  205 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~  205 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+|+.++||||+++++++.....   .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            456799999999999999999999999999999988532      2234589999999999999999998855321   1


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....+|+||||++++++..+..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~  157 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLI  157 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             CCceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEE
Confidence            1446899999999988775543   23568999999999999999999998 999999999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.92  E-value=5.3e-25  Score=188.21  Aligned_cols=129  Identities=30%  Similarity=0.454  Sum_probs=109.5

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+....       ....+|+.+++.++||||++++++|.     ..
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   83 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DS   83 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CS
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cC
Confidence            3457999999999999999999999999999999985431       34568999999999999999999983     44


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|+||||+++ ++..++.   .....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili  145 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLL  145 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHH---TCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEE
T ss_pred             CeEEEEEecCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            569999999985 4444333   223568999999999999999999998 899999999999985

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.92  E-value=2.2e-25  Score=205.76  Aligned_cols=128  Identities=25%  Similarity=0.406  Sum_probs=109.8

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec------cchhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ...+|.+.+.||+|+||+||+|.+..+++.||||++..      ......+|+.+|+.++||||++++++|     ....
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence            44579999999999999999999999999999999853      233456899999999999999999998     3445


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|+||||+.+ .+.+.+..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~  154 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILL  154 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEE
Confidence            59999999985 55554433    2468999999999999999999998 999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.92  E-value=8.6e-25  Score=187.05  Aligned_cols=133  Identities=23%  Similarity=0.429  Sum_probs=113.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeeccc-----------C
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-----------K  205 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----------~  205 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||.+........+|+.+++.++||||++++++|.....           .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   90 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS   90 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence            46999999999999999999999999999999998777778899999999999999999998743211           2


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...++|+||||+++ ++.+++...  ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~  155 (284)
T 2a19_B           91 KTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFL  155 (284)
T ss_dssp             EEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             CcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEE
Confidence            24568999999996 666655432  23568999999999999999999998 999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.92  E-value=5.9e-25  Score=188.38  Aligned_cols=127  Identities=28%  Similarity=0.450  Sum_probs=108.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++     ....+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence            457999999999999999999999999999999986432      2345799999999999999999998     34445


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|+||||+.+ .+...+..    ...+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        80 ~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~  138 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLL  138 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEE
Confidence            8999999986 55444332    3468999999999999999999998 999999999999985

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.92  E-value=6.2e-25  Score=205.88  Aligned_cols=131  Identities=29%  Similarity=0.385  Sum_probs=109.8

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ....+|.+.++||+|+||.||+|++..+|+.||||++...       .....+|+.+|+.++||||++++++|     .+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  255 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET  255 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence            4456799999999999999999999999999999998542       22345799999999999999999988     34


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++||||||+.+ ++..++..  .....+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       256 ~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILl  319 (576)
T 2acx_A          256 KDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILL  319 (576)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEE
Confidence            4569999999985 54443332  123458999999999999999999998 999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.92  E-value=3.4e-25  Score=197.62  Aligned_cols=131  Identities=21%  Similarity=0.243  Sum_probs=106.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEE-----CCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ..+|.+.+.||+|+||.||+|.+     ..+++.||||.+...     ...+.+|+.+++.++||||++++++|..    
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            45799999999999999999994     456789999998542     2234579999999999999999999843    


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       ....|+||||+.+ +|.+++.....   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll  214 (367)
T 3l9p_A          146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLL  214 (367)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEE
Confidence             3337999999974 66666554331   12458899999999999999999998 999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.92  E-value=4.4e-25  Score=192.98  Aligned_cols=127  Identities=25%  Similarity=0.402  Sum_probs=109.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----------chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...          ...+.+|+.+|+.+.||||++++++|.     
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   85 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-----   85 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence            45699999999999999999999999999999998642          233568999999999999999999983     


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....+|+||||+.+ ++.+++.    ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~  148 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIML  148 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             cCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEE
Confidence            34459999999974 6555443    24568999999999999999999998 999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.92  E-value=2.7e-25  Score=204.96  Aligned_cols=127  Identities=31%  Similarity=0.510  Sum_probs=109.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+|+.++||||++++++|     ....
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence            45799999999999999999999999999999998532       23456899999999999999999998     4445


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+.+ .+.+.+.    ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~  159 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLL  159 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             EEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEE
Confidence            69999999985 5544333    24568999999999999999999998 999999999999985

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.92  E-value=1.9e-25  Score=199.79  Aligned_cols=128  Identities=27%  Similarity=0.456  Sum_probs=102.5

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHH-HHHcCCCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQI-MRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|.+++.||+|+||.||+|++..+++.||||++.+..       ....+|..+ ++.++||||++++++|     .+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~  110 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QT  110 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----EC
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----Ee
Confidence            3457999999999999999999999999999999986532       122345555 5678999999999998     34


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++|+||||+.+ .+..++..    ...+++..++.++.||+.||+|||+ ++|+||||||+||||
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll  172 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILL  172 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEE
Confidence            4569999999986 55444432    3468899999999999999999998 999999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.92  E-value=5e-25  Score=188.57  Aligned_cols=129  Identities=33%  Similarity=0.486  Sum_probs=109.8

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+++.++||||++++++|.     +
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   80 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----D   80 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----c
Confidence            4556899999999999999999999999999999998542       233557999999999999999999983     3


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+|+||||+++ .+...+..    ...+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili  142 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLL  142 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEE
T ss_pred             CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEE
Confidence            4459999999985 55554433    2458999999999999999999998 999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.92  E-value=1.3e-24  Score=190.22  Aligned_cols=134  Identities=27%  Similarity=0.414  Sum_probs=113.9

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----hhHHHHHHHHHHcC-CCCeeecceeeeeccc---CCce
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTE---KDEL  208 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~---~~~~  208 (272)
                      .+|++.+.||+|+||.||+|.+..+++.||||.+....    ....+|+.+++.+. ||||+++++++.....   ....
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            36999999999999999999999999999999885432    23457999999996 9999999998854322   4556


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~--iiHrDlKp~NILl  272 (272)
                      .+++||||+++++.+++.... ....+++..++.++.||+.||.|||+ ++  |+||||||+||||
T Consensus       108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~  171 (337)
T 3ll6_A          108 EFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLL  171 (337)
T ss_dssp             EEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEE
T ss_pred             eEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEE
Confidence            789999999999888765433 34569999999999999999999998 88  9999999999985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.92  E-value=5.2e-25  Score=188.19  Aligned_cols=127  Identities=29%  Similarity=0.407  Sum_probs=109.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|.+.+.||+|+||.||+|.+..++..||+|.+...    ...+.+|+.+++.++||||++++++|.     ....+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence            34699999999999999999999999999999998642    344568999999999999999999983     444599


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+.+..    ...+++..++.++.|++.||.|||+ ++|+||||||+|||+
T Consensus        83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~  139 (277)
T 3f3z_A           83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLF  139 (277)
T ss_dssp             EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEE
Confidence            99999985 55454433    3458999999999999999999998 999999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.92  E-value=7.3e-25  Score=192.38  Aligned_cols=130  Identities=31%  Similarity=0.521  Sum_probs=111.5

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||++++++|.     ..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   96 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KK   96 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cC
Confidence            45568999999999999999999999999999999885432      22347999999999999999999984     33


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+|+||||++++++..+.   .....+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus        97 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~  157 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILV  157 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHH---HSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             CEEEEEEecCCcchHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEE
Confidence            4589999999988776433   234568999999999999999999998 999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=5.5e-25  Score=196.30  Aligned_cols=130  Identities=32%  Similarity=0.535  Sum_probs=103.7

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc-CCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  209 (272)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||.+...      .....+|+.+|+.++||||++++++|..... .+...
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4699999999999999999999999999999998432      2234589999999999999999999854321 12234


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+++++..++..     ..+++..++.++.||+.||.|||+ +||+||||||+||||
T Consensus       105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll  161 (367)
T 1cm8_A          105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAV  161 (367)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEE
Confidence            799999998777766543     468999999999999999999998 999999999999985

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=8.6e-25  Score=186.14  Aligned_cols=129  Identities=23%  Similarity=0.362  Sum_probs=107.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ....+|.+.+.||+|+||.||+|.+. +++.||||.+...   ...+.+|+.+++.++||||++++++|..     ...+
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   80 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPI   80 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSE
T ss_pred             eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCce
Confidence            34457999999999999999999986 4678999998653   3445689999999999999999999843     3348


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+++ ++.+++..   ....+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~  139 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLV  139 (269)
T ss_dssp             EEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             EEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEE
Confidence            999999986 45444322   24568999999999999999999998 999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.92  E-value=6.4e-25  Score=193.23  Aligned_cols=127  Identities=28%  Similarity=0.409  Sum_probs=108.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|.+.+.||+|+||.||++.+..+++.||+|++...       ...+.+|+.+++.+.||||++++++|.     +..
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence            44699999999999999999999999999999998643       233457999999999999999999983     445


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+||||+.+ ++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~  174 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFL  174 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             eEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEE
Confidence            69999999985 55554332    3568999999999999999999998 999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.92  E-value=1.5e-24  Score=185.28  Aligned_cols=135  Identities=27%  Similarity=0.364  Sum_probs=113.3

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||+|.+...      ...+.+|+.+++.++||||++++++|....   .
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~   79 (279)
T 2w5a_A            3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---N   79 (279)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---G
T ss_pred             CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---C
Confidence            4456899999999999999999999999999999998642      233457999999999999999999875432   2


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----ceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-----VCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~-----iiHrDlKp~NILl  272 (272)
                      ..+|+||||+.+ ++.+++.........+++..++.++.||+.||.|||+ .+     |+||||||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~  149 (279)
T 2w5a_A           80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFL  149 (279)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEE
T ss_pred             ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEE
Confidence            358999999985 7777666555455669999999999999999999998 78     9999999999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.92  E-value=3.6e-25  Score=204.80  Aligned_cols=127  Identities=27%  Similarity=0.450  Sum_probs=105.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ..+|.+++.||+|+||.||+|++..++..||||++...      .....+|+.+|+.++||||++++++|     .....
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            34699999999999999999999999999999998642      23456899999999999999999998     34455


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+|||||.+ .+.+.+..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       111 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~  169 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLL  169 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEE
Confidence            9999999985 55554433    3468999999999999999999998 999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.92  E-value=5.6e-25  Score=190.38  Aligned_cols=131  Identities=28%  Similarity=0.459  Sum_probs=110.3

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...        .....+|+.+++.++||||++++++++...   .
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE---K   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---C
Confidence            35799999999999999999999999999999998543        234568999999999999999999875332   2


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+|+||||+.+++..++...  ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~  142 (305)
T 2wtk_C           81 QKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLL  142 (305)
T ss_dssp             -CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             CeEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEE
Confidence            348999999998877665543  24568999999999999999999998 999999999999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.92  E-value=1.1e-24  Score=193.84  Aligned_cols=132  Identities=19%  Similarity=0.253  Sum_probs=106.9

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCC-----CCEEEEEEeeccchhHHHHH---------------HHHHHcCCCCeeec
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDKRYKNREL---------------QIMRLLNHPNVVSL  195 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAvK~i~~~~~~~~~E~---------------~~l~~l~h~nIv~l  195 (272)
                      ..+|.+.+.||+|+||.||+|.+..+     ++.||||++........+|+               ..++.+.||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            34699999999999999999998764     58899999876544444444               44556679999999


Q ss_pred             ceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       196 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++++.... ....++||||||+++++..++..   ....+++..++.|+.||+.||.|||+ ++|+||||||+||||
T Consensus       114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill  185 (364)
T 3op5_A          114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEE
Confidence            99986543 44577999999997777665543   24579999999999999999999998 899999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.92  E-value=1.6e-24  Score=195.49  Aligned_cols=133  Identities=25%  Similarity=0.355  Sum_probs=107.5

Q ss_pred             cccCeeee-EEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHH-HHcCCCCeeecceeeeecccCCceEEEE
Q 024091          135 QTISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       135 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ...+|.+. ++||+|+||+||+|.+..+++.||||++... ....+|+.++ +.++||||++++++|.... .+..++||
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l  136 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI  136 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence            34468776 7899999999999999999999999998643 4456788887 5568999999999875422 34567999


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||.+ ++.+++..  .....+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       137 v~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill  194 (400)
T 1nxk_A          137 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLY  194 (400)
T ss_dssp             EEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEE
Confidence            9999985 66554432  123468999999999999999999998 999999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.92  E-value=7.9e-25  Score=187.49  Aligned_cols=126  Identities=25%  Similarity=0.455  Sum_probs=108.5

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++...          ...+.+|+.+++.++||||++++++|.     .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence            3699999999999999999999999999999998642          234568999999999999999999984     3


Q ss_pred             ceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+|+||||+. +++.+++..    ...+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~  141 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIML  141 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEE
Confidence            445899999997 566555433    3468999999999999999999998 999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.92  E-value=1.3e-24  Score=192.05  Aligned_cols=131  Identities=29%  Similarity=0.435  Sum_probs=112.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||.+....     ....+|+.+++.++||||+++++++..........+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            457999999999999999999999999999999985432     233479999999999999999998754433344568


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+++++..++..     ..+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        90 ~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~  145 (353)
T 2b9h_A           90 YIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLI  145 (353)
T ss_dssp             EEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             EEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEE
Confidence            99999999988776543     468999999999999999999998 999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.92  E-value=8.5e-25  Score=188.53  Aligned_cols=128  Identities=28%  Similarity=0.406  Sum_probs=108.8

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.+.||||++++++|.     ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cC
Confidence            345799999999999999999999999999999998543       223457999999999999999999983     44


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|+||||+.+ ++..++..    ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~  148 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFL  148 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEE
Confidence            469999999985 55444332    3468999999999999999999998 999999999999985

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.92  E-value=1e-24  Score=192.55  Aligned_cols=125  Identities=22%  Similarity=0.323  Sum_probs=107.2

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCC--CCeeecceeeeecccCCce
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNH--PNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~~~  208 (272)
                      .+|.+.+.||+|+||.||+|.+ .+++.||||++....      ..+.+|+.+|+.+.|  |||+++++++.     ...
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~   82 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ   82 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eCC
Confidence            4699999999999999999987 468899999986432      334579999999987  99999999884     444


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||||+.++++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        83 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll  141 (343)
T 3dbq_A           83 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLI  141 (343)
T ss_dssp             EEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEE
Confidence            6999999888888776653    4568999999999999999999998 899999999999985

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.92  E-value=5.2e-25  Score=197.06  Aligned_cols=130  Identities=19%  Similarity=0.290  Sum_probs=109.7

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||.+....     ..+.+|+.+|+.++||||+++++++..     ..
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~  185 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQ  185 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CC
Confidence            44567999999999999999999999899999999986432     234579999999999999999999843     33


Q ss_pred             EEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|+||||++ +++.+++...   ...+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~  246 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLV  246 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             CcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEE
Confidence            4899999998 5666655432   3458899999999999999999998 999999999999985

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.92  E-value=3.1e-25  Score=195.51  Aligned_cols=127  Identities=23%  Similarity=0.410  Sum_probs=108.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------------hhHHHHHHHHHHcCCCCeeecceeeeecc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTT  203 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  203 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....            ..+.+|+.+|+.++||||++++++|    
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~----   98 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF----   98 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            347999999999999999999999999999999986532            1334799999999999999999998    


Q ss_pred             cCCceEEEEEeecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       ....++++||||+.+  .+..++.    ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        99 -~~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll  163 (335)
T 3dls_A           99 -ENQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVI  163 (335)
T ss_dssp             -ECSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             -eeCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEE
Confidence             444569999999874  5544333    34569999999999999999999998 999999999999985

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.92  E-value=6.5e-25  Score=193.05  Aligned_cols=132  Identities=23%  Similarity=0.312  Sum_probs=108.7

Q ss_pred             cccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeeccc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  204 (272)
                      ...+|.+.+.||+|+||.||+|.+.     .+++.||||.+....     ..+.+|+.+++.++||||++++++|..   
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV---  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc---
Confidence            3457999999999999999999986     345899999986532     334589999999999999999999843   


Q ss_pred             CCceEEEEEeecccc-cHHHHHHHhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceec
Q 024091          205 KDELYLNLVLEYISE-TVYRVSKHYTRM--------------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHR  263 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------------------~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHr  263 (272)
                        ...+|+||||+.+ ++.+++......                    ...+++..++.++.||+.||.|||+ ++|+||
T Consensus       122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~  198 (343)
T 1luf_A          122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHR  198 (343)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred             --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence              3348999999985 666655542211                    2568999999999999999999998 999999


Q ss_pred             CCCCCCeeC
Q 024091          264 DIKPQNLLM  272 (272)
Q Consensus       264 DlKp~NILl  272 (272)
                      ||||+||||
T Consensus       199 Dlkp~NIl~  207 (343)
T 1luf_A          199 DLATRNCLV  207 (343)
T ss_dssp             CCSGGGEEE
T ss_pred             CCCcceEEE
Confidence            999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.92  E-value=1.6e-24  Score=193.34  Aligned_cols=130  Identities=26%  Similarity=0.428  Sum_probs=110.4

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc-CCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~  208 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++||||++++++|..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            35799999999999999999999999999999998642      1234579999999999999999998854321 2234


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|+||||+++++...+.      ..+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       104 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~  160 (371)
T 2xrw_A          104 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVV  160 (371)
T ss_dssp             EEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             ceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEE
Confidence            689999999998876553      348899999999999999999998 999999999999985

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.92  E-value=1.1e-24  Score=187.94  Aligned_cols=128  Identities=32%  Similarity=0.577  Sum_probs=109.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||.+...      .....+|+.+++.++||||+++++++...     ..+
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   77 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL   77 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecC-----Cce
Confidence            4799999999999999999999999999999988543      23456899999999999999999998543     348


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.+++.+++....  ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus        78 ~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nili  136 (299)
T 2r3i_A           78 YLVFEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLI  136 (299)
T ss_dssp             EEEEECCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             EEEEEcccCCHHHHHHhhh--ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHeEE
Confidence            9999999998877665422  2458899999999999999999998 999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.92  E-value=7.7e-25  Score=190.55  Aligned_cols=127  Identities=27%  Similarity=0.405  Sum_probs=107.1

Q ss_pred             ccCeeee-EEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHc-CCCCeeecceeeeecccCCceE
Q 024091          136 TISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ..+|.+. +.||+|+||.||+|.+..+++.||||++...    .....+|+++|..+ .||||++++++|..     ..+
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCE
Confidence            4568885 7899999999999999999999999998643    23456899999885 79999999999843     335


Q ss_pred             EEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+. +++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        86 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~  144 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILC  144 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             EEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEE
Confidence            999999998 566555443    2468999999999999999999998 899999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=4.2e-25  Score=195.23  Aligned_cols=129  Identities=29%  Similarity=0.494  Sum_probs=105.6

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---------chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||++...         .....+|+.+++.++||||++++++|.     
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   82 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----   82 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-----
Confidence            345799999999999999999999999999999998532         123458999999999999999999984     


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....+|+||||+++++...+..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        83 ~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~  145 (346)
T 1ua2_A           83 HKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLL  145 (346)
T ss_dssp             CTTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             eCCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEE
Confidence            3334899999999987764432   34468888899999999999999998 999999999999985

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.92  E-value=5e-25  Score=192.05  Aligned_cols=130  Identities=29%  Similarity=0.496  Sum_probs=106.3

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....+|.+.+.||+|+||.||+|.+  +++.||||++....      ..+.+|+.+|+.++||||++++++|.     ..
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~  106 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----QP  106 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----ST
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence            3455799999999999999999987  68899999985432      23457999999999999999999984     33


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~--iiHrDlKp~NILl  272 (272)
                      ..+|+||||+.+ ++.+++.... ....+++..++.++.||+.||.|||+ ++  |+||||||+||||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll  172 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLV  172 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEE
T ss_pred             CceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEE
Confidence            348999999985 5555443211 11238899999999999999999998 89  9999999999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.92  E-value=4e-24  Score=185.09  Aligned_cols=134  Identities=24%  Similarity=0.335  Sum_probs=110.7

Q ss_pred             CcccCeeee-EEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHH-HHcCCCCeeecceeeeecccCCceEEE
Q 024091          134 KQTISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       134 ~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ....+|.+. +.||+|+||.||+|.+..+++.||||++... ....+|+.++ +.+.||||++++++|.... ....++|
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~   91 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL   91 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEE
Confidence            344568877 8899999999999999999999999998643 4456788887 6678999999999875422 3456799


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+++...  ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~  150 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLY  150 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEE
Confidence            99999985 666655432  23468999999999999999999998 999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.92  E-value=7.7e-25  Score=197.59  Aligned_cols=131  Identities=31%  Similarity=0.508  Sum_probs=103.1

Q ss_pred             Ceee-eEEeccCCceEEEEEEEC--CCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMA-ERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~-~~~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .|.+ .++||+|+||.||+|.+.  .+++.||||++...  .....+|+.+|+.|+||||++++++|....   ..++||
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeEEE
Confidence            4766 568999999999999976  46889999998653  334568999999999999999999985432   335899


Q ss_pred             EeecccccHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRM-----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||++++++.++......     ...+++..++.|+.||+.||.|||+ ++|+||||||+||||
T Consensus        98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll  161 (405)
T 3rgf_A           98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILV  161 (405)
T ss_dssp             EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEE
Confidence            9999999988876543321     2248999999999999999999998 999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.92  E-value=1.1e-24  Score=198.18  Aligned_cols=130  Identities=29%  Similarity=0.437  Sum_probs=110.9

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHc------CCCCeeecceeeeecccC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL------NHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~  205 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||++....   ....+|+.+++.+      .|+||++++++|...   
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~---  171 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR---  171 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET---
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC---
Confidence            3457999999999999999999999999999999997653   3345789998887      577999999998443   


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        .++|+||||+++++++++....  ...+++..++.++.||+.||.|||+ ++||||||||+||||
T Consensus       172 --~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl  233 (429)
T 3kvw_A          172 --NHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILL  233 (429)
T ss_dssp             --TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEE
T ss_pred             --CeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEE
Confidence              4599999999999888765432  3458999999999999999999998 899999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.92  E-value=9e-25  Score=190.96  Aligned_cols=125  Identities=33%  Similarity=0.520  Sum_probs=105.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------------hhHHHHHHHHHHcCCCCeeecceeeeeccc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  204 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++....            ....+|+.+|+.++||||+++++++..   
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   86 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA---   86 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC---
Confidence            46999999999999999999999999999999985421            234589999999999999999998732   


Q ss_pred             CCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        .. +|+||||+.+ ++.+.+    .....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        87 --~~-~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~  147 (322)
T 2ycf_A           87 --ED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLL  147 (322)
T ss_dssp             --SS-EEEEEECCTTEETHHHH----STTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             --Cc-eEEEEecCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEE
Confidence              11 7899999985 554433    234578999999999999999999998 999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.92  E-value=1.4e-24  Score=188.62  Aligned_cols=130  Identities=31%  Similarity=0.482  Sum_probs=105.2

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecc---------
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTT---------  203 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---------  203 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||.+....    ....+|+.+++.++||||+++++++....         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            46999999999999999999999999999999886432    33458999999999999999999874321         


Q ss_pred             cCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ......+|+||||+++++.+++.     ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        91 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~  153 (320)
T 2i6l_A           91 LTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFI  153 (320)
T ss_dssp             CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEE
T ss_pred             ccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEE
Confidence            12345689999999988776543     3568999999999999999999998 999999999999985

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.92  E-value=6.9e-25  Score=188.40  Aligned_cols=129  Identities=19%  Similarity=0.253  Sum_probs=107.5

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCC-------CEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETG-------DSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTT  203 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-------~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  203 (272)
                      ...+|.+.+.||+|+||.||+|.+..++       ..||+|.+....    ..+.+|+.+++.++||||++++++|... 
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   84 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-   84 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-
Confidence            3457999999999999999999988776       469999985432    3355899999999999999999998443 


Q ss_pred             cCCceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          ...|+||||+. +++.+++...   ...+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        85 ----~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll  146 (289)
T 4fvq_A           85 ----DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILL  146 (289)
T ss_dssp             ----TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             ----CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEE
Confidence                33789999998 5666555432   2348899999999999999999998 999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.92  E-value=1.5e-24  Score=195.09  Aligned_cols=124  Identities=22%  Similarity=0.318  Sum_probs=105.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcC--CCCeeecceeeeecccCCceE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLN--HPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      +|.+.+.||+|+||.||+|.+.. ++.||||++....      ..+.+|+.+|+.|.  ||||+++++++..     ..+
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~~  130 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQY  130 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CCE
Confidence            59999999999999999998765 8999999985432      33458999999997  5999999998843     345


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||||+.++++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       131 ~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll  188 (390)
T 2zmd_A          131 IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLI  188 (390)
T ss_dssp             EEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEE
T ss_pred             EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEE
Confidence            999999877888776554    3468888999999999999999998 999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.92  E-value=3.1e-24  Score=186.38  Aligned_cols=132  Identities=35%  Similarity=0.577  Sum_probs=111.3

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+...       ...+.+|+.+++.++||||++++++|...     
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----
Confidence            345799999999999999999999999999999998641       22345799999999999999999998543     


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+++||||+.+ ++.+++.........+++..++.++.||+.||.|||+ .+|+|+||||+||||
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~  169 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFI  169 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEE
Confidence            348999999985 6666666555556779999999999999999999998 999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.92  E-value=3.9e-24  Score=188.43  Aligned_cols=135  Identities=21%  Similarity=0.332  Sum_probs=110.3

Q ss_pred             CcccCeeeeE-EeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          134 KQTISYMAER-VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       134 ~~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ....+|.+.+ +||+|+||.||+|.+..+++.||||++.............++.+.||||++++++|.... ....++|+
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l  103 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLI  103 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEE
Confidence            4456799854 699999999999999999999999999766554444555678889999999999875433 34567999


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+.+ ++.+++..  .....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       104 v~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll  161 (336)
T 3fhr_A          104 IMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLY  161 (336)
T ss_dssp             EEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            9999986 66555443  223468999999999999999999998 999999999999985

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.92  E-value=3e-25  Score=195.46  Aligned_cols=131  Identities=32%  Similarity=0.501  Sum_probs=105.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...         .....+|+.+|+.++||||++++++|     .+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence            34699999999999999999999999999999998543         13455799999999999999999998     34


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhh------------------------------------cCCCCCHHHHHHHHHHHHH
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTR------------------------------------MNQHVPILYVQLYTYQICR  249 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------~~~~~~~~~~~~i~~qi~~  249 (272)
                      ..++|+||||+.+ ++.+++..+..                                    ....+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            4569999999975 54443321000                                    0122457778889999999


Q ss_pred             HHHHHHhcCCceecCCCCCCeeC
Q 024091          250 ALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       250 ~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||.|||+ .+|+||||||+||||
T Consensus       180 ~l~~LH~-~~ivH~Dlkp~NIll  201 (345)
T 3hko_A          180 ALHYLHN-QGICHRDIKPENFLF  201 (345)
T ss_dssp             HHHHHHH-TTEECCCCCGGGEEE
T ss_pred             HHHHHHH-CCccccCCChhhEEE
Confidence            9999998 899999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.92  E-value=4.7e-24  Score=186.24  Aligned_cols=136  Identities=32%  Similarity=0.507  Sum_probs=113.3

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEEC-CCCCEEEEEEeecc------chhHHHHHHHHHHc---CCCCeeecceeeeecc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCL-ETGDSVAIKKVLQD------KRYKNRELQIMRLL---NHPNVVSLKHCFFSTT  203 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vAvK~i~~~------~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~  203 (272)
                      ....+|.+.+.||+|+||.||+|.+. .+++.||||++...      .....+|+.+++.+   .||||++++++|....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            44567999999999999999999995 67899999988532      22455788888777   8999999999986544


Q ss_pred             cCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ......+++||||+++++..++....  ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili  153 (326)
T 1blx_A           88 TDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILV  153 (326)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             cCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEE
Confidence            44667799999999998877665422  3458999999999999999999998 999999999999985

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.92  E-value=2.9e-24  Score=185.11  Aligned_cols=128  Identities=24%  Similarity=0.356  Sum_probs=110.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec--cchhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++..  ......+|+.+++.+ .|+||+++++++.     ...+.|+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCceeEE
Confidence            3469999999999999999999999999999998854  334567899999999 7999999998873     3345899


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||+++++.+++...   ...+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        84 v~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~  139 (298)
T 1csn_A           84 VIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLI  139 (298)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEE
T ss_pred             EEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEe
Confidence            9999988887766532   3468999999999999999999998 999999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.92  E-value=1.3e-24  Score=185.34  Aligned_cols=126  Identities=31%  Similarity=0.414  Sum_probs=107.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++..     ....|
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   81 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQY   81 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEEE
Confidence            46999999999999999999999999999999986432     345689999999999999999998843     34589


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+    +......+++..++.++.||+.||.|||+ ++|+|+||||+|||+
T Consensus        82 lv~e~~~~~~L~~----~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~  138 (276)
T 2yex_A           82 LFLEYCSGGELFD----RIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLL  138 (276)
T ss_dssp             EEEECCTTEEGGG----GSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEEEecCCCcHHH----HHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEE
Confidence            99999986 4433    23334578999999999999999999998 999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.92  E-value=2.8e-25  Score=203.03  Aligned_cols=129  Identities=26%  Similarity=0.360  Sum_probs=102.9

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+|+.++||||++++++|...     
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----  220 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----  220 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----
Confidence            456799999999999999999999999999999998643       12334789999999999999999998433     


Q ss_pred             eEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++||||||++++ +...+..    ...+++..++.++.||+.||.|||+.++||||||||+||||
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll  282 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML  282 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE
T ss_pred             CEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE
Confidence            3499999999864 4443322    34689999999999999999999952699999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.92  E-value=2.2e-24  Score=186.40  Aligned_cols=129  Identities=25%  Similarity=0.392  Sum_probs=106.3

Q ss_pred             cCeeeeEEeccCCceEEEEEE----ECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          137 ISYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      .+|++.+.||+|+||.||+|.    +..+++.||||.+...     .....+|+.+|+.++||||++++++|....   .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---G   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---C
Confidence            459999999999999999998    4568899999998643     234568999999999999999999885432   2


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++++||||+.+ ++.+++..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~  159 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLV  159 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             ceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEE
Confidence            348999999985 66555432   24568999999999999999999998 999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.92  E-value=2.9e-24  Score=187.99  Aligned_cols=127  Identities=28%  Similarity=0.511  Sum_probs=107.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-chhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+|+.+. ||||+++++++....   ..+.++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCceEEE
Confidence            34699999999999999999999999999999998643 445678999999997 999999999885322   3448999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+.++.+..+.      ..+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       112 ~e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~  163 (330)
T 3nsz_A          112 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMI  163 (330)
T ss_dssp             EECCCCCCHHHHG------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EeccCchhHHHHH------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEE
Confidence            9999966543221      238889999999999999999998 999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.92  E-value=1.6e-24  Score=188.06  Aligned_cols=132  Identities=22%  Similarity=0.407  Sum_probs=107.6

Q ss_pred             cccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeeccc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  204 (272)
                      ...+|.+.+.||+|+||.||+|.+.     .+++.||||++....     ..+.+|+.+|+.++||||++++++|..   
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ---   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence            3457999999999999999999984     355889999986532     334579999999999999999998843   


Q ss_pred             CCceEEEEEeeccc-ccHHHHHHHhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceec
Q 024091          205 KDELYLNLVLEYIS-ETVYRVSKHYTR--------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHR  263 (272)
Q Consensus       205 ~~~~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHr  263 (272)
                        ...+|+||||+. +++.+++.....                    ....+++..++.++.||+.||.|||+ ++|+||
T Consensus        98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~  174 (314)
T 2ivs_A           98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHR  174 (314)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred             --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCccc
Confidence              334899999998 566665554322                    12348899999999999999999998 999999


Q ss_pred             CCCCCCeeC
Q 024091          264 DIKPQNLLM  272 (272)
Q Consensus       264 DlKp~NILl  272 (272)
                      ||||+||||
T Consensus       175 dikp~NIli  183 (314)
T 2ivs_A          175 DLAARNILV  183 (314)
T ss_dssp             CCSGGGEEE
T ss_pred             ccchheEEE
Confidence            999999985

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.91  E-value=1.1e-24  Score=190.65  Aligned_cols=129  Identities=24%  Similarity=0.331  Sum_probs=107.1

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch---hHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ...+|.+.++||+|+||.||+|++.  ++.||||++.....   ...+|+.+|+.++||||++++++|.... .....+|
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence            3457999999999999999999874  78999999864432   2346888899999999999999986543 2345689


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------CceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV----------GVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~----------~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+++..     ..+++..++.++.||+.||.|||+ .          +|+||||||+||||
T Consensus        99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill  164 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLL  164 (322)
T ss_dssp             EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEE
T ss_pred             EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEE
Confidence            99999985 66555432     358999999999999999999998 8          99999999999985

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.91  E-value=1.2e-24  Score=201.37  Aligned_cols=131  Identities=21%  Similarity=0.342  Sum_probs=111.2

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ....+|.+.+.||+|+||.||+|.+..++..||||.+...   ...+.+|+.+|+.++||||++++++|...     ..+
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~  291 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPF  291 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSC
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CcE
Confidence            3455799999999999999999999988999999998654   33456899999999999999999998433     348


Q ss_pred             EEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||+. ++|.+++...  ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       292 ~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll  351 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLV  351 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEE
Confidence            99999998 5666655432  23458899999999999999999998 999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.91  E-value=3.4e-24  Score=185.00  Aligned_cols=129  Identities=22%  Similarity=0.345  Sum_probs=106.7

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-hhHHHHHHHHHH--cCCCCeeecceeeeecccCCceEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRL--LNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ...+|.+.+.||+|+||.||+|.+  +++.||||++.... ....+|.+++..  ++||||+++++++.... .....+|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~   82 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLW   82 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeE
Confidence            345799999999999999999988  68999999986543 334467777777  78999999999876543 3456789


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--------HVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH--------~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+++.     ...+++..+..++.||+.||.|||        + ++|+||||||+||||
T Consensus        83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill  146 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILV  146 (301)
T ss_dssp             EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEE
T ss_pred             EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEE
Confidence            99999985 5555442     346899999999999999999999        8 899999999999985

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.91  E-value=2.5e-24  Score=184.80  Aligned_cols=127  Identities=24%  Similarity=0.432  Sum_probs=106.8

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----------hhHHHHHHHHHHcCCCCeeecceeeeecc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----------RYKNRELQIMRLLNHPNVVSLKHCFFSTT  203 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  203 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+....           ..+.+|+.+++.++||||+++++++    
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----   92 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM----   92 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee----
Confidence            3457999999999999999999999999999999984321           3456899999999999999999987    


Q ss_pred             cCCceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~--iiHrDlKp~NILl  272 (272)
                       .+.  .++||||+. +++.+.+.   .....+++..++.++.|++.||.|||+ ++  |+||||||+||||
T Consensus        93 -~~~--~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~  157 (287)
T 4f0f_A           93 -HNP--PRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFL  157 (287)
T ss_dssp             -TTT--TEEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEE
T ss_pred             -cCC--CeEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEE
Confidence             222  258999998 55555433   234568999999999999999999998 89  9999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.91  E-value=1.6e-24  Score=191.82  Aligned_cols=134  Identities=22%  Similarity=0.325  Sum_probs=107.5

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEE-----CCCCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeec
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST  202 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  202 (272)
                      ....+|.+.+.||+|+||.||+|.+     ..+++.||||++....     ..+.+|+.+|+.+ +||||++++++|...
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            3455799999999999999999984     4567899999986532     2356899999999 789999999988533


Q ss_pred             ccCCceEEEEEeecccc-cHHHHHHHhhhc--------------------------------------------------
Q 024091          203 TEKDELYLNLVLEYISE-TVYRVSKHYTRM--------------------------------------------------  231 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------------------------------------------------  231 (272)
                      .    .++++||||+.+ ++.+++......                                                  
T Consensus        99 ~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           99 G----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             T----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             C----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            2    337899999985 655555432210                                                  


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          232 ------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       232 ------------~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                                  ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll  226 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL  226 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEE
Confidence                        1228899999999999999999998 999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.91  E-value=8.6e-25  Score=195.53  Aligned_cols=125  Identities=26%  Similarity=0.447  Sum_probs=100.3

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      |...+.||+|+||.||+|.+..+++.||||++...    ...+.+|+.+|+.|+||||++++++|.     ....+||||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEE
Confidence            34467899999999999999999999999998653    334568999999999999999999984     344599999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+++ ++.+.+..   ....+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus       166 E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll  220 (373)
T 2x4f_A          166 EYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILC  220 (373)
T ss_dssp             ECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             eCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEE
Confidence            99985 55554432   23458899999999999999999998 999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.91  E-value=1.6e-24  Score=185.97  Aligned_cols=131  Identities=22%  Similarity=0.362  Sum_probs=111.2

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ....+|.+.+.||+|+||.||+|.+..++..||||.+....   ..+.+|+.+++.++||||+++++++.     ....+
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   84 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF   84 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCE
Confidence            44567999999999999999999999999999999986543   33558999999999999999999883     33448


Q ss_pred             EEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+. +++.+++...  ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~  144 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV  144 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEE
T ss_pred             EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEE
Confidence            99999998 5666555432  23568999999999999999999998 899999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.91  E-value=1.9e-24  Score=185.46  Aligned_cols=129  Identities=29%  Similarity=0.471  Sum_probs=110.1

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+++.++||||++++++|.     .
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   85 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----D   85 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----c
Confidence            3456799999999999999999999999999999998542       234568999999999999999999984     3


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+|+||||+.+ ++.+.+..    ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~  147 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLM  147 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEE
T ss_pred             CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEE
Confidence            4458999999985 66555443    2468999999999999999999998 999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.91  E-value=2.8e-24  Score=184.92  Aligned_cols=129  Identities=27%  Similarity=0.375  Sum_probs=109.5

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .|.+.+.||+|+||.||+|.+..++..||+|.+....      ..+.+|+.+|+.++||||++++++|.... ....++|
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  105 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV  105 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEE
Confidence            4899999999999999999999999999999986432      23457999999999999999999875443 4567799


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~--iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+++..    ...+++..++.++.||+.||.|||+ .+  |+||||||+||||
T Consensus       106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~  164 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFI  164 (290)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEE
T ss_pred             EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEE
Confidence            99999975 65555433    3568899999999999999999998 88  9999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.91  E-value=2.3e-24  Score=184.74  Aligned_cols=129  Identities=23%  Similarity=0.317  Sum_probs=104.9

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ....+|.+.+.||+|+||.||+|.+. ++..||||++...   ...+.+|+.+++.++||||++++++|.     ....+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   94 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPI   94 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCe
Confidence            44557999999999999999999875 5678999998653   344568999999999999999999883     33448


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.+ ++.+++..   ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        95 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili  153 (283)
T 3gen_A           95 FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLV  153 (283)
T ss_dssp             EEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEE
T ss_pred             EEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEE
Confidence            999999974 55554432   23458999999999999999999998 999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.91  E-value=1.9e-24  Score=187.26  Aligned_cols=127  Identities=27%  Similarity=0.439  Sum_probs=108.3

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...    .....+|+.+++.++||||++++++|.     ....+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence            34699999999999999999999999999999998643    233568999999999999999999883     344589


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+.+..    ...+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~  139 (304)
T 2jam_A           83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLY  139 (304)
T ss_dssp             EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEE
T ss_pred             EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEE
Confidence            99999985 66555433    2468999999999999999999998 999999999999985

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.91  E-value=3e-24  Score=187.99  Aligned_cols=125  Identities=26%  Similarity=0.343  Sum_probs=106.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .|...+.||+|+||.||+|.+..+|+.||||++...    .....+|+.+|+.++||||++++++|....     .+|+|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-----ELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EEEEE
Confidence            478888999999999999999999999999998643    233568999999999999999999985433     48999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+.++.+..+..    ...+++..+..++.||+.||.|||+ .+|+||||||+||||
T Consensus       121 ~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll  174 (321)
T 2c30_A          121 MEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILL  174 (321)
T ss_dssp             ECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEE
Confidence            99998654442221    3468999999999999999999998 999999999999985

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.91  E-value=2.6e-24  Score=183.00  Aligned_cols=128  Identities=24%  Similarity=0.348  Sum_probs=107.2

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ...+|.+.+.||+|+||.||+|.+. ++..||||.+...   .....+|+.+++.++||||+++++++     .....+|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence            4457999999999999999999875 5677999998653   33456899999999999999999988     3344489


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+++ ++.+++...   ...+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus        80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~  137 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLV  137 (268)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEE
T ss_pred             EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEE
Confidence            99999975 565555432   3458999999999999999999998 999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.91  E-value=2.3e-24  Score=183.89  Aligned_cols=129  Identities=28%  Similarity=0.432  Sum_probs=109.7

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+++.++||||+++++++.     .
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   82 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----T   82 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----c
Confidence            3456799999999999999999999999999999998543       124458999999999999999999884     3


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+|+||||+.+ ++.+++..    ...+++..+..++.||+.||.|||+ ++|+|+||||+|||+
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~  144 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLL  144 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEE
T ss_pred             CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEE
Confidence            3458999999975 66555443    2468899999999999999999998 899999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.91  E-value=4.1e-24  Score=184.69  Aligned_cols=129  Identities=26%  Similarity=0.384  Sum_probs=107.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++...    ...+.+|+.+++.++||||++++++|...     ..+|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   92 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLW   92 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEE
Confidence            34699999999999999999999999999999988542    23455799999999999999999998543     3489


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||++++.+..+..  .....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        93 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~  150 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIML--ELDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLM  150 (302)
T ss_dssp             EEEECCTTEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEE
T ss_pred             EEEEeCCCCcHHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEE
Confidence            9999998655442221  224568999999999999999999998 999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.91  E-value=3.7e-24  Score=184.64  Aligned_cols=128  Identities=21%  Similarity=0.381  Sum_probs=109.0

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------------hhHHHHHHHHHHcC-CCCeeecceeee
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------------RYKNRELQIMRLLN-HPNVVSLKHCFF  200 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------------~~~~~E~~~l~~l~-h~nIv~l~~~~~  200 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||++....             ....+|+.+++.+. ||||++++++| 
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-   93 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-   93 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence            3557999999999999999999999999999999985431             23347999999996 99999999988 


Q ss_pred             ecccCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          201 STTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       201 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          ....++|+||||+.+ ++.+++..    ...+++..++.++.||+.||.|||+ ++|+|+||||+|||+
T Consensus        94 ----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~  157 (298)
T 1phk_A           94 ----ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILL  157 (298)
T ss_dssp             ----ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             ----ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEE
Confidence                344569999999984 66555443    3468999999999999999999998 999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.6e-24  Score=192.32  Aligned_cols=128  Identities=30%  Similarity=0.492  Sum_probs=106.8

Q ss_pred             cccCeeeeEEeccCCceEEEEEEEC---CCCCEEEEEEeecc--------chhHHHHHHHHHHc-CCCCeeecceeeeec
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLL-NHPNVVSLKHCFFST  202 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~--------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  202 (272)
                      ...+|.+.+.||+|+||.||+|++.   .+++.||||++...        .....+|+++|+.+ .||||++++++|.. 
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  130 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-  130 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-
Confidence            3457999999999999999999985   48999999988532        23344799999999 69999999998843 


Q ss_pred             ccCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          ...+||||||+.+ ++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       131 ----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll  192 (355)
T 1vzo_A          131 ----ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILL  192 (355)
T ss_dssp             ----TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             ----CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence                3348999999985 55554443    2468999999999999999999998 999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.91  E-value=2.9e-25  Score=198.61  Aligned_cols=136  Identities=15%  Similarity=0.232  Sum_probs=102.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHH---HHHHHcCCCCeeecceeee-----
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNREL---QIMRLLNHPNVVSLKHCFF-----  200 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~---~~l~~l~h~nIv~l~~~~~-----  200 (272)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++...       ...+.+|+   .+|+.++|||||++++.|.     
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            34699999999999999999999889999999998532       23455899   4555568999999984432     


Q ss_pred             --ecc---------cCCce---EEEEEeecccccHHHHHHHhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCceec
Q 024091          201 --STT---------EKDEL---YLNLVLEYISETVYRVSKHYTRMNQ---HVPILYVQLYTYQICRALNYLHHVVGVCHR  263 (272)
Q Consensus       201 --~~~---------~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~~---~~~~~~~~~i~~qi~~~L~ylH~~~~iiHr  263 (272)
                        ..+         .....   ..||||||++|++.+++........   .+++..+..|+.||+.||.|||+ ++|+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence              111         01111   2789999999988887765432221   23457778899999999999998 999999


Q ss_pred             CCCCCCeeC
Q 024091          264 DIKPQNLLM  272 (272)
Q Consensus       264 DlKp~NILl  272 (272)
                      ||||+||||
T Consensus       231 Dikp~NIll  239 (377)
T 3byv_A          231 YLRPVDIVL  239 (377)
T ss_dssp             CCCGGGEEE
T ss_pred             CCCHHHEEE
Confidence            999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.91  E-value=3.6e-24  Score=184.53  Aligned_cols=132  Identities=28%  Similarity=0.388  Sum_probs=110.1

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCeeecceeeeecc--------cC
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTT--------EK  205 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--------~~  205 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||.+....   ....+|+.+++.++||||++++++|....        ..
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            46999999999999999999999999999999986532   33457999999999999999999875432        12


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....+|+||||+.+ ++.+++..   ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~  149 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFI  149 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             cCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEE
Confidence            35679999999985 66665543   23457888899999999999999998 999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.91  E-value=4e-24  Score=190.06  Aligned_cols=135  Identities=29%  Similarity=0.520  Sum_probs=114.2

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcC-----------CCCeeecceee
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN-----------HPNVVSLKHCF  199 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~-----------h~nIv~l~~~~  199 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++....   ....+|+.+++.+.           ||||++++++|
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            34457999999999999999999999999999999987542   33457999998886           89999999998


Q ss_pred             eecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeeC
Q 024091          200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLM  272 (272)
Q Consensus       200 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~-~iiHrDlKp~NILl  272 (272)
                      .... .+..++++||||+++++..++....  ...+++..++.++.||+.||.|||+ + +|+||||||+||||
T Consensus        96 ~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll  165 (373)
T 1q8y_A           96 NHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLM  165 (373)
T ss_dssp             EEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEE
T ss_pred             hccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEE
Confidence            6543 3455799999999888887765432  3458999999999999999999998 8 99999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.91  E-value=1.9e-24  Score=188.03  Aligned_cols=129  Identities=26%  Similarity=0.308  Sum_probs=108.8

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++....       ..+.+|+.+++.++||||+++++++..     
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----  105 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----  105 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----
Confidence            44567999999999999999999999999999999986431       334579999999999999999998844     


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+|+||||+.+ ++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~  167 (309)
T 2h34_A          106 DGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILV  167 (309)
T ss_dssp             TTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             CCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEE
Confidence            3358999999986 65555443    3468999999999999999999998 999999999999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.91  E-value=1.1e-24  Score=194.73  Aligned_cols=129  Identities=25%  Similarity=0.407  Sum_probs=106.2

Q ss_pred             cccCeeeeEEeccCCceEEEEEEEC---CCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|.+.+.||+|+||.||+|++.   .++..||||.+...     ...+.+|+.+|+.++||||+++++++..     
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----  117 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----  117 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----
Confidence            3457999999999999999999876   45778999998643     2335589999999999999999999843     


Q ss_pred             ceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+|+||||++ +++.+++..   ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll  180 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILI  180 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             CCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEE
Confidence            334899999997 465554432   23468999999999999999999998 999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.91  E-value=1.1e-24  Score=194.45  Aligned_cols=130  Identities=32%  Similarity=0.476  Sum_probs=103.2

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc-CCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  209 (272)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+|+.++||||++++++|..... .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4799999999999999999999999999999998542      2234479999999999999999998854311 12234


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+|||++++++..++..     ..+++..++.++.||+.||.|||+ .||+||||||+||||
T Consensus       109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll  165 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAV  165 (367)
T ss_dssp             CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEE
Confidence            799999998877665432     468999999999999999999998 999999999999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.91  E-value=2.4e-24  Score=206.31  Aligned_cols=129  Identities=23%  Similarity=0.351  Sum_probs=108.1

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHc-CCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  205 (272)
                      ....+|.++++||+|+||.||+|++..+++.||||++.+.       ......|..+|..+ .||||+.++++|     .
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~  412 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----Q  412 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----B
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----E
Confidence            3456799999999999999999999999999999998642       22345788898887 699999999988     4


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +..++||||||+.+ +|..++..    ...+++..++.|+.||+.||+|||+ ++||||||||+||||
T Consensus       413 ~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl  475 (674)
T 3pfq_A          413 TMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVML  475 (674)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEE
T ss_pred             eCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEE
Confidence            55569999999985 55444433    3469999999999999999999998 999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.91  E-value=3.7e-24  Score=191.01  Aligned_cols=129  Identities=29%  Similarity=0.530  Sum_probs=108.6

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccC-CceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~~~~  209 (272)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++||||++++++|...... ....
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            4699999999999999999999999999999998642      23345799999999999999999998544321 1122


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+.+++...+      ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll  177 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAV  177 (371)
T ss_dssp             CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEE
Confidence            4899999998876533      3458999999999999999999998 899999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.91  E-value=6.7e-24  Score=190.09  Aligned_cols=133  Identities=22%  Similarity=0.354  Sum_probs=108.1

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCC-------CCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeee
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLET-------GDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFF  200 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~-------~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~  200 (272)
                      ....+|.+.+.||+|+||.||+|.+..+       +..||||++....     ..+.+|+++++.+ +||||++++++|.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            3445799999999999999999997543       3579999986532     3345899999999 8999999999984


Q ss_pred             ecccCCceEEEEEeecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 024091          201 STTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP  267 (272)
Q Consensus       201 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp  267 (272)
                      .     ...+|+||||+.+ +|.+++.....            ....+++..++.++.||+.||.|||+ ++|+||||||
T Consensus       146 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp  219 (382)
T 3tt0_A          146 Q-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAA  219 (382)
T ss_dssp             S-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCG
T ss_pred             c-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCc
Confidence            3     3338999999985 66665554321            12458999999999999999999998 8999999999


Q ss_pred             CCeeC
Q 024091          268 QNLLM  272 (272)
Q Consensus       268 ~NILl  272 (272)
                      +||||
T Consensus       220 ~NIll  224 (382)
T 3tt0_A          220 RNVLV  224 (382)
T ss_dssp             GGEEE
T ss_pred             ceEEE
Confidence            99986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.91  E-value=5.8e-24  Score=186.44  Aligned_cols=132  Identities=23%  Similarity=0.358  Sum_probs=108.3

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCC-----EEEEEEeecc-----chhHHHHHHHHHHc-CCCCeeecceeeeecc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTT  203 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vAvK~i~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  203 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++     .||+|.+...     ...+.+|+.+|+.+ +||||++++++|..  
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  121 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH--  121 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence            34579999999999999999999977654     7999998653     23355899999999 89999999999843  


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhhh----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYTR----------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~----------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                         ...+|+||||+.+ ++.+++.....          ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       122 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          122 ---GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLL  197 (333)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEE
T ss_pred             ---CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEE
Confidence               3348999999985 66666554322          13467899999999999999999998 999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.91  E-value=4.6e-24  Score=186.86  Aligned_cols=132  Identities=26%  Similarity=0.414  Sum_probs=109.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEE----CCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~----~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ....+|++.+.||+|+||.||+|++    ..+++.||||++....    ..+.+|+++++.++||||++++++++..   
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   96 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---   96 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---
Confidence            4455799999999999999999984    5688999999986542    2356899999999999999999987532   


Q ss_pred             CceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +..++|+||||++ +++.+++...   ...+++..++.++.||+.||.|||+ .+|+||||||+||||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~  160 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILV  160 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEE
Confidence            3455899999996 5665555432   2358999999999999999999998 999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.91  E-value=8e-24  Score=183.19  Aligned_cols=125  Identities=24%  Similarity=0.353  Sum_probs=107.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++...     ...+.+|+.+++.+.||||++++++|...     ..+|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence            4699999999999999999999999999999998543     23456899999999999999999988543     3489


Q ss_pred             EEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||++++ +.+++.     ...+++..+..++.||+.||.|||+ .+|+|+||||+|||+
T Consensus        97 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~  152 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLL  152 (303)
T ss_dssp             EEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEE
Confidence            999999864 443322     3568999999999999999999998 999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.91  E-value=1.6e-24  Score=189.49  Aligned_cols=131  Identities=22%  Similarity=0.398  Sum_probs=109.2

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ...+|.+.+.||+|+||.||+|.+ .+++.||||.+...     ...+.+|+.+++.+.||||++++++|...     ..
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~  101 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE  101 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-----SC
T ss_pred             HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC-----Cc
Confidence            345799999999999999999974 46899999998643     22457899999999999999999998433     34


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC---CceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV---GVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~---~iiHrDlKp~NILl  272 (272)
                      .++||||+.+ ++.+++.........+++..+..++.||+.||.|||+ +   +|+||||||+||||
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~  167 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILL  167 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEE
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEE
Confidence            7899999985 6666655544445569999999999999999999998 8   99999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.91  E-value=4.1e-24  Score=187.18  Aligned_cols=132  Identities=25%  Similarity=0.432  Sum_probs=109.0

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEE--EEEEeec-----cchhHHHHHHHHHHc-CCCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSV--AIKKVLQ-----DKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~v--AvK~i~~-----~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|.+.+.||+|+||.||+|.+..++..+  |||.+..     ....+.+|+.+|+.+ +||||++++++|..     
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----   97 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----   97 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----
Confidence            3457999999999999999999998888765  9998864     233456899999999 89999999999843     


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++|+||||+++ ++.+++....            .....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV  175 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEE
Confidence            3459999999975 6666554322            223468999999999999999999998 999999999999985

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.91  E-value=6.5e-24  Score=180.64  Aligned_cols=126  Identities=30%  Similarity=0.529  Sum_probs=103.1

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|.+.+.||+|+||.||+|.+  +++.||||++...        .....+|+.+++.++||||++++++|.     .
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   77 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----K   77 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----C
T ss_pred             chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----c
Confidence            345799999999999999999998  4889999988542        234457999999999999999999983     4


Q ss_pred             ceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC---ceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG---VCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~---iiHrDlKp~NILl  272 (272)
                      ...+|+||||+.++.+..+.    ....+++..++.++.|++.||.|||+ ++   |+||||||+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~  141 (271)
T 3dtc_A           78 EPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILI  141 (271)
T ss_dssp             C--CEEEEECCTTEEHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEE
T ss_pred             CCceEEEEEcCCCCCHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEE
Confidence            44589999999865544222    14578999999999999999999998 88   9999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.91  E-value=1.2e-23  Score=192.56  Aligned_cols=131  Identities=23%  Similarity=0.351  Sum_probs=109.0

Q ss_pred             CCcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       133 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .....+|.+.+.||+|+||.||+|.+  .++.||||.++..  ...+.+|+.+|+.++||||+++++++....    ..+
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~  262 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGL  262 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----Cce
Confidence            34556899999999999999999988  4789999998654  344568999999999999999999875432    238


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||+.+ +|.+++...  ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       263 ~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill  322 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLV  322 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             EEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEE
Confidence            999999985 666655432  23347889999999999999999998 999999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.91  E-value=5.9e-24  Score=186.45  Aligned_cols=128  Identities=23%  Similarity=0.464  Sum_probs=101.0

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCE----EEEEEeec-----cchhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~----vAvK~i~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.    ||+|.+..     ....+.+|+.+++.++||||++++++|....  
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   90 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--   90 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence            345799999999999999999999887765    47776643     2234568999999999999999999885321  


Q ss_pred             CceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          .++||||+. +++.+++..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        91 ----~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll  150 (327)
T 3poz_A           91 ----VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLV  150 (327)
T ss_dssp             ----EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             ----eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEE
Confidence                678888888 555554432   24568999999999999999999998 899999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.91  E-value=1.8e-23  Score=182.72  Aligned_cols=135  Identities=25%  Similarity=0.397  Sum_probs=111.9

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHc-CCCCeeecceeeeecccC-CceE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK-DELY  209 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~-~~~~  209 (272)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++...   .....+|+.+++.+ .||||++++++|...... ...+
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            345799999999999999999999999999999998543   34566899999999 799999999998654311 1356


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+++ ++.+++....  ...+++..++.++.||+.||.|||+ .+|+|+||||+||||
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~  162 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLL  162 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEE
Confidence            8999999986 6665554321  3468899999999999999999998 899999999999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.91  E-value=4.8e-24  Score=186.19  Aligned_cols=137  Identities=20%  Similarity=0.313  Sum_probs=100.7

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCC---EEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ...+|.+.+.||+|+||.||+|.+..++.   .||||++...      ...+.+|+.+++.++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34579999999999999999999877665   8999988543      23455899999999999999999998554321


Q ss_pred             C-ceEEEEEeecccc-cHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 D-ELYLNLVLEYISE-TVYRVSKHYT--RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~-~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      . ....++||||+.+ ++..++....  .....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli  170 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCML  170 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEE
Confidence            1 1124899999986 5555544322  122258999999999999999999998 999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.91  E-value=2.3e-24  Score=191.25  Aligned_cols=128  Identities=25%  Similarity=0.410  Sum_probs=109.1

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++...     .....+|+.+|+.++||||++++++|...     ..
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~  105 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE  105 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CE
Confidence            345799999999999999999999999999999998653     23345899999999999999999998543     34


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~-~iiHrDlKp~NILl  272 (272)
                      +|+||||+.+ ++.+++..    ...+++..+..++.||+.||.|||+ . +|+||||||+||||
T Consensus       106 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~  165 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILV  165 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEE
T ss_pred             EEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEE
Confidence            9999999985 66555443    2468899999999999999999997 5 89999999999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.91  E-value=8.6e-24  Score=183.82  Aligned_cols=138  Identities=20%  Similarity=0.302  Sum_probs=105.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECC---CCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeeccc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  204 (272)
                      ....+|.+.+.||+|+||.||+|.+..   ++..||||.+....      ..+.+|+.+++.++||||+++++++.....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            334579999999999999999998765   45689999986431      234579999999999999999999866554


Q ss_pred             CCceEEEEEeecccc-cHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          205 KDELYLNLVLEYISE-TVYRVSKHYT--RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....+.++||||+.+ ++..++....  .....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli  180 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCML  180 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEE
Confidence            433457999999985 5555443221  234569999999999999999999998 999999999999985

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.91  E-value=5.5e-24  Score=189.62  Aligned_cols=126  Identities=23%  Similarity=0.419  Sum_probs=107.5

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------------hhHHHHHHHHHHc-CCCCeeecceeeeecc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLL-NHPNVVSLKHCFFSTT  203 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  203 (272)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++....            ....+|+.+++.+ .||||++++++|.   
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  170 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE---  170 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence            46999999999999999999999899999999986432            2345799999999 7999999999883   


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ...+.|+||||+.+ .+.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+||||
T Consensus       171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~  233 (365)
T 2y7j_A          171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILL  233 (365)
T ss_dssp             --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence              34459999999986 55554432    3468999999999999999999998 999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.91  E-value=1.1e-23  Score=181.17  Aligned_cols=129  Identities=23%  Similarity=0.356  Sum_probs=107.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec--cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++..  ......+|+.+++.+.|++++..+.++...    ..+.++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCceEEE
Confidence            3479999999999999999999999999999998643  334567899999999999988877766433    3358999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+++++.+++..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        84 ~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~  138 (296)
T 4hgt_A           84 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLM  138 (296)
T ss_dssp             EECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeee
Confidence            99998887776543   24568999999999999999999998 999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=6.4e-24  Score=187.00  Aligned_cols=132  Identities=22%  Similarity=0.358  Sum_probs=106.1

Q ss_pred             cccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeecc-----chhHHHHHHHHHHc-CCCCeeecceeeeecc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTT  203 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  203 (272)
                      ...+|.+.+.||+|+||.||+|.+.     .++..||||++...     ...+.+|+.+|+.+ .||||++++++|... 
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence            3457999999999999999999973     35678999998642     23456899999999 899999999998433 


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhhhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceec
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYTRM-------------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHR  263 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------------------~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHr  263 (272)
                          ..+|+||||+++ ++.+++......                   ...+++..++.++.||+.||.|||+ ++|+||
T Consensus       122 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~  196 (344)
T 1rjb_A          122 ----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHR  196 (344)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred             ----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence                348999999975 666655432210                   1347889999999999999999998 999999


Q ss_pred             CCCCCCeeC
Q 024091          264 DIKPQNLLM  272 (272)
Q Consensus       264 DlKp~NILl  272 (272)
                      ||||+||||
T Consensus       197 Dikp~NIll  205 (344)
T 1rjb_A          197 DLAARNVLV  205 (344)
T ss_dssp             TCSGGGEEE
T ss_pred             CCChhhEEE
Confidence            999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.91  E-value=7.3e-24  Score=181.63  Aligned_cols=129  Identities=26%  Similarity=0.354  Sum_probs=105.7

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCC---CCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ....+|.+.+.||+|+||.||+|.+..+   +..||||.+...     ...+.+|+.+++.++||||+++++++. .   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~---   87 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E---   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S---
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c---
Confidence            4456799999999999999999998654   457999987542     223457999999999999999999862 1   


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ..+|+||||+.+ ++.+++..   ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        88 --~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~  149 (281)
T 1mp8_A           88 --NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLV  149 (281)
T ss_dssp             --SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             --CccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEE
Confidence              127899999996 55554432   23468999999999999999999998 999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.91  E-value=5.6e-24  Score=186.15  Aligned_cols=129  Identities=26%  Similarity=0.425  Sum_probs=108.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEE-CCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCC------eeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKC-LETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPN------VVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~-~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~  205 (272)
                      ..+|.+.+.||+|+||.||+|.+ ..+++.||||++....   ....+|+.+++.+.|++      |++++++|..    
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~----   88 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH----   88 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE----
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc----
Confidence            34799999999999999999998 5678999999986543   33457999999987654      9999998843    


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       ..++|+||||+++++.+++...  ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        89 -~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~  151 (339)
T 1z57_A           89 -HGHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILF  151 (339)
T ss_dssp             -TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             -CCcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEE
Confidence             3459999999998988766542  23468899999999999999999998 999999999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.91  E-value=1.2e-23  Score=182.93  Aligned_cols=128  Identities=30%  Similarity=0.428  Sum_probs=105.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||.+...  .....+|+.+++.+.||||+++++++...     ..+|+|
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv  102 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLWIV  102 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEE
Confidence            34699999999999999999999999999999998654  34456899999999999999999998543     348999


Q ss_pred             eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+++ ++.+++..   ....+++..+..++.||+.||.|||+ .+|+|+||||+|||+
T Consensus       103 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~  158 (314)
T 3com_A          103 MEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILL  158 (314)
T ss_dssp             EECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             eecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEE
Confidence            999986 55544432   24578999999999999999999998 999999999999985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.91  E-value=6.4e-24  Score=184.24  Aligned_cols=132  Identities=20%  Similarity=0.319  Sum_probs=107.7

Q ss_pred             cccCeeeeEEeccCCceEEEEEEE-----CCCCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeecc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTT  203 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  203 (272)
                      ...+|.+.+.||+|+||.||+|.+     ..+++.||||.+....     ..+.+|+.+++.+ +||||++++++|... 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-   99 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-   99 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-
Confidence            345799999999999999999985     3567899999986432     3445899999999 899999999998433 


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYTR--------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ  268 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~  268 (272)
                          ...++||||+.+ ++.+++.....              ....+++..++.++.||+.||.|||+ ++|+||||||+
T Consensus       100 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~  174 (313)
T 1t46_A          100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR  174 (313)
T ss_dssp             ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred             ----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccc
Confidence                348999999985 66665544221              12258999999999999999999998 99999999999


Q ss_pred             CeeC
Q 024091          269 NLLM  272 (272)
Q Consensus       269 NILl  272 (272)
                      |||+
T Consensus       175 Nil~  178 (313)
T 1t46_A          175 NILL  178 (313)
T ss_dssp             GEEE
T ss_pred             eEEE
Confidence            9985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.91  E-value=1.7e-23  Score=180.10  Aligned_cols=129  Identities=23%  Similarity=0.356  Sum_probs=109.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...  .....+|+.+++.+.|++++..+.++...    ..+.++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCC----CCceEEE
Confidence            35799999999999999999999999999999987543  34567899999999999988777665432    3358999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+++++.+++..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        84 ~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~  138 (296)
T 3uzp_A           84 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLM  138 (296)
T ss_dssp             EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             EEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEE
Confidence            99998887776543   24569999999999999999999998 999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.91  E-value=4.4e-24  Score=187.02  Aligned_cols=128  Identities=22%  Similarity=0.370  Sum_probs=104.0

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCE----EEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~----vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ...+|++.+.||+|+||.||+|.+..+++.    ||+|.+...     .....+|+.+++.++||||+++++++. .   
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~---   86 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G---   86 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B---
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C---
Confidence            345799999999999999999999888876    677766322     233457999999999999999999872 1   


Q ss_pred             CceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ..+++||||+. +++.+.+..   ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        87 --~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~  148 (325)
T 3kex_A           87 --SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLL  148 (325)
T ss_dssp             --SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEE
T ss_pred             --CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEE
Confidence              12789999998 566554432   23468888899999999999999998 999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.91  E-value=4.6e-24  Score=188.45  Aligned_cols=130  Identities=19%  Similarity=0.254  Sum_probs=101.7

Q ss_pred             cCeeeeEEeccCCceEEEEEEECC---CCCEEEEEEeeccchh---------------HHHHHHHHHHcCCCCeeeccee
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQDKRY---------------KNRELQIMRLLNHPNVVSLKHC  198 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~~~---------------~~~E~~~l~~l~h~nIv~l~~~  198 (272)
                      .+|.+.+.||+|+||.||+|.+..   ++..||||.+......               ..+|+.+++.+.||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            469999999999999999999987   7889999998654321               2357778888899999999999


Q ss_pred             eeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       199 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +.... .+..++|+||||++++|.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll  184 (345)
T 2v62_A          117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLL  184 (345)
T ss_dssp             EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEE
Confidence            86543 34567999999996666554332    2378999999999999999999998 899999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.91  E-value=1.6e-24  Score=189.26  Aligned_cols=132  Identities=23%  Similarity=0.337  Sum_probs=106.7

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ....+|.+.+.||+|+||.||+|.+ .+++.||||.+....    ..+.+|+.+++.++||||++++++|..     ...
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  109 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNE  109 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----TTC
T ss_pred             HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCe
Confidence            3445799999999999999999985 468999999885432    345689999999999999999998843     334


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+.+ ++.+++.........+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~  172 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILL  172 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEE
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEE
Confidence            8999999985 5443332222222358999999999999999999998 999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.91  E-value=1.3e-23  Score=184.67  Aligned_cols=132  Identities=23%  Similarity=0.389  Sum_probs=105.4

Q ss_pred             cccCeeeeEEeccCCceEEEEEEEC-------CCCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeee
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS  201 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~  201 (272)
                      ...+|.+.+.||+|+||.||+|.+.       .++..||||++....     ..+.+|+.+++.+ +||||++++++|. 
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-  111 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-  111 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc-
Confidence            3457999999999999999999986       356789999986532     2345799999999 8999999999884 


Q ss_pred             cccCCceEEEEEeecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 024091          202 TTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ  268 (272)
Q Consensus       202 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~  268 (272)
                          ....+|+||||+.+ ++.+++.....            ....+++..++.++.||+.||.|||+ ++|+||||||+
T Consensus       112 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~  186 (334)
T 2pvf_A          112 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR  186 (334)
T ss_dssp             ----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGG
T ss_pred             ----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCccc
Confidence                33448999999985 66665543221            12348899999999999999999998 99999999999


Q ss_pred             CeeC
Q 024091          269 NLLM  272 (272)
Q Consensus       269 NILl  272 (272)
                      ||||
T Consensus       187 NIll  190 (334)
T 2pvf_A          187 NVLV  190 (334)
T ss_dssp             GEEE
T ss_pred             eEEE
Confidence            9985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.90  E-value=7.5e-24  Score=182.10  Aligned_cols=127  Identities=24%  Similarity=0.390  Sum_probs=108.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++||||+++++++.     ....
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   95 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence            34799999999999999999999999999999998542      234558999999999999999999884     3345


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+.+ ++.+.+..    ...+++..++.++.||+.||.|||+ ++|+|+||||+||||
T Consensus        96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv  154 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILL  154 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             EEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEE
Confidence            8999999975 55554433    2468999999999999999999998 999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.90  E-value=7.3e-24  Score=185.57  Aligned_cols=131  Identities=21%  Similarity=0.237  Sum_probs=103.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEE-----ECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAK-----CLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~-----~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ..+|.+.+.||+|+||.||+|.     +..+++.||||.+...     ...+.+|+.+++.++||||+++++++...   
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  105 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS---  105 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC---
Confidence            4579999999999999999998     4567889999998532     22345799999999999999999998433   


Q ss_pred             CceEEEEEeeccc-ccHHHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYIS-ETVYRVSKHYTRM---NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ..+|+||||+. +++.+++......   ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       106 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli  173 (327)
T 2yfx_A          106 --LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLL  173 (327)
T ss_dssp             --SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             --CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEE
Confidence              33799999996 5666655543211   1458899999999999999999998 999999999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.90  E-value=9.8e-24  Score=181.55  Aligned_cols=127  Identities=24%  Similarity=0.416  Sum_probs=104.0

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      |....+||+|+||.||+|.+..+++.||||.+...    ...+.+|+.+++.++||||++++++|..     ..++++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEE
Confidence            44445899999999999999999999999998643    2335689999999999999999999843     33589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.+ ++..++.. ......+++..++.++.||+.||.|||+ ++|+|+||||+||||
T Consensus        99 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~  155 (295)
T 2clq_A           99 EQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLI  155 (295)
T ss_dssp             ECCSEEEHHHHHHH-TTCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EeCCCCCHHHHHHh-hccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEE
Confidence            99975 55554433 2223456788899999999999999998 999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.90  E-value=1.1e-23  Score=178.62  Aligned_cols=128  Identities=23%  Similarity=0.358  Sum_probs=107.4

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ...+|.+.+.||+|+||.||+|.+. +++.||||.+...   .....+|+.+++.++||||+++++++...     ..+|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   79 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APIC   79 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCeE
Confidence            3457999999999999999999986 5778999998654   23456899999999999999999988433     3489


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+++ ++.+++..   ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        80 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili  137 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLV  137 (267)
T ss_dssp             EEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEE
T ss_pred             EEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEE
Confidence            99999985 55554432   23568899999999999999999998 999999999999985

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.90  E-value=8.5e-24  Score=185.58  Aligned_cols=128  Identities=23%  Similarity=0.464  Sum_probs=104.3

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEE----EEEEeec-----cchhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSV----AIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~v----AvK~i~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.|    |+|.+..     ....+.+|+.+++.++||||++++++|....  
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--   90 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--   90 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--
Confidence            3457999999999999999999998888765    5665532     2234568999999999999999999885321  


Q ss_pred             CceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          .++||||+. +++.+++..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        91 ----~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~  150 (327)
T 3lzb_A           91 ----VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLV  150 (327)
T ss_dssp             ----EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             ----ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEE
Confidence                677888887 566554433   24568999999999999999999998 999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.90  E-value=9.1e-24  Score=184.26  Aligned_cols=133  Identities=20%  Similarity=0.248  Sum_probs=108.4

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTT  203 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  203 (272)
                      ....+|.+.+.||+|+||.||+|.+.     .+++.||||.+....     ..+.+|+.+++.++||||+++++++..  
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   99 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--   99 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--
Confidence            44567999999999999999999876     357889999986432     234579999999999999999998833  


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYTR------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                         ....|+||||+.+ ++.+++.....      ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       100 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli  171 (322)
T 1p4o_A          100 ---GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMV  171 (322)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEE
T ss_pred             ---CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEE
Confidence               3348999999985 66666554321      12457889999999999999999998 999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.90  E-value=5.1e-24  Score=188.63  Aligned_cols=128  Identities=15%  Similarity=0.172  Sum_probs=105.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCC--------CCEEEEEEeeccchhHHHHHHHHHHcCCCCeeec-------------
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLET--------GDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSL-------------  195 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~--------~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l-------------  195 (272)
                      .+|.+.+.||+|+||.||+|.+..+        ++.||||.+... ....+|+.+++.++||||+++             
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            4699999999999999999999874        889999998755 456789999999999999984             


Q ss_pred             --ceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          196 --KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       196 --~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ++++..    ...++|+||||++++|.+++....  ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFV  192 (352)
T ss_dssp             CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEE
T ss_pred             chhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEE
Confidence              444422    234689999999778777665421  3568999999999999999999998 999999999999985

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.90  E-value=4.5e-24  Score=181.22  Aligned_cols=131  Identities=15%  Similarity=0.273  Sum_probs=107.5

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....+|.+.+.||+|+||.||+|.+  .++.||||++...      ...+.+|+.+++.++||||++++++|....   .
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~   81 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---A   81 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---S
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---C
Confidence            4456799999999999999999998  4889999998643      223557999999999999999999884431   2


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~--iiHrDlKp~NILl  272 (272)
                      .++++||||+.+ ++.+++..  .....+++..+..++.||+.||.|||+ ++  |+||||||+|||+
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~  146 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMI  146 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEE
T ss_pred             CCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEE
Confidence            348999999985 66655542  122358999999999999999999998 89  9999999999985

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.90  E-value=1.5e-23  Score=183.93  Aligned_cols=131  Identities=21%  Similarity=0.313  Sum_probs=105.0

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch-hHHHHHHH--HHHcCCCCeeecceeeeecccCCceEE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YKNRELQI--MRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~E~~~--l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ....+|.+.+.||+|+||.||+|.+  +++.||||++..... ....|.++  +..+.||||+++++++..........+
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            4456799999999999999999987  789999999865432 22334444  456899999999987765555666778


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV---------GVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~---------~iiHrDlKp~NILl  272 (272)
                      |+||||+++ +|.+++..     ...++..+..++.||+.||.|||+ .         +|+||||||+||||
T Consensus        88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill  153 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLV  153 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEE
T ss_pred             EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEE
Confidence            999999975 66555432     235888899999999999999998 8         99999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.90  E-value=4.6e-24  Score=204.70  Aligned_cols=131  Identities=24%  Similarity=0.424  Sum_probs=109.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECC-CCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .++|.+.+.||+|+||.||+|.+.. +++.||||++....     ..+.+|+.+|+.++||||++++++|.........+
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3579999999999999999999976 78999999885432     23457999999999999999999987665545556


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .||||||++++.+...   .  ...+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       159 ~~lv~E~~~g~~L~~~---~--~~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll  215 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRS---K--GQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIML  215 (681)
T ss_dssp             EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             eEEEEEeCCCCcHHHH---H--hCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEE
Confidence            7999999996554321   1  2368999999999999999999998 999999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.90  E-value=5.9e-24  Score=189.61  Aligned_cols=131  Identities=15%  Similarity=0.122  Sum_probs=91.1

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHc--CCCCeeecceeee-------e
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL--NHPNVVSLKHCFF-------S  201 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l--~h~nIv~l~~~~~-------~  201 (272)
                      .|.+.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+++.|  +||||++++..|+       .
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            4999999999999999999999999999999997532       2234675555555  6999888654332       1


Q ss_pred             ccc------------CCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHH------HHHHHHHHHHHHHHHhcCCceec
Q 024091          202 TTE------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV------QLYTYQICRALNYLHHVVGVCHR  263 (272)
Q Consensus       202 ~~~------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~------~~i~~qi~~~L~ylH~~~~iiHr  263 (272)
                      ...            .....+||||||++++|.+++.....   .+.+...      ..++.||+.||.|||+ ++||||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~ivHr  218 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLVHG  218 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCccC
Confidence            111            01155899999999988887765432   2233333      5666999999999998 999999


Q ss_pred             CCCCCCeeC
Q 024091          264 DIKPQNLLM  272 (272)
Q Consensus       264 DlKp~NILl  272 (272)
                      ||||+||||
T Consensus       219 Dikp~NIll  227 (371)
T 3q60_A          219 HFTPDNLFI  227 (371)
T ss_dssp             TCSGGGEEE
T ss_pred             cCCHHHEEE
Confidence            999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.90  E-value=1.2e-23  Score=185.36  Aligned_cols=129  Identities=24%  Similarity=0.415  Sum_probs=108.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCC-CEEEEEEeeccc---hhHHHHHHHHHHcCCCC------eeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETG-DSVAIKKVLQDK---RYKNRELQIMRLLNHPN------VVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~vAvK~i~~~~---~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~  205 (272)
                      ..+|.+.+.||+|+||.||+|.+..++ +.||||++....   ....+|+.+++.+.|++      |+.++++|..    
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~----   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF----   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE----
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee----
Confidence            357999999999999999999998776 689999986532   33457999999998766      8888887743    


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       ..++||||||++++++..+...  ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        94 -~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll  156 (355)
T 2eu9_A           94 -HGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILF  156 (355)
T ss_dssp             -TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEE
T ss_pred             -CCeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEE
Confidence             3359999999999988765542  23468999999999999999999998 999999999999985

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=1.8e-23  Score=183.84  Aligned_cols=129  Identities=21%  Similarity=0.339  Sum_probs=105.4

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCC----CEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ...+|.+.+.||+|+||.||+|.+..++    ..||||.+....     ..+.+|+.+++.++||||+++++++.     
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----  116 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----  116 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----
Confidence            3457999999999999999999886543    359999986432     23457999999999999999999983     


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....+|+||||+.+ ++.+++..   ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~  180 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILV  180 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEE
Confidence            33448999999986 55554432   24568999999999999999999998 899999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.90  E-value=1.6e-23  Score=183.37  Aligned_cols=133  Identities=23%  Similarity=0.317  Sum_probs=108.9

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch-----hHHHHHH-HHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQ-IMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-----~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++.....     ....|+. +++.+.||||+++++++..     .
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~   93 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----E   93 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----S
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----C
Confidence            334579999999999999999999999999999999865321     2224554 6777899999999999843     3


Q ss_pred             eEEEEEeecccccHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYT-RMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~L~ylH~~~-~iiHrDlKp~NILl  272 (272)
                      ..+|+||||+.+++..++.... .....+++..+..++.|++.||.|||+ . +|+||||||+||||
T Consensus        94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll  159 (327)
T 3aln_A           94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILL  159 (327)
T ss_dssp             SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEE
T ss_pred             CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEE
Confidence            4589999999998877665432 235678999999999999999999998 7 99999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.90  E-value=8.4e-24  Score=187.18  Aligned_cols=129  Identities=29%  Similarity=0.529  Sum_probs=107.7

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccC-CceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~~~~  209 (272)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||++++++|...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            4699999999999999999999999999999998542      12345799999999999999999988543221 1123


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+||||+.+++..++      ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus       104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~  159 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAV  159 (353)
T ss_dssp             CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEE
T ss_pred             EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeE
Confidence            6899999998765422      3358999999999999999999998 999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.90  E-value=1.7e-23  Score=180.22  Aligned_cols=126  Identities=23%  Similarity=0.327  Sum_probs=103.6

Q ss_pred             ccCeeeeE-EeccCCceEEEEEEE--CCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          136 TISYMAER-VVGTGSFGVVFQAKC--LETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       136 ~~~y~~~~-~lG~G~fg~V~~~~~--~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ..+|.+.+ .||+|+||.||+|.+  ..+++.||||++...      ...+.+|+.+++.++||||+++++++ ...   
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~---   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE---   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS---
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC---
Confidence            34699988 999999999999955  456789999998643      23455899999999999999999987 222   


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        .+|+||||+.+ ++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus        91 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~  150 (291)
T 1xbb_A           91 --SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLL  150 (291)
T ss_dssp             --SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             --CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEE
Confidence              27899999985 55554432    4568999999999999999999998 999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.90  E-value=5.1e-24  Score=183.86  Aligned_cols=133  Identities=29%  Similarity=0.423  Sum_probs=97.1

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||.+...     .....+|+.+++.++||||++++++|....     
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   86 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----   86 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----
Confidence            3445799999999999999999999889999999987532     233457999999999999999999885433     


Q ss_pred             EEEEEeeccc-ccHHHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYIS-ETVYRVSKHYTR----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..|+||||+. +++.+++.....    ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~  154 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILL  154 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEE
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEE
Confidence            3899999997 466665543221    23458999999999999999999998 999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.90  E-value=2.1e-23  Score=192.37  Aligned_cols=129  Identities=24%  Similarity=0.364  Sum_probs=107.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ..+|.+.++||+|+||.||+|.+..+++.||||++...  ...+.+|+.+++.|.|++++..+.+|..    ...+.|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEEE
Confidence            45799999999999999999999999999999987533  3456789999999998665555544432    23358999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||++++|.+++...   ...+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus        82 me~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl  136 (483)
T 3sv0_A           82 MDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLM  136 (483)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEE
Confidence            999988888766532   4569999999999999999999998 999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.90  E-value=1.4e-23  Score=181.83  Aligned_cols=125  Identities=25%  Similarity=0.324  Sum_probs=103.7

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      |...+.||+|+||.||+|.+  +++.||||.+...        ...+.+|+.+++.++||||+++++++..     ....
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDL  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-----CCce
Confidence            56678999999999999986  6889999988532        2345589999999999999999998843     3348


Q ss_pred             EEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+. +++.+++.. ......+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus       106 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili  166 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILL  166 (307)
T ss_dssp             EEEEECCTTCBHHHHHHT-GGGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             EEEEEecCCCcHHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEE
Confidence            99999997 566555543 3334568999999999999999999998 999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.90  E-value=2.6e-23  Score=179.40  Aligned_cols=129  Identities=22%  Similarity=0.349  Sum_probs=103.4

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCC---CEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ..+|.+.+.||+|+||.||+|.+..++   ..||+|.+....     ..+.+|+.+++.++||||++++++++..    .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence            346999999999999999999976433   368999885422     2345799999999999999999986433    2


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...|+||||+.+ ++.+++..   ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~  161 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCML  161 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEE
Confidence            347899999986 55554432   24568899999999999999999998 999999999999985

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.90  E-value=3e-23  Score=177.70  Aligned_cols=129  Identities=28%  Similarity=0.439  Sum_probs=105.3

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECC---CCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ....+|.+.+.||+|+||.||+|.+..   ++..||||.+...     ...+.+|+.+++.++||||+++++++..    
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   84 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----   84 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS----
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC----
Confidence            445679999999999999999998754   3446999998653     2344579999999999999999998632    


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       . ..|+||||+.+ ++.+++..   ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        85 -~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~  146 (281)
T 3cc6_A           85 -E-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILV  146 (281)
T ss_dssp             -S-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEE
T ss_pred             -C-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEE
Confidence             1 15899999985 55554433   24568999999999999999999998 999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.90  E-value=2.9e-23  Score=181.83  Aligned_cols=131  Identities=28%  Similarity=0.485  Sum_probs=107.2

Q ss_pred             cccCeeeeEEeccCCceEEEEEEE----CCCCCEEEEEEeeccc----hhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~----~~~~~~vAvK~i~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|.+.+.||+|+||.||+|.+    ..+++.||||.+....    ..+.+|+.+++.++||||+++++++....   
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---  115 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---  115 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---
Confidence            345699999999999999999984    5678999999986432    24568999999999999999999875432   


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...+++||||+++ ++.+++..   ....+++..+..++.||+.||.|||+ .+|+||||||+||||
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli  178 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILV  178 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEE
Confidence            2248899999985 66655443   23468999999999999999999998 999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=3.1e-23  Score=178.64  Aligned_cols=129  Identities=25%  Similarity=0.445  Sum_probs=104.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCC---EEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...|.+.++||+|+||.||+|.+..++.   .||+|.+....     ..+.+|+.+++.++||||++++++|....    
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   95 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence            3458888999999999999999866554   79999886422     23457999999999999999999885332    


Q ss_pred             eEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ...++||||+. +++.+++..   ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili  157 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCML  157 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEE
Confidence            22489999997 565554432   34568899999999999999999998 899999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.90  E-value=1.7e-23  Score=179.01  Aligned_cols=130  Identities=23%  Similarity=0.359  Sum_probs=106.8

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ....+|.+.+.||+|+||.||+|.+  +++.||||.+...  ...+.+|+.+++.++||||+++++++....    ..+|
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~   91 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   91 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----CceE
Confidence            4456799999999999999999987  5889999998654  334568999999999999999999864332    2489


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +||||+.+ ++.+++....  ...+++..+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~  150 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLV  150 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             EEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEE
Confidence            99999986 6666554322  2237888899999999999999998 999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.90  E-value=2.8e-23  Score=181.62  Aligned_cols=127  Identities=24%  Similarity=0.393  Sum_probs=108.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----------hhHHHHHHHHHHcC--CCCeeecceeeeecc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN--HPNVVSLKHCFFSTT  203 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~  203 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....          ....+|+.+++.+.  |+||++++++|.   
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~---  118 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE---  118 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe---
Confidence            457999999999999999999999999999999986432          23447999999996  599999999984   


Q ss_pred             cCCceEEEEEeeccc--ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        ....+++|||++.  +++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       119 --~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll  182 (320)
T 3a99_A          119 --RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILI  182 (320)
T ss_dssp             --CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             --cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEE
Confidence              3345899999997  566665543    3568999999999999999999998 999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.90  E-value=2.9e-23  Score=182.06  Aligned_cols=128  Identities=27%  Similarity=0.427  Sum_probs=105.5

Q ss_pred             cCeeee-EEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcC-CCCeeecceeeeecccCCce
Q 024091          137 ISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       137 ~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .+|.+. +.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.+. ||||++++++|     ....
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~~  102 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENTS  102 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeCC
Confidence            357777 8999999999999999999999999998642      234568999999995 69999999998     3444


Q ss_pred             EEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|+||||+.++ +..++.  ......+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~  164 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCL--PELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILL  164 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGS--SCC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             eEEEEEEecCCCcHHHHHH--HhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEE
Confidence            599999999864 433221  1224568999999999999999999998 999999999999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.90  E-value=1.8e-23  Score=181.68  Aligned_cols=132  Identities=22%  Similarity=0.347  Sum_probs=106.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeeccc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  204 (272)
                      ..+|.+.+.||+|+||.||+|.+.     .+++.||||++....     ..+.+|+.+++.+ +||||++++++|...  
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence            457999999999999999999853     467899999986532     2345799999999 699999999987533  


Q ss_pred             CCceEEEEEeecccc-cHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCee
Q 024091          205 KDELYLNLVLEYISE-TVYRVSKHYTRM------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL  271 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NIL  271 (272)
                        ..++|+||||+.+ ++.+++......            ...+++..+..++.||+.||.|||+ ++|+||||||+|||
T Consensus       104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil  180 (316)
T 2xir_A          104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  180 (316)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence              2348899999985 665554432211            1227899999999999999999998 99999999999998


Q ss_pred             C
Q 024091          272 M  272 (272)
Q Consensus       272 l  272 (272)
                      |
T Consensus       181 ~  181 (316)
T 2xir_A          181 L  181 (316)
T ss_dssp             E
T ss_pred             E
Confidence            5

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.90  E-value=2.1e-23  Score=191.09  Aligned_cols=129  Identities=21%  Similarity=0.336  Sum_probs=106.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ....+|.+.+.||+|+||.||+|.+. .+..||||.+...   ...+.+|+.+|+.|+||||+++++++. .     ..+
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~-----~~~  257 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K-----EPI  257 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-----SSC
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C-----Ccc
Confidence            44567999999999999999999975 4678999998653   344568999999999999999999873 1     127


Q ss_pred             EEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||+. ++|.+++....  ...+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill  317 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILV  317 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEE
T ss_pred             EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEE
Confidence            89999998 46666554322  2357888899999999999999998 999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=6.5e-23  Score=176.22  Aligned_cols=127  Identities=27%  Similarity=0.354  Sum_probs=103.1

Q ss_pred             ccCeeeeE-EeccCCceEEEEEEEC--CCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          136 TISYMAER-VVGTGSFGVVFQAKCL--ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       136 ~~~y~~~~-~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ..+|.+.+ .||+|+||.||+|.+.  .++..||||++...     ...+.+|+.+++.++||||+++++++ ...    
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~----   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE----   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS----
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC----
Confidence            34577766 9999999999999864  46788999998653     22345899999999999999999987 222    


Q ss_pred             eEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       .+++||||+.++ +..++.   .....+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus        83 -~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili  143 (287)
T 1u59_A           83 -ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLL  143 (287)
T ss_dssp             -SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             -CcEEEEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEE
Confidence             288999999964 444332   234568999999999999999999998 999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.89  E-value=2.5e-23  Score=190.52  Aligned_cols=129  Identities=24%  Similarity=0.312  Sum_probs=106.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ....+|.+.+.||+|+||.||+|.+.. +..||||.+...   ...+.+|+.+|+.|+||||+++++++..      ..+
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~  253 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  253 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence            445679999999999999999999865 457999998653   2345689999999999999999998732      227


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||+.+ +|.+++...  ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       254 ~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill  313 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILV  313 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             EEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEE
Confidence            899999985 666655322  12458899999999999999999998 999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.89  E-value=3.3e-23  Score=185.55  Aligned_cols=131  Identities=30%  Similarity=0.467  Sum_probs=108.6

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcC-CC-----CeeecceeeeecccC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN-HP-----NVVSLKHCFFSTTEK  205 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~~  205 (272)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||++....   ....+|+.+++.+. |+     +|++++++|...   
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~---  128 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR---  128 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET---
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC---
Confidence            3457999999999999999999999999999999997543   23456888988886 55     488988888443   


Q ss_pred             CceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-VVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~-~~~iiHrDlKp~NILl  272 (272)
                        .++||||||+++++.+++....  ...+++..++.++.||+.||.|||. ..+||||||||+||||
T Consensus       129 --~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll  192 (382)
T 2vx3_A          129 --NHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL  192 (382)
T ss_dssp             --TEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEE
T ss_pred             --CceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEE
Confidence              4599999999999888765432  2458999999999999999999993 2699999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.89  E-value=1.7e-23  Score=184.42  Aligned_cols=130  Identities=20%  Similarity=0.375  Sum_probs=106.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---------------------hhHHHHHHHHHHcCCCCeee
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------------------RYKNRELQIMRLLNHPNVVS  194 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------------------~~~~~E~~~l~~l~h~nIv~  194 (272)
                      ..+|.+.+.||+|+||.||+|.+  +++.||||.+....                     ..+.+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            45799999999999999999998  89999999985321                     55678999999999999999


Q ss_pred             cceeeeecccCCceEEEEEeecccc-cHHHHHHHh--hhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 024091          195 LKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHY--TRM--NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN  269 (272)
Q Consensus       195 l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~--~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~N  269 (272)
                      +++++..     ...+|+||||+.+ ++.+++...  ...  ...+++..++.++.||+.||.|||+.++|+||||||+|
T Consensus       108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9999843     3459999999986 443321000  111  46789999999999999999999953699999999999


Q ss_pred             eeC
Q 024091          270 LLM  272 (272)
Q Consensus       270 ILl  272 (272)
                      ||+
T Consensus       183 il~  185 (348)
T 2pml_X          183 ILM  185 (348)
T ss_dssp             EEE
T ss_pred             EEE
Confidence            985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.89  E-value=2.4e-23  Score=194.44  Aligned_cols=128  Identities=24%  Similarity=0.320  Sum_probs=105.9

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ...+|.+.+.||+|+||.||+|.+.. +..||||++...   ...+.+|+.+|+.|+||||+++++++..      ..+|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence            34579999999999999999999865 467999998653   2346689999999999999999998732      2278


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||+.+ +|.+++...  ....+++..+..++.||+.||.|||+ ++||||||||+||||
T Consensus       338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll  396 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILV  396 (535)
T ss_dssp             EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEE
Confidence            99999985 666655322  12458899999999999999999998 999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.89  E-value=6e-23  Score=178.59  Aligned_cols=126  Identities=21%  Similarity=0.297  Sum_probs=106.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcC--CCCeeecceeeeecccCCc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLN--HPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~~  207 (272)
                      ..+|.+.+.||+|+||.||+|.+. +++.||||++....      ..+.+|+.+++.+.  ||||+++++++.     ..
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~  100 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD  100 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----CS
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----cC
Confidence            346999999999999999999875 58899999985431      33457999999997  599999999884     34


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .++|+|||+.++++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus       101 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~  160 (313)
T 3cek_A          101 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLI  160 (313)
T ss_dssp             SEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             CEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEE
Confidence            45999999887888776653    3568899999999999999999998 999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.89  E-value=1.4e-23  Score=191.19  Aligned_cols=126  Identities=27%  Similarity=0.427  Sum_probs=102.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-chhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEEe
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      .+|.+.++||+|+||+||. ....+++.||||.+... .....+|+++|+.+ +|||||++++++     .+..++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEE
Confidence            3599999999999999764 33457899999998543 34467899999999 799999999987     3444589999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||++++.+++...   ...+.+..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        98 E~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll  151 (432)
T 3p23_A           98 ELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILI  151 (432)
T ss_dssp             ECCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEE
T ss_pred             ECCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEE
Confidence            99999888765532   2234444567899999999999998 999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.89  E-value=4.8e-23  Score=176.12  Aligned_cols=129  Identities=20%  Similarity=0.277  Sum_probs=104.9

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ....+|.+.+.||+|+||.||+|.+. ++..||||.+...   ...+.+|+++|+.++||||+++++++.. .     .+
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-----~~   82 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E-----PI   82 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-----SC
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-C-----Cc
Confidence            33457999999999999999999975 5678999998653   3445689999999999999999998631 1     27


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++||||+.+ ++.+++...  ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus        83 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~  142 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILV  142 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEE
Confidence            899999974 555543221  11258899999999999999999998 999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.89  E-value=3.4e-23  Score=180.85  Aligned_cols=125  Identities=29%  Similarity=0.461  Sum_probs=102.8

Q ss_pred             eeeeEEeccCCceEEEEEEE----CCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          139 YMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~----~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      |++++.||+|+||.||++.+    ..+++.||||++....     ..+.+|+.+|+.++||||+++++++....   ..+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---AAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---TTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---Cce
Confidence            49999999999999988864    3478899999986542     33468999999999999999999885432   345


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++||||+.+ ++.+++.     ...+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus       110 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~  167 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLL  167 (318)
T ss_dssp             EEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEE
Confidence            8999999985 5544332     2348999999999999999999998 999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.89  E-value=4.9e-23  Score=179.03  Aligned_cols=130  Identities=23%  Similarity=0.377  Sum_probs=100.2

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch------hHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++.....      ....+..+++.++||||+++++++..     .
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~   96 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----N   96 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----C
Confidence            445679999999999999999999999999999999865321      12244557888899999999999843     3


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~-~iiHrDlKp~NILl  272 (272)
                      ..+|+||||+++.+..+...   ....+++..++.++.||+.||.|||+ . +|+||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~  158 (318)
T 2dyl_A           97 TDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILL  158 (318)
T ss_dssp             SEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEE
T ss_pred             CcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEE
Confidence            45999999996555443322   24578999999999999999999997 5 99999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=7.6e-23  Score=179.25  Aligned_cols=127  Identities=24%  Similarity=0.370  Sum_probs=103.0

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch-hHHHHHHHHHHc--CCCCeeecceeeeecccCCceEEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YKNRELQIMRLL--NHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~E~~~l~~l--~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .+|.+.+.||+|+||.||+|.+  +++.||||++..... ...+|.+++..+  +||||+++++++.... ....++|+|
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv  113 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYLI  113 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEEE
Confidence            4699999999999999999988  489999999865432 234566665554  8999999999876543 223568999


Q ss_pred             eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CceecCCCCCCeeC
Q 024091          214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--------GVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~--------~iiHrDlKp~NILl  272 (272)
                      |||+.+ ++.+++..     ..+++..+..++.|++.||.|||+ .        +|+||||||+||||
T Consensus       114 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill  175 (337)
T 3mdy_A          114 TDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILV  175 (337)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEE
T ss_pred             EeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEE
Confidence            999985 66665532     358999999999999999999997 7        99999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.89  E-value=3e-23  Score=189.03  Aligned_cols=128  Identities=25%  Similarity=0.354  Sum_probs=99.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-hhHHHHHHHHHHc-CCCCeeecceeeeecccCCceEEEEEee
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLE  215 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~e  215 (272)
                      .|.+.+.||+|+||+||.+. ..+|+.||||.+..+. ....+|+.+|+.+ +||||+++++++     ....++|||||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEEe
Confidence            47778999999999998754 4579999999986543 3456899999876 899999999887     44456999999


Q ss_pred             cccccHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          216 YISETVYRVSKHYTRMNQH---VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       216 ~~~~~l~~~~~~~~~~~~~---~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||++++.+++.........   ..+..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl  148 (434)
T 2rio_A           90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILV  148 (434)
T ss_dssp             CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEE
Confidence            9999888766543221111   1233456799999999999998 999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.89  E-value=1.7e-23  Score=181.83  Aligned_cols=127  Identities=27%  Similarity=0.384  Sum_probs=103.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----------hhHHHHHHHHHHc----CCCCeeecceeeee
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLL----NHPNVVSLKHCFFS  201 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------~~~~~E~~~l~~l----~h~nIv~l~~~~~~  201 (272)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....          ....+|+.+++.+    .||||++++++|. 
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~-  108 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE-  108 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe-
Confidence            346999999999999999999999999999999985432          2233699999999    8999999999883 


Q ss_pred             cccCCceEEEEEeec-cc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          202 TTEKDELYLNLVLEY-IS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       202 ~~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                          .....++|||+ +. +++.+++..    ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus       109 ----~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~  172 (312)
T 2iwi_A          109 ----TQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILI  172 (312)
T ss_dssp             --------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEE
T ss_pred             ----cCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEE
Confidence                33448899998 55 566655443    3468999999999999999999998 899999999999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.89  E-value=5.1e-23  Score=177.13  Aligned_cols=126  Identities=21%  Similarity=0.345  Sum_probs=100.1

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...++|.+.+.||+|+||.||+|.+   ...||||++....      ..+.+|+.+|+.++||||+++++++. .     
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~-----   91 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A-----   91 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-----
T ss_pred             cCccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-C-----
Confidence            3445799999999999999999985   3459999985332      33458999999999999999998642 1     


Q ss_pred             eEEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..+++||||+.++ +...+   ......+++..+..++.||+.||.|||+ .+|+||||||+||||
T Consensus        92 ~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~  153 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFL  153 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHH---TTC---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             CccEEEEEecCCCcHHHHH---hhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEE
Confidence            1278999999854 44433   2234568999999999999999999998 999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.89  E-value=6.2e-23  Score=178.38  Aligned_cols=128  Identities=32%  Similarity=0.484  Sum_probs=103.3

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ...+|.+.+.||+|+||.||+|.+  .++.||||.+...  ...+.+|+.+|+.++||||+++++++.     +.  .|+
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~l   76 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCL   76 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEE
T ss_pred             CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEE
Confidence            345799999999999999999987  4788999998654  234568999999999999999999873     22  689


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc--CCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV--VGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~--~~iiHrDlKp~NILl  272 (272)
                      ||||+.+ ++.+++... .....+++..+..++.||+.||.|||+.  ++|+||||||+||||
T Consensus        77 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll  138 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL  138 (307)
T ss_dssp             EEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEE
T ss_pred             EEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEE
Confidence            9999985 655554322 1122477888999999999999999963  589999999999985

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.89  E-value=6.4e-23  Score=194.50  Aligned_cols=126  Identities=26%  Similarity=0.337  Sum_probs=102.5

Q ss_pred             cCeeeeE-EeccCCceEEEEEEECC--CCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          137 ISYMAER-VVGTGSFGVVFQAKCLE--TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       137 ~~y~~~~-~lG~G~fg~V~~~~~~~--~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .++.+.+ .||+|+||.||+|.+..  ++..||||+++..     ...+.+|+.+|+.++|||||+++++|.. .     
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~-----  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-----  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S-----
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C-----
Confidence            3455555 89999999999998763  4567999998653     2345689999999999999999998742 1     


Q ss_pred             EEEEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+||||||+.++ +.+++.   .....+++..+..++.||+.||.|||+ ++||||||||+||||
T Consensus       409 ~~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl  469 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLL  469 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             CeEEEEEeCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEE
Confidence            289999999965 444332   234568999999999999999999998 999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=2.7e-23  Score=185.80  Aligned_cols=128  Identities=21%  Similarity=0.323  Sum_probs=103.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCC---CCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..|.+.+.||+|+||.||+|.+..+   +..||||.+...     ...+.+|+.+|+.++||||++++++++...    .
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----G  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----S
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----C
Confidence            4589999999999999999987543   246899988542     233457999999999999999999864332    2


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..|+||||+.+ ++.+++..   ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll  225 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCML  225 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             CeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEE
Confidence            37899999985 65554432   23457888999999999999999998 999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.89  E-value=8.5e-23  Score=194.32  Aligned_cols=120  Identities=23%  Similarity=0.350  Sum_probs=99.2

Q ss_pred             eEEeccCCceEEEEEEEC--CCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEE
Q 024091          142 ERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~--~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .+.||+|+||.||+|.+.  .+++.||||+++..      ...+.+|+++|+.|+|||||++++++. ..     .++||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~-----~~~lv  447 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AE-----SWMLV  447 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS-----SEEEE
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC-----CEEEE
Confidence            358999999999999653  56789999998643      234568999999999999999999872 21     17899


Q ss_pred             eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+.+ ++.+++.    ....+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       448 ~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl  502 (635)
T 4fl3_A          448 MEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLL  502 (635)
T ss_dssp             EECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             EEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEE
Confidence            999985 4554443    24568999999999999999999998 999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.88  E-value=1.4e-22  Score=178.09  Aligned_cols=127  Identities=24%  Similarity=0.360  Sum_probs=105.7

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-chhHHHHHHHHHH--cCCCCeeecceeeeecccCCceEEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRL--LNHPNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      .+|.+.+.||+|+||.||+|.+  +++.||||++... .....+|++++..  ++||||+++++++.... ....++|+|
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv  118 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV  118 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence            4699999999999999999998  5899999998643 3344578899888  78999999999875443 222358999


Q ss_pred             eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCceecCCCCCCeeC
Q 024091          214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--------HVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH--------~~~~iiHrDlKp~NILl  272 (272)
                      |||+.+ ++.+++..     ..+++..++.++.||+.||.|||        + .+|+||||||+||||
T Consensus       119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILV  180 (342)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEE
T ss_pred             EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEE
Confidence            999986 66665532     35899999999999999999999        7 899999999999985

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.88  E-value=1.7e-22  Score=173.42  Aligned_cols=127  Identities=26%  Similarity=0.377  Sum_probs=97.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECC-CCC--EEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLE-TGD--SVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~--~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ..+|.+.+.||+|+||.||+|.+.. ++.  .||||++...       ...+.+|+.+++.++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            3479999999999999999998643 333  6999988532       22345899999999999999999987432   


Q ss_pred             CceEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        . .++||||+. +++.+.+...   ...+++..+..++.||+.||.|||+ ++|+|+||||+|||+
T Consensus        94 --~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili  154 (291)
T 1u46_A           94 --P-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLL  154 (291)
T ss_dssp             --S-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             --C-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEE
Confidence              1 789999998 5666555432   3458899999999999999999998 999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.87  E-value=1.8e-23  Score=198.48  Aligned_cols=135  Identities=30%  Similarity=0.381  Sum_probs=106.4

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecc-cCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTT-EKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~~~~  209 (272)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++...     ...+.+|+.+|+.++||||+++++++.... .....+
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            45799999999999999999999999999999988643     233457999999999999999998863311 112445


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .|+||||+.+ ++..++.. ......+++..++.++.||+.||.|||+ .||+||||||+||||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~-~~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl  154 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVL  154 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHS-SSCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEE
T ss_pred             EEEEEEeCCCCCHHHHHHh-cccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEe
Confidence            7899999975 55554443 2223358888999999999999999998 999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.87  E-value=4.3e-22  Score=190.16  Aligned_cols=129  Identities=26%  Similarity=0.357  Sum_probs=105.5

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCC---CCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      ....+|.+.+.||+|+||.||+|.+..+   +..||||.+....     ..+.+|+.+|+.++||||+++++++. ..  
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~--  463 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN--  463 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS--
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC--
Confidence            4456799999999999999999998654   4579999876432     33457999999999999999999872 11  


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                         .+|+||||+.+ ++.+++..   ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus       464 ---~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl  524 (656)
T 2j0j_A          464 ---PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLV  524 (656)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             ---ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEE
Confidence               27899999984 55554432   23468899999999999999999998 999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.87  E-value=1.4e-22  Score=176.28  Aligned_cols=127  Identities=23%  Similarity=0.365  Sum_probs=103.6

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ....+|.+.+.||+|+||.||+|.+..   .||+|.+...      ...+.+|+.+++.++||||+++++++....    
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----  102 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP----  102 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS----
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC----
Confidence            344579999999999999999998743   4999988532      233457999999999999999999985433    


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       .+++||||+.+ ++.+++   ......+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus       103 -~~~iv~e~~~~~~L~~~l---~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~  163 (319)
T 2y4i_B          103 -HLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFY  163 (319)
T ss_dssp             -CEEEECBCCCSEEHHHHT---TSSCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEE
T ss_pred             -ceEEEeecccCCcHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEE
Confidence             38999999985 444433   2223468899999999999999999998 999999999999985

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.85  E-value=7.3e-22  Score=185.59  Aligned_cols=116  Identities=15%  Similarity=0.101  Sum_probs=86.1

Q ss_pred             EeccCCceEEEEEEECCCCCEEEEEEeecc--------------chhHHHHHHHHHHc-CCCCeeecceeeeecccCCce
Q 024091          144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       144 ~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--------------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .++.|++|.+..++....|+.||||++..+              ...+.+|+++|+.+ .|+||++++++|     .+..
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            467788888887777778999999998543              12345799999999 699999999998     4555


Q ss_pred             EEEEEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|||||||+|+.+ +++.    ..+++++.   .|+.||+.||.|||+ +|||||||||+||||
T Consensus       316 ~~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL  372 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMV  372 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEE
T ss_pred             EEEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEE
Confidence            69999999997544 4333    24556653   578999999999998 999999999999996

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.85  E-value=1.9e-21  Score=176.10  Aligned_cols=135  Identities=18%  Similarity=0.197  Sum_probs=98.8

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCC-CCeeecc------------
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNH-PNVVSLK------------  196 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h-~nIv~l~------------  196 (272)
                      ..|.+.++||+|+||.||+|.+..+|+.||||++...       ...+.+|+.+++.+.| .|+..++            
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            3588999999999999999999999999999988622       2345689999999987 3221111            


Q ss_pred             ---------eeeeecccCCceEEEEEeecccccHHHHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 024091          197 ---------HCFFSTTEKDELYLNLVLEYISETVYRVSKHYT---RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD  264 (272)
Q Consensus       197 ---------~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrD  264 (272)
                               .++..........++++|+++.+++.+++....   .....+++..+..++.||+.||.|||+ ++|||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence                     111100001122378899999998887765432   223456777888899999999999998 9999999


Q ss_pred             CCCCCeeC
Q 024091          265 IKPQNLLM  272 (272)
Q Consensus       265 lKp~NILl  272 (272)
                      |||+||||
T Consensus       237 iKp~NILl  244 (413)
T 3dzo_A          237 LRPVDIVL  244 (413)
T ss_dssp             CCGGGEEE
T ss_pred             cccceEEE
Confidence            99999986

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.84  E-value=3.5e-21  Score=165.80  Aligned_cols=113  Identities=17%  Similarity=0.188  Sum_probs=88.7

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----------------------chhHHHHHHHHHHcCCCCeeecc
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------------------KRYKNRELQIMRLLNHPNVVSLK  196 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------------------~~~~~~E~~~l~~l~h~nIv~l~  196 (272)
                      |.+.+.||+|+||.||+|.+ .+|+.||||.+...                      ...+.+|+.+|+.+.  | ++++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            66779999999999999999 88999999998532                      122458999999999  5 7777


Q ss_pred             eeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       197 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +++. ..     ..|+||||++++.+..+      .  .  .....++.||+.||.|||+ +||+||||||+||||
T Consensus       168 ~~~~-~~-----~~~lvmE~~~g~~L~~l------~--~--~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl  226 (282)
T 1zar_A          168 KVYA-WE-----GNAVLMELIDAKELYRV------R--V--ENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLV  226 (282)
T ss_dssp             CEEE-EE-----TTEEEEECCCCEEGGGC------C--C--SCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEE
T ss_pred             eEEe-cc-----ceEEEEEecCCCcHHHc------c--h--hhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEE
Confidence            7552 22     26899999987543211      1  1  2245789999999999998 999999999999985

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.82  E-value=1.8e-20  Score=175.09  Aligned_cols=113  Identities=19%  Similarity=0.264  Sum_probs=80.6

Q ss_pred             eeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------------chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       140 ~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ...++||+|+||.||+|..  .+..+|+|.....            ...+.+|+++|+.++||||+++..++.....   
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~---  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN---  413 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence            4467899999999999943  6788999976321            1124689999999999999965555443322   


Q ss_pred             eEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        .||||||+++ +|.+++..            +..++.||+.||.|||+ ++|+||||||+|||+
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl  464 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIF  464 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEE
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEE
Confidence              6899999984 54443221            45789999999999998 999999999999985

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=3.4e-20  Score=157.54  Aligned_cols=119  Identities=18%  Similarity=0.254  Sum_probs=88.4

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCE--EEEEEeeccc----------------------------hhHHHHHHHHHHcC
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDK----------------------------RYKNRELQIMRLLN  188 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~--vAvK~i~~~~----------------------------~~~~~E~~~l~~l~  188 (272)
                      |.+.+.||+|+||.||+|.+..+|+.  ||||+++...                            ....+|+.+|+.|.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78899999999999999998778888  9999864321                            13467999999999


Q ss_pred             CCCeeecceeeeecccCCceEEEEEeecccc------cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCce
Q 024091          189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISE------TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVVGVC  261 (272)
Q Consensus       189 h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH-~~~~ii  261 (272)
                      |++|....-+..  .     ..+|||||+++      .+.++..       ..++..+..++.||+.||.||| + +|||
T Consensus       129 ~~~i~~p~~~~~--~-----~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~giv  193 (258)
T 1zth_A          129 EAGVSVPQPYTY--M-----KNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-AELV  193 (258)
T ss_dssp             HTTCCCCCEEEE--E-----TTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-SCEE
T ss_pred             hCCCCCCeEEEc--C-----CCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-CCEE
Confidence            886532211111  1     16899999953      3332211       1223456788999999999999 8 8999


Q ss_pred             ecCCCCCCeeC
Q 024091          262 HRDIKPQNLLM  272 (272)
Q Consensus       262 HrDlKp~NILl  272 (272)
                      ||||||+|||+
T Consensus       194 HrDlkp~NILl  204 (258)
T 1zth_A          194 HADLSEYNIMY  204 (258)
T ss_dssp             CSSCSTTSEEE
T ss_pred             eCCCCHHHEEE
Confidence            99999999985

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=6.4e-19  Score=157.04  Aligned_cols=116  Identities=15%  Similarity=0.163  Sum_probs=79.7

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccch------------------h--------HHHHHHHHHHcCCCCe
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------Y--------KNRELQIMRLLNHPNV  192 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------------------~--------~~~E~~~l~~l~h~nI  192 (272)
                      |.+...||.|+||.||+|.+. +|+.||||+++....                  .        ..+|...|..|.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999874 699999998743110                  0        1235555555544433


Q ss_pred             eecceeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       193 v~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .-. ..+. .. .    .+|||||++|..+.   ...    ..  ..+..++.||+.+|.|||+ +|||||||||.||||
T Consensus       176 ~vp-~p~~-~~-~----~~LVME~i~G~~L~---~l~----~~--~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl  238 (397)
T 4gyi_A          176 PVP-EPIA-QS-R----HTIVMSLVDALPMR---QVS----SV--PDPASLYADLIALILRLAK-HGLIHGDFNEFNILI  238 (397)
T ss_dssp             SCC-CEEE-EE-T----TEEEEECCSCEEGG---GCC----CC--SCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEE
T ss_pred             CCC-eeee-cc-C----ceEEEEecCCccHh---hhc----cc--HHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEE
Confidence            211 1111 11 1    36999999976542   111    11  2345678899999999998 899999999999996

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.16  E-value=1.6e-10  Score=97.46  Aligned_cols=105  Identities=13%  Similarity=0.079  Sum_probs=76.6

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec----cchhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~----~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..|.+...++.|+++.||++..  .+..+++|....    ......+|+.+|+.|. +..+.++++++.     .....|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~   86 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSN   86 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEE
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceE
Confidence            3588889999999999999874  368899998863    3345778999999995 667778887763     234589


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH  256 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~  256 (272)
                      +||||++|..+...  ..      +......++.++..+|..||+
T Consensus        87 lv~e~i~G~~l~~~--~~------~~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           87 LLMSEADGVLCSEE--YE------DEQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             EEEECCSSEEHHHH--CC------TTTCHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCeehhhc--cC------CcccHHHHHHHHHHHHHHHhC
Confidence            99999998755421  10      111234567788899999997

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.91  E-value=2.7e-09  Score=89.20  Aligned_cols=102  Identities=14%  Similarity=0.032  Sum_probs=64.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-chhHHHHHHHHHHcCCCC--eeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      .|.+..+.+.|.++.||++. ..+|..+++|..... .....+|+.+|+.|.+.+  +.++++++..     ....++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEE
Confidence            35554444466679999986 355778999987543 234678999999997545  4456665522     22378999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH  256 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~  256 (272)
                      ||++|..+.    ..    ...   ...++.++...|..||+
T Consensus        95 e~i~G~~l~----~~----~~~---~~~~~~~l~~~l~~lh~  125 (264)
T 1nd4_A           95 GEVPGQDLL----SS----HLA---PAEKVSIMADAMRRLHT  125 (264)
T ss_dssp             ECCSSEETT----TS----CCC---HHHHHHHHHHHHHHHTT
T ss_pred             EecCCcccC----cC----cCC---HhHHHHHHHHHHHHHhC
Confidence            999986432    10    011   12445566667777775

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.89  E-value=3.7e-09  Score=93.22  Aligned_cols=107  Identities=12%  Similarity=0.088  Sum_probs=72.5

Q ss_pred             eeEEeccCCceEEEEEEECCCCCEEEEEEee--cc-----chhHHHHHHHHHHcCC--CCeeecceeeeecccCCceEEE
Q 024091          141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVL--QD-----KRYKNRELQIMRLLNH--PNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       141 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~--~~-----~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..+.|+.|.++.||+...  .+..+++|...  ..     .....+|+.+|+.|..  ..+++++.++...  ......|
T Consensus        42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred             eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence            457789999999999875  34678888765  22     3356689999999984  4567777665322  1113367


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH  256 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~  256 (272)
                      +||||++|..+.     ......++......++.+++..|..||+
T Consensus       118 ~vme~v~G~~l~-----~~~~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A          118 YIMEFVSGRVLW-----DQSLPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             EEEECCCCBCCC-----CTTCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCeecC-----CCccccCCHHHHHHHHHHHHHHHHHHhC
Confidence            999999986431     0112235677777888899999999996

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.06  E-value=8.7e-06  Score=69.80  Aligned_cols=102  Identities=11%  Similarity=0.065  Sum_probs=59.2

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcC-CCCe--eecceeeeecccCCceEEEEEeecc
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLN-HPNV--VSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      +.++.|.+..||+..     ..+++|.....  .....+|..+|+.|. +..|  .+++...  .........|+|||++
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCEEEECC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceEEEccc
Confidence            458999999999853     46888976433  234568999999884 3332  2332221  1111112357899999


Q ss_pred             cccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 024091          218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH  256 (272)
Q Consensus       218 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~  256 (272)
                      +|..+.....     ..++......++.|++..|..||+
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~  132 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHS  132 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHc
Confidence            9754321100     124444555556666666666663

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.02  E-value=4.9e-05  Score=65.36  Aligned_cols=72  Identities=11%  Similarity=0.032  Sum_probs=47.2

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCC---CeeecceeeeecccCCceEEEEEeec
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHP---NVVSLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      ...++.|....||+.     +..+++|+-...  .....+|.++|+.|.+.   .|.+++.+..    ....+.|+|||+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEec
Confidence            356788988999987     567888875322  23456899999999753   2334443332    112336799999


Q ss_pred             ccccHH
Q 024091          217 ISETVY  222 (272)
Q Consensus       217 ~~~~l~  222 (272)
                      ++|..+
T Consensus        95 i~G~~l  100 (306)
T 3tdw_A           95 VQGQIL  100 (306)
T ss_dssp             CCSEEC
T ss_pred             cCCeEC
Confidence            997543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.79  E-value=0.00017  Score=60.33  Aligned_cols=72  Identities=13%  Similarity=0.082  Sum_probs=47.6

Q ss_pred             eccCCce-EEEEEEECCCCCEEEEEEeecc-chhHHHHHHHHHHcCC-CCeeecceeeeecccCCceEEEEEeecccccH
Q 024091          145 VGTGSFG-VVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLVLEYISETV  221 (272)
Q Consensus       145 lG~G~fg-~V~~~~~~~~~~~vAvK~i~~~-~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l  221 (272)
                      +..|..| .||+......+..+.+|.-... .....+|..+|+.|.. --+.+++.++..     ....|+|||+++|..
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeCCcc
Confidence            4445544 6898876666778999976543 2345689999998852 234555555422     234789999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.59  E-value=0.00016  Score=64.30  Aligned_cols=71  Identities=20%  Similarity=0.178  Sum_probs=45.4

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeecc-----------chhHHHHHHHHHHcCC--CC-eeecceeeeecccCCc
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----------KRYKNRELQIMRLLNH--PN-VVSLKHCFFSTTEKDE  207 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----------~~~~~~E~~~l~~l~h--~n-Iv~l~~~~~~~~~~~~  207 (272)
                      .+.||.|.++.||++.....++.|+||.....           ......|.++|+.+..  +. +.+++.+  ...  . 
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~--~-  109 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE--M-  109 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT--T-
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC--c-
Confidence            46799999999999976556788999976422           1223579999988743  33 3344432  111  1 


Q ss_pred             eEEEEEeecccc
Q 024091          208 LYLNLVLEYISE  219 (272)
Q Consensus       208 ~~~~lv~e~~~~  219 (272)
                        .++|||++++
T Consensus       110 --~~lvmE~l~g  119 (397)
T 2olc_A          110 --AVTVMEDLSH  119 (397)
T ss_dssp             --TEEEECCCTT
T ss_pred             --cEEEEEeCCC
Confidence              4689999975

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.47  E-value=0.0014  Score=56.47  Aligned_cols=74  Identities=16%  Similarity=0.258  Sum_probs=41.1

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCC--CCeeeccee----eeecccCCceEEEEEee
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNH--PNVVSLKHC----FFSTTEKDELYLNLVLE  215 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h--~nIv~l~~~----~~~~~~~~~~~~~lv~e  215 (272)
                      .+.|+.|..+.||+....  +..+++|...........|..+++.|..  -.+.+++..    ++.   ......+++|+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~---~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYS---KHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCE---EETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEE---EECCEEEEEEE
Confidence            345666778999998752  3458999887544444456777766642  123333321    110   01224789999


Q ss_pred             ccccc
Q 024091          216 YISET  220 (272)
Q Consensus       216 ~~~~~  220 (272)
                      |++|.
T Consensus       112 ~i~G~  116 (346)
T 2q83_A          112 WIEGR  116 (346)
T ss_dssp             CCCCB
T ss_pred             eecCc
Confidence            99873

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.44  E-value=0.00022  Score=62.27  Aligned_cols=79  Identities=10%  Similarity=0.097  Sum_probs=50.4

Q ss_pred             eeeEEe-ccCCceEEEEEEEC--C----CCCEEEEEEeeccc-------hhHHHHHHHHHHcCC---CCeeecceeeeec
Q 024091          140 MAERVV-GTGSFGVVFQAKCL--E----TGDSVAIKKVLQDK-------RYKNRELQIMRLLNH---PNVVSLKHCFFST  202 (272)
Q Consensus       140 ~~~~~l-G~G~fg~V~~~~~~--~----~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h---~nIv~l~~~~~~~  202 (272)
                      ...+.| +.|....+|+....  .    .+..+++|......       ....+|+.+|+.|..   -.+.+++.+....
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345678 88889999987653  0    15678899765432       346789999988853   2455666544211


Q ss_pred             ccCCceEEEEEeeccccc
Q 024091          203 TEKDELYLNLVLEYISET  220 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~~  220 (272)
                        ......|+|||+++|.
T Consensus       103 --~~~g~~~~v~e~l~G~  118 (357)
T 3ats_A          103 --DVLGTPFFLMDYVEGV  118 (357)
T ss_dssp             --TTTSSCEEEEECCCCB
T ss_pred             --CccCCceEEEEecCCC
Confidence              1112357899999863

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.79  E-value=0.016  Score=51.62  Aligned_cols=69  Identities=22%  Similarity=0.263  Sum_probs=41.6

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeec-------c-c---hhHHHHHHHHHHc---CCCCeeecceeeeecccCCc
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------D-K---RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-------~-~---~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~  207 (272)
                      .+.||.|....||++..  .+..++||....       . .   .....|.+++..+   ....+.+++.+.  ..    
T Consensus        39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~----  110 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RT----  110 (420)
T ss_dssp             EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TT----
T ss_pred             EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CC----
Confidence            46789999999999853  567899994321       1 1   1223354444433   234455655443  11    


Q ss_pred             eEEEEEeecc-cc
Q 024091          208 LYLNLVLEYI-SE  219 (272)
Q Consensus       208 ~~~~lv~e~~-~~  219 (272)
                       ..++|||++ ++
T Consensus       111 -~~~lv~e~l~~g  122 (420)
T 2pyw_A          111 -MALIGMRYLEPP  122 (420)
T ss_dssp             -TTEEEECCCCTT
T ss_pred             -ccEEEEeecCCc
Confidence             157999999 75

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.69  E-value=0.046  Score=46.21  Aligned_cols=65  Identities=17%  Similarity=0.112  Sum_probs=41.2

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCe-eecceeeeecccCCceEEEEEeecc
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNLVLEYI  217 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~~~~lv~e~~  217 (272)
                      .+.|+.|....+|+.      ..+.+|+.....   ....+|+.+++.+...++ .+++.++     ...  -++++||+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence            577888999999998      458888765321   223578888887753333 3444332     111  25789999


Q ss_pred             -cc
Q 024091          218 -SE  219 (272)
Q Consensus       218 -~~  219 (272)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             64

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.66  E-value=0.12  Score=46.21  Aligned_cols=69  Identities=19%  Similarity=0.240  Sum_probs=47.3

Q ss_pred             eEEeccCCceEEEEEEECC-------CCCEEEEEEeec-cc-hhHHHHHHHHHHcCCCCe-eecceeeeecccCCceEEE
Q 024091          142 ERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQ-DK-RYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~-~~-~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~~~~  211 (272)
                      .+.|+.|....||++....       .+..+.+|+... .. ....+|..+++.|...++ .++++.+     .+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence            4678888889999998643       257899998743 22 344579999988864444 4566544     22    2


Q ss_pred             EEeecccc
Q 024091          212 LVLEYISE  219 (272)
Q Consensus       212 lv~e~~~~  219 (272)
                      +||||++|
T Consensus       149 ~v~e~l~G  156 (429)
T 1nw1_A          149 RLEEYIPS  156 (429)
T ss_dssp             EEECCCCE
T ss_pred             EEEEEeCC
Confidence            78999875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=95.42  E-value=0.056  Score=45.95  Aligned_cols=75  Identities=9%  Similarity=0.014  Sum_probs=43.4

Q ss_pred             eeEEeccCCceEEEEEEECCCCCEEEEEEeec--cchhHHHHHHHHHHcCCCC--eeeccee----eeecccCCceEEEE
Q 024091          141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLLNHPN--VVSLKHC----FFSTTEKDELYLNL  212 (272)
Q Consensus       141 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~--~~~~~~~E~~~l~~l~h~n--Iv~l~~~----~~~~~~~~~~~~~l  212 (272)
                      -.+.|+.|....+|+....  +..+++|....  .......|+.+++.|...+  +.+++..    ++..   .....++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~---~~g~~~~  100 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE---LSGRPAA  100 (322)
T ss_dssp             EEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE---ETTEEEE
T ss_pred             EeeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEE---ECCEEEE
Confidence            4567888888999998753  33688998765  3445567888888775322  2333321    0000   1123688


Q ss_pred             Eeeccccc
Q 024091          213 VLEYISET  220 (272)
Q Consensus       213 v~e~~~~~  220 (272)
                      +|+|++|.
T Consensus       101 l~~~l~G~  108 (322)
T 2ppq_A          101 LISFLEGM  108 (322)
T ss_dssp             EEECCCCB
T ss_pred             EEEeCCCc
Confidence            99999864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.29  E-value=0.17  Score=45.80  Aligned_cols=70  Identities=14%  Similarity=0.243  Sum_probs=46.2

Q ss_pred             eeEEeccCCceEEEEEEECCCCCEEEEEEeeccch---hHHHHHHHHHHcCCCCe-eecceeeeecccCCceEEEEEeec
Q 024091          141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       141 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      -.+.|+.|-...+|++.....+..+.+|+......   ...+|..+++.|...++ .+++++|     .+    .+||||
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence            34678888889999998754457888997643221   22589999999975555 4566554     22    148999


Q ss_pred             ccc
Q 024091          217 ISE  219 (272)
Q Consensus       217 ~~~  219 (272)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=95.16  E-value=0.058  Score=46.24  Aligned_cols=92  Identities=14%  Similarity=0.064  Sum_probs=64.0

Q ss_pred             eeEEeccCCceEEEEEEECCCCCEEEEEEeecc-chhHHHHHHHHHHcC---CCCeeecceeeeecccCCceEEEEEeec
Q 024091          141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELYLNLVLEY  216 (272)
Q Consensus       141 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~~~~~lv~e~  216 (272)
                      -.+.|+.|.+..+|+...  .+..+++|..... ......|...|+.|.   ...+++++.+..     .....|+||||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEe
Confidence            356789999999999874  4678899977543 334568999998885   245666666542     12348899999


Q ss_pred             ccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 024091          217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH  256 (272)
Q Consensus       217 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~  256 (272)
                      +++....             .    ..+.++...|.-||+
T Consensus       113 l~G~~~~-------------~----~~~~~lG~~LA~LH~  135 (312)
T 3jr1_A          113 LNKSKNK-------------Q----SSFTIFAEKIAQLHQ  135 (312)
T ss_dssp             CCCCCCC-------------T----THHHHHHHHHHHHHH
T ss_pred             ccCCCCC-------------c----hhHHHHHHHHHHHHc
Confidence            9976311             0    123567788889997

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=94.89  E-value=0.2  Score=41.86  Aligned_cols=72  Identities=15%  Similarity=0.170  Sum_probs=50.5

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCC---CeeecceeeeecccCCceEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHP---NVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ..-...+|.|..+.||+.+. .+|+.|.+|+-...    ...+.+|...|+.|.-.   -+.+++.+   ..      -+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~------~~   86 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---DD------RT   86 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ET------TE
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---cC------ce
Confidence            55678899999999999974 57889999976432    23467899999998532   23343332   11      36


Q ss_pred             EEeeccccc
Q 024091          212 LVLEYISET  220 (272)
Q Consensus       212 lv~e~~~~~  220 (272)
                      +||||+.+.
T Consensus        87 lv~e~l~~~   95 (288)
T 3f7w_A           87 LAMEWVDER   95 (288)
T ss_dssp             EEEECCCCC
T ss_pred             EEEEeeccc
Confidence            899998754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=94.54  E-value=0.25  Score=43.51  Aligned_cols=68  Identities=15%  Similarity=0.153  Sum_probs=39.5

Q ss_pred             EEeccCCceEEEEEEECC-------CCCEEEEEEeec---cchhHHHHHHHHHHcCCCCe-eecceeeeecccCCceEEE
Q 024091          143 RVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQ---DKRYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~---~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~~~~  211 (272)
                      +.|..|-...+|++....       .++.+.+|+.-.   ......+|..+++.|.-.++ .++++++     .++    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~g----  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PEG----  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TTE----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CCc----
Confidence            456667778888887532       346888897532   22334579999988853333 4555544     322    


Q ss_pred             EEeecccc
Q 024091          212 LVLEYISE  219 (272)
Q Consensus       212 lv~e~~~~  219 (272)
                      +||||++|
T Consensus       127 ~v~e~i~G  134 (379)
T 3feg_A          127 RLEQYIPS  134 (379)
T ss_dssp             EEEECCSE
T ss_pred             cEEEEecC
Confidence            78999986

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=94.32  E-value=0.2  Score=42.61  Aligned_cols=74  Identities=12%  Similarity=0.027  Sum_probs=44.6

Q ss_pred             EEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCC--eeecceeeeeccc--CCceEEEEEee
Q 024091          143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPN--VVSLKHCFFSTTE--KDELYLNLVLE  215 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~--~~~~~~~lv~e  215 (272)
                      ..|+ |....||+... ..|+.+++|.....   ......|..+++.|....  +++++..  ....  ....+.+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence            3466 77789998753 34667999988632   334567888888775322  3444332  0000  01234678999


Q ss_pred             ccccc
Q 024091          216 YISET  220 (272)
Q Consensus       216 ~~~~~  220 (272)
                      +++|.
T Consensus       108 ~i~G~  112 (328)
T 1zyl_A          108 SVGGR  112 (328)
T ss_dssp             CCCCE
T ss_pred             ecCCC
Confidence            99863

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=93.76  E-value=0.15  Score=43.51  Aligned_cols=68  Identities=7%  Similarity=0.056  Sum_probs=34.4

Q ss_pred             EeccCCceE-EEEEEECCCCCEEEEEEeeccc-hhHHHHHHHHHHcCCCC--eeecceeeeecccCCceEEEEEeecccc
Q 024091          144 VVGTGSFGV-VFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLEYISE  219 (272)
Q Consensus       144 ~lG~G~fg~-V~~~~~~~~~~~vAvK~i~~~~-~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~~~~~~lv~e~~~~  219 (272)
                      .|+.|.... +|+... .++..+.+|...... .....|+.+++.|...+  +.+++.+.   . ..+   +++||++++
T Consensus        25 ~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d---~-~~g---~ll~e~l~~   96 (333)
T 3csv_A           25 PLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE---H-ARG---LLLIEDLGD   96 (333)
T ss_dssp             C--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE---T-TTT---EEEECCCCS
T ss_pred             ECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec---C-CCC---EEEEeeCCC
Confidence            454454443 556542 225677777654433 45567888888875323  34444331   1 222   578999875

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=90.35  E-value=0.46  Score=40.86  Aligned_cols=71  Identities=20%  Similarity=0.270  Sum_probs=40.7

Q ss_pred             ccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCC---CCeeecceeeeec-ccCCceEEEEEeeccccc
Q 024091          146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNH---PNVVSLKHCFFST-TEKDELYLNLVLEYISET  220 (272)
Q Consensus       146 G~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~-~~~~~~~~~lv~e~~~~~  220 (272)
                      |.|....||+... ..| .+++|+.....  ...|+.+++.|..   |++++++...... -.....+.+++|+|++|.
T Consensus        32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~--~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           32 GADTNAFAYQADS-ESK-SYFIKLKYGYH--DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             TSCSSCEEEEEEC-SSC-EEEEEEEECSS--CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             cCccccceEEEEe-CCC-CEEEEEecCcc--chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            3333678999864 334 89999775543  2467888877742   2244443221000 001234578999999864

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=88.57  E-value=0.027  Score=51.11  Aligned_cols=55  Identities=13%  Similarity=0.043  Sum_probs=16.2

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEE------EEeecc------chhHHHHHHHHHHcCCCCeeecceee
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAI------KKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCF  199 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAv------K~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~  199 (272)
                      .+.||   ||.||++........||+      |..+..      ...+.+|..+++.+.|||+++.+++-
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            45566   999999988665567888      655431      12334688889999999999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	272
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-46
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-31
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-29
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-29
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-28
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-28
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-28
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-27
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-27
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-27
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-27
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-26
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-26
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-25
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-25
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-25
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-25
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-24
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-24
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-24
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-24
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-24
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-24
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-24
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-24
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-24
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-23
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-23
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-23
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-23
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-22
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-22
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-22
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-22
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-22
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-21
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-21
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-21
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-21
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-21
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-21
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-21
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-20
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-20
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-20
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-20
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-20
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-20
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-19
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-19
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-18
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-18
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-17
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-17
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-16
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-16
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-16
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-16
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-12

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-46
 Identities = 89/152 (58%), Positives = 120/152 (78%), Gaps = 3/152 (1%)

Query: 122 IATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL 181
           +  T G    +P Q +SY   +V+G GSFGVV+QAK  ++G+ VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64

Query: 182 QIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV 240
           QIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R  Q +P++YV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +LY YQ+ R+L Y+H   G+CHRDIKPQNLL+
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL 155

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 1e-31
 Identities = 30/139 (21%), Positives = 57/139 (41%), Gaps = 13/139 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           +     +G G+ GVVF+     +G  +A K +  + +        RELQ++   N P +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
                F       E+ +   +E++            +    +P   +   +  + + L Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMDGGSLD---QVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           L     + HRD+KP N+L+
Sbjct: 120 LREKHKIMHRDVKPSNILV 138

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  112 bits (281), Expect = 1e-29
 Identities = 37/138 (26%), Positives = 67/138 (48%), Gaps = 12/138 (8%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVS 194
           Y     +GTG+FGVV +     TG++ A K V+     DK    +E+Q M +L HP +V+
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   F     +D+  + ++ E++S     + +     +  +       Y  Q+C+ L ++
Sbjct: 88  LHDAF-----EDDNEMVMIYEFMSGG--ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H      H D+KP+N++ 
Sbjct: 141 HE-NNYVHLDLKPENIMF 157

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-29
 Identities = 39/139 (28%), Positives = 62/139 (44%), Gaps = 14/139 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           +   + +G G++G V  A    T ++VA+K V   +         +E+ I ++LNH NVV
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
                             L LEY S             +  +P    Q + +Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH  +G+ HRDIKP+NLL+
Sbjct: 119 LHG-IGITHRDIKPENLLL 136

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 5e-29
 Identities = 35/133 (26%), Positives = 61/133 (45%), Gaps = 7/133 (5%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFF 200
            +V+G G  G V Q     T +  A+K +LQD     RE+++  R    P++V +   + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 201 STTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
           +     +  L +V+E +    ++   +   R +Q             I  A+ YLH  + 
Sbjct: 76  NLYAGRK-CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-IN 131

Query: 260 VCHRDIKPQNLLM 272
           + HRD+KP+NLL 
Sbjct: 132 IAHRDVKPENLLY 144

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-28
 Identities = 36/145 (24%), Positives = 60/145 (41%), Gaps = 14/145 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNV 192
           Y     +GTGS+G   + +    G  +  K++        +K+    E+ ++R L HPN+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           V         T      L +V+EY     +  V    T+  Q++   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 252 NYLH----HVVGVCHRDIKPQNLLM 272
              H        V HRD+KP N+ +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFL 147

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 1e-28
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 12/138 (8%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
           +     +G G+FG V++A+  ET    A K +     ++      E+ I+   +HPN+V 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   F       E  L +++E+ +            + + +    +Q+   Q   ALNYL
Sbjct: 74  LLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    + HRD+K  N+L 
Sbjct: 127 HD-NKIIHRDLKAGNILF 143

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (266), Expect = 8e-28
 Identities = 36/141 (25%), Positives = 67/141 (47%), Gaps = 16/141 (11%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
           +   R +G GSFG V+ A+ +   + VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
            +  + C+       E    LV+EY   +   + + +    + +  + +   T+   + L
Sbjct: 77  TIQYRGCYL-----REHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGL 128

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            YLH    + HRD+K  N+L+
Sbjct: 129 AYLHS-HNMIHRDVKAGNILL 148

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 2e-27
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 14/138 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
           Y     +G G+ G V+ A  + TG  VAI+++       K     E+ +MR   +PN+V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
               +      DEL+  +V+EY    +   S         +    +     +  +AL +L
Sbjct: 82  YLDSY---LVGDELW--VVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    V HRDIK  N+L+
Sbjct: 133 HS-NQVIHRDIKSDNILL 149

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  105 bits (264), Expect = 3e-27
 Identities = 37/138 (26%), Positives = 62/138 (44%), Gaps = 12/138 (8%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
           Y     +G+G+FGVV +     TG     K +      DK     E+ IM  L+HP +++
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L   F     +D+  + L+LE++S     +       +  +    V  Y  Q C  L ++
Sbjct: 91  LHDAF-----EDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143

Query: 255 HHVVGVCHRDIKPQNLLM 272
           H    + H DIKP+N++ 
Sbjct: 144 HE-HSIVHLDIKPENIMC 160

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 4e-27
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 11/139 (7%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKN---RELQIMRLLNHPNVV 193
           Y     +G G++G+V  A        VAIKK+   + + Y     RE++I+    H N++
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
            +     + T +    + LV   +   +Y++ K      QH+   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           +H    V HRD+KP NLL+
Sbjct: 125 IHS-ANVLHRDLKPSNLLL 142

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (259), Expect = 6e-27
 Identities = 44/150 (29%), Positives = 65/150 (43%), Gaps = 18/150 (12%)

Query: 132 QPKQTI--SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQ 182
           QP++     +   +++G GSF  V  A+ L T    AIK + +    K        RE  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60

Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
           +M  L+HP  V L   F    + ++LY    L Y           Y R          + 
Sbjct: 61  VMSRLDHPFFVKLYFTF---QDDEKLY--FGLSYAKNGELL---KYIRKIGSFDETCTRF 112

Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           YT +I  AL YLH    + HRD+KP+N+L+
Sbjct: 113 YTAEIVSALEYLHGKG-IIHRDLKPENILL 141

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-26
 Identities = 34/138 (24%), Positives = 66/138 (47%), Gaps = 11/138 (7%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
           +  +G GSF  V++    ET   VA  ++   K  K+       E ++++ L HPN+V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
            +  + +T K +  + LV E ++    +    Y +  + + I  ++ +  QI + L +LH
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMTSGTLK---TYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 256 -HVVGVCHRDIKPQNLLM 272
                + HRD+K  N+ +
Sbjct: 130 TRTPPIIHRDLKCDNIFI 147

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (253), Expect = 5e-26
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 16/141 (11%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPN 191
           +   R +GTGSFG V   +    G   A+K +       L+   + N E  ++ ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           ++ +   F     +D   + ++++YI            R +Q  P    + Y  ++C AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIEGGELF---SLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            YLH    + +RD+KP+N+L+
Sbjct: 118 EYLHS-KDIIYRDLKPENILL 137

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  100 bits (251), Expect = 5e-26
 Identities = 34/141 (24%), Positives = 54/141 (38%), Gaps = 12/141 (8%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
           Y    ++G G    V  A+ L     VA+K +  D            RE Q    LNHP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           +V++ +              +V+EY+     R           +            C+AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVDGVTLR---DIVHTEGPMTPKRAIEVIADACQAL 124

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
           N+ H   G+ HRD+KP N+++
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMI 144

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 1e-25
 Identities = 38/140 (27%), Positives = 64/140 (45%), Gaps = 11/140 (7%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
           Y     VG+G++G V  A   +TG  VA+KK+      +   +   REL++++ + H NV
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           + L   F      +E     ++ ++            ++       +VQ   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD----HVQFLIYQILRGLK 135

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           Y+H    + HRD+KP NL +
Sbjct: 136 YIHS-ADIIHRDLKPSNLAV 154

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 2e-25
 Identities = 42/141 (29%), Positives = 71/141 (50%), Gaps = 13/141 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
           Y   + VG+G++G V  A    TG  VAIKK+ +  + +       REL++++ + H NV
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 193 VSLKHCFFS-TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           + L   F    T  D     LV+ ++   + ++ KH     + +    +Q   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134

Query: 252 NYLHHVVGVCHRDIKPQNLLM 272
            Y+H   G+ HRD+KP NL +
Sbjct: 135 RYIHA-AGIIHRDLKPGNLAV 154

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.5 bits (245), Expect = 4e-25
 Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 18/142 (12%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
           +   R +G G FG V+ A+  ++   +A+K + + +  K        RE++I   L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           ++ L   F      D   + L+LEY    TVYR  +  ++ ++         Y  ++  A
Sbjct: 68  ILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQR----TATYITELANA 118

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L+Y H    V HRDIKP+NLL+
Sbjct: 119 LSYCHS-KRVIHRDIKPENLLL 139

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 99.1 bits (246), Expect = 4e-25
 Identities = 33/149 (22%), Positives = 61/149 (40%), Gaps = 19/149 (12%)

Query: 126 VGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQI 183
           VG R         Y   R +G+GSFG ++    +  G+ VAIK      ++     E +I
Sbjct: 5   VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55

Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
            +++     +       +    +  Y  +V+E +  ++      +   ++   +  V L 
Sbjct: 56  YKMMQGGVGIPTIRWCGA----EGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLL 108

Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q+   + Y+H      HRD+KP N LM
Sbjct: 109 ADQMISRIEYIHS-KNFIHRDVKPDNFLM 136

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.2 bits (244), Expect = 6e-25
 Identities = 29/137 (21%), Positives = 52/137 (37%), Gaps = 12/137 (8%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL 195
                 +G G FG V+          VA+K + Q     +    E  +M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
                    ++ +Y  ++ EY+ E    V    T     + I  +     QI   + ++ 
Sbjct: 74  YAVV----TQEPIY--IITEYM-ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 256 HVVGVCHRDIKPQNLLM 272
                 HRD++  N+L+
Sbjct: 127 E-RNYIHRDLRAANILV 142

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 8e-25
 Identities = 37/143 (25%), Positives = 68/143 (47%), Gaps = 13/143 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
           Y     +G G+FG VF+A+  +TG  VA+KKVL +   +       RE++I++LL H NV
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 193 VSLKHCFFSTTE---KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           V+L     +      + +  + LV ++    +       + +     +  ++     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLN 128

Query: 250 ALNYLHHVVGVCHRDIKPQNLLM 272
            L Y+H    + HRD+K  N+L+
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLI 150

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.2 bits (244), Expect = 1e-24
 Identities = 32/137 (23%), Positives = 60/137 (43%), Gaps = 11/137 (8%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQIMRLLNHPNVVSL 195
           YM    +G G FG+V +     +  +   K V     D+    +E+ I+ +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
              F     +    L ++ E+IS     + +        +    +  Y +Q+C AL +LH
Sbjct: 67  HESF-----ESMEELVMIFEFISGL--DIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 256 HVVGVCHRDIKPQNLLM 272
               + H DI+P+N++ 
Sbjct: 120 S-HNIGHFDIRPENIIY 135

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.6 bits (242), Expect = 2e-24
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 13/144 (9%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN------RELQIMRLL---N 188
           Y     +G G++G VF+A+ L+ G   VA+K+V      +       RE+ ++R L    
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           HPNVV L      +    E  L LV E++ + +             VP   ++   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY--LDKVPEPGVPTETIKDMMFQLL 126

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
           R L++LH    V HRD+KPQN+L+
Sbjct: 127 RGLDFLHS-HRVVHRDLKPQNILV 149

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 98.6 bits (244), Expect = 2e-24
 Identities = 39/147 (26%), Positives = 73/147 (49%), Gaps = 15/147 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL 195
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E+++++ +N  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 196 KH----------CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
                         F+    + +++ +V E + E +  + K Y   ++ +P++YV+  + 
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISK 132

Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLM 272
           Q+   L+Y+H   G+ H DIKP+N+LM
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLM 159

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 98.3 bits (244), Expect = 2e-24
 Identities = 28/144 (19%), Positives = 63/144 (43%), Gaps = 19/144 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN 188
           +   R++G G FG V+  +  +TG   A+K + + +            +   L ++   +
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
            P +V + + F      D+L    +L+ ++        ++   +       ++ Y  +I 
Sbjct: 66  CPFIVCMSYAF---HTPDKLS--FILDLMNGGDLH---YHLSQHGVFSEADMRFYAAEII 117

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             L ++H+   V +RD+KP N+L+
Sbjct: 118 LGLEHMHN-RFVVYRDLKPANILL 140

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.2 bits (239), Expect = 3e-24
 Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 10/132 (7%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFF 200
           + +G G FG V        G+ VA+K +  D   +    E  +M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
               +++  L +V EY+++         +R    +    +  ++  +C A+ YL      
Sbjct: 71  ----EEKGGLYIVTEYMAKGSLV-DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNF 124

Query: 261 CHRDIKPQNLLM 272
            HRD+  +N+L+
Sbjct: 125 VHRDLAARNVLV 136

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.6 bits (239), Expect = 3e-24
 Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 15/140 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
           Y     +G G++G VF+AK  ET + VA+K+V  D   +       RE+ +++ L H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           V L           +  L LV E+  + + +   ++   N  +    V+ + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           + H    V HRD+KPQNLL+
Sbjct: 116 FCHS-RNVLHRDLKPQNLLI 134

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 97.2 bits (241), Expect = 3e-24
 Identities = 37/136 (27%), Positives = 71/136 (52%), Gaps = 12/136 (8%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-NRELQIMRLLN-HPNVVSLK 196
           Y   R +G G +  VF+A  +   + V +K +   K+ K  RE++I+  L   PN+++L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
                  +       LV E+++ T ++      ++ Q +    ++ Y Y+I +AL+Y H 
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147

Query: 257 VVGVCHRDIKPQNLLM 272
            +G+ HRD+KP N+++
Sbjct: 148 -MGIMHRDVKPHNVMI 162

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 96.6 bits (240), Expect = 4e-24
 Identities = 36/139 (25%), Positives = 59/139 (42%), Gaps = 14/139 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           Y    V+GTG+F  V  A+   T   VAIK + +            E+ ++  + HPN+V
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           +L   +        LY  L+++ +S                          +Q+  A+ Y
Sbjct: 71  ALDDIY---ESGGHLY--LIMQLVSGGELF---DRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           LH +  + HRD+KP+NLL 
Sbjct: 123 LHDLG-IVHRDLKPENLLY 140

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.1 bits (238), Expect = 5e-24
 Identities = 36/138 (26%), Positives = 63/138 (45%), Gaps = 18/138 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVV 193
             +G G F  V++A+   T   VAIKK+    R +          RE+++++ L+HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
            L   F     K  +   LV +++   +          +  +   +++ Y     + L Y
Sbjct: 64  GLLDAF---GHKSNIS--LVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 254 LHHVVGVCHRDIKPQNLL 271
           LH    + HRD+KP NLL
Sbjct: 116 LHQHW-ILHRDLKPNNLL 132

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 95.1 bits (236), Expect = 1e-23
 Identities = 28/148 (18%), Positives = 59/148 (39%), Gaps = 23/148 (15%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-------------LQDKRYKNRELQIMR 185
           Y  + ++G G   VV +     T    A+K +              + +    +E+ I+R
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 186 LLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
            ++ HPN++ LK  +     +   +  LV + + +        Y      +     +   
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELF---DYLTEKVTLSEKETRKIM 116

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
             +   +  LH  + + HRD+KP+N+L+
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILL 143

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 1e-23
 Identities = 42/140 (30%), Positives = 73/140 (52%), Gaps = 14/140 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
           +     +G G++GVV++A+   TG+ VA+KK+  D   +       RE+ +++ LNHPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           V L           E  L LV E++ + + +           +P+  ++ Y +Q+ + L 
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           + H    V HRD+KPQNLL+
Sbjct: 117 FCHSHR-VLHRDLKPQNLLI 135

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 94.9 bits (235), Expect = 3e-23
 Identities = 35/137 (25%), Positives = 61/137 (44%), Gaps = 16/137 (11%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
           + +GTGSFG V   K  E+G+  A+K + + K  K         E +I++ +N P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           +  F   +    +   +    +   + R               + + Y  QI     YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLH 158

Query: 256 HVVGVCHRDIKPQNLLM 272
             + + +RD+KP+NLL+
Sbjct: 159 S-LDLIYRDLKPENLLI 174

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.0 bits (233), Expect = 4e-23
 Identities = 31/142 (21%), Positives = 63/142 (44%), Gaps = 17/142 (11%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ--------IMRLLNHP 190
           ++  +++G GSFG VF A+  +T    AIK + +D    + +++        +     HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
            +  +   F     + +  L  V+EY++        ++ +      +     Y  +I   
Sbjct: 64  FLTHMFCTF-----QTKENLFFVMEYLNGGDLM---YHIQSCHKFDLSRATFYAAEIILG 115

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L +LH   G+ +RD+K  N+L+
Sbjct: 116 LQFLHS-KGIVYRDLKLDNILL 136

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.7 bits (227), Expect = 2e-22
 Identities = 35/138 (25%), Positives = 57/138 (41%), Gaps = 16/138 (11%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKN-----RELQIMRLLNHPNVVS 194
           +  +G G+FG V Q           VAIK + Q     +     RE QIM  L++P +V 
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
           L        + + L   LV+E        + K      + +P+  V    +Q+   + YL
Sbjct: 74  LIGVC----QAEALM--LVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125

Query: 255 HHVVGVCHRDIKPQNLLM 272
                  HRD+  +N+L+
Sbjct: 126 EE-KNFVHRDLAARNVLL 142

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 91.7 bits (227), Expect = 3e-22
 Identities = 31/142 (21%), Positives = 55/142 (38%), Gaps = 16/142 (11%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDS---VAIKKVL-----QDKRYKNRELQIMRLLNH 189
               E+V+G G FG V        G     VAIK +      + +R    E  IM   +H
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
           PNV+ L+      T+   +   ++ E++            + +    ++ +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMENGSLD--SFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 250 ALNYLHHVVGVCHRDIKPQNLL 271
            + YL   +   HRD+  +N+L
Sbjct: 140 GMKYLAD-MNYVHRDLAARNIL 160

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (228), Expect = 3e-22
 Identities = 36/138 (26%), Positives = 67/138 (48%), Gaps = 14/138 (10%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
           Y   + +G+G+ G+V  A       +VAIKK+ +  + +       REL +M+ +NH N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 193 VSLKHCFFS-TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
           +SL + F    T ++   + LV+E +   + +V      +   +    +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV------IQMELDHERMSYLLYQMLCGI 132

Query: 252 NYLHHVVGVCHRDIKPQN 269
            +LH    + HRD+KP N
Sbjct: 133 KHLHSAG-IIHRDLKPSN 149

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 90.6 bits (224), Expect = 4e-22
 Identities = 33/149 (22%), Positives = 57/149 (38%), Gaps = 19/149 (12%)

Query: 126 VGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQI 183
           VG           Y   R +G GSFGV+F+   L     VAIK   +         E + 
Sbjct: 3   VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53

Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
            +LL     +   + F      + L+  LV++ +  ++           +   +  V + 
Sbjct: 54  YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLE---DLLDLCGRKFSVKTVAMA 106

Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLM 272
             Q+   +  +H    + +RDIKP N L+
Sbjct: 107 AKQMLARVQSIHE-KSLVYRDIKPDNFLI 134

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.0 bits (223), Expect = 5e-22
 Identities = 26/137 (18%), Positives = 54/137 (39%), Gaps = 18/137 (13%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
            + +G+GSFG V++ K       VA+K +               E+ ++R   H N++  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
                         L +V ++   +   +  H   +     ++ +     Q  + ++YLH
Sbjct: 70  MGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 256 HVVGVCHRDIKPQNLLM 272
               + HRD+K  N+ +
Sbjct: 122 A-KSIIHRDLKSNNIFL 137

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.0 bits (220), Expect = 2e-21
 Identities = 31/146 (21%), Positives = 59/146 (40%), Gaps = 20/146 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLLN 188
           Y    ++G+G FG V+    +     VAIK V +D+               E+ +++ ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 189 --HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
                V+ L   F            L+LE       +    +      +     + + +Q
Sbjct: 66  SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           +  A+ + H+  GV HRDIK +N+L+
Sbjct: 119 VLEAVRHCHN-CGVLHRDIKDENILI 143

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.1 bits (220), Expect = 2e-21
 Identities = 30/156 (19%), Positives = 59/156 (37%), Gaps = 32/156 (20%)

Query: 142 ERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDKRYKN-----RELQIM-RLLNHP 190
            + +G G+FG V +A        +   +VA+K +              EL+++  L NH 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILY------- 239
           N+V+L       T        ++ EY          R  +     ++  P +        
Sbjct: 88  NIVNLLGAC---TIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 240 ----VQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
               +  ++YQ+ + + +L       HRD+  +N+L
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNIL 177

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 88.0 bits (217), Expect = 4e-21
 Identities = 37/140 (26%), Positives = 67/140 (47%), Gaps = 16/140 (11%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
           Y     +G G++GVV++A+    G++ A+KK+  +K  +       RE+ I++ L H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           V L           +  L LV E++ + + +           +  +  + +  Q+   + 
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           Y H    V HRD+KPQNLL+
Sbjct: 115 YCHD-RRVLHRDLKPQNLLI 133

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.3 bits (218), Expect = 4e-21
 Identities = 30/151 (19%), Positives = 67/151 (44%), Gaps = 21/151 (13%)

Query: 134 KQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------REL 181
           ++ +   Y     +G+G F VV + +   TG   A K + + +   +          RE+
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
            I++ + HPNV++L   +     +++  + L+LE ++         +    + +      
Sbjct: 65  SILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELF---DFLAEKESLTEEEAT 116

Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
            +  QI   + Y  H + + H D+KP+N+++
Sbjct: 117 EFLKQILNGVYY-LHSLQIAHFDLKPENIML 146

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.4 bits (216), Expect = 4e-21
 Identities = 31/133 (23%), Positives = 57/133 (42%), Gaps = 12/133 (9%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCF 199
           + +GTG FGVV   K       VAIK + +    ++    E ++M  L+H  +V L    
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
              T++  ++  ++ EY++     +  +   M        +      +C A+ YL     
Sbjct: 69  ---TKQRPIF--IITEYMANG--CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120

Query: 260 VCHRDIKPQNLLM 272
             HRD+  +N L+
Sbjct: 121 FLHRDLAARNCLV 133

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.7 bits (219), Expect = 5e-21
 Identities = 32/137 (23%), Positives = 59/137 (43%), Gaps = 16/137 (11%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
           +++G G+FG V   +   TG   A+K + ++             E ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
           K+ F      D L   +      E  + +S+      +       + Y  +I  AL Y  
Sbjct: 71  KYAF---QTHDRLCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY-L 121

Query: 256 HVVGVCHRDIKPQNLLM 272
           H   V +RDIK +NL++
Sbjct: 122 HSRDVVYRDIKLENLML 138

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 87.9 bits (217), Expect = 5e-21
 Identities = 30/134 (22%), Positives = 56/134 (41%), Gaps = 10/134 (7%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
           +  +G G +G V++    +   +VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
               T +   Y+          +  + +   +    V +LY      QI  A+ YL    
Sbjct: 82  C---TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY---MATQISSAMEYLEK-K 134

Query: 259 GVCHRDIKPQNLLM 272
              HRD+  +N L+
Sbjct: 135 NFIHRDLAARNCLV 148

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.5 bits (216), Expect = 1e-20
 Identities = 35/162 (21%), Positives = 62/162 (38%), Gaps = 37/162 (22%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKVLQDKRYKN-----RELQIM-RLLNHP 190
            +V+G+G+FG V  A       +     VA+K + +            EL++M +L +H 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS------------------ETVYRVSKHYTRMN 232
           N+V+L       T    +Y  L+ EY                    E  Y   K      
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 233 QHVPILYVQL--YTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
               + +  L  + YQ+ + + +L       HRD+  +N+L+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLV 197

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.3 bits (213), Expect = 1e-20
 Identities = 31/133 (23%), Positives = 54/133 (40%), Gaps = 12/133 (9%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCF 199
           + +G+G FG+V         D VAIK + +    +     E ++M  L+HP +V L    
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
               E+  +   LV E++      +S +            +      +C  + YL     
Sbjct: 70  ---LEQAPIC--LVFEFMEHG--CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121

Query: 260 VCHRDIKPQNLLM 272
           V HRD+  +N L+
Sbjct: 122 VIHRDLAARNCLV 134

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.8 bits (214), Expect = 2e-20
 Identities = 30/139 (21%), Positives = 65/139 (46%), Gaps = 18/139 (12%)

Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
           +V+G+G+FG V++   +  G+     VAIK++ +    K       E  +M  +++P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
            L     ++T      + L+ + +      +  +      ++   Y+  +  QI + +NY
Sbjct: 75  RLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           L     + HRD+  +N+L+
Sbjct: 127 LED-RRLVHRDLAARNVLV 144

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.2 bits (210), Expect = 3e-20
 Identities = 35/142 (24%), Positives = 54/142 (38%), Gaps = 17/142 (11%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-----RELQIMRLLNHP 190
               R +G G FG V Q   +   +    VAIK               +E   MR  +HP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
           ++V L           E  + +++E  +    R           + +  + LY YQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120

Query: 251 LNYLHHVVGVCHRDIKPQNLLM 272
           L YL       HRDI  +N+L+
Sbjct: 121 LAYLES-KRFVHRDIAARNVLV 141

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.2 bits (210), Expect = 4e-20
 Identities = 30/134 (22%), Positives = 55/134 (41%), Gaps = 12/134 (8%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
           E  +G G FG V+          VAIK +           +E Q+M+ L H  +V L   
Sbjct: 22  EVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
                 ++ +Y  +V EY+S+             +++ +  +     QI   + Y+   +
Sbjct: 81  V----SEEPIY--IVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132

Query: 259 GVCHRDIKPQNLLM 272
              HRD++  N+L+
Sbjct: 133 NYVHRDLRAANILV 146

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.4 bits (208), Expect = 7e-20
 Identities = 29/139 (20%), Positives = 58/139 (41%), Gaps = 18/139 (12%)

Query: 142 ERVVGTGSFGVVFQAKC--LETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVV 193
           ++ +G+G+FG V +      +   +VA+K +  +            E  +M+ L++P +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
            +        E +     LV+E            Y + N+HV    +    +Q+   + Y
Sbjct: 72  RMIGIC----EAESWM--LVMEMAELGPLN---KYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 254 LHHVVGVCHRDIKPQNLLM 272
           L       HRD+  +N+L+
Sbjct: 123 LEE-SNFVHRDLAARNVLL 140

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.6 bits (203), Expect = 4e-19
 Identities = 29/144 (20%), Positives = 54/144 (37%), Gaps = 17/144 (11%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLN 188
               ++V+G G FG V++     +       VAIK +      K       E  IM   +
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
           H N++ L+             + ++ EY+        K     +    +L +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             + YL + +   HRD+  +N+L+
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILV 143

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.5 bits (203), Expect = 4e-19
 Identities = 31/140 (22%), Positives = 51/140 (36%), Gaps = 19/140 (13%)

Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-------RELQIMRLLNHPNV 192
             +G GSFGVV + +          VA+K +  D   +        RE+  M  L+H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
           + L            +   +V E              +   H  +  +  Y  Q+   + 
Sbjct: 74  IRLYGVV----LTPPMK--MVTELAPLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 253 YLHHVVGVCHRDIKPQNLLM 272
           YL       HRD+  +NLL+
Sbjct: 126 YLES-KRFIHRDLAARNLLL 144

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.4 bits (200), Expect = 1e-18
 Identities = 29/146 (19%), Positives = 58/146 (39%), Gaps = 19/146 (13%)

Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVS 194
           + + +  +G G FG V++ K    G+ VA+K     +    ++  E+    +L H N++ 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 195 LKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
                 +        L LV +Y    +++     YT   +      +          L +
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG-----MIKLALSTASGLAH 115

Query: 254 LHHVV-------GVCHRDIKPQNLLM 272
           LH  +        + HRD+K +N+L+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILV 141

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.8 bits (196), Expect = 5e-18
 Identities = 28/139 (20%), Positives = 52/139 (37%), Gaps = 15/139 (10%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
             V+G G FG V+    L+        A+K + +            E  IM+  +HPNV+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
           SL         + E    +VL Y+     R          +  +  +  +  Q+ + + +
Sbjct: 92  SLLGICL----RSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 254 LHHVVGVCHRDIKPQNLLM 272
                   HRD+  +N ++
Sbjct: 146 -LASKKFVHRDLAARNCML 163

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.1 bits (194), Expect = 1e-17
 Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 21/146 (14%)

Query: 139 YMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKV--------LQDKRYKNRELQIMRLL 187
           +   +V+GTG++G VF  + +   +TG   A+K +         +   +   E Q++  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 188 NH-PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
              P +V+L + F     + E  L+L+L+YI+         +    +      VQ+Y  +
Sbjct: 86  RQSPFLVTLHYAF-----QTETKLHLILDYINGGELF---THLSQRERFTEHEVQIYVGE 137

Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLM 272
           I  AL +LH  +G+ +RDIK +N+L+
Sbjct: 138 IVLALEHLHK-LGIIYRDIKLENILL 162

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.5 bits (190), Expect = 3e-17
 Identities = 31/150 (20%), Positives = 61/150 (40%), Gaps = 23/150 (15%)

Query: 142 ERVVGTGSFGVVFQAKCLETGDS--VAIKKV-----LQDKRYKNRELQIM-RLLNHPNVV 193
           + V+G G+FG V +A+  + G     AIK++       D R    EL+++ +L +HPN++
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 194 SLKHCFFSTTEKDELYL-----------NLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
           +L         +  LYL           + + +                   +    +  
Sbjct: 75  NLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           +   + R ++YL       HRD+  +N+L+
Sbjct: 132 FAADVARGMDYLSQ-KQFIHRDLAARNILV 160

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.7 bits (185), Expect = 1e-16
 Identities = 32/160 (20%), Positives = 63/160 (39%), Gaps = 32/160 (20%)

Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS-------VAIKKVLQDKRYKN-----RELQIM-R 185
            +  + +G G+FG V  A+ +            VA+K +  D   K+      E+++M  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISET-------------VYRVSKHYTRMN 232
           +  H N+++L       T+   LY  +++EY S+              +           
Sbjct: 75  IGKHKNIINLLGAC---TQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
           + +    +    YQ+ R + YL       HRD+  +N+L+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLV 168

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.7 bits (185), Expect = 1e-16
 Identities = 26/153 (16%), Positives = 58/153 (37%), Gaps = 21/153 (13%)

Query: 139 YMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQD------KRYKNRELQIMRLL 187
               + +G G+FG V +A         T  +VA+K + +       +   +    ++ + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVP---------IL 238
           +H NVV+L            + +         T  R  ++     +  P         + 
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271
           ++  Y++Q+ + + +L       HRD+  +N+L
Sbjct: 135 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 166

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 74.5 bits (182), Expect = 4e-16
 Identities = 30/161 (18%), Positives = 55/161 (34%), Gaps = 37/161 (22%)

Query: 143 RVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
           R +G G+FG VFQA+       E    VA+K + ++          RE  +M   ++PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS---------------------ETVYRVSKHYTRM 231
           V              +   L+ EY++                       +   ++  +  
Sbjct: 79  V---KLLGVCAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM 272
              +          Q+   + YL       HRD+  +N L+
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLV 173

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.5 bits (182), Expect = 4e-16
 Identities = 28/148 (18%), Positives = 58/148 (39%), Gaps = 23/148 (15%)

Query: 142 ERVVGTGSFGVVFQAKC-----LETGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
            R +G GSFG+V++         E    VAIK V     ++++     E  +M+  N  +
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPIL------YVQLYT 244
           VV         ++       +++E ++   +    +       + P+L       +    
Sbjct: 85  VV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLM 272
            +I   + YL+      HRD+  +N ++
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMV 166

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 61.7 bits (149), Expect = 3e-12
 Identities = 15/144 (10%), Positives = 34/144 (23%), Gaps = 27/144 (18%)

Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV--------------LQDKRYKNRELQIMRLLN 188
           +++G G    VF     E      +K                     + +          
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
              +  L+               +++E              +    V +         I 
Sbjct: 65  FRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEVLDMIL 113

Query: 249 RALNYLHHVVGVCHRDIKPQNLLM 272
             +   +H   + H D+   N+L+
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV 136

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	272
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.97
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.97
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.97
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.97
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.97
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.97
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.97
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.97
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.97
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.96
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.96
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.96
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.96
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.96
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.96
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.96
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.96
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.96
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.96
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.95
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.95
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.95
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.95
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.95
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.95
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.95
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.95
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.95
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.95
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.95
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.94
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.94
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.94
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.94
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.94
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.94
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.94
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.94
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.93
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.93
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.91
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.52
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.91
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.58
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	94.91
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.32

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-33  Score=243.61  Aligned_cols=134  Identities=63%  Similarity=1.110  Sum_probs=121.4

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHHHcCCCCeeecceeeeeccc-CCceEEEEEeec
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEY  216 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~~~lv~e~  216 (272)
                      +|..+++||+|+||+||+|++..+|+.||||++..+.....+|+++|+.|+|||||+++++|+.... .+..|+||||||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            6999999999999999999999999999999998877777789999999999999999999876543 456789999999


Q ss_pred             ccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       217 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+++++..+..+......+++..++.|+.||+.||+|||+ +|||||||||+||||
T Consensus       101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl  155 (350)
T d1q5ka_         101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLL  155 (350)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEE
T ss_pred             cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEE
Confidence            9999888777766667789999999999999999999998 999999999999986

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.8e-32  Score=233.02  Aligned_cols=127  Identities=31%  Similarity=0.400  Sum_probs=109.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .++|++++.||+|+||+||+|++..+|+.||||++...     .....+|+++|+.|+|||||+++++|..     ..++
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ccee
Confidence            34699999999999999999999999999999998543     2345689999999999999999999844     3459


Q ss_pred             EEEeeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||||.++ |.+    +......+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus        79 ~ivmEy~~gg~L~~----~l~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl  136 (271)
T d1nvra_          79 YLFLEYCSGGELFD----RIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLL  136 (271)
T ss_dssp             EEEEECCTTEEGGG----GSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             EEEEeccCCCcHHH----HHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEE
Confidence            9999999864 433    23345679999999999999999999998 999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.1e-32  Score=233.31  Aligned_cols=126  Identities=27%  Similarity=0.378  Sum_probs=108.2

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .+|.+.+.||+|+||+||+|.+..+|+.||||++...    .....+|+++|+.++|||||+++++|...     .++||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEE
Confidence            3699999999999999999999999999999998642    23456899999999999999999998543     35999


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||+++.+..+..    ...+++..++.|+.||+.||.|||+ +|||||||||+||||
T Consensus        95 vmEy~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl  149 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILL  149 (293)
T ss_dssp             EEECCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EEEecCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEE
Confidence            999999655442222    2469999999999999999999998 999999999999986

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.8e-32  Score=228.20  Aligned_cols=127  Identities=33%  Similarity=0.503  Sum_probs=109.4

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .++|.+++.||+|+||+||+|++..+++.||||++.+.       .....+|+++|+.++|||||+++++|.     +..
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECC
Confidence            35799999999999999999999999999999998532       233458999999999999999999984     445


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||||||++ ++..++..    ...+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill  139 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLL  139 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeecccccee
Confidence            59999999995 55454433    3569999999999999999999998 999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-31  Score=230.40  Aligned_cols=128  Identities=27%  Similarity=0.363  Sum_probs=109.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      +.|++++.||+|+||+||+|++..+++.||||++...    ...+.+|+++|+.|+|||||+++++|...     ..+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEE
Confidence            3599999999999999999999999999999998542    23456899999999999999999998543     34999


Q ss_pred             EeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||.++.+..+.  ......+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus        87 vmEy~~~g~L~~~~--~~~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll  143 (288)
T d2jfla1          87 LIEFCAGGAVDAVM--LELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILF  143 (288)
T ss_dssp             EEECCTTEEHHHHH--HHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EEecCCCCcHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeE
Confidence            99999965544221  1224569999999999999999999998 999999999999986

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9e-32  Score=228.57  Aligned_cols=133  Identities=26%  Similarity=0.358  Sum_probs=106.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .++|++++.||+|+||+||+|++..+|+.||||.+....      ..+.+|+++|+.++|||||+++++|....   ...
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCE
Confidence            357999999999999999999999999999999985431      23457999999999999999999885432   223


Q ss_pred             EEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----ceecCCCCCCeeC
Q 024091          210 LNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-----VCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~-----iiHrDlKp~NILl  272 (272)
                      +|||||||+ |+|.+++.........+++..++.++.||+.||.|||+ ++     ||||||||+||||
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll  147 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFL  147 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEE
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCc
Confidence            899999998 46666666555567789999999999999999999997 55     9999999999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-31  Score=232.97  Aligned_cols=128  Identities=24%  Similarity=0.418  Sum_probs=109.9

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .++|.+++.||+|+||+||+|.+..+++.||||++....   ....+|+++|+.++|||||+++++|.     +..++||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~l   78 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEE
Confidence            457999999999999999999999999999999996543   23458999999999999999999984     3345999


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||.| +|.+.+.   .....+++..++.|+.||+.||+|||+ +||+||||||+||||
T Consensus        79 vmE~~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll  135 (321)
T d1tkia_          79 IFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIY  135 (321)
T ss_dssp             EECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceee
Confidence            9999996 5544332   223469999999999999999999998 999999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.2e-31  Score=232.14  Aligned_cols=126  Identities=27%  Similarity=0.450  Sum_probs=109.6

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .|.+++.||+|+||+||+|++..+++.||||++....       ..+.+|+.+|+.|+|||||+++++|...     .++
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CEE
Confidence            4999999999999999999999999999999986432       2345799999999999999999998543     349


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||||.++++..+..   ....+++..++.|+.||+.||.|||+ +|||||||||+||||
T Consensus        91 ~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl  148 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILL  148 (309)
T ss_dssp             EEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEE
T ss_pred             EEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEE
Confidence            99999999887764332   24679999999999999999999998 999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=2.2e-31  Score=226.99  Aligned_cols=132  Identities=27%  Similarity=0.350  Sum_probs=111.4

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .++|.+.+.||+|+||+||+|++..+|+.||||++....       ..+.+|+++|+.++|||||++++++.... ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            356999999999999999999999999999999986431       23458999999999999999999886554 3456


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||||||.|+.+...   ....+.+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus        85 ~~~lvmE~~~g~~L~~~---~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll  144 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMI  144 (277)
T ss_dssp             EEEEEEECCCEEEHHHH---HHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             eEEEEEECCCCCEehhh---hcccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCccccc
Confidence            68999999996544322   2224579999999999999999999998 999999999999985

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.7e-31  Score=228.27  Aligned_cols=127  Identities=24%  Similarity=0.443  Sum_probs=109.9

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----------chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      .++|.+++.||+|+||+||+|++..+|+.||||++.+.          ...+.+|+++|+.|+|||||+++++|     .
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            35799999999999999999999999999999998532          23356899999999999999999998     4


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +..++|||||||.+ +|.+++..    ...+++..++.++.||+.||.|||+ ++||||||||+||||
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill  146 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIML  146 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             ECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEE
Confidence            44569999999985 55555443    3469999999999999999999998 999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.8e-31  Score=228.84  Aligned_cols=127  Identities=32%  Similarity=0.515  Sum_probs=109.5

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .++|++++.||+|+||+||+|++..+++.||||++...       .....+|+++|+.|+|||||+++++|     .+..
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~   81 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE   81 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSS
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECC
Confidence            35799999999999999999999999999999998532       23456899999999999999999998     3445


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||||||.+ ++.+++..    .+.+++..++.++.||+.||.|||+ ++||||||||+||||
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll  141 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILL  141 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCcccccc
Confidence            69999999996 44444332    3579999999999999999999998 999999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.97  E-value=2e-31  Score=234.56  Aligned_cols=129  Identities=28%  Similarity=0.427  Sum_probs=110.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .++|++++.||+|+||+||+|.+..+|+.||||++...    .....+|+.+|+.|+|||||+++++|     .+..++|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            45699999999999999999999999999999998643    23345799999999999999999998     3445699


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||+++.+.  .........+++..++.|+.||+.||.|||+ +|||||||||+||||
T Consensus       103 ivmE~~~gg~L~--~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl  160 (352)
T d1koba_         103 LILEFLSGGELF--DRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMC  160 (352)
T ss_dssp             EEEECCCCCBHH--HHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEEcCCCChHH--HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccc
Confidence            999999965432  1223334569999999999999999999998 999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.1e-31  Score=228.36  Aligned_cols=128  Identities=33%  Similarity=0.587  Sum_probs=110.9

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ++|++++.||+|+||+||+|.+..+|+.||||++...      .....+|+++|+.++|||||+++++|..     ..++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence            4799999999999999999999999999999998532      3345689999999999999999999944     3459


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.++++.++..  .....+++..++.|+.||+.||.|||+ ++||||||||+|||+
T Consensus        77 ~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~  135 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLI  135 (298)
T ss_dssp             EEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             eEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheee
Confidence            99999999887765433  234569999999999999999999998 999999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.4e-32  Score=234.13  Aligned_cols=129  Identities=24%  Similarity=0.404  Sum_probs=109.4

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      ..++|.+++.||+|+||+||+|++..+|+.||||++...     .....+|+.+|+.++|||||+++++|.     +..+
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~   78 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE   78 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence            345799999999999999999999999999999998643     223458999999999999999999994     3445


Q ss_pred             EEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||||||.+ ++..++..    ...+++..++.++.||+.||.|||+.++||||||||+||||
T Consensus        79 ~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl  138 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV  138 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE
Confidence            9999999996 45444433    34689999999999999999999962489999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.97  E-value=3.2e-31  Score=233.13  Aligned_cols=128  Identities=27%  Similarity=0.470  Sum_probs=109.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .++|.+++.||+|+||.||+|++..+|+.||||++...    .....+|+.+|+.|+|||||+++++|..     ..++|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence            35799999999999999999999999999999998643    2334589999999999999999999843     34599


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||.+ +|.+++   ......+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       100 ivmE~~~gg~L~~~l---~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll  157 (350)
T d1koaa2         100 MIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMF  157 (350)
T ss_dssp             EEECCCCSCBHHHHH---TCTTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEEcCCCCCHHHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeee
Confidence            99999985 544433   2234569999999999999999999998 999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.9e-31  Score=224.05  Aligned_cols=128  Identities=27%  Similarity=0.383  Sum_probs=107.9

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEE
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      |++.+.||+|+||+||+|++..+++.||+|.+...      ...+.+|+++|+.|+|||||+++++|.... ....++||
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            47788999999999999999999999999998543      223458999999999999999999875543 44567899


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~--iiHrDlKp~NILl  272 (272)
                      |||||++ +|.+++..    ...+++..++.|+.||+.||.|||+ ++  ||||||||+||||
T Consensus        90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl  147 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFI  147 (270)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEE
T ss_pred             EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhcee
Confidence            9999986 54444433    3568999999999999999999998 78  9999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=3.6e-31  Score=228.92  Aligned_cols=127  Identities=28%  Similarity=0.456  Sum_probs=108.2

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      .+.|.+.+.||+|+||+||+|++..+++.||||++....     ....+|+.+|+.|+|||||+++++|     .+..++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            346999999999999999999999999999999986432     2344799999999999999999998     444569


Q ss_pred             EEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||||.| +|.+++..    ...+++..++.|+.||+.||.|||+ ++||||||||+|||+
T Consensus        83 ~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~  140 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLY  140 (307)
T ss_dssp             EEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             EEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceee
Confidence            999999984 55554432    5679999999999999999999998 999999999999985

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=3.4e-31  Score=227.01  Aligned_cols=130  Identities=22%  Similarity=0.345  Sum_probs=110.6

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ...+|.+.+.||+|+||+||+|.+..+++.||||++..+   ...+.+|+++|+.|+|||||+++++|...     ..+|
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~   89 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY   89 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeC-----CeeE
Confidence            345799999999999999999999999999999998654   33456899999999999999999998433     3389


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||||||.+ ++..++..  .....+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus        90 iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl  148 (287)
T d1opja_          90 IITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV  148 (287)
T ss_dssp             EEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             EEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEE
Confidence            99999995 55554432  234578999999999999999999998 999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.3e-31  Score=230.06  Aligned_cols=127  Identities=26%  Similarity=0.355  Sum_probs=109.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..+|.+++.||+|+||+||+|++..+|+.||||++.+.       .....+|+.+|+.++|||||+++++|     .+..
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence            35799999999999999999999999999999998642       23345899999999999999999998     4555


Q ss_pred             EEEEEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|+|||||.++.+ .++.    ....+++..++.|+.||+.||+|||+ ++||||||||+||||
T Consensus        79 ~~~iv~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl  138 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLML  138 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEE
T ss_pred             ccccceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEe
Confidence            69999999996544 3332    24578999999999999999999999 999999999999986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=9.2e-31  Score=227.19  Aligned_cols=127  Identities=28%  Similarity=0.491  Sum_probs=109.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  209 (272)
                      .+|++++.||+|+||+||+|++..+|+.||||++.+.       .....+|+.+|+.++|||||+++++|.     +..+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence            4699999999999999999999999999999998642       234558999999999999999999984     4456


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+|||||.|+.+...   ......+++..++.++.||+.||.|||+ ++||||||||+||||
T Consensus        79 ~~ivmE~~~gg~l~~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl  137 (316)
T d1fota_          79 IFMIMDYIEGGELFSL---LRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILL  137 (316)
T ss_dssp             EEEEECCCCSCBHHHH---HHHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEE
T ss_pred             eeeEeeecCCcccccc---ccccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeE
Confidence            9999999997655422   2335668899999999999999999998 999999999999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=1.6e-30  Score=221.69  Aligned_cols=126  Identities=21%  Similarity=0.399  Sum_probs=109.5

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------------hhHHHHHHHHHHcC-CCCeeecceeeeec
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------------RYKNRELQIMRLLN-HPNVVSLKHCFFST  202 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~  202 (272)
                      ++|++.+.||+|+||+||+|++..+++.||||++....             ....+|+.+|+.|. |||||+++++|   
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY---   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence            47999999999999999999999999999999986431             12447999999997 99999999998   


Q ss_pred             ccCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        .+..++|||||||++ +|.+++..    ...+++..++.|+.||+.||+|||+ ++||||||||+||||
T Consensus        80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill  143 (277)
T d1phka_          80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILL  143 (277)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEE
Confidence              445569999999985 66665543    4579999999999999999999998 999999999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.7e-30  Score=222.46  Aligned_cols=123  Identities=28%  Similarity=0.492  Sum_probs=104.5

Q ss_pred             eeEEeccCCceEEEEEEECCCCCEEEEEEeecc---------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       141 ~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .+++||+|+||+||+|++..+|+.||||++...         .....+|+.+|+.++|||||+++++|.     ...++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCcee
Confidence            468899999999999999999999999998532         123558999999999999999999984     344599


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||+.++++..+   ......+++..++.++.||+.||+|||+ ++||||||||+|||+
T Consensus        77 ivmE~~~~~~~~~~---~~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli  133 (299)
T d1ua2a_          77 LVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLL  133 (299)
T ss_dssp             EEEECCSEEHHHHH---TTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             ehhhhhcchHHhhh---hhcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEe
Confidence            99999998876533   3345678899999999999999999998 999999999999985

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=6e-30  Score=224.99  Aligned_cols=127  Identities=30%  Similarity=0.470  Sum_probs=108.7

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      .++|.+++.||+|+||.||+|++..+|+.||||++.+.       .....+|+.+|+.++|||||+++++|     ....
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~  114 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence            45799999999999999999999999999999998532       12345899999999999999999998     4445


Q ss_pred             EEEEEeecccccH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++++||||+.++. ...+..    ...+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl  174 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLI  174 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             ccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHccc
Confidence            5999999999654 443332    3469999999999999999999998 999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-29  Score=221.96  Aligned_cols=133  Identities=24%  Similarity=0.339  Sum_probs=110.0

Q ss_pred             cccCeeee-EEeccCCceEEEEEEECCCCCEEEEEEeeccchhHHHHHHHHH-HcCCCCeeecceeeeecccCCceEEEE
Q 024091          135 QTISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR-LLNHPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       135 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      ..++|.+. ++||+|+||+||+|++..+++.||||++... ....+|+.++. .++|||||+++++|.... ....++||
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~i   86 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI   86 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEE
Confidence            35679876 4699999999999999999999999998643 45668999865 458999999999874432 34567999


Q ss_pred             Eeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       213 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||+| +|.+++..  .....+++..++.|+.||+.||.|||+ ++|+||||||+|||+
T Consensus        87 vmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll  144 (335)
T d2ozaa1          87 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLY  144 (335)
T ss_dssp             EEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             EEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCcccccccccccc
Confidence            9999985 66665542  224579999999999999999999998 999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.5e-30  Score=223.36  Aligned_cols=130  Identities=30%  Similarity=0.460  Sum_probs=110.1

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      .+|.+++.||+|+||+||+|++..+|+.||||++....     ..+.+|+++|+.|+||||+++++++.........++|
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            46999999999999999999999999999999986432     2345799999999999999999998666555556688


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+|++++++|.+++..     ..+++..++.++.||+.||+|||+ +|||||||||+||||
T Consensus        88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl  142 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLL  142 (345)
T ss_dssp             EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEE
Confidence            8888888888876643     368999999999999999999998 999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.96  E-value=8.2e-30  Score=218.04  Aligned_cols=126  Identities=29%  Similarity=0.492  Sum_probs=109.6

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ++|.+++.||+|+||+||+|++. +|+.||||++...      ...+.+|+.+|+.++|||||+++++|....     +.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence            47999999999999999999985 7899999998543      234568999999999999999999985443     48


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |++|||+.++++..+.   .....+++..++.|+.||+.||+|||+ .+||||||||+||||
T Consensus        76 ~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll  133 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLI  133 (286)
T ss_dssp             EEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             eEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeE
Confidence            9999999998776543   335679999999999999999999998 899999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.8e-29  Score=216.46  Aligned_cols=135  Identities=33%  Similarity=0.501  Sum_probs=113.2

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCC-CCEEEEEEeecc------chhHHHHHHHHHHc---CCCCeeecceeeeeccc
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLET-GDSVAIKKVLQD------KRYKNRELQIMRLL---NHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~vAvK~i~~~------~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~  204 (272)
                      ...+|++++.||+|+||+||+|++..+ ++.||||++...      .....+|+.+|+.|   +||||++++++|.....
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            345799999999999999999999765 667999998532      23445788888776   79999999999877665


Q ss_pred             CCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ....++|++|||+.++++.+...  .....+++..++.++.||+.||+|||+ ++||||||||+|||+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi  149 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILV  149 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             ccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEE
Confidence            67778999999999887764433  335568999999999999999999998 999999999999985

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=9.8e-30  Score=219.06  Aligned_cols=129  Identities=24%  Similarity=0.367  Sum_probs=104.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCC---EEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ..+|.+.++||+|+||+||+|.+..+++   .||||.+...     .+.+.+|+++|+.|+|||||+++++|....    
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~----  100 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST----  100 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence            3469999999999999999999987664   5899987542     234568999999999999999999984433    


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       .+|||||||+++.+..+.  ......+++..+..|+.||+.||.|||+ ++||||||||+||||
T Consensus       101 -~~~iv~Ey~~~g~L~~~~--~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl  161 (299)
T d1jpaa_         101 -PVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILV  161 (299)
T ss_dssp             -SCEEEEECCTTEEHHHHH--HTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             -EEEEEEEecCCCcceeee--ccccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEE
Confidence             389999999976554322  2224568999999999999999999998 999999999999996

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-29  Score=220.21  Aligned_cols=126  Identities=25%  Similarity=0.438  Sum_probs=105.4

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHHHHHHHH-HcCCCCeeecceeeeecccCCce
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMR-LLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ++|.+++.||+|+||+||+|.+..+++.||||++.+..       .....|+.++. .++|||||+++++|     .+..
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            46999999999999999999999999999999986421       22345666654 78999999999998     4445


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||||||.+ ++..++..    ...+++..++.++.||+.||+|||+ ++||||||||+|||+
T Consensus        77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~  136 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILL  136 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEE
T ss_pred             ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceee
Confidence            69999999996 54444332    4568999999999999999999998 999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.1e-29  Score=215.70  Aligned_cols=127  Identities=32%  Similarity=0.525  Sum_probs=110.6

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ++|++++.||+|+||+||+|++..+++.||||+++..      .....+|+.+|+.++||||++++++|.     +..++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence            4799999999999999999999999999999998543      234458999999999999999999984     44458


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++|||++.++.+..+.   ...+.+++..++.++.|++.||+|||+ ++||||||||+||||
T Consensus        77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli  134 (292)
T d1unla_          77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLI  134 (292)
T ss_dssp             EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCccccc
Confidence            9999999988765433   345678999999999999999999998 999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.3e-29  Score=221.71  Aligned_cols=129  Identities=28%  Similarity=0.444  Sum_probs=110.1

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc-CCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  209 (272)
                      .+|+++++||+|+||+||+|++..+|+.||||++...      .....+|+.+|+.++|||||+++++|..... ....+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            4799999999999999999999999999999999643      1234589999999999999999999854432 24568


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|+|||||.++++...      ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus        97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~  152 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVV  152 (355)
T ss_dssp             EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccc
Confidence            9999999999987643      3468999999999999999999999 899999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.4e-29  Score=222.17  Aligned_cols=131  Identities=31%  Similarity=0.518  Sum_probs=105.4

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc-CCce
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL  208 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~  208 (272)
                      ..+|.+++.||+|+||+||+|.+..+|+.||||++...      .....+|+++|+.|+|||||+++++|..... ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            45799999999999999999999999999999998642      1234579999999999999999999855432 2334


Q ss_pred             EEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++||||||++..+..+..     ...+++..++.++.||+.||.|||+ +|||||||||+|||+
T Consensus        97 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~  154 (346)
T d1cm8a_          97 DFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAV  154 (346)
T ss_dssp             CCEEEEECCSEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             eEEEEEecccccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhc
Confidence            589999999877665543     2469999999999999999999998 999999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=2.2e-29  Score=219.37  Aligned_cols=126  Identities=29%  Similarity=0.538  Sum_probs=108.7

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc-chhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEEEEe
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ++|+++++||+|+||+||+|++..+|+.||||++... .....+|+++|+.+. ||||++++++|....   ..++++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~---~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecC---CCceeEEE
Confidence            4799999999999999999999999999999998754 345668999999996 999999999875432   23489999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||.++.+.      ...+.+++..++.++.||+.||.|||+ +|||||||||+||||
T Consensus       112 e~~~~~~L~------~~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi  162 (328)
T d3bqca1         112 EHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMI  162 (328)
T ss_dssp             ECCCSCBGG------GTTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             eecCCCcHH------HHhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEE
Confidence            999976543      123569999999999999999999998 999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=1.1e-29  Score=224.33  Aligned_cols=127  Identities=21%  Similarity=0.358  Sum_probs=104.8

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc-------hhHHH---HHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNR---ELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-------~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      .++|.++++||+|+||.||+|++..+|+.||||++....       ....+   |+.+++.++|||||+++++|.     
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-----   77 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----   77 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----
Confidence            347999999999999999999999999999999985321       12223   456667778999999999984     


Q ss_pred             CceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       206 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +...+|||||||.+ +|..++..    ...+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl  140 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILL  140 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEE
Confidence            34459999999995 55544433    3568899999999999999999998 999999999999996

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.2e-29  Score=213.00  Aligned_cols=125  Identities=24%  Similarity=0.380  Sum_probs=105.3

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +|.+.+.||+|+||.||+|.+. +++.||||++...   ...+.+|+++|+.++|||||+++++|....     .+|+||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~lv~   79 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLVF   79 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEEEE
Confidence            6999999999999999999975 4678999998653   344568999999999999999999985443     389999


Q ss_pred             eccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++ +.+++.   .....+++..+..|+.||+.||.|||+ ++|+||||||+||||
T Consensus        80 E~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill  134 (263)
T d1sm2a_          80 EFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLV  134 (263)
T ss_dssp             ECCTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEE
T ss_pred             EecCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheee
Confidence            999955 444332   234568899999999999999999998 999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.1e-29  Score=214.31  Aligned_cols=126  Identities=25%  Similarity=0.390  Sum_probs=106.7

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----------hhHHHHHHHHHHcC--CCCeeecceeeeeccc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN--HPNVVSLKHCFFSTTE  204 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~  204 (272)
                      .+|++.++||+|+||+||+|++..+|+.||||++....          ....+|+.+|+.++  |||||+++++|.    
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~----   79 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE----   79 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE----
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe----
Confidence            46999999999999999999999999999999986421          22348999999997  899999999984    


Q ss_pred             CCceEEEEEeecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          205 KDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       +...+|+||||+.+  .+..++..    ...+++..++.++.||+.||.|||+ ++||||||||+||||
T Consensus        80 -~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll  143 (273)
T d1xwsa_          80 -RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILI  143 (273)
T ss_dssp             -CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             -eCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEE
Confidence             44459999999974  44443332    3569999999999999999999998 999999999999985

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.3e-29  Score=212.94  Aligned_cols=128  Identities=20%  Similarity=0.278  Sum_probs=104.9

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ...+|++.+.||+|+||.||+|.+. ++..||||++...   ...+.+|+.+|+.++|||||++++++.. .     .+|
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~-----~~~   83 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E-----PIY   83 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-----SCE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-C-----CeE
Confidence            3457999999999999999999975 5678999998653   3345689999999999999999997632 1     168


Q ss_pred             EEeecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||++++.+ +++..  .....+++..+..|+.||+.||.|||+ ++|+||||||+||||
T Consensus        84 iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll  142 (272)
T d1qpca_          84 IITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILV  142 (272)
T ss_dssp             EEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheee
Confidence            99999996544 32221  222358999999999999999999998 999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.5e-29  Score=211.72  Aligned_cols=128  Identities=27%  Similarity=0.339  Sum_probs=103.1

Q ss_pred             ccCeeeeEE-eccCCceEEEEEEECC--CCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          136 TISYMAERV-VGTGSFGVVFQAKCLE--TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       136 ~~~y~~~~~-lG~G~fg~V~~~~~~~--~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ..+|.+.+. ||+|+||.||+|.+..  ++..||||++...     ...+.+|+++|+.|+|||||++++++.. .    
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~----   81 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E----   81 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S----
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C----
Confidence            346888885 9999999999998764  3457999998643     2334589999999999999999998732 1    


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       .+|||||||+++.+..+  .......+++..+..|+.||+.||.|||+ ++||||||||+||||
T Consensus        82 -~~~lvmE~~~~g~L~~~--l~~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill  142 (285)
T d1u59a_          82 -ALMLVMEMAGGGPLHKF--LVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLL  142 (285)
T ss_dssp             -SEEEEEECCTTEEHHHH--HTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEE
T ss_pred             -eEEEEEEeCCCCcHHHH--hhccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheee
Confidence             17899999996544322  12234579999999999999999999998 999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.7e-29  Score=214.32  Aligned_cols=133  Identities=28%  Similarity=0.440  Sum_probs=109.1

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeeccc---CC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KD  206 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~  206 (272)
                      .++|.+++.||+|+||+||+|++..+|+.||||++...      .....+|+++|+.++||||+++++.|.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            46899999999999999999999999999999988432      2334589999999999999999998754321   12


Q ss_pred             ceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ..++|+||||+.++++...   ......+++..++.++.||+.||.|||+ ++||||||||+||||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~---~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl  150 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLI  150 (318)
T ss_dssp             --CEEEEEECCCEEHHHHH---TCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEE
T ss_pred             CceEEEEEeccCCCccchh---hhcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheee
Confidence            3458999999998876533   3345678999999999999999999998 999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.9e-29  Score=218.21  Aligned_cols=130  Identities=32%  Similarity=0.467  Sum_probs=107.9

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc------hhHHHHHHHHHHcCCCCeeecceeeeeccc-CCceE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY  209 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  209 (272)
                      ++|++++.||+|+||+||+|++..+|+.||||++....      ....+|+++|+.|+|||||+++++|..... .+..+
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            47999999999999999999999999999999986432      234589999999999999999998854432 23344


Q ss_pred             EEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       210 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++++|++++++|.+++.     ...+++..++.++.||+.||.|||+ +|||||||||+|||+
T Consensus        98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi  154 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAV  154 (348)
T ss_dssp             CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccc
Confidence            66666666677665442     3469999999999999999999998 999999999999985

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.8e-29  Score=212.35  Aligned_cols=125  Identities=21%  Similarity=0.369  Sum_probs=102.5

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCce
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL  208 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  208 (272)
                      ..++|.+.+.||+|+||.||+|+.   +..||||++...      ...+.+|+.+|+.++|||||++++++.. .     
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~-----   76 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P-----   76 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S-----
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c-----
Confidence            345799999999999999999975   346999998532      2345589999999999999999997632 1     


Q ss_pred             EEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       209 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      .+|||||||++ +|.+++.   .....+++..+..|+.||+.||+|||+ ++||||||||+||||
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl  137 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFL  137 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             EEEEEEecCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEE
Confidence            27899999995 5544433   234569999999999999999999998 999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.9e-29  Score=209.35  Aligned_cols=126  Identities=24%  Similarity=0.310  Sum_probs=105.7

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +|++.+.||+|+||+||+|++. +++.||||.++..   ...+.+|+.+++.++||||++++++|....     .+++||
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-----~~~iv~   78 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIFIIT   78 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-----SEEEEE
T ss_pred             HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceEEEE
Confidence            5889999999999999999984 6788999998653   345668999999999999999999985433     399999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+.++.+...  .......+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        79 Ey~~~g~l~~~--~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill  133 (258)
T d1k2pa_          79 EYMANGCLLNY--LREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLV  133 (258)
T ss_dssp             ECCTTEEHHHH--HHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEE
T ss_pred             EccCCCcHHHh--hhccccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEE
Confidence            99986544322  12234568899999999999999999998 999999999999985

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.5e-28  Score=214.04  Aligned_cols=131  Identities=22%  Similarity=0.366  Sum_probs=104.4

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECCCCC-----EEEEEEeecc-----chhHHHHHHHHHHc-CCCCeeecceeeeeccc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vAvK~i~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  204 (272)
                      ..+|.++++||+|+||+||+|++..+++     .||+|.+...     ...+.+|+.+|+.+ +|||||+++++|...  
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS--  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence            3579999999999999999999876543     6999988532     23455899999998 899999999998433  


Q ss_pred             CCceEEEEEeecccc-cHHHHHHHhhh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 024091          205 KDELYLNLVLEYISE-TVYRVSKHYTR-------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD  264 (272)
Q Consensus       205 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-------------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrD  264 (272)
                         ..+|||||||++ ++.+++.....                   ....+++..++.|+.||+.||.|||+ ++|||||
T Consensus       114 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRD  189 (325)
T d1rjba_         114 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD  189 (325)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred             ---CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecc
Confidence               348999999984 66555543211                   12358899999999999999999998 9999999


Q ss_pred             CCCCCeeC
Q 024091          265 IKPQNLLM  272 (272)
Q Consensus       265 lKp~NILl  272 (272)
                      |||+|||+
T Consensus       190 lKp~Nill  197 (325)
T d1rjba_         190 LAARNVLV  197 (325)
T ss_dssp             CSGGGEEE
T ss_pred             Cchhcccc
Confidence            99999985

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.4e-28  Score=209.63  Aligned_cols=119  Identities=24%  Similarity=0.332  Sum_probs=97.6

Q ss_pred             EEeccCCceEEEEEEECC--CCCEEEEEEeecc------chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          143 RVVGTGSFGVVFQAKCLE--TGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       143 ~~lG~G~fg~V~~~~~~~--~~~~vAvK~i~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +.||+|+||+||+|.+..  +++.||||++...      ...+.+|+.+|++|+|||||+++++|. ..    . +||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~----~-~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AE----S-WMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SS----S-EEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cC----C-EEEEE
Confidence            479999999999998653  5678999998542      234568999999999999999999873 21    1 68999


Q ss_pred             eccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+++ |.+++.    ....+++..+..|+.||+.||.|||+ ++||||||||+||||
T Consensus        87 E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill  140 (277)
T d1xbba_          87 EMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLL  140 (277)
T ss_dssp             ECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             EcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcc
Confidence            999965 444333    35679999999999999999999998 999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.3e-28  Score=208.81  Aligned_cols=128  Identities=21%  Similarity=0.322  Sum_probs=104.9

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCC----CEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~----~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      ..|.+.++||+|+||.||+|.+..++    ..||||.+....     ..+.+|+.+|+.|+|||||++++++....    
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~----   82 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK----   82 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC----
Confidence            35999999999999999999987654    469999985432     23458999999999999999999985433    


Q ss_pred             eEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       .+++||||+.++++...  .......+++..+..++.||+.||.|||+ ++||||||||+||||
T Consensus        83 -~~~~v~e~~~~~~l~~~--~~~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl  143 (283)
T d1mqba_          83 -PMMIITEYMENGALDKF--LREKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILV  143 (283)
T ss_dssp             -SEEEEEECCTTEEHHHH--HHHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             -ceEEEEEecccCcchhh--hhcccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEE
Confidence             38999999997655422  22334679999999999999999999998 999999999999996

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=4.2e-28  Score=208.59  Aligned_cols=128  Identities=23%  Similarity=0.362  Sum_probs=107.6

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec--cchhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      ++|++.+.||+|+||+||+|++..+|+.||||++..  ......+|+++++.+.|+|+|.++..+...    ....++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEEE
Confidence            369999999999999999999999999999998754  334567899999999988777665554332    33588999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ||+++++...+..   ....+++..+..++.|++.||+|||+ ++||||||||+|||+
T Consensus        83 e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~  136 (299)
T d1ckia_          83 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLM  136 (299)
T ss_dssp             ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             EEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccc
Confidence            9999988764432   35679999999999999999999998 999999999999974

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.3e-28  Score=208.97  Aligned_cols=130  Identities=24%  Similarity=0.300  Sum_probs=106.2

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL  210 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  210 (272)
                      ....+|++.+.||+|+||+||+|.+..+ +.||||++...   ...+.+|+.+|+.++|||||+++++|. ...     +
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~-----~   86 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEP-----I   86 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS-----C
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCC-----e
Confidence            3446799999999999999999998655 56999998643   345668999999999999999999873 221     6


Q ss_pred             EEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       211 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |+||||+.++.+..+.. ......+++..++.|+.||+.||.|||+ ++|+||||||+||||
T Consensus        87 ~lv~Ey~~~g~l~~~~~-~~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll  146 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILV  146 (285)
T ss_dssp             EEEECCCTTCBHHHHHS-HHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             EEEEEecCCCchhhhhh-hcccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEE
Confidence            89999999664432222 1223468999999999999999999998 899999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.9e-28  Score=207.05  Aligned_cols=129  Identities=27%  Similarity=0.353  Sum_probs=104.6

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCC---CEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|.+++.||+|+||.||+|.+..++   ..||||.+...     ...+.+|+.+|+.++|||||+++++|..     
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----   79 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----   79 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            3457999999999999999999987543   46899988532     2234589999999999999999998731     


Q ss_pred             ceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                       ..+|+||||+.++.+..+  .......+++..++.++.||+.||.|||+ ++||||||||+|||+
T Consensus        80 -~~~~iv~E~~~~g~l~~~--~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll  141 (273)
T d1mp8a_          80 -NPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLV  141 (273)
T ss_dssp             -SSCEEEEECCTTEEHHHH--HHHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             -CeEEEEEEeccCCcHHhh--hhccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheee
Confidence             127899999996544322  12335578999999999999999999998 999999999999985

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.9e-28  Score=208.67  Aligned_cols=126  Identities=23%  Similarity=0.468  Sum_probs=101.3

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCC----EEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCc
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  207 (272)
                      .+|+++++||+|+||+||+|.+..+|+    .||+|.+...     .+.+.+|+.+|+.++|||||+++++|....    
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~----   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST----   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----
Confidence            469999999999999999999988876    5788877432     234568999999999999999999985322    


Q ss_pred             eEEEEEeeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          208 LYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       208 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        .+++|||+. ++++..+.   .....+++..++.|+.||+.||.|||+ ++||||||||+||||
T Consensus        85 --~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll  144 (317)
T d1xkka_          85 --VQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLV  144 (317)
T ss_dssp             --EEEEEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             --eeEEEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhccee
Confidence              556677666 66665433   335679999999999999999999998 999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.4e-28  Score=206.49  Aligned_cols=130  Identities=23%  Similarity=0.353  Sum_probs=106.9

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc--chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ....+|++++.||+|+||.||+|.+  .|..||||.++.+  ...+.+|+++|+.++||||++++++|....    ..+|
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~   77 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   77 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEE
Confidence            4456799999999999999999998  5788999999654  345668999999999999999999875432    2279


Q ss_pred             EEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||||+++ ++.+++...  ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus        78 lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~  136 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLV  136 (262)
T ss_dssp             EEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhhee
Confidence            99999985 555544322  12358899999999999999999998 999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.95  E-value=8.6e-28  Score=206.23  Aligned_cols=127  Identities=24%  Similarity=0.359  Sum_probs=109.6

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeec--cchhHHHHHHHHHHcCC-CCeeecceeeeecccCCceEEEEE
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLV  213 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~--~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~~~~lv  213 (272)
                      ++|++++.||+|+||+||+|++..+|+.||||++..  ......+|+++++.|.| +||+.+++++.     ...+.|+|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccEEE
Confidence            469999999999999999999999999999998754  34456789999999986 89999988873     33458999


Q ss_pred             eecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       214 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      |||+++++..++..   ....+++..+..++.|++.||+|||+ +|||||||||+||||
T Consensus        80 me~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili  134 (293)
T d1csna_          80 IDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLI  134 (293)
T ss_dssp             EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEE
T ss_pred             EEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceee
Confidence            99999888776543   24568999999999999999999998 999999999999985

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.7e-27  Score=206.04  Aligned_cols=133  Identities=20%  Similarity=0.310  Sum_probs=106.1

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEEC-----CCCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeec
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST  202 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  202 (272)
                      ....+|.+.++||+|+||.||+|++.     .+++.||||++....     ..+.+|+.+++.+ +|||||++++++...
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            33467999999999999999999863     456789999986432     2345799999999 699999999998433


Q ss_pred             ccCCceEEEEEeeccccc-HHHHHHHhh--------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 024091          203 TEKDELYLNLVLEYISET-VYRVSKHYT--------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP  267 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~--------------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp  267 (272)
                           ..+|||||||+++ +..++....              .....+++..+..|+.||+.||.|||+ ++||||||||
T Consensus       100 -----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp  173 (311)
T d1t46a_         100 -----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAA  173 (311)
T ss_dssp             -----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSG
T ss_pred             -----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccc
Confidence                 3389999999954 444443321              123358899999999999999999998 9999999999


Q ss_pred             CCeeC
Q 024091          268 QNLLM  272 (272)
Q Consensus       268 ~NILl  272 (272)
                      +|||+
T Consensus       174 ~NIl~  178 (311)
T d1t46a_         174 RNILL  178 (311)
T ss_dssp             GGEEE
T ss_pred             ccccc
Confidence            99985

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.9e-27  Score=205.53  Aligned_cols=132  Identities=25%  Similarity=0.434  Sum_probs=107.8

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCCCE--EEEEEeec-----cchhHHHHHHHHHHc-CCCCeeecceeeeecccCC
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQ-----DKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--vAvK~i~~-----~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  206 (272)
                      ...+|++.++||+|+||.||+|++..++..  ||||.+..     ....+.+|+++|+.+ +|||||+++++|....   
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~---   84 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG---   84 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT---
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC---
Confidence            345799999999999999999999888764  67787643     233456899999998 6999999999985443   


Q ss_pred             ceEEEEEeeccc-ccHHHHHHHh------------hhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYIS-ETVYRVSKHY------------TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~-~~l~~~~~~~------------~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        .+||||||++ |++.+++...            ......+++..+..++.||+.||.|||+ ++||||||||+|||+
T Consensus        85 --~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~  160 (309)
T d1fvra_          85 --YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV  160 (309)
T ss_dssp             --EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             --eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEE
Confidence              4999999999 5555554322            1234679999999999999999999998 999999999999985

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.6e-27  Score=205.03  Aligned_cols=132  Identities=22%  Similarity=0.367  Sum_probs=100.0

Q ss_pred             cccCeeeeEEeccCCceEEEEEEECCCC-------CEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeee
Q 024091          135 QTISYMAERVVGTGSFGVVFQAKCLETG-------DSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS  201 (272)
Q Consensus       135 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-------~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~  201 (272)
                      ...+|.+++.||+|+||.||+|++..++       ..||||.+..+.     ....+|...+..+ +|||||+++++|..
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            3457999999999999999999986554       379999986543     2334688888888 79999999999843


Q ss_pred             cccCCceEEEEEeecccc-cHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 024091          202 TTEKDELYLNLVLEYISE-TVYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ  268 (272)
Q Consensus       202 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~  268 (272)
                      .     ..+|+||||+.+ ++..++....            .....+++..++.++.||+.||.|||+ ++||||||||+
T Consensus        91 ~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~  164 (299)
T d1fgka_          91 D-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAAR  164 (299)
T ss_dssp             S-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred             C-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeeccc
Confidence            3     348999999995 5555443321            113468999999999999999999998 99999999999


Q ss_pred             CeeC
Q 024091          269 NLLM  272 (272)
Q Consensus       269 NILl  272 (272)
                      |||+
T Consensus       165 NiLl  168 (299)
T d1fgka_         165 NVLV  168 (299)
T ss_dssp             GEEE
T ss_pred             ceee
Confidence            9985

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-27  Score=203.64  Aligned_cols=126  Identities=26%  Similarity=0.366  Sum_probs=96.6

Q ss_pred             cCeeeeEEeccCCceEEEEEEECC-CC--CEEEEEEeecc-------chhHHHHHHHHHHcCCCCeeecceeeeecccCC
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLE-TG--DSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD  206 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~-~~--~~vAvK~i~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  206 (272)
                      .+|++.+.||+|+||.||+|++.. ++  ..||||++...       ...+.+|+.+|+.++|||||+++++|...    
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~----   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP----   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence            469999999999999999998753 33  36899987532       22346899999999999999999988422    


Q ss_pred             ceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       207 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        .+++||||+.+ ++.+.+..   ....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        84 --~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll  144 (273)
T d1u46a_          84 --PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLL  144 (273)
T ss_dssp             --SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEE
T ss_pred             --chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcc
Confidence              26899999985 54443322   24569999999999999999999998 999999999999985

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=4.2e-27  Score=202.62  Aligned_cols=131  Identities=23%  Similarity=0.312  Sum_probs=106.3

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccC
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK  205 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  205 (272)
                      .++|.+.+.||+|+||+||+|++..     +++.||||++...     ...+.+|+.+|+.++||||++++++|....  
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--   89 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK--   89 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC--
Confidence            4569999999999999999999753     5678999998643     234568999999999999999999985433  


Q ss_pred             CceEEEEEeeccc-ccHHHHHHHhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 024091          206 DELYLNLVLEYIS-ETVYRVSKHYT--------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD  264 (272)
Q Consensus       206 ~~~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrD  264 (272)
                         .++++|||+. +++.+++....                    .....+++..+..|+.||+.||.|||+ ++|||||
T Consensus        90 ---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD  165 (301)
T d1lufa_          90 ---PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD  165 (301)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred             ---ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence               3899999998 55555543211                    112347888999999999999999998 9999999


Q ss_pred             CCCCCeeC
Q 024091          265 IKPQNLLM  272 (272)
Q Consensus       265 lKp~NILl  272 (272)
                      |||+||||
T Consensus       166 lKp~NILl  173 (301)
T d1lufa_         166 LATRNCLV  173 (301)
T ss_dssp             CSGGGEEE
T ss_pred             EcccceEE
Confidence            99999996

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.2e-26  Score=199.38  Aligned_cols=132  Identities=22%  Similarity=0.357  Sum_probs=100.6

Q ss_pred             ccCeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeeccc-----hhHHHHHHHHHHc-CCCCeeecceeeeeccc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE  204 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  204 (272)
                      ..+|.+++.||+|+||.||+|.+..     +++.||||++....     ....+|+.++..+ +|+||+.+++++.... 
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-   90 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-   90 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC-
Confidence            3579999999999999999999754     34689999986432     2234567777666 6899999988875433 


Q ss_pred             CCceEEEEEeeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCee
Q 024091          205 KDELYLNLVLEYIS-ETVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL  271 (272)
Q Consensus       205 ~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NIL  271 (272)
                         ..+++|||||+ |++..++.....            ....+++..+..|+.||+.||.|||+ ++||||||||+|||
T Consensus        91 ---~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NIL  166 (299)
T d1ywna1          91 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  166 (299)
T ss_dssp             ---SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEE
T ss_pred             ---CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCcccee
Confidence               23899999999 555555543221            13458899999999999999999998 99999999999998


Q ss_pred             C
Q 024091          272 M  272 (272)
Q Consensus       272 l  272 (272)
                      |
T Consensus       167 l  167 (299)
T d1ywna1         167 L  167 (299)
T ss_dssp             E
T ss_pred             E
Confidence            6

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.1e-27  Score=205.35  Aligned_cols=127  Identities=30%  Similarity=0.497  Sum_probs=105.0

Q ss_pred             ccCeeeeEEeccCCceEEEEEEEC---CCCCEEEEEEeecc--------chhHHHHHHHHHHcCC-CCeeecceeeeecc
Q 024091          136 TISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLLNH-PNVVSLKHCFFSTT  203 (272)
Q Consensus       136 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAvK~i~~~--------~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~  203 (272)
                      ..+|.+++.||+|+||+||+|.+.   .+|+.||||++...        .....+|+++|+.++| |||++++++|.   
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---   99 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---   99 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec---
Confidence            357999999999999999999984   46899999988532        2234579999999977 89999999883   


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                        +..+++++|||+.+ ++...+..    ...+++..++.++.||+.||.|||+ ++||||||||+||||
T Consensus       100 --~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill  162 (322)
T d1vzoa_         100 --TETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILL  162 (322)
T ss_dssp             --ETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEE
T ss_pred             --cCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceee
Confidence              34459999999995 44443332    3467889999999999999999998 899999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.2e-26  Score=199.02  Aligned_cols=126  Identities=22%  Similarity=0.309  Sum_probs=100.3

Q ss_pred             eeeEEeccCCceEEEEEEECCCC---CEEEEEEeecc-----chhHHHHHHHHHHcCCCCeeecceeeeecccCCceEEE
Q 024091          140 MAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       140 ~~~~~lG~G~fg~V~~~~~~~~~---~~vAvK~i~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  211 (272)
                      ...++||+|+||+||+|++..++   ..||||.+...     ...+.+|+++|++|+|||||++++++....    ..++
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~  105 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPL  105 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceE
Confidence            34688999999999999987643   36999998532     233568999999999999999999875432    3489


Q ss_pred             EEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       212 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      +|||||.++.+..+.  ......+++..+..++.|++.||.|||+ .+|+||||||+||||
T Consensus       106 lv~E~~~~g~l~~~~--~~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl  163 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCML  163 (311)
T ss_dssp             EEEECCTTCBHHHHH--HCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             EEEEEeecCchhhhh--ccccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeE
Confidence            999999965554322  2234457788889999999999999998 999999999999996

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.4e-26  Score=199.51  Aligned_cols=127  Identities=22%  Similarity=0.329  Sum_probs=102.5

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccchh-H--HHHHHHHHHcCCCCeeecceeeeecccCCceEEEEEe
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-K--NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL  214 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~--~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  214 (272)
                      +|.+.+.||+|+||.||+|++  +|+.||||++...... .  +.|+..+..++|||||++++++.... .....+||||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence            599999999999999999987  6899999998644322 2  23555556789999999999986654 4455689999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-------cCCceecCCCCCCeeC
Q 024091          215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-------VVGVCHRDIKPQNLLM  272 (272)
Q Consensus       215 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~-------~~~iiHrDlKp~NILl  272 (272)
                      |||.+ ++..++..     ..+++.....++.|++.||.|||.       .++||||||||+||||
T Consensus        81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl  141 (303)
T d1vjya_          81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV  141 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE
T ss_pred             ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE
Confidence            99985 55554432     358899999999999999999995       1599999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3e-26  Score=197.83  Aligned_cols=133  Identities=20%  Similarity=0.240  Sum_probs=106.0

Q ss_pred             CcccCeeeeEEeccCCceEEEEEEECC-----CCCEEEEEEeeccc-----hhHHHHHHHHHHcCCCCeeecceeeeecc
Q 024091          134 KQTISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTT  203 (272)
Q Consensus       134 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  203 (272)
                      ....+|.+.+.||+|+||.||+|.+..     ++..||||++....     ..+.+|+.+|+.++|||||+++++|....
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            334579999999999999999998753     35789999986432     23458999999999999999999984333


Q ss_pred             cCCceEEEEEeecccc-cHHHHHHHhh------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          204 EKDELYLNLVLEYISE-TVYRVSKHYT------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       204 ~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                           .+++||||+.+ ++..++....      .....+++..+..++.||+.||.|||+ ++|+||||||+||||
T Consensus        97 -----~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLl  166 (308)
T d1p4oa_          97 -----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMV  166 (308)
T ss_dssp             -----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEE
T ss_pred             -----ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceee
Confidence                 38999999985 4544433211      122346888899999999999999998 999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.91  E-value=9.7e-25  Score=191.85  Aligned_cols=131  Identities=27%  Similarity=0.490  Sum_probs=102.5

Q ss_pred             cCeeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc---hhHHHHHHHHHHcC-----------CCCeeecceeeeec
Q 024091          137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN-----------HPNVVSLKHCFFST  202 (272)
Q Consensus       137 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~~  202 (272)
                      ++|+++++||+|+||+||+|++..+|+.||||++..+.   ....+|+.+|+.+.           |+||+++++++...
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            46999999999999999999999999999999997653   33457999988875           57899999887543


Q ss_pred             ccCCceEEEEEeecc--cccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          203 TEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       203 ~~~~~~~~~lv~e~~--~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      . ...  .+++|+++  .++....  ........+++..++.++.||+.||.|||+..||+||||||+||||
T Consensus        93 ~-~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll  159 (362)
T d1q8ya_          93 G-PNG--VHVVMVFEVLGENLLAL--IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM  159 (362)
T ss_dssp             E-TTE--EEEEEEECCCCEEHHHH--HHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred             c-ccc--eeeeeeecccccccccc--cccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeee
Confidence            3 222  44445544  4443332  2334456789999999999999999999964789999999999985

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=1e-22  Score=163.57  Aligned_cols=113  Identities=17%  Similarity=0.165  Sum_probs=88.9

Q ss_pred             eeeeEEeccCCceEEEEEEECCCCCEEEEEEeeccc----------------------hhHHHHHHHHHHcCCCCeeecc
Q 024091          139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------------------RYKNRELQIMRLLNHPNVVSLK  196 (272)
Q Consensus       139 y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~  196 (272)
                      +.+++.||+|+||.||+|.+. +|+.||||+++...                      ....+|...+..+.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568899999999999999874 68999999864210                      1113588899999999999877


Q ss_pred             eeeeecccCCceEEEEEeecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeeC
Q 024091          197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLM  272 (272)
Q Consensus       197 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ylH~~~~iiHrDlKp~NILl  272 (272)
                      ++.     .    .+++|||+++....          .++...+..++.|++.+|.|||+ +||+||||||+|||+
T Consensus        81 ~~~-----~----~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv  136 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLV  136 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEE
T ss_pred             Eec-----C----CEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheee
Confidence            543     2    36899999975322          13334467789999999999998 999999999999986

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.52  E-value=0.00018  Score=57.85  Aligned_cols=78  Identities=15%  Similarity=0.134  Sum_probs=50.2

Q ss_pred             CeeeeEEeccCCceEEEEEEECCCCCEEEEEEeecc----chhHHHHHHHHHHcC-CCCeeecceeeeecccCCceEEEE
Q 024091          138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL  212 (272)
Q Consensus       138 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~~----~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l  212 (272)
                      .|++.+..+-++...||+..  ..++.+.||.....    .....+|..++..|. +--+.+++.++     ......|+
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence            47766665555567899875  35677888877532    234568999988775 32244555443     22234789


Q ss_pred             EeecccccHH
Q 024091          213 VLEYISETVY  222 (272)
Q Consensus       213 v~e~~~~~l~  222 (272)
                      ||++++|..+
T Consensus        88 v~~~l~G~~~   97 (263)
T d1j7la_          88 LMSEADGVLC   97 (263)
T ss_dssp             EEECCSSEEH
T ss_pred             EEEecccccc
Confidence            9999987544

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.91  E-value=0.0012  Score=56.60  Aligned_cols=71  Identities=20%  Similarity=0.165  Sum_probs=44.2

Q ss_pred             eEEeccCCceEEEEEEECCCCCEEEEEEeec-----------cchhHHHHHHHHHHcC-C--CCeeecceeeeecccCCc
Q 024091          142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----------DKRYKNRELQIMRLLN-H--PNVVSLKHCFFSTTEKDE  207 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~~~~~vAvK~i~~-----------~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~~  207 (272)
                      .+.||.|....||+..+..+++.|.||.-..           .......|.+.|+.+. +  ..+.+++.+  ... .  
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~-~--  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE-M--  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT-T--
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC-C--
Confidence            4568999999999998777788999997532           1122346888888764 2  234455432  221 1  


Q ss_pred             eEEEEEeecccc
Q 024091          208 LYLNLVLEYISE  219 (272)
Q Consensus       208 ~~~~lv~e~~~~  219 (272)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              3589999975

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.58  E-value=0.0031  Score=49.93  Aligned_cols=71  Identities=13%  Similarity=0.070  Sum_probs=44.9

Q ss_pred             EeccCCc-eEEEEEEECCCCCEEEEEEeeccc-hhHHHHHHHHHHcCCCC--eeecceeeeecccCCceEEEEEeecccc
Q 024091          144 VVGTGSF-GVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLEYISE  219 (272)
Q Consensus       144 ~lG~G~f-g~V~~~~~~~~~~~vAvK~i~~~~-~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~~~~~~lv~e~~~~  219 (272)
                      .+..|.. ..||+... ..+..+.+|...... .....|...|+.|....  +.+++.+..     +....++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEeeec
Confidence            3444543 67898863 456678889765432 34567999998876433  345555432     22347899999975


Q ss_pred             c
Q 024091          220 T  220 (272)
Q Consensus       220 ~  220 (272)
                      .
T Consensus        91 ~   91 (255)
T d1nd4a_          91 Q   91 (255)
T ss_dssp             E
T ss_pred             c
Confidence            3

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=94.91  E-value=0.032  Score=45.90  Aligned_cols=68  Identities=15%  Similarity=0.000  Sum_probs=39.9

Q ss_pred             eEEEEEEECCCCCEEEEEEeecc---chhHHHHHHHHHHcCCCCee--ecceeeeecccCCceEEEEEeecccc
Q 024091          151 GVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVV--SLKHCFFSTTEKDELYLNLVLEYISE  219 (272)
Q Consensus       151 g~V~~~~~~~~~~~vAvK~i~~~---~~~~~~E~~~l~~l~h~nIv--~l~~~~~~~~~~~~~~~~lv~e~~~~  219 (272)
                      -.||++.. .+|..|++|+.+..   ......|.+.|..|...+|.  .....--........+.+.++++++|
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            58999874 56888999988654   34456788888887533221  11110000000123357788998875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.32  E-value=0.079  Score=44.62  Aligned_cols=69  Identities=19%  Similarity=0.229  Sum_probs=45.3

Q ss_pred             eEEeccCCceEEEEEEECC-------CCCEEEEEEeecc--chhHHHHHHHHHHcCCCCe-eecceeeeecccCCceEEE
Q 024091          142 ERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLN  211 (272)
Q Consensus       142 ~~~lG~G~fg~V~~~~~~~-------~~~~vAvK~i~~~--~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~~~~  211 (272)
                      ++.|+.|--=.+|++....       ..+.|.+++.-..  .....+|..+++.+.-.++ .+++++|     .+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence            4578888888999987643       2356777765422  2234479999988863344 4666665     32    4


Q ss_pred             EEeecccc
Q 024091          212 LVLEYISE  219 (272)
Q Consensus       212 lv~e~~~~  219 (272)
                      +||||+.|
T Consensus       118 ~I~efi~g  125 (395)
T d1nw1a_         118 RLEEYIPS  125 (395)
T ss_dssp             EEECCCCE
T ss_pred             eEEEEecc
Confidence            78999875